data_1zit_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zit _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 12.5 mmtm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.83 0.348 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.62 127.74 14.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 61.3 t -126.15 163.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 55.4 tp -121.28 134.95 55.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.015 0.436 . . . . 0.0 111.671 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' THR . 12.8 t -119.41 128.23 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.127 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 11.9 t -119.56 125.82 74.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.993 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.0 t0 -162.1 145.86 12.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.653 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.32 51.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.871 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 12.4 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.072 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 53.3 p . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.899 0.381 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.87 133.18 22.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 m 78.77 -14.31 0.88 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.653 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.468 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -76.77 -54.79 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.942 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.41 -64.27 0.76 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.519 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.98 -40.76 31.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.197 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.406 HD12 ' CG2' ' A' ' 106' ' ' VAL . 56.0 mt -63.14 -67.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.218 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -49.44 -31.14 9.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 110.851 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.61 -27.47 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.879 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.47 -34.91 27.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.317 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -80.38 -36.28 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.051 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.4 49.76 2.52 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.066 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 3.8 m-85 -103.8 -174.61 2.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.326 0.584 . . . . 0.0 111.429 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.13 77.13 76.95 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.938 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 97.3 Cg_endo -85.79 142.78 8.03 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.836 2.358 . . . . 0.0 113.851 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 8.6 t0 -123.67 120.33 32.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.145 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 47.5 p -100.81 139.86 35.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.11 0.481 . . . . 0.0 112.011 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.48 -164.37 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.228 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 2.4 mttt -134.65 -7.67 2.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.36 -172.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 0.0 110.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.471 HD22 ' CD2' ' A' ' 63' ' ' PHE . 96.3 mt -78.64 -28.73 45.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.473 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.49 -41.64 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -34.0 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.233 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.51 -52.39 13.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 42' ' ' LYS . 41.3 mt-10 -46.38 -45.08 17.58 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.525 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -53.35 58.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -61.86 -23.9 66.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.075 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.5 mt -95.82 -14.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.688 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 1.2 tmtt? -78.83 -5.32 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.645 0.26 . . . . 0.0 111.48 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -136.96 -49.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.382 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.32 116.29 16.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.783 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -74.75 64.12 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.518 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 22.9 m-85 -58.35 122.08 56.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.087 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 10.8 Cg_exo -66.1 -50.05 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.468 2.112 . . . . 0.0 112.277 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.467 ' CG2' ' CE1' ' A' ' 117' ' ' PHE . 35.8 t -116.85 127.11 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.671 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 14.6 mm -113.81 127.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.273 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.431 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 84.7 t -124.3 105.93 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 52' ' ' ASP . 4.9 tp -93.52 145.36 24.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.711 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 2.7 t70 -110.33 178.66 4.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.115 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 53' ' ' VAL . 4.8 m -149.52 42.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.155 0.502 . . . . 0.0 111.527 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.401 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 57.6 t-105 -49.9 -90.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 25.6 ttp -149.6 50.84 0.83 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.312 . . . . 0.0 111.072 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 55' ' ' MET . 73.0 Cg_endo -75.95 -168.29 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.487 2.125 . . . . 0.0 112.281 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -145.4 39.77 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.26 20.86 2.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.647 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.07 -159.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.612 0.244 . . . . 0.0 110.488 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.11 -39.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.641 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.453 HG21 ' HG2' ' A' ' 90' ' ' LYS . 40.3 t -56.85 -42.1 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.059 0.457 . . . . 0.0 110.756 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -20.24 64.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.674 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.471 ' CD2' HD22 ' A' ' 34' ' ' LEU . 36.0 t80 -80.53 -33.32 36.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 61' ' ' VAL . 4.6 mm -47.03 -29.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.81 0.338 . . . . 0.0 111.154 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -75.17 -47.54 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 12.2 t80 -50.02 -42.47 49.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.451 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 4.2 mp -60.6 -44.04 95.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.351 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -80.31 -17.45 52.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.807 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 31.6 tt0 -71.4 -46.7 59.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.495 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -112.49 7.51 19.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.186 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.425 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -154.63 65.38 4.79 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 110.656 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 71' ' ' SER . 2.7 Cg_exo -74.65 -15.59 21.58 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.683 2.255 . . . . 0.0 112.103 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -97.48 -9.47 27.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.216 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t -80.36 -173.95 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.584 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.441 ' HB ' ' HA ' ' A' ' 48' ' ' VAL . 31.1 t -120.5 157.23 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.094 0.473 . . . . 0.0 111.217 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.1 t -143.19 89.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.093 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 mm -80.5 -45.35 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.413 HG12 ' CE1' ' A' ' 99' ' ' PHE . 58.5 t 54.99 101.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.791 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.412 ' CD1' ' CB ' ' A' ' 100' ' ' LEU . 7.7 mt -133.1 145.69 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.763 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.424 HG23 HG22 ' A' ' 53' ' ' VAL . 14.5 m . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.832 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.812 0.339 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.5 -12.93 62.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.5 -35.46 27.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.09 0.471 . . . . 0.0 109.798 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.09 -57.56 12.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HG2' HG21 ' A' ' 61' ' ' VAL . 12.7 ttmt -89.75 39.92 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.019 0.438 . . . . 0.0 110.554 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.24 -42.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 7.9 pt -71.25 -28.08 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.263 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.53 19.83 6.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -0.63 8.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.483 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.91 11.5 1.84 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.13 -168.67 2.18 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.252 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.408 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 17.8 t80 -116.22 27.39 9.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.344 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 79.29 141.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -67.45 129.3 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.124 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.2 OUTLIER -71.42 106.42 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 3.1 m . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.3 -47.52 79.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -34.14 77.2 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 8.3 t80 -56.75 -35.26 68.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.366 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 tt -56.85 -53.3 59.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.031 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.98 -42.61 94.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.7 m -64.83 -40.42 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.883 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.427 HG12 ' CE1' ' A' ' 109' ' ' PHE . 1.6 mm -44.11 -52.68 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.785 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.55 -56.8 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.321 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -60.48 -32.47 71.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.57 -39.04 82.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.467 ' CE1' ' CG2' ' A' ' 48' ' ' VAL . 39.2 m-85 -77.78 -13.2 59.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.43 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 120.798 0.332 . . . . 0.0 111.248 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 32.3 mmtp . . . . . 0 C--O 1.225 -0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 3.5 mpt_? 64.64 108.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 17.8 t -123.22 159.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.911 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.44 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 42.9 tp -115.43 135.17 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.847 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 30' ' ' THR . 17.2 t -117.53 89.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.696 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.47 107.55 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -143.17 140.73 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 111.301 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 34.9 t0 -64.04 -70.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.974 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.716 0.293 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.34 -43.01 67.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.2 p -101.81 -53.2 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.328 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' CD1' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -47.84 -51.84 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.081 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 m -50.68 -46.61 58.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.773 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.07 91.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.777 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 mt -55.99 -59.92 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.532 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -46.9 -40.23 13.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.854 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.22 -27.96 69.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.987 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -80.09 -34.73 37.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.982 0.42 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -76.71 -24.73 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 28.38 6.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.416 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 59.9 m-85 -98.93 -175.86 3.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -134.56 90.0 24.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 74.4 Cg_endo -78.8 132.64 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.432 2.088 . . . . 0.0 112.873 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -108.78 6.0 25.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.235 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.524 ' O ' ' O ' ' A' ' 29' ' ' ASP . 14.3 p 4.33 122.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.83 -164.17 1.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.925 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' ASP . 13.2 tttt -115.1 -40.08 3.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 p -159.23 -173.95 4.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.466 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -65.64 -45.34 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.617 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -61.67 -48.65 79.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.074 0.464 . . . . 0.0 109.749 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.06 -32.22 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.01 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.77 66.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.699 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 17.6 mt-10 -68.58 -44.27 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -36.28 78.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.106 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -74.12 -43.03 59.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 mt -73.61 -24.17 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -51.58 -25.89 7.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.277 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -124.37 -58.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.096 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.75 123.64 18.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.04 79.93 8.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 29' ' ' ASP . 33.0 m-85 -73.94 116.34 51.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.025 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.519 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 74.0 Cg_endo -73.2 -16.16 25.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.524 2.149 . . . . 0.0 111.816 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.407 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.5 t -147.23 132.29 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.2 mm -118.18 159.96 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.11 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.1 t -147.97 97.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.252 0.548 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.39 130.03 34.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.468 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.62 89.71 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.033 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.8 m -67.31 66.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.875 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 69.3 t-105 -69.86 -96.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.195 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.604 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -134.66 32.16 0.21 Allowed Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.8 Cg_endo -81.97 -165.18 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.106 1.871 . . . . 0.0 112.236 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -116.29 28.54 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.866 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.07 -99.49 0.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.499 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 56.91 46.39 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.773 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.93 103.81 2.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.1 t -61.07 -40.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 0.0 110.828 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -13.01 61.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.362 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 34' ' ' LEU . 35.6 t80 -54.3 -39.23 66.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 111.265 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 91' ' ' ALA . 3.5 mt -50.01 -29.8 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' GLU . 1.5 t0 -75.81 -34.19 60.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 51.4 t80 -59.56 -47.48 85.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.015 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.408 HD13 ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -58.34 -43.7 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.398 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -77.03 -22.85 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.699 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 65' ' ' ASP . 42.3 tt0 -65.0 -34.23 77.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -129.55 18.65 5.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.853 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.91 75.6 0.66 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.2 -8.08 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.162 2.575 . . . . 0.0 112.733 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -107.31 12.96 27.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.459 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.23 -160.15 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.98 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -148.94 134.42 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 111.47 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 23.9 t -115.01 109.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.575 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.47 HD11 HG23 ' A' ' 77' ' ' ILE . 31.7 mm -90.36 -51.06 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.956 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 99' ' ' PHE . 30.1 t 54.21 97.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.427 HD11 ' CE2' ' A' ' 109' ' ' PHE . 1.7 mt -102.68 -170.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.315 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.416 ' H ' ' CG2' ' A' ' 79' ' ' ILE . 2.8 m . . . . . 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.342 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.609 0.242 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.3 -1.88 28.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.326 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.59 -37.06 14.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.456 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -58.55 -57.44 12.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.159 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.9 m -58.27 -29.27 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.314 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -76.86 -14.96 59.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.378 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -112.91 -44.8 3.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 111.528 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 2.2 pt -67.6 169.84 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.038 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.8 mttp 74.31 -44.01 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -16.44 63.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.077 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.95 -29.43 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.26 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -59.56 -178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.421 . . . . 0.0 111.11 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 85.0 t80 -115.67 27.49 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.904 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 86.65 157.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.376 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -86.16 100.27 12.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.024 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 39.2 tp -70.47 131.47 44.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.008 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.352 179.617 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.513 0.196 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -45.8 -34.6 3.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -38.96 62.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.153 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.447 ' CE1' ' CG1' ' A' ' 113' ' ' ILE . 4.2 t80 -55.61 -28.64 56.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.41 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.87 -39.57 19.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.4 mp -57.97 -58.06 10.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.874 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.3 m -45.95 -43.65 14.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.447 ' CG1' ' CE1' ' A' ' 109' ' ' PHE . 18.6 mm -53.66 -66.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 110.382 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -16.21 5.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.979 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -90.19 -26.53 20.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 110.518 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.59 -40.83 40.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.018 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 38.0 m-85 -76.35 -19.03 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.699 -179.864 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 1.4 mptp? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.795 0.331 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.415 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -145.49 133.57 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 20.8 t -126.2 160.66 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.435 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 40.9 tp -118.8 136.34 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.808 0.337 . . . . 0.0 110.996 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.425 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 13.7 t -117.35 90.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.89 104.86 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.842 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -140.32 137.99 34.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -88.76 48.83 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.841 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.628 0.252 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -90.04 -26.42 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.731 0.3 . . . . 0.0 111.231 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.24 -63.03 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.199 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.438 ' O ' HD11 ' A' ' 21' ' ' LEU . 2.1 tm? -52.24 -50.18 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.02 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.0 t -53.09 -59.42 4.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.217 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.0 -39.51 59.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.05 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 20' ' ' ILE . 8.9 mt -57.41 -58.3 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -47.9 -39.61 19.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.408 . . . . 0.0 110.78 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.59 -28.34 68.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.6 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.37 -34.47 31.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.233 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HG3' ' CD2' ' A' ' 110' ' ' LEU . 15.8 mm-40 -76.49 -70.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 149.23 57.45 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 81.0 m-85 -129.84 -169.31 2.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.53 88.04 20.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.967 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HB3' ' CD1' ' A' ' 21' ' ' LEU . 66.6 Cg_endo -78.81 132.6 10.85 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.419 2.079 . . . . 0.0 113.148 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 30' ' ' THR . 17.5 t70 -111.56 8.43 20.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.221 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.507 ' O ' ' O ' ' A' ' 29' ' ' ASP . 5.9 p 0.83 123.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 -165.69 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.702 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -116.61 -33.52 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.03 175.23 12.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.612 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.417 HD21 ' CD2' ' A' ' 63' ' ' PHE . 54.3 mt -55.56 -33.41 63.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.757 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -48.13 76.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.506 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.838 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.32 -36.02 63.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 83.6 mt-10 -68.48 -40.81 80.81 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.06 -35.09 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.9 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -76.65 -44.72 32.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.721 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.96 -26.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.18 -25.79 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.427 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -125.67 -45.58 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.012 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -74.66 135.06 41.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -92.25 95.47 9.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 75.8 m-85 -91.98 113.4 58.85 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.8 Cg_endo -73.43 -16.5 24.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.387 2.058 . . . . 0.0 111.886 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.406 HG23 ' CE2' ' A' ' 117' ' ' PHE . 3.8 t -148.43 131.61 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.47 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.3 mm -119.16 162.65 17.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.5 t -149.85 98.42 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.178 0.514 . . . . 0.0 111.454 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.405 ' HB3' HG11 ' A' ' 78' ' ' VAL . 37.7 tp -81.73 148.87 28.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 53' ' ' VAL . 8.0 t70 -107.84 -19.92 13.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.484 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 52' ' ' ASP . 2.4 m 45.93 32.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -56.6 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.676 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.564 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 13.3 mtp -152.54 57.52 2.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.964 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.9 Cg_endo -86.3 -156.38 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.061 2.507 . . . . 0.0 112.199 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -157.39 37.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.94 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -127.98 -0.69 6.48 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.065 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 58.4 105.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.18 -0.8 87.04 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.142 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.25 -66.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 120.898 0.38 . . . . 0.0 111.161 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -67.09 -14.33 62.8 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.417 ' CD2' HD21 ' A' ' 34' ' ' LEU . 21.4 t80 -63.4 -38.92 93.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.407 HD11 ' CB ' ' A' ' 91' ' ' ALA . 3.1 mt -48.35 -33.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.5 t70 -70.03 -32.8 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.29 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 6.9 t80 -62.33 -43.96 97.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.7 mp -59.57 -44.64 93.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.41 -21.31 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.563 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' ASP . 37.4 tt0 -67.0 -31.77 72.55 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -134.05 18.63 3.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.044 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.86 70.06 0.88 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.24 -19.37 38.71 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.721 2.281 . . . . 0.0 112.241 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.22 29.14 3.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.978 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 48.0 t -110.87 -163.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.9 t -154.55 136.2 5.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 120.836 0.351 . . . . 0.0 111.399 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.0 t -115.43 109.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.412 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -83.27 -59.68 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.913 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.45 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 55.7 t 55.48 89.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.436 HG22 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -96.21 -152.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.401 ' CB ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.809 0.338 . . . . 0.0 110.976 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.562 0.22 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.52 -8.97 57.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.79 -39.29 13.21 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.437 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -56.42 -57.99 9.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.3 m -55.19 -31.1 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.772 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -5.38 48.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' CB ' HD11 ' A' ' 64' ' ' ILE . . . -119.91 -38.12 3.0 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 89' ' ' VAL . 9.1 pt -73.93 -34.52 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.435 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -65.34 -18.12 65.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.935 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -85.89 -56.27 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.045 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.29 32.03 0.05 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.043 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.477 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.27 -162.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.329 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.437 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 81.3 t80 -111.98 23.32 13.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER 83.89 20.33 0.17 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.95 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CE1' ' CG1' ' A' ' 78' ' ' VAL . 0.2 OUTLIER 58.43 163.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 0.0 111.453 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.436 ' HB3' HG22 ' A' ' 79' ' ' ILE . 1.8 tm? -116.02 81.23 1.57 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.222 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.415 ' CG2' HD22 ' A' ' 17' ' ' LEU . 11.4 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.657 0.265 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -40.62 -40.57 1.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.913 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -39.3 74.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.765 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.23 -30.04 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -50.76 -34.92 29.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.8 -51.65 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.313 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.412 HG22 ' CE2' ' A' ' 97' ' ' TYR . 87.9 m -51.51 -39.2 57.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.997 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.6 mm -53.58 -65.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.981 0.419 . . . . 0.0 110.132 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -13.45 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.716 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -90.49 -25.49 20.26 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 110.065 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.94 -47.37 13.78 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.406 ' CE2' HG23 ' A' ' 48' ' ' VAL . 34.2 m-85 -57.93 -21.8 45.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.195 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.185 -179.93 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 23.8 mmtt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.804 0.335 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.67 135.41 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.411 HG21 ' CE1' ' A' ' 117' ' ' PHE . 17.4 t -127.12 143.92 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.824 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 29' ' ' ASP . 15.1 tp -99.99 125.33 46.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.11 88.78 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.07 103.47 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -137.08 138.8 40.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.43 38.5 1.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 17.0 tp10 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.64 0.257 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.1 t -90.14 23.16 2.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.524 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.9 t -163.27 -53.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.583 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' A' ' 21' ' ' LEU . 1.6 tm? -57.88 -50.97 71.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.572 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.99 -51.52 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.336 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.54 70.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.538 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.16 -66.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.678 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.2 mt -49.7 -31.42 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.469 . . . . 0.0 110.369 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.42 -30.63 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.57 -34.89 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.037 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -75.08 -12.09 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.207 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 53.36 1.08 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.197 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 64.5 m-85 -126.38 -176.33 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 111.108 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.48 71.95 51.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.34 138.66 82.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.776 2.318 . . . . 0.0 112.645 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.9 t70 -121.04 4.59 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 29' ' ' ASP . 12.8 p 3.38 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 -163.21 0.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.391 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -118.85 -28.26 5.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.278 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.48 -170.12 2.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.806 0.336 . . . . 0.0 110.806 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 HD22 ' CG ' ' A' ' 63' ' ' PHE . 47.0 mt -68.41 -45.87 71.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -48.56 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.67 -30.19 69.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.491 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.29 -25.32 54.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 45.7 mt-10 -75.56 -36.27 60.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -37.33 77.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.58 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -71.82 -37.48 70.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.542 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 mt -85.76 -16.86 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.387 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -52.59 -22.19 4.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.619 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -133.3 -51.66 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.824 0.345 . . . . 0.0 111.154 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 118.71 5.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -73.96 72.26 1.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 38.8 m-85 -66.41 111.24 6.23 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.476 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.42 -20.67 18.09 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.628 2.219 . . . . 0.0 112.207 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 3.4 t -144.0 130.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.295 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 mm -117.7 156.99 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.407 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.15 102.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 tp -86.12 84.72 7.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.976 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.49 77.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.66 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 3.2 p -59.33 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.599 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.437 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 44.5 t-105 -74.46 -82.78 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.097 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.521 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.39 45.45 0.35 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.313 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 55' ' ' MET . 82.3 Cg_endo -85.12 -165.54 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.442 2.095 . . . . 0.0 112.261 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -154.55 48.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.949 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.0 -16.67 6.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.85 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 62.58 104.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.791 0.329 . . . . 0.0 110.733 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.06 18.57 57.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.895 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 t -58.98 -58.36 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.879 0.371 . . . . 0.0 111.098 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.05 -4.79 43.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.745 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CG ' HD22 ' A' ' 34' ' ' LEU . 26.7 t80 -69.15 -39.99 78.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.618 0.247 . . . . 0.0 111.496 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.402 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.3 mp -46.89 -33.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.766 0.317 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -70.04 -34.75 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 75.0 t80 -63.06 -39.92 96.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 63' ' ' PHE . 3.7 mp -62.77 -47.12 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.909 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -75.41 -18.95 59.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 36.6 tt0 -69.45 -42.75 74.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.718 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -120.75 18.36 11.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.054 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.85 67.11 1.09 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.81 -20.29 34.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.653 2.235 . . . . 0.0 112.218 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.41 32.72 2.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 t -113.2 -157.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.2 t -155.37 137.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 111.505 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.8 t -117.83 100.4 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.376 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mm -81.5 -55.12 8.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.739 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 99' ' ' PHE . 40.3 t 57.69 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.426 ' CG2' ' H ' ' A' ' 80' ' ' THR . 1.7 mt -114.31 -159.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.334 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.426 ' H ' ' CG2' ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.893 0.378 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.57 -22.26 28.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -79.78 -36.38 37.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.144 0.497 . . . . 0.0 109.726 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -56.1 -57.74 10.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.203 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 -26.17 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.948 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -87.93 40.54 0.95 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.625 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -170.36 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.457 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 7.4 pt -75.08 -29.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.501 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -80.08 -19.27 47.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -23.15 58.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.76 22.88 0.14 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.595 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.452 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.36 -165.15 1.28 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 117.22 0.51 . . . . 0.0 111.147 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 97' ' ' TYR . 70.3 t80 -114.11 25.14 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 79.95 139.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.473 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -57.19 130.11 44.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.26 120.3 22.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.684 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.014 -179.838 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 109' ' ' PHE . 11.7 p . . . . . 0 CA--C 1.526 0.029 0 CA-C-O 120.614 0.245 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -38.96 -44.16 1.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.635 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -64.45 -42.33 96.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 0.0 110.345 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 106' ' ' VAL . 8.8 t80 -59.51 -27.24 65.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.692 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.27 -48.15 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.404 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.9 mp -51.39 -51.52 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.227 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.91 -41.34 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.4 mm -50.35 -56.15 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.608 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -63.22 1.13 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -49.97 -32.56 15.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.776 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.35 95.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.458 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.427 ' CZ ' HG21 ' A' ' 48' ' ' VAL . 32.6 m-85 -76.13 -34.81 59.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.597 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.437 ' HB3' ' CG ' ' A' ' 26' ' ' TYR . 13.3 mmtt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.905 0.383 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.22 121.95 9.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.633 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.0 t -127.36 158.15 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 52.3 tp -117.96 141.55 48.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 111.43 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.9 t -121.24 141.65 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.158 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 14.2 t -132.84 121.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.1 t70 -159.25 159.75 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 110.621 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.53 50.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.936 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 179.765 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.431 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 30.1 p . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 16' ' ' SER . 29.6 t -54.21 132.46 43.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.955 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 15' ' ' SER . 5.7 t 83.08 -15.02 0.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.719 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.431 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -77.4 -48.49 17.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.855 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -50.7 -57.0 9.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.31 80.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.413 HD13 ' CG1' ' A' ' 106' ' ' VAL . 81.9 mt -59.91 -70.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -47.84 -31.17 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -73.79 -30.54 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.884 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.16 -35.53 25.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.89 -33.74 62.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.5 42.17 3.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.437 ' CG ' ' HB3' ' A' ' 2' ' ' LYS . 3.1 m-85 -104.12 -175.67 2.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -127.59 82.27 68.62 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.05 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.44 130.94 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 113.884 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.4 ' O ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -119.74 116.82 26.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.856 178.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -105.76 137.14 44.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 112.039 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.93 -164.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.076 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -131.59 -5.84 3.68 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.7 167.66 7.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 63' ' ' PHE . 33.8 mt -60.78 -29.6 69.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.848 0.356 . . . . 0.0 110.225 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -70.63 -45.98 64.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.722 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.66 -33.07 74.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.069 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.97 34.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.718 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' LYS . 49.8 mt-10 -46.17 -46.55 17.41 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -58.95 -54.45 47.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.51 -24.63 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.014 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.2 mt -97.07 -13.49 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.22 -9.28 58.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.587 0.232 . . . . 0.0 111.288 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.03 -62.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 113.12 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.21 68.26 0.49 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.481 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 35.2 m-85 -63.28 130.18 94.04 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 5.1 Cg_endo -80.39 -45.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.393 2.062 . . . . 0.0 111.924 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.418 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 23.9 t -117.37 123.41 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.91 128.35 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.785 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.35 106.27 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.068 0.461 . . . . 0.0 111.552 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 31.8 tp -89.07 153.84 20.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.68 109.03 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.9 t -86.75 70.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.973 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.419 ' CZ2' ' HE3' ' A' ' 55' ' ' MET . 31.1 t-105 -71.96 -80.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.485 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.612 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.97 55.0 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.96 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 55' ' ' MET . 6.9 Cg_endo -88.34 -156.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.136 2.557 . . . . 0.0 112.161 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -146.34 36.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.97 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.21 129.25 3.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.447 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.49 141.99 53.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.72 -23.06 11.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.658 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 64' ' ' ILE . 21.7 t -53.51 -46.73 60.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.572 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -75.65 -5.39 45.29 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.1 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.438 ' CD2' HD22 ' A' ' 34' ' ' LEU . 16.4 t80 -84.43 -35.72 22.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.571 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.408 HD13 ' CB ' ' A' ' 91' ' ' ALA . 2.9 mp -45.07 -29.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.466 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.613 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 9.9 t0 -72.34 -51.45 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.12 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.41 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 8.8 t80 -50.58 -41.63 54.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.942 0.401 . . . . 0.0 110.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.425 ' CD1' ' CD2' ' A' ' 63' ' ' PHE . 4.1 mp -63.6 -50.19 79.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.42 -15.79 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 110.688 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -73.42 -52.09 14.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.673 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.14 19.75 17.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.438 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -163.67 64.29 1.3 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.684 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 71' ' ' SER . 5.0 Cg_exo -76.02 -13.5 19.33 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.602 2.201 . . . . 0.0 111.99 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 25.54 11.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.083 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.5 t -108.76 -173.3 2.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.976 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 48' ' ' VAL . 21.2 t -123.9 162.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.009 0.433 . . . . 0.0 111.293 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.5 t -140.34 105.54 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.378 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 mm -107.25 41.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.434 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 58.8 t -46.23 97.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.7 mt -71.61 -101.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.455 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.416 ' OG1' ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.696 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.09 -14.0 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.33 -35.43 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 109.799 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.457 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -58.87 -57.59 12.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.172 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.2 m -59.38 -29.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -75.79 -12.9 60.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.408 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -116.57 -36.34 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 89' ' ' VAL . 1.3 pt -80.31 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.917 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.4 mptp? 73.64 -46.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.613 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -62.42 -21.92 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.786 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.15 -30.07 0.11 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.62 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -62.48 176.52 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.95 0.405 . . . . 0.0 111.331 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -104.82 27.43 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.406 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 79.64 142.67 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.855 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 1.5 m-30 -63.82 149.39 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.57 101.72 10.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.205 -179.788 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.413 ' CG1' HD13 ' A' ' 20' ' ' ILE . 8.0 p . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.673 0.273 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -37.58 87.81 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.81 -36.32 83.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.675 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -59.46 -37.04 77.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.643 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.411 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.53 -42.95 79.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.136 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.34 -47.07 76.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.408 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.7 m -66.15 -41.69 90.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 mm -45.27 -54.33 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.52 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.29 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.033 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -60.92 -30.36 70.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.989 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.37 87.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.914 0.387 . . . . 0.0 110.857 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -69.6 -15.04 63.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.345 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.77 0.319 . . . . 0.0 111.428 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.422 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.835 0.35 . . . . 0.0 111.013 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.417 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -144.98 151.04 37.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.787 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.404 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 30.3 t -133.37 143.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.711 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 46.3 tp -106.45 129.75 54.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' THR . 17.7 t -117.94 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 52' ' ' ASP . 42.9 t -81.84 119.14 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 52' ' ' ASP . 26.3 t0 -155.15 149.99 26.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 32.3 t70 -90.31 51.43 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.732 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.788 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.436 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 61.1 p . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.886 0.374 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 t -58.84 138.03 57.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.981 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.437 ' O ' HD13 ' A' ' 20' ' ' ILE . 3.1 m 75.84 -0.89 3.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.417 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -89.96 -52.67 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.347 . . . . 0.0 110.804 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.85 -58.59 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.024 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.22 48.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.011 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 16' ' ' SER . 62.1 mt -68.18 -71.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.331 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.414 ' CD2' ' HB3' ' A' ' 28' ' ' PRO . 1.1 mt -49.59 -29.72 7.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -74.32 -27.02 60.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.654 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.28 -35.07 28.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -81.17 -34.62 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.045 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.19 53.27 1.91 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.227 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' CE2' ' CG2' ' A' ' 113' ' ' ILE . 7.8 m-85 -112.03 -175.69 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.357 0.599 . . . . 0.0 111.259 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 82.03 31.23 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.816 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HB3' ' CD2' ' A' ' 21' ' ' LEU . 78.2 Cg_endo -82.06 128.02 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.752 2.301 . . . . 0.0 113.926 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.67 114.23 20.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 20.3 p -95.46 128.83 42.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.009 0.433 . . . . 0.0 111.648 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.96 163.35 12.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.39 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -111.93 -9.15 14.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.61 152.71 3.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.2 mt -52.16 -26.64 11.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.55 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -43.45 59.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.986 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.24 -48.83 31.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 66' ' ' PHE . 4.8 tt0 -47.11 -47.39 23.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.33 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -55.39 35.64 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -58.23 -26.33 62.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.5 mt -90.16 -13.27 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.32 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -97.53 20.71 11.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -140.89 -52.65 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' CD2' ' CG ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -98.83 155.51 17.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.379 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.409 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 52.5 t80 -88.67 78.23 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.047 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.475 ' CG ' ' CD2' ' A' ' 44' ' ' LEU . 16.1 m-85 -66.49 120.39 70.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.7 Cg_endo -80.63 -47.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.311 2.007 . . . . 0.0 111.889 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' CG2' ' CE1' ' A' ' 117' ' ' PHE . 36.6 t -115.06 124.9 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.577 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 29.2 mm -112.82 124.48 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.51 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.427 HG13 ' CZ ' ' A' ' 109' ' ' PHE . 46.4 t -128.12 108.58 18.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 112.051 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 52' ' ' ASP . 49.7 tp -82.76 157.76 23.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.408 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -140.17 89.93 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.41 ' N ' ' HB ' ' A' ' 80' ' ' THR . 39.3 t -67.71 66.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.154 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -77.94 -80.51 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.561 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.65 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.8 ttm -146.0 50.46 1.05 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.029 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.65 ' HD3' ' N ' ' A' ' 55' ' ' MET . 58.0 Cg_endo -92.66 -165.92 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.96 2.44 . . . . 0.0 112.377 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.01 30.6 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.82 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.67 -73.54 0.89 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.562 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 31.2 20.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.17 91.33 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.813 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.69 -39.78 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.836 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -15.51 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.348 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 45.9 t80 -53.26 -47.12 69.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.8 mt -46.62 -29.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -65.72 -49.67 67.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.418 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.455 ' CE2' ' HG3' ' A' ' 38' ' ' GLU . 2.0 t80 -53.92 -41.4 67.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.95 0.405 . . . . 0.0 110.138 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -62.47 -43.89 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 -17.35 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.041 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 65' ' ' ASP . 4.0 tt0 -72.07 -45.5 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.45 8.06 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.198 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.439 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -155.54 63.95 3.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.877 0.37 . . . . 0.0 110.57 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 71' ' ' SER . 15.0 Cg_exo -67.86 -20.87 45.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.548 2.165 . . . . 0.0 112.082 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.48 23.03 7.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.869 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.7 t -104.81 -176.98 3.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.643 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 47' ' ' PRO . 31.0 t -123.36 157.23 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.068 0.461 . . . . 0.0 111.257 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -146.2 104.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.134 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.3 mm -90.11 -42.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.407 ' O ' ' CE1' ' A' ' 99' ' ' PHE . 47.2 t 45.97 88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.351 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -104.28 -177.74 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.503 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.41 ' HB ' ' N ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.594 0.235 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.24 -17.07 62.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.344 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -74.25 -35.23 63.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 0.0 109.944 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.87 -58.78 6.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.044 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 92' ' ' ILE . 21.3 m -60.25 -25.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.101 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -76.22 -17.27 59.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.78 -39.67 4.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.463 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 2.8 pt -72.76 -22.73 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.689 0.28 . . . . 0.0 111.53 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -68.72 -30.65 69.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.385 . . . . 0.0 110.41 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -64.76 -57.07 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 34.75 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.29 -167.77 1.93 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.158 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 75.2 t80 -107.64 -17.97 13.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.45 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 4.6 pt-20 145.17 -173.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.504 0.721 . . . . 0.0 110.066 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.474 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -121.45 94.24 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.436 ' HB3' HG21 ' A' ' 79' ' ' ILE . 11.7 tp -54.15 140.74 31.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.294 -179.816 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 8.1 p . . . . . 0 C--O 1.232 0.143 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -46.74 -35.87 6.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -39.53 80.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.941 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 113' ' ' ILE . 18.0 t80 -55.97 -31.46 63.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.926 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.55 -52.55 64.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.147 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -47.05 -40.87 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.499 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.7 m -64.69 -50.19 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 109' ' ' PHE . 1.4 mp -45.5 -52.95 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.922 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -59.12 4.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.0 0.429 . . . . 0.0 109.962 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -31.7 70.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.838 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.63 -28.36 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.498 ' CE1' ' CG2' ' A' ' 48' ' ' VAL . 10.7 m-85 -86.93 -56.4 3.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.529 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.442 ' HB2' ' CG ' ' A' ' 26' ' ' TYR . 13.8 mmtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.837 0.351 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.404 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.62 122.65 12.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 48.2 t -129.89 144.81 36.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.5 tp -106.67 140.1 40.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.496 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.4 ' CG2' ' CD1' ' A' ' 17' ' ' LEU . 19.2 t -118.39 127.07 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.182 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 51' ' ' LEU . 37.4 t -117.01 115.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -140.49 162.59 34.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.618 -179.256 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' HB2' ' CG ' ' A' ' 56' ' ' PRO . 17.4 t70 -63.54 -85.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.618 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.44 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 68.4 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.704 0.288 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -50.6 138.7 17.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.796 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.408 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 2.2 m 78.04 -1.98 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.283 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -90.12 -53.95 4.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.8 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.31 -60.59 2.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.36 -39.86 47.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.078 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' A' ' 16' ' ' SER . 46.3 mt -64.26 -66.61 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.159 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.417 ' CD2' ' HB3' ' A' ' 28' ' ' PRO . 0.9 OUTLIER -50.66 -28.78 9.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -72.61 -27.98 62.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.649 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -82.6 -35.01 27.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.281 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -80.99 -39.85 25.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.037 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.31 51.0 2.29 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.166 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 2' ' ' LYS . 3.4 m-30 -104.1 -174.85 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.376 0.608 . . . . 0.0 111.315 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 77.47 59.45 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.722 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 92.1 Cg_endo -86.45 154.29 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.685 2.257 . . . . 0.0 114.585 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -140.3 137.36 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.558 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.1 p -114.89 143.38 45.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.208 0.528 . . . . 0.0 112.135 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.89 -173.69 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.056 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER -117.65 -22.24 8.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.773 0.321 . . . . 0.0 111.288 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.08 167.38 16.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.379 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.427 HD22 ' CD2' ' A' ' 63' ' ' PHE . 12.1 mt -54.53 -32.51 58.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.708 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.002 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -35.42 80.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.01 -56.21 16.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 27.3 mt-10 -45.86 -42.61 12.71 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -45.89 86.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.874 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -71.73 -42.02 67.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.9 mt -71.54 -21.28 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -61.8 -20.73 63.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.125 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -126.68 -55.98 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -64.92 115.62 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -74.26 65.77 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 44' ' ' LEU . 37.8 m-85 -63.75 128.78 93.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 74' ' ' SER . 11.1 Cg_endo -82.57 -27.6 2.11 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.491 2.127 . . . . 0.0 112.125 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.6 t -130.48 139.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 2.0 mm -139.03 108.84 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.727 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.447 ' CG1' HG13 ' A' ' 79' ' ' ILE . 41.8 t -111.05 142.18 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 110.662 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 78' ' ' VAL . 20.2 tp -101.39 159.88 14.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 6.9 t70 -141.99 79.82 1.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.89 68.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.666 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.424 ' CD1' ' HE2' ' A' ' 55' ' ' MET . 31.0 t-105 -68.57 -79.62 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.923 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.745 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.2 ptt? -144.07 40.61 0.3 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.667 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.745 ' HD3' ' N ' ' A' ' 55' ' ' MET . 57.1 Cg_endo -99.45 -162.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.201 2.601 . . . . 0.0 112.198 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -91.52 -47.27 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.451 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.06 -121.65 14.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.014 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.96 31.32 18.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.04 59.65 1.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.524 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -56.39 -38.11 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.153 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.09 15.96 9.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.44 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 47.8 t80 -79.7 -38.42 33.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.81 0.338 . . . . 0.0 110.742 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.2 mp -48.58 -28.52 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.29 -37.78 60.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 19.4 t80 -57.68 -44.87 86.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.281 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.431 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 5.0 mp -59.29 -41.88 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.361 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.66 -24.85 49.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.551 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.14 -41.5 94.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.71 12.86 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 68.15 1.18 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.842 0.354 . . . . 0.0 110.668 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -67.98 -20.32 44.84 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.771 2.314 . . . . 0.0 112.138 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.6 28.73 6.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 47.5 t -112.1 -176.25 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.973 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.03 143.59 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.125 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.06 95.84 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.726 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.22 -65.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.483 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.462 ' HA ' ' HB3' ' A' ' 51' ' ' LEU . 11.3 t 67.8 88.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.447 HG13 ' CG1' ' A' ' 50' ' ' VAL . 1.8 mt -106.45 175.7 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.563 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.916 0.389 . . . . 0.0 110.892 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.878 0.371 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.5 -31.56 32.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 2.6 t -63.16 -34.48 77.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.874 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -60.13 -59.84 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.227 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.411 ' HA ' HG12 ' A' ' 92' ' ' ILE . 10.3 m -64.53 -23.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.019 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 89' ' ' VAL . 22.0 ttpt -81.25 -7.6 59.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.427 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.29 -40.13 2.41 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.428 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 3.5 pt -69.8 -40.75 79.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.288 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -56.42 -25.46 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -19.75 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.347 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.85 -3.68 3.49 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.063 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -56.52 -167.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.901 0.381 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 97' ' ' TYR . 36.8 t80 -108.53 26.05 10.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.44 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 79.66 152.65 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.203 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -74.83 103.08 4.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.948 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.405 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 11.4 tp -80.61 53.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.654 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 111.323 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' PHE . 5.4 m . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -40.95 -50.51 3.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.203 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -35.41 80.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.23 0.538 . . . . 0.0 109.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -58.3 -24.09 58.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.213 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.404 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 1.2 tt -60.27 -49.08 79.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.221 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.31 -56.15 24.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.33 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 113' ' ' ILE . 60.8 m -53.72 -57.95 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.447 HG13 ' CZ ' ' A' ' 109' ' ' PHE . 7.4 mm -31.58 -62.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.5 -59.2 3.97 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -52.67 -28.33 21.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.693 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.27 -32.66 70.57 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS . 26.6 m-85 -68.75 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.141 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.377 -179.575 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.2 mptt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.912 0.387 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.8 132.5 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 7.4 t -123.75 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.63 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.432 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 43.5 tp -103.66 132.74 49.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.403 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 34.1 t -113.26 90.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.254 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.14 104.63 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -135.32 134.39 39.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.95 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 t0 -73.29 -40.79 64.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.41 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.7 p . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 t -76.99 -65.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.44 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m -73.16 -53.43 11.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.396 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 109' ' ' PHE . 1.7 tm? -46.81 -53.94 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.246 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.3 m -52.8 -43.58 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.94 96.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.424 ' CG2' ' CD1' ' A' ' 110' ' ' LEU . 55.5 mt -56.22 -67.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.59 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.417 ' CD1' ' CD1' ' A' ' 17' ' ' LEU . 1.4 mt -47.47 -33.32 6.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 110.497 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.23 -29.96 71.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.589 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -78.51 -37.07 44.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.61 -22.27 62.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.085 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.54 58.47 0.81 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.378 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.464 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 55.7 m-85 -130.14 -177.27 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.431 . . . . 0.0 111.116 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.1 76.18 77.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.448 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 11.7 Cg_exo -67.7 137.7 42.94 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.795 2.33 . . . . 0.0 112.631 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.2 t70 -120.63 7.85 10.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 29' ' ' ASP . 13.7 p 6.04 122.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.24 -162.41 0.93 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.86 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' ASP . 1.4 ttpt -117.22 -38.46 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.9 p -161.3 -173.06 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.538 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 63' ' ' PHE . 16.5 mt -66.79 -45.75 77.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.456 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -62.85 -45.88 90.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.157 0.504 . . . . 0.0 109.937 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -32.35 71.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.93 -28.68 62.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.704 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mt-10 -69.76 -43.49 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -60.04 -39.9 87.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.66 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -70.37 -46.82 63.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.721 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mt -73.0 -20.43 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.567 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -57.98 -21.17 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.371 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -126.46 -43.73 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -77.76 122.93 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.044 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -81.05 85.25 6.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 61.1 m-85 -80.79 113.97 44.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.367 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 74' ' ' SER . 71.6 Cg_endo -74.17 -20.39 19.01 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.72 129.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.299 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 mm -117.22 157.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.251 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.9 t -149.34 102.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 110.767 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HB3' HG11 ' A' ' 78' ' ' VAL . 60.1 tp -78.42 148.17 33.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.312 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.5 OUTLIER -130.24 84.06 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.242 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.3 t -62.88 72.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.978 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 55' ' ' MET . 27.9 t90 -64.92 -97.15 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.595 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -135.99 38.58 0.39 Allowed Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 55' ' ' MET . 69.5 Cg_endo -85.33 -164.72 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.425 2.083 . . . . 0.0 112.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -143.96 41.45 1.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.5 179.9 36.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.388 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.97 77.46 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.83 -25.87 62.09 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.554 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.4 t -54.56 -44.53 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 120.756 0.312 . . . . 0.0 111.45 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.7 6.67 40.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.472 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CD2' HD22 ' A' ' 34' ' ' LEU . 34.9 t80 -90.07 -37.51 14.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.95 -28.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.359 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -77.15 -36.22 55.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.703 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 61.2 t80 -59.15 -42.83 91.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.974 0.416 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.5 mp -59.85 -43.27 91.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.317 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.25 -16.04 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.41 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 3.1 tm-20 -74.0 -34.34 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.412 . . . . 0.0 110.737 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.442 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -126.41 13.31 7.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.029 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.29 66.89 1.94 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.584 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.25 -20.9 42.48 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.655 2.237 . . . . 0.0 112.187 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -100.04 30.42 3.76 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 44.5 t -113.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.404 ' N ' ' OG ' ' A' ' 74' ' ' SER . 58.0 t -152.92 136.83 8.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 111.646 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 3.4 t -108.77 113.94 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.866 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.22 -65.33 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.423 HG12 ' CE1' ' A' ' 99' ' ' PHE . 58.0 t 52.8 97.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.134 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 mt -126.22 142.54 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.736 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.758 0.313 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -83.76 3.44 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.216 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -37.57 13.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . . . -58.28 -57.66 11.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.154 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.7 m -60.96 -25.89 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.478 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -81.22 -18.21 46.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.531 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.7 -30.12 8.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 89' ' ' VAL . 4.7 pt -82.17 -23.45 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.197 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -68.95 -35.37 76.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpm? -59.25 -27.51 65.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.888 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.82 35.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.934 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.44 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.06 -165.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.455 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 59.2 t80 -110.98 25.09 12.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.303 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.8 OUTLIER 85.37 161.9 0.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.653 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.474 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -95.36 95.07 8.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.306 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 20.2 tp -49.88 98.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.541 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 106' ' ' VAL . 7.2 p . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.76 -43.66 18.07 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -62.24 -34.83 77.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.307 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.434 ' CE2' HD21 ' A' ' 17' ' ' LEU . 1.6 t80 -63.32 -46.44 86.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.167 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.424 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -48.91 -37.26 19.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.456 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.21 -45.79 72.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.328 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.8 m -46.46 -40.79 12.92 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.399 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.429 HG22 ' CZ ' ' A' ' 26' ' ' TYR . 12.9 mm -62.32 -65.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.716 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -14.9 3.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.743 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.25 -30.92 18.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.112 0.482 . . . . 0.0 109.718 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.44 -33.94 42.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.385 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 14.8 m-85 -70.26 -29.59 66.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.815 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.52 120.26 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.609 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.404 HG21 ' CE2' ' A' ' 117' ' ' PHE . 22.9 t -116.28 159.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 49.8 tp -109.58 129.66 55.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 30' ' ' THR . 24.6 t -115.38 89.45 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.673 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.13 115.21 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.137 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -149.35 143.15 25.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.403 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -87.44 50.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.437 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.42 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 52.6 p . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.8 136.3 47.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.138 0.494 . . . . 0.0 112.028 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 74.26 0.57 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.364 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.411 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -90.05 -53.35 4.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.859 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 t -44.57 -55.56 5.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.29 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.482 HD12 HG23 ' A' ' 20' ' ' ILE . 64.6 mt -65.22 -69.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.97 -30.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.192 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.51 -30.32 67.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -34.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 110.273 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -83.41 -36.98 23.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.08 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.11 54.26 1.77 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.269 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -108.59 -173.3 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 111.241 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.42 88.8 33.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.219 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.93 130.98 7.75 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.653 2.235 . . . . 0.0 112.811 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.4 t70 -105.57 5.04 30.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.347 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 29' ' ' ASP . 10.4 p 2.14 124.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.71 -163.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.625 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -118.14 -36.45 3.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.56 179.94 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.429 HD22 ' CD2' ' A' ' 63' ' ' PHE . 56.3 mt -60.03 -47.41 85.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.92 -45.26 86.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.542 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -70.87 -32.15 69.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 40' ' ' LYS . . . -75.19 -28.97 60.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 55.4 mt-10 -72.1 -39.95 68.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -32.26 69.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.688 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' CE ' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -78.31 -37.6 44.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.773 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.97 -27.16 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -5.48 30.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.776 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.03 -27.38 10.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -134.83 156.38 49.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.44 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 69.1 t80 -91.66 96.46 10.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.947 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 38.9 m-85 -79.76 122.49 83.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.341 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.71 -20.5 7.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.511 2.141 . . . . 0.0 111.934 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -148.31 133.82 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.17 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 6.2 mm -121.01 163.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.439 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 60.1 t -154.06 99.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.408 ' HG ' ' N ' ' A' ' 52' ' ' ASP . 42.5 tp -79.6 163.3 24.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 8.7 t70 -151.17 88.84 1.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.224 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.63 66.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.652 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -58.32 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.43 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.678 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.8 OUTLIER -152.5 49.5 0.53 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.104 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.678 ' HD3' ' N ' ' A' ' 55' ' ' MET . 36.6 Cg_endo -94.53 -162.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.09 2.527 . . . . 0.0 112.293 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -152.08 43.64 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.92 -21.26 5.02 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.815 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.97 123.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.758 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.65 11.98 69.28 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.971 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.78 -41.9 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.851 0.358 . . . . 0.0 111.045 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.28 4.79 49.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.429 ' CD2' HD22 ' A' ' 34' ' ' LEU . 24.8 t80 -90.09 -36.63 14.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.285 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.2 mp -47.05 -29.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.366 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -35.35 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 29.8 t80 -59.88 -41.36 91.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.418 HD13 ' CD2' ' A' ' 63' ' ' PHE . 4.2 mp -61.57 -43.46 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.212 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -25.89 58.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.396 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -63.84 -39.98 95.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 16.38 11.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.418 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -166.56 70.13 1.09 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.817 0.341 . . . . 0.0 110.822 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.46 -18.4 29.58 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.795 2.33 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.75 27.19 9.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.989 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.7 t -104.4 -159.82 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.395 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.4 t -150.11 135.15 10.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 111.695 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 8.2 t -110.53 116.05 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.643 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 77' ' ' ILE . 16.1 mm -118.49 50.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.453 HG13 ' CE1' ' A' ' 99' ' ' PHE . 44.7 t -49.64 115.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.433 ' O ' ' CB ' ' A' ' 80' ' ' THR . 1.8 mt -110.26 179.16 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.749 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.433 ' CB ' ' O ' ' A' ' 79' ' ' ILE . 2.4 m . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.832 0.348 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -94.84 -19.88 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -34.31 23.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HB3' ' CD2' ' A' ' 99' ' ' PHE . . . -58.49 -59.38 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.846 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.8 m -55.39 -28.02 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.096 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -80.13 -9.16 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.414 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.08 -31.41 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 89' ' ' VAL . 7.3 pt -79.21 -44.72 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.738 0.304 . . . . 0.0 111.417 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -63.21 -17.93 62.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.782 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -25.87 52.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.2 -16.13 0.29 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.629 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -59.17 -179.65 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.41 0.605 . . . . 0.0 111.043 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.566 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 85.1 t80 -99.81 -7.8 24.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.785 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.566 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 17.9 pt-20 140.99 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.276 0.63 . . . . 0.0 110.663 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD2' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.41 91.11 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.751 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 14.6 tp -55.64 167.34 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 109' ' ' PHE . 7.3 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.666 0.269 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -44.96 -31.94 1.46 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.939 0.4 . . . . 0.0 110.481 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -70.17 -41.44 73.79 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 106' ' ' VAL . 3.7 t80 -55.02 -29.26 57.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.954 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.36 -39.74 73.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.764 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.21 -60.03 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 116' ' ' ALA . 80.0 m -44.12 -48.38 9.07 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.148 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.7 mm -54.76 -73.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.603 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -17.75 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -90.13 -20.81 22.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.4 -47.24 12.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 4' ' ' VAL . 57.7 m-85 -56.8 -29.86 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.103 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 179.88 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 17.1 mmtm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.919 0.39 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.9 134.65 23.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.597 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 48' ' ' VAL . 10.9 t -125.34 160.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.486 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 61.5 tp -112.93 128.59 56.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 30' ' ' THR . 44.4 t -108.47 90.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -86.89 119.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.159 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -158.93 139.67 12.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.495 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.417 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 43.4 t0 -90.24 50.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.897 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 p . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 p -63.37 140.59 58.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.9 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.4 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 2.5 m 79.37 -5.36 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.563 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.422 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.18 -49.06 6.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 110.922 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.2 p -47.68 -49.24 28.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.79 68.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 23' ' ' GLU . 91.4 mt -54.2 -69.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.162 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' CD1' ' CD1' ' A' ' 17' ' ' LEU . 1.3 mt -45.08 -33.65 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.18 -28.82 65.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -83.07 -35.65 25.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -78.21 -38.72 42.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.58 26.58 7.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.354 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 49.2 m-85 -84.25 -174.94 5.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.989 0.423 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -133.13 86.57 41.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -81.38 129.54 6.69 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.663 2.242 . . . . 0.0 112.442 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.0 t70 -106.92 -4.65 18.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 112.049 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 29' ' ' ASP . 69.2 p 43.72 174.54 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.703 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -164.01 170.43 16.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.419 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -104.76 -40.75 5.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.86 -174.49 4.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.571 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.435 HD22 ' CD2' ' A' ' 63' ' ' PHE . 45.8 mt -65.26 -41.34 94.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.708 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -61.53 -49.29 77.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 109.989 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.86 -34.85 77.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.57 -26.85 63.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 27.4 mt-10 -69.97 -46.62 64.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.873 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -62.28 -32.96 73.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.223 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -77.95 -40.36 39.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.229 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.87 -29.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 111.308 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.27 -25.84 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.358 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.79 -60.43 1.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.082 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.406 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -59.4 129.34 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.14 80.9 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 56.8 m-85 -78.77 119.2 76.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 95.8 Cg_endo -78.97 -22.11 8.96 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.512 2.141 . . . . 0.0 111.958 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' A' ' 4' ' ' VAL . 4.6 t -145.43 127.6 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.623 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mm -113.98 152.09 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.827 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.419 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 84.5 t -139.56 94.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.508 . . . . 0.0 110.682 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.6 tp -76.75 160.27 29.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.592 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -153.55 79.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.984 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.458 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 28.6 m -59.24 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.283 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.432 ' CG ' ' N ' ' A' ' 55' ' ' MET . 14.8 t90 -63.41 -90.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.642 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.5 tpt -148.5 51.68 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.87 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.642 ' HD3' ' N ' ' A' ' 55' ' ' MET . 44.5 Cg_endo -92.54 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.898 2.399 . . . . 0.0 112.676 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -170.22 -68.5 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.785 0.326 . . . . 0.0 111.296 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.36 159.35 3.99 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.97 23.72 14.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 10.24 8.81 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.779 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 64' ' ' ILE . 27.3 t -84.34 -44.39 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.512 0.656 . . . . 0.0 110.964 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -68.39 -13.52 62.35 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.856 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.435 ' CD2' HD22 ' A' ' 34' ' ' LEU . 4.7 t80 -86.88 -27.45 23.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.315 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 61' ' ' VAL . 15.2 mm -47.59 -46.05 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.0 111.204 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -42.42 93.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.523 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.441 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 26.6 t80 -58.71 -29.97 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.113 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.431 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mm -64.71 -48.44 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.491 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -82.04 -14.28 56.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.24 -39.37 68.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.917 0.389 . . . . 0.0 110.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.48 11.48 9.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -157.43 66.62 3.77 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 110.673 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.0 Cg_exo -70.17 -19.49 34.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.745 2.297 . . . . 0.0 112.207 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.39 29.74 6.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.675 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 t -111.83 -162.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.757 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' PRO . 25.8 t -151.51 134.41 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.035 0.445 . . . . 0.0 111.81 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.0 t -111.44 111.79 37.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.756 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.474 HD11 HG23 ' A' ' 77' ' ' ILE . 37.5 mm -92.83 -42.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.309 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.471 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 40.7 t 46.0 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.271 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.422 HG12 ' CB ' ' A' ' 100' ' ' LEU . 31.8 mt -56.3 -101.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.212 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.421 ' OG1' ' CE2' ' A' ' 99' ' ' PHE . 1.1 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 110.752 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.764 0.316 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.67 -60.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.729 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 5.3 t -46.09 -32.77 3.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.139 0.495 . . . . 0.0 110.305 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.49 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -57.24 -60.27 3.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.086 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 92' ' ' ILE . 28.0 m -61.88 -24.43 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.223 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -32.48 33.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.14 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.17 -34.92 14.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.48 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 92' ' ' ILE . 2.7 pt -80.3 157.19 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.781 0.324 . . . . 0.0 110.754 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 mttm 72.42 6.1 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.162 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.49 26.66 5.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 110.565 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.62 -18.82 5.97 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.402 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.415 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -84.96 -169.8 2.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 111.248 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 82.9 t80 -125.72 29.77 5.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' A' ' 92' ' ' ILE . 0.8 OUTLIER 80.95 138.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.921 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.49 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 1.6 m-85 -66.08 128.97 38.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.061 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.422 ' CB ' HG12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -71.93 118.11 14.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 7.4 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.666 0.27 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.411 ' N ' HG11 ' A' ' 106' ' ' VAL . 23.3 tt0 -45.23 -34.1 2.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.6 -39.99 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.9 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 109' ' ' PHE . 1.5 t80 -56.39 -30.45 62.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.961 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -51.81 -42.84 62.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.229 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mp -57.61 -58.76 6.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.055 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 116' ' ' ALA . 94.0 m -46.94 -41.28 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.0 mm -54.13 -68.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.313 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -15.51 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.839 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -90.27 -22.3 21.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -84.31 -37.75 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.06 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.419 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -66.84 -34.42 77.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.311 -179.832 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.432 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.944 0.402 . . . . 0.0 110.931 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.495 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -143.98 139.98 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.966 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.2 t -128.56 155.18 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.959 0.409 . . . . 0.0 111.065 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.437 ' CD1' ' O ' ' A' ' 29' ' ' ASP . 40.6 tp -115.19 134.55 55.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 30' ' ' THR . 14.4 t -120.35 102.61 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.986 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.9 t -93.21 117.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.576 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 23.1 t0 -159.5 157.47 30.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 26.6 t70 -89.6 51.12 2.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.181 0.515 . . . . 0.0 110.569 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.515 179.795 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.8 0.333 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 52.8 p -50.06 141.74 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.619 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.3 m 85.95 -20.93 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.196 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.416 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -86.99 -47.12 9.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -50.33 -47.42 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.32 74.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 23' ' ' GLU . 97.8 mt -58.12 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' CD1' ' CD1' ' A' ' 17' ' ' LEU . 1.3 mt -45.12 -32.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.388 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.06 -29.79 63.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -83.52 -35.76 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.563 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -75.33 -35.49 61.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.21 44.4 2.79 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.529 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 53.6 m-85 -102.97 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 81.46 67.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.429 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.12 142.11 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.78 2.32 . . . . 0.0 113.468 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.437 ' O ' ' CD1' ' A' ' 5' ' ' LEU . 24.2 t0 -136.23 65.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.373 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 10.5 p -56.14 133.29 52.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.832 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.07 -160.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.336 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 3.7 mttt -120.66 -30.17 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.622 0.248 . . . . 0.0 111.336 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -163.18 179.2 7.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.424 HD22 ' CD2' ' A' ' 63' ' ' PHE . 9.0 mt -61.45 -40.2 93.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.52 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 110.093 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -61.6 -33.53 74.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.196 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.68 -57.41 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 38.3 mt-10 -46.77 -41.13 14.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.766 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -43.41 95.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -44.44 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.854 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mt -71.17 -19.83 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.41 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -22.96 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -129.92 -59.38 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.88 114.45 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -79.83 67.05 5.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 46.0 m-85 -57.63 132.53 82.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 1.1 Cg_endo -77.74 -36.0 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.544 2.163 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.82 133.93 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.034 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.43 ' CD1' ' CB ' ' A' ' 46' ' ' PHE . 1.8 mm -132.67 102.13 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.666 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 77' ' ' ILE . 31.0 t -100.47 125.61 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.279 . . . . 0.0 110.976 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.413 ' CD2' HG11 ' A' ' 78' ' ' VAL . 37.7 tp -90.53 161.49 15.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.45 . . . . 0.0 110.842 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -152.8 93.14 1.72 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.2 t -73.9 63.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.404 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -63.39 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.319 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 35.6 mmm -139.71 37.19 0.27 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.648 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 55' ' ' MET . 92.8 Cg_endo -79.24 -165.42 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.294 1.996 . . . . 0.0 112.278 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -134.37 27.36 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.53 -86.64 1.9 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 59.16 54.37 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.69 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.35 110.49 3.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.831 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.0 t -63.22 -36.13 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -6.53 48.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.61 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 48.3 t80 -62.07 -38.07 87.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.698 0.285 . . . . 0.0 111.165 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 91' ' ' ALA . 3.3 mt -48.57 -30.2 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.154 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.39 -34.01 63.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.651 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 26.8 t80 -61.2 -44.27 97.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -60.85 -41.2 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.393 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -21.0 46.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -68.03 -37.29 81.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.33 9.04 10.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.309 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.64 67.26 2.54 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.51 -18.93 33.15 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.702 2.268 . . . . 0.0 112.233 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -102.18 30.35 4.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.714 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.4 t -117.93 -179.79 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.797 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.6 143.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.574 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -123.01 100.31 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.888 0.375 . . . . 0.0 110.976 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.421 ' O ' ' CG1' ' A' ' 50' ' ' VAL . 12.2 mm -104.18 74.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.425 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 19.6 t -67.79 118.75 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 17.1 mt -125.83 157.97 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.479 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.1 p . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.117 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.787 0.327 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.32 -23.64 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.092 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -35.38 76.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -55.32 -59.16 5.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 92' ' ' ILE . 26.3 m -62.38 -34.74 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.996 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -72.67 -10.67 60.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.603 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.426 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -106.9 -27.97 10.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 89' ' ' VAL . 11.3 pt -88.17 -35.75 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -61.25 -31.33 71.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.32 -65.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.744 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 25.69 0.08 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.044 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.38 -167.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.834 0.317 . . . . 0.0 110.897 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.521 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 62.0 t80 -108.98 -17.56 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.31 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 13.1 pt-20 152.01 -173.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.244 0.617 . . . . 0.0 110.375 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -122.66 90.45 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.616 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.1 tp -50.46 107.82 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.34 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.958 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 10.5 p . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.844 0.354 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.06 -37.03 19.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 tpt85 -68.17 -40.07 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.768 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.414 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 2.0 t80 -57.46 -27.09 62.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.992 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.71 -48.4 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.137 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.4 mp -52.64 -53.19 50.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.307 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 m -51.89 -58.61 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.387 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.0 mm -32.93 -63.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.969 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -59.58 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -51.46 -27.54 10.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.688 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.56 -35.34 70.58 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.817 0.341 . . . . 0.0 111.033 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.7 -39.18 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.978 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.274 -179.607 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 3.6 mptt . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 124.21 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.71 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 22.5 t -122.64 143.75 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.992 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.452 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 20.3 tp -90.12 132.5 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' THR . 14.0 t -119.3 89.59 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.66 114.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 31.6 t0 -155.09 152.1 29.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 24.7 t70 -87.5 48.73 1.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.677 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.42 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 81.3 p . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 t -71.42 131.9 44.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.961 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m 77.35 -5.84 2.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.511 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.427 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -90.39 -55.15 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.063 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -47.07 -56.99 5.53 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.373 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.41 -39.2 64.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.05 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.447 HD12 HG22 ' A' ' 106' ' ' VAL . 45.2 mt -64.56 -66.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.304 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mt -47.62 -29.73 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -69.92 -28.82 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.902 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.79 -36.06 23.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.487 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.73 -39.0 24.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.914 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.39 31.89 5.97 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.177 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.428 ' CE2' ' CG2' ' A' ' 113' ' ' ILE . 4.9 m-85 -81.66 -172.79 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 88.76 25.4 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 74.3 Cg_endo -78.63 129.35 9.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.469 2.113 . . . . 0.0 112.592 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 30' ' ' THR . 18.2 t70 -99.96 2.17 43.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.754 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 29' ' ' ASP . 3.2 p 1.76 124.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.93 -160.65 0.73 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.349 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 19.0 mttp -113.65 -31.94 6.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.12 -175.28 4.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 9.6 mt -63.23 -44.23 95.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.638 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.03 -54.02 51.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.195 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.119 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.44 -28.62 64.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.772 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 19.0 mt-10 -71.47 -43.18 67.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.23 75.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.009 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -75.59 -35.35 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.03 -26.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.787 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -77.77 -5.4 50.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.26 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -101.07 -51.74 3.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.764 0.316 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 46' ' ' PHE . 3.0 pp -117.69 -179.61 3.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.077 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -107.14 111.02 23.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.522 ' CZ ' ' CD2' ' A' ' 44' ' ' LEU . 64.0 m-85 -98.08 113.01 63.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.406 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.449 ' HG2' ' CE2' ' A' ' 117' ' ' PHE . 63.6 Cg_endo -73.15 -19.38 22.78 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.659 2.239 . . . . 0.0 111.929 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 117' ' ' PHE . 3.5 t -148.63 134.23 11.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.422 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.4 mm -116.89 157.15 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' A' ' 109' ' ' PHE . 43.1 t -151.42 101.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.183 0.516 . . . . 0.0 112.073 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.03 168.63 19.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.797 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -127.37 -47.27 1.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.674 0.273 . . . . 0.0 111.404 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.2 t 68.54 37.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.965 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -63.92 -82.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.53 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.69 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.2 ttm -152.1 47.69 0.42 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.358 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.69 ' HD3' ' N ' ' A' ' 55' ' ' MET . 29.3 Cg_endo -95.05 -161.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.06 2.507 . . . . 0.0 112.162 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.32 29.68 7.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.65 -97.79 2.08 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.601 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 55.36 54.21 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.418 . . . . 0.0 110.535 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.1 106.66 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.746 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 64' ' ' ILE . 97.0 t -63.69 -32.47 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.825 0.345 . . . . 0.0 111.012 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -3.77 48.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 23.6 t80 -60.77 -31.38 70.73 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.578 0.228 . . . . 0.0 110.987 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -46.74 -38.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.59 -53.29 56.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 38' ' ' GLU . 20.1 t80 -51.11 -30.75 17.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 110.217 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.464 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 3.8 mm -64.87 -53.34 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -74.21 -19.05 60.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.851 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.17 -44.62 83.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.867 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.56 10.19 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.436 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.69 66.62 2.79 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.777 0.322 . . . . 0.0 110.832 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.54 -19.62 32.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.84 2.36 . . . . 0.0 112.305 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -107.33 34.66 3.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 75' ' ' VAL . 48.5 t -116.35 -158.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.407 ' N ' ' OG ' ' A' ' 74' ' ' SER . 39.2 t -150.57 135.58 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-O 120.917 0.389 . . . . 0.0 111.449 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.7 t -112.53 106.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.414 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 36.5 mm -89.0 -49.38 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.72 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.436 ' HB ' ' CE1' ' A' ' 99' ' ' PHE . 59.3 t 52.69 81.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.363 . . . . 0.0 111.104 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mt -105.39 155.11 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.353 . . . . 0.0 111.006 -179.855 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.748 0.309 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.86 -26.47 65.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.407 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.5 t -75.55 -33.26 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.94 -59.28 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.99 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.44 ' HA ' HG12 ' A' ' 92' ' ' ILE . 18.0 m -58.78 -21.48 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.018 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -83.85 -9.65 58.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.591 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.32 -33.93 4.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.477 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 12.2 pt -73.05 -38.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.673 0.273 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -25.29 64.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.636 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.6 -57.54 3.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.11 33.45 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.19 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -90.11 -164.29 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 110.727 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 97' ' ' TYR . 36.1 t80 -108.53 25.32 11.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.245 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 82.49 17.98 0.33 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.013 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER 57.56 166.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.25 179.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -119.56 122.17 41.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.786 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 34.3 m . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.596 0.236 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -41.46 -44.7 2.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.815 0.341 . . . . 0.0 111.225 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -36.07 74.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.138 0.494 . . . . 0.0 109.816 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.567 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 1.4 t80 -56.17 -23.97 38.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.414 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.9 OUTLIER -62.23 -49.2 76.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.663 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -57.09 -57.68 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.418 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 97.4 m -54.47 -43.68 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.49 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -41.8 -54.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.011 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 0.0 109.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -55.87 -24.89 39.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.55 -37.68 83.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.049 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.449 ' CE2' ' HG2' ' A' ' 47' ' ' PRO . 27.4 m-85 -75.57 -17.49 60.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.956 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.257 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.457 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 6.0 mptt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.878 0.371 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 126.25 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.726 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 23.8 t -122.47 152.53 26.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 110.867 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 50' ' ' VAL . 47.0 tp -103.48 135.33 45.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 30' ' ' THR . 15.1 t -120.74 89.01 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.69 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.88 115.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.716 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 22.5 t70 -155.27 163.24 40.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.313 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -83.8 48.75 1.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.987 0.422 . . . . 0.0 111.08 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.674 179.697 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.426 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 60.7 p . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.5 t -83.77 134.96 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 111.679 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m 81.35 -10.38 1.19 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.306 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -90.15 -50.67 5.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 110.613 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.06 -54.95 7.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.86 66.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.452 HG23 HD12 ' A' ' 20' ' ' ILE . 70.8 mt -69.22 -69.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.309 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.72 -32.7 2.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.486 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -27.83 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.013 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -82.94 -35.56 25.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.441 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -81.31 -31.87 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.988 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.2 29.83 6.58 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.189 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CE1' ' CG ' ' A' ' 2' ' ' LYS . 46.1 m-85 -86.31 -173.97 4.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.049 0.452 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -138.25 89.36 14.3 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.037 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 73.3 Cg_endo -77.95 132.38 11.7 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.54 2.16 . . . . 0.0 112.594 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -104.5 -4.31 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.193 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 29' ' ' ASP . 43.0 p 12.95 121.75 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.38 156.35 21.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.364 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 2.2 mtmp? -80.68 -28.36 36.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.93 178.76 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.615 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.447 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 16.6 mt -57.5 -33.12 67.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -56.32 18.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.22 -29.43 70.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.33 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.9 -29.02 62.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 26.5 mt-10 -71.19 -41.23 70.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 109.903 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -33.9 76.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -77.83 -35.91 50.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.854 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.9 mt -78.47 -25.17 13.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.812 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -90.26 28.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.257 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -146.17 -46.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.469 ' CD2' ' CD1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -113.55 155.52 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.451 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.427 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 9.1 t80 -85.5 90.42 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.332 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.469 ' CD1' ' CD2' ' A' ' 44' ' ' LEU . 9.5 m-85 -76.66 113.82 33.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.55 -23.8 9.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.472 2.115 . . . . 0.0 112.146 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.58 133.41 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.625 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.8 mm -115.96 150.01 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.098 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 5' ' ' LEU . 77.9 t -142.78 100.06 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.398 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 52' ' ' ASP . 8.9 tp -86.09 149.1 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 t0 -140.2 107.15 5.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.419 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 20.3 m -75.31 61.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.673 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -69.58 -79.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.801 0.334 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.693 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 6.1 ttt -153.72 49.96 0.53 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.983 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.693 ' HD3' ' N ' ' A' ' 55' ' ' MET . 19.5 Cg_endo -93.47 -159.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.143 2.562 . . . . 0.0 112.119 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -142.61 38.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.22 -82.24 1.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.34 68.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.824 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.42 93.29 0.66 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.641 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 81.6 t -58.96 -33.84 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.927 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.19 -0.85 42.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.447 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 12.6 t80 -60.15 -38.13 82.2 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.8 mp -46.44 -42.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -43.03 95.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.134 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.403 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 12.1 t80 -57.84 -33.66 68.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.762 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.434 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mm -65.12 -53.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.266 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -72.69 -16.71 61.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.727 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.27 -44.29 72.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.53 13.07 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.326 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.42 66.57 1.86 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.37 -18.75 29.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.754 2.302 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -106.57 31.35 5.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.666 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.9 t -111.41 -158.3 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.545 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -149.64 136.24 12.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.777 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 16.4 t -114.13 115.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.674 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mm -100.95 -47.47 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.75 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 99' ' ' PHE . 59.9 t 49.74 86.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.314 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.9 mt -94.22 162.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.915 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.448 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 48.4 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.792 0.329 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.79 -12.62 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.42 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.8 t -78.78 -35.45 44.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.069 0.461 . . . . 0.0 109.864 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.521 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -58.54 -58.55 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.091 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.32 -25.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.769 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -90.06 39.01 0.95 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.556 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.415 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -170.26 -39.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 2.9 pt -74.88 -42.46 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -21.46 63.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.781 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -73.95 -27.65 61.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.17 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.29 -18.29 0.38 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.378 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -50.9 176.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.152 0.476 . . . . 0.0 111.464 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 74.4 t80 -97.6 26.14 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.456 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.6 OUTLIER 77.44 146.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.521 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.9 OUTLIER -65.83 138.87 58.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.908 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -68.93 137.94 54.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.502 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.244 -179.751 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.444 HG11 ' N ' ' A' ' 107' ' ' GLU . 9.5 p . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.64 0.257 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.444 ' N ' HG11 ' A' ' 106' ' ' VAL . 1.9 tt0 -45.2 -36.18 3.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.95 0.405 . . . . 0.0 110.743 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -67.29 -41.03 86.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.776 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 24.4 t80 -57.54 -27.27 62.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.153 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.07 -47.81 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.243 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.5 mp -51.79 -52.6 47.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.187 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.8 m -57.41 -45.92 84.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.14 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.9 mm -45.47 -56.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.587 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.29 -62.57 1.42 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -49.56 -27.34 4.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.926 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.73 -29.55 68.81 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.914 0.388 . . . . 0.0 110.782 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -89.67 -26.45 20.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.818 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.044 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.418 ' CD ' ' CD2' ' A' ' 117' ' ' PHE . 5.1 mmtm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.832 0.349 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.536 ' HB3' ' CB ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -175.43 93.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 18.3 t -77.41 160.49 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.45 HD12 ' CE2' ' A' ' 46' ' ' PHE . 60.7 tp -117.07 135.09 53.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.31 90.66 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.732 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 t -88.91 121.44 39.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.342 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -157.37 141.16 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.859 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.51 48.8 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.438 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 7.8 tp10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.801 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.748 0.309 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -26.32 65.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 t -93.27 -68.31 0.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -46.17 -56.89 5.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.487 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.531 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 21.3 t -41.25 -51.52 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.271 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -38.54 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.095 0.474 . . . . 0.0 110.622 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' LEU . 6.1 mt -69.06 -70.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.322 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.642 HD21 ' HG3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -50.49 -23.72 2.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.508 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.578 ' N ' HD13 ' A' ' 21' ' ' LEU . 31.5 mt-10 -78.48 -29.92 47.04 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 -37.92 58.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 109.923 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HG3' ' CD2' ' A' ' 110' ' ' LEU . 19.2 mm-40 -59.34 -18.89 42.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.207 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.4 73.45 1.14 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.767 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.489 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 29.5 m-85 -147.01 -178.86 6.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 111.649 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -121.42 81.95 39.05 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.642 ' HG3' HD21 ' A' ' 21' ' ' LEU . 37.4 Cg_endo -89.86 137.9 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.699 2.266 . . . . 0.0 114.041 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 13.1 t70 -126.15 125.07 41.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.6 p -97.2 135.96 38.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 111.643 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.44 178.5 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -122.75 -8.79 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.92 -171.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.36 -32.34 43.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 0.0 110.154 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -70.9 -44.38 66.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.795 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.12 -33.81 76.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.58 -49.23 33.78 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -46.93 -45.94 21.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.365 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -54.89 41.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -57.66 -27.87 63.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.692 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.9 mt -92.82 -8.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.55 8.22 29.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.73 0.3 . . . . 0.0 111.147 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -148.9 -48.14 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.58 116.09 21.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -69.22 71.29 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.45 ' CE2' HD12 ' A' ' 5' ' ' LEU . 13.1 m-85 -69.68 116.16 40.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' A' ' 117' ' ' PHE . 4.1 Cg_exo -74.56 -35.7 3.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.183 1.922 . . . . 0.0 111.44 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.556 ' CG2' ' CE1' ' A' ' 117' ' ' PHE . 16.5 t -124.8 126.59 71.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.784 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.5 mm -113.61 130.1 68.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.605 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.0 t -123.81 107.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.103 0.477 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.0 tp -93.87 147.08 23.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 1.1 t70 -126.02 97.37 5.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 80' ' ' THR . 23.4 t -67.05 72.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.354 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.438 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 59.4 t-105 -80.04 -91.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 ttp -140.73 46.0 0.86 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.102 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 55' ' ' MET . 86.2 Cg_endo -77.65 -167.02 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.547 2.164 . . . . 0.0 112.4 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.8 -44.09 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.72 163.76 51.67 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.582 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.39 120.47 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.17 -20.96 80.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.57 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.4 t -57.36 -38.13 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.32 -22.09 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.429 ' CE2' HD13 ' A' ' 67' ' ' ILE . 14.9 t80 -65.01 -40.66 95.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.811 0.339 . . . . 0.0 111.057 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.2 mt -46.32 -28.68 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -70.48 -51.7 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -48.82 -40.67 30.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.826 0.346 . . . . 0.0 110.559 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.429 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.5 mp -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.412 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -76.45 -19.58 57.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.789 0.328 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.8 -50.87 54.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.712 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.08 14.7 20.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.372 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.2 66.86 2.65 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.9 -19.1 35.89 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.21 . . . . 0.0 112.113 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.8 28.11 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.805 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.9 t -117.31 -175.77 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.775 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 47' ' ' PRO . 45.6 t -127.17 139.95 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.371 0.605 . . . . 0.0 111.783 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.7 t -122.96 88.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -73.8 -69.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.369 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.407 HG12 ' CE1' ' A' ' 99' ' ' PHE . 38.2 t 63.15 118.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.302 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.422 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.6 mt -121.0 -142.36 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.424 ' HB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.839 0.352 . . . . 0.0 110.815 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.861 0.363 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -90.08 -24.44 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.415 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 5.5 t -77.48 -35.28 53.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.188 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.69 -57.52 12.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.94 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.1 m -55.72 -30.37 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.844 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -76.84 -13.28 60.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.088 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.45 -41.77 5.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.658 0.266 . . . . 0.0 111.433 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.48 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 11.3 pt -70.47 -31.36 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 111.028 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -24.32 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.18 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -84.93 -54.89 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.661 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.87 28.98 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.641 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.523 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.25 177.62 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.24 0.52 . . . . 0.0 110.565 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.496 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 39.8 t80 -88.24 -23.34 23.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.526 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 2.6 pt-20 152.56 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.292 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 1.5 t80 80.61 111.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.644 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.95 96.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.207 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.915 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 12.5 p . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 120.63 0.252 . . . . 0.0 111.617 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -52.11 -51.11 59.86 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 110.902 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -38.69 74.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 79' ' ' ILE . 28.0 t80 -60.58 -29.77 69.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.379 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.406 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -70.12 -46.21 65.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.038 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mp -50.23 -42.78 52.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 75.1 m -69.37 -46.7 66.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.891 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.8 mm -45.52 -59.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.727 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -55.64 7.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.78 -29.2 69.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.74 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.65 85.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 0.0 110.853 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.556 ' CE1' ' CG2' ' A' ' 48' ' ' VAL . 6.4 m-85 -73.02 -17.1 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.372 179.912 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.896 0.379 . . . . 0.0 110.984 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.423 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.45 85.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.447 HG21 ' CE1' ' A' ' 117' ' ' PHE . 21.9 t -81.79 146.43 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.42 HD13 ' CE2' ' A' ' 46' ' ' PHE . 37.3 tp -106.96 139.77 40.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 0.0 111.218 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.432 ' CG2' HD11 ' A' ' 17' ' ' LEU . 21.7 t -117.3 145.9 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.44 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 52' ' ' ASP . 15.5 t -132.94 120.96 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.284 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 9.9 t0 -156.68 148.69 22.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -83.79 49.32 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.449 . . . . 0.0 111.19 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.662 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 20.3 p . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.896 0.379 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.7 m -41.01 133.82 2.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.477 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 6.5 t 79.72 -9.05 1.49 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.486 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -90.15 -53.88 4.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.33 . . . . 0.0 111.103 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -51.52 -52.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.92 79.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.011 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.442 ' CD1' HG23 ' A' ' 106' ' ' VAL . 38.4 mt -60.54 -66.52 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.034 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.435 ' CD1' HD13 ' A' ' 17' ' ' LEU . 1.4 mt -50.98 -34.1 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -68.72 -26.75 65.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.74 -35.1 30.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.068 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -81.23 -27.97 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.057 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.12 1.21 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.233 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 6.2 m-85 -120.9 -176.18 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.307 0.575 . . . . 0.0 111.357 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.62 79.54 67.51 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.554 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.7 Cg_endo -84.34 146.86 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.864 2.376 . . . . 0.0 114.348 -177.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -139.24 135.27 33.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.545 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -122.53 133.75 54.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 111.883 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.33 -163.14 0.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 11.0 mttm -112.76 -31.21 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.76 -175.04 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.678 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.4 mt -64.31 -41.16 96.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -61.42 -46.04 91.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 109.94 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.57 -38.58 89.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.3 -56.06 19.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.435 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 41.0 mt-10 -47.27 -41.4 18.75 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.756 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -59.73 -43.06 94.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.922 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -73.25 -44.03 60.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.84 -18.56 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.472 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.2 -23.6 15.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -127.17 -52.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.99 121.61 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.28 58.34 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.42 ' CE2' HD13 ' A' ' 5' ' ' LEU . 16.0 m-85 -57.73 123.35 62.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.447 ' O ' ' HA ' ' A' ' 74' ' ' SER . 58.5 Cg_endo -71.97 -32.56 10.99 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.548 2.165 . . . . 0.0 112.21 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.421 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 8.0 t -128.32 139.55 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.257 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.408 HD11 ' CB ' ' A' ' 46' ' ' PHE . 1.2 mm -139.77 108.34 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.299 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.443 HG21 ' CE1' ' A' ' 109' ' ' PHE . 50.9 t -105.54 133.69 49.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.769 0.318 . . . . 0.0 110.305 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 30.7 tp -101.96 136.44 41.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.88 81.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.015 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 3.4 p -60.58 80.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.3 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 13.6 t-105 -84.82 -78.04 0.26 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.355 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.673 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.65 50.34 0.97 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.673 ' HD3' ' N ' ' A' ' 55' ' ' MET . 15.3 Cg_endo -92.78 -159.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.163 2.575 . . . . 0.0 112.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -153.6 62.84 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.93 0.395 . . . . 0.0 111.004 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.39 162.78 29.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.541 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.07 116.54 23.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 110.864 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.49 -26.58 24.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.629 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.35 -41.21 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 111.2 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.74 -26.88 57.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 34' ' ' LEU . 16.0 t80 -61.05 -36.01 78.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.08 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.423 ' CG2' ' HA3' ' A' ' 95' ' ' GLY . 2.1 mp -45.81 -29.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.373 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -78.77 -38.67 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 38' ' ' GLU . 16.3 t80 -56.84 -41.64 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.42 HD13 ' CD2' ' A' ' 63' ' ' PHE . 3.9 mp -58.99 -46.3 91.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.382 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -75.34 -25.01 57.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -63.74 -43.68 95.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.86 16.93 13.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.04 69.44 0.98 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.81 -19.27 41.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.726 2.284 . . . . 0.0 112.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -104.99 28.24 7.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.6 t -111.72 179.99 3.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.15 146.11 33.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 0.0 111.206 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 3.7 t -125.43 119.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.335 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -97.33 -63.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.592 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.453 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 6.0 t 63.13 115.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.482 ' CG2' ' HB3' ' A' ' 100' ' ' LEU . 1.4 mt -129.31 -145.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.879 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.444 ' H ' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 121.008 0.433 . . . . 0.0 111.368 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -100.03 -47.86 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.0 t -55.6 -31.55 62.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.966 0.413 . . . . 0.0 110.353 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.73 -60.0 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.123 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 92' ' ' ILE . 32.8 m -58.11 -24.73 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.914 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -83.03 -10.92 58.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.27 -37.52 5.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.683 0.278 . . . . 0.0 111.6 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.507 HG21 HD13 ' A' ' 92' ' ' ILE . 14.1 pt -71.99 159.66 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.167 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 7.7 mmmt 80.52 -47.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.579 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.4 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' A' ' 64' ' ' ILE . . . -175.52 -33.19 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.464 -0.875 . . . . 0.0 113.237 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -62.8 176.22 0.72 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.194 0.497 . . . . 0.0 110.671 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.562 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -100.67 -8.35 22.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 140.23 -11.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.411 0.684 . . . . 0.0 111.438 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER 77.71 120.27 0.05 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.88 0.372 . . . . 0.0 110.924 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -72.93 157.95 36.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.551 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 -179.849 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -44.19 -42.1 6.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.952 0.406 . . . . 0.0 110.706 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -68.2 -37.51 80.98 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 5.0 t80 -58.52 -22.86 56.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.261 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.8 -51.15 66.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.319 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mp -53.78 -54.49 37.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.018 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 86.3 m -51.39 -56.78 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.091 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.442 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 9.9 mm -30.06 -63.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.695 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.67 -59.29 3.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.64 -24.86 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.828 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.87 -45.38 64.52 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 0.0 111.379 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.447 ' CE1' HG21 ' A' ' 4' ' ' VAL . 55.1 m-85 -66.53 -13.26 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.32 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.441 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.848 0.356 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.59 127.11 16.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.777 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 42.7 t -115.59 154.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.428 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 37.0 tp -115.01 132.78 56.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.403 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 25.0 t -116.62 89.55 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.338 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' VAL . 14.0 t -84.7 96.92 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.3 132.14 53.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.56 -65.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.763 0.316 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 t -90.28 29.41 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.565 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.3 p -157.97 -61.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.683 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.431 HD12 ' CD1' ' A' ' 21' ' ' LEU . 1.5 tm? -56.58 -49.73 74.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.594 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 p -54.75 -46.2 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.383 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.62 85.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.576 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 ' CG2' ' CD1' ' A' ' 110' ' ' LEU . 24.1 mt -57.28 -64.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.843 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.431 ' CD1' HD12 ' A' ' 17' ' ' LEU . 1.4 mt -49.27 -32.58 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -27.43 68.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -79.01 -37.39 39.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.985 0.421 . . . . 0.0 110.013 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.09 -51.06 34.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 58.91 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.522 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -135.88 -173.89 3.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -136.47 75.04 52.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.066 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 50.5 Cg_exo -54.8 151.4 32.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.684 2.256 . . . . 0.0 112.638 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -132.66 6.25 4.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' 29' ' ' ASP . 3.5 p 0.7 126.52 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 166.14 21.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.222 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 mtpt -79.41 -163.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.38 168.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.136 0.493 . . . . 0.0 111.82 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.3 mt -36.41 -35.53 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.261 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -54.34 -63.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.056 0.455 . . . . 0.0 110.146 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 2.0 mp0 -65.18 -33.8 76.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.426 ' CB ' HG13 ' A' ' 7' ' ' VAL . . . -63.22 -65.5 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -43.13 -42.25 4.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.525 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -61.06 -51.0 71.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.63 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -34.78 79.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.191 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.4 mt -86.07 -6.15 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.844 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.64 31.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.79 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -150.26 -52.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.447 ' CD2' ' CD2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -103.36 154.96 18.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.926 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.431 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 42.5 t80 -93.65 87.19 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.644 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.447 ' CD2' ' CD2' ' A' ' 44' ' ' LEU . 28.6 m-85 -70.15 125.2 91.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.37 -26.2 7.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.585 2.19 . . . . 0.0 112.062 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.414 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 3.0 t -139.28 130.94 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 mm -120.31 153.02 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.617 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' VAL . 49.1 t -143.23 107.09 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.451 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.6 tp -96.9 85.89 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.257 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.6 OUTLIER -68.02 72.52 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.527 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.459 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 3.3 p -53.16 85.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.716 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 21.8 t-105 -71.94 -80.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.608 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.9 54.99 0.61 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 55' ' ' MET . 5.6 Cg_endo -87.55 -155.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.172 2.581 . . . . 0.0 112.141 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -159.81 49.69 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.14 11.68 9.87 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.86 78.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.06 -20.9 63.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.888 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.416 ' HA ' ' CD1' ' A' ' 64' ' ' ILE . 23.8 t -50.95 -44.82 27.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.423 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.14 -25.03 59.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.412 ' CD2' HD13 ' A' ' 67' ' ' ILE . 14.0 t80 -60.97 -39.63 90.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 61' ' ' VAL . 2.6 mp -47.02 -28.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -75.63 -41.46 54.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.815 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.76 -42.07 83.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.412 HD13 ' CD2' ' A' ' 63' ' ' PHE . 4.7 mp -63.92 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -12.02 58.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.7 -40.69 47.94 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.004 0.431 . . . . 0.0 110.593 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 9.76 12.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.983 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.41 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.07 66.23 3.38 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.866 0.365 . . . . 0.0 110.787 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.4 Cg_exo -76.03 -14.32 19.03 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 112.22 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -109.53 29.55 7.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.813 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -106.96 -155.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.62 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.8 t -147.2 137.96 17.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 121.039 0.447 . . . . 0.0 112.018 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.2 t -123.39 112.08 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.448 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.63 44.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.506 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.417 HG13 ' CE1' ' A' ' 99' ' ' PHE . 49.0 t -45.43 116.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.261 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.465 HG21 ' HB3' ' A' ' 100' ' ' LEU . 1.6 mt -106.43 -148.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.194 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.55 -17.31 15.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -36.16 30.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB3' ' CD2' ' A' ' 99' ' ' PHE . . . -59.27 -59.36 5.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.968 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.586 ' HA ' HG12 ' A' ' 92' ' ' ILE . 12.4 m -58.99 -30.77 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.949 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -75.04 -8.5 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.347 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.27 -35.54 3.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.475 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.586 HG12 ' HA ' ' A' ' 89' ' ' VAL . 8.7 pt -80.02 158.07 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.192 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.408 ' CG ' HG13 ' A' ' 92' ' ' ILE . 9.2 mmtt 80.77 -45.83 0.25 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -22.97 64.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.97 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.03 -29.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.187 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.51 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -79.77 175.82 10.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.082 0.441 . . . . 0.0 111.009 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.524 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 56.0 t80 -100.69 -12.06 19.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.323 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 147.54 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.158 0.583 . . . . 0.0 110.368 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -118.97 131.09 56.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.534 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.465 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -93.88 44.81 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.822 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.265 -179.805 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.596 0.236 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -47.52 76.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.861 0.362 . . . . 0.0 110.367 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.29 -33.61 69.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.071 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -64.44 -37.8 88.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.183 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.415 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -55.33 -48.21 74.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -44.71 83.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.1 m -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 mm -57.22 -53.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -59.46 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -55.75 -30.79 61.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.738 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.77 88.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.414 ' CZ ' HG21 ' A' ' 48' ' ' VAL . 31.0 m-85 -75.23 -28.75 60.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.906 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmmp? . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.775 0.321 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.409 ' HB3' ' CB ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -136.06 142.22 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.497 HG12 ' HB ' ' A' ' 48' ' ' VAL . 17.5 t -125.96 163.9 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.445 HD23 ' CD2' ' A' ' 46' ' ' PHE . 34.0 tp -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.2 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 50' ' ' VAL . 27.6 t -115.28 97.33 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.95 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.23 119.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.797 0.332 . . . . 0.0 110.985 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -154.35 131.57 11.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.9 46.77 1.39 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.29 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 110.99 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.423 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 76.0 p . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -65.43 141.91 58.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.158 0.504 . . . . 0.0 112.259 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 m 65.1 9.39 5.48 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.721 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.441 HD23 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -90.49 -53.07 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.483 179.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -45.88 -59.67 2.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.23 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.52 53.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.08 0.467 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 HD13 HG12 ' A' ' 106' ' ' VAL . 75.1 mt -68.29 -70.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.441 HD11 HD23 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.73 -30.36 3.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.044 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -73.42 -29.67 62.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.845 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -81.08 -34.84 32.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 110.12 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.48 -35.0 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.4 47.75 2.72 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.221 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.443 ' CZ ' HG22 ' A' ' 113' ' ' ILE . 44.3 m-85 -105.23 -173.26 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.127 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.56 85.68 47.16 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 91.4 Cg_endo -82.45 127.71 5.2 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.689 2.259 . . . . 0.0 111.953 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -105.65 -1.01 25.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.482 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.625 ' O ' ' O ' ' A' ' 29' ' ' ASP . 58.7 p 24.49 122.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.82 167.72 9.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.549 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -88.29 -46.06 9.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.821 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.47 -167.03 2.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.1 mt -67.44 -46.53 72.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -63.1 -45.47 91.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.044 0.45 . . . . 0.0 109.873 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -32.2 70.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.38 -28.82 63.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.686 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 13.6 mt-10 -70.85 -42.03 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -63.77 -35.33 80.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.009 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -75.68 -42.41 51.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.898 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.77 -27.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.031 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -52.03 -25.98 9.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -120.72 -55.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.19 133.57 50.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -95.28 102.04 13.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CD2' HD23 ' A' ' 5' ' ' LEU . 40.7 m-85 -102.74 122.04 47.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.537 ' O ' ' HA ' ' A' ' 74' ' ' SER . 65.4 Cg_endo -73.68 -19.16 21.63 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.331 2.021 . . . . 0.0 111.788 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.497 ' HB ' HG12 ' A' ' 4' ' ' VAL . 10.8 t -143.7 120.53 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 46' ' ' PHE . 6.5 mm -107.18 153.75 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.83 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 6' ' ' VAL . 7.4 t -135.49 174.59 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.2 tp -159.92 117.27 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.548 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.46 89.62 3.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.141 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 35.2 m -58.68 82.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.834 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -81.52 -83.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.402 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.504 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 3.2 mtt -148.45 44.78 0.37 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 55' ' ' MET . 85.4 Cg_endo -80.19 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.461 2.107 . . . . 0.0 112.226 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -137.99 49.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 110.97 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.47 139.85 6.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.445 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.44 144.27 37.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.63 -15.94 47.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.892 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.2 t -53.81 -52.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.014 0.435 . . . . 0.0 111.209 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.7 -6.29 47.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.765 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.424 ' CD2' HD13 ' A' ' 67' ' ' ILE . 22.3 t80 -85.67 -36.52 20.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.645 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.403 ' CD1' ' CB ' ' A' ' 91' ' ' ALA . 3.0 mp -49.52 -31.95 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.681 0.277 . . . . 0.0 111.084 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.3 t70 -79.41 -25.26 42.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.572 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 48.1 t80 -67.85 -42.32 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.424 HD13 ' CD2' ' A' ' 63' ' ' PHE . 3.8 mp -60.03 -43.23 92.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.035 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.88 -20.96 52.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.72 -34.8 76.25 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.407 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -126.39 14.58 7.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.034 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.49 67.39 1.38 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.889 0.376 . . . . 0.0 110.579 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.02 -20.79 50.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.65 2.233 . . . . 0.0 112.064 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.29 25.5 6.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.055 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 33.5 t -113.37 -166.18 1.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -148.67 131.56 7.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 121.248 0.547 . . . . 0.0 112.428 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 38.9 t -100.89 113.65 37.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.63 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -94.01 -62.35 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.915 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.459 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 99.4 t 59.15 111.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 109' ' ' PHE . 1.8 mt -122.48 178.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 179.922 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.862 0.363 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -139.2 -60.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.842 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 t -48.8 -30.74 6.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.261 0.553 . . . . 0.0 110.1 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.469 ' HB2' ' CG ' ' A' ' 99' ' ' PHE . . . -59.26 -59.72 5.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.156 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.61 -21.96 26.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.325 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -87.32 -14.22 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.673 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 64' ' ' ILE . . . -114.8 -31.82 6.01 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 8.7 pt -74.63 -21.88 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.692 0.282 . . . . 0.0 111.625 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.65 15.38 16.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.22 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -119.64 -21.2 7.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.555 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.39 -24.2 0.16 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.937 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.477 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -55.13 176.26 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.584 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.458 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 56.4 t80 -108.5 27.37 9.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.422 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.9 OUTLIER 85.61 138.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.187 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CG ' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -71.38 94.77 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.608 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.475 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 28.3 tp -54.94 146.69 17.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 7.4 p . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.641 0.258 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -46.22 -35.45 5.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -35.78 70.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.934 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.475 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 29.3 t80 -58.16 -30.82 66.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.0 -43.33 50.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.318 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mp -59.3 -60.21 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.121 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 116' ' ' ALA . 97.8 m -44.12 -39.14 4.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.343 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 29.2 mm -56.23 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -54.16 -21.09 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.739 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -85.66 -24.73 26.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.695 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -80.55 -30.86 37.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -78.29 -20.08 52.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.365 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.658 -179.58 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 7.8 mmmt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 131.18 20.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.718 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.437 HG21 ' CE1' ' A' ' 117' ' ' PHE . 27.0 t -121.31 144.15 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.408 ' N ' HG12 ' A' ' 4' ' ' VAL . 29.9 tp -107.2 137.7 44.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 0.0 111.214 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.8 t -116.3 123.88 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.528 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.29 110.38 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.24 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 40.8 t0 -158.76 160.63 36.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.057 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -89.16 49.45 1.77 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.05 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.771 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 16' ' ' SER . 73.5 m -43.0 136.44 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.775 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.4 m 88.16 -36.35 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.161 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.465 HD22 ' CG2' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -65.89 -50.82 63.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 110.93 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.5 -64.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.463 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.27 60.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 111.443 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' CD1' HG23 ' A' ' 106' ' ' VAL . 91.5 mt -65.72 -70.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -46.94 -31.03 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.938 0.399 . . . . 0.0 111.071 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.46 -31.67 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.707 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -83.0 -35.21 26.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -75.1 -29.98 60.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.046 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.88 1.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.227 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 43.2 m-85 -131.76 -176.3 4.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.243 0.544 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.41 80.74 46.04 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.837 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.5 141.53 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.838 2.359 . . . . 0.0 113.759 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -138.54 136.18 35.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.868 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 14.7 p -121.62 132.58 54.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.114 0.483 . . . . 0.0 111.745 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.69 -121.57 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.226 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 13.8 mttp -157.63 -41.75 0.07 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.937 0.399 . . . . 0.0 110.59 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 p -152.83 175.66 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.43 HD22 ' CE2' ' A' ' 63' ' ' PHE . 39.8 mt -58.14 -37.34 74.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -44.83 78.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -35.81 82.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.336 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.27 61.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 34.1 mt-10 -49.16 -44.21 42.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.533 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -56.43 -44.6 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.063 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -73.23 -44.39 59.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.979 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.3 mt -70.32 -17.75 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.556 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -21.25 41.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.218 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.99 -63.46 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.12 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -55.35 132.42 48.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 45' ' ' PHE . 60.4 t80 -97.2 59.56 1.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.77 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -57.93 126.53 77.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 53.1 Cg_endo -70.93 -28.79 19.21 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.318 2.012 . . . . 0.0 111.66 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 117' ' ' PHE . 15.2 t -128.66 136.59 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.567 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 49' ' ' ILE . 5.9 mm -135.78 103.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.63 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.411 HG21 ' CE1' ' A' ' 109' ' ' PHE . 59.8 t -101.79 129.81 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 78' ' ' VAL . 28.6 tp -92.13 162.84 14.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.334 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.492 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -153.81 69.96 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.806 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 2.4 p -59.79 81.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.683 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 52' ' ' ASP . 65.3 t-105 -86.41 -92.23 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.772 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.563 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mtt -64.25 -52.09 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.075 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 55' ' ' MET . 39.7 Cg_endo -65.97 -169.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.37 2.047 . . . . 0.0 112.37 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.92 -24.07 7.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.84 -89.13 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.428 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 48.69 30.76 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.2 72.28 2.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.562 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.403 ' O ' ' CD1' ' A' ' 64' ' ' ILE . 58.2 t -58.11 -39.65 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -75.0 -11.79 60.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.523 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.458 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 50.4 t80 -64.36 -43.77 93.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.734 0.302 . . . . 0.0 111.429 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.437 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.3 mp -48.24 -28.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -77.58 -30.85 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 4.5 t80 -63.73 -44.76 92.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -61.21 -43.62 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.21 -22.52 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.667 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 21.6 tt0 -62.91 -39.81 95.67 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.073 0.463 . . . . 0.0 110.222 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.53 15.68 9.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.26 71.21 0.6 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.71 -7.71 11.43 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.039 2.493 . . . . 0.0 112.56 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.03 -3.06 30.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.558 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -170.31 2.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 0.0 111.302 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.1 t -127.34 147.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 3.3 t -126.7 100.45 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.476 HD11 HG23 ' A' ' 77' ' ' ILE . 6.0 mm -101.62 71.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.145 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.475 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 32.1 t -67.09 133.31 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.176 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 100' ' ' LEU . 2.1 mt -142.4 175.64 4.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.524 ' HB ' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.901 0.381 . . . . 0.0 111.163 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.882 0.373 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -115.51 -34.29 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.82 -31.1 70.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -61.28 -59.62 5.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 m -62.75 -23.33 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.931 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.73 27.68 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.6 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.437 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -154.53 -41.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.035 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 11.8 pt -69.17 -21.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.505 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.53 26.47 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -133.8 7.27 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.517 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.25 -23.26 3.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.912 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -60.48 -177.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.373 . . . . 0.0 111.266 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.451 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 48.9 t80 -117.21 29.14 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.269 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.453 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 87.89 158.13 0.07 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.227 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -91.97 103.91 16.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.078 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 79' ' ' ILE . 11.4 tp -57.97 160.9 4.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.041 -179.628 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.465 ' CG2' HD22 ' A' ' 17' ' ' LEU . 1.2 m . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -45.78 44.77 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.919 0.39 . . . . 0.0 110.608 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.5 tpt85 -66.59 -36.67 83.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.819 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.458 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 7.2 t80 -59.82 -27.81 66.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.245 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.407 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -60.11 -44.25 95.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.364 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.5 mp -54.38 -56.64 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' ILE . 92.4 m -51.73 -59.53 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.342 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 13.6 mm -31.05 -64.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.891 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -58.1 5.76 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -27.32 15.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.41 -36.57 66.01 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.437 ' CE1' HG21 ' A' ' 4' ' ' VAL . 27.2 m-85 -66.85 -14.93 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.257 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--N 1.332 -0.181 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.468 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 21.1 mmtt . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.85 0.357 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.415 ' HD2' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 73.95 113.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.044 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 43.6 t -118.99 158.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.489 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 56.2 tp -112.65 127.98 56.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 111.394 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.26 91.97 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.317 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -85.02 117.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.483 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -156.51 147.03 21.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.914 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.421 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 36.3 t70 -72.62 -73.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.096 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 1.6 tm-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.115 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -66.06 -32.95 74.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 t -102.13 -59.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -47.04 -57.21 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.428 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.509 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 8.7 t -41.41 -54.66 3.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.158 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.96 -36.62 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.508 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 17' ' ' LEU . 14.3 mt -72.92 -70.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.84 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.628 ' CD2' ' HG3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -52.56 -28.51 21.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.465 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -79.73 -23.67 42.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.814 0.34 . . . . 0.0 110.667 178.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -78.82 -39.08 36.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.903 0.383 . . . . 0.0 110.026 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.91 -43.73 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 60.68 0.16 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.32 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.502 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 61.7 m-85 -132.31 -171.51 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 111.061 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.39 82.9 56.33 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.628 ' HG3' ' CD2' ' A' ' 21' ' ' LEU . 21.3 Cg_exo -65.28 143.44 77.12 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.682 2.254 . . . . 0.0 112.634 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 30' ' ' THR . 6.2 t70 -116.78 -10.72 11.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.139 0.495 . . . . 0.0 111.983 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 29' ' ' ASP . 41.9 p 43.12 176.05 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.289 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -165.57 174.81 9.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.908 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.82 -26.65 8.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.801 0.334 . . . . 0.0 111.236 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.12 -178.33 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.62 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 63' ' ' PHE . 96.5 mt -61.01 -39.2 88.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -50.34 71.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.031 0.443 . . . . 0.0 109.831 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -33.16 75.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.172 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.07 -20.2 57.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 4.3 mt-10 -77.56 -38.31 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 109.85 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.41 -39.14 81.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.661 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mmtm -71.22 -36.19 71.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.769 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.5 mt -86.19 -17.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.201 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -58.38 -19.09 32.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.441 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -134.8 -53.76 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.062 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -58.45 118.22 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.052 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -74.11 64.52 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.438 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 31.2 m-85 -56.65 113.69 6.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.297 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.14 -27.38 13.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 112.032 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.75 128.29 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.479 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.4 mm -112.59 146.85 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.68 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.418 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 97.6 t -139.06 98.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.488 . . . . 0.0 110.576 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 78' ' ' VAL . 24.7 tp -77.16 166.25 23.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.89 93.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.252 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.454 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 6.8 m -76.71 57.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.55 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.424 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 55.7 t-105 -61.54 -90.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.652 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.666 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -90.64 -27.09 0.3 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 55' ' ' MET . 62.3 Cg_endo -85.93 -168.29 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.341 2.027 . . . . 0.0 113.021 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -147.59 -47.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.411 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 46.79 -171.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.948 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.57 48.29 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.634 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -47.78 -34.38 10.7 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.452 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.87 -49.91 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.942 0.401 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.54 8.34 34.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.384 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.429 ' CE2' HD13 ' A' ' 67' ' ' ILE . 36.1 t80 -84.55 -41.83 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.772 0.32 . . . . 0.0 111.224 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.4 mp -46.01 -30.44 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.242 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -40.62 66.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.565 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 68.5 t80 -55.97 -43.36 77.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.429 HD13 ' CE2' ' A' ' 63' ' ' PHE . 4.0 mp -61.79 -44.37 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.462 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -78.95 -14.52 59.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.833 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.3 -43.07 58.31 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.968 0.413 . . . . 0.0 110.593 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.68 12.46 14.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.08 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.54 66.79 2.51 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.728 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.68 -19.04 32.23 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.616 2.211 . . . . 0.0 112.232 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -103.97 32.39 3.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.673 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 t -113.63 -158.45 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.689 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.2 t -147.49 136.2 15.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 18.3 t -114.25 110.99 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.608 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.5 mm -99.23 -39.91 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.558 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.452 HG12 ' CE1' ' A' ' 99' ' ' PHE . 59.1 t 45.25 77.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.433 HD11 ' CD1' ' A' ' 109' ' ' PHE . 4.2 mt -93.45 148.51 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.579 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 1.4 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.025 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.929 0.395 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -111.52 -24.21 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.192 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -32.08 22.67 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.501 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -61.96 -57.27 12.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.897 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.6 m -58.08 -26.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.016 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -81.76 -9.25 59.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.96 -26.45 4.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 5.5 pt -83.32 -42.16 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -23.73 41.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.679 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -25.06 65.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.94 -16.1 1.05 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.106 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.427 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -51.9 177.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.97 0.385 . . . . 0.0 111.464 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 72.3 t80 -95.29 28.55 2.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.503 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 1.2 tt0 70.09 139.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.208 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.8 OUTLIER -55.11 146.07 19.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.4 OUTLIER -87.23 109.65 19.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.059 -179.87 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.528 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 32.8 m . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.971 0.415 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.15 -60.67 2.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -30.55 53.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.528 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 80.8 t80 -61.91 -40.57 95.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.607 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.1 tt -52.41 -59.09 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.395 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mp -66.23 -44.46 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.544 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.3 m -60.2 -37.8 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.125 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.446 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -49.02 -52.36 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.482 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -56.56 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.042 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.55 -36.49 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.9 -38.54 79.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 110.57 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.452 ' CE1' ' CA ' ' A' ' 2' ' ' LYS . 34.7 m-85 -82.73 -17.18 45.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.792 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.911 0.386 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.498 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -149.2 140.87 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.545 HG11 ' HB ' ' A' ' 48' ' ' VAL . 17.7 t -124.67 162.27 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.978 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 57.5 tp -119.8 121.82 39.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 110.588 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 30' ' ' THR . 40.0 t -102.77 122.88 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.19 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 52' ' ' ASP . 41.3 t -111.41 105.26 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.866 0.365 . . . . 0.0 111.191 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -117.57 151.76 36.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.934 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -81.27 49.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 111.667 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.361 179.241 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 2.3 p . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 m -54.68 145.94 18.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.434 ' HB3' HG13 ' A' ' 106' ' ' VAL . 42.1 t 66.03 10.86 7.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.839 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.487 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -90.22 -52.23 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.443 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 t -50.08 -55.26 15.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.06 73.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.968 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' A' ' 16' ' ' SER . 54.3 mt -62.19 -66.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.38 -28.62 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.44 -27.68 61.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.79 -34.46 30.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.149 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 30.5 mm-40 -87.18 -30.58 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 60.53 1.48 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.45 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 44.8 m-85 -113.09 -173.67 2.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.25 83.83 54.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.882 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 92.2 Cg_endo -84.74 117.62 2.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.79 2.326 . . . . 0.0 111.636 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.26 -9.2 33.84 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.403 0.62 . . . . 0.0 112.046 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 71.5 p 49.66 173.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.216 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' VAL . . . -158.55 -154.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.493 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 27.3 mttt -143.65 -42.96 0.28 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.0 170.07 20.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.591 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.3 mt -61.41 -26.77 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.51 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -76.2 -43.59 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.083 0.468 . . . . 0.0 109.819 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -25.98 59.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.607 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.52 -34.03 58.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.634 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 44.8 mt-10 -69.75 -41.46 75.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -61.83 -37.98 86.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.837 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -72.41 -47.03 52.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.615 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 mt -68.71 -27.97 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.976 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.55 -29.12 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -116.82 -44.21 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.63 112.75 18.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -75.13 63.94 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 42.4 m-85 -56.03 125.58 63.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.498 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 72.2 Cg_endo -76.45 -34.04 2.9 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.307 2.004 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.545 ' HB ' HG11 ' A' ' 4' ' ' VAL . 23.5 t -130.16 111.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.007 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.3 mm -97.01 142.38 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.795 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 6' ' ' VAL . 6.6 t -128.66 165.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 78' ' ' VAL . 16.2 tp -142.41 157.69 44.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.119 0.485 . . . . 0.0 111.539 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -141.93 79.95 1.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.011 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.67 66.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.188 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.412 ' N ' ' O ' ' A' ' 52' ' ' ASP . 26.7 t-105 -67.16 -74.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.643 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 31.4 mtt -147.54 52.75 1.37 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.763 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.4 Cg_endo -89.72 -156.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -136.89 -43.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.246 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.44 148.37 34.11 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.647 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 127.53 43.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.71 -13.8 83.17 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.823 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.57 -45.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.789 0.328 . . . . 0.0 111.339 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 -5.9 55.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.537 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 34' ' ' LEU . 15.7 t80 -74.15 -37.74 63.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.347 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.5 mp -49.7 -27.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -39.45 69.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.632 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 18.8 t80 -60.3 -43.35 96.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.061 0.458 . . . . 0.0 109.914 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.404 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -57.33 -41.76 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -81.64 -24.16 36.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.0 110.638 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -66.39 -26.18 67.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -138.0 16.58 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.026 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.15 69.17 0.82 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.864 0.364 . . . . 0.0 110.748 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.44 -20.26 48.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.76 2.307 . . . . 0.0 112.11 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.78 39.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.853 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.8 t -119.61 177.59 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.437 ' HB ' ' CG1' ' A' ' 48' ' ' VAL . 2.7 t -107.9 178.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 0.9 OUTLIER -157.52 79.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.898 0.38 . . . . 0.0 110.146 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.413 ' HB ' HG12 ' A' ' 50' ' ' VAL . 31.2 mm -62.21 -53.02 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.364 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 5.2 t 45.39 89.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.422 ' O ' ' CB ' ' A' ' 80' ' ' THR . 13.8 mt -104.21 167.2 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.614 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 79' ' ' ILE . 2.6 m . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.425 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.793 0.33 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.81 -32.91 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.39 -34.76 49.49 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.19 0.519 . . . . 0.0 109.954 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.5 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -56.41 -61.27 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.315 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.4 m -61.92 -22.73 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.243 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -85.52 -25.13 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.91 -26.1 14.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.419 ' CG2' ' HA ' ' A' ' 98' ' ' GLU . 4.2 pt -89.32 -17.0 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.436 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -71.71 -32.66 68.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 110.43 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -64.78 -61.99 1.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.84 33.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.986 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.433 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.11 -179.0 5.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 97' ' ' TYR . 26.4 t80 -98.52 28.54 4.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.452 . . . . 0.0 111.062 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 2.7 tp10 67.47 134.15 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.193 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.502 ' CE1' ' CG1' ' A' ' 78' ' ' VAL . 2.3 m-85 -61.64 131.48 50.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.014 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -74.81 80.81 2.1 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.412 -179.681 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 16' ' ' SER . 7.6 p . . . . . 0 CA--C 1.526 0.039 0 CA-C-O 120.69 0.281 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -46.51 -33.92 4.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 110.838 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -36.25 69.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.933 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 113' ' ' ILE . 3.4 t80 -59.64 -31.16 69.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.181 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.16 -49.21 43.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.29 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.424 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 5.6 mp -56.93 -57.56 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.75 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.402 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 93.0 m -44.68 -39.28 4.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.301 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 24.1 mm -59.13 -70.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.427 ' HE3' ' CE1' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -55.24 -23.07 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.563 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.427 ' CE1' ' HE3' ' A' ' 114' ' ' LYS . 13.9 m-70 -84.75 -20.62 30.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.668 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -87.19 -45.22 10.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.45 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -60.44 -22.53 63.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.271 -179.965 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.746 0.308 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -111.71 135.07 52.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.862 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.0 t -126.5 154.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.411 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.435 HD23 ' CD2' ' A' ' 46' ' ' PHE . 28.8 tp -105.73 127.98 53.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.709 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 17' ' ' LEU . 45.2 t -107.52 90.1 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 5.1 t -85.08 105.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -138.36 143.04 39.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.037 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -91.9 50.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' SER . 40.0 p . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.674 0.273 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.51 -45.85 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 111.258 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 p -73.58 -68.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.444 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -44.78 -42.86 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 14' ' ' THR . 10.1 m -57.15 -44.18 83.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.43 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.69 78.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.431 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mt -59.76 -57.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.587 179.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -50.33 -33.49 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.664 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.02 -24.59 66.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.794 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.38 -36.61 45.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -78.34 -19.12 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.157 179.693 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.17 52.95 2.11 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.186 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.1 m-85 -112.07 -172.21 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 0.0 111.163 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -131.41 69.41 81.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.805 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.415 ' HG3' ' CB ' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -62.61 143.26 92.35 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.628 2.218 . . . . 0.0 111.931 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.8 t70 -126.56 -9.11 6.24 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.625 ' O ' ' O ' ' A' ' 29' ' ' ASP . 29.9 p 41.9 163.68 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -170.61 142.87 2.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.778 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 41.5 mttt -74.01 -166.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.73 156.24 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 111.705 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.445 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 20.2 mt -27.36 -43.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.833 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -50.56 -59.59 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.083 0.468 . . . . 0.0 110.333 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 1.4 tp10 -66.07 -39.1 89.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.15 -60.5 3.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.595 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 19.7 mt-10 -45.67 -42.18 11.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -60.8 -52.75 63.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -62.44 -34.59 77.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.328 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 mt -89.54 -6.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.52 -16.56 48.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.633 0.254 . . . . 0.0 111.262 179.901 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -132.95 -52.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.769 0.318 . . . . 0.0 111.093 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.95 133.25 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.073 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -96.52 63.89 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.706 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CD2' HD23 ' A' ' 5' ' ' LEU . 45.2 m-85 -58.27 125.23 74.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.036 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.74 -24.78 17.83 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.317 2.011 . . . . 0.0 111.892 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 2.8 t -141.59 134.12 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.524 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.8 mm -119.24 148.18 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.547 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 7' ' ' VAL . 82.9 t -136.59 105.62 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.587 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.04 84.11 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.751 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 54' ' ' TRP . 1.2 t70 -66.35 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 2.5 p -53.24 88.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ASP . 34.0 t-105 -88.47 -80.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.49 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 mmt -147.22 47.27 0.55 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 55' ' ' MET . 97.8 Cg_endo -78.6 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.562 2.175 . . . . 0.0 112.323 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -152.2 30.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.57 -147.17 18.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.411 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -129.49 81.2 2.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.863 0.363 . . . . 0.0 110.9 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.9 92.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 64' ' ' ILE . 78.0 t -59.87 -38.64 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -23.41 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.108 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 13.4 t80 -75.35 -30.22 60.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.819 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 61' ' ' VAL . 7.9 mm -47.8 -37.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' GLU . 39.1 t70 -70.07 -42.93 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 23.4 t80 -50.99 -39.91 56.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.935 0.398 . . . . 0.0 110.651 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.411 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.7 mp -62.74 -52.08 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -74.63 -9.51 58.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.701 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 18.0 tt0 -77.1 -48.04 18.86 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -114.33 16.83 17.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.925 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.66 67.54 1.6 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.2 -18.59 34.86 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.672 2.248 . . . . 0.0 112.156 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.75 40.66 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.66 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.0 t -119.06 -157.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.01 139.0 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 112.102 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.1 t -120.74 94.16 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.175 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.6 mm -73.63 -57.11 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.917 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.434 HG12 ' CE1' ' A' ' 99' ' ' PHE . 21.7 t 52.59 94.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.409 HD12 ' CD1' ' A' ' 109' ' ' PHE . 1.7 mt -108.45 -148.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.326 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.45 ' HB ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.829 0.347 . . . . 0.0 111.106 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.687 0.28 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.0 -24.77 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.288 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -33.56 26.62 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . . . -61.1 -57.09 13.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.116 178.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 92' ' ' ILE . 13.4 m -59.94 -28.22 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.43 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -78.74 -2.26 38.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.606 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.05 -35.04 1.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 89' ' ' VAL . 4.7 pt -73.69 -43.59 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 111.413 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -59.42 -31.44 69.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -64.71 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.736 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.34 29.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.845 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.25 -166.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.722 0.296 . . . . 0.0 111.135 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 20.9 t80 -113.51 26.71 10.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HA ' HG23 ' A' ' 92' ' ' ILE . 0.5 OUTLIER 79.5 147.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.229 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.471 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -79.31 88.3 4.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.802 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 13.8 tp -59.06 148.23 31.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.01 -179.986 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 32.4 m . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -62.19 1.53 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -29.32 57.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.163 0.506 . . . . 0.0 109.69 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.487 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 43.3 t80 -61.62 -44.18 97.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.985 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.8 mt -52.5 -31.17 33.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.465 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.628 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 4.1 mp -79.75 -36.05 37.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 m -69.16 -36.88 77.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.491 . . . . 0.0 109.811 179.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 mm -67.17 -51.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.068 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -47.26 -57.2 5.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.311 -179.018 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.403 ' H ' ' HG3' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -57.33 -34.76 69.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.818 179.537 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.92 -32.42 61.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 48' ' ' VAL . 29.8 m-85 -74.6 -46.11 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.076 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.658 -179.762 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 8.5 mmtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.812 0.339 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 75.53 105.96 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.093 -179.781 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 44.4 t -112.78 162.51 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.42 HD21 ' CD2' ' A' ' 46' ' ' PHE . 59.5 tp -119.81 139.12 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.445 ' CG2' HD11 ' A' ' 17' ' ' LEU . 10.5 t -121.05 117.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.133 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.75 111.6 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.361 179.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.01 157.21 38.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -83.5 -70.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.423 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.0 mm-40 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 111.241 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.753 0.311 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -82.1 58.56 4.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.065 0.459 . . . . 0.0 110.966 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 170.6 -56.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.415 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.445 HD11 ' CG2' ' A' ' 6' ' ' VAL . 1.4 tm? -59.81 -55.87 28.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 m -54.66 -41.8 70.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 179.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.474 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.1 mt -57.64 -64.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.69 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.442 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.73 -36.46 11.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.51 179.518 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -29.39 70.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.97 -35.06 57.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -77.48 -8.58 57.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.161 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.14 51.93 1.99 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.964 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 51.0 m-85 -124.04 -175.92 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 111.345 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -140.23 77.92 24.07 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.061 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 71.8 Cg_endo -84.05 148.91 12.09 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.582 2.188 . . . . 0.0 113.617 -178.312 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.88 134.1 45.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.719 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.4 p -99.36 147.4 25.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.909 0.385 . . . . 0.0 111.166 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -147.24 145.77 29.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -62.83 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.0 p -48.65 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.255 0.55 . . . . 0.0 111.817 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.451 HD21 ' CE2' ' A' ' 63' ' ' PHE . 10.9 mt -45.51 -30.47 1.44 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.959 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -59.92 -61.67 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -58.76 -38.46 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.86 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . . . -58.85 -50.02 75.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.06 -48.66 22.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.964 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -55.73 31.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -26.38 61.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.172 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 10.0 mt -97.17 -6.87 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.75 25.21 5.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.359 . . . . 0.0 110.805 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.34 -58.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.457 ' CD2' ' CG ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -100.04 153.52 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.45 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 18.0 t80 -86.93 81.68 8.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.457 ' CG ' ' CD2' ' A' ' 44' ' ' LEU . 14.6 m-85 -67.88 117.17 45.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.4 -38.88 3.17 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.493 2.128 . . . . 0.0 112.325 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.2 t -124.83 125.92 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.96 0.409 . . . . 0.0 111.79 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.9 mm -115.2 134.29 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.42 109.71 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 111.841 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.44 170.58 16.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.423 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -134.63 -54.91 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.455 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.4 t 59.82 41.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.763 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.435 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 60.5 t-105 -62.73 -91.18 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.095 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.538 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -71.02 -48.76 13.55 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.438 -179.771 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 55' ' ' MET . 64.8 Cg_endo -72.52 -167.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.242 1.962 . . . . 0.0 112.283 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.07 55.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.833 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.02 115.89 8.54 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -92.84 31.19 1.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.806 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.09 64.37 0.95 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.365 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.0 -43.02 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.939 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.54 -18.43 40.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.451 ' CE2' HD21 ' A' ' 34' ' ' LEU . 45.8 t80 -49.96 -43.32 50.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.569 0.223 . . . . 0.0 111.227 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.434 HD11 ' HA ' ' A' ' 91' ' ' ALA . 3.2 mt -48.07 -30.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.056 0.455 . . . . 0.0 110.604 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -67.6 -53.25 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.184 179.373 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 41' ' ' ILE . 6.7 t80 -46.26 -44.2 16.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.795 0.331 . . . . 0.0 110.863 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.434 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.6 mp -61.94 -47.8 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -14.32 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.886 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' ASP . 28.0 tt0 -73.23 -51.43 17.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.013 0.435 . . . . 0.0 110.546 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.33 14.14 22.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.086 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.414 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -159.49 65.14 2.6 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.648 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 71' ' ' SER . 14.8 Cg_exo -67.75 -20.88 45.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.647 2.231 . . . . 0.0 112.091 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -104.68 33.1 3.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.617 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.8 t -110.63 -178.22 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -129.11 139.64 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.826 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.9 t -125.68 104.74 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.444 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -91.35 -43.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.566 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.2 t 48.15 96.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.721 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.1 mt -118.62 149.45 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.54 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.62 0.247 . . . . 0.0 111.267 -179.92 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.683 0.278 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -88.84 -15.43 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.459 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.98 -34.43 26.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.476 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -60.02 -61.28 2.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.93 178.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 92' ' ' ILE . 11.1 m -58.59 -29.11 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.849 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.54 -3.33 43.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -119.25 -39.88 2.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.373 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 88' ' ' ALA . 5.9 pt -74.35 -46.26 44.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.435 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -60.49 -26.92 67.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.536 179.729 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -62.82 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.5 19.09 0.07 OUTLIER Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.537 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.41 -169.68 2.48 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.285 0.542 . . . . 0.0 110.961 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.522 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 62.0 t80 -103.91 -18.95 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.534 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 9.0 pt-20 151.28 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.34 0.656 . . . . 0.0 110.003 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.476 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -133.49 98.51 4.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.93 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.8 tp -64.11 169.78 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.995 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.011 179.948 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.718 0.294 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.65 -42.23 92.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -34.73 78.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.244 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.418 ' CE1' HG12 ' A' ' 113' ' ' ILE . 9.7 t80 -60.66 -39.52 88.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.174 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.85 -36.46 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.187 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.44 -42.71 96.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.167 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.9 m -70.97 -46.67 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.418 HG12 ' CE1' ' A' ' 109' ' ' PHE . 5.1 mm -43.68 -58.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.508 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -47.41 -54.51 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.079 0.466 . . . . 0.0 110.123 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.07 66.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.41 -34.68 78.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.945 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE1' ' CA ' ' A' ' 2' ' ' LYS . 25.8 m-85 -74.45 -13.74 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.823 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 . . . . . 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.282 . . . . 0.0 111.358 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HD3' ' CD2' ' A' ' 117' ' ' PHE . 9.8 mmtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.836 0.35 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -147.84 83.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.774 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.438 HG21 ' CE1' ' A' ' 117' ' ' PHE . 22.9 t -68.94 160.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.467 HD11 ' CE2' ' A' ' 46' ' ' PHE . 55.3 tp -118.94 135.86 54.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' CG2' HD11 ' A' ' 17' ' ' LEU . 14.2 t -118.17 139.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.052 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.3 t -125.85 119.27 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.496 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 52' ' ' ASP . 22.9 t0 -170.32 160.68 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -179.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 27.4 t70 -88.27 50.53 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.586 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.711 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 54.7 p . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 16' ' ' SER . 1.6 m -55.77 133.79 51.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.851 0.357 . . . . 0.0 111.771 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 15' ' ' SER . 0.9 OUTLIER 82.36 -43.55 0.14 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.328 179.159 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.507 HD11 ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -52.21 -53.92 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.755 0.312 . . . . 0.0 111.367 -179.33 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.4 t -46.47 -71.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.54 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.3 -40.63 11.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 0.0 111.482 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.406 HD12 ' CG2' ' A' ' 106' ' ' VAL . 16.3 mt -64.18 -68.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.155 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' CD1' HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.62 -29.92 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.89 -24.0 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.998 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.52 -37.46 27.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.234 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.09 -25.44 43.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.7 2.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.267 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -112.4 -178.01 3.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 111.366 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.12 78.75 72.37 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.539 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.3 Cg_endo -84.27 139.29 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.862 2.375 . . . . 0.0 113.889 -177.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.408 ' HB3' HD12 ' A' ' 5' ' ' LEU . 11.1 t0 -121.97 118.27 28.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.342 178.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 72.8 p -102.34 127.05 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.93 0.395 . . . . 0.0 111.627 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.73 -165.18 1.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.526 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 -5.68 5.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.639 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.58 -176.28 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.479 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 24.8 mt -77.36 -31.49 54.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.731 0.301 . . . . 0.0 110.339 179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -45.64 67.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -35.72 80.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.075 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 41' ' ' ILE . . . -69.96 -48.18 59.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -46.42 -48.36 18.82 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.905 0.383 . . . . 0.0 110.503 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.84 -52.79 64.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.712 178.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -63.71 -23.47 67.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.283 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 37' ' ' ALA . 21.0 mt -93.33 -16.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.86 22.26 12.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.53 ' CB ' HD11 ' A' ' 44' ' ' LEU . 26.7 mt-10 -143.22 -52.98 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.771 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -99.64 12.95 35.2 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.413 0.625 . . . . 0.0 109.818 179.691 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 44' ' ' LEU . 16.1 t80 23.72 86.19 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.748 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 5' ' ' LEU . 49.3 m-85 -68.42 148.57 98.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.407 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 8.4 Cg_endo -83.67 -47.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.792 2.328 . . . . 0.0 111.88 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.94 126.79 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 49' ' ' ILE . 21.5 mm -111.97 125.68 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.853 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.411 HG21 ' CE1' ' A' ' 109' ' ' PHE . 52.9 t -127.16 106.31 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.08 0.467 . . . . 0.0 112.031 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.9 tp -79.04 165.11 23.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.304 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' CB ' ' HB2' ' A' ' 8' ' ' ASP . 42.4 t0 -127.59 -56.79 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.668 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.1 t 67.96 66.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.935 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -96.54 -82.93 0.39 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 111.442 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.607 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.2 mtt -83.68 -31.76 0.5 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 55' ' ' MET . 87.7 Cg_endo -83.05 -174.25 1.96 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.099 1.866 . . . . 0.0 112.922 -179.225 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -170.19 58.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.563 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.71 12.69 60.74 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.955 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.45 92.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.792 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.33 -9.05 60.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.852 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.0 t -51.32 -49.72 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.403 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.58 -3.9 40.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.941 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.479 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 12.2 t80 -88.64 -42.09 12.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.538 0.209 . . . . 0.0 111.504 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.8 mp -43.84 -30.07 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.771 0.319 . . . . 0.0 111.272 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -67.24 -54.63 19.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -48.15 -40.6 24.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 110.52 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' SER . 3.7 mp -60.45 -48.34 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.511 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -77.24 -18.97 57.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.971 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.89 -50.68 54.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.956 0.408 . . . . 0.0 110.716 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.07 17.26 16.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.6 OUTLIER -161.26 68.33 2.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.771 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.11 -16.63 25.28 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.764 2.309 . . . . 0.0 112.297 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.07 -2.45 34.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.377 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.6 t -82.37 176.82 9.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.051 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.61 159.25 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.88 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 t -143.54 83.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.571 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.4 mm -71.53 -45.32 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.656 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 6.8 t 48.67 85.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.489 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 7.6 mt -107.19 152.5 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 -179.977 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.66 0.267 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.3 -22.17 66.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.315 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.7 39.48 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -61.51 -58.58 7.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.004 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.12 -23.43 27.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.842 179.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -91.09 39.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.376 179.566 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.16 -38.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.083 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.418 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 7.6 pt -74.36 -30.03 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -29.84 67.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.7 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.69 65.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.144 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.77 -2.18 3.31 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.231 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -56.99 -168.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.046 0.423 . . . . 0.0 111.111 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 6.8 t80 -110.73 27.87 9.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 80.67 156.78 0.14 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.434 179.705 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.513 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -88.54 110.26 20.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 -179.993 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 tp -63.72 149.42 46.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.862 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.875 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 32.8 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.024 0.44 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.7 -55.64 18.7 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.14 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -60.94 -31.54 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.807 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 27.8 t80 -57.65 -39.28 76.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.893 179.065 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.45 -51.03 71.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.174 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -57.29 -46.13 83.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.549 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 m -69.27 -44.96 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 0.0 110.959 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.431 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 1.6 mm -40.63 -52.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.78 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.19 12.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.651 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -62.08 -36.21 80.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.46 85.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.988 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.438 ' CE1' HG21 ' A' ' 4' ' ' VAL . 19.5 m-85 -65.36 -19.42 65.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.291 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.333 -179.878 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.415 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -142.35 118.09 10.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.967 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 117' ' ' PHE . 14.3 t -118.6 160.81 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.438 HD23 ' CD2' ' A' ' 46' ' ' PHE . 42.5 tp -114.74 133.44 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.871 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 30' ' ' THR . 24.5 t -113.58 90.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.407 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 t -82.2 111.85 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.87 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -147.73 137.54 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 13.2 t0 -61.38 -80.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.995 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 p . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.722 0.296 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -80.43 -54.54 5.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.024 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -69.62 -63.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.637 HD23 ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -45.21 -46.17 12.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.315 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.55 ' HA ' HD12 ' A' ' 21' ' ' LEU . 5.7 t -44.73 -37.76 3.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.2 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.238 0.542 . . . . 0.0 110.391 179.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CD1' HG13 ' A' ' 106' ' ' VAL . 3.0 mp -68.54 -68.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.144 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.637 ' HB3' HD23 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -48.51 -27.24 2.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.316 179.438 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.501 ' N ' HD13 ' A' ' 21' ' ' LEU . 15.5 mt-10 -73.71 -28.44 61.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.711 0.291 . . . . 0.0 111.011 179.129 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.1 tt0 -80.31 -36.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.826 0.346 . . . . 0.0 110.511 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.442 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -64.46 -17.37 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 -179.98 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.99 65.51 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.22 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.556 ' HB2' HD23 ' A' ' 21' ' ' LEU . 20.3 m-85 -137.69 -176.92 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.217 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.84 91.89 43.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.716 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.583 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 72.7 Cg_endo -84.3 133.3 5.45 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.625 2.216 . . . . 0.0 112.91 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.549 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -110.26 7.23 23.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.344 -179.731 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.549 ' O ' ' O ' ' A' ' 29' ' ' ASP . 15.4 p 6.5 122.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 -170.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.116 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 18.9 tttt -104.39 -43.33 5.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -161.15 -168.28 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.317 179.535 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.433 HD21 ' CD2' ' A' ' 63' ' ' PHE . 32.1 mt -67.19 -52.9 35.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -57.36 -45.78 84.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.58 -35.16 75.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.36 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.45 -34.73 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 77.5 mt-10 -64.51 -43.38 94.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -39.11 78.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -72.36 -49.93 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.687 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.0 mt -64.19 -27.33 42.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.074 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -27.92 5.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -124.2 -42.34 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.08 115.01 19.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -80.34 101.34 8.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.709 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.438 ' CD2' HD23 ' A' ' 5' ' ' LEU . 35.2 m-85 -97.25 119.15 63.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.0 Cg_endo -73.06 -17.69 24.63 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.477 2.118 . . . . 0.0 111.899 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.48 HG23 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -147.85 132.21 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.565 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.77 160.1 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.428 HG21 ' CE1' ' A' ' 109' ' ' PHE . 60.0 t -152.67 99.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.206 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -71.39 164.56 25.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' TRP . 4.8 t70 -152.61 57.6 0.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -44.43 91.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.04 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.414 ' N ' ' O ' ' A' ' 52' ' ' ASP . 30.3 t-105 -88.16 -75.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.828 179.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.729 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 7.8 ttp -147.18 46.22 0.48 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.161 179.002 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.729 ' HD3' ' N ' ' A' ' 55' ' ' MET . 28.1 Cg_endo -95.48 -160.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.235 2.623 . . . . 0.0 112.204 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -149.54 60.03 1.01 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.03 131.24 4.49 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.508 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -74.23 144.94 44.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.973 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.79 -18.95 12.69 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.766 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.0 t -52.94 -40.61 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.16 -11.44 49.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.433 ' CD2' HD21 ' A' ' 34' ' ' LEU . 26.5 t80 -78.76 -39.64 35.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.371 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.57 -32.79 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.359 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.64 -32.96 60.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.662 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 48.3 t80 -61.29 -44.96 96.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.417 HD13 ' CD2' ' A' ' 63' ' ' PHE . 4.1 mp -58.02 -42.64 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.271 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -80.25 -19.23 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 18.4 tt0 -71.15 -30.92 67.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.947 0.403 . . . . 0.0 110.703 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.438 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -132.37 17.21 4.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 180.0 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.57 68.73 1.05 Allowed Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.59 -21.25 46.16 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.77 2.313 . . . . 0.0 112.183 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.67 31.09 3.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.9 t -112.65 -163.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.402 ' N ' ' OG ' ' A' ' 74' ' ' SER . 45.8 t -152.58 135.85 7.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-O 121.025 0.441 . . . . 0.0 111.421 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.5 t -107.89 109.85 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.723 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.7 mm -87.75 -56.32 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.48 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 20.3 t 53.65 103.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.518 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mt -102.98 -173.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.227 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.414 ' O ' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.85 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.763 0.316 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -78.85 -52.93 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.694 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.401 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.2 t -47.29 -32.5 4.73 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.205 0.526 . . . . 0.0 110.062 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . . . -59.99 -60.04 4.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.16 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.408 ' HA ' HG12 ' A' ' 92' ' ' ILE . 17.5 m -66.32 -24.66 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.118 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -83.63 -20.23 34.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.258 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -102.52 -39.14 7.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.662 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 92' ' ' ILE . 11.8 pt -69.32 -27.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.408 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -32.08 64.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.697 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -64.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 29.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.916 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.401 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -90.18 -167.22 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 84.1 t80 -117.67 26.03 9.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.1 pt-20 85.74 146.43 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.415 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.48 ' CE1' ' CG1' ' A' ' 78' ' ' VAL . 1.0 OUTLIER -78.8 105.39 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.772 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 tp -57.59 167.01 1.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.05 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 179.942 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' PHE . 13.4 p . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.764 0.316 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -39.87 -38.31 0.66 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.04 -39.77 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.413 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 106' ' ' VAL . 21.0 t80 -57.14 -28.32 62.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.74 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -48.03 67.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.331 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.468 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 5.4 mp -66.73 -52.19 47.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.973 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 m -46.36 -32.61 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 0.0 110.728 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.427 HG12 ' CE1' ' A' ' 109' ' ' PHE . 22.1 mm -78.18 -67.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -50.42 -19.66 0.91 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.941 -179.939 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.41 ' CG ' ' OH ' ' A' ' 97' ' ' TYR . 1.8 t-80 -89.58 -27.84 19.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 110.754 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.01 -35.49 57.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.48 ' CE1' HG23 ' A' ' 48' ' ' VAL . 63.7 m-85 -79.73 -45.77 18.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.783 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.912 0.386 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -162.37 127.66 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.721 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 39.5 t -116.86 143.72 26.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.727 0.298 . . . . 0.0 110.685 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.425 HD23 ' CD2' ' A' ' 46' ' ' PHE . 19.1 tp -96.88 132.3 42.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.061 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.425 ' CG1' ' CG2' ' A' ' 14' ' ' THR . 21.9 t -116.35 89.0 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 23.9 t -84.88 112.74 22.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.104 0.478 . . . . 0.0 111.167 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -146.12 136.51 23.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.565 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -51.27 -24.31 4.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.688 179.621 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.425 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 72.0 p . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -68.2 137.11 54.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.601 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 15' ' ' SER . 0.8 OUTLIER 83.59 -16.94 0.52 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.28 179.316 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -86.39 -50.18 7.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 110.796 -179.899 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.15 -53.67 12.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' GLU . 85.9 mt -67.85 -69.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.403 ' CD1' ' CD1' ' A' ' 17' ' ' LEU . 1.1 mt -45.94 -30.23 1.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.98 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.87 -30.59 69.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.734 179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.47 -35.29 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.014 179.486 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -85.06 178.56 7.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.662 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.25 31.58 6.93 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.219 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.36 -175.55 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.199 0.523 . . . . 0.0 111.301 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.9 OUTLIER -151.05 95.79 3.35 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.811 179.61 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 57.6 Cg_endo -72.94 140.51 31.77 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.251 1.968 . . . . 0.0 112.481 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -115.42 -1.31 12.87 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.584 ' O ' ' O ' ' A' ' 29' ' ' ASP . 48.9 p 12.66 122.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -132.38 159.96 37.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.444 178.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' HB2' ' CB ' ' A' ' 36' ' ' GLU . 31.5 mttt -73.48 -168.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.401 ' CG2' ' HB3' ' A' ' 56' ' ' PRO . 16.8 p -48.04 161.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 111.909 -178.212 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 63' ' ' PHE . 10.4 mt -27.24 -44.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.648 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.18 -62.36 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.318 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 2.1 tp10 -65.38 -34.73 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.22 -63.14 1.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -44.67 -40.7 6.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.382 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -52.62 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.42 -34.28 76.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.835 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mt -85.27 -5.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.667 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -93.02 29.18 1.9 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.959 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -147.69 -53.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -99.31 -174.63 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -122.48 111.16 16.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.527 ' CZ ' ' CD2' ' A' ' 44' ' ' LEU . 67.6 m-85 -98.58 125.59 42.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.41 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.3 Cg_endo -81.44 -23.97 4.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.711 2.274 . . . . 0.0 111.485 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.2 t -141.55 131.06 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.567 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.8 mm -118.25 152.08 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.344 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.52 102.29 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.036 0.445 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 8.8 tp -94.3 129.62 40.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.063 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -113.33 113.15 24.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.417 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.463 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 5.2 m -76.08 56.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.41 . . . . 0.0 111.542 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.409 ' CE2' ' HE3' ' A' ' 55' ' ' MET . 31.3 t-105 -64.76 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.489 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.671 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 35.1 mtm -149.01 51.78 1.03 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.949 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.671 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.5 Cg_exo -81.12 -153.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -163.19 30.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.23 134.51 7.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -58.64 105.79 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 34' ' ' LEU . . . -69.89 -33.82 70.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 64' ' ' ILE . 57.4 t -55.49 -39.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.014 0.435 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -23.64 59.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.183 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.43 ' CD2' HD22 ' A' ' 34' ' ' LEU . 39.7 t80 -75.35 -30.16 60.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 61' ' ' VAL . 5.4 mm -50.65 -33.74 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 69' ' ' GLU . 27.3 t70 -71.56 -39.57 70.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.401 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 14.7 t80 -55.19 -43.68 74.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.428 HD13 ' CE2' ' A' ' 63' ' ' PHE . 4.0 mp -59.57 -46.28 93.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.397 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -79.31 -13.27 59.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.748 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.427 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 43.2 tt0 -74.38 -43.15 57.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.113 0.483 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.476 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -118.55 13.61 13.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.037 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.89 66.43 2.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.925 0.393 . . . . 0.0 110.72 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.4 Cg_exo -69.13 -19.63 38.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.632 2.221 . . . . 0.0 112.243 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.29 27.3 7.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -109.68 -157.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -150.23 137.54 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.064 0.459 . . . . 0.0 111.726 179.212 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.6 t -116.35 91.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.6 mm -72.38 -59.26 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.114 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.464 HG12 ' CE1' ' A' ' 99' ' ' PHE . 47.9 t 51.63 92.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.837 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 100' ' ' LEU . 3.0 mt -116.42 145.71 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.992 0.425 . . . . 0.0 111.558 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.42 ' HB ' ' CG2' ' A' ' 53' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.686 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.948 0.404 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -103.92 -28.78 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -85.47 -31.81 22.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 109.953 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -61.55 -56.59 18.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.777 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.8 m -52.58 -30.71 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.888 179.445 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 ttmt -75.98 -22.34 55.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.48 -40.72 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.87 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 89' ' ' VAL . 9.2 pt -70.91 -42.94 77.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.321 -179.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -23.38 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.554 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -79.76 -57.83 3.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.61 28.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.495 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.18 -164.52 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.12 0.46 . . . . 0.0 110.68 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.519 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 54.8 t80 -101.87 -23.18 14.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.6 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 3.8 pt-20 150.07 -11.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.603 0.565 . . . . 0.0 111.932 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 1.5 t80 69.98 71.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.121 0.486 . . . . 0.0 110.085 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 66.1 tp -49.77 165.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.189 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.434 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 7.7 mt-10 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.632 0.254 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.93 -41.91 77.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -60.83 -34.85 75.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.455 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.482 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 6.2 t80 -61.35 -39.78 91.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.429 178.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.407 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 1.2 tt -48.72 -51.71 27.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.31 179.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -57.35 -46.57 83.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.4 m -60.8 -40.17 91.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.223 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 109' ' ' PHE . 2.0 mm -47.97 -54.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.535 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.91 -59.15 3.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -51.73 -29.46 18.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.867 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.33 -33.94 77.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.965 0.412 . . . . 0.0 110.672 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 4' ' ' VAL . 35.1 m-85 -78.45 -23.01 46.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.291 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.808 0.337 . . . . 0.0 111.186 179.969 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.429 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmtp . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.866 0.365 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.33 133.57 24.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.842 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 18.6 t -128.03 161.08 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.799 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' VAL . 28.0 tp -112.51 134.64 53.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 30' ' ' THR . 22.0 t -116.23 90.28 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.823 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.6 106.02 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.772 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -136.66 133.11 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.989 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 16.8 t70 -51.85 -45.1 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.277 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.661 -179.99 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.639 0.257 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -90.11 -47.02 8.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.544 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -74.88 -69.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.661 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.442 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -40.71 -48.02 2.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.68 -179.393 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.546 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.6 t -51.17 -41.73 60.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 110.924 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.35 74.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.313 0.577 . . . . 0.0 109.892 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 ' CD1' ' CG1' ' A' ' 106' ' ' VAL . 2.0 mp -75.51 -63.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.965 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.62 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.11 -13.35 1.17 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.088 -179.241 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.58 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.6 mt-10 -85.07 -26.03 27.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.79 0.329 . . . . 0.0 110.313 179.034 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -35.55 26.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.394 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -73.98 -50.37 20.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.67 57.05 0.22 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.194 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 82.1 m-85 -120.24 -174.74 2.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.072 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.77 89.17 40.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.058 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 85.2 Cg_endo -81.32 124.95 4.97 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.522 2.148 . . . . 0.0 113.062 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.97 7.52 46.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 29' ' ' ASP . 11.7 p 4.42 122.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.2 168.18 10.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.428 178.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 9' ' ' ASP . 37.1 mttm -88.93 -37.89 14.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -155.95 -179.5 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.734 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.2 mt -61.88 -33.89 75.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.549 179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -48.19 71.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.191 179.293 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.51 -30.15 68.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.4 -33.9 69.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -67.84 -42.56 81.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -33.73 76.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.088 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -75.83 -42.81 48.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.509 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.3 mt -72.49 -26.95 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -26.76 13.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -122.27 -42.5 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 139.83 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -103.72 101.93 11.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.77 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.47 ' CZ ' ' CB ' ' A' ' 29' ' ' ASP . 25.8 m-85 -94.82 120.09 65.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.9 Cg_endo -73.64 -12.38 24.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.43 2.087 . . . . 0.0 111.759 179.096 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.424 HG23 ' CE2' ' A' ' 117' ' ' PHE . 2.4 t -151.94 135.11 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 12.3 mm -115.83 161.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.633 178.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' LEU . 60.7 t -149.72 94.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.542 . . . . 0.0 111.642 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.421 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 11.6 tp -77.59 171.1 15.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.289 179.624 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 6.4 t70 -139.65 -46.43 0.45 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.395 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t 66.24 40.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 111.215 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -57.79 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.525 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.672 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.7 mmm -148.05 51.36 1.03 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.059 179.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.672 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.8 Cg_endo -87.56 -155.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.036 2.49 . . . . 0.0 112.021 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -148.67 38.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.02 168.87 22.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.515 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.0 111.58 24.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.38 -19.4 66.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.752 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.8 t -53.12 -48.85 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.859 0.362 . . . . 0.0 111.357 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -14.08 58.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.299 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.429 ' CE2' HD13 ' A' ' 67' ' ' ILE . 44.6 t80 -71.87 -37.7 70.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.683 0.277 . . . . 0.0 111.225 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.2 mt -47.89 -28.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.285 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -34.24 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -60.12 -38.68 83.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.139 179.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.429 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -60.32 -45.97 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 179.369 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -77.91 -24.24 48.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 25.9 tt0 -64.57 -33.61 76.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.42 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -131.0 17.52 5.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.182 -179.836 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.82 70.02 1.04 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.823 0.344 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.2 -18.79 34.73 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.842 2.361 . . . . 0.0 112.254 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -98.89 30.42 3.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.824 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 41.6 t -114.71 -162.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.8 t -154.31 136.5 6.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.68 0.276 . . . . 0.0 111.284 179.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 4.9 t -110.38 110.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.837 -179.036 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 79' ' ' ILE . 28.1 mm -111.11 43.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.662 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.424 ' HB ' ' CE1' ' A' ' 99' ' ' PHE . 47.7 t -43.36 121.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.587 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 3.8 mt -121.34 150.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.805 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.9 179.941 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -111.25 -10.36 14.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -89.38 -36.5 15.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -57.62 -58.21 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.843 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.402 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.1 m -55.14 -27.11 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.578 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -82.21 -20.35 37.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.134 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.59 -40.3 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.498 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.491 HD13 HG21 ' A' ' 92' ' ' ILE . 12.5 pt -68.71 -31.52 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -26.4 67.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.697 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -73.74 -59.59 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 31.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.332 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.09 -164.67 1.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.025 0.412 . . . . 0.0 110.438 179.3 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.555 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.6 t80 -105.22 -22.02 13.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.53 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 144.52 14.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.733 0.645 . . . . 0.0 111.773 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER 62.15 163.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 110.643 -179.881 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.48 97.04 6.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.649 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.032 -179.889 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.414 ' CG1' ' CD1' ' A' ' 20' ' ' ILE . 12.4 p . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.746 0.308 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -45.94 -41.82 12.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.936 0.398 . . . . 0.0 110.909 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -34.79 78.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.166 179.362 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 6.3 t80 -68.03 -28.93 67.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.522 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.67 -42.69 56.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.37 -56.2 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.836 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.9 m -46.62 -44.06 17.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.055 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.2 mm -54.53 -69.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.037 0.446 . . . . 0.0 110.43 179.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.412 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -54.9 -17.9 4.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.876 179.111 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -89.8 -21.23 22.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.34 -37.34 18.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.971 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.424 ' CE2' HG23 ' A' ' 48' ' ' VAL . 35.0 m-85 -73.09 -39.29 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.294 -179.741 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 25.4 mmtt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.861 0.362 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.405 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -147.99 124.75 11.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' A' ' 117' ' ' PHE . 25.2 t -119.6 159.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.442 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 41.7 tp -114.04 136.29 53.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.579 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.6 t -120.79 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.14 119.47 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.567 179.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 12.3 t0 -163.75 154.74 16.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.747 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -85.23 48.99 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.653 179.707 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.2 p . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.46 -155.13 0.39 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.745 0.307 . . . . 0.0 111.523 -179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' LEU . 52.6 m -47.53 -22.23 0.45 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.869 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -32.14 -49.55 0.2 Allowed 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 110.482 179.238 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 t -47.78 -67.14 0.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.111 179.289 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.53 75.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 23' ' ' GLU . 13.7 mt -61.59 -63.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.346 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' CD1' ' O ' ' A' ' 17' ' ' LEU . 1.5 mt -45.07 -36.18 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.329 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -27.85 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.136 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' ILE . 12.3 tt0 -87.1 -41.98 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -75.31 -43.33 51.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.75 32.71 5.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.558 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 48.9 m-85 -81.42 -174.63 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.894 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.98 86.05 53.1 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.031 179.332 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.46 136.82 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 112.505 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 30' ' ' THR . 7.2 t70 -113.53 3.02 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.03 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.564 ' O ' ' O ' ' A' ' 29' ' ' ASP . 26.4 p 9.84 121.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.12 -178.54 3.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.699 179.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 30.7 tttp -95.39 -38.62 10.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.667 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 6.2 t -165.76 -162.47 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 14.9 mt -68.4 -47.36 67.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.657 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -60.78 -45.63 93.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 109.989 179.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -34.13 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.06 73.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.705 179.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 90.3 mt-10 -65.92 -41.31 91.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -38.07 85.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.601 178.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -74.06 -49.94 21.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.873 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 mt -66.9 -27.75 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.145 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -62.85 -23.99 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.095 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.06 -42.89 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.247 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 129.16 38.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -82.18 62.39 5.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.461 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 60.0 m-85 -55.34 121.31 36.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.475 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.427 ' O ' ' HA ' ' A' ' 74' ' ' SER . 61.0 Cg_endo -72.9 -22.92 19.35 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.435 2.09 . . . . 0.0 111.805 179.318 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 4.5 t -142.68 125.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.316 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 46' ' ' PHE . 8.3 mm -111.91 152.52 13.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.029 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.426 ' CG1' ' H ' ' A' ' 51' ' ' LEU . 4.9 t -134.87 177.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.432 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 29.4 tp -161.74 78.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.072 0.463 . . . . 0.0 111.101 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.72 67.84 0.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.517 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.412 ' CG2' ' HG ' ' A' ' 51' ' ' LEU . 50.4 t -47.12 92.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.474 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -79.19 -80.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.502 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.675 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -152.5 50.6 0.64 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.13 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.675 ' HD3' ' N ' ' A' ' 55' ' ' MET . 10.1 Cg_endo -90.57 -158.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.043 2.495 . . . . 0.0 112.015 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -157.74 58.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.096 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.48 10.79 4.06 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.788 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 52.98 -162.02 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.717 0.258 . . . . 0.0 110.679 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.23 28.96 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.674 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.416 HG22 ' HD3' ' A' ' 90' ' ' LYS . 17.6 t -89.44 -44.91 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.13 9.56 27.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.569 -179.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.451 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 17.6 t80 -90.03 -36.88 14.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.442 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.6 mp -46.79 -28.97 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.403 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -35.89 65.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.425 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 12.3 t80 -62.74 -44.2 96.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.422 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.0 mp -59.27 -37.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.321 179.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -85.7 -20.19 29.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.719 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -69.59 -29.26 66.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -131.93 9.05 4.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.251 -179.873 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.03 67.79 3.21 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.854 0.359 . . . . 0.0 110.745 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.65 -15.37 21.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.799 2.333 . . . . 0.0 112.285 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.35 27.35 9.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.067 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 39.8 t -107.18 -163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.489 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.36 131.64 12.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 121.239 0.542 . . . . 0.0 112.457 179.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.3 t -105.25 110.72 31.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.094 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -109.25 38.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.472 HG13 ' CE1' ' A' ' 99' ' ' PHE . 60.0 t -42.63 115.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.295 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -105.64 179.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.87 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 111.289 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.935 0.398 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -104.12 -18.92 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -90.84 -36.16 14.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' CB ' ' CG ' ' A' ' 99' ' ' PHE . . . -56.78 -57.27 13.17 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.84 178.794 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -51.76 -26.86 7.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.416 ' HD3' HG22 ' A' ' 61' ' ' VAL . 8.9 tttt -89.09 36.74 0.83 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.22 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.442 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -170.31 -42.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.614 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.47 157.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.808 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.16 -3.2 2.52 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.102 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -112.6 -25.33 9.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.31 -34.92 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.25 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -68.91 177.63 2.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.773 0.321 . . . . 0.0 111.151 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 45.4 t80 -108.77 29.94 6.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.486 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.1 OUTLIER 80.15 142.71 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.932 179.773 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.491 ' CG ' ' CB ' ' A' ' 88' ' ' ALA . 1.6 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.38 -179.605 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -89.94 89.46 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.593 179.655 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.26 -179.882 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 33.3 m . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -45.93 -47.85 16.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.664 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -70.45 -30.34 67.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.987 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.435 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -65.71 -25.15 67.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.447 179.522 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.44 -50.15 23.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.883 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.468 ' HA ' ' CG ' ' A' ' 114' ' ' LYS . 5.5 mp -55.63 -47.56 76.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.476 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.7 m -49.29 -38.36 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.632 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.42 HG21 ' CD1' ' A' ' 117' ' ' PHE . 8.3 mm -66.48 -62.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.16 179.237 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.468 ' CG ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -55.56 -14.94 2.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.456 179.402 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.42 ' N ' ' HD3' ' A' ' 114' ' ' LYS . 2.0 m80 -90.41 -19.69 23.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.072 0.463 . . . . 0.0 110.266 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.98 -49.1 6.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.963 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.426 ' CZ ' HG21 ' A' ' 48' ' ' VAL . 36.9 m-85 -56.8 -30.8 64.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.985 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 19.9 mmtt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.836 0.351 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.64 128.04 17.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.651 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 22.2 t -121.5 151.45 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 -179.806 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.458 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 33.5 tp -101.24 136.53 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.752 0.31 . . . . 0.0 110.516 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.482 HG23 HD11 ' A' ' 17' ' ' LEU . 8.4 t -117.14 95.57 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 87.6 t -89.34 116.22 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 0.0 111.243 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -145.37 112.68 6.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.879 179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -50.42 -79.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -178.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' CB ' ' CD1' ' A' ' 54' ' ' TRP . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.915 0.388 . . . . 0.0 111.244 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.506 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 2.7 p . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -42.57 140.92 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.285 -178.733 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.6 m 85.56 -17.57 0.41 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.62 179.054 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -70.66 -54.45 11.87 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.052 -179.672 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.0 -67.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.676 -179.562 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.65 -40.36 27.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.496 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.447 ' CD1' HG23 ' A' ' 106' ' ' VAL . 60.3 mt -64.72 -66.27 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' A' ' 17' ' ' LEU . 1.1 mt -47.65 -29.44 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.13 -25.09 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.09 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -81.89 -41.11 21.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.869 0.366 . . . . 0.0 110.246 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.85 -32.09 59.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.059 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.74 31.17 6.46 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 51.1 m-85 -88.27 -174.69 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -139.01 91.61 11.38 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.635 179.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 66.9 Cg_endo -76.88 145.49 25.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.18 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.9 t70 -120.09 -4.61 10.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.703 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.613 ' O ' ' O ' ' A' ' 29' ' ' ASP . 10.2 p 23.54 123.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.64 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -131.74 145.69 51.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.297 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.463 ' CB ' ' CB ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -58.61 -173.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.521 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.36 167.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 111.654 -178.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 63' ' ' PHE . 11.8 mt -31.44 -39.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.481 -178.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -62.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.149 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.463 ' CB ' ' CB ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -64.81 -27.25 68.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.865 179.568 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.45 -57.39 4.47 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.391 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 42' ' ' LYS . 64.5 mt-10 -46.31 -41.34 13.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -61.0 -53.28 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -59.66 -35.03 73.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.129 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mt -92.3 -5.23 10.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLU . 2.8 tmtm? -56.75 -19.61 17.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.299 -179.813 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -139.43 -46.23 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 121.07 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -87.14 75.22 9.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 27.2 m-85 -66.09 132.33 94.56 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.23 -30.38 6.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.411 2.074 . . . . 0.0 111.878 179.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.418 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 2.4 t -140.32 132.98 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.537 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.9 mm -115.47 145.23 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.453 179.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.441 HG23 ' CE1' ' A' ' 109' ' ' PHE . 44.1 t -130.3 105.74 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 111.446 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.7 tp -100.33 147.88 25.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.3 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -119.11 -31.76 4.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.563 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' A' ' 80' ' ' THR . 88.5 t 60.64 63.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.73 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.452 ' CD1' ' CB ' ' A' ' 10' ' ' GLU . 37.1 t-105 -58.83 -81.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.834 0.349 . . . . 0.0 110.383 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.703 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 ttt -151.97 48.82 0.5 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.085 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.703 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.8 Cg_exo -76.87 -150.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.789 2.326 . . . . 0.0 112.032 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -135.18 21.48 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.212 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.67 -3.71 4.98 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.029 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 52.64 25.1 3.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.018 0.437 . . . . 0.0 111.167 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 49.6 18.63 1.73 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.623 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 64' ' ' ILE . 23.2 t -87.25 -45.1 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 117.149 0.474 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -65.78 -16.16 63.53 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.47 ' CE2' HD13 ' A' ' 67' ' ' ILE . 3.7 t80 -85.65 -29.05 24.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 61' ' ' VAL . 20.2 mm -46.59 -43.47 6.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.327 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -44.91 70.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.43 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 21.1 t80 -49.4 -41.06 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.975 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.47 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.1 mp -62.61 -49.97 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -12.09 60.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.466 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.92 -49.37 20.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.059 0.457 . . . . 0.0 110.394 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.18 17.04 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.976 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.05 67.2 2.05 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.736 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.22 -15.77 22.66 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.776 2.317 . . . . 0.0 112.265 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -112.61 32.91 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.83 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -111.89 -159.83 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.878 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.2 t -138.08 138.98 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.309 0.576 . . . . 0.0 112.293 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 6.2 t -114.41 99.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.317 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 79' ' ' ILE . 35.0 mm -103.41 43.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.431 HG12 ' CE1' ' A' ' 99' ' ' PHE . 98.9 t -54.72 87.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 100' ' ' LEU . 19.2 mt -66.25 -101.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.424 HG22 ' CG2' ' A' ' 53' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.237 . . . . 0.0 111.041 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 C--O 1.231 0.094 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.72 -27.06 68.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.685 0.279 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.52 -34.24 54.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -59.8 -57.81 11.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.018 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 m -56.84 -22.83 16.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.956 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.41 2.81 23.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.248 179.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -138.71 -40.53 0.5 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.445 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 1.6 pt -70.84 -24.59 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -71.74 -35.58 70.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -59.21 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.65 31.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.995 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.24 -178.74 5.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -101.25 27.91 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.426 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 77.64 151.96 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.971 179.927 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -74.19 139.26 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.418 ' CB ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -83.64 92.11 7.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.556 179.869 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.066 -179.823 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.503 ' CG2' HD22 ' A' ' 17' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.465 0.304 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.1 -50.86 29.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -61.94 -29.63 70.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.417 178.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.468 ' CZ ' ' CG1' ' A' ' 113' ' ' ILE . 24.0 t80 -62.12 -40.71 96.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.712 178.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.417 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 2.0 mt -54.65 -48.83 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.263 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.54 -50.45 73.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.028 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.0 m -61.5 -37.55 84.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.707 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.468 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 1.6 mm -55.76 -53.13 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.375 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -60.0 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 109.853 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -58.4 -26.13 62.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.998 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.14 -38.35 87.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.926 0.393 . . . . 0.0 110.977 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.418 ' CZ ' HG21 ' A' ' 48' ' ' VAL . 20.7 m-85 -68.84 -20.04 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.632 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.961 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG3' ' CD2' ' A' ' 117' ' ' PHE . 2.0 mptt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.909 0.385 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -111.39 124.73 52.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.458 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 26.9 t -124.33 144.33 34.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.329 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.435 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 46.8 tp -95.02 128.76 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.321 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.434 ' CG1' ' CG2' ' A' ' 14' ' ' THR . 18.9 t -112.91 92.56 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.482 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 60.1 t -89.99 118.72 35.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.029 0.442 . . . . 0.0 111.082 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -153.63 125.12 7.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -85.73 47.59 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' CG ' ' CD1' ' A' ' 54' ' ' TRP . 4.0 tm-20 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.676 179.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.434 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 65.6 p . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.799 0.333 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -52.19 139.46 23.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 0.0 112.185 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.426 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 8.7 t 73.54 0.72 3.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.449 179.109 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.36 -59.45 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.157 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.562 ' HA ' HD21 ' A' ' 21' ' ' LEU . 7.8 t -46.5 -45.94 18.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.591 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.14 73.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.376 0.607 . . . . 0.0 110.17 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.508 HD12 ' CG2' ' A' ' 106' ' ' VAL . 41.7 mt -76.14 -64.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.774 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.65 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -56.74 -10.46 1.04 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.978 -179.186 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.538 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 17.4 mt-10 -89.23 -28.6 19.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -36.1 32.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.013 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.403 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 30.5 mm-40 -77.77 -31.33 51.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.019 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 42.89 3.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.512 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 7.2 m-85 -95.83 -170.31 2.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 -179.066 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.08 93.47 5.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HD3' ' HG ' ' A' ' 21' ' ' LEU . 73.3 Cg_endo -79.67 146.78 19.17 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.384 2.056 . . . . 0.0 112.011 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.658 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -115.76 -7.26 12.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 29' ' ' ASP . 11.7 p 25.51 124.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -141.89 141.88 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.901 178.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 7' ' ' VAL . 39.4 mtmt -58.79 -165.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.56 0.219 . . . . 0.0 110.564 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 p -47.89 168.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 112.149 -177.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' A' ' 59' ' ' ASP . 22.5 mt -40.81 -31.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.97 -179.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -64.3 0.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.14 0.495 . . . . 0.0 109.84 179.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.5 -33.72 76.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.461 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.88 -61.66 2.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.729 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 42' ' ' LYS . 7.5 mt-10 -44.05 -42.12 5.93 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -61.44 -51.74 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -63.35 -33.95 76.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.336 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.3 mt -88.95 -9.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -57.67 -19.42 26.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.501 -179.735 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -134.64 -47.25 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 124.72 20.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -84.96 72.0 10.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 25.0 m-85 -65.79 126.77 92.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.79 -27.62 3.84 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.508 2.139 . . . . 0.0 112.074 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 2.8 t -140.51 132.62 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.346 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mm -118.73 148.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.138 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 49.0 t -136.86 104.57 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.488 179.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp -98.99 97.68 8.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -83.42 92.79 7.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.953 178.936 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 53' ' ' VAL . 28.0 m -63.87 74.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.789 -179.211 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.442 ' CD1' ' CG ' ' A' ' 10' ' ' GLU . 30.3 t-105 -81.75 -80.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.514 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.493 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 21.9 mmt -145.67 61.4 7.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.809 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 55' ' ' MET . 11.1 Cg_endo -89.2 -159.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.128 2.552 . . . . 0.0 112.32 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -153.77 25.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.141 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.96 10.66 5.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.629 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.411 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.7 OUTLIER 55.92 -157.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.788 0.294 . . . . 0.0 110.212 -179.703 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.7 22.04 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.4 t -86.83 -45.15 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 110.879 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -1.16 50.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.471 ' CE1' ' CD2' ' A' ' 66' ' ' PHE . 6.5 t80 -76.32 -41.14 49.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.403 HD11 ' O ' ' A' ' 91' ' ' ALA . 2.4 mt -43.81 -38.42 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.329 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.32 -51.37 57.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.427 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 34.0 t80 -53.68 -28.5 33.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.097 179.289 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 63' ' ' PHE . 2.9 mm -68.25 -54.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -71.3 -22.06 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.557 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.93 -52.89 61.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.701 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.62 18.0 18.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.161 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.4 68.15 1.71 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 110.801 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.35 -19.33 33.45 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.804 2.336 . . . . 0.0 112.361 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -113.17 35.96 3.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -112.64 -156.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.809 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.0 t -146.49 138.72 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.436 0.636 . . . . 0.0 112.16 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.8 t -118.35 80.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.149 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -65.56 -54.93 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.78 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.421 HG12 ' CE1' ' A' ' 99' ' ' PHE . 34.4 t 49.44 89.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.32 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.425 ' O ' ' CB ' ' A' ' 80' ' ' THR . 1.8 mt -99.33 -173.96 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 79' ' ' ILE . 2.7 m . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.352 . . . . 0.0 110.963 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.618 0.247 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.49 -15.87 28.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.099 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.13 -32.86 38.92 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.51 -57.95 10.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.099 178.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.455 ' HA ' HG12 ' A' ' 92' ' ' ILE . 17.5 m -61.84 -27.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.207 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -80.56 -12.91 59.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.647 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.403 ' O ' HD11 ' A' ' 64' ' ' ILE . . . -114.1 -24.34 9.05 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.559 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 89' ' ' VAL . 4.9 pt -90.1 -15.05 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.272 . . . . 0.0 111.635 -179.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.69 -42.74 67.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.737 0.303 . . . . 0.0 111.123 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -54.82 -35.1 63.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.77 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.157 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.1 -167.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.33 . . . . 0.0 110.899 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 9.3 t80 -108.44 27.28 9.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.219 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.9 OUTLIER 80.66 159.7 0.16 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.154 179.759 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -92.13 104.39 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.827 -179.962 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 9.9 tp -57.78 147.33 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.992 -179.974 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.508 ' CG2' HD12 ' A' ' 20' ' ' ILE . 3.5 m . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -70.72 -51.89 24.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -58.64 -32.22 68.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.428 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 28.4 t80 -61.54 -36.92 81.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.267 178.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.414 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 3.2 tt -55.61 -60.09 3.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.1 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mp -60.29 -46.98 87.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.628 -179.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.6 m -61.19 -40.07 92.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.45 ' CG2' ' CE2' ' A' ' 26' ' ' TYR . 1.7 mm -50.28 -52.38 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.657 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -55.52 7.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.115 0.483 . . . . 0.0 110.323 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -56.03 -27.37 52.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.949 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.19 82.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.98 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.465 ' CD2' ' HG3' ' A' ' 2' ' ' LYS . 50.9 m-85 -80.82 -35.23 33.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.229 -179.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.849 0.356 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.01 134.21 21.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.6 t -124.16 152.6 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.905 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.466 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 52.4 tp -105.03 127.93 53.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.166 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.51 ' HB ' HG23 ' A' ' 30' ' ' THR . 21.5 t -113.42 92.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.372 . . . . 0.0 111.604 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 43.8 t -78.97 115.24 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 34.5 t70 -157.31 155.53 30.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.806 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -88.27 49.33 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.969 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.983 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 37.5 p . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.19 127.11 31.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 t 80.41 -39.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.52 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -46.04 -61.13 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.145 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.581 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -39.79 -61.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.7 -178.703 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.98 12.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.277 0.561 . . . . 0.0 110.88 179.427 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.421 HD11 ' CG2' ' A' ' 106' ' ' VAL . 10.4 mt -76.04 -71.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.019 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.599 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.49 -30.25 12.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.416 -179.558 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' SER . 1.0 OUTLIER -74.22 -25.95 59.97 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.764 0.316 . . . . 0.0 110.705 178.945 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.75 -37.13 30.99 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.171 179.43 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 16.5 mm-40 -66.84 -28.82 68.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.46 42.91 3.31 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.377 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.552 ' HB2' HD23 ' A' ' 21' ' ' LEU . 72.5 m-85 -113.82 -177.61 3.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 111.156 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.95 106.7 28.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.776 179.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.468 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 98.3 Cg_endo -92.9 128.32 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.809 2.34 . . . . 0.0 113.218 -178.806 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.1 t70 -107.32 6.55 28.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.794 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.51 HG23 ' HB ' ' A' ' 6' ' ' VAL . 1.7 p -2.74 125.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.31 -162.2 0.88 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.713 179.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -109.4 -40.86 4.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.016 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.11 -175.58 5.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.449 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 60.8 mt -61.77 -45.99 91.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -61.26 -46.77 88.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.993 0.425 . . . . 0.0 110.1 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.23 -30.49 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.413 179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -31.62 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.677 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 60.9 mt-10 -70.14 -40.16 74.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.9 77.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.317 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -75.04 -37.54 61.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.811 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.9 mt -75.48 -26.04 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -7.33 47.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -112.82 -30.73 6.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.76 0.314 . . . . 0.0 111.233 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -128.21 156.1 43.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.786 -179.862 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.434 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 48.2 t80 -93.96 98.14 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 39.4 m-85 -80.44 123.54 82.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.33 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.459 ' O ' ' HA ' ' A' ' 74' ' ' SER . 87.9 Cg_endo -82.75 -21.59 4.88 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.578 2.186 . . . . 0.0 111.905 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.412 ' CG2' ' CE1' ' A' ' 117' ' ' PHE . 2.8 t -148.76 133.57 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.095 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 50' ' ' VAL . 15.3 mm -119.66 160.81 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.794 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 5' ' ' LEU . 95.1 t -153.27 99.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.42 ' CD2' HG11 ' A' ' 78' ' ' VAL . 12.6 tp -69.1 166.17 18.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.553 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -161.88 76.09 0.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.422 -179.742 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -63.42 75.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.583 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -66.94 -80.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.741 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -152.65 44.28 0.26 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.28 178.767 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.741 ' HD3' ' N ' ' A' ' 55' ' ' MET . 41.1 Cg_endo -97.96 -77.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.178 2.585 . . . . 0.0 112.368 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -170.15 -51.39 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.509 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.45 -131.64 42.74 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.946 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.59 44.08 7.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.54 67.93 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.1 t -59.35 -33.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.035 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.11 5.96 24.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.449 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 19.4 t80 -72.17 -35.26 68.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.756 0.312 . . . . 0.0 111.164 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.2 mp -51.38 -32.96 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.222 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.86 -33.36 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.553 179.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 33.7 t80 -60.19 -42.87 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.423 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.3 mp -61.32 -44.85 99.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.21 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -74.85 -22.66 58.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.54 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -67.09 -38.06 85.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.36 18.23 8.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.431 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -167.73 69.58 0.89 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.629 -179.941 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.85 -20.04 39.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.788 2.325 . . . . 0.0 112.312 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -107.26 30.9 5.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.895 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 32.3 t -108.27 -162.48 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.7 t -149.9 135.02 10.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 111.834 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.6 t -107.42 116.8 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.063 -178.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.429 ' HB ' HG23 ' A' ' 50' ' ' VAL . 17.2 mm -120.85 48.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.118 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 99' ' ' PHE . 89.3 t -45.64 134.31 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.228 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.48 HD12 HG21 ' A' ' 79' ' ' ILE . 3.3 mt -132.66 167.74 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 179.565 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.7 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -115.01 -58.62 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -47.34 -34.2 6.61 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.12 0.485 . . . . 0.0 110.498 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -57.94 -59.49 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.192 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.409 ' HA ' HG12 ' A' ' 92' ' ' ILE . 25.0 m -62.03 -24.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.005 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -84.77 -18.95 33.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.356 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.05 -32.54 8.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.7 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 8.1 pt -78.19 -17.73 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.774 -179.382 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -85.68 -17.18 36.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.68 0.276 . . . . 0.0 111.209 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -80.1 -24.52 40.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.302 -179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.27 -17.73 0.37 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.297 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.39 176.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.0 0.428 . . . . 0.0 111.426 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 75.8 t80 -104.32 28.28 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.269 -179.458 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.425 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 81.63 140.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -59.48 143.96 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.105 -179.755 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -85.51 104.98 15.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.734 179.938 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.117 -179.8 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.533 ' HB ' ' CG ' ' A' ' 109' ' ' PHE . 2.9 m . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.1 -52.97 30.5 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.543 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.69 -27.76 66.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.05 0.453 . . . . 0.0 110.138 179.115 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.533 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -61.22 -26.27 67.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.563 179.607 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.13 -47.56 65.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.607 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 3.5 mp -70.8 -53.02 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.422 ' CG2' ' CD1' ' A' ' 77' ' ' ILE . 54.3 m -44.49 -35.78 2.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.12 0.485 . . . . 0.0 110.151 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.473 HG13 ' CZ ' ' A' ' 109' ' ' PHE . 14.3 mm -67.17 -66.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.173 178.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -55.88 -19.52 12.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 179.581 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -90.43 -35.51 15.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.649 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.66 -53.81 16.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.173 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.474 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 29.7 m-85 -56.04 -24.55 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.391 179.896 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 9.6 mmtm . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.802 0.334 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.66 100.65 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 36.3 t -90.57 161.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.686 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 49' ' ' ILE . 25.8 tp -108.78 136.17 48.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 30' ' ' THR . 6.5 t -123.94 90.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.33 104.3 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.071 179.567 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.7 142.71 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.479 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.26 48.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 0.0 111.025 -179.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.469 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.8 tp10 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.99 179.848 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.429 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 63.2 p . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.0 t -57.44 133.52 55.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.028 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 15' ' ' SER . 7.0 t 84.95 -31.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.752 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.417 HD22 ' CG2' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -66.77 -59.79 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.49 -179.122 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.603 ' HA ' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -47.32 -49.73 23.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.623 -179.211 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.435 0.636 . . . . 0.0 110.122 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 HD12 ' CG2' ' A' ' 106' ' ' VAL . 45.4 mt -75.88 -65.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.723 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.632 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.82 -11.47 1.01 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.172 -179.181 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 6.0 mt-10 -88.07 -27.29 22.07 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.891 0.377 . . . . 0.0 110.155 178.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.86 -36.06 23.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -76.53 -29.87 56.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.247 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.36 47.9 2.49 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.179 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.567 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.0 m-85 -103.66 -172.08 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.056 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -143.56 89.9 7.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.357 179.568 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.7 Cg_endo -80.46 137.26 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.484 2.123 . . . . 0.0 112.612 -179.377 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -99.6 -1.41 38.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.574 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 29' ' ' ASP . 12.9 p 8.51 123.43 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.14 -162.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.209 178.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -117.96 -28.55 5.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.754 0.311 . . . . 0.0 111.361 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.57 -168.91 1.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.804 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 63' ' ' PHE . 29.5 mt -65.06 -43.85 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.79 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -57.67 -50.79 72.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.447 179.566 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -69.42 -29.47 67.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.717 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.51 -29.59 59.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 71.4 mt-10 -73.03 -37.37 66.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.979 0.418 . . . . 0.0 109.887 179.088 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -68.46 -35.65 77.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.167 179.223 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.16 -32.55 61.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.697 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.9 mt -86.95 -24.67 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.183 179.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -25.61 8.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.228 179.997 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.92 -61.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 122.82 15.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.9 76.38 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.877 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 74' ' ' SER . 55.6 m-85 -64.91 141.28 98.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.704 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 2.7 Cg_endo -84.48 -20.45 3.95 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.938 2.425 . . . . 0.0 111.81 179.382 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.6 t -146.57 133.03 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 23.7 mm -116.52 157.09 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.3 t -149.76 97.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.156 0.503 . . . . 0.0 111.139 -179.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 tp -92.37 129.59 38.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.747 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.441 ' HA ' HG23 ' A' ' 80' ' ' THR . 8.2 t70 -110.49 115.67 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.668 179.693 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.482 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 4.7 m -78.52 56.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.839 -179.346 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.469 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 35.4 t-105 -63.07 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.778 179.83 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.517 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.4 ttt -147.4 44.05 0.36 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.252 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.3 Cg_endo -76.97 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.441 2.094 . . . . 0.0 112.144 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -125.27 -42.86 1.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.989 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.57 148.05 51.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -76.38 116.24 16.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.16 -30.28 63.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 t -54.18 -44.67 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 111.514 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.89 0.84 37.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.742 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.428 ' CD2' HD22 ' A' ' 34' ' ' LEU . 23.5 t80 -89.81 -34.0 16.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.891 0.377 . . . . 0.0 111.043 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.406 HG23 ' CA ' ' A' ' 95' ' ' GLY . 2.7 mp -47.74 -28.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.428 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 16.1 t0 -79.64 -32.87 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.711 179.797 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 17.2 t80 -61.87 -39.31 91.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.412 HD13 ' CE2' ' A' ' 63' ' ' PHE . 4.5 mp -63.86 -50.54 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.174 179.14 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -69.29 -26.7 64.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.404 179.205 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 17.8 tt0 -60.3 -42.51 95.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.657 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.9 18.5 13.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.9 75.12 0.48 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.337 . . . . 0.0 110.844 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -85.96 -6.71 8.46 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.202 2.601 . . . . 0.0 113.099 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -98.74 -15.62 19.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.986 0.422 . . . . 0.0 111.303 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -72.18 -153.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -179.914 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -144.48 133.59 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-O 121.335 0.588 . . . . 0.0 111.921 178.692 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 97.3 t -104.83 99.16 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.147 -179.368 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.8 mm -90.36 -56.41 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.123 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.435 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 44.7 t 49.4 85.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.495 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 109' ' ' PHE . 2.1 mt -96.31 143.0 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.044 0.45 . . . . 0.0 111.757 -179.259 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.441 HG23 ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.46 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.888 0.375 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -82.25 -26.85 32.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.949 179.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.405 HG23 ' CE2' ' A' ' 99' ' ' PHE . 4.5 t -71.56 -34.78 70.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 179.392 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.504 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -56.45 -58.86 6.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.066 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 m -55.08 -24.89 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.913 179.378 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -85.85 7.42 24.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.265 179.805 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.72 -41.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.618 -179.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.44 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 11.9 pt -65.01 -18.44 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.322 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -94.67 21.79 7.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.743 179.382 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -138.33 -51.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.406 ' CA ' HG23 ' A' ' 64' ' ' ILE . . . -167.48 15.08 0.07 OUTLIER Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.802 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.559 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -89.26 175.08 7.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.602 0.701 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.549 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 67.4 t80 -94.77 -14.86 24.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.62 -179.356 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 5.5 pt-20 142.87 -13.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.523 0.729 . . . . 0.0 111.163 179.275 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.504 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER 73.71 131.66 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.912 0.387 . . . . 0.0 110.539 -179.67 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.2 OUTLIER -91.67 155.59 18.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -179.866 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.522 179.668 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 24.5 m . . . . . 0 CA--C 1.53 0.177 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -38.34 -44.77 0.93 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.741 0.305 . . . . 0.0 111.627 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -36.22 64.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.133 179.385 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 0.9 OUTLIER -54.99 -24.16 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.696 179.278 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -44.45 86.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.508 -179.831 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 mp -54.98 -55.85 26.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.044 -179.647 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 98.1 m -60.82 -39.03 87.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.2 -179.872 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.463 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -45.91 -53.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.754 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.48 -61.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -56.66 -27.31 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.924 179.606 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.11 96.03 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.903 0.383 . . . . 0.0 110.926 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.447 ' CE1' HG23 ' A' ' 4' ' ' VAL . 19.0 m-85 -69.5 -22.4 63.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.274 -179.964 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.202 -179.878 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.836 0.351 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.63 126.29 15.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.913 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 24.8 t -117.72 144.37 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 110.592 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.448 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 61.7 tp -100.89 127.54 47.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.23 -179.488 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.3 t -112.71 94.99 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 179.875 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.6 117.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.505 179.596 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -159.26 149.97 19.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.947 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.22 -74.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.064 179.938 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.91 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.616 0.246 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -30.28 57.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.16 -61.61 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.961 -179.846 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 1.8 tm? -43.54 -50.8 7.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.038 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -54.27 -39.35 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.424 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.02 84.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.402 ' CG2' ' CD1' ' A' ' 110' ' ' LEU . 1.6 mp -56.61 -64.0 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.705 179.661 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -50.36 -35.43 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.122 0.487 . . . . 0.0 110.472 179.374 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -24.15 65.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.948 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.78 -37.62 26.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.41 179.877 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -69.61 -48.38 60.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 179.912 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.19 44.84 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 98.9 m-85 -113.74 -170.46 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 0.0 111.159 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -139.5 72.08 37.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.388 179.578 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 35.8 Cg_exo -57.76 136.62 76.63 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.804 2.336 . . . . 0.0 112.359 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.1 t70 -113.54 -12.95 12.82 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.694 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 29' ' ' ASP . 69.5 p 44.39 177.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.677 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.84 -165.51 1.4 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.374 179.771 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -124.84 -35.27 2.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.849 0.357 . . . . 0.0 111.064 179.883 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.36 177.06 7.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.216 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.06 -37.04 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.645 179.964 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -47.88 69.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.51 -31.58 72.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.37 -65.06 0.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.487 179.588 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -41.58 -41.23 2.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -64.43 -48.85 73.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.825 178.937 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -69.2 -25.65 64.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.543 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.417 ' HB ' ' CE2' ' A' ' 66' ' ' PHE . 7.2 mt -92.43 -20.82 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.699 0.285 . . . . 0.0 111.439 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -47.53 -26.96 1.58 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.656 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.02 -51.08 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.134 -179.779 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.11 128.75 38.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.137 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -85.57 68.83 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.653 179.64 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 26.1 m-85 -65.54 122.82 82.37 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.309 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' VAL . 77.3 Cg_endo -77.21 -28.49 5.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.629 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 t -140.39 125.66 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.496 -179.632 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.13 149.2 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.497 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.8 t -141.57 96.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.428 ' HB3' HG11 ' A' ' 78' ' ' VAL . 24.2 tp -84.63 78.35 9.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.5 t0 -73.32 83.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.503 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 3.4 m -63.1 109.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -108.12 -84.39 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.56 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -72.85 -43.43 8.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.327 179.428 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 55' ' ' MET . 78.7 Cg_endo -76.09 -167.9 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.338 2.025 . . . . 0.0 112.345 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -102.92 -33.01 9.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.93 50.36 68.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.398 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -96.78 32.48 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.71 63.59 1.9 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.341 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -51.48 -44.63 33.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -70.98 -24.57 62.43 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.418 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 59.2 t80 -56.34 -46.56 79.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.288 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.405 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.3 mp -47.02 -29.04 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.108 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -37.4 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 4.4 t80 -56.43 -47.26 79.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.449 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -55.55 -42.78 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.585 179.605 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -78.61 -23.16 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.663 179.361 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.71 -41.63 83.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.987 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.86 12.78 13.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.246 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.88 66.87 2.07 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.66 179.792 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.59 -19.74 41.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.594 2.196 . . . . 0.0 112.029 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.2 18.18 18.13 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.3 t -99.39 -161.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.408 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 47' ' ' PRO . 21.4 t -151.22 135.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.314 0.578 . . . . 0.0 112.536 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 6.1 t -102.95 90.94 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.579 -179.564 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.1 mm -101.01 36.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.219 179.283 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.468 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 63.2 t -43.95 107.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.785 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 4.4 mt -101.4 147.99 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 30.9 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.87 0.367 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -94.5 -41.95 9.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -53.68 -30.91 45.72 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 121.157 0.504 . . . . 0.0 109.876 179.146 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 99' ' ' PHE . . . -57.69 -60.14 4.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.33 179.096 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.9 m -63.06 -25.3 38.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.579 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.82 -29.84 25.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.405 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -88.66 -39.05 14.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.495 HG21 HD13 ' A' ' 92' ' ' ILE . 7.8 pt -72.06 -11.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.473 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.86 -35.03 22.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.926 0.393 . . . . 0.0 110.495 179.573 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -60.03 -61.61 2.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.32 28.63 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.111 179.897 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.501 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.21 176.36 6.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.928 0.364 . . . . 0.0 110.962 179.717 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -101.08 29.38 4.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.779 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 78.22 138.46 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.995 179.904 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.505 ' CD2' ' CB ' ' A' ' 88' ' ' ALA . 1.3 m-85 -66.1 126.28 28.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.715 -179.916 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.9 67.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.884 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.057 -179.816 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.405 ' CG2' HD22 ' A' ' 17' ' ' LEU . 13.6 p . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.612 0.244 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -40.2 -43.26 1.63 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.587 -179.751 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.68 -41.19 88.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 0.0 110.462 179.65 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.437 ' CE1' HG12 ' A' ' 113' ' ' ILE . 6.4 t80 -59.02 -29.08 66.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.651 179.497 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -65.92 -38.37 88.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.48 -55.57 33.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.3 m -59.94 -42.65 94.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.437 HG12 ' CE1' ' A' ' 109' ' ' PHE . 3.9 mm -44.25 -56.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.781 -179.588 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -59.88 3.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.808 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -53.65 -27.0 24.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.936 179.508 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.17 -40.75 82.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.912 0.386 . . . . 0.0 110.774 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -69.69 -24.65 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.503 -179.87 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.286 -179.895 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.43 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 6.2 mmtp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.884 0.374 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.471 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -145.93 110.21 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -95.31 149.09 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 110.803 179.851 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' A' ' 29' ' ' ASP . 61.5 tp -111.33 137.06 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 0.0 111.288 -179.438 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.448 ' CG2' HD11 ' A' ' 17' ' ' LEU . 21.8 t -118.31 138.37 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.56 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 8.1 t -129.58 115.99 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.306 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.17 135.06 12.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -92.0 50.03 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.877 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 7.2 p . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.4 m -51.07 131.45 27.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.995 -179.04 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' SER . 0.9 OUTLIER 85.85 -31.46 0.05 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.94 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER -57.06 -61.82 2.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.701 0.286 . . . . 0.0 111.126 -179.498 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.51 -64.98 0.55 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.474 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.86 -39.93 40.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.233 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 23' ' ' GLU . 46.3 mt -67.68 -70.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 -179.917 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.06 -30.14 4.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.056 0.455 . . . . 0.0 110.368 179.507 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.84 -30.03 71.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -78.19 -39.45 40.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.076 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -79.23 -174.25 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.355 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.28 42.84 1.83 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.119 179.852 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.469 ' CE2' ' CG2' ' A' ' 113' ' ' ILE . 22.0 m-85 -100.8 178.95 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.491 0.662 . . . . 0.0 111.731 -179.428 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.3 85.82 60.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.762 178.458 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -79.97 127.54 6.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.7 2.266 . . . . 0.0 114.041 -177.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' HB3' HD13 ' A' ' 5' ' ' LEU . 5.1 t70 -119.14 117.32 28.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.474 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.7 p -104.08 143.3 33.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 112.061 -178.558 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.2 -167.04 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.054 179.13 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -130.82 -6.55 4.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -170.72 175.13 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.765 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.43 ' N ' ' OG1' ' A' ' 33' ' ' THR . 87.6 mt -66.12 -32.98 74.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -70.11 -40.19 75.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.997 179.203 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.1 -36.17 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.344 179.375 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.51 -50.22 22.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.608 179.521 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 4.9 tt0 -47.22 -45.87 23.75 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.409 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -53.73 54.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.584 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -58.0 -24.57 58.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.823 179.498 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.4 mt -98.53 -11.77 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.589 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -73.17 -10.42 59.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.691 0.281 . . . . 0.0 111.316 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -135.78 -46.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.763 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.1 116.5 15.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.715 179.869 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.2 64.32 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.36 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 19.9 m-85 -58.12 119.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.092 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 46.4 Cg_endo -69.13 -45.1 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.696 2.264 . . . . 0.0 111.946 179.772 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.54 125.02 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.553 -179.437 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -109.26 128.29 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' A' ' 109' ' ' PHE . 62.0 t -123.02 104.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.061 0.457 . . . . 0.0 111.206 -179.872 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 36.5 tp -92.96 83.9 4.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.958 179.954 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.4 OUTLIER -72.62 75.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 -179.85 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.463 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 3.2 p -55.36 84.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.459 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 25.3 t-105 -86.34 -82.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.735 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.465 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 3.4 ptm -142.04 48.46 1.14 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 111.131 179.456 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 55' ' ' MET . 72.7 Cg_endo -76.31 -168.19 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.493 2.129 . . . . 0.0 112.253 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -137.59 31.27 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.76 175.35 18.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.16 93.64 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.16 65.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.652 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.3 t -53.85 -43.6 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 111.419 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 2.75 32.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.536 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CD2' HD13 ' A' ' 67' ' ' ILE . 20.0 t80 -89.99 -43.26 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.054 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 mp -45.37 -28.84 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.652 -179.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -70.38 -56.06 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.431 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 1.5 t80 -48.57 -37.63 18.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.832 0.348 . . . . 0.0 110.557 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.448 HD13 ' CD2' ' A' ' 63' ' ' PHE . 1.5 mp -60.77 -46.44 96.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.085 179.435 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -77.31 -21.44 53.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.549 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.85 -50.6 63.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.67 12.58 21.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.379 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -158.48 66.65 3.29 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.803 0.335 . . . . 0.0 110.784 179.766 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 6.5 Cg_exo -72.72 -16.95 26.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.727 2.285 . . . . 0.0 112.205 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.71 28.41 6.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -112.07 -178.05 3.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.4 t -119.35 162.99 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.786 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.7 t -137.92 83.77 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mm -91.84 48.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.045 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.466 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 34.9 t -57.42 136.31 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.82 -149.0 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.365 -179.506 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.463 ' HB ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 111.006 179.791 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.924 0.392 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -109.54 -26.48 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.32 -32.29 62.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.909 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.79 -59.22 5.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.16 178.927 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -59.23 -23.47 24.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.013 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -90.74 40.58 1.02 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.06 -38.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.762 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.511 HG21 HD13 ' A' ' 92' ' ' ILE . 7.6 pt -76.16 -28.68 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.947 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -31.4 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.597 179.713 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -63.76 -30.26 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.67 28.31 0.12 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.265 179.792 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -90.14 178.87 6.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.901 0.35 . . . . 0.0 110.808 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 47.9 t80 -97.49 28.27 3.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER 85.11 162.75 0.1 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.556 179.583 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.56 97.01 10.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.728 179.982 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.466 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 16.1 tp -55.84 160.68 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.191 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 179.796 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.451 ' CG2' HD22 ' A' ' 17' ' ' LEU . 3.0 m . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.17 -51.87 58.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.338 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -60.43 -33.92 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.466 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 13.7 t80 -59.44 -33.4 71.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.415 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -44.65 91.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.772 179.116 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.92 -46.47 78.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.213 -179.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.0 m -67.84 -41.43 82.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.423 . . . . 0.0 110.366 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CG2' ' CE2' ' A' ' 26' ' ' TYR . 1.6 mm -46.96 -52.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.194 179.758 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.3 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 179.798 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -56.87 -39.93 75.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.561 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.52 -30.89 55.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.504 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 2' ' ' LYS . 52.7 m-85 -91.13 -55.44 3.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.462 -179.799 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.606 -179.53 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.846 0.355 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.444 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 136.07 25.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.993 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.434 HG23 ' CZ ' ' A' ' 117' ' ' PHE . 34.4 t -128.53 150.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.984 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 49' ' ' ILE . 24.4 tp -113.75 142.52 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.038 0.447 . . . . 0.0 111.575 -179.195 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.06 143.81 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.298 179.866 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.26 119.76 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.339 179.251 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 2.8 t70 -154.59 163.5 40.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.487 -179.324 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.58 49.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.0 111.104 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.715 179.706 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -45.95 142.42 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.302 -179.611 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 87.85 -36.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.768 179.799 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -48.17 46.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 -179.968 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 p -50.74 -65.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.81 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.457 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.64 -69.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.966 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.57 -31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 179.819 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.63 66.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.829 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.3 -34.49 31.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -77.57 -38.1 49.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.141 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.51 43.83 3.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.052 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 9.6 m-85 -102.29 -174.93 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.218 0.533 . . . . 0.0 111.328 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.5 80.01 16.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.904 178.381 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.45 131.78 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.756 2.304 . . . . 0.0 113.972 -178.088 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -129.24 132.35 47.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.447 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.8 p -119.97 139.24 52.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.0 112.069 -178.837 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.82 -165.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 179.313 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 31.3 mttt -117.65 -25.73 6.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.844 0.354 . . . . 0.0 111.228 -179.975 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.11 174.18 11.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.398 179.891 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.456 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 15.9 mt -58.63 -28.85 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.606 179.835 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -47.83 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -35.0 79.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.374 179.263 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.39 -53.46 48.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.478 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.417 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 28.6 mt-10 -50.83 -38.98 52.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.452 179.55 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -59.89 -43.29 94.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.721 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -73.88 -47.01 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.641 179.41 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.62 -18.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -19.82 61.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.729 0.299 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.14 -50.73 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 117.38 13.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -83.42 66.26 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.751 179.825 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.413 ' CB ' ' CD1' ' A' ' 49' ' ' ILE . 44.8 m-85 -58.62 135.84 86.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.963 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 7.4 Cg_endo -81.16 -35.19 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.512 2.141 . . . . 0.0 112.009 179.451 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.3 t -126.69 136.3 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 179.691 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 5' ' ' LEU . 1.6 mm -135.67 105.37 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.407 HG21 ' CE1' ' A' ' 109' ' ' PHE . 21.8 t -103.42 131.8 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.759 0.314 . . . . 0.0 110.632 179.519 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.5 tp -99.78 146.87 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.138 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.83 106.85 9.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.415 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.95 70.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.521 -179.482 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.416 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 4.4 t-105 -72.06 -78.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.081 179.399 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.687 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.6 ptt? -149.15 48.95 0.63 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.213 179.132 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.687 ' HD3' ' N ' ' A' ' 55' ' ' MET . 14.7 Cg_endo -92.86 -159.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.164 2.576 . . . . 0.0 112.165 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -161.22 52.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.932 179.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.86 149.79 19.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.553 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.21 108.74 10.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.17 -18.73 48.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.903 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.403 HG22 ' HD3' ' A' ' 90' ' ' LYS . 21.4 t -58.52 -58.96 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.27 -21.9 63.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 33.8 t80 -60.32 -40.46 90.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.406 HD11 ' CB ' ' A' ' 91' ' ' ALA . 3.5 mt -47.19 -28.33 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -74.76 -35.67 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.679 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.439 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 19.1 t80 -61.57 -45.14 95.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.323 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.425 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.2 mp -58.0 -41.68 80.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 179.341 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -81.44 -23.3 37.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 179.521 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.409 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 61.7 tt0 -64.36 -31.6 72.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.361 179.476 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -132.67 16.04 4.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.923 179.944 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -169.53 73.41 0.69 Allowed Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.725 179.948 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.09 -7.35 11.12 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.093 2.529 . . . . 0.0 112.604 -179.79 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.5 -6.25 27.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.63 -179.866 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.44 -172.65 4.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 -179.768 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.2 t -127.24 144.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 -179.781 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.1 t -123.12 98.08 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.06 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.2 mm -73.91 -67.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.731 -179.068 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.453 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 12.2 t 63.17 98.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mt -98.14 -144.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.623 -179.109 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.827 0.346 . . . . 0.0 110.897 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.64 0.257 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.28 -34.4 57.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.126 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.2 t -59.15 -33.95 71.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.969 0.414 . . . . 0.0 110.376 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.453 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -59.21 -59.11 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.248 179.355 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.43 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.5 m -58.94 -27.52 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.056 179.499 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HD3' HG22 ' A' ' 61' ' ' VAL . 4.2 ttmm -80.54 -13.25 59.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 179.962 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.406 ' CB ' HD11 ' A' ' 64' ' ' ILE . . . -109.94 -35.02 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 111.736 -179.574 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 92' ' ' ILE . 7.6 pt -77.16 -26.32 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.65 -179.484 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -66.19 -28.33 68.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.587 179.652 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -58.12 3.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.8 37.2 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -89.99 -163.77 1.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.903 179.797 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 40.1 t80 -107.99 23.37 14.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.544 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 80.56 19.89 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.755 179.449 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.453 ' CE1' ' CG1' ' A' ' 78' ' ' VAL . 0.2 OUTLIER 61.78 162.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 111.038 179.465 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -101.02 133.28 45.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.602 179.935 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.955 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 13.2 p . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.721 0.296 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -45.69 -38.17 6.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 179.877 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.53 80.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.02 179.282 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 113' ' ' ILE . 4.7 t80 -58.52 -26.47 63.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.168 179.293 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -49.67 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.102 179.708 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.3 -54.78 35.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.083 -179.797 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 113' ' ' ILE . 66.5 m -49.48 -57.32 7.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 11.3 mm -29.9 -63.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.64 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 114' ' ' LYS . 4.9 tmmm? -48.91 -58.66 4.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.792 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.415 ' CE1' ' HE3' ' A' ' 114' ' ' LYS . 98.4 m-70 -53.69 -27.72 29.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.579 178.979 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.89 -42.55 69.85 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.762 179.692 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.438 ' CE2' ' HG3' ' A' ' 2' ' ' LYS . 24.7 m-85 -59.63 -21.48 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.0 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.943 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HG3' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.907 0.384 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -153.69 133.85 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 179.88 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.54 162.0 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.781 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 29' ' ' ASP . 66.8 tp -118.21 147.24 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 111.446 -179.526 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -126.42 142.56 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.058 179.775 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 7.0 t -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.301 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 3.3 t70 -150.6 153.98 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.333 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.6 48.71 1.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.841 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.685 179.881 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 29.3 p . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.797 0.332 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 16' ' ' SER . 13.9 p -35.07 128.02 0.52 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 15' ' ' SER . 3.2 p 82.99 -43.84 0.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.222 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.453 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -53.23 -50.84 63.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 111.216 -179.566 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.69 -65.47 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.47 -40.65 18.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' CD1' HG23 ' A' ' 106' ' ' VAL . 37.4 mt -59.44 -67.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.417 ' CD1' ' CD1' ' A' ' 17' ' ' LEU . 1.3 mt -48.74 -31.72 7.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.805 179.525 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.16 -31.63 71.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.748 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.91 -34.89 22.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.472 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -81.29 -38.39 26.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.206 -179.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 76.8 1.32 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.168 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 39.8 m-85 -130.65 -174.43 3.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.349 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -119.84 80.8 25.47 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.17 178.798 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.22 135.03 6.14 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.771 2.314 . . . . 0.0 113.928 -178.335 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.472 ' HB3' HD13 ' A' ' 5' ' ' LEU . 16.3 t70 -123.42 128.63 50.12 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.384 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.7 p -98.66 146.74 25.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.87 128.9 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.433 178.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 7.7 mttm -82.48 -10.32 59.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.65 167.11 7.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.304 179.791 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.8 mt -59.18 -22.35 60.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 110.329 179.436 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -46.2 33.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.794 178.834 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.92 -30.96 71.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.135 179.176 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.69 -56.05 5.21 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.619 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 42' ' ' LYS . 54.3 mt-10 -44.81 -43.27 8.54 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.618 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.95 -53.0 61.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.74 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -60.6 -30.01 69.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.978 179.581 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.9 mt -92.23 -9.29 10.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 38' ' ' GLU . 13.7 tttt -74.3 -8.64 56.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 111.027 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.36 -47.13 0.51 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.91 118.54 16.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.708 179.764 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -76.46 62.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.757 179.856 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 25.4 m-85 -55.3 116.75 12.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.77 -31.51 10.32 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.333 2.022 . . . . 0.0 112.203 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.16 129.87 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.587 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 49' ' ' ILE . 14.3 mm -118.71 144.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.185 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.6 t -137.23 109.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.388 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 42.1 tp -98.28 93.13 6.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -77.88 91.93 4.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.398 179.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.451 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 27.9 m -62.65 79.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.793 -179.383 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -78.9 -91.05 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.249 179.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.543 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 ttm -143.36 58.72 6.79 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.639 0.257 . . . . 0.0 110.855 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.7 Cg_endo -89.51 -157.64 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.176 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -155.59 28.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.37 149.43 18.64 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 81.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.75 0.309 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.26 90.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 64' ' ' ILE . 50.8 t -62.03 -40.25 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.965 0.412 . . . . 0.0 110.909 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -15.45 62.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.39 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.403 ' CE2' HD12 ' A' ' 67' ' ' ILE . 30.4 t80 -84.33 -30.0 25.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 61' ' ' VAL . 6.4 mm -48.63 -30.57 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.092 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 69' ' ' GLU . 8.3 t0 -74.14 -47.95 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.734 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.425 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 10.2 t80 -48.25 -43.52 32.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.851 0.357 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.403 HD12 ' CE2' ' A' ' 63' ' ' PHE . 3.9 mp -59.96 -47.85 90.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.421 179.438 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.85 -16.19 59.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.964 179.576 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.468 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 12.2 tt0 -73.12 -46.69 49.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.765 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.489 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -114.41 13.72 17.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.948 -179.78 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.42 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.44 65.53 2.35 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.776 179.836 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.6 Cg_exo -76.07 -13.97 19.06 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.646 2.231 . . . . 0.0 112.192 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.06 27.63 8.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -112.28 -166.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 76' ' ' VAL . 21.4 t -129.02 139.96 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.342 0.592 . . . . 0.0 111.831 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 3.0 t -128.18 89.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.08 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.426 HD11 HG23 ' A' ' 77' ' ' ILE . 40.8 mm -79.63 -43.03 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.857 179.947 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.425 ' O ' ' CE1' ' A' ' 99' ' ' PHE . 59.7 t 45.17 89.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.445 HG22 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -99.66 179.05 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.035 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.332 -0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.054 179.925 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.798 0.332 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -75.93 -37.19 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -33.18 63.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.054 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.91 -59.07 5.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.109 179.032 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 92' ' ' ILE . 14.2 m -58.9 -26.08 31.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.118 179.812 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -78.03 -4.59 47.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.244 179.83 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.71 -38.67 2.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.379 -179.911 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 89' ' ' VAL . 6.1 pt -76.95 -41.65 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.133 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -57.95 -28.79 64.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -62.57 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 179.63 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.092 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.512 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.35 -174.7 4.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.983 0.392 . . . . 0.0 110.943 179.725 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.536 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 69.0 t80 -94.46 -23.1 17.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 11.3 pt-20 147.87 -167.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.54 0.736 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.05 107.07 10.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.708 0.29 . . . . 0.0 110.622 179.606 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.445 ' HB3' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -56.4 92.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.07 -179.908 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 179.951 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 18.0 m . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.05 0.452 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.58 -52.7 28.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -31.4 70.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.431 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 15.8 t80 -57.52 -40.95 79.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.43 -48.39 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.236 179.349 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mp -54.98 -45.57 75.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.399 -179.561 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -67.12 -39.8 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.457 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 2.7 mm -47.43 -55.88 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -55.62 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 110.16 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.71 69.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.81 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.86 -37.08 83.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.798 179.793 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.425 ' CD1' ' HG3' ' A' ' 2' ' ' LYS . 49.0 m-85 -80.27 -28.6 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.058 179.862 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.994 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 7.5 mmtp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.867 0.365 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -121.23 139.99 52.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.284 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 21.3 t -128.61 158.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 110.932 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.433 HD21 ' CE2' ' A' ' 46' ' ' PHE . 16.4 tp -117.03 131.83 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.651 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.409 ' CG2' HD13 ' A' ' 17' ' ' LEU . 25.4 t -115.81 89.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.201 179.866 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.92 103.16 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.757 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.81 137.63 45.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.782 -179.769 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.07 48.65 1.67 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.042 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.438 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.54 0.209 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -80.13 -43.33 21.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.283 . . . . 0.0 111.146 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -60.23 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.209 -179.673 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.422 HD12 ' CD1' ' A' ' 21' ' ' LEU . 2.3 tm? -46.9 -50.95 17.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.088 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -56.67 -48.91 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.572 179.75 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.24 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 23' ' ' GLU . 57.0 mt -57.41 -66.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.822 179.755 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.02 -35.43 11.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.139 0.495 . . . . 0.0 110.468 179.615 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.51 -28.22 69.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -79.84 -35.18 38.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.079 179.469 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -4.63 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.487 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.39 56.38 1.57 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.383 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.439 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-85 -128.41 -176.16 3.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -138.9 70.8 42.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.76 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 34.9 Cg_exo -60.15 142.3 98.02 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.821 2.347 . . . . 0.0 112.581 -179.678 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -121.64 2.97 10.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.398 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 29' ' ' ASP . 13.7 p 9.86 122.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.996 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.22 -164.22 1.02 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.436 178.631 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -118.47 -30.2 5.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.122 -179.754 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.25 -172.71 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.668 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.448 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 29.8 mt -65.86 -49.5 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.516 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.84 -48.83 80.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.447 . . . . 0.0 109.852 179.195 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.1 -30.8 71.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.17 179.144 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.41 -62.92 1.23 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.253 179.337 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 22.7 mt-10 -41.88 -39.93 1.97 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -49.24 73.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 178.91 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -68.19 -32.39 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.148 179.8 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.5 mt -86.34 -15.79 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.572 -179.755 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -24.29 6.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.548 -179.741 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -122.41 -55.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 129.03 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.21 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -92.03 86.41 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.528 179.621 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' A' ' 29' ' ' ASP . 49.8 m-85 -79.32 119.31 76.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.508 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.432 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 59.7 Cg_endo -73.54 -19.45 21.66 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.474 2.116 . . . . 0.0 111.974 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 117' ' ' PHE . 3.2 t -143.44 130.15 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.724 -179.911 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mm -118.59 156.19 20.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 179.54 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.7 t -146.31 102.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.494 . . . . 0.0 110.679 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.426 ' CD2' ' HA3' ' A' ' 60' ' ' GLY . 57.0 tp -90.09 91.1 8.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.42 92.3 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.857 178.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 53' ' ' VAL . 35.4 m -64.5 72.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.14 -179.006 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.438 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 25.5 t-105 -73.39 -77.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.361 . . . . 0.0 110.324 179.35 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.487 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.2 ttm -162.23 61.99 1.29 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.4 Cg_endo -84.61 -155.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.068 2.512 . . . . 0.0 112.216 -179.825 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.82 -42.2 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.93 177.55 53.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.07 127.77 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.426 ' HA3' ' CD2' ' A' ' 51' ' ' LEU . . . -79.16 -1.55 85.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.989 -179.969 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.49 -59.75 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.989 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.4 -21.5 62.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.512 -179.856 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 14.0 t80 -61.33 -36.7 80.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.468 -179.565 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.6 mt -47.64 -27.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.285 -179.853 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.56 -40.91 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 38' ' ' GLU . 17.6 t80 -57.25 -43.02 82.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.469 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.9 mp -61.41 -42.78 95.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 179.417 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -18.85 56.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.326 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.48 -42.33 68.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.551 179.701 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.93 14.15 15.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.068 -179.843 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.74 67.65 1.59 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.847 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.84 -20.24 39.67 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.673 2.249 . . . . 0.0 112.232 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -104.12 35.67 2.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.747 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -111.79 -157.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.798 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -154.53 137.94 7.95 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 111.659 179.498 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.5 t -117.43 100.26 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.335 -179.478 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -82.68 -51.12 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.737 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t 52.37 96.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 179.648 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.413 ' CG2' ' H ' ' A' ' 80' ' ' THR . 1.7 mt -106.12 -155.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.085 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.413 ' H ' ' CG2' ' A' ' 79' ' ' ILE . 8.3 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 179.918 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.872 0.368 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.05 -24.65 12.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -82.49 -38.69 23.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.019 0.437 . . . . 0.0 109.944 179.292 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -57.31 -57.38 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.142 178.991 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.1 m -58.01 -28.95 35.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.289 179.702 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -15.86 57.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.626 -179.694 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.87 -33.86 6.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 -179.546 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.434 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 2.2 pt -79.3 -34.99 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.263 -179.554 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -31.26 71.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.781 179.889 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.2 32.91 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.859 -179.956 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -90.16 -165.3 1.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 110.998 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.437 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 26.0 t80 -114.16 27.14 9.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 -179.787 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 76.01 141.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.09 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -66.0 118.33 9.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 -179.707 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.05 129.14 40.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.883 179.703 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 -179.993 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 109' ' ' PHE . 9.5 p . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.558 0.218 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -38.02 -38.46 0.32 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.823 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -70.82 -41.65 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.482 . . . . 0.0 110.494 179.642 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' VAL . 6.2 t80 -57.38 -30.43 64.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.802 179.528 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -59.18 -43.77 92.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.505 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mp -53.66 -52.29 60.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.829 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.3 m -59.61 -40.98 89.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.777 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mm -49.78 -57.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.634 -179.634 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.58 -63.4 1.1 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -50.81 -27.35 7.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.821 179.31 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.96 87.64 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.927 0.394 . . . . 0.0 110.479 179.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 48' ' ' VAL . 23.1 m-85 -71.88 -30.03 64.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.233 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.368 -179.686 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -164.33 125.42 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 -179.906 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 22.5 t -114.64 143.56 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.862 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.453 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 59.6 tp -93.95 129.63 40.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.808 -179.875 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' CG2' ' CD1' ' A' ' 17' ' ' LEU . 17.5 t -115.44 104.71 17.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.6 124.07 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.744 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -168.9 157.75 8.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 -179.839 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -89.56 49.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.168 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.721 179.807 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.429 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 71.5 p . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -52.94 136.68 34.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.695 -179.213 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 84.77 -36.55 0.05 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.08 179.442 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.463 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -59.74 -52.64 64.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 -179.582 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -45.63 -67.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.588 -179.488 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.33 -40.58 35.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.495 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.417 ' CD1' ' CG2' ' A' ' 106' ' ' VAL . 60.0 mt -65.88 -67.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.37 -179.717 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.926 0.394 . . . . 0.0 111.452 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.55 -31.32 66.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 tt0 -85.0 -36.04 21.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.513 179.716 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -78.16 -39.13 41.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.43 30.28 5.98 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.632 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -89.6 -175.56 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.92 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.2 OUTLIER -140.06 94.84 8.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 179.81 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 72.1 Cg_endo -77.45 134.2 13.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.501 2.134 . . . . 0.0 112.818 -179.514 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.9 t0 -103.66 -12.01 17.3 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.414 0.626 . . . . 0.0 111.618 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' ASP . 71.5 p 44.07 175.3 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.832 179.353 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -158.75 -166.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.438 179.833 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 mtpt -129.48 -37.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 110.963 179.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 p -163.07 178.24 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.304 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.36 -41.45 98.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 110.536 179.869 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.96 48.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 178.962 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.79 -29.63 70.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.205 179.036 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.33 -22.04 57.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.946 179.535 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.439 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 13.9 mt-10 -75.46 -41.52 55.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.897 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.3 -37.38 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.061 178.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -72.52 -30.07 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 mt -89.44 -23.13 6.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.906 179.671 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -81.07 -0.29 39.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 179.941 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -117.36 -41.33 2.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.681 179.789 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.472 HD23 ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -116.26 156.03 27.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.174 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.417 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 8.1 t80 -96.55 94.95 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.726 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.472 ' CE2' HD23 ' A' ' 44' ' ' LEU . 26.3 m-85 -78.18 124.8 85.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.72 -29.33 8.86 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.402 2.068 . . . . 0.0 111.928 179.616 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 t -142.86 129.01 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.446 -179.819 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 49' ' ' ILE . 26.8 mm -111.71 151.31 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.91 179.124 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.429 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 46.6 t -144.19 100.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.0 111.752 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.28 175.02 8.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.038 179.339 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -146.41 -52.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.568 -179.543 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t 61.82 50.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.052 0.454 . . . . 0.0 110.47 -179.562 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -71.16 -82.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.799 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.495 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -76.06 -48.64 3.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 55' ' ' MET . 96.7 Cg_endo -77.73 -173.18 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.436 2.091 . . . . 0.0 112.619 -179.518 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -158.28 47.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.671 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.03 166.77 3.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.656 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -82.97 74.05 9.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.26 -22.39 36.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.692 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.402 ' O ' HD12 ' A' ' 64' ' ' ILE . 32.7 t -54.26 -41.7 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 111.496 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.35 4.96 44.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.436 ' O ' HG12 ' A' ' 67' ' ' ILE . 8.0 t80 -90.03 -37.07 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.58 0.229 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.424 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.2 mp -45.15 -44.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.908 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.84 -47.45 83.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 42.5 t80 -55.22 -31.46 61.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.005 179.244 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 63' ' ' PHE . 3.8 mm -66.25 -53.42 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.184 179.145 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -71.93 -19.98 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.369 179.206 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 20.0 tt0 -67.08 -50.0 63.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.538 179.588 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.475 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -113.98 19.67 16.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.135 -179.812 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.35 67.92 1.05 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.42 -16.03 22.0 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.781 2.321 . . . . 0.0 112.302 -179.898 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.61 31.12 6.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -112.99 -159.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.6 t -148.07 135.68 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.371 0.605 . . . . 0.0 112.251 179.453 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 24.7 t -105.44 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.514 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.6 mm -120.23 44.25 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.997 179.677 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 57.4 t -46.52 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.665 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -74.2 -107.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.35 -179.639 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.65 -179.865 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.715 0.293 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.87 -8.55 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.473 179.997 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.62 -33.64 31.34 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.067 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . . . -60.74 -57.65 11.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.125 178.998 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.62 -22.64 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -91.29 25.89 2.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.874 0.369 . . . . 0.0 110.772 179.606 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.424 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -155.2 -40.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.818 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 5.3 pt -71.86 -43.91 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.172 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 2.2 ttmt -63.13 -22.77 67.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -71.65 -28.37 63.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.076 179.901 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.01 -19.7 0.35 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.32 179.971 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -50.73 176.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.001 0.401 . . . . 0.0 111.318 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.407 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 32.5 t80 -98.98 28.5 4.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.477 -179.582 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.521 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 79.82 147.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.135 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 1.1 m-85 -73.85 139.89 45.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.082 -179.72 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -90.32 130.23 36.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.545 179.708 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 . . . . . 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 179.946 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 33.5 m . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -40.87 -47.36 2.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.819 0.342 . . . . 0.0 111.281 -179.856 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -36.11 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.0 110.011 179.188 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 1.9 t80 -56.53 -23.54 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 179.229 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.64 -43.76 95.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.353 179.937 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 mp -54.27 -57.06 12.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 -179.739 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.3 m -57.71 -43.25 85.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -44.35 -53.38 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.786 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.08 -61.6 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -53.64 -28.24 31.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.17 -41.47 94.63 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 179.706 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 45.3 m-85 -79.66 -29.78 41.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 179.974 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 3.8 mmtm . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.433 ' CB ' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -117.62 141.5 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 179.989 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.408 HG21 ' CE1' ' A' ' 117' ' ' PHE . 41.3 t -126.66 159.87 35.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.422 HD21 ' CE2' ' A' ' 46' ' ' PHE . 35.4 tp -113.12 129.26 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.079 -179.901 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 30' ' ' THR . 23.5 t -115.62 89.95 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.517 179.916 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 t -83.56 103.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.9 140.2 42.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.435 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 33.6 t70 -88.45 27.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.508 -179.865 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.419 ' HG3' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.809 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.704 0.288 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.18 -43.41 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.4 -57.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -46.21 -56.87 5.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -52.86 -45.11 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.769 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.13 96.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.67 179.58 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.421 ' CD1' ' CG1' ' A' ' 106' ' ' VAL . 5.9 mt -57.59 -65.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.65 -32.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.731 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.26 -29.61 69.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -79.27 -34.4 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 109.887 179.441 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.52 -12.11 59.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.114 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.06 62.71 1.16 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.892 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 46.3 m-85 -127.22 -172.69 2.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 111.38 -179.319 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -135.9 68.43 64.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.498 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.74 131.09 35.86 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.641 2.227 . . . . 0.0 111.952 179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -109.6 3.31 20.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.266 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 29' ' ' ASP . 8.7 p 1.87 123.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.74 -162.46 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.487 178.836 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -114.93 -31.63 6.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.16 -168.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.686 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -63.95 -45.38 89.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -50.68 72.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.259 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.76 -29.64 67.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.49 179.422 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.63 -26.31 54.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.95 179.793 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 30.8 mt-10 -74.74 -38.47 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.073 0.463 . . . . 0.0 109.931 179.124 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.65 77.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.903 179.036 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -74.67 -35.64 62.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.676 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.5 mt -84.11 -21.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.095 179.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -18.65 59.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.279 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -129.02 -44.82 1.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.13 120.6 25.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 71' ' ' SER . 52.1 t80 -83.27 88.66 6.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.718 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.1 m-85 -79.23 133.37 60.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 9.3 Cg_endo -84.55 -20.4 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.815 2.344 . . . . 0.0 111.947 179.204 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.408 HG23 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -145.25 131.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mm -119.04 156.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.483 179.609 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -146.86 101.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 110.764 179.787 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.8 tp -88.94 108.14 19.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.825 -179.255 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.06 91.32 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.141 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.426 HG22 ' CG2' ' A' ' 80' ' ' THR . 33.4 m -67.47 68.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.727 -179.154 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.45 ' CG ' ' N ' ' A' ' 55' ' ' MET . 29.0 t90 -67.16 -96.97 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.208 179.426 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.541 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -129.36 41.62 0.76 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.471 0.177 . . . . 0.0 111.27 179.361 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 55' ' ' MET . 91.6 Cg_endo -80.38 -165.98 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.52 2.147 . . . . 0.0 112.286 179.949 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -150.02 46.91 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.85 -179.35 16.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -104.83 95.42 5.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.97 -30.56 63.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.19 -44.74 80.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.352 -179.93 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 1.89 35.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.507 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 34' ' ' LEU . 11.9 t80 -88.5 -36.37 16.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.801 0.334 . . . . 0.0 111.098 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.2 mp -47.5 -29.33 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.147 -179.936 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -78.38 -35.62 47.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.637 179.708 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.438 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 9.0 t80 -58.64 -41.53 86.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.411 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.0 mp -61.58 -45.74 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.376 179.5 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -76.63 -20.16 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.75 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.59 -42.25 78.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.828 179.749 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.39 15.4 12.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.193 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.41 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -163.48 67.75 1.66 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.809 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.39 -20.39 36.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.737 2.291 . . . . 0.0 112.232 -179.93 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -103.13 28.02 6.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.79 179.774 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 t -107.56 -156.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.363 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -153.91 137.66 8.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.996 0.426 . . . . 0.0 111.406 179.114 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 13.1 t -119.85 108.46 23.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.373 -179.257 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mm -93.16 -53.7 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.412 HG13 ' CE1' ' A' ' 99' ' ' PHE . 24.6 t 54.31 94.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 179.702 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.414 ' CG2' ' H ' ' A' ' 80' ' ' THR . 1.8 mt -94.8 -157.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 179.679 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.426 ' CG2' HG22 ' A' ' 53' ' ' VAL . 2.4 m . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.877 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.778 0.323 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -95.6 -15.51 22.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 179.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.15 -34.89 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.112 0.482 . . . . 0.0 109.734 179.104 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . . . -59.16 -58.54 8.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.117 178.895 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.7 m -57.53 -28.99 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -75.44 -6.61 50.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.442 -179.916 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.77 -44.33 1.95 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 111.387 -179.772 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 89' ' ' VAL . 2.4 pt -67.89 155.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.924 -179.723 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 81.46 -47.27 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 -179.148 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -65.13 -16.83 63.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.495 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.23 -29.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.791 -179.955 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -74.5 176.31 6.95 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 111.31 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 13.4 t80 -102.16 -8.95 20.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.048 -179.983 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 8.5 pt-20 137.03 172.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.778 0.831 . . . . 0.0 110.181 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -103.67 96.77 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.616 179.687 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 109' ' ' PHE . 13.1 tp -54.98 90.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.282 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.296 -179.84 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 109' ' ' PHE . 7.6 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.702 0.287 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -36.07 -44.76 0.39 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.126 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -42.36 84.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 0.0 110.734 179.798 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' VAL . 8.4 t80 -53.59 -30.88 44.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.889 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -44.2 80.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.3 -179.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mp -56.7 -55.16 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.33 -179.701 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.9 m -56.37 -41.85 76.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.409 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.1 mm -44.62 -54.48 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -48.35 -61.31 2.07 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -48.18 -31.87 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.749 179.287 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.47 83.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.978 0.418 . . . . 0.0 110.504 179.417 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 2' ' ' LYS . 48.6 m-85 -83.77 -28.29 28.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 179.853 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.428 -179.809 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.871 0.367 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 12.5 mmtm -120.98 124.15 44.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.982 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.62 127.74 14.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 61.3 t -126.15 163.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 55.4 tp -121.28 134.95 55.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.015 0.436 . . . . 0.0 111.671 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' THR . 12.8 t -119.41 128.23 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.127 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 11.9 t -119.56 125.82 74.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.993 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.0 t0 -162.1 145.86 12.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.653 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.32 51.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.871 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 12.4 pt-20 -173.58 127.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.072 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 58.82 160.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.049 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -69.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.553 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.7 mm -96.96 164.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 53.3 p -89.25 130.86 35.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.354 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.87 133.18 22.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 m 78.77 -14.31 0.88 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.653 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.468 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -76.77 -54.79 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.942 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.41 -64.27 0.76 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.519 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.98 -40.76 31.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.197 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.406 HD12 ' CG2' ' A' ' 106' ' ' VAL . 56.0 mt -63.14 -67.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.218 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -49.44 -31.14 9.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 110.851 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.61 -27.47 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.879 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.47 -34.91 27.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.317 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -80.38 -36.28 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.051 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.4 49.76 2.52 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.066 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 3.8 m-85 -103.8 -174.61 2.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.326 0.584 . . . . 0.0 111.429 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.13 77.13 76.95 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.938 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 97.3 Cg_endo -85.79 142.78 8.03 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.836 2.358 . . . . 0.0 113.851 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 8.6 t0 -123.67 120.33 32.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.145 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 47.5 p -100.81 139.86 35.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.11 0.481 . . . . 0.0 112.011 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.48 -164.37 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.228 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 2.4 mttt -134.65 -7.67 2.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.36 -172.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 0.0 110.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.471 HD22 ' CD2' ' A' ' 63' ' ' PHE . 96.3 mt -78.64 -28.73 45.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.473 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.49 -41.64 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -34.0 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.233 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.51 -52.39 13.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 42' ' ' LYS . 41.3 mt-10 -46.38 -45.08 17.58 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.525 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -53.35 58.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -61.86 -23.9 66.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.075 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.5 mt -95.82 -14.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.688 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 1.2 tmtt? -78.83 -5.32 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.645 0.26 . . . . 0.0 111.48 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -136.96 -49.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.382 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.32 116.29 16.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.783 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -74.75 64.12 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.518 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 22.9 m-85 -58.35 122.08 56.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.087 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 10.8 Cg_exo -66.1 -50.05 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.468 2.112 . . . . 0.0 112.277 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.467 ' CG2' ' CE1' ' A' ' 117' ' ' PHE . 35.8 t -116.85 127.11 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.671 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 14.6 mm -113.81 127.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.273 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.431 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 84.7 t -124.3 105.93 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 52' ' ' ASP . 4.9 tp -93.52 145.36 24.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.711 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 2.7 t70 -110.33 178.66 4.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.115 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 53' ' ' VAL . 4.8 m -149.52 42.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.155 0.502 . . . . 0.0 111.527 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.401 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 57.6 t-105 -49.9 -90.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 25.6 ttp -149.6 50.84 0.83 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.312 . . . . 0.0 111.072 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 55' ' ' MET . 73.0 Cg_endo -75.95 -168.29 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.487 2.125 . . . . 0.0 112.281 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -145.4 39.77 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.26 20.86 2.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.647 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.07 -159.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.612 0.244 . . . . 0.0 110.488 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.11 -39.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.641 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.453 HG21 ' HG2' ' A' ' 90' ' ' LYS . 40.3 t -56.85 -42.1 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.059 0.457 . . . . 0.0 110.756 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -20.24 64.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.674 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.471 ' CD2' HD22 ' A' ' 34' ' ' LEU . 36.0 t80 -80.53 -33.32 36.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 61' ' ' VAL . 4.6 mm -47.03 -29.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.81 0.338 . . . . 0.0 111.154 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -75.17 -47.54 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 12.2 t80 -50.02 -42.47 49.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.451 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 4.2 mp -60.6 -44.04 95.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.351 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -80.31 -17.45 52.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.807 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 31.6 tt0 -71.4 -46.7 59.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.495 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -112.49 7.51 19.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.186 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.425 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -154.63 65.38 4.79 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 110.656 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 71' ' ' SER . 2.7 Cg_exo -74.65 -15.59 21.58 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.683 2.255 . . . . 0.0 112.103 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -97.48 -9.47 27.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.216 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t -80.36 -173.95 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.584 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.441 ' HB ' ' HA ' ' A' ' 48' ' ' VAL . 31.1 t -120.5 157.23 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.094 0.473 . . . . 0.0 111.217 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.1 t -143.19 89.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.093 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 mm -80.5 -45.35 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.413 HG12 ' CE1' ' A' ' 99' ' ' PHE . 58.5 t 54.99 101.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.791 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.412 ' CD1' ' CB ' ' A' ' 100' ' ' LEU . 7.7 mt -133.1 145.69 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.763 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.424 HG23 HG22 ' A' ' 53' ' ' VAL . 14.5 m -166.53 163.63 17.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.832 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA3' ' CE2' ' A' ' 104' ' ' PHE . . . -120.72 34.59 4.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.47 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -156.4 101.34 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 110.84 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 166.57 -110.31 0.4 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.1 t -174.39 154.14 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.91 -26.27 27.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.253 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.5 -12.93 62.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.5 -35.46 27.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.09 0.471 . . . . 0.0 109.798 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.09 -57.56 12.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HG2' HG21 ' A' ' 61' ' ' VAL . 12.7 ttmt -89.75 39.92 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.019 0.438 . . . . 0.0 110.554 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.24 -42.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 7.9 pt -71.25 -28.08 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.263 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.53 19.83 6.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -0.63 8.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.483 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.91 11.5 1.84 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.13 -168.67 2.18 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.252 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.408 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 17.8 t80 -116.22 27.39 9.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.344 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 79.29 141.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -67.45 129.3 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.124 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.2 OUTLIER -71.42 106.42 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.05 69.25 4.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.49 58.7 0.1 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.813 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.64 176.03 9.91 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.563 2.176 . . . . 0.0 112.407 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' CE2' ' HA3' ' A' ' 81' ' ' GLY . 60.4 m-85 58.92 38.11 24.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.9 OUTLIER 171.7 -28.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.394 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 105' ' ' SER . 3.1 m 41.12 28.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.3 -47.52 79.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -34.14 77.2 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 8.3 t80 -56.75 -35.26 68.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.366 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 tt -56.85 -53.3 59.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.031 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.98 -42.61 94.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.7 m -64.83 -40.42 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.883 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.427 HG12 ' CE1' ' A' ' 109' ' ' PHE . 1.6 mm -44.11 -52.68 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.785 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.55 -56.8 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.321 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -60.48 -32.47 71.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.57 -39.04 82.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.467 ' CE1' ' CG2' ' A' ' 48' ' ' VAL . 39.2 m-85 -77.78 -13.2 59.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.43 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -55.91 -30.75 62.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.798 0.332 . . . . 0.0 111.248 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 82.6 mm-40 -75.24 -6.48 49.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.447 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -140.83 24.72 2.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.97 179.918 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.765 0.316 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 32.3 mmtp 59.66 -170.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.949 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 3.5 mpt_? 64.64 108.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 17.8 t -123.22 159.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.911 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.44 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 42.9 tp -115.43 135.17 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.847 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 30' ' ' THR . 17.2 t -117.53 89.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.696 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.47 107.55 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -143.17 140.73 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 111.301 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 34.9 t0 -64.04 -70.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -81.47 -174.38 4.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.974 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -114.18 69.38 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -108.63 -49.48 3.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.9 mm -82.36 -41.44 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p -56.26 -22.06 27.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.317 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.34 -43.01 67.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.2 p -101.81 -53.2 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.328 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' CD1' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -47.84 -51.84 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.081 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 m -50.68 -46.61 58.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.773 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.07 91.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.777 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 mt -55.99 -59.92 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.532 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -46.9 -40.23 13.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.854 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.22 -27.96 69.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.987 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -80.09 -34.73 37.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.982 0.42 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -76.71 -24.73 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 28.38 6.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.416 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 59.9 m-85 -98.93 -175.86 3.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -134.56 90.0 24.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 74.4 Cg_endo -78.8 132.64 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.432 2.088 . . . . 0.0 112.873 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -108.78 6.0 25.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.235 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.524 ' O ' ' O ' ' A' ' 29' ' ' ASP . 14.3 p 4.33 122.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.83 -164.17 1.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.925 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' ASP . 13.2 tttt -115.1 -40.08 3.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 p -159.23 -173.95 4.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.466 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -65.64 -45.34 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.617 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -61.67 -48.65 79.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.074 0.464 . . . . 0.0 109.749 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.06 -32.22 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.01 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.77 66.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.699 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 17.6 mt-10 -68.58 -44.27 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -36.28 78.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.106 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -74.12 -43.03 59.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 mt -73.61 -24.17 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -51.58 -25.89 7.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.277 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -124.37 -58.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.096 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.75 123.64 18.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.04 79.93 8.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 29' ' ' ASP . 33.0 m-85 -73.94 116.34 51.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.025 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.519 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 74.0 Cg_endo -73.2 -16.16 25.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.524 2.149 . . . . 0.0 111.816 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.407 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.5 t -147.23 132.29 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.2 mm -118.18 159.96 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.11 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.1 t -147.97 97.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.252 0.548 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.39 130.03 34.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.468 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.62 89.71 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.033 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.8 m -67.31 66.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.875 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 69.3 t-105 -69.86 -96.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.195 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.604 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -134.66 32.16 0.21 Allowed Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.8 Cg_endo -81.97 -165.18 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.106 1.871 . . . . 0.0 112.236 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -116.29 28.54 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.866 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.07 -99.49 0.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.499 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 56.91 46.39 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.773 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.93 103.81 2.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.1 t -61.07 -40.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 0.0 110.828 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -13.01 61.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.362 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 34' ' ' LEU . 35.6 t80 -54.3 -39.23 66.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 111.265 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 91' ' ' ALA . 3.5 mt -50.01 -29.8 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' GLU . 1.5 t0 -75.81 -34.19 60.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 51.4 t80 -59.56 -47.48 85.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.015 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.408 HD13 ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -58.34 -43.7 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.398 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -77.03 -22.85 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.699 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 65' ' ' ASP . 42.3 tt0 -65.0 -34.23 77.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -129.55 18.65 5.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.853 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.91 75.6 0.66 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.2 -8.08 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.162 2.575 . . . . 0.0 112.733 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' OD2' ' CE2' ' A' ' 120' ' ' TYR . 5.8 t0 -107.31 12.96 27.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.459 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.23 -160.15 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.98 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -148.94 134.42 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 111.47 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 23.9 t -115.01 109.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.575 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.47 HD11 HG23 ' A' ' 77' ' ' ILE . 31.7 mm -90.36 -51.06 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.956 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 99' ' ' PHE . 30.1 t 54.21 97.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.427 HD11 ' CE2' ' A' ' 109' ' ' PHE . 1.7 mt -102.68 -170.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.315 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.416 ' H ' ' CG2' ' A' ' 79' ' ' ILE . 2.8 m 74.98 114.25 0.06 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.342 . . . . 0.0 110.878 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.12 75.51 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.431 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.13 -54.29 3.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.795 0.331 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.37 46.15 2.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 p -178.13 86.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.888 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.46 9.15 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.498 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.3 -1.88 28.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.326 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.59 -37.06 14.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.456 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -58.55 -57.44 12.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.159 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.9 m -58.27 -29.27 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.314 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -76.86 -14.96 59.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.378 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -112.91 -44.8 3.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 111.528 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 2.2 pt -67.6 169.84 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.038 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.8 mttp 74.31 -44.01 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -16.44 63.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.077 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.95 -29.43 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.26 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -59.56 -178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.421 . . . . 0.0 111.11 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 85.0 t80 -115.67 27.49 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.904 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 86.65 157.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.376 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -86.16 100.27 12.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.024 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 39.2 tp -70.47 131.47 44.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.008 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 2.2 mm-40 -65.17 -169.84 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.352 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.489 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 1.2 mmpm? -135.63 45.3 1.31 Allowed Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 92.8 Cg_endo -78.38 138.85 16.05 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.5 2.133 . . . . 0.0 112.151 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 58.18 36.93 26.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.048 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.75 -169.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.184 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.92 -19.69 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.498 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -45.8 -34.6 3.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -38.96 62.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.153 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.447 ' CE1' ' CG1' ' A' ' 113' ' ' ILE . 4.2 t80 -55.61 -28.64 56.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.41 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.87 -39.57 19.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.4 mp -57.97 -58.06 10.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.874 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.3 m -45.95 -43.65 14.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.447 ' CG1' ' CE1' ' A' ' 109' ' ' PHE . 18.6 mm -53.66 -66.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 110.382 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -16.21 5.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.979 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -90.19 -26.53 20.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 110.518 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.59 -40.83 40.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.018 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 38.0 m-85 -76.35 -19.03 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -72.2 -6.85 45.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.699 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.59 42.38 1.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.402 ' CE2' ' OD2' ' A' ' 73' ' ' ASP . 5.2 t80 -168.26 31.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.989 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ptp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.957 0.408 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 1.4 mptp? -160.53 122.48 3.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.976 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.415 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -145.49 133.57 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 20.8 t -126.2 160.66 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.435 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 40.9 tp -118.8 136.34 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.808 0.337 . . . . 0.0 110.996 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.425 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 13.7 t -117.35 90.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.89 104.86 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.842 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -140.32 137.99 34.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -88.76 48.83 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.841 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 179.89 167.4 1.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.35 54.12 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 m -111.31 -56.02 2.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.971 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.6 mp -79.69 -33.14 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.756 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p -59.85 -19.73 52.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -90.04 -26.42 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.731 0.3 . . . . 0.0 111.231 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.24 -63.03 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.199 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.438 ' O ' HD11 ' A' ' 21' ' ' LEU . 2.1 tm? -52.24 -50.18 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.02 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.0 t -53.09 -59.42 4.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.217 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.0 -39.51 59.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.05 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 20' ' ' ILE . 8.9 mt -57.41 -58.3 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -47.9 -39.61 19.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.408 . . . . 0.0 110.78 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.59 -28.34 68.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.6 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.37 -34.47 31.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.233 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HG3' ' CD2' ' A' ' 110' ' ' LEU . 15.8 mm-40 -76.49 -70.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 149.23 57.45 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 81.0 m-85 -129.84 -169.31 2.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.53 88.04 20.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.967 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HB3' ' CD1' ' A' ' 21' ' ' LEU . 66.6 Cg_endo -78.81 132.6 10.85 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.419 2.079 . . . . 0.0 113.148 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 30' ' ' THR . 17.5 t70 -111.56 8.43 20.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.221 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.507 ' O ' ' O ' ' A' ' 29' ' ' ASP . 5.9 p 0.83 123.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 -165.69 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.702 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -116.61 -33.52 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.03 175.23 12.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.612 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.417 HD21 ' CD2' ' A' ' 63' ' ' PHE . 54.3 mt -55.56 -33.41 63.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.757 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -48.13 76.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.506 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.838 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.32 -36.02 63.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 83.6 mt-10 -68.48 -40.81 80.81 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.06 -35.09 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.9 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -76.65 -44.72 32.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.721 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.96 -26.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.18 -25.79 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.427 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -125.67 -45.58 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.012 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -74.66 135.06 41.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -92.25 95.47 9.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 75.8 m-85 -91.98 113.4 58.85 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.8 Cg_endo -73.43 -16.5 24.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.387 2.058 . . . . 0.0 111.886 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.406 HG23 ' CE2' ' A' ' 117' ' ' PHE . 3.8 t -148.43 131.61 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.47 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.3 mm -119.16 162.65 17.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.5 t -149.85 98.42 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.178 0.514 . . . . 0.0 111.454 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.405 ' HB3' HG11 ' A' ' 78' ' ' VAL . 37.7 tp -81.73 148.87 28.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 53' ' ' VAL . 8.0 t70 -107.84 -19.92 13.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.484 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 52' ' ' ASP . 2.4 m 45.93 32.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -56.6 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.676 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.564 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 13.3 mtp -152.54 57.52 2.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.964 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.9 Cg_endo -86.3 -156.38 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.061 2.507 . . . . 0.0 112.199 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -157.39 37.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.94 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -127.98 -0.69 6.48 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.065 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 58.4 105.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.18 -0.8 87.04 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.142 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.25 -66.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 120.898 0.38 . . . . 0.0 111.161 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -67.09 -14.33 62.8 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.417 ' CD2' HD21 ' A' ' 34' ' ' LEU . 21.4 t80 -63.4 -38.92 93.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.407 HD11 ' CB ' ' A' ' 91' ' ' ALA . 3.1 mt -48.35 -33.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.5 t70 -70.03 -32.8 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.29 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 6.9 t80 -62.33 -43.96 97.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.7 mp -59.57 -44.64 93.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.41 -21.31 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.563 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' ASP . 37.4 tt0 -67.0 -31.77 72.55 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -134.05 18.63 3.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.044 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.86 70.06 0.88 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.24 -19.37 38.71 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.721 2.281 . . . . 0.0 112.241 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.22 29.14 3.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.978 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 48.0 t -110.87 -163.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.9 t -154.55 136.2 5.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 120.836 0.351 . . . . 0.0 111.399 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.0 t -115.43 109.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.412 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -83.27 -59.68 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.913 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.45 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 55.7 t 55.48 89.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.436 HG22 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -96.21 -152.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.401 ' CB ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER 69.16 139.86 0.04 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.809 0.338 . . . . 0.0 110.976 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.04 37.92 0.67 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.435 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -69.89 71.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.825 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.9 -33.96 0.14 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.431 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 m -129.43 106.18 8.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 110.865 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -81.21 -0.1 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.584 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.52 -8.97 57.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.79 -39.29 13.21 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.437 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -56.42 -57.99 9.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.3 m -55.19 -31.1 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.772 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -5.38 48.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' CB ' HD11 ' A' ' 64' ' ' ILE . . . -119.91 -38.12 3.0 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 89' ' ' VAL . 9.1 pt -73.93 -34.52 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.435 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -65.34 -18.12 65.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.935 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -85.89 -56.27 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.045 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.29 32.03 0.05 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.043 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.477 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.27 -162.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.329 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.437 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 81.3 t80 -111.98 23.32 13.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER 83.89 20.33 0.17 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.95 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CE1' ' CG1' ' A' ' 78' ' ' VAL . 0.2 OUTLIER 58.43 163.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 0.0 111.453 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.436 ' HB3' HG22 ' A' ' 79' ' ' ILE . 1.8 tm? -116.02 81.23 1.57 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.12 112.42 22.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.222 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.61 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 0.3 OUTLIER 177.21 -54.42 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.944 179.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 102' ' ' LYS . 89.9 Cg_endo -81.04 -168.03 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.383 2.055 . . . . 0.0 112.601 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -145.84 25.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.8 t -149.38 -84.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.966 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.415 ' CG2' HD22 ' A' ' 17' ' ' LEU . 11.4 p 178.7 -39.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.657 0.265 . . . . 0.0 111.313 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -40.62 -40.57 1.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.913 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.416 ' CB ' ' HB3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -70.43 -39.3 74.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.765 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.23 -30.04 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.402 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -50.76 -34.92 29.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.8 -51.65 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.313 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.412 HG22 ' CE2' ' A' ' 97' ' ' TYR . 87.9 m -51.51 -39.2 57.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.997 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.6 mm -53.58 -65.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.981 0.419 . . . . 0.0 110.132 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -13.45 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.716 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -90.49 -25.49 20.26 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 110.065 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.94 -47.37 13.78 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.406 ' CE2' HG23 ' A' ' 48' ' ' VAL . 34.2 m-85 -57.93 -21.8 45.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.195 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -49.53 -28.01 5.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.185 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -98.32 31.08 2.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -149.41 31.26 0.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.737 0.303 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 23.8 mmtt -146.77 96.07 2.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.979 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.67 135.41 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.411 HG21 ' CE1' ' A' ' 117' ' ' PHE . 17.4 t -127.12 143.92 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.824 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 29' ' ' ASP . 15.1 tp -99.99 125.33 46.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.11 88.78 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.07 103.47 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -137.08 138.8 40.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.43 38.5 1.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 17.0 tp10 -150.21 164.84 34.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.4 -36.13 58.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.009 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 14' ' ' THR . 38.4 t -59.08 -173.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.8 mm 62.52 -72.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.194 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' SER . 31.4 p -53.8 -22.75 10.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.353 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.1 t -90.14 23.16 2.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.524 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.9 t -163.27 -53.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.583 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' A' ' 21' ' ' LEU . 1.6 tm? -57.88 -50.97 71.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.572 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.99 -51.52 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.336 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.54 70.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.538 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.16 -66.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.678 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.2 mt -49.7 -31.42 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.469 . . . . 0.0 110.369 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.42 -30.63 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.57 -34.89 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.037 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -75.08 -12.09 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.207 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 53.36 1.08 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.197 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 64.5 m-85 -126.38 -176.33 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 111.108 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.48 71.95 51.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.34 138.66 82.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.776 2.318 . . . . 0.0 112.645 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.9 t70 -121.04 4.59 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 29' ' ' ASP . 12.8 p 3.38 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 -163.21 0.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.391 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -118.85 -28.26 5.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.278 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.48 -170.12 2.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.806 0.336 . . . . 0.0 110.806 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 HD22 ' CG ' ' A' ' 63' ' ' PHE . 47.0 mt -68.41 -45.87 71.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -48.56 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.67 -30.19 69.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.491 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.29 -25.32 54.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 45.7 mt-10 -75.56 -36.27 60.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -37.33 77.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.58 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -71.82 -37.48 70.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.542 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 mt -85.76 -16.86 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.387 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -52.59 -22.19 4.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.619 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -133.3 -51.66 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.824 0.345 . . . . 0.0 111.154 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 118.71 5.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -73.96 72.26 1.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 38.8 m-85 -66.41 111.24 6.23 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.476 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.42 -20.67 18.09 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.628 2.219 . . . . 0.0 112.207 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 3.4 t -144.0 130.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.295 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 mm -117.7 156.99 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.407 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.15 102.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 tp -86.12 84.72 7.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.976 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.49 77.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.66 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 3.2 p -59.33 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.599 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.437 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 44.5 t-105 -74.46 -82.78 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.097 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.521 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.39 45.45 0.35 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.313 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 55' ' ' MET . 82.3 Cg_endo -85.12 -165.54 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.442 2.095 . . . . 0.0 112.261 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -154.55 48.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.949 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.0 -16.67 6.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.85 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 62.58 104.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.791 0.329 . . . . 0.0 110.733 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.06 18.57 57.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.895 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 t -58.98 -58.36 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.879 0.371 . . . . 0.0 111.098 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.05 -4.79 43.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.745 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CG ' HD22 ' A' ' 34' ' ' LEU . 26.7 t80 -69.15 -39.99 78.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.618 0.247 . . . . 0.0 111.496 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.402 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.3 mp -46.89 -33.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.766 0.317 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -70.04 -34.75 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 75.0 t80 -63.06 -39.92 96.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 63' ' ' PHE . 3.7 mp -62.77 -47.12 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.909 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -75.41 -18.95 59.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 36.6 tt0 -69.45 -42.75 74.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.718 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -120.75 18.36 11.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.054 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.85 67.11 1.09 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.81 -20.29 34.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.653 2.235 . . . . 0.0 112.218 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.41 32.72 2.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 t -113.2 -157.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.43 HG22 ' CD2' ' A' ' 120' ' ' TYR . 39.2 t -155.37 137.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 111.505 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.8 t -117.83 100.4 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.376 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mm -81.5 -55.12 8.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.739 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 99' ' ' PHE . 40.3 t 57.69 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.426 ' CG2' ' H ' ' A' ' 80' ' ' THR . 1.7 mt -114.31 -159.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.334 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.426 ' H ' ' CG2' ' A' ' 79' ' ' ILE . 0.0 OUTLIER 57.36 165.04 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.21 43.16 0.41 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.413 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -59.17 139.57 56.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.49 99.05 1.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m 63.06 146.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.0 p -105.96 37.79 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.047 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.57 -22.26 28.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -79.78 -36.38 37.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.144 0.497 . . . . 0.0 109.726 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -56.1 -57.74 10.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.203 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 -26.17 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.948 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -87.93 40.54 0.95 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.625 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -170.36 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.457 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 7.4 pt -75.08 -29.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.501 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -80.08 -19.27 47.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -23.15 58.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.76 22.88 0.14 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.595 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.452 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.36 -165.15 1.28 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 117.22 0.51 . . . . 0.0 111.147 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 97' ' ' TYR . 70.3 t80 -114.11 25.14 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 79.95 139.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.473 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -57.19 130.11 44.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.26 120.3 22.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.684 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.49 -168.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.014 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -150.52 53.62 1.27 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.857 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.17 -2.32 12.16 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.592 2.194 . . . . 0.0 112.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.96 -75.72 0.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.737 0.303 . . . . 0.0 110.845 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.7 t 178.15 -51.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 109' ' ' PHE . 11.7 p -155.79 -44.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -38.96 -44.16 1.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.635 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -64.45 -42.33 96.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 0.0 110.345 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 106' ' ' VAL . 8.8 t80 -59.51 -27.24 65.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.692 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.27 -48.15 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.404 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.9 mp -51.39 -51.52 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.227 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.91 -41.34 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.4 mm -50.35 -56.15 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.608 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -63.22 1.13 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -49.97 -32.56 15.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.776 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.35 95.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.458 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.427 ' CZ ' HG21 ' A' ' 48' ' ' VAL . 32.6 m-85 -76.13 -34.81 59.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 -77.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.597 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 -21.44 12.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.788 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.43 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -127.3 54.95 1.62 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.88 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttm . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.9 0.381 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.437 ' HB3' ' CG ' ' A' ' 26' ' ' TYR . 13.3 mmtt 65.39 100.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.22 121.95 9.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.633 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.0 t -127.36 158.15 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.931 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 52.3 tp -117.96 141.55 48.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 111.43 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.9 t -121.24 141.65 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.158 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 14.2 t -132.84 121.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.1 t70 -159.25 159.75 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 110.621 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.53 50.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.936 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -138.55 123.9 19.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -88.12 53.8 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -164.56 36.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.798 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 14' ' ' THR . 23.2 mm 55.71 168.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 121.116 0.484 . . . . 0.0 110.923 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.454 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 30.1 p -86.1 122.15 29.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.129 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 16' ' ' SER . 29.6 t -54.21 132.46 43.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.955 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 15' ' ' SER . 5.7 t 83.08 -15.02 0.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.719 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.431 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -77.4 -48.49 17.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.855 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -50.7 -57.0 9.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.31 80.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.413 HD13 ' CG1' ' A' ' 106' ' ' VAL . 81.9 mt -59.91 -70.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -47.84 -31.17 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -73.79 -30.54 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.884 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.16 -35.53 25.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.89 -33.74 62.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.5 42.17 3.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.437 ' CG ' ' HB3' ' A' ' 2' ' ' LYS . 3.1 m-85 -104.12 -175.67 2.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -127.59 82.27 68.62 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.05 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.44 130.94 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 113.884 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.4 ' O ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -119.74 116.82 26.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.856 178.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.5 p -105.76 137.14 44.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 112.039 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.93 -164.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.076 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -131.59 -5.84 3.68 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.7 167.66 7.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 63' ' ' PHE . 33.8 mt -60.78 -29.6 69.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.848 0.356 . . . . 0.0 110.225 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -70.63 -45.98 64.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.722 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.66 -33.07 74.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.069 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.97 34.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.718 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' LYS . 49.8 mt-10 -46.17 -46.55 17.41 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -58.95 -54.45 47.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.51 -24.63 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.014 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.2 mt -97.07 -13.49 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.22 -9.28 58.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.587 0.232 . . . . 0.0 111.288 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.03 -62.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 113.12 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.21 68.26 0.49 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.481 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 35.2 m-85 -63.28 130.18 94.04 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 5.1 Cg_endo -80.39 -45.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.393 2.062 . . . . 0.0 111.924 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.418 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 23.9 t -117.37 123.41 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.91 128.35 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.785 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.35 106.27 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.068 0.461 . . . . 0.0 111.552 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 31.8 tp -89.07 153.84 20.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.68 109.03 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.9 t -86.75 70.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.973 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.419 ' CZ2' ' HE3' ' A' ' 55' ' ' MET . 31.1 t-105 -71.96 -80.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.485 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.612 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.97 55.0 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.96 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 55' ' ' MET . 6.9 Cg_endo -88.34 -156.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.136 2.557 . . . . 0.0 112.161 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -146.34 36.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.97 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.21 129.25 3.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.447 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.49 141.99 53.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.72 -23.06 11.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.658 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 64' ' ' ILE . 21.7 t -53.51 -46.73 60.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.572 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -75.65 -5.39 45.29 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.1 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.438 ' CD2' HD22 ' A' ' 34' ' ' LEU . 16.4 t80 -84.43 -35.72 22.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.571 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.408 HD13 ' CB ' ' A' ' 91' ' ' ALA . 2.9 mp -45.07 -29.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.466 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.613 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 9.9 t0 -72.34 -51.45 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.12 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.41 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 8.8 t80 -50.58 -41.63 54.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.942 0.401 . . . . 0.0 110.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.425 ' CD1' ' CD2' ' A' ' 63' ' ' PHE . 4.1 mp -63.6 -50.19 79.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.42 -15.79 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 110.688 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -73.42 -52.09 14.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.673 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.14 19.75 17.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.438 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -163.67 64.29 1.3 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.684 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 71' ' ' SER . 5.0 Cg_exo -76.02 -13.5 19.33 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.602 2.201 . . . . 0.0 111.99 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 25.54 11.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.083 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.5 t -108.76 -173.3 2.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.976 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 48' ' ' VAL . 21.2 t -123.9 162.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.009 0.433 . . . . 0.0 111.293 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.5 t -140.34 105.54 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.378 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 mm -107.25 41.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.434 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 58.8 t -46.23 97.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.7 mt -71.61 -101.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.455 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.416 ' OG1' ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER 69.8 130.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.696 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.79 -111.2 1.79 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.58 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 62.92 -79.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 111.061 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.77 51.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.565 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.41 80.59 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.74 0.305 . . . . 0.0 110.916 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.59 -30.73 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.09 -14.0 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.33 -35.43 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 109.799 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.457 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -58.87 -57.59 12.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.172 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.2 m -59.38 -29.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -75.79 -12.9 60.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.408 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -116.57 -36.34 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 89' ' ' VAL . 1.3 pt -80.31 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.917 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.4 mptp? 73.64 -46.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.613 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -62.42 -21.92 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.786 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.15 -30.07 0.11 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.62 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -62.48 176.52 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.95 0.405 . . . . 0.0 111.331 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -104.82 27.43 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.406 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 79.64 142.67 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.855 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 1.5 m-30 -63.82 149.39 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.57 101.72 10.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -53.27 154.61 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.205 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.39 72.48 0.67 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.63 61.59 3.63 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.576 2.184 . . . . 0.0 112.303 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -147.56 -47.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 p -96.88 136.37 37.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.413 ' CG1' HD13 ' A' ' 20' ' ' ILE . 8.0 p -100.26 -15.73 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.235 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -37.58 87.81 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.81 -36.32 83.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.675 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -59.46 -37.04 77.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.643 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.411 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.53 -42.95 79.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.136 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.34 -47.07 76.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.408 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.7 m -66.15 -41.69 90.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 mm -45.27 -54.33 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.52 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.29 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.033 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -60.92 -30.36 70.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.989 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.37 87.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.914 0.387 . . . . 0.0 110.857 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -69.6 -15.04 63.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.345 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.25 -25.4 9.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.77 0.319 . . . . 0.0 111.428 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.76 40.84 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -166.19 32.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.837 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.881 0.372 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.422 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -109.16 135.09 50.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.013 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.417 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -144.98 151.04 37.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.787 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 30.3 t -133.37 143.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.711 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 46.3 tp -106.45 129.75 54.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' THR . 17.7 t -117.94 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 52' ' ' ASP . 42.9 t -81.84 119.14 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 52' ' ' ASP . 26.3 t0 -155.15 149.99 26.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 32.3 t70 -90.31 51.43 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.732 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.43 -165.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.788 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.99 -67.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.984 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 m -129.3 105.25 8.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 14' ' ' THR . 15.1 mm 55.54 168.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.439 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 61.1 p -90.36 128.58 36.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.203 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 t -58.84 138.03 57.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.981 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.437 ' O ' HD13 ' A' ' 20' ' ' ILE . 3.1 m 75.84 -0.89 3.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.417 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -89.96 -52.67 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.347 . . . . 0.0 110.804 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.85 -58.59 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.024 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.22 48.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.011 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 16' ' ' SER . 62.1 mt -68.18 -71.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.331 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.414 ' CD2' ' HB3' ' A' ' 28' ' ' PRO . 1.1 mt -49.59 -29.72 7.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -74.32 -27.02 60.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.654 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.28 -35.07 28.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -81.17 -34.62 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.045 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.19 53.27 1.91 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.227 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' CE2' ' CG2' ' A' ' 113' ' ' ILE . 7.8 m-85 -112.03 -175.69 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.357 0.599 . . . . 0.0 111.259 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 82.03 31.23 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.816 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HB3' ' CD2' ' A' ' 21' ' ' LEU . 78.2 Cg_endo -82.06 128.02 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.752 2.301 . . . . 0.0 113.926 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.67 114.23 20.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 20.3 p -95.46 128.83 42.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.009 0.433 . . . . 0.0 111.648 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.96 163.35 12.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.39 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -111.93 -9.15 14.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.61 152.71 3.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.2 mt -52.16 -26.64 11.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.55 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -43.45 59.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.986 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.24 -48.83 31.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 66' ' ' PHE . 4.8 tt0 -47.11 -47.39 23.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.33 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -55.39 35.64 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -58.23 -26.33 62.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.5 mt -90.16 -13.27 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.32 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -97.53 20.71 11.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -140.89 -52.65 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' CD2' ' CG ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -98.83 155.51 17.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.379 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.409 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 52.5 t80 -88.67 78.23 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.047 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.475 ' CG ' ' CD2' ' A' ' 44' ' ' LEU . 16.1 m-85 -66.49 120.39 70.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.7 Cg_endo -80.63 -47.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.311 2.007 . . . . 0.0 111.889 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' CG2' ' CE1' ' A' ' 117' ' ' PHE . 36.6 t -115.06 124.9 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.577 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 29.2 mm -112.82 124.48 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.51 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.427 HG13 ' CZ ' ' A' ' 109' ' ' PHE . 46.4 t -128.12 108.58 18.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 112.051 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 52' ' ' ASP . 49.7 tp -82.76 157.76 23.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.408 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -140.17 89.93 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.41 ' N ' ' HB ' ' A' ' 80' ' ' THR . 39.3 t -67.71 66.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.154 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -77.94 -80.51 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.561 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.65 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.8 ttm -146.0 50.46 1.05 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.029 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.65 ' HD3' ' N ' ' A' ' 55' ' ' MET . 58.0 Cg_endo -92.66 -165.92 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.96 2.44 . . . . 0.0 112.377 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.01 30.6 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.82 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.67 -73.54 0.89 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.562 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 31.2 20.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.17 91.33 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.813 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.69 -39.78 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.836 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -15.51 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.348 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 45.9 t80 -53.26 -47.12 69.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.8 mt -46.62 -29.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -65.72 -49.67 67.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.418 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.455 ' CE2' ' HG3' ' A' ' 38' ' ' GLU . 2.0 t80 -53.92 -41.4 67.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.95 0.405 . . . . 0.0 110.138 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -62.47 -43.89 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 -17.35 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.041 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 65' ' ' ASP . 4.0 tt0 -72.07 -45.5 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.45 8.06 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.198 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.439 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -155.54 63.95 3.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.877 0.37 . . . . 0.0 110.57 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 71' ' ' SER . 15.0 Cg_exo -67.86 -20.87 45.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.548 2.165 . . . . 0.0 112.082 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.48 23.03 7.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.869 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.7 t -104.81 -176.98 3.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.643 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 120' ' ' TYR . 31.0 t -123.36 157.23 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.068 0.461 . . . . 0.0 111.257 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -146.2 104.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.134 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.3 mm -90.11 -42.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.407 ' O ' ' CE1' ' A' ' 99' ' ' PHE . 47.2 t 45.97 88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.351 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -104.28 -177.74 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.503 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.41 ' HB ' ' N ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 78.37 143.52 0.08 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.29 -116.6 0.41 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.365 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 179.25 -50.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.68 -41.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.482 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 t -81.41 124.52 29.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 110.99 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.56 -5.59 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.455 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.24 -17.07 62.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.344 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -74.25 -35.23 63.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 0.0 109.944 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.87 -58.78 6.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.044 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 92' ' ' ILE . 21.3 m -60.25 -25.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.101 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -76.22 -17.27 59.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.78 -39.67 4.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.463 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 2.8 pt -72.76 -22.73 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.689 0.28 . . . . 0.0 111.53 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -68.72 -30.65 69.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.385 . . . . 0.0 110.41 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -64.76 -57.07 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 34.75 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.29 -167.77 1.93 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.158 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 75.2 t80 -107.64 -17.97 13.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.45 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 4.6 pt-20 145.17 -173.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.504 0.721 . . . . 0.0 110.066 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.474 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -121.45 94.24 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.436 ' HB3' HG21 ' A' ' 79' ' ' ILE . 11.7 tp -54.15 140.74 31.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.75 16.49 12.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.294 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.554 ' N ' ' HD3' ' A' ' 103' ' ' PRO . 9.1 tttt 50.81 54.38 15.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.277 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 102' ' ' LYS . 39.3 Cg_exo -59.99 138.96 85.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.309 2.006 . . . . 0.0 112.114 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 63.98 -76.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.8 p -166.23 -39.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.2 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 8.1 p -176.66 -27.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.814 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -46.74 -35.87 6.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -39.53 80.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.941 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 113' ' ' ILE . 18.0 t80 -55.97 -31.46 63.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.926 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.55 -52.55 64.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.147 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -47.05 -40.87 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.499 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.7 m -64.69 -50.19 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 109' ' ' PHE . 1.4 mp -45.5 -52.95 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.922 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -59.12 4.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.0 0.429 . . . . 0.0 109.962 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -31.7 70.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.838 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.63 -28.36 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.498 ' CE1' ' CG2' ' A' ' 48' ' ' VAL . 10.7 m-85 -86.93 -56.4 3.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -48.82 79.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.529 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.17 -5.21 43.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.774 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.414 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -140.05 39.36 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 111.035 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.93 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.844 0.354 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' HB2' ' CG ' ' A' ' 26' ' ' TYR . 13.8 mmtm -132.3 161.66 32.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.404 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.62 122.65 12.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 48.2 t -129.89 144.81 36.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.5 tp -106.67 140.1 40.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.496 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.4 ' CG2' ' CD1' ' A' ' 17' ' ' LEU . 19.2 t -118.39 127.07 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.182 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 51' ' ' LEU . 37.4 t -117.01 115.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -140.49 162.59 34.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.618 -179.256 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' HB2' ' CG ' ' A' ' 56' ' ' PRO . 17.4 t70 -63.54 -85.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.618 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.13 -164.94 1.25 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.44 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 74.86 126.03 0.04 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t -54.61 109.98 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.006 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 14' ' ' THR . 26.2 mm 58.13 166.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 68.4 p -90.27 117.64 29.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.233 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -50.6 138.7 17.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.796 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.408 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 2.2 m 78.04 -1.98 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.283 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -90.12 -53.95 4.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.8 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.31 -60.59 2.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.36 -39.86 47.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.078 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' A' ' 16' ' ' SER . 46.3 mt -64.26 -66.61 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.159 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' CD2' ' HB3' ' A' ' 28' ' ' PRO . 0.9 OUTLIER -50.66 -28.78 9.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -72.61 -27.98 62.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.649 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -82.6 -35.01 27.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.281 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -80.99 -39.85 25.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.037 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.31 51.0 2.29 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.166 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 2' ' ' LYS . 3.4 m-30 -104.1 -174.85 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.376 0.608 . . . . 0.0 111.315 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 77.47 59.45 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.722 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 92.1 Cg_endo -86.45 154.29 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.685 2.257 . . . . 0.0 114.585 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -140.3 137.36 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.558 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.1 p -114.89 143.38 45.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.208 0.528 . . . . 0.0 112.135 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.89 -173.69 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.056 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER -117.65 -22.24 8.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.773 0.321 . . . . 0.0 111.288 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.08 167.38 16.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.379 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.427 HD22 ' CD2' ' A' ' 63' ' ' PHE . 12.1 mt -54.53 -32.51 58.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.708 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.002 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -35.42 80.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.01 -56.21 16.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 27.3 mt-10 -45.86 -42.61 12.71 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -45.89 86.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.874 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -71.73 -42.02 67.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.9 mt -71.54 -21.28 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -61.8 -20.73 63.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.125 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -126.68 -55.98 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -64.92 115.62 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -74.26 65.77 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 44' ' ' LEU . 37.8 m-85 -63.75 128.78 93.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 74' ' ' SER . 11.1 Cg_endo -82.57 -27.6 2.11 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.491 2.127 . . . . 0.0 112.125 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.6 t -130.48 139.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 2.0 mm -139.03 108.84 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.727 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.447 ' CG1' HG13 ' A' ' 79' ' ' ILE . 41.8 t -111.05 142.18 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 110.662 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 78' ' ' VAL . 20.2 tp -101.39 159.88 14.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 6.9 t70 -141.99 79.82 1.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.89 68.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.666 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.424 ' CD1' ' HE2' ' A' ' 55' ' ' MET . 31.0 t-105 -68.57 -79.62 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.923 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.745 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.2 ptt? -144.07 40.61 0.3 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.667 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.745 ' HD3' ' N ' ' A' ' 55' ' ' MET . 57.1 Cg_endo -99.45 -162.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.201 2.601 . . . . 0.0 112.198 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -91.52 -47.27 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.451 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.06 -121.65 14.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.014 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.96 31.32 18.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.04 59.65 1.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.524 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -56.39 -38.11 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.153 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.09 15.96 9.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.44 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 47.8 t80 -79.7 -38.42 33.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.81 0.338 . . . . 0.0 110.742 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.2 mp -48.58 -28.52 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.29 -37.78 60.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 19.4 t80 -57.68 -44.87 86.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.281 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.431 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 5.0 mp -59.29 -41.88 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.361 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.66 -24.85 49.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.551 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.14 -41.5 94.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.71 12.86 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 68.15 1.18 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.842 0.354 . . . . 0.0 110.668 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -67.98 -20.32 44.84 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.771 2.314 . . . . 0.0 112.138 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.6 28.73 6.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 47.5 t -112.1 -176.25 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.973 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.03 143.59 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.125 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.06 95.84 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.726 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.22 -65.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.483 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.462 ' HA ' ' HB3' ' A' ' 51' ' ' LEU . 11.3 t 67.8 88.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.447 HG13 ' CG1' ' A' ' 50' ' ' VAL . 1.8 mt -106.45 175.7 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.563 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER 72.24 121.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.916 0.389 . . . . 0.0 110.892 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.09 150.08 11.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.475 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -128.81 -178.15 4.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.357 . . . . 0.0 110.956 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.39 -139.73 16.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.7 m -98.42 29.52 3.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.2 t 58.28 30.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.073 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.5 -31.56 32.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 2.6 t -63.16 -34.48 77.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.874 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -60.13 -59.84 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.227 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.411 ' HA ' HG12 ' A' ' 92' ' ' ILE . 10.3 m -64.53 -23.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.019 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 89' ' ' VAL . 22.0 ttpt -81.25 -7.6 59.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.427 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.29 -40.13 2.41 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.428 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 3.5 pt -69.8 -40.75 79.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.288 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -56.42 -25.46 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -19.75 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.347 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.85 -3.68 3.49 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.063 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -56.52 -167.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.901 0.381 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 97' ' ' TYR . 36.8 t80 -108.53 26.05 10.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.44 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 79.66 152.65 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.203 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -74.83 103.08 4.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.948 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.405 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 11.4 tp -80.61 53.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.654 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.34 133.24 55.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 111.323 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.417 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.3 OUTLIER 175.41 -58.0 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 102' ' ' LYS . 97.2 Cg_endo -84.19 6.21 5.89 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.761 2.307 . . . . 0.0 112.743 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 61.88 171.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.704 0.288 . . . . 0.0 110.754 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m 59.06 -166.17 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.684 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' PHE . 5.4 m -116.4 -11.82 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.648 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -40.95 -50.51 3.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.203 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -35.41 80.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.23 0.538 . . . . 0.0 109.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -58.3 -24.09 58.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.213 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.404 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 1.2 tt -60.27 -49.08 79.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.221 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.31 -56.15 24.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.33 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 113' ' ' ILE . 60.8 m -53.72 -57.95 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.447 HG13 ' CZ ' ' A' ' 109' ' ' PHE . 7.4 mm -31.58 -62.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.5 -59.2 3.97 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -52.67 -28.33 21.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.693 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.27 -32.66 70.57 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS . 26.6 m-85 -68.75 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.141 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -60.32 -41.23 93.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.377 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -72.28 -8.35 54.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.583 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.62 39.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.2 mptt 63.53 95.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.257 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.8 132.5 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 7.4 t -123.75 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.63 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.432 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 43.5 tp -103.66 132.74 49.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.403 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 34.1 t -113.26 90.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.254 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.14 104.63 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -135.32 134.39 39.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.95 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 t0 -73.29 -40.79 64.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.41 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -178.72 120.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 179.73 -179.04 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.26 19.34 10.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.116 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.424 HG21 ' HB2' ' A' ' 17' ' ' LEU . 2.0 mp -80.69 -59.38 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.366 . . . . 0.0 110.716 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.7 p -46.0 -26.7 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.799 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 t -76.99 -65.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.44 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m -73.16 -53.43 11.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.396 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 109' ' ' PHE . 1.7 tm? -46.81 -53.94 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.246 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.3 m -52.8 -43.58 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.94 96.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.424 ' CG2' ' CD1' ' A' ' 110' ' ' LEU . 55.5 mt -56.22 -67.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.59 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' CD1' ' CD1' ' A' ' 17' ' ' LEU . 1.4 mt -47.47 -33.32 6.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 110.497 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.23 -29.96 71.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.589 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -78.51 -37.07 44.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.61 -22.27 62.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.085 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.54 58.47 0.81 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.378 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.464 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 55.7 m-85 -130.14 -177.27 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.431 . . . . 0.0 111.116 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.1 76.18 77.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.448 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 11.7 Cg_exo -67.7 137.7 42.94 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.795 2.33 . . . . 0.0 112.631 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.2 t70 -120.63 7.85 10.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.544 ' O ' ' O ' ' A' ' 29' ' ' ASP . 13.7 p 6.04 122.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.24 -162.41 0.93 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.86 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' ASP . 1.4 ttpt -117.22 -38.46 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.9 p -161.3 -173.06 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.538 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 63' ' ' PHE . 16.5 mt -66.79 -45.75 77.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.456 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -62.85 -45.88 90.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.157 0.504 . . . . 0.0 109.937 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -32.35 71.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.93 -28.68 62.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.704 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mt-10 -69.76 -43.49 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -60.04 -39.9 87.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.66 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -70.37 -46.82 63.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.721 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mt -73.0 -20.43 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.567 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -57.98 -21.17 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.371 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -126.46 -43.73 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -77.76 122.93 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.044 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -81.05 85.25 6.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 61.1 m-85 -80.79 113.97 44.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.367 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 74' ' ' SER . 71.6 Cg_endo -74.17 -20.39 19.01 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.72 129.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.299 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 mm -117.22 157.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.251 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.9 t -149.34 102.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 110.767 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HB3' HG11 ' A' ' 78' ' ' VAL . 60.1 tp -78.42 148.17 33.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.312 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.5 OUTLIER -130.24 84.06 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.242 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.3 t -62.88 72.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.978 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 55' ' ' MET . 27.9 t90 -64.92 -97.15 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.595 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -135.99 38.58 0.39 Allowed Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 55' ' ' MET . 69.5 Cg_endo -85.33 -164.72 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.425 2.083 . . . . 0.0 112.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -143.96 41.45 1.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.5 179.9 36.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.388 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.97 77.46 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.83 -25.87 62.09 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.554 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.4 t -54.56 -44.53 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 120.756 0.312 . . . . 0.0 111.45 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.7 6.67 40.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.472 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CD2' HD22 ' A' ' 34' ' ' LEU . 34.9 t80 -90.07 -37.51 14.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.95 -28.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.359 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -77.15 -36.22 55.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.703 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 61.2 t80 -59.15 -42.83 91.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.974 0.416 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.5 mp -59.85 -43.27 91.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.317 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.25 -16.04 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.41 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 3.1 tm-20 -74.0 -34.34 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.412 . . . . 0.0 110.737 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.442 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -126.41 13.31 7.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.029 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.29 66.89 1.94 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.584 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.25 -20.9 42.48 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.655 2.237 . . . . 0.0 112.187 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -100.04 30.42 3.76 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 44.5 t -113.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.436 HG22 ' CG ' ' A' ' 120' ' ' TYR . 58.0 t -152.92 136.83 8.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 111.646 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 3.4 t -108.77 113.94 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.866 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.22 -65.33 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.423 HG12 ' CE1' ' A' ' 99' ' ' PHE . 58.0 t 52.8 97.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.134 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 mt -126.22 142.54 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 173.42 111.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.736 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.16 86.21 0.41 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.579 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -122.21 31.43 6.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.1 40.27 3.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.9 p -142.91 103.53 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 m -99.24 -27.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -83.76 3.44 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.216 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -37.57 13.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . . . -58.28 -57.66 11.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.154 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.7 m -60.96 -25.89 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.478 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -81.22 -18.21 46.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.531 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.7 -30.12 8.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 89' ' ' VAL . 4.7 pt -82.17 -23.45 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.197 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -68.95 -35.37 76.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpm? -59.25 -27.51 65.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.888 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.82 35.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.934 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.44 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.06 -165.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.455 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 59.2 t80 -110.98 25.09 12.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.303 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.8 OUTLIER 85.37 161.9 0.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.653 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.474 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -95.36 95.07 8.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.306 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 20.2 tp -49.88 98.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.541 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.62 75.82 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -151.58 59.26 3.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.76 90.42 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.604 2.203 . . . . 0.0 112.411 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.32 -71.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.47 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 15.3 p -159.85 42.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.61 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 106' ' ' VAL . 7.2 p 48.01 15.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.473 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.76 -43.66 18.07 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -62.24 -34.83 77.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.307 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.434 ' CE2' HD21 ' A' ' 17' ' ' LEU . 1.6 t80 -63.32 -46.44 86.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.167 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.424 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -48.91 -37.26 19.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.456 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.21 -45.79 72.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.328 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.8 m -46.46 -40.79 12.92 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.399 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.429 HG22 ' CZ ' ' A' ' 26' ' ' TYR . 12.9 mm -62.32 -65.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.716 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -14.9 3.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.743 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.429 ' CD2' ' HG3' ' A' ' 119' ' ' GLU . 1.9 t-160 -89.25 -30.92 18.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.112 0.482 . . . . 0.0 109.718 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.44 -33.94 42.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.385 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 14.8 m-85 -70.26 -29.59 66.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.59 -35.67 9.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.815 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.429 ' HG3' ' CD2' ' A' ' 115' ' ' HIS . 2.0 mm-40 -91.61 18.78 6.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.653 0.263 . . . . 0.0 111.593 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.436 ' CG ' HG22 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -154.65 38.11 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 110.83 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.816 0.341 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 61.88 108.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.52 120.26 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.609 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 HG21 ' CE2' ' A' ' 117' ' ' PHE . 22.9 t -116.28 159.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 49.8 tp -109.58 129.66 55.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 30' ' ' THR . 24.6 t -115.38 89.45 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.673 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.13 115.21 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.137 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -149.35 143.15 25.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.403 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -87.44 50.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.99 5.43 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.437 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.6 148.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.809 0.338 . . . . 0.0 110.976 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m 54.03 178.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.936 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mm -52.93 163.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.867 0.365 . . . . 0.0 111.01 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.42 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 52.6 p -86.09 158.23 19.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.015 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.8 136.3 47.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.138 0.494 . . . . 0.0 112.028 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 74.26 0.57 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.364 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -90.05 -53.35 4.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.859 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 t -44.57 -55.56 5.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.29 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.482 HD12 HG23 ' A' ' 20' ' ' ILE . 64.6 mt -65.22 -69.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.97 -30.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.192 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.51 -30.32 67.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -34.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 110.273 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -83.41 -36.98 23.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.08 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.11 54.26 1.77 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.269 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -108.59 -173.3 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 111.241 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.42 88.8 33.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.219 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.93 130.98 7.75 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.653 2.235 . . . . 0.0 112.811 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.4 t70 -105.57 5.04 30.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.347 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 29' ' ' ASP . 10.4 p 2.14 124.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.71 -163.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.625 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -118.14 -36.45 3.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.56 179.94 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.429 HD22 ' CD2' ' A' ' 63' ' ' PHE . 56.3 mt -60.03 -47.41 85.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.92 -45.26 86.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.542 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -70.87 -32.15 69.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 40' ' ' LYS . . . -75.19 -28.97 60.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 55.4 mt-10 -72.1 -39.95 68.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -32.26 69.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.688 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' CE ' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -78.31 -37.6 44.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.773 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.97 -27.16 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -5.48 30.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.776 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.03 -27.38 10.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -134.83 156.38 49.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.44 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 69.1 t80 -91.66 96.46 10.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.947 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 38.9 m-85 -79.76 122.49 83.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.341 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.71 -20.5 7.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.511 2.141 . . . . 0.0 111.934 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -148.31 133.82 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.17 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 6.2 mm -121.01 163.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.439 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 60.1 t -154.06 99.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.408 ' HG ' ' N ' ' A' ' 52' ' ' ASP . 42.5 tp -79.6 163.3 24.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 8.7 t70 -151.17 88.84 1.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.224 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.63 66.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.652 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -58.32 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.43 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.678 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.8 OUTLIER -152.5 49.5 0.53 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.104 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.678 ' HD3' ' N ' ' A' ' 55' ' ' MET . 36.6 Cg_endo -94.53 -162.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.09 2.527 . . . . 0.0 112.293 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -152.08 43.64 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.92 -21.26 5.02 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.815 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.97 123.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.758 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.65 11.98 69.28 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.971 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.78 -41.9 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.851 0.358 . . . . 0.0 111.045 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.28 4.79 49.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.429 ' CD2' HD22 ' A' ' 34' ' ' LEU . 24.8 t80 -90.09 -36.63 14.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.285 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.2 mp -47.05 -29.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.366 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -35.35 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 29.8 t80 -59.88 -41.36 91.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.418 HD13 ' CD2' ' A' ' 63' ' ' PHE . 4.2 mp -61.57 -43.46 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.212 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -25.89 58.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.396 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -63.84 -39.98 95.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 16.38 11.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.418 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -166.56 70.13 1.09 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.817 0.341 . . . . 0.0 110.822 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.46 -18.4 29.58 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.795 2.33 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.75 27.19 9.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.989 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.7 t -104.4 -159.82 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.395 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.4 t -150.11 135.15 10.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 111.695 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 8.2 t -110.53 116.05 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.643 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 77' ' ' ILE . 16.1 mm -118.49 50.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.453 HG13 ' CE1' ' A' ' 99' ' ' PHE . 44.7 t -49.64 115.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.433 ' O ' ' CB ' ' A' ' 80' ' ' THR . 1.8 mt -110.26 179.16 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.749 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.433 ' CB ' ' O ' ' A' ' 79' ' ' ILE . 2.4 m 81.73 110.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.832 0.348 . . . . 0.0 110.995 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.62 109.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.49 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -95.74 162.54 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.35 -153.87 31.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.523 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -59.76 129.93 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 m -71.74 64.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -94.84 -19.88 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -34.31 23.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HB3' ' CD2' ' A' ' 99' ' ' PHE . . . -58.49 -59.38 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.846 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.8 m -55.39 -28.02 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.096 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -80.13 -9.16 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.414 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.08 -31.41 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 89' ' ' VAL . 7.3 pt -79.21 -44.72 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.738 0.304 . . . . 0.0 111.417 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -63.21 -17.93 62.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.782 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -25.87 52.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.2 -16.13 0.29 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.629 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -59.17 -179.65 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.41 0.605 . . . . 0.0 111.043 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.566 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 85.1 t80 -99.81 -7.8 24.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.785 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.566 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 17.9 pt-20 140.99 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.276 0.63 . . . . 0.0 110.663 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD2' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.41 91.11 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.751 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 14.6 tp -55.64 167.34 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -93.0 116.21 28.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -57.58 -58.09 20.71 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.089 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 28.6 Cg_endo -62.7 -164.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.385 2.057 . . . . 0.0 112.141 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 74.95 -72.99 0.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.0 t 174.46 164.2 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.985 0.422 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 109' ' ' PHE . 7.3 p -88.66 -28.82 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.8 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -44.96 -31.94 1.46 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.939 0.4 . . . . 0.0 110.481 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -70.17 -41.44 73.79 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 106' ' ' VAL . 3.7 t80 -55.02 -29.26 57.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.954 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.36 -39.74 73.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.764 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.21 -60.03 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 116' ' ' ALA . 80.0 m -44.12 -48.38 9.07 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.148 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.7 mm -54.76 -73.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.603 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -17.75 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -90.13 -20.81 22.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.4 -47.24 12.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 4' ' ' VAL . 57.7 m-85 -56.8 -29.86 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.103 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -57.48 -22.3 42.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -97.03 29.97 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 20.9 t80 -119.75 29.43 7.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.756 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.797 0.332 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 17.1 mmtm 61.59 99.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.072 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.9 134.65 23.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.597 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 48' ' ' VAL . 10.9 t -125.34 160.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.486 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 61.5 tp -112.93 128.59 56.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 30' ' ' THR . 44.4 t -108.47 90.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -86.89 119.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.159 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -158.93 139.67 12.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.495 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.417 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 43.4 t0 -90.24 50.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.897 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -152.23 104.48 2.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 61.15 167.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.059 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.3 p -58.16 -56.65 19.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.415 ' CD1' ' CG2' ' A' ' 30' ' ' THR . 7.6 mm -112.4 161.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.047 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 p -90.51 138.44 31.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.577 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 p -63.37 140.59 58.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.9 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.4 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 2.5 m 79.37 -5.36 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.563 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.422 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.18 -49.06 6.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 110.922 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.2 p -47.68 -49.24 28.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.79 68.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 23' ' ' GLU . 91.4 mt -54.2 -69.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.162 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' CD1' ' CD1' ' A' ' 17' ' ' LEU . 1.3 mt -45.08 -33.65 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.18 -28.82 65.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -83.07 -35.65 25.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -78.21 -38.72 42.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.58 26.58 7.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.354 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 49.2 m-85 -84.25 -174.94 5.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.989 0.423 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -133.13 86.57 41.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -81.38 129.54 6.69 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.663 2.242 . . . . 0.0 112.442 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.0 t70 -106.92 -4.65 18.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 112.049 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 29' ' ' ASP . 69.2 p 43.72 174.54 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.703 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -164.01 170.43 16.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.419 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -104.76 -40.75 5.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.86 -174.49 4.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.571 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.435 HD22 ' CD2' ' A' ' 63' ' ' PHE . 45.8 mt -65.26 -41.34 94.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.708 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -61.53 -49.29 77.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 109.989 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.86 -34.85 77.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.57 -26.85 63.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 27.4 mt-10 -69.97 -46.62 64.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.873 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -62.28 -32.96 73.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.223 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -77.95 -40.36 39.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.229 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.87 -29.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 111.308 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.27 -25.84 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.358 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.79 -60.43 1.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.082 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.406 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -59.4 129.34 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.14 80.9 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 56.8 m-85 -78.77 119.2 76.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 95.8 Cg_endo -78.97 -22.11 8.96 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.512 2.141 . . . . 0.0 111.958 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' A' ' 4' ' ' VAL . 4.6 t -145.43 127.6 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.623 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mm -113.98 152.09 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.827 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.419 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 84.5 t -139.56 94.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.508 . . . . 0.0 110.682 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.6 tp -76.75 160.27 29.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.592 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -153.55 79.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.984 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.458 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 28.6 m -59.24 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.283 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.432 ' CG ' ' N ' ' A' ' 55' ' ' MET . 14.8 t90 -63.41 -90.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.642 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.5 tpt -148.5 51.68 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.87 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.642 ' HD3' ' N ' ' A' ' 55' ' ' MET . 44.5 Cg_endo -92.54 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.898 2.399 . . . . 0.0 112.676 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -170.22 -68.5 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.785 0.326 . . . . 0.0 111.296 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.36 159.35 3.99 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.97 23.72 14.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 10.24 8.81 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.779 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 64' ' ' ILE . 27.3 t -84.34 -44.39 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.512 0.656 . . . . 0.0 110.964 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -68.39 -13.52 62.35 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.856 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.435 ' CD2' HD22 ' A' ' 34' ' ' LEU . 4.7 t80 -86.88 -27.45 23.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.315 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 61' ' ' VAL . 15.2 mm -47.59 -46.05 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.0 111.204 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -42.42 93.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.523 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.441 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 26.6 t80 -58.71 -29.97 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.113 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.431 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mm -64.71 -48.44 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.491 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -82.04 -14.28 56.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.24 -39.37 68.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.917 0.389 . . . . 0.0 110.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.48 11.48 9.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -157.43 66.62 3.77 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 110.673 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.0 Cg_exo -70.17 -19.49 34.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.745 2.297 . . . . 0.0 112.207 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.39 29.74 6.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.675 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 t -111.83 -162.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.757 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.418 HG22 ' CD2' ' A' ' 120' ' ' TYR . 25.8 t -151.51 134.41 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.035 0.445 . . . . 0.0 111.81 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.0 t -111.44 111.79 37.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.756 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.474 HD11 HG23 ' A' ' 77' ' ' ILE . 37.5 mm -92.83 -42.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.309 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.471 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 40.7 t 46.0 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.271 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.422 HG12 ' CB ' ' A' ' 100' ' ' LEU . 31.8 mt -56.3 -101.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.212 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.421 ' OG1' ' CE2' ' A' ' 99' ' ' PHE . 1.1 p 68.87 -168.93 0.18 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 110.752 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.54 -151.02 18.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.557 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.0 43.2 9.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.389 . . . . 0.0 110.903 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 175.28 -62.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 m -130.85 -173.59 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.761 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.9 m -152.01 28.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.258 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.67 -60.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.729 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 5.3 t -46.09 -32.77 3.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.139 0.495 . . . . 0.0 110.305 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.49 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -57.24 -60.27 3.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.086 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 92' ' ' ILE . 28.0 m -61.88 -24.43 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.223 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -32.48 33.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.14 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.17 -34.92 14.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.48 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 92' ' ' ILE . 2.7 pt -80.3 157.19 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.781 0.324 . . . . 0.0 110.754 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 mttm 72.42 6.1 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.162 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.49 26.66 5.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 110.565 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.62 -18.82 5.97 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.402 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.415 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -84.96 -169.8 2.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 111.248 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 82.9 t80 -125.72 29.77 5.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' A' ' 92' ' ' ILE . 0.8 OUTLIER 80.95 138.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.921 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.49 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 1.6 m-85 -66.08 128.97 38.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.061 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.422 ' CB ' HG12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -71.93 118.11 14.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.92 171.86 14.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.493 ' N ' ' HD3' ' A' ' 103' ' ' PRO . 25.9 mmtt 63.44 60.29 1.9 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.034 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 102' ' ' LYS . 17.7 Cg_exo -65.24 -10.67 26.75 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.597 2.198 . . . . 0.0 112.721 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -73.64 -56.65 4.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -95.62 119.11 33.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 7.4 p -78.32 -30.26 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.411 ' N ' HG11 ' A' ' 106' ' ' VAL . 23.3 tt0 -45.23 -34.1 2.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.6 -39.99 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.9 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 109' ' ' PHE . 1.5 t80 -56.39 -30.45 62.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.961 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -51.81 -42.84 62.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.229 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mp -57.61 -58.76 6.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.055 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 116' ' ' ALA . 94.0 m -46.94 -41.28 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.0 mm -54.13 -68.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.313 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -15.51 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.839 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -90.27 -22.3 21.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -84.31 -37.75 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.06 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.419 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -66.84 -34.42 77.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -81.43 -22.49 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.311 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -88.99 11.38 18.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.598 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.418 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -154.27 38.99 0.45 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 0.0 110.886 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.78 0.324 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.432 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -157.3 121.61 4.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.931 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.495 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -143.98 139.98 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.966 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.2 t -128.56 155.18 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.959 0.409 . . . . 0.0 111.065 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.437 ' CD1' ' O ' ' A' ' 29' ' ' ASP . 40.6 tp -115.19 134.55 55.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 30' ' ' THR . 14.4 t -120.35 102.61 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.986 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.9 t -93.21 117.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.576 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 23.1 t0 -159.5 157.47 30.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 26.6 t70 -89.6 51.12 2.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.181 0.515 . . . . 0.0 110.569 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.71 137.54 50.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.515 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.94 154.19 20.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.93 53.17 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.204 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 14' ' ' THR . 21.3 mm 57.1 168.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.432 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 20.6 p -90.26 118.61 29.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.225 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 52.8 p -50.06 141.74 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.619 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.3 m 85.95 -20.93 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.196 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.416 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -86.99 -47.12 9.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -50.33 -47.42 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.32 74.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 23' ' ' GLU . 97.8 mt -58.12 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' CD1' ' CD1' ' A' ' 17' ' ' LEU . 1.3 mt -45.12 -32.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.388 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.06 -29.79 63.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -83.52 -35.76 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.563 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -75.33 -35.49 61.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.21 44.4 2.79 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.529 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 53.6 m-85 -102.97 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 81.46 67.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.429 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.12 142.11 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.78 2.32 . . . . 0.0 113.468 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.437 ' O ' ' CD1' ' A' ' 5' ' ' LEU . 24.2 t0 -136.23 65.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.373 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 10.5 p -56.14 133.29 52.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.832 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.07 -160.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.336 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 3.7 mttt -120.66 -30.17 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.622 0.248 . . . . 0.0 111.336 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -163.18 179.2 7.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.424 HD22 ' CD2' ' A' ' 63' ' ' PHE . 9.0 mt -61.45 -40.2 93.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.52 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 110.093 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -61.6 -33.53 74.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.196 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.68 -57.41 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 38.3 mt-10 -46.77 -41.13 14.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.766 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -43.41 95.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -44.44 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.854 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mt -71.17 -19.83 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.41 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -22.96 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -129.92 -59.38 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.88 114.45 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -79.83 67.05 5.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 46.0 m-85 -57.63 132.53 82.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 1.1 Cg_endo -77.74 -36.0 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.544 2.163 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.82 133.93 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.034 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.43 ' CD1' ' CB ' ' A' ' 46' ' ' PHE . 1.8 mm -132.67 102.13 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.666 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 77' ' ' ILE . 31.0 t -100.47 125.61 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.279 . . . . 0.0 110.976 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.413 ' CD2' HG11 ' A' ' 78' ' ' VAL . 37.7 tp -90.53 161.49 15.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.45 . . . . 0.0 110.842 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -152.8 93.14 1.72 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.2 t -73.9 63.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.404 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -63.39 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.319 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 35.6 mmm -139.71 37.19 0.27 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.648 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 55' ' ' MET . 92.8 Cg_endo -79.24 -165.42 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.294 1.996 . . . . 0.0 112.278 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -134.37 27.36 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.53 -86.64 1.9 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 59.16 54.37 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.69 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.35 110.49 3.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.831 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.0 t -63.22 -36.13 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -6.53 48.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.61 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 48.3 t80 -62.07 -38.07 87.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.698 0.285 . . . . 0.0 111.165 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 91' ' ' ALA . 3.3 mt -48.57 -30.2 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.154 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.39 -34.01 63.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.651 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 26.8 t80 -61.2 -44.27 97.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -60.85 -41.2 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.393 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -21.0 46.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -68.03 -37.29 81.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.33 9.04 10.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.309 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.64 67.26 2.54 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.51 -18.93 33.15 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.702 2.268 . . . . 0.0 112.233 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -102.18 30.35 4.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.714 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.4 t -117.93 -179.79 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.797 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.6 143.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.574 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -123.01 100.31 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.888 0.375 . . . . 0.0 110.976 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.421 ' O ' ' CG1' ' A' ' 50' ' ' VAL . 12.2 mm -104.18 74.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.425 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 19.6 t -67.79 118.75 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 17.1 mt -125.83 157.97 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.479 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.1 p -156.55 28.22 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.117 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.58 -125.02 33.44 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.652 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.3 136.5 42.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.827 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.74 147.85 8.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m 59.89 85.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.15 -31.29 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.32 -23.64 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.092 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -35.38 76.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -55.32 -59.16 5.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 92' ' ' ILE . 26.3 m -62.38 -34.74 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.996 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -72.67 -10.67 60.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.603 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.426 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -106.9 -27.97 10.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 89' ' ' VAL . 11.3 pt -88.17 -35.75 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -61.25 -31.33 71.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.32 -65.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.744 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 25.69 0.08 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.044 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.38 -167.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.834 0.317 . . . . 0.0 110.897 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.521 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 62.0 t80 -108.98 -17.56 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.31 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 13.1 pt-20 152.01 -173.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.244 0.617 . . . . 0.0 110.375 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -122.66 90.45 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.616 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.1 tp -50.46 107.82 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.34 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -95.09 -170.37 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.1 mttt 60.71 80.13 0.27 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.26 -177.1 1.87 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.506 2.138 . . . . 0.0 112.221 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 59.99 31.41 20.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.3 m -160.69 76.38 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 10.5 p -76.62 -28.61 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.06 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.06 -37.03 19.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 tpt85 -68.17 -40.07 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.768 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.414 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 2.0 t80 -57.46 -27.09 62.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.992 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.71 -48.4 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.137 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.4 mp -52.64 -53.19 50.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.307 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 m -51.89 -58.61 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.387 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.0 mm -32.93 -63.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.969 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -59.58 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -51.46 -27.54 10.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.688 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.56 -35.34 70.58 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.817 0.341 . . . . 0.0 111.033 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.7 -39.18 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.978 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.37 -36.63 33.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.274 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -74.11 -6.46 47.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.634 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.37 42.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 110.869 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.853 0.358 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 3.6 mptt -121.56 125.17 46.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 124.21 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.71 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 22.5 t -122.64 143.75 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.992 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.452 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 20.3 tp -90.12 132.5 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' THR . 14.0 t -119.3 89.59 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.66 114.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 31.6 t0 -155.09 152.1 29.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 24.7 t70 -87.5 48.73 1.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.85 -167.16 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.677 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -74.03 -46.67 41.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.829 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.33 -78.45 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.069 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 30' ' ' THR . 9.4 mm -95.34 163.24 2.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.306 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.42 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 81.3 p -90.14 164.9 14.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.218 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 t -71.42 131.9 44.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.961 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m 77.35 -5.84 2.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.511 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.427 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -90.39 -55.15 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.063 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -47.07 -56.99 5.53 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.373 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.41 -39.2 64.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.05 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.447 HD12 HG22 ' A' ' 106' ' ' VAL . 45.2 mt -64.56 -66.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.304 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mt -47.62 -29.73 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -69.92 -28.82 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.902 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.79 -36.06 23.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.487 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.73 -39.0 24.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.914 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.39 31.89 5.97 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.177 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.428 ' CE2' ' CG2' ' A' ' 113' ' ' ILE . 4.9 m-85 -81.66 -172.79 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 88.76 25.4 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 74.3 Cg_endo -78.63 129.35 9.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.469 2.113 . . . . 0.0 112.592 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 30' ' ' THR . 18.2 t70 -99.96 2.17 43.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.754 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 29' ' ' ASP . 3.2 p 1.76 124.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.93 -160.65 0.73 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.349 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 19.0 mttp -113.65 -31.94 6.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.12 -175.28 4.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 9.6 mt -63.23 -44.23 95.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.638 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.03 -54.02 51.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.195 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.119 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.44 -28.62 64.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.772 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 19.0 mt-10 -71.47 -43.18 67.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.23 75.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.009 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -75.59 -35.35 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.03 -26.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.787 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -77.77 -5.4 50.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.26 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -101.07 -51.74 3.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.764 0.316 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 46' ' ' PHE . 3.0 pp -117.69 -179.61 3.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.077 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -107.14 111.02 23.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.522 ' CZ ' ' CD2' ' A' ' 44' ' ' LEU . 64.0 m-85 -98.08 113.01 63.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.406 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.449 ' HG2' ' CE2' ' A' ' 117' ' ' PHE . 63.6 Cg_endo -73.15 -19.38 22.78 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.659 2.239 . . . . 0.0 111.929 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 117' ' ' PHE . 3.5 t -148.63 134.23 11.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.422 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.4 mm -116.89 157.15 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' A' ' 109' ' ' PHE . 43.1 t -151.42 101.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.183 0.516 . . . . 0.0 112.073 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.03 168.63 19.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.797 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -127.37 -47.27 1.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.674 0.273 . . . . 0.0 111.404 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.2 t 68.54 37.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.965 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -63.92 -82.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.53 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.69 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.2 ttm -152.1 47.69 0.42 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.358 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.69 ' HD3' ' N ' ' A' ' 55' ' ' MET . 29.3 Cg_endo -95.05 -161.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.06 2.507 . . . . 0.0 112.162 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.32 29.68 7.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.65 -97.79 2.08 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.601 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 55.36 54.21 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.418 . . . . 0.0 110.535 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.1 106.66 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.746 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 64' ' ' ILE . 97.0 t -63.69 -32.47 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.825 0.345 . . . . 0.0 111.012 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -3.77 48.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 23.6 t80 -60.77 -31.38 70.73 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.578 0.228 . . . . 0.0 110.987 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -46.74 -38.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.59 -53.29 56.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 38' ' ' GLU . 20.1 t80 -51.11 -30.75 17.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 110.217 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.464 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 3.8 mm -64.87 -53.34 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -74.21 -19.05 60.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.851 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.17 -44.62 83.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.867 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.56 10.19 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.436 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.69 66.62 2.79 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.777 0.322 . . . . 0.0 110.832 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.54 -19.62 32.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.84 2.36 . . . . 0.0 112.305 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -107.33 34.66 3.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 48.5 t -116.35 -158.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.407 ' N ' ' OG ' ' A' ' 74' ' ' SER . 39.2 t -150.57 135.58 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-O 120.917 0.389 . . . . 0.0 111.449 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.7 t -112.53 106.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.414 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 36.5 mm -89.0 -49.38 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.72 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.436 ' HB ' ' CE1' ' A' ' 99' ' ' PHE . 59.3 t 52.69 81.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.363 . . . . 0.0 111.104 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mt -105.39 155.11 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.1 p -149.95 122.88 8.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.353 . . . . 0.0 111.006 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.6 95.17 2.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.604 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -165.78 -44.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.26 55.25 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.536 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 p -131.47 124.91 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 0.0 110.921 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.09 -30.44 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.221 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.86 -26.47 65.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.407 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.5 t -75.55 -33.26 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.94 -59.28 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.99 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.44 ' HA ' HG12 ' A' ' 92' ' ' ILE . 18.0 m -58.78 -21.48 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.018 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -83.85 -9.65 58.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.591 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.32 -33.93 4.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.477 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 12.2 pt -73.05 -38.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.673 0.273 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -25.29 64.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.636 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.6 -57.54 3.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.11 33.45 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.19 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -90.11 -164.29 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 110.727 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.452 ' CD2' ' O ' ' A' ' 97' ' ' TYR . 36.1 t80 -108.53 25.32 11.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.245 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 82.49 17.98 0.33 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.013 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER 57.56 166.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.25 179.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -119.56 122.17 41.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -170.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.786 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.0 80.41 0.24 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.784 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.36 -2.95 12.49 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.723 2.282 . . . . 0.0 113.004 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.75 -57.11 4.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.097 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -143.5 168.26 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.053 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 34.3 m -91.31 3.63 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.562 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -41.46 -44.7 2.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.815 0.341 . . . . 0.0 111.225 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -36.07 74.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.138 0.494 . . . . 0.0 109.816 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.567 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 1.4 t80 -56.17 -23.97 38.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.414 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.9 OUTLIER -62.23 -49.2 76.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.663 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 mp -57.09 -57.68 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.418 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 97.4 m -54.47 -43.68 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.49 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -41.8 -54.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.011 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 0.0 109.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -55.87 -24.89 39.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.55 -37.68 83.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.049 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.449 ' CE2' ' HG2' ' A' ' 47' ' ' PRO . 27.4 m-85 -75.57 -17.49 60.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.956 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -109.86 -27.78 9.1 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -75.73 -4.68 41.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.706 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.414 ' CG ' ' O ' ' A' ' 74' ' ' SER . 0.2 OUTLIER -131.9 38.24 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.021 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.771 0.319 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.457 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 6.0 mptt 61.08 99.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 126.25 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.726 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 23.8 t -122.47 152.53 26.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 110.867 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 50' ' ' VAL . 47.0 tp -103.48 135.33 45.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 30' ' ' THR . 15.1 t -120.74 89.01 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.69 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.88 115.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.716 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 22.5 t70 -155.27 163.24 40.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.313 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -83.8 48.75 1.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.987 0.422 . . . . 0.0 111.08 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -117.16 167.71 10.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.674 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.48 -81.52 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.054 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 13' ' ' ILE . 10.4 m -107.11 113.76 27.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 12' ' ' SER . 14.0 mm 49.62 163.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.508 0.671 . . . . 0.0 112.312 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.426 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 60.7 p -90.91 165.53 13.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.302 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.5 t -83.77 134.96 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 111.679 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m 81.35 -10.38 1.19 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.306 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -90.15 -50.67 5.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 110.613 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.06 -54.95 7.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.86 66.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.452 HG23 HD12 ' A' ' 20' ' ' ILE . 70.8 mt -69.22 -69.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.309 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.72 -32.7 2.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.486 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -27.83 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.013 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -82.94 -35.56 25.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.441 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -81.31 -31.87 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.988 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.2 29.83 6.58 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.189 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CE1' ' CG ' ' A' ' 2' ' ' LYS . 46.1 m-85 -86.31 -173.97 4.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.049 0.452 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -138.25 89.36 14.3 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.037 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 73.3 Cg_endo -77.95 132.38 11.7 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.54 2.16 . . . . 0.0 112.594 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -104.5 -4.31 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.193 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 29' ' ' ASP . 43.0 p 12.95 121.75 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.38 156.35 21.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.364 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 2.2 mtmp? -80.68 -28.36 36.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.93 178.76 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.615 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.447 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 16.6 mt -57.5 -33.12 67.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -56.32 18.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.22 -29.43 70.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.33 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.9 -29.02 62.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 26.5 mt-10 -71.19 -41.23 70.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 109.903 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -33.9 76.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -77.83 -35.91 50.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.854 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.9 mt -78.47 -25.17 13.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.812 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -90.26 28.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.257 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -146.17 -46.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.469 ' CD2' ' CD1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -113.55 155.52 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.451 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 9.1 t80 -85.5 90.42 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.332 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.469 ' CD1' ' CD2' ' A' ' 44' ' ' LEU . 9.5 m-85 -76.66 113.82 33.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.55 -23.8 9.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.472 2.115 . . . . 0.0 112.146 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.58 133.41 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.625 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.8 mm -115.96 150.01 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.098 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 5' ' ' LEU . 77.9 t -142.78 100.06 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.398 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 52' ' ' ASP . 8.9 tp -86.09 149.1 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 t0 -140.2 107.15 5.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.419 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 20.3 m -75.31 61.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.673 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -69.58 -79.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.801 0.334 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.693 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 6.1 ttt -153.72 49.96 0.53 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.983 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.693 ' HD3' ' N ' ' A' ' 55' ' ' MET . 19.5 Cg_endo -93.47 -159.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.143 2.562 . . . . 0.0 112.119 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -142.61 38.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.22 -82.24 1.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.34 68.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.824 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.42 93.29 0.66 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.641 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 81.6 t -58.96 -33.84 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.927 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.19 -0.85 42.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.447 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 12.6 t80 -60.15 -38.13 82.2 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.8 mp -46.44 -42.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -43.03 95.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.134 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.403 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 12.1 t80 -57.84 -33.66 68.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.762 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.434 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mm -65.12 -53.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.266 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -72.69 -16.71 61.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.727 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.27 -44.29 72.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.53 13.07 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.326 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.42 66.57 1.86 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.37 -18.75 29.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.754 2.302 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -106.57 31.35 5.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.666 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.9 t -111.41 -158.3 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.545 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG22 ' CG ' ' A' ' 120' ' ' TYR . 46.7 t -149.64 136.24 12.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.777 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 16.4 t -114.13 115.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.674 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mm -100.95 -47.47 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.75 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 99' ' ' PHE . 59.9 t 49.74 86.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.314 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.9 mt -94.22 162.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.915 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.448 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 48.4 p -156.52 156.49 33.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.09 -169.3 11.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.474 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.04 -77.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.777 0.322 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -159.15 108.09 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.519 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -170.43 119.17 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 0.0 110.929 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.44 -52.09 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.074 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.79 -12.62 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.42 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.8 t -78.78 -35.45 44.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.069 0.461 . . . . 0.0 109.864 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.521 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -58.54 -58.55 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.091 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.32 -25.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.769 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -90.06 39.01 0.95 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.556 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.415 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -170.26 -39.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 2.9 pt -74.88 -42.46 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -21.46 63.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.781 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -73.95 -27.65 61.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.17 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.29 -18.29 0.38 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.378 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -50.9 176.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.152 0.476 . . . . 0.0 111.464 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 74.4 t80 -97.6 26.14 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.456 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.6 OUTLIER 77.44 146.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.521 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.9 OUTLIER -65.83 138.87 58.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.908 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -68.93 137.94 54.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.502 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -49.89 123.71 8.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.244 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.3 mptp? -57.02 -55.04 48.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.337 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 19.8 Cg_endo -58.71 -178.07 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.359 2.039 . . . . 0.0 112.111 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 62.22 147.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.724 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 t -73.5 171.29 13.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.444 HG11 ' N ' ' A' ' 107' ' ' GLU . 9.5 p -55.42 -32.08 28.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.081 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.444 ' N ' HG11 ' A' ' 106' ' ' VAL . 1.9 tt0 -45.2 -36.18 3.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.95 0.405 . . . . 0.0 110.743 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -67.29 -41.03 86.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.776 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 24.4 t80 -57.54 -27.27 62.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.153 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.07 -47.81 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.243 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.5 mp -51.79 -52.6 47.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.187 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.8 m -57.41 -45.92 84.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.14 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.9 mm -45.47 -56.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.587 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.29 -62.57 1.42 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -49.56 -27.34 4.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.926 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.73 -29.55 68.81 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.914 0.388 . . . . 0.0 110.782 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -89.67 -26.45 20.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.818 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.36 -41.35 7.87 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -91.41 27.16 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.685 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.452 ' CG ' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -161.85 38.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 0.0 110.872 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.831 0.348 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' CD ' ' CD2' ' A' ' 117' ' ' PHE . 5.1 mmtm -138.22 140.0 39.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.536 ' HB3' ' CB ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -175.43 93.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 18.3 t -77.41 160.49 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.45 HD12 ' CE2' ' A' ' 46' ' ' PHE . 60.7 tp -117.07 135.09 53.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.31 90.66 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.732 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 t -88.91 121.44 39.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.342 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -157.37 141.16 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.859 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.51 48.8 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.438 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 7.8 tp10 -176.72 163.89 2.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.801 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.48 43.51 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.94 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.65 -86.21 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mm -54.53 -40.45 49.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.749 0.309 . . . . 0.0 111.357 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.0 p -44.58 -46.58 10.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.456 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -26.32 65.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 t -93.27 -68.31 0.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -46.17 -56.89 5.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.487 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.531 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 21.3 t -41.25 -51.52 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.271 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -38.54 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.095 0.474 . . . . 0.0 110.622 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' LEU . 6.1 mt -69.06 -70.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.322 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.642 HD21 ' HG3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -50.49 -23.72 2.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.508 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.578 ' N ' HD13 ' A' ' 21' ' ' LEU . 31.5 mt-10 -78.48 -29.92 47.04 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 -37.92 58.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 109.923 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HG3' ' CD2' ' A' ' 110' ' ' LEU . 19.2 mm-40 -59.34 -18.89 42.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.207 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.4 73.45 1.14 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.767 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.489 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 29.5 m-85 -147.01 -178.86 6.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 111.649 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -121.42 81.95 39.05 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.642 ' HG3' HD21 ' A' ' 21' ' ' LEU . 37.4 Cg_endo -89.86 137.9 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.699 2.266 . . . . 0.0 114.041 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 13.1 t70 -126.15 125.07 41.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.6 p -97.2 135.96 38.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 111.643 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.44 178.5 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -122.75 -8.79 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.92 -171.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.36 -32.34 43.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 0.0 110.154 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -70.9 -44.38 66.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.795 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.12 -33.81 76.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.58 -49.23 33.78 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -46.93 -45.94 21.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.365 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -54.89 41.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -57.66 -27.87 63.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.692 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.9 mt -92.82 -8.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.55 8.22 29.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.73 0.3 . . . . 0.0 111.147 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -148.9 -48.14 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.58 116.09 21.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -69.22 71.29 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.45 ' CE2' HD12 ' A' ' 5' ' ' LEU . 13.1 m-85 -69.68 116.16 40.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' A' ' 117' ' ' PHE . 4.1 Cg_exo -74.56 -35.7 3.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.183 1.922 . . . . 0.0 111.44 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.556 ' CG2' ' CE1' ' A' ' 117' ' ' PHE . 16.5 t -124.8 126.59 71.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.784 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.5 mm -113.61 130.1 68.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.605 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.0 t -123.81 107.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.103 0.477 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.0 tp -93.87 147.08 23.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 1.1 t70 -126.02 97.37 5.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 80' ' ' THR . 23.4 t -67.05 72.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.354 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.438 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 59.4 t-105 -80.04 -91.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 ttp -140.73 46.0 0.86 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.102 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 55' ' ' MET . 86.2 Cg_endo -77.65 -167.02 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.547 2.164 . . . . 0.0 112.4 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.8 -44.09 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.72 163.76 51.67 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.582 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.39 120.47 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.17 -20.96 80.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.57 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.4 t -57.36 -38.13 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.32 -22.09 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.429 ' CE2' HD13 ' A' ' 67' ' ' ILE . 14.9 t80 -65.01 -40.66 95.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.811 0.339 . . . . 0.0 111.057 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.2 mt -46.32 -28.68 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -70.48 -51.7 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -48.82 -40.67 30.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.826 0.346 . . . . 0.0 110.559 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.429 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.5 mp -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.412 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -76.45 -19.58 57.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.789 0.328 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.8 -50.87 54.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.712 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.08 14.7 20.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.372 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.2 66.86 2.65 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.9 -19.1 35.89 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.21 . . . . 0.0 112.113 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.8 28.11 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.805 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.9 t -117.31 -175.77 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.775 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 47' ' ' PRO . 45.6 t -127.17 139.95 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.371 0.605 . . . . 0.0 111.783 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.7 t -122.96 88.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -73.8 -69.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.369 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.407 HG12 ' CE1' ' A' ' 99' ' ' PHE . 38.2 t 63.15 118.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.302 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.422 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.6 mt -121.0 -142.36 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.424 ' HB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 64.31 101.44 0.04 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.839 0.352 . . . . 0.0 110.815 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.52 39.14 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.389 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.57 88.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.72 -29.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -161.06 139.08 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 t -97.7 33.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.048 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -90.08 -24.44 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.415 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 5.5 t -77.48 -35.28 53.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.188 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.69 -57.52 12.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.94 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.1 m -55.72 -30.37 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.844 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -76.84 -13.28 60.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.088 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.45 -41.77 5.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.658 0.266 . . . . 0.0 111.433 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.48 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 11.3 pt -70.47 -31.36 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 111.028 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -24.32 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.18 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -84.93 -54.89 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.661 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.87 28.98 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.641 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.523 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.25 177.62 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.24 0.52 . . . . 0.0 110.565 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.496 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 39.8 t80 -88.24 -23.34 23.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.526 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 2.6 pt-20 152.56 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.292 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 1.5 t80 80.61 111.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.644 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.95 96.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.207 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.09 161.73 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.402 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 8.3 ttmt 60.07 53.19 3.63 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 68.8 Cg_endo -74.15 105.48 2.04 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.633 2.222 . . . . 0.0 112.322 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -85.17 -31.33 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.6 t -176.96 -57.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.991 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 12.5 p 179.11 -26.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.617 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -52.11 -51.11 59.86 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 110.902 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -38.69 74.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 79' ' ' ILE . 28.0 t80 -60.58 -29.77 69.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.379 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.406 ' CD2' ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -70.12 -46.21 65.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.038 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mp -50.23 -42.78 52.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 75.1 m -69.37 -46.7 66.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.891 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.8 mm -45.52 -59.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.727 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -55.64 7.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.78 -29.2 69.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.74 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.65 85.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 0.0 110.853 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.556 ' CE1' ' CG2' ' A' ' 48' ' ' VAL . 6.4 m-85 -73.02 -17.1 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -57.3 -21.47 35.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.372 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -95.47 35.18 1.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.839 0.352 . . . . 0.0 111.078 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 13.6 t80 -135.85 26.98 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.797 0.332 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER 61.13 99.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.423 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.45 85.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.447 HG21 ' CE1' ' A' ' 117' ' ' PHE . 21.9 t -81.79 146.43 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.42 HD13 ' CE2' ' A' ' 46' ' ' PHE . 37.3 tp -106.96 139.77 40.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 0.0 111.218 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.432 ' CG2' HD11 ' A' ' 17' ' ' LEU . 21.7 t -117.3 145.9 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.44 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 52' ' ' ASP . 15.5 t -132.94 120.96 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.284 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 9.9 t0 -156.68 148.69 22.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -83.79 49.32 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.449 . . . . 0.0 111.19 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.78 -167.39 1.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.662 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -112.7 132.31 55.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' ILE . 16.8 p 58.01 164.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 12' ' ' SER . 6.4 mm -31.32 158.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 20.3 p -86.31 124.31 32.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.295 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.7 m -41.01 133.82 2.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.477 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 6.5 t 79.72 -9.05 1.49 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.486 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -90.15 -53.88 4.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.33 . . . . 0.0 111.103 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -51.52 -52.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.92 79.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.011 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.442 ' CD1' HG23 ' A' ' 106' ' ' VAL . 38.4 mt -60.54 -66.52 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.034 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.435 ' CD1' HD13 ' A' ' 17' ' ' LEU . 1.4 mt -50.98 -34.1 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -68.72 -26.75 65.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.74 -35.1 30.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.068 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -81.23 -27.97 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.057 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.12 1.21 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.233 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 6.2 m-85 -120.9 -176.18 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.307 0.575 . . . . 0.0 111.357 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.62 79.54 67.51 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.554 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.7 Cg_endo -84.34 146.86 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.864 2.376 . . . . 0.0 114.348 -177.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -139.24 135.27 33.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.545 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.457 HG22 ' CD1' ' A' ' 13' ' ' ILE . 17.7 p -122.53 133.75 54.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 111.883 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.33 -163.14 0.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 11.0 mttm -112.76 -31.21 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.76 -175.04 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.678 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.4 mt -64.31 -41.16 96.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -61.42 -46.04 91.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 109.94 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.57 -38.58 89.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.3 -56.06 19.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.435 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 41.0 mt-10 -47.27 -41.4 18.75 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.756 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -59.73 -43.06 94.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.922 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -73.25 -44.03 60.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.84 -18.56 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.472 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.2 -23.6 15.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -127.17 -52.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.99 121.61 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.28 58.34 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.42 ' CE2' HD13 ' A' ' 5' ' ' LEU . 16.0 m-85 -57.73 123.35 62.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.447 ' O ' ' HA ' ' A' ' 74' ' ' SER . 58.5 Cg_endo -71.97 -32.56 10.99 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.548 2.165 . . . . 0.0 112.21 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.421 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 8.0 t -128.32 139.55 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.257 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.408 HD11 ' CB ' ' A' ' 46' ' ' PHE . 1.2 mm -139.77 108.34 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.299 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.443 HG21 ' CE1' ' A' ' 109' ' ' PHE . 50.9 t -105.54 133.69 49.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.769 0.318 . . . . 0.0 110.305 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 30.7 tp -101.96 136.44 41.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.88 81.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.015 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 3.4 p -60.58 80.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.3 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 13.6 t-105 -84.82 -78.04 0.26 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.355 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.673 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.65 50.34 0.97 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.673 ' HD3' ' N ' ' A' ' 55' ' ' MET . 15.3 Cg_endo -92.78 -159.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.163 2.575 . . . . 0.0 112.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -153.6 62.84 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.93 0.395 . . . . 0.0 111.004 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.39 162.78 29.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.541 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.07 116.54 23.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 110.864 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.49 -26.58 24.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.629 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.35 -41.21 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 111.2 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.74 -26.88 57.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 34' ' ' LEU . 16.0 t80 -61.05 -36.01 78.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.08 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.423 ' CG2' ' HA3' ' A' ' 95' ' ' GLY . 2.1 mp -45.81 -29.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.373 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -78.77 -38.67 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 38' ' ' GLU . 16.3 t80 -56.84 -41.64 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.42 HD13 ' CD2' ' A' ' 63' ' ' PHE . 3.9 mp -58.99 -46.3 91.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.382 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -75.34 -25.01 57.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -63.74 -43.68 95.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.86 16.93 13.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.04 69.44 0.98 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.81 -19.27 41.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.726 2.284 . . . . 0.0 112.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -104.99 28.24 7.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.6 t -111.72 179.99 3.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.15 146.11 33.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 0.0 111.206 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 3.7 t -125.43 119.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.335 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -97.33 -63.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.592 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.453 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 6.0 t 63.13 115.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.482 ' CG2' ' HB3' ' A' ' 100' ' ' LEU . 1.4 mt -129.31 -145.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.879 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.444 ' H ' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 51.32 179.87 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.008 0.433 . . . . 0.0 111.368 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.32 176.38 28.36 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.264 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.93 43.91 3.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.361 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.34 156.33 32.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.532 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.3 t 59.93 99.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.833 0.349 . . . . 0.0 111.007 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.2 t -70.39 65.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -100.03 -47.86 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.0 t -55.6 -31.55 62.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.966 0.413 . . . . 0.0 110.353 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.73 -60.0 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.123 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 92' ' ' ILE . 32.8 m -58.11 -24.73 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.914 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -83.03 -10.92 58.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.27 -37.52 5.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.683 0.278 . . . . 0.0 111.6 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.507 HG21 HD13 ' A' ' 92' ' ' ILE . 14.1 pt -71.99 159.66 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.167 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 7.7 mmmt 80.52 -47.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.579 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.4 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' A' ' 64' ' ' ILE . . . -175.52 -33.19 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.464 -0.875 . . . . 0.0 113.237 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -62.8 176.22 0.72 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.194 0.497 . . . . 0.0 110.671 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.562 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -100.67 -8.35 22.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 140.23 -11.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.411 0.684 . . . . 0.0 111.438 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER 77.71 120.27 0.05 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.88 0.372 . . . . 0.0 110.924 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -72.93 157.95 36.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.551 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -117.28 153.86 32.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt 65.1 80.49 0.23 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.62 60.08 3.43 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.634 2.223 . . . . 0.0 112.428 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -150.28 121.63 7.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.517 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.508 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 1.7 p 81.4 -47.44 0.23 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 1.0 OUTLIER 76.71 1.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.877 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -44.19 -42.1 6.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.952 0.406 . . . . 0.0 110.706 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -68.2 -37.51 80.98 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 5.0 t80 -58.52 -22.86 56.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.261 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.8 -51.15 66.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.319 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mp -53.78 -54.49 37.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.018 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 86.3 m -51.39 -56.78 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.091 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.442 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 9.9 mm -30.06 -63.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.695 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.67 -59.29 3.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.64 -24.86 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.828 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.87 -45.38 64.52 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 0.0 111.379 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.447 ' CE1' HG21 ' A' ' 4' ' ' VAL . 55.1 m-85 -66.53 -13.26 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.32 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.24 -17.38 27.73 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.441 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -92.08 36.43 0.98 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.787 0.327 . . . . 0.0 111.269 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.94 22.93 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.954 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.883 179.986 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.783 0.325 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -99.06 95.25 7.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.141 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.59 127.11 16.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.777 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 42.7 t -115.59 154.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.428 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 37.0 tp -115.01 132.78 56.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.403 ' HB ' ' CG2' ' A' ' 30' ' ' THR . 25.0 t -116.62 89.55 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.338 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' VAL . 14.0 t -84.7 96.92 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.3 132.14 53.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.56 -65.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.45 115.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -162.35 -89.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -178.8 23.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.448 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.4 mp -84.38 -36.5 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.783 0.325 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p -59.84 -33.24 71.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.976 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 t -90.28 29.41 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.565 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.3 p -157.97 -61.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.683 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.431 HD12 ' CD1' ' A' ' 21' ' ' LEU . 1.5 tm? -56.58 -49.73 74.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.594 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 p -54.75 -46.2 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.383 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.62 85.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.576 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 ' CG2' ' CD1' ' A' ' 110' ' ' LEU . 24.1 mt -57.28 -64.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.843 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.431 ' CD1' HD12 ' A' ' 17' ' ' LEU . 1.4 mt -49.27 -32.58 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -27.43 68.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -79.01 -37.39 39.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.985 0.421 . . . . 0.0 110.013 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.09 -51.06 34.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 58.91 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.522 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -135.88 -173.89 3.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -136.47 75.04 52.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.066 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 50.5 Cg_exo -54.8 151.4 32.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.684 2.256 . . . . 0.0 112.638 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -132.66 6.25 4.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' 29' ' ' ASP . 3.5 p 0.7 126.52 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 166.14 21.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.222 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 mtpt -79.41 -163.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.38 168.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.136 0.493 . . . . 0.0 111.82 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.3 mt -36.41 -35.53 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.261 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -54.34 -63.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.056 0.455 . . . . 0.0 110.146 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 2.0 mp0 -65.18 -33.8 76.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.426 ' CB ' HG13 ' A' ' 7' ' ' VAL . . . -63.22 -65.5 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -43.13 -42.25 4.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.525 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -61.06 -51.0 71.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.63 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -34.78 79.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.191 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.4 mt -86.07 -6.15 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.844 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.64 31.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.79 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -150.26 -52.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.447 ' CD2' ' CD2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -103.36 154.96 18.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.926 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.431 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 42.5 t80 -93.65 87.19 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.644 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.447 ' CD2' ' CD2' ' A' ' 44' ' ' LEU . 28.6 m-85 -70.15 125.2 91.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 83.2 Cg_endo -77.37 -26.2 7.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.585 2.19 . . . . 0.0 112.062 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.414 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 3.0 t -139.28 130.94 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 mm -120.31 153.02 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.617 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' VAL . 49.1 t -143.23 107.09 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.451 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.6 tp -96.9 85.89 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.257 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.6 OUTLIER -68.02 72.52 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.527 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.459 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 3.3 p -53.16 85.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.716 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 21.8 t-105 -71.94 -80.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.608 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.9 54.99 0.61 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 55' ' ' MET . 5.6 Cg_endo -87.55 -155.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.172 2.581 . . . . 0.0 112.141 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -159.81 49.69 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.14 11.68 9.87 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.86 78.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.06 -20.9 63.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.888 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.416 ' HA ' ' CD1' ' A' ' 64' ' ' ILE . 23.8 t -50.95 -44.82 27.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.423 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.14 -25.03 59.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.412 ' CD2' HD13 ' A' ' 67' ' ' ILE . 14.0 t80 -60.97 -39.63 90.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 61' ' ' VAL . 2.6 mp -47.02 -28.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -75.63 -41.46 54.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.815 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.76 -42.07 83.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.412 HD13 ' CD2' ' A' ' 63' ' ' PHE . 4.7 mp -63.92 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -12.02 58.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.7 -40.69 47.94 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.004 0.431 . . . . 0.0 110.593 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 9.76 12.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.983 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.41 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.07 66.23 3.38 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.866 0.365 . . . . 0.0 110.787 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.4 Cg_exo -76.03 -14.32 19.03 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 112.22 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -109.53 29.55 7.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.813 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -106.96 -155.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.62 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.8 t -147.2 137.96 17.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 121.039 0.447 . . . . 0.0 112.018 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.2 t -123.39 112.08 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.448 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.63 44.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.506 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.417 HG13 ' CE1' ' A' ' 99' ' ' PHE . 49.0 t -45.43 116.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.261 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.465 HG21 ' HB3' ' A' ' 100' ' ' LEU . 1.6 mt -106.43 -148.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.194 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER 56.46 173.67 0.04 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.74 76.81 1.07 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.476 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -98.27 28.8 3.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.74 -38.81 2.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.421 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 80.2 p -178.72 173.56 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.839 0.352 . . . . 0.0 110.797 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m -97.82 31.65 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.0 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.55 -17.31 15.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -36.16 30.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB3' ' CD2' ' A' ' 99' ' ' PHE . . . -59.27 -59.36 5.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.968 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.586 ' HA ' HG12 ' A' ' 92' ' ' ILE . 12.4 m -58.99 -30.77 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.949 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -75.04 -8.5 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.347 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.27 -35.54 3.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.475 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.586 HG12 ' HA ' ' A' ' 89' ' ' VAL . 8.7 pt -80.02 158.07 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.192 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.408 ' CG ' HG13 ' A' ' 92' ' ' ILE . 9.2 mmtt 80.77 -45.83 0.25 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -22.97 64.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.97 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.03 -29.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.187 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.51 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -79.77 175.82 10.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.082 0.441 . . . . 0.0 111.009 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.524 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 56.0 t80 -100.69 -12.06 19.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.323 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 147.54 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.158 0.583 . . . . 0.0 110.368 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -118.97 131.09 56.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.534 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.465 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -93.88 44.81 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.822 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.33 -17.58 17.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.265 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.06 -58.8 8.43 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.69 -168.52 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.525 2.15 . . . . 0.0 112.299 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -137.2 31.2 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.825 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.7 m -144.33 -171.91 3.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.4 p -118.0 -8.65 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.524 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -47.52 76.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.861 0.362 . . . . 0.0 110.367 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.29 -33.61 69.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.071 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -64.44 -37.8 88.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.183 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.415 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -55.33 -48.21 74.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -44.71 83.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.1 m -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 mm -57.22 -53.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -59.46 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -55.75 -30.79 61.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.738 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.77 88.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.414 ' CZ ' HG21 ' A' ' 48' ' ' VAL . 31.0 m-85 -75.23 -28.75 60.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.906 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.13 -28.77 62.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -97.41 30.08 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 47' ' ' PRO . 64.2 t80 -107.63 27.95 8.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.77 0.319 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmmp? -112.01 92.87 4.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.409 ' HB3' ' CB ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -136.06 142.22 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.497 HG12 ' HB ' ' A' ' 48' ' ' VAL . 17.5 t -125.96 163.9 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD23 ' CD2' ' A' ' 46' ' ' PHE . 34.0 tp -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.2 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 50' ' ' VAL . 27.6 t -115.28 97.33 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.95 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.23 119.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.797 0.332 . . . . 0.0 110.985 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -154.35 131.57 11.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.9 46.77 1.39 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.29 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -50.72 2.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 110.99 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.36 -168.21 1.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 t -57.34 -58.43 8.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.817 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 mm -116.96 163.0 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.423 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 76.0 p -90.1 145.55 24.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.79 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -65.43 141.91 58.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.158 0.504 . . . . 0.0 112.259 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 m 65.1 9.39 5.48 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.721 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.441 HD23 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -90.49 -53.07 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.483 179.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -45.88 -59.67 2.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.23 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.52 53.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.08 0.467 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 HD13 HG12 ' A' ' 106' ' ' VAL . 75.1 mt -68.29 -70.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.441 HD11 HD23 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.73 -30.36 3.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.044 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -73.42 -29.67 62.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.845 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -81.08 -34.84 32.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 110.12 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.48 -35.0 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.4 47.75 2.72 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.221 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.443 ' CZ ' HG22 ' A' ' 113' ' ' ILE . 44.3 m-85 -105.23 -173.26 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.127 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.56 85.68 47.16 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 91.4 Cg_endo -82.45 127.71 5.2 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.689 2.259 . . . . 0.0 111.953 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -105.65 -1.01 25.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.482 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.625 ' O ' ' O ' ' A' ' 29' ' ' ASP . 58.7 p 24.49 122.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.82 167.72 9.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.549 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -88.29 -46.06 9.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.821 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.47 -167.03 2.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.1 mt -67.44 -46.53 72.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -63.1 -45.47 91.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.044 0.45 . . . . 0.0 109.873 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -32.2 70.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.38 -28.82 63.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.686 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 13.6 mt-10 -70.85 -42.03 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -63.77 -35.33 80.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.009 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -75.68 -42.41 51.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.898 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.77 -27.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.031 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -52.03 -25.98 9.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -120.72 -55.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.19 133.57 50.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -95.28 102.04 13.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CD2' HD23 ' A' ' 5' ' ' LEU . 40.7 m-85 -102.74 122.04 47.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.537 ' O ' ' HA ' ' A' ' 74' ' ' SER . 65.4 Cg_endo -73.68 -19.16 21.63 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.331 2.021 . . . . 0.0 111.788 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' HB ' HG12 ' A' ' 4' ' ' VAL . 10.8 t -143.7 120.53 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 46' ' ' PHE . 6.5 mm -107.18 153.75 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.83 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 6' ' ' VAL . 7.4 t -135.49 174.59 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.2 tp -159.92 117.27 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.548 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.46 89.62 3.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.141 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 35.2 m -58.68 82.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.834 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -81.52 -83.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.402 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.504 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 3.2 mtt -148.45 44.78 0.37 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 55' ' ' MET . 85.4 Cg_endo -80.19 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.461 2.107 . . . . 0.0 112.226 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -137.99 49.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 110.97 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.47 139.85 6.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.445 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.44 144.27 37.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.63 -15.94 47.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.892 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.2 t -53.81 -52.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.014 0.435 . . . . 0.0 111.209 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.7 -6.29 47.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.765 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.424 ' CD2' HD13 ' A' ' 67' ' ' ILE . 22.3 t80 -85.67 -36.52 20.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.645 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.403 ' CD1' ' CB ' ' A' ' 91' ' ' ALA . 3.0 mp -49.52 -31.95 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.681 0.277 . . . . 0.0 111.084 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.3 t70 -79.41 -25.26 42.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.572 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 48.1 t80 -67.85 -42.32 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.424 HD13 ' CD2' ' A' ' 63' ' ' PHE . 3.8 mp -60.03 -43.23 92.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.035 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.88 -20.96 52.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.72 -34.8 76.25 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.407 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -126.39 14.58 7.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.034 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.49 67.39 1.38 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.889 0.376 . . . . 0.0 110.579 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.02 -20.79 50.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.65 2.233 . . . . 0.0 112.064 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.29 25.5 6.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.055 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 33.5 t -113.37 -166.18 1.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -148.67 131.56 7.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 121.248 0.547 . . . . 0.0 112.428 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 38.9 t -100.89 113.65 37.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.63 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -94.01 -62.35 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.915 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.459 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 99.4 t 59.15 111.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 109' ' ' PHE . 1.8 mt -122.48 178.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m 73.59 155.25 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.65 141.83 7.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.396 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -124.75 37.52 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.929 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.21 46.26 0.39 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.422 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.91 -78.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.726 0.298 . . . . 0.0 110.922 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -178.95 85.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.131 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -139.2 -60.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.842 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 t -48.8 -30.74 6.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.261 0.553 . . . . 0.0 110.1 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.469 ' HB2' ' CG ' ' A' ' 99' ' ' PHE . . . -59.26 -59.72 5.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.156 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.61 -21.96 26.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.325 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -87.32 -14.22 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.673 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 64' ' ' ILE . . . -114.8 -31.82 6.01 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 8.7 pt -74.63 -21.88 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.692 0.282 . . . . 0.0 111.625 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.65 15.38 16.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.22 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -119.64 -21.2 7.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.555 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.39 -24.2 0.16 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.937 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.477 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -55.13 176.26 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.584 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.458 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 56.4 t80 -108.5 27.37 9.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.422 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.9 OUTLIER 85.61 138.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.187 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CG ' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -71.38 94.77 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.608 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.475 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 28.3 tp -54.94 146.69 17.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.06 163.8 18.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -165.15 54.25 0.35 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.773 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.88 1.52 9.06 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.517 2.145 . . . . 0.0 112.897 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.26 -68.08 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.737 0.303 . . . . 0.0 111.084 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.1 t -159.82 -178.24 6.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.411 . . . . 0.0 111.334 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 7.4 p -73.93 -16.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.417 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -46.22 -35.45 5.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -35.78 70.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.934 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.475 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 29.3 t80 -58.16 -30.82 66.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.0 -43.33 50.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.318 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mp -59.3 -60.21 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.121 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 116' ' ' ALA . 97.8 m -44.12 -39.14 4.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.343 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 29.2 mm -56.23 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -54.16 -21.09 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.739 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -85.66 -24.73 26.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.695 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -80.55 -30.86 37.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -78.29 -20.08 52.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.365 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -105.22 -20.4 13.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.658 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -95.46 34.38 1.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.736 0.303 . . . . 0.0 111.296 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.407 ' CE2' ' O ' ' A' ' 74' ' ' SER . 1.5 t80 -162.17 36.73 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.928 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 -179.998 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 tpp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.82 0.343 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 7.8 mmmt -117.45 112.81 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 131.18 20.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.718 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.437 HG21 ' CE1' ' A' ' 117' ' ' PHE . 27.0 t -121.31 144.15 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.408 ' N ' HG12 ' A' ' 4' ' ' VAL . 29.9 tp -107.2 137.7 44.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 0.0 111.214 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.8 t -116.3 123.88 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.528 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.29 110.38 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.24 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 40.8 t0 -158.76 160.63 36.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.057 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -89.16 49.45 1.77 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.05 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -109.01 -176.24 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.771 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -127.97 134.82 49.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.056 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t 58.12 71.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 14' ' ' THR . 23.5 mm 57.91 166.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.44 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 72.3 p -90.37 114.4 26.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.045 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 16' ' ' SER . 73.5 m -43.0 136.44 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.775 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.4 m 88.16 -36.35 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.161 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.465 HD22 ' CG2' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -65.89 -50.82 63.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 110.93 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.5 -64.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.463 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.27 60.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 111.443 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' CD1' HG23 ' A' ' 106' ' ' VAL . 91.5 mt -65.72 -70.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -46.94 -31.03 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.938 0.399 . . . . 0.0 111.071 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.46 -31.67 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.707 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -83.0 -35.21 26.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -75.1 -29.98 60.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.046 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.88 1.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.227 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 43.2 m-85 -131.76 -176.3 4.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.243 0.544 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.41 80.74 46.04 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.837 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.5 141.53 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.838 2.359 . . . . 0.0 113.759 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -138.54 136.18 35.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.868 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.411 HG22 ' CD1' ' A' ' 13' ' ' ILE . 14.7 p -121.62 132.58 54.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.114 0.483 . . . . 0.0 111.745 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.69 -121.57 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.226 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 13.8 mttp -157.63 -41.75 0.07 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.937 0.399 . . . . 0.0 110.59 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 p -152.83 175.66 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.43 HD22 ' CE2' ' A' ' 63' ' ' PHE . 39.8 mt -58.14 -37.34 74.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -44.83 78.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -35.81 82.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.336 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.27 61.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 34.1 mt-10 -49.16 -44.21 42.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.533 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -56.43 -44.6 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.063 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -73.23 -44.39 59.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.979 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.3 mt -70.32 -17.75 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.556 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -21.25 41.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.218 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.99 -63.46 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.12 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -55.35 132.42 48.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 45' ' ' PHE . 60.4 t80 -97.2 59.56 1.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.77 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -57.93 126.53 77.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 53.1 Cg_endo -70.93 -28.79 19.21 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.318 2.012 . . . . 0.0 111.66 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 117' ' ' PHE . 15.2 t -128.66 136.59 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.567 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 49' ' ' ILE . 5.9 mm -135.78 103.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.63 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.411 HG21 ' CE1' ' A' ' 109' ' ' PHE . 59.8 t -101.79 129.81 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 78' ' ' VAL . 28.6 tp -92.13 162.84 14.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.334 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.492 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -153.81 69.96 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.806 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 2.4 p -59.79 81.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.683 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 52' ' ' ASP . 65.3 t-105 -86.41 -92.23 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.772 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.563 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mtt -64.25 -52.09 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.075 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 55' ' ' MET . 39.7 Cg_endo -65.97 -169.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.37 2.047 . . . . 0.0 112.37 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.92 -24.07 7.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.84 -89.13 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.428 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 48.69 30.76 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.2 72.28 2.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.562 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.403 ' O ' ' CD1' ' A' ' 64' ' ' ILE . 58.2 t -58.11 -39.65 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -75.0 -11.79 60.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.523 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.458 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 50.4 t80 -64.36 -43.77 93.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.734 0.302 . . . . 0.0 111.429 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.437 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.3 mp -48.24 -28.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -77.58 -30.85 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 4.5 t80 -63.73 -44.76 92.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -61.21 -43.62 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.21 -22.52 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.667 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 21.6 tt0 -62.91 -39.81 95.67 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.073 0.463 . . . . 0.0 110.222 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.53 15.68 9.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.26 71.21 0.6 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.71 -7.71 11.43 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.039 2.493 . . . . 0.0 112.56 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.03 -3.06 30.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.558 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -170.31 2.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 0.0 111.302 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.1 t -127.34 147.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 3.3 t -126.7 100.45 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.476 HD11 HG23 ' A' ' 77' ' ' ILE . 6.0 mm -101.62 71.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.145 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.475 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 32.1 t -67.09 133.31 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.176 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 100' ' ' LEU . 2.1 mt -142.4 175.64 4.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.524 ' HB ' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 79.55 148.92 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.901 0.381 . . . . 0.0 111.163 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.61 82.21 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.379 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -58.73 110.35 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.828 0.347 . . . . 0.0 111.177 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.13 59.8 9.41 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.666 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 m -167.49 101.67 0.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.83 0.348 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 p -109.79 30.62 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.0 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -115.51 -34.29 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.82 -31.1 70.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -61.28 -59.62 5.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 m -62.75 -23.33 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.931 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.73 27.68 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.6 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.437 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -154.53 -41.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.035 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 11.8 pt -69.17 -21.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.505 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.53 26.47 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -133.8 7.27 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.517 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.25 -23.26 3.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.912 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -60.48 -177.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.373 . . . . 0.0 111.266 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.451 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 48.9 t80 -117.21 29.14 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.269 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.453 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 87.89 158.13 0.07 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.227 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -91.97 103.91 16.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.078 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 79' ' ' ILE . 11.4 tp -57.97 160.9 4.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -58.02 -108.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.041 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -178.94 52.61 0.06 OUTLIER Pre-proline 0 C--O 1.232 0.155 0 CA-C-O 120.77 0.319 . . . . 0.0 110.79 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 14.9 Cg_endo -56.93 159.95 13.48 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.749 2.299 . . . . 0.0 112.242 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.83 -53.27 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 30.3 t -96.12 6.93 47.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.358 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.465 ' CG2' HD22 ' A' ' 17' ' ' LEU . 1.2 m 61.17 12.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -45.78 44.77 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.919 0.39 . . . . 0.0 110.608 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.5 tpt85 -66.59 -36.67 83.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.819 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.458 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 7.2 t80 -59.82 -27.81 66.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.245 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.407 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -60.11 -44.25 95.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.364 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.5 mp -54.38 -56.64 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' ILE . 92.4 m -51.73 -59.53 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.342 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.458 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 13.6 mm -31.05 -64.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.891 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -58.1 5.76 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -27.32 15.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.41 -36.57 66.01 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.437 ' CE1' HG21 ' A' ' 4' ' ' VAL . 27.2 m-85 -66.85 -14.93 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.257 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -57.57 -20.13 30.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.468 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -91.76 44.38 1.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.011 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.407 ' CD2' ' O ' ' A' ' 120' ' ' TYR . 22.6 t80 -140.29 16.56 2.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.975 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.816 0.341 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 21.1 mmtt 63.72 -179.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.415 ' HD2' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 73.95 113.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.044 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 43.6 t -118.99 158.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.489 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 56.2 tp -112.65 127.98 56.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 111.394 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.26 91.97 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.317 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -85.02 117.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.483 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -156.51 147.03 21.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.914 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.421 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 36.3 t70 -72.62 -73.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.096 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 1.6 tm-20 -88.87 172.07 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.115 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -85.04 61.95 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.4 m -89.5 -65.73 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 mm -84.3 -43.72 17.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.289 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p -46.47 -35.3 5.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.524 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -66.06 -32.95 74.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 t -102.13 -59.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -47.04 -57.21 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.428 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.509 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 8.7 t -41.41 -54.66 3.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.158 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.96 -36.62 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.508 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 17' ' ' LEU . 14.3 mt -72.92 -70.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.84 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.628 ' CD2' ' HG3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -52.56 -28.51 21.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.465 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -79.73 -23.67 42.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.814 0.34 . . . . 0.0 110.667 178.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -78.82 -39.08 36.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.903 0.383 . . . . 0.0 110.026 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.91 -43.73 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 60.68 0.16 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.32 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.502 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 61.7 m-85 -132.31 -171.51 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 111.061 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.39 82.9 56.33 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.628 ' HG3' ' CD2' ' A' ' 21' ' ' LEU . 21.3 Cg_exo -65.28 143.44 77.12 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.682 2.254 . . . . 0.0 112.634 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 30' ' ' THR . 6.2 t70 -116.78 -10.72 11.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.139 0.495 . . . . 0.0 111.983 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 29' ' ' ASP . 41.9 p 43.12 176.05 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.289 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -165.57 174.81 9.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.908 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.82 -26.65 8.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.801 0.334 . . . . 0.0 111.236 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.12 -178.33 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.62 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 63' ' ' PHE . 96.5 mt -61.01 -39.2 88.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -50.34 71.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.031 0.443 . . . . 0.0 109.831 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -33.16 75.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.172 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.07 -20.2 57.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 4.3 mt-10 -77.56 -38.31 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 109.85 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.41 -39.14 81.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.661 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mmtm -71.22 -36.19 71.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.769 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.5 mt -86.19 -17.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.201 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -58.38 -19.09 32.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.441 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -134.8 -53.76 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.062 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -58.45 118.22 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.052 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -74.11 64.52 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.438 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 31.2 m-85 -56.65 113.69 6.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.297 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.14 -27.38 13.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 112.032 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.75 128.29 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.479 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.4 mm -112.59 146.85 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.68 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 97.6 t -139.06 98.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.488 . . . . 0.0 110.576 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 78' ' ' VAL . 24.7 tp -77.16 166.25 23.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.89 93.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.252 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.454 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 6.8 m -76.71 57.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.55 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.424 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 55.7 t-105 -61.54 -90.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.652 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.666 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -90.64 -27.09 0.3 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 55' ' ' MET . 62.3 Cg_endo -85.93 -168.29 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.341 2.027 . . . . 0.0 113.021 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -147.59 -47.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.411 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 46.79 -171.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.948 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.57 48.29 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.634 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -47.78 -34.38 10.7 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.452 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.87 -49.91 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.942 0.401 . . . . 0.0 110.65 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.54 8.34 34.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.384 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.429 ' CE2' HD13 ' A' ' 67' ' ' ILE . 36.1 t80 -84.55 -41.83 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.772 0.32 . . . . 0.0 111.224 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.4 mp -46.01 -30.44 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.242 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -40.62 66.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.565 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 68.5 t80 -55.97 -43.36 77.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.429 HD13 ' CE2' ' A' ' 63' ' ' PHE . 4.0 mp -61.79 -44.37 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.462 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -78.95 -14.52 59.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.833 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.3 -43.07 58.31 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.968 0.413 . . . . 0.0 110.593 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.68 12.46 14.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.08 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.54 66.79 2.51 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.728 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.68 -19.04 32.23 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.616 2.211 . . . . 0.0 112.232 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -103.97 32.39 3.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.673 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 t -113.63 -158.45 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.689 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG22 ' CD1' ' A' ' 120' ' ' TYR . 39.2 t -147.49 136.2 15.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 18.3 t -114.25 110.99 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.608 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.5 mm -99.23 -39.91 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.558 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.452 HG12 ' CE1' ' A' ' 99' ' ' PHE . 59.1 t 45.25 77.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.433 HD11 ' CD1' ' A' ' 109' ' ' PHE . 4.2 mt -93.45 148.51 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.579 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 1.4 p -149.82 -57.75 0.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.025 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 53.23 98.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.642 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -150.34 -47.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.316 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 173.13 137.87 2.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.37 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m 60.31 -175.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.814 0.34 . . . . 0.0 110.833 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.15 65.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -111.52 -24.21 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.192 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -32.08 22.67 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.501 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -61.96 -57.27 12.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.897 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.6 m -58.08 -26.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.016 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -81.76 -9.25 59.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.96 -26.45 4.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 5.5 pt -83.32 -42.16 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -23.73 41.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.679 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -25.06 65.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.94 -16.1 1.05 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.106 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.427 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -51.9 177.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.97 0.385 . . . . 0.0 111.464 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 72.3 t80 -95.29 28.55 2.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.503 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 1.2 tt0 70.09 139.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.208 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.8 OUTLIER -55.11 146.07 19.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.4 OUTLIER -87.23 109.65 19.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -56.99 -170.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.059 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.5 mttm 62.69 83.58 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.91 146.26 82.42 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.623 2.215 . . . . 0.0 112.22 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.85 27.86 15.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.3 p -162.79 155.49 19.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.528 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 32.8 m -141.69 49.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.15 -60.67 2.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -30.55 53.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.528 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 80.8 t80 -61.91 -40.57 95.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.607 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.1 tt -52.41 -59.09 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.395 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mp -66.23 -44.46 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.544 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.3 m -60.2 -37.8 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.125 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.446 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -49.02 -52.36 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.482 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -56.56 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.042 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.425 ' CE1' ' HG3' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -52.55 -36.49 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.9 -38.54 79.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 110.57 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.452 ' CE1' ' CA ' ' A' ' 2' ' ' LYS . 34.7 m-85 -82.73 -17.18 45.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.792 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -102.99 -65.45 1.0 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 115' ' ' HIS . 50.2 mm-40 -88.54 22.67 2.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.444 ' CD1' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -155.78 40.36 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.933 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.837 0.351 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.39 127.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.033 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.498 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -149.2 140.87 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.545 HG11 ' HB ' ' A' ' 48' ' ' VAL . 17.7 t -124.67 162.27 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.978 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 57.5 tp -119.8 121.82 39.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 110.588 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 30' ' ' THR . 40.0 t -102.77 122.88 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.19 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 52' ' ' ASP . 41.3 t -111.41 105.26 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.866 0.365 . . . . 0.0 111.191 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -117.57 151.76 36.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.934 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -81.27 49.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 111.667 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 61.96 116.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.361 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 175.63 39.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.318 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.3 t 58.01 58.49 3.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.262 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 14' ' ' THR . 11.9 mm 55.6 169.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.499 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 2.3 p -81.72 118.36 22.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 m -54.68 145.94 18.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.434 ' HB3' HG13 ' A' ' 106' ' ' VAL . 42.1 t 66.03 10.86 7.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.839 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.487 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -90.22 -52.23 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.443 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 t -50.08 -55.26 15.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.06 73.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.968 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' A' ' 16' ' ' SER . 54.3 mt -62.19 -66.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.38 -28.62 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.44 -27.68 61.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.79 -34.46 30.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.149 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 30.5 mm-40 -87.18 -30.58 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 60.53 1.48 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.45 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 44.8 m-85 -113.09 -173.67 2.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.25 83.83 54.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.882 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 92.2 Cg_endo -84.74 117.62 2.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.79 2.326 . . . . 0.0 111.636 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.26 -9.2 33.84 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.403 0.62 . . . . 0.0 112.046 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 71.5 p 49.66 173.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.216 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' VAL . . . -158.55 -154.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.493 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 27.3 mttt -143.65 -42.96 0.28 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.0 170.07 20.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.591 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.3 mt -61.41 -26.77 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.51 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -76.2 -43.59 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.083 0.468 . . . . 0.0 109.819 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -25.98 59.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.607 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.52 -34.03 58.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.634 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 44.8 mt-10 -69.75 -41.46 75.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -61.83 -37.98 86.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.837 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -72.41 -47.03 52.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.615 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 mt -68.71 -27.97 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.976 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.55 -29.12 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -116.82 -44.21 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.63 112.75 18.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -75.13 63.94 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 42.4 m-85 -56.03 125.58 63.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.498 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 72.2 Cg_endo -76.45 -34.04 2.9 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.307 2.004 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.545 ' HB ' HG11 ' A' ' 4' ' ' VAL . 23.5 t -130.16 111.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.007 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.3 mm -97.01 142.38 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.795 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 6' ' ' VAL . 6.6 t -128.66 165.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 78' ' ' VAL . 16.2 tp -142.41 157.69 44.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.119 0.485 . . . . 0.0 111.539 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -141.93 79.95 1.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.011 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.67 66.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.188 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.412 ' N ' ' O ' ' A' ' 52' ' ' ASP . 26.7 t-105 -67.16 -74.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.643 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 31.4 mtt -147.54 52.75 1.37 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.763 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.4 Cg_endo -89.72 -156.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -136.89 -43.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.246 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.44 148.37 34.11 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.647 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 127.53 43.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.71 -13.8 83.17 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.823 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.57 -45.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.789 0.328 . . . . 0.0 111.339 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 -5.9 55.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.537 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 34' ' ' LEU . 15.7 t80 -74.15 -37.74 63.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.347 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.5 mp -49.7 -27.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -39.45 69.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.632 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 18.8 t80 -60.3 -43.35 96.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.061 0.458 . . . . 0.0 109.914 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.404 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -57.33 -41.76 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -81.64 -24.16 36.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.0 110.638 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -66.39 -26.18 67.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -138.0 16.58 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.026 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.15 69.17 0.82 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.864 0.364 . . . . 0.0 110.748 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.44 -20.26 48.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.76 2.307 . . . . 0.0 112.11 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.78 39.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.853 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.8 t -119.61 177.59 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.437 ' HB ' ' CG1' ' A' ' 48' ' ' VAL . 2.7 t -107.9 178.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 0.9 OUTLIER -157.52 79.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.898 0.38 . . . . 0.0 110.146 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.413 ' HB ' HG12 ' A' ' 50' ' ' VAL . 31.2 mm -62.21 -53.02 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.364 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 5.2 t 45.39 89.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.422 ' O ' ' CB ' ' A' ' 80' ' ' THR . 13.8 mt -104.21 167.2 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.614 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 79' ' ' ILE . 2.6 m 84.21 147.49 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.425 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.43 49.26 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.168 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -55.18 -78.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.737 0.303 . . . . 0.0 111.203 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.95 46.48 2.69 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.542 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.32 52.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.819 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.1 -31.94 52.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.96 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.81 -32.91 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.39 -34.76 49.49 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.19 0.519 . . . . 0.0 109.954 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.5 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -56.41 -61.27 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.315 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.4 m -61.92 -22.73 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.243 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -85.52 -25.13 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.91 -26.1 14.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.419 ' CG2' ' HA ' ' A' ' 98' ' ' GLU . 4.2 pt -89.32 -17.0 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.436 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -71.71 -32.66 68.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 110.43 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -64.78 -61.99 1.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.84 33.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.986 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.433 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.11 -179.0 5.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 97' ' ' TYR . 26.4 t80 -98.52 28.54 4.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.452 . . . . 0.0 111.062 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 2.7 tp10 67.47 134.15 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.193 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.502 ' CE1' ' CG1' ' A' ' 78' ' ' VAL . 2.3 m-85 -61.64 131.48 50.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.014 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -74.81 80.81 2.1 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -50.06 176.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.412 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.05 80.6 0.23 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.917 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.34 171.56 15.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.577 2.185 . . . . 0.0 112.249 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 56.83 23.47 8.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 p -147.99 60.74 1.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 110.657 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 16' ' ' SER . 7.6 p -53.91 -26.91 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.461 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -46.51 -33.92 4.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 110.838 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -36.25 69.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.933 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 113' ' ' ILE . 3.4 t80 -59.64 -31.16 69.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.181 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.16 -49.21 43.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.29 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.424 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 5.6 mp -56.93 -57.56 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.75 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.402 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 93.0 m -44.68 -39.28 4.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.301 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 24.1 mm -59.13 -70.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.427 ' HE3' ' CE1' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -55.24 -23.07 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.563 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.427 ' CE1' ' HE3' ' A' ' 114' ' ' LYS . 13.9 m-70 -84.75 -20.62 30.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.668 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -87.19 -45.22 10.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.45 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -60.44 -22.53 63.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -52.84 -25.46 11.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.271 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.72 30.62 2.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.009 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -115.99 28.31 8.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 -179.981 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt 60.74 91.89 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.95 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -111.71 135.07 52.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.862 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.0 t -126.5 154.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.411 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.435 HD23 ' CD2' ' A' ' 46' ' ' PHE . 28.8 tp -105.73 127.98 53.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.709 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 17' ' ' LEU . 45.2 t -107.52 90.1 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 5.1 t -85.08 105.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -138.36 143.04 39.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.037 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -91.9 50.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.9 -172.69 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -127.93 40.54 3.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -100.38 -42.15 6.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.7 mm -98.88 -40.77 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' SER . 40.0 p -47.64 -29.54 3.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.427 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.51 -45.85 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 111.258 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 p -73.58 -68.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.444 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -44.78 -42.86 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 14' ' ' THR . 10.1 m -57.15 -44.18 83.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.43 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.69 78.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.431 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mt -59.76 -57.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.587 179.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -50.33 -33.49 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.664 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.02 -24.59 66.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.794 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.38 -36.61 45.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -78.34 -19.12 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.157 179.693 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.17 52.95 2.11 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.186 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.1 m-85 -112.07 -172.21 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 0.0 111.163 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -131.41 69.41 81.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.805 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.415 ' HG3' ' CB ' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -62.61 143.26 92.35 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.628 2.218 . . . . 0.0 111.931 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.8 t70 -126.56 -9.11 6.24 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.625 ' O ' ' O ' ' A' ' 29' ' ' ASP . 29.9 p 41.9 163.68 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -170.61 142.87 2.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.778 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 41.5 mttt -74.01 -166.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.73 156.24 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 111.705 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.445 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 20.2 mt -27.36 -43.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.833 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -50.56 -59.59 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.083 0.468 . . . . 0.0 110.333 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 1.4 tp10 -66.07 -39.1 89.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.15 -60.5 3.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.595 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 19.7 mt-10 -45.67 -42.18 11.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -60.8 -52.75 63.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -62.44 -34.59 77.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.328 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 mt -89.54 -6.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.52 -16.56 48.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.633 0.254 . . . . 0.0 111.262 179.901 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -132.95 -52.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.769 0.318 . . . . 0.0 111.093 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.95 133.25 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.073 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -96.52 63.89 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.706 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CD2' HD23 ' A' ' 5' ' ' LEU . 45.2 m-85 -58.27 125.23 74.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.036 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.74 -24.78 17.83 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.317 2.011 . . . . 0.0 111.892 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 2.8 t -141.59 134.12 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.524 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.8 mm -119.24 148.18 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.547 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 7' ' ' VAL . 82.9 t -136.59 105.62 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.587 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.04 84.11 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.751 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 54' ' ' TRP . 1.2 t70 -66.35 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 2.5 p -53.24 88.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ASP . 34.0 t-105 -88.47 -80.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.49 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 mmt -147.22 47.27 0.55 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 55' ' ' MET . 97.8 Cg_endo -78.6 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.562 2.175 . . . . 0.0 112.323 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -152.2 30.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.57 -147.17 18.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.411 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -129.49 81.2 2.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.863 0.363 . . . . 0.0 110.9 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.9 92.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 64' ' ' ILE . 78.0 t -59.87 -38.64 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -23.41 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.108 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 13.4 t80 -75.35 -30.22 60.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.819 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 61' ' ' VAL . 7.9 mm -47.8 -37.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' GLU . 39.1 t70 -70.07 -42.93 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 23.4 t80 -50.99 -39.91 56.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.935 0.398 . . . . 0.0 110.651 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.411 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.7 mp -62.74 -52.08 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -74.63 -9.51 58.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.701 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 18.0 tt0 -77.1 -48.04 18.86 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -114.33 16.83 17.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.925 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.66 67.54 1.6 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.2 -18.59 34.86 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.672 2.248 . . . . 0.0 112.156 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.75 40.66 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.66 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.403 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 34.0 t -119.06 -157.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.01 139.0 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 112.102 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.1 t -120.74 94.16 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.175 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.6 mm -73.63 -57.11 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.917 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.434 HG12 ' CE1' ' A' ' 99' ' ' PHE . 21.7 t 52.59 94.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.409 HD12 ' CD1' ' A' ' 109' ' ' PHE . 1.7 mt -108.45 -148.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.326 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.45 ' HB ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 54.85 174.54 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.829 0.347 . . . . 0.0 111.106 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.0 142.98 5.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.378 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -57.64 -61.8 2.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.994 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.41 -31.66 3.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.422 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m 58.02 51.36 8.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 m -127.1 -41.3 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.326 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.0 -24.77 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.288 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -33.56 26.62 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . . . -61.1 -57.09 13.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.116 178.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 92' ' ' ILE . 13.4 m -59.94 -28.22 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.43 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -78.74 -2.26 38.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.606 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.05 -35.04 1.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 89' ' ' VAL . 4.7 pt -73.69 -43.59 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 111.413 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -59.42 -31.44 69.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -64.71 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.736 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.34 29.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.845 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.25 -166.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.722 0.296 . . . . 0.0 111.135 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 20.9 t80 -113.51 26.71 10.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HA ' HG23 ' A' ' 92' ' ' ILE . 0.5 OUTLIER 79.5 147.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.229 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.471 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -79.31 88.3 4.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.802 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 13.8 tp -59.06 148.23 31.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -57.0 177.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.01 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -139.88 52.37 3.65 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.993 -179.991 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 41.8 Cg_endo -67.23 -166.07 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.509 2.14 . . . . 0.0 112.176 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -55.95 109.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.019 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.5 m 65.15 163.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.031 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 32.4 m -89.81 49.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.162 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -62.19 1.53 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -29.32 57.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.163 0.506 . . . . 0.0 109.69 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.487 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 43.3 t80 -61.62 -44.18 97.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.985 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.8 mt -52.5 -31.17 33.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.465 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.628 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 4.1 mp -79.75 -36.05 37.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 m -69.16 -36.88 77.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.491 . . . . 0.0 109.811 179.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 mm -67.17 -51.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.068 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -47.26 -57.2 5.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.311 -179.018 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.419 ' CG ' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -57.33 -34.76 69.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.818 179.537 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.92 -32.42 61.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 48' ' ' VAL . 29.8 m-85 -74.6 -46.11 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.076 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -88.9 6.95 36.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.658 -179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.419 ' HG3' ' CG ' ' A' ' 115' ' ' HIS . 1.2 mm-40 -117.74 -8.45 10.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.684 0.278 . . . . 0.0 111.57 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -153.23 71.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.849 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.934 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.846 0.355 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 8.5 mmtt 65.42 -176.44 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 75.53 105.96 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.093 -179.781 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 44.4 t -112.78 162.51 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.42 HD21 ' CD2' ' A' ' 46' ' ' PHE . 59.5 tp -119.81 139.12 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.445 ' CG2' HD11 ' A' ' 17' ' ' LEU . 10.5 t -121.05 117.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.133 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.75 111.6 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.361 179.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.01 157.21 38.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -83.5 -70.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.423 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.0 mm-40 -84.7 177.58 7.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 111.241 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -96.89 70.47 2.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.848 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.6 m -106.63 -37.03 6.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.462 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.6 mp -110.81 -33.24 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.748 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.3 p -54.93 -44.63 74.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -82.1 58.56 4.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.065 0.459 . . . . 0.0 110.966 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 170.6 -56.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.415 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.445 HD11 ' CG2' ' A' ' 6' ' ' VAL . 1.4 tm? -59.81 -55.87 28.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 m -54.66 -41.8 70.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 179.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.474 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.1 mt -57.64 -64.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.69 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.442 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.73 -36.46 11.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.51 179.518 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -29.39 70.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.97 -35.06 57.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -77.48 -8.58 57.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.161 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.14 51.93 1.99 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.964 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 51.0 m-85 -124.04 -175.92 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 111.345 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -140.23 77.92 24.07 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.061 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 71.8 Cg_endo -84.05 148.91 12.09 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.582 2.188 . . . . 0.0 113.617 -178.312 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.88 134.1 45.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.719 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.4 p -99.36 147.4 25.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.909 0.385 . . . . 0.0 111.166 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -147.24 145.77 29.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -62.83 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.0 p -48.65 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.255 0.55 . . . . 0.0 111.817 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.451 HD21 ' CE2' ' A' ' 63' ' ' PHE . 10.9 mt -45.51 -30.47 1.44 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.959 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -59.92 -61.67 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -58.76 -38.46 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.86 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . . . -58.85 -50.02 75.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.06 -48.66 22.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.964 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -55.73 31.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -26.38 61.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.172 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 10.0 mt -97.17 -6.87 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.75 25.21 5.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.359 . . . . 0.0 110.805 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.34 -58.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.457 ' CD2' ' CG ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -100.04 153.52 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 18.0 t80 -86.93 81.68 8.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.457 ' CG ' ' CD2' ' A' ' 44' ' ' LEU . 14.6 m-85 -67.88 117.17 45.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.4 -38.88 3.17 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.493 2.128 . . . . 0.0 112.325 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.2 t -124.83 125.92 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.96 0.409 . . . . 0.0 111.79 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.9 mm -115.2 134.29 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.42 109.71 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 111.841 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.44 170.58 16.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.423 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -134.63 -54.91 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.455 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.4 t 59.82 41.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.763 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.435 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 60.5 t-105 -62.73 -91.18 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.095 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.538 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -71.02 -48.76 13.55 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.438 -179.771 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 55' ' ' MET . 64.8 Cg_endo -72.52 -167.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.242 1.962 . . . . 0.0 112.283 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.07 55.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.833 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.02 115.89 8.54 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -92.84 31.19 1.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.806 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.09 64.37 0.95 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.365 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.0 -43.02 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.939 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.54 -18.43 40.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.451 ' CE2' HD21 ' A' ' 34' ' ' LEU . 45.8 t80 -49.96 -43.32 50.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.569 0.223 . . . . 0.0 111.227 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.434 HD11 ' HA ' ' A' ' 91' ' ' ALA . 3.2 mt -48.07 -30.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.056 0.455 . . . . 0.0 110.604 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -67.6 -53.25 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.184 179.373 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 41' ' ' ILE . 6.7 t80 -46.26 -44.2 16.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.795 0.331 . . . . 0.0 110.863 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.434 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.6 mp -61.94 -47.8 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -14.32 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.886 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' ASP . 28.0 tt0 -73.23 -51.43 17.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.013 0.435 . . . . 0.0 110.546 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.33 14.14 22.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.086 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.414 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -159.49 65.14 2.6 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.648 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 71' ' ' SER . 14.8 Cg_exo -67.75 -20.88 45.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.647 2.231 . . . . 0.0 112.091 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -104.68 33.1 3.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.617 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.8 t -110.63 -178.22 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -129.11 139.64 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.826 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.9 t -125.68 104.74 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.444 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -91.35 -43.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.566 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.2 t 48.15 96.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.721 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.1 mt -118.62 149.45 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.54 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 p -152.31 -57.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.62 0.247 . . . . 0.0 111.267 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.23 -169.64 39.15 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.821 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -80.61 -23.21 39.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.627 0.251 . . . . 0.0 111.153 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.58 55.72 4.44 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.643 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.4 56.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.103 0.478 . . . . 0.0 110.622 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m -70.62 -25.09 25.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.514 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -88.84 -15.43 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.459 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.98 -34.43 26.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.476 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -60.02 -61.28 2.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.93 178.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 92' ' ' ILE . 11.1 m -58.59 -29.11 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.849 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.54 -3.33 43.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -119.25 -39.88 2.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.373 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 88' ' ' ALA . 5.9 pt -74.35 -46.26 44.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.435 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -60.49 -26.92 67.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.536 179.729 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -62.82 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.5 19.09 0.07 OUTLIER Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.537 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.41 -169.68 2.48 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.285 0.542 . . . . 0.0 110.961 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.522 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 62.0 t80 -103.91 -18.95 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.534 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 9.0 pt-20 151.28 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.34 0.656 . . . . 0.0 110.003 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.476 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -133.49 98.51 4.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.93 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.8 tp -64.11 169.78 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.995 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.16 115.12 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.011 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.1 tmtt? -64.85 -48.01 73.33 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.6 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 48.6 Cg_endo -69.14 -5.55 16.09 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.17 1.914 . . . . 0.0 113.0 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -82.22 -172.98 4.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.732 0.301 . . . . 0.0 110.656 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.8 t -85.25 127.23 34.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.924 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.47 -18.82 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.248 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.65 -42.23 92.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -34.73 78.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.244 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.418 ' CE1' HG12 ' A' ' 113' ' ' ILE . 9.7 t80 -60.66 -39.52 88.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.174 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.85 -36.46 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.187 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.44 -42.71 96.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.167 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.9 m -70.97 -46.67 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.418 HG12 ' CE1' ' A' ' 109' ' ' PHE . 5.1 mm -43.68 -58.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.508 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -47.41 -54.51 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.079 0.466 . . . . 0.0 110.123 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.07 66.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.41 -34.68 78.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.945 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE1' ' CA ' ' A' ' 2' ' ' LYS . 25.8 m-85 -74.45 -13.74 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.823 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -58.71 -20.82 52.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.282 . . . . 0.0 111.358 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.95 41.76 1.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.98 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -159.16 28.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.999 179.94 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.9 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.884 0.373 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HD3' ' CD2' ' A' ' 117' ' ' PHE . 9.8 mmtt -138.53 121.08 16.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -147.84 83.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.774 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.438 HG21 ' CE1' ' A' ' 117' ' ' PHE . 22.9 t -68.94 160.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.467 HD11 ' CE2' ' A' ' 46' ' ' PHE . 55.3 tp -118.94 135.86 54.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' CG2' HD11 ' A' ' 17' ' ' LEU . 14.2 t -118.17 139.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.052 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.3 t -125.85 119.27 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.496 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 52' ' ' ASP . 22.9 t0 -170.32 160.68 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -179.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 27.4 t70 -88.27 50.53 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.586 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.21 127.31 41.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.711 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -80.31 149.34 30.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.172 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.89 66.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.228 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 14' ' ' THR . 23.0 mm 53.63 168.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.183 0.516 . . . . 0.0 111.454 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 54.7 p -90.16 146.05 24.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.986 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 16' ' ' SER . 1.6 m -55.77 133.79 51.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.851 0.357 . . . . 0.0 111.771 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 15' ' ' SER . 0.9 OUTLIER 82.36 -43.55 0.14 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.328 179.159 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.507 HD11 ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -52.21 -53.92 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.755 0.312 . . . . 0.0 111.367 -179.33 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.4 t -46.47 -71.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.54 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.3 -40.63 11.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 0.0 111.482 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.406 HD12 ' CG2' ' A' ' 106' ' ' VAL . 16.3 mt -64.18 -68.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.155 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' CD1' HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.62 -29.92 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.89 -24.0 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.998 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.52 -37.46 27.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.234 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.09 -25.44 43.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.7 2.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.267 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -112.4 -178.01 3.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 111.366 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.12 78.75 72.37 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.539 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.3 Cg_endo -84.27 139.29 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.862 2.375 . . . . 0.0 113.889 -177.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.408 ' HB3' HD12 ' A' ' 5' ' ' LEU . 11.1 t0 -121.97 118.27 28.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.342 178.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.402 HG22 ' CD1' ' A' ' 13' ' ' ILE . 72.8 p -102.34 127.05 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.93 0.395 . . . . 0.0 111.627 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.73 -165.18 1.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.526 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 -5.68 5.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.639 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.58 -176.28 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.479 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 24.8 mt -77.36 -31.49 54.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.731 0.301 . . . . 0.0 110.339 179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -45.64 67.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -35.72 80.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.075 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 41' ' ' ILE . . . -69.96 -48.18 59.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -46.42 -48.36 18.82 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.905 0.383 . . . . 0.0 110.503 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.84 -52.79 64.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.712 178.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -63.71 -23.47 67.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.283 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 37' ' ' ALA . 21.0 mt -93.33 -16.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.86 22.26 12.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.53 ' CB ' HD11 ' A' ' 44' ' ' LEU . 26.7 mt-10 -143.22 -52.98 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.771 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -99.64 12.95 35.2 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.413 0.625 . . . . 0.0 109.818 179.691 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 44' ' ' LEU . 16.1 t80 23.72 86.19 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.748 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 5' ' ' LEU . 49.3 m-85 -68.42 148.57 98.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.407 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 8.4 Cg_endo -83.67 -47.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.792 2.328 . . . . 0.0 111.88 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.94 126.79 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 49' ' ' ILE . 21.5 mm -111.97 125.68 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.853 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.411 HG21 ' CE1' ' A' ' 109' ' ' PHE . 52.9 t -127.16 106.31 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.08 0.467 . . . . 0.0 112.031 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.9 tp -79.04 165.11 23.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.304 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' CB ' ' HB2' ' A' ' 8' ' ' ASP . 42.4 t0 -127.59 -56.79 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.668 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.1 t 67.96 66.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.935 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -96.54 -82.93 0.39 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 111.442 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.607 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.2 mtt -83.68 -31.76 0.5 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 55' ' ' MET . 87.7 Cg_endo -83.05 -174.25 1.96 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.099 1.866 . . . . 0.0 112.922 -179.225 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -170.19 58.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.563 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.71 12.69 60.74 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.955 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.45 92.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.792 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.33 -9.05 60.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.852 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.0 t -51.32 -49.72 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.403 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.58 -3.9 40.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.941 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.479 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 12.2 t80 -88.64 -42.09 12.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.538 0.209 . . . . 0.0 111.504 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.8 mp -43.84 -30.07 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.771 0.319 . . . . 0.0 111.272 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -67.24 -54.63 19.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -48.15 -40.6 24.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 110.52 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' SER . 3.7 mp -60.45 -48.34 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.511 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -77.24 -18.97 57.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.971 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.89 -50.68 54.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.956 0.408 . . . . 0.0 110.716 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.07 17.26 16.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.6 OUTLIER -161.26 68.33 2.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.771 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.11 -16.63 25.28 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.764 2.309 . . . . 0.0 112.297 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.07 -2.45 34.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.377 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.6 t -82.37 176.82 9.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.051 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.61 159.25 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.88 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 t -143.54 83.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.571 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.4 mm -71.53 -45.32 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.656 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 6.8 t 48.67 85.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.489 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 7.6 mt -107.19 152.5 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 p -155.58 -171.59 3.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.94 -43.28 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.54 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -77.34 62.83 2.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.68 -161.46 26.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.507 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -116.23 168.83 9.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.3 -14.81 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.496 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.3 -22.17 66.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.315 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.7 39.48 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -61.51 -58.58 7.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.004 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.12 -23.43 27.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.842 179.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -91.09 39.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.376 179.566 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.16 -38.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.083 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.418 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 7.6 pt -74.36 -30.03 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -29.84 67.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.7 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.69 65.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.144 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.77 -2.18 3.31 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.231 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -56.99 -168.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.046 0.423 . . . . 0.0 111.111 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 6.8 t80 -110.73 27.87 9.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 80.67 156.78 0.14 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.434 179.705 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.513 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -88.54 110.26 20.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 -179.993 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 tp -63.72 149.42 46.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.862 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -99.75 166.84 10.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.7 78.77 0.28 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.71 -3.94 14.59 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.628 2.219 . . . . 0.0 112.788 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -77.07 -59.22 2.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.712 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.6 t -112.86 131.82 55.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 32.8 m -95.99 37.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.024 0.44 . . . . 0.0 111.181 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.7 -55.64 18.7 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.14 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -60.94 -31.54 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.807 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 27.8 t80 -57.65 -39.28 76.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.893 179.065 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.45 -51.03 71.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.174 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -57.29 -46.13 83.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.549 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 m -69.27 -44.96 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 0.0 110.959 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.431 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 1.6 mm -40.63 -52.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.78 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.19 12.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.651 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -62.08 -36.21 80.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.46 85.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.988 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.438 ' CE1' HG21 ' A' ' 4' ' ' VAL . 19.5 m-85 -65.36 -19.42 65.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.291 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -52.17 -25.32 8.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.333 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -74.68 -6.59 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -162.03 61.66 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.907 0.384 . . . . 0.0 110.813 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.942 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mmt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.865 0.364 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp 59.81 87.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.415 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -142.35 118.09 10.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.967 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 117' ' ' PHE . 14.3 t -118.6 160.81 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.438 HD23 ' CD2' ' A' ' 46' ' ' PHE . 42.5 tp -114.74 133.44 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.871 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 30' ' ' THR . 24.5 t -113.58 90.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.407 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 t -82.2 111.85 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.87 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -147.73 137.54 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 13.2 t0 -61.38 -80.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.68 163.0 18.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.995 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -84.6 78.87 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -109.91 -35.25 6.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.6 mp -114.21 -35.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.817 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 p -47.85 -28.05 2.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.438 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -80.43 -54.54 5.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.024 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -69.62 -63.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.637 HD23 ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -45.21 -46.17 12.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.315 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.55 ' HA ' HD12 ' A' ' 21' ' ' LEU . 5.7 t -44.73 -37.76 3.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.2 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.238 0.542 . . . . 0.0 110.391 179.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CD1' HG13 ' A' ' 106' ' ' VAL . 3.0 mp -68.54 -68.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.144 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.637 ' HB3' HD23 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -48.51 -27.24 2.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.316 179.438 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' N ' HD13 ' A' ' 21' ' ' LEU . 15.5 mt-10 -73.71 -28.44 61.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.711 0.291 . . . . 0.0 111.011 179.129 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.1 tt0 -80.31 -36.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.826 0.346 . . . . 0.0 110.511 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.442 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -64.46 -17.37 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 -179.98 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.99 65.51 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.22 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.556 ' HB2' HD23 ' A' ' 21' ' ' LEU . 20.3 m-85 -137.69 -176.92 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.217 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.84 91.89 43.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.716 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.583 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 72.7 Cg_endo -84.3 133.3 5.45 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.625 2.216 . . . . 0.0 112.91 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.549 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -110.26 7.23 23.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.344 -179.731 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.549 ' O ' ' O ' ' A' ' 29' ' ' ASP . 15.4 p 6.5 122.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 -170.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.116 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 18.9 tttt -104.39 -43.33 5.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -161.15 -168.28 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.317 179.535 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.433 HD21 ' CD2' ' A' ' 63' ' ' PHE . 32.1 mt -67.19 -52.9 35.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -57.36 -45.78 84.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.58 -35.16 75.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.36 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.45 -34.73 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 77.5 mt-10 -64.51 -43.38 94.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -39.11 78.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -72.36 -49.93 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.687 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.0 mt -64.19 -27.33 42.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.074 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -27.92 5.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -124.2 -42.34 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.08 115.01 19.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -80.34 101.34 8.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.709 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.438 ' CD2' HD23 ' A' ' 5' ' ' LEU . 35.2 m-85 -97.25 119.15 63.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.0 Cg_endo -73.06 -17.69 24.63 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.477 2.118 . . . . 0.0 111.899 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.48 HG23 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -147.85 132.21 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.565 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.77 160.1 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.428 HG21 ' CE1' ' A' ' 109' ' ' PHE . 60.0 t -152.67 99.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.206 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -71.39 164.56 25.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' TRP . 4.8 t70 -152.61 57.6 0.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -44.43 91.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.04 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.414 ' N ' ' O ' ' A' ' 52' ' ' ASP . 30.3 t-105 -88.16 -75.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.828 179.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.729 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 7.8 ttp -147.18 46.22 0.48 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.161 179.002 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.729 ' HD3' ' N ' ' A' ' 55' ' ' MET . 28.1 Cg_endo -95.48 -160.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.235 2.623 . . . . 0.0 112.204 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -149.54 60.03 1.01 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.03 131.24 4.49 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.508 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -74.23 144.94 44.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.973 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.79 -18.95 12.69 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.766 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.0 t -52.94 -40.61 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.16 -11.44 49.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.433 ' CD2' HD21 ' A' ' 34' ' ' LEU . 26.5 t80 -78.76 -39.64 35.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.371 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.57 -32.79 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.359 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.64 -32.96 60.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.662 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 48.3 t80 -61.29 -44.96 96.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.417 HD13 ' CD2' ' A' ' 63' ' ' PHE . 4.1 mp -58.02 -42.64 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.271 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -80.25 -19.23 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 18.4 tt0 -71.15 -30.92 67.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.947 0.403 . . . . 0.0 110.703 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.438 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -132.37 17.21 4.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 180.0 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.57 68.73 1.05 Allowed Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.59 -21.25 46.16 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.77 2.313 . . . . 0.0 112.183 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.67 31.09 3.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.9 t -112.65 -163.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.402 ' N ' ' OG ' ' A' ' 74' ' ' SER . 45.8 t -152.58 135.85 7.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-O 121.025 0.441 . . . . 0.0 111.421 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.5 t -107.89 109.85 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.723 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.7 mm -87.75 -56.32 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.48 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 20.3 t 53.65 103.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.518 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mt -102.98 -173.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.227 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.414 ' O ' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER 59.28 162.25 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.85 179.923 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.84 -155.63 14.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.555 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -159.11 30.98 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.92 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.1 -97.35 0.47 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.617 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.409 ' O ' ' CG2' ' A' ' 85' ' ' VAL . 1.2 m -97.93 36.8 1.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.809 0.337 . . . . 0.0 110.94 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 84' ' ' SER . 35.4 m 43.34 30.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.825 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -78.85 -52.93 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.694 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.401 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.2 t -47.29 -32.5 4.73 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.205 0.526 . . . . 0.0 110.062 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . . . -59.99 -60.04 4.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.16 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' HA ' HG12 ' A' ' 92' ' ' ILE . 17.5 m -66.32 -24.66 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.118 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -83.63 -20.23 34.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.258 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -102.52 -39.14 7.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.662 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 92' ' ' ILE . 11.8 pt -69.32 -27.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.408 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -32.08 64.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.697 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -64.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 29.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.916 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.401 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -90.18 -167.22 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 84.1 t80 -117.67 26.03 9.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.1 pt-20 85.74 146.43 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.415 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.48 ' CE1' ' CG1' ' A' ' 78' ' ' VAL . 1.0 OUTLIER -78.8 105.39 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.772 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 tp -57.59 167.01 1.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.05 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.65 132.35 53.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.456 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 10.9 mtmm -81.21 -48.34 1.06 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 90.2 Cg_endo -83.73 52.89 3.92 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.501 2.134 . . . . 0.0 112.462 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CE1' ' HB2' ' A' ' 108' ' ' ARG . 0.6 OUTLIER -127.31 160.89 29.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 179.888 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -63.56 1.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.159 -179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' PHE . 13.4 p -179.99 -34.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 -179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -39.87 -38.31 0.66 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.414 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 0.6 OUTLIER -71.04 -39.77 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.413 179.564 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 106' ' ' VAL . 21.0 t80 -57.14 -28.32 62.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.74 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -48.03 67.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.331 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 5.4 mp -66.73 -52.19 47.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.973 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 m -46.36 -32.61 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 0.0 110.728 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.427 HG12 ' CE1' ' A' ' 109' ' ' PHE . 22.1 mm -78.18 -67.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -50.42 -19.66 0.91 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.941 -179.939 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.41 ' CG ' ' OH ' ' A' ' 97' ' ' TYR . 1.8 t-80 -89.58 -27.84 19.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 110.754 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.01 -35.49 57.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.48 ' CE1' HG23 ' A' ' 48' ' ' VAL . 63.7 m-85 -79.73 -45.77 18.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -54.52 -50.27 68.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.1 -3.65 46.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.41 44.41 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.977 0.418 . . . . 0.0 110.962 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.84 179.978 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.795 0.331 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm 63.82 128.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -162.37 127.66 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.721 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 39.5 t -116.86 143.72 26.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.727 0.298 . . . . 0.0 110.685 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.425 HD23 ' CD2' ' A' ' 46' ' ' PHE . 19.1 tp -96.88 132.3 42.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.061 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.425 ' CG1' ' CG2' ' A' ' 14' ' ' THR . 21.9 t -116.35 89.0 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 23.9 t -84.88 112.74 22.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.104 0.478 . . . . 0.0 111.167 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -146.12 136.51 23.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.565 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -51.27 -24.31 4.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -58.82 -163.47 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.688 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -147.15 150.16 34.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.915 0.388 . . . . 0.0 111.283 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 13' ' ' ILE . 2.9 m 58.73 77.27 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.211 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.486 ' O ' ' O ' ' A' ' 12' ' ' SER . 8.1 mm 50.55 159.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.742 0.782 . . . . 0.0 112.557 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.425 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 72.0 p -91.55 145.81 24.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.983 178.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -68.2 137.11 54.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.601 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 15' ' ' SER . 0.8 OUTLIER 83.59 -16.94 0.52 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.28 179.316 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -86.39 -50.18 7.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 110.796 -179.899 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.15 -53.67 12.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' GLU . 85.9 mt -67.85 -69.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.403 ' CD1' ' CD1' ' A' ' 17' ' ' LEU . 1.1 mt -45.94 -30.23 1.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.98 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.87 -30.59 69.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.734 179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.47 -35.29 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.014 179.486 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -85.06 178.56 7.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.662 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.25 31.58 6.93 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.219 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.36 -175.55 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.199 0.523 . . . . 0.0 111.301 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.9 OUTLIER -151.05 95.79 3.35 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.811 179.61 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 57.6 Cg_endo -72.94 140.51 31.77 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.251 1.968 . . . . 0.0 112.481 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -115.42 -1.31 12.87 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.584 ' O ' ' O ' ' A' ' 29' ' ' ASP . 48.9 p 12.66 122.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -132.38 159.96 37.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.444 178.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' HB2' ' CB ' ' A' ' 36' ' ' GLU . 31.5 mttt -73.48 -168.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.401 ' CG2' ' HB3' ' A' ' 56' ' ' PRO . 16.8 p -48.04 161.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 111.909 -178.212 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 63' ' ' PHE . 10.4 mt -27.24 -44.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.648 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.18 -62.36 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.318 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 2.1 tp10 -65.38 -34.73 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.22 -63.14 1.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -44.67 -40.7 6.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.382 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -52.62 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.42 -34.28 76.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.835 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mt -85.27 -5.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.667 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -93.02 29.18 1.9 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.959 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -147.69 -53.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -99.31 -174.63 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -122.48 111.16 16.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.527 ' CZ ' ' CD2' ' A' ' 44' ' ' LEU . 67.6 m-85 -98.58 125.59 42.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.41 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.3 Cg_endo -81.44 -23.97 4.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.711 2.274 . . . . 0.0 111.485 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.2 t -141.55 131.06 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.567 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.8 mm -118.25 152.08 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.344 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.52 102.29 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.036 0.445 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 8.8 tp -94.3 129.62 40.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.063 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -113.33 113.15 24.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.417 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.463 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 5.2 m -76.08 56.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.41 . . . . 0.0 111.542 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.409 ' CE2' ' HE3' ' A' ' 55' ' ' MET . 31.3 t-105 -64.76 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.489 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.671 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 35.1 mtm -149.01 51.78 1.03 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.949 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.671 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.5 Cg_exo -81.12 -153.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -163.19 30.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.23 134.51 7.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -58.64 105.79 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 34' ' ' LEU . . . -69.89 -33.82 70.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 64' ' ' ILE . 57.4 t -55.49 -39.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.014 0.435 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -23.64 59.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.183 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.43 ' CD2' HD22 ' A' ' 34' ' ' LEU . 39.7 t80 -75.35 -30.16 60.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 61' ' ' VAL . 5.4 mm -50.65 -33.74 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 69' ' ' GLU . 27.3 t70 -71.56 -39.57 70.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.401 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 14.7 t80 -55.19 -43.68 74.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.428 HD13 ' CE2' ' A' ' 63' ' ' PHE . 4.0 mp -59.57 -46.28 93.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.397 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -79.31 -13.27 59.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.748 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.427 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 43.2 tt0 -74.38 -43.15 57.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.113 0.483 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.476 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -118.55 13.61 13.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.037 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.89 66.43 2.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.925 0.393 . . . . 0.0 110.72 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.4 Cg_exo -69.13 -19.63 38.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.632 2.221 . . . . 0.0 112.243 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.424 ' HB3' ' CD2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -103.29 27.3 7.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.931 179.909 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -109.68 -157.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -150.23 137.54 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.064 0.459 . . . . 0.0 111.726 179.212 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.6 t -116.35 91.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.6 mm -72.38 -59.26 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.114 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.464 HG12 ' CE1' ' A' ' 99' ' ' PHE . 47.9 t 51.63 92.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.837 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 100' ' ' LEU . 3.0 mt -116.42 145.71 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.992 0.425 . . . . 0.0 111.558 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.42 ' HB ' ' CG2' ' A' ' 53' ' ' VAL . 0.1 OUTLIER 168.27 104.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.686 179.504 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.77 119.64 6.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.496 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 31.6 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 162.68 -113.71 0.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.47 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.92 168.48 9.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.06 59.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.021 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -103.92 -28.78 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -85.47 -31.81 22.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 109.953 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -61.55 -56.59 18.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.777 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.8 m -52.58 -30.71 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.888 179.445 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 ttmt -75.98 -22.34 55.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.48 -40.72 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.87 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 89' ' ' VAL . 9.2 pt -70.91 -42.94 77.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.321 -179.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -23.38 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.554 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -79.76 -57.83 3.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.61 28.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.495 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.18 -164.52 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.12 0.46 . . . . 0.0 110.68 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.519 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 54.8 t80 -101.87 -23.18 14.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.6 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 3.8 pt-20 150.07 -11.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.603 0.565 . . . . 0.0 111.932 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 1.5 t80 69.98 71.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.121 0.486 . . . . 0.0 110.085 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 66.1 tp -49.77 165.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.189 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.434 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 7.7 mt-10 -124.12 97.43 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -142.25 51.72 2.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.058 -179.781 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 60.2 Cg_endo -71.73 -5.8 17.82 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.483 2.122 . . . . 0.0 112.812 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -137.44 -45.43 0.55 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.048 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 92.5 p -107.23 96.03 6.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.0 -1.97 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.389 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.93 -41.91 77.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -60.83 -34.85 75.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.455 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.482 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 6.2 t80 -61.35 -39.78 91.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.429 178.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.407 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 1.2 tt -48.72 -51.71 27.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.31 179.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -57.35 -46.57 83.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.4 m -60.8 -40.17 91.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.223 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 109' ' ' PHE . 2.0 mm -47.97 -54.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.535 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.91 -59.15 3.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -51.73 -29.46 18.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.867 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.33 -33.94 77.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.965 0.412 . . . . 0.0 110.672 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 4' ' ' VAL . 35.1 m-85 -78.45 -23.01 46.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.291 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.37 -25.58 10.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.808 0.337 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.7 -12.8 61.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.198 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -138.25 34.56 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.755 179.8 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.988 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.812 0.339 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmtp -128.42 116.93 20.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.33 133.57 24.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.842 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 18.6 t -128.03 161.08 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.799 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' VAL . 28.0 tp -112.51 134.64 53.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 30' ' ' THR . 22.0 t -116.23 90.28 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.823 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.6 106.02 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.772 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -136.66 133.11 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.989 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 16.8 t70 -51.85 -45.1 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.277 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -176.64 135.87 0.24 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.661 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 12' ' ' SER . 3.8 pt-20 45.34 -161.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.779 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 47.3 t 74.39 -86.3 0.03 OUTLIER 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.39 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 17' ' ' LEU . 32.4 mm -78.63 -49.84 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.761 0.315 . . . . 0.0 111.674 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 p -49.9 -31.3 11.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.63 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -90.11 -47.02 8.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.544 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -74.88 -69.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.661 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.442 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -40.71 -48.02 2.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.68 -179.393 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.546 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.6 t -51.17 -41.73 60.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 110.924 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.35 74.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.313 0.577 . . . . 0.0 109.892 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 ' CD1' ' CG1' ' A' ' 106' ' ' VAL . 2.0 mp -75.51 -63.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.965 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.62 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.11 -13.35 1.17 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.088 -179.241 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.58 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.6 mt-10 -85.07 -26.03 27.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.79 0.329 . . . . 0.0 110.313 179.034 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -35.55 26.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.394 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -73.98 -50.37 20.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.67 57.05 0.22 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.194 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 82.1 m-85 -120.24 -174.74 2.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.072 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.77 89.17 40.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.058 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 85.2 Cg_endo -81.32 124.95 4.97 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.522 2.148 . . . . 0.0 113.062 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.97 7.52 46.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 29' ' ' ASP . 11.7 p 4.42 122.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.2 168.18 10.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.428 178.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 9' ' ' ASP . 37.1 mttm -88.93 -37.89 14.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -155.95 -179.5 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.734 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.2 mt -61.88 -33.89 75.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.549 179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -48.19 71.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.191 179.293 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.51 -30.15 68.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.4 -33.9 69.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -67.84 -42.56 81.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -33.73 76.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.088 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -75.83 -42.81 48.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.509 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.3 mt -72.49 -26.95 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -26.76 13.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -122.27 -42.5 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 139.83 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -103.72 101.93 11.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.77 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.47 ' CZ ' ' CB ' ' A' ' 29' ' ' ASP . 25.8 m-85 -94.82 120.09 65.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.9 Cg_endo -73.64 -12.38 24.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.43 2.087 . . . . 0.0 111.759 179.096 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.424 HG23 ' CE2' ' A' ' 117' ' ' PHE . 2.4 t -151.94 135.11 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 12.3 mm -115.83 161.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.633 178.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' LEU . 60.7 t -149.72 94.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.542 . . . . 0.0 111.642 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.421 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 11.6 tp -77.59 171.1 15.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.289 179.624 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 6.4 t70 -139.65 -46.43 0.45 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.395 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t 66.24 40.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 111.215 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -57.79 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.525 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.672 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.7 mmm -148.05 51.36 1.03 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.059 179.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.672 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.8 Cg_endo -87.56 -155.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.036 2.49 . . . . 0.0 112.021 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -148.67 38.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.02 168.87 22.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.515 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.0 111.58 24.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.38 -19.4 66.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.752 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.8 t -53.12 -48.85 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.859 0.362 . . . . 0.0 111.357 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -14.08 58.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.299 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.429 ' CE2' HD13 ' A' ' 67' ' ' ILE . 44.6 t80 -71.87 -37.7 70.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.683 0.277 . . . . 0.0 111.225 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.2 mt -47.89 -28.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.285 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -34.24 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -60.12 -38.68 83.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.139 179.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.429 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -60.32 -45.97 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 179.369 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -77.91 -24.24 48.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 25.9 tt0 -64.57 -33.61 76.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.42 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -131.0 17.52 5.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.182 -179.836 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.82 70.02 1.04 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.823 0.344 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.2 -18.79 34.73 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.842 2.361 . . . . 0.0 112.254 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -98.89 30.42 3.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.824 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 41.6 t -114.71 -162.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.8 t -154.31 136.5 6.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.68 0.276 . . . . 0.0 111.284 179.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 4.9 t -110.38 110.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.837 -179.036 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 79' ' ' ILE . 28.1 mm -111.11 43.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.662 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.424 ' HB ' ' CE1' ' A' ' 99' ' ' PHE . 47.7 t -43.36 121.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.587 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 3.8 mt -121.34 150.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.805 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.5 p -157.66 166.32 33.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.76 65.83 0.58 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.505 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -93.79 -30.53 14.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.778 0.323 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.77 20.14 69.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.6 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.4 m -119.06 -7.51 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m 43.11 31.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.727 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -111.25 -10.36 14.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -89.38 -36.5 15.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -57.62 -58.21 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.843 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.402 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.1 m -55.14 -27.11 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.578 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -82.21 -20.35 37.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.134 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.59 -40.3 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.498 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.491 HD13 HG21 ' A' ' 92' ' ' ILE . 12.5 pt -68.71 -31.52 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -26.4 67.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.697 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -73.74 -59.59 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 31.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.332 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.09 -164.67 1.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.025 0.412 . . . . 0.0 110.438 179.3 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.555 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.6 t80 -105.22 -22.02 13.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.53 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 144.52 14.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.733 0.645 . . . . 0.0 111.773 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER 62.15 163.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 110.643 -179.881 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.48 97.04 6.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.649 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.1 164.76 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.522 ' N ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER 64.3 58.71 1.63 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.244 -179.914 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 102' ' ' LYS . 15.5 Cg_exo -67.47 63.99 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.571 2.181 . . . . 0.0 112.108 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.29 -61.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.03 -179.849 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.5 p -97.97 136.42 38.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' CG1' ' CD1' ' A' ' 20' ' ' ILE . 12.4 p -80.23 -35.84 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.007 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -45.94 -41.82 12.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.936 0.398 . . . . 0.0 110.909 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -34.79 78.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.166 179.362 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 6.3 t80 -68.03 -28.93 67.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.522 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.67 -42.69 56.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.37 -56.2 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.836 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.9 m -46.62 -44.06 17.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.055 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.2 mm -54.53 -69.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.037 0.446 . . . . 0.0 110.43 179.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.412 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -54.9 -17.9 4.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.876 179.111 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -89.8 -21.23 22.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.34 -37.34 18.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.971 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.424 ' CE2' HG23 ' A' ' 48' ' ' VAL . 35.0 m-85 -73.09 -39.29 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.9 -28.2 61.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.294 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.65 -5.72 44.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.596 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.48 31.23 2.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.899 0.38 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 25.4 mmtt 62.26 117.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.405 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -147.99 124.75 11.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' A' ' 117' ' ' PHE . 25.2 t -119.6 159.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.442 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 41.7 tp -114.04 136.29 53.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.579 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.6 t -120.79 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.14 119.47 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.567 179.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 12.3 t0 -163.75 154.74 16.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.747 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -85.23 48.99 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.73 139.44 50.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.653 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.87 -67.66 0.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.109 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.5 p -85.28 -165.79 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.008 -179.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 18' ' ' SER . 7.6 mm -49.28 164.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.813 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.2 p -90.23 -99.42 0.1 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.46 -155.13 0.39 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.745 0.307 . . . . 0.0 111.523 -179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' LEU . 52.6 m -47.53 -22.23 0.45 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.869 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -32.14 -49.55 0.2 Allowed 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 110.482 179.238 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.426 ' HB2' ' CG2' ' A' ' 13' ' ' ILE . 7.7 t -47.78 -67.14 0.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.111 179.289 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.53 75.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 23' ' ' GLU . 13.7 mt -61.59 -63.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.346 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' CD1' ' O ' ' A' ' 17' ' ' LEU . 1.5 mt -45.07 -36.18 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.329 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -27.85 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.136 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' ILE . 12.3 tt0 -87.1 -41.98 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -75.31 -43.33 51.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.75 32.71 5.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.558 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 48.9 m-85 -81.42 -174.63 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.894 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.98 86.05 53.1 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.031 179.332 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.46 136.82 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 112.505 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 30' ' ' THR . 7.2 t70 -113.53 3.02 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.03 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.564 ' O ' ' O ' ' A' ' 29' ' ' ASP . 26.4 p 9.84 121.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.12 -178.54 3.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.699 179.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 30.7 tttp -95.39 -38.62 10.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.667 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 6.2 t -165.76 -162.47 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 14.9 mt -68.4 -47.36 67.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.657 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -60.78 -45.63 93.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 109.989 179.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -34.13 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.06 73.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.705 179.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 90.3 mt-10 -65.92 -41.31 91.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -38.07 85.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.601 178.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -74.06 -49.94 21.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.873 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 mt -66.9 -27.75 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.145 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -62.85 -23.99 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.095 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.06 -42.89 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.247 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 129.16 38.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -82.18 62.39 5.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.461 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 60.0 m-85 -55.34 121.31 36.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.475 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.427 ' O ' ' HA ' ' A' ' 74' ' ' SER . 61.0 Cg_endo -72.9 -22.92 19.35 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.435 2.09 . . . . 0.0 111.805 179.318 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 4.5 t -142.68 125.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.316 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 46' ' ' PHE . 8.3 mm -111.91 152.52 13.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.029 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.426 ' CG1' ' H ' ' A' ' 51' ' ' LEU . 4.9 t -134.87 177.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.432 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 29.4 tp -161.74 78.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.072 0.463 . . . . 0.0 111.101 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.72 67.84 0.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.517 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.412 ' CG2' ' HG ' ' A' ' 51' ' ' LEU . 50.4 t -47.12 92.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.474 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -79.19 -80.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.502 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.675 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -152.5 50.6 0.64 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.13 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.675 ' HD3' ' N ' ' A' ' 55' ' ' MET . 10.1 Cg_endo -90.57 -158.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.043 2.495 . . . . 0.0 112.015 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -157.74 58.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.096 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.48 10.79 4.06 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.788 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 52.98 -162.02 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.717 0.258 . . . . 0.0 110.679 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.23 28.96 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.674 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.416 HG22 ' HD3' ' A' ' 90' ' ' LYS . 17.6 t -89.44 -44.91 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.13 9.56 27.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.569 -179.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.451 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 17.6 t80 -90.03 -36.88 14.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.442 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.6 mp -46.79 -28.97 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.403 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -35.89 65.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.425 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 12.3 t80 -62.74 -44.2 96.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.422 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.0 mp -59.27 -37.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.321 179.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -85.7 -20.19 29.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.719 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -69.59 -29.26 66.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -131.93 9.05 4.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.251 -179.873 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.03 67.79 3.21 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.854 0.359 . . . . 0.0 110.745 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.65 -15.37 21.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.799 2.333 . . . . 0.0 112.285 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.35 27.35 9.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.067 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 39.8 t -107.18 -163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.489 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.36 131.64 12.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 121.239 0.542 . . . . 0.0 112.457 179.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.3 t -105.25 110.72 31.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.094 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -109.25 38.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.472 HG13 ' CE1' ' A' ' 99' ' ' PHE . 60.0 t -42.63 115.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.295 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -105.64 179.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.87 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 59.5 122.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 111.289 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.54 172.85 22.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.431 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -68.1 -68.35 0.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 110.939 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.53 144.56 5.92 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.5 p 57.81 30.79 19.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.708 0.29 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m 42.18 59.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.776 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -104.12 -18.92 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -90.84 -36.16 14.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' CB ' ' CG ' ' A' ' 99' ' ' PHE . . . -56.78 -57.27 13.17 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.84 178.794 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -51.76 -26.86 7.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.416 ' HD3' HG22 ' A' ' 61' ' ' VAL . 8.9 tttt -89.09 36.74 0.83 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.22 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.442 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -170.31 -42.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.614 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.47 157.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.808 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.16 -3.2 2.52 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.102 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -112.6 -25.33 9.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.31 -34.92 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.25 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -68.91 177.63 2.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.773 0.321 . . . . 0.0 111.151 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 45.4 t80 -108.77 29.94 6.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.486 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.1 OUTLIER 80.15 142.71 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.932 179.773 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.491 ' CG ' ' CB ' ' A' ' 88' ' ' ALA . 1.6 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.38 -179.605 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -89.94 89.46 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.593 179.655 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -54.93 179.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.26 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp 61.59 64.44 2.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.99 178.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.538 2.159 . . . . 0.0 112.295 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 63.35 127.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.7 m 60.57 110.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 33.3 m -86.65 10.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.761 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -45.93 -47.85 16.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.664 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -70.45 -30.34 67.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.987 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.435 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -65.71 -25.15 67.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.447 179.522 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.44 -50.15 23.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.883 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' HA ' ' CG ' ' A' ' 114' ' ' LYS . 5.5 mp -55.63 -47.56 76.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.476 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.7 m -49.29 -38.36 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.632 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.42 HG21 ' CD1' ' A' ' 117' ' ' PHE . 8.3 mm -66.48 -62.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.16 179.237 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.468 ' CG ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -55.56 -14.94 2.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.456 179.402 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.42 ' N ' ' HD3' ' A' ' 114' ' ' LYS . 2.0 m80 -90.41 -19.69 23.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.072 0.463 . . . . 0.0 110.266 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.98 -49.1 6.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.963 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.426 ' CZ ' HG21 ' A' ' 48' ' ' VAL . 36.9 m-85 -56.8 -30.8 64.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -55.4 -24.45 30.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.2 32.13 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -134.89 30.47 3.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.951 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.9 mtm . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.786 0.327 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 19.9 mmtt 61.05 97.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.64 128.04 17.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.651 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 22.2 t -121.5 151.45 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 -179.806 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.458 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 33.5 tp -101.24 136.53 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.752 0.31 . . . . 0.0 110.516 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.482 HG23 HD11 ' A' ' 17' ' ' LEU . 8.4 t -117.14 95.57 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 87.6 t -89.34 116.22 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 0.0 111.243 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -145.37 112.68 6.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.879 179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -50.42 -79.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -178.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' CB ' ' CD1' ' A' ' 54' ' ' TRP . 0.7 OUTLIER -89.77 174.1 7.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.915 0.388 . . . . 0.0 111.244 -179.411 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.83 112.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.402 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 26.2 t -53.57 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 14' ' ' THR . 24.0 mm 66.45 165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 121.163 0.506 . . . . 0.0 110.442 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.506 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 2.7 p -90.34 101.59 14.32 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.788 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -42.57 140.92 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.285 -178.733 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.6 m 85.56 -17.57 0.41 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.62 179.054 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -70.66 -54.45 11.87 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.052 -179.672 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.0 -67.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.676 -179.562 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.65 -40.36 27.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.496 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.447 ' CD1' HG23 ' A' ' 106' ' ' VAL . 60.3 mt -64.72 -66.27 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' A' ' 17' ' ' LEU . 1.1 mt -47.65 -29.44 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.13 -25.09 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.09 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -81.89 -41.11 21.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.869 0.366 . . . . 0.0 110.246 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.85 -32.09 59.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.059 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.74 31.17 6.46 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 51.1 m-85 -88.27 -174.69 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -139.01 91.61 11.38 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.635 179.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 66.9 Cg_endo -76.88 145.49 25.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.18 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.9 t70 -120.09 -4.61 10.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.703 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.613 ' O ' ' O ' ' A' ' 29' ' ' ASP . 10.2 p 23.54 123.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.64 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -131.74 145.69 51.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.297 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' CB ' ' CB ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -58.61 -173.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.521 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.36 167.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 111.654 -178.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 63' ' ' PHE . 11.8 mt -31.44 -39.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.481 -178.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -62.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.149 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.463 ' CB ' ' CB ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -64.81 -27.25 68.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.865 179.568 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.45 -57.39 4.47 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.391 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 42' ' ' LYS . 64.5 mt-10 -46.31 -41.34 13.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -61.0 -53.28 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -59.66 -35.03 73.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.129 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mt -92.3 -5.23 10.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLU . 2.8 tmtm? -56.75 -19.61 17.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.299 -179.813 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -139.43 -46.23 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 121.07 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -87.14 75.22 9.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 27.2 m-85 -66.09 132.33 94.56 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.23 -30.38 6.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.411 2.074 . . . . 0.0 111.878 179.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.418 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 2.4 t -140.32 132.98 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.537 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.9 mm -115.47 145.23 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.453 179.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.441 HG23 ' CE1' ' A' ' 109' ' ' PHE . 44.1 t -130.3 105.74 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 111.446 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.7 tp -100.33 147.88 25.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.3 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -119.11 -31.76 4.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.563 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' A' ' 80' ' ' THR . 88.5 t 60.64 63.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.73 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.452 ' CD1' ' CB ' ' A' ' 10' ' ' GLU . 37.1 t-105 -58.83 -81.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.834 0.349 . . . . 0.0 110.383 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.703 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 ttt -151.97 48.82 0.5 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.085 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.703 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.8 Cg_exo -76.87 -150.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.789 2.326 . . . . 0.0 112.032 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -135.18 21.48 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.212 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.67 -3.71 4.98 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.029 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 52.64 25.1 3.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.018 0.437 . . . . 0.0 111.167 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 49.6 18.63 1.73 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.623 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 64' ' ' ILE . 23.2 t -87.25 -45.1 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 117.149 0.474 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -65.78 -16.16 63.53 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.47 ' CE2' HD13 ' A' ' 67' ' ' ILE . 3.7 t80 -85.65 -29.05 24.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 61' ' ' VAL . 20.2 mm -46.59 -43.47 6.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.327 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -44.91 70.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.43 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 21.1 t80 -49.4 -41.06 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.975 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.47 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.1 mp -62.61 -49.97 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -12.09 60.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.466 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.92 -49.37 20.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.059 0.457 . . . . 0.0 110.394 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.18 17.04 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.976 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.05 67.2 2.05 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.736 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.22 -15.77 22.66 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.776 2.317 . . . . 0.0 112.265 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -112.61 32.91 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.83 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -111.89 -159.83 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.878 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.2 t -138.08 138.98 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.309 0.576 . . . . 0.0 112.293 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 6.2 t -114.41 99.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.317 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 79' ' ' ILE . 35.0 mm -103.41 43.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.431 HG12 ' CE1' ' A' ' 99' ' ' PHE . 98.9 t -54.72 87.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 100' ' ' LEU . 19.2 mt -66.25 -101.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 81' ' ' GLY . 1.0 OUTLIER 72.05 -61.96 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.237 . . . . 0.0 111.041 179.55 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' N ' ' OG1' ' A' ' 80' ' ' THR . . . 57.51 -88.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.565 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.68 29.0 18.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.951 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.17 -61.8 3.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.547 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.71 135.5 55.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.3 m -107.25 -7.74 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.609 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.72 -27.06 68.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.685 0.279 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.52 -34.24 54.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -59.8 -57.81 11.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.018 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 m -56.84 -22.83 16.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.956 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.41 2.81 23.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.248 179.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -138.71 -40.53 0.5 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.445 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 1.6 pt -70.84 -24.59 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -71.74 -35.58 70.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -59.21 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.65 31.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.995 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.24 -178.74 5.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -101.25 27.91 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.426 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 77.64 151.96 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.971 179.927 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -74.19 139.26 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.418 ' CB ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -83.64 92.11 7.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.556 179.869 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.53 154.16 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.066 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.42 72.59 0.72 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.995 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.23 57.0 6.27 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.575 2.183 . . . . 0.0 112.401 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -101.56 105.77 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.415 ' O ' HG23 ' A' ' 106' ' ' VAL . 45.1 t 56.61 24.25 8.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.994 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.503 ' CG2' HD22 ' A' ' 17' ' ' LEU . 2.6 m 39.88 35.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.041 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.1 -50.86 29.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -61.94 -29.63 70.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.417 178.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.468 ' CZ ' ' CG1' ' A' ' 113' ' ' ILE . 24.0 t80 -62.12 -40.71 96.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.712 178.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.417 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 2.0 mt -54.65 -48.83 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.263 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.54 -50.45 73.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.028 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.0 m -61.5 -37.55 84.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.707 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.468 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 1.6 mm -55.76 -53.13 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.375 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -60.0 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 109.853 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -58.4 -26.13 62.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.998 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.14 -38.35 87.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.926 0.393 . . . . 0.0 110.977 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.418 ' CZ ' HG21 ' A' ' 48' ' ' VAL . 20.7 m-85 -68.84 -20.04 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.632 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -56.99 -21.82 33.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -94.79 28.78 2.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.173 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -115.3 28.08 8.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.919 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ptp . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.862 0.363 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG3' ' CD2' ' A' ' 117' ' ' PHE . 2.0 mptt -111.94 119.59 39.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -111.39 124.73 52.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.458 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 26.9 t -124.33 144.33 34.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.329 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.435 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 46.8 tp -95.02 128.76 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.321 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.434 ' CG1' ' CG2' ' A' ' 14' ' ' THR . 18.9 t -112.91 92.56 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.482 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 60.1 t -89.99 118.72 35.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.029 0.442 . . . . 0.0 111.082 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -153.63 125.12 7.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -85.73 47.59 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' CG ' ' CD1' ' A' ' 54' ' ' TRP . 4.0 tm-20 -120.68 -40.63 2.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.676 179.727 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -178.37 -165.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.407 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 p -56.81 -93.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.456 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.423 ' CD1' ' CG2' ' A' ' 30' ' ' THR . 7.8 mm -87.84 161.37 2.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.951 0.405 . . . . 0.0 111.052 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.434 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 65.6 p -90.34 131.37 36.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.242 179.249 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -52.19 139.46 23.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 0.0 112.185 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.426 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 8.7 t 73.54 0.72 3.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.449 179.109 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.36 -59.45 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.157 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.562 ' HA ' HD21 ' A' ' 21' ' ' LEU . 7.8 t -46.5 -45.94 18.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.591 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.14 73.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.376 0.607 . . . . 0.0 110.17 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.508 HD12 ' CG2' ' A' ' 106' ' ' VAL . 41.7 mt -76.14 -64.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.774 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.65 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -56.74 -10.46 1.04 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.978 -179.186 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.538 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 17.4 mt-10 -89.23 -28.6 19.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -36.1 32.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.013 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.403 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 30.5 mm-40 -77.77 -31.33 51.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.019 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 42.89 3.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.512 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 7.2 m-85 -95.83 -170.31 2.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 -179.066 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.08 93.47 5.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HD3' ' HG ' ' A' ' 21' ' ' LEU . 73.3 Cg_endo -79.67 146.78 19.17 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.384 2.056 . . . . 0.0 112.011 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.658 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -115.76 -7.26 12.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 29' ' ' ASP . 11.7 p 25.51 124.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -141.89 141.88 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.901 178.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 7' ' ' VAL . 39.4 mtmt -58.79 -165.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.56 0.219 . . . . 0.0 110.564 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 p -47.89 168.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 112.149 -177.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' A' ' 59' ' ' ASP . 22.5 mt -40.81 -31.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.97 -179.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -64.3 0.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.14 0.495 . . . . 0.0 109.84 179.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.5 -33.72 76.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.461 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.88 -61.66 2.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.729 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 42' ' ' LYS . 7.5 mt-10 -44.05 -42.12 5.93 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -61.44 -51.74 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -63.35 -33.95 76.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.336 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.3 mt -88.95 -9.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -57.67 -19.42 26.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.501 -179.735 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -134.64 -47.25 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 124.72 20.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -84.96 72.0 10.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CZ ' HD12 ' A' ' 5' ' ' LEU . 25.0 m-85 -65.79 126.77 92.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.79 -27.62 3.84 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.508 2.139 . . . . 0.0 112.074 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 117' ' ' PHE . 2.8 t -140.51 132.62 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.346 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mm -118.73 148.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.138 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 49.0 t -136.86 104.57 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.488 179.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp -98.99 97.68 8.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -83.42 92.79 7.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.953 178.936 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 53' ' ' VAL . 28.0 m -63.87 74.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.789 -179.211 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.442 ' CD1' ' CG ' ' A' ' 10' ' ' GLU . 30.3 t-105 -81.75 -80.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.514 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.493 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 21.9 mmt -145.67 61.4 7.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.809 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 55' ' ' MET . 11.1 Cg_endo -89.2 -159.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.128 2.552 . . . . 0.0 112.32 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -153.77 25.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.141 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.96 10.66 5.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.629 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.411 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.7 OUTLIER 55.92 -157.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.788 0.294 . . . . 0.0 110.212 -179.703 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.7 22.04 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.4 t -86.83 -45.15 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 110.879 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -1.16 50.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.471 ' CE1' ' CD2' ' A' ' 66' ' ' PHE . 6.5 t80 -76.32 -41.14 49.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.403 HD11 ' O ' ' A' ' 91' ' ' ALA . 2.4 mt -43.81 -38.42 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.329 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.32 -51.37 57.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.427 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 34.0 t80 -53.68 -28.5 33.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.097 179.289 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 63' ' ' PHE . 2.9 mm -68.25 -54.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -71.3 -22.06 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.557 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.93 -52.89 61.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.701 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.62 18.0 18.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.161 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.4 68.15 1.71 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 110.801 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.35 -19.33 33.45 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.804 2.336 . . . . 0.0 112.361 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -113.17 35.96 3.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -112.64 -156.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.809 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.0 t -146.49 138.72 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.436 0.636 . . . . 0.0 112.16 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.8 t -118.35 80.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.149 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -65.56 -54.93 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.78 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.421 HG12 ' CE1' ' A' ' 99' ' ' PHE . 34.4 t 49.44 89.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.32 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.425 ' O ' ' CB ' ' A' ' 80' ' ' THR . 1.8 mt -99.33 -173.96 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 79' ' ' ILE . 2.7 m 80.22 103.62 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.352 . . . . 0.0 110.963 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.76 59.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.43 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.0 -54.81 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 110.97 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.45 -91.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.546 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 t -63.82 110.29 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.6 t -92.09 14.38 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.407 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.49 -15.87 28.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.099 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.13 -32.86 38.92 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.51 -57.95 10.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.099 178.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.455 ' HA ' HG12 ' A' ' 92' ' ' ILE . 17.5 m -61.84 -27.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.207 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -80.56 -12.91 59.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.647 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.403 ' O ' HD11 ' A' ' 64' ' ' ILE . . . -114.1 -24.34 9.05 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.559 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 89' ' ' VAL . 4.9 pt -90.1 -15.05 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.272 . . . . 0.0 111.635 -179.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.69 -42.74 67.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.737 0.303 . . . . 0.0 111.123 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -54.82 -35.1 63.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.77 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.157 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.1 -167.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.33 . . . . 0.0 110.899 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 9.3 t80 -108.44 27.28 9.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.219 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.9 OUTLIER 80.66 159.7 0.16 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.154 179.759 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -92.13 104.39 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.827 -179.962 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 9.9 tp -57.78 147.33 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -102.01 167.64 9.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.992 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.1 mttm 62.75 55.91 2.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.32 81.53 2.01 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.523 2.149 . . . . 0.0 112.239 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -148.17 -66.07 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 106' ' ' VAL . 29.2 t -100.83 9.32 42.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.625 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.508 ' CG2' HD12 ' A' ' 20' ' ' ILE . 3.5 m 33.9 36.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -70.72 -51.89 24.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -58.64 -32.22 68.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.428 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 28.4 t80 -61.54 -36.92 81.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.267 178.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.414 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 3.2 tt -55.61 -60.09 3.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.1 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mp -60.29 -46.98 87.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.628 -179.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.6 m -61.19 -40.07 92.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.45 ' CG2' ' CE2' ' A' ' 26' ' ' TYR . 1.7 mm -50.28 -52.38 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.657 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -55.52 7.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.115 0.483 . . . . 0.0 110.323 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -56.03 -27.37 52.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.949 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.19 82.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.98 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.465 ' CD2' ' HG3' ' A' ' 2' ' ' LYS . 50.9 m-85 -80.82 -35.23 33.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.69 -54.18 5.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.229 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -72.89 -7.43 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.542 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.47 41.02 1.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.347 . . . . 0.0 110.92 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.942 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -134.37 125.33 27.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.786 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.01 134.21 21.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.6 t -124.16 152.6 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.905 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.466 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 52.4 tp -105.03 127.93 53.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.166 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.51 ' HB ' HG23 ' A' ' 30' ' ' THR . 21.5 t -113.42 92.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.372 . . . . 0.0 111.604 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 43.8 t -78.97 115.24 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 34.5 t70 -157.31 155.53 30.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.806 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -88.27 49.33 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.969 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -126.75 167.16 16.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.24 -149.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -44.09 106.41 0.07 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.895 0.378 . . . . 0.0 111.178 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.453 ' CD1' HG22 ' A' ' 30' ' ' THR . 19.8 mm 56.05 168.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.644 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 37.5 p -83.58 168.17 16.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.19 127.11 31.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 t 80.41 -39.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.52 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -46.04 -61.13 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.145 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.581 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -39.79 -61.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.7 -178.703 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.98 12.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.277 0.561 . . . . 0.0 110.88 179.427 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.421 HD11 ' CG2' ' A' ' 106' ' ' VAL . 10.4 mt -76.04 -71.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.019 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.599 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.49 -30.25 12.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.416 -179.558 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' SER . 1.0 OUTLIER -74.22 -25.95 59.97 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.764 0.316 . . . . 0.0 110.705 178.945 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.75 -37.13 30.99 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.171 179.43 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 16.5 mm-40 -66.84 -28.82 68.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.46 42.91 3.31 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.377 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.552 ' HB2' HD23 ' A' ' 21' ' ' LEU . 72.5 m-85 -113.82 -177.61 3.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 111.156 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.95 106.7 28.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.776 179.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.468 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 98.3 Cg_endo -92.9 128.32 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.809 2.34 . . . . 0.0 113.218 -178.806 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.1 t70 -107.32 6.55 28.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.794 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.51 HG23 ' HB ' ' A' ' 6' ' ' VAL . 1.7 p -2.74 125.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.31 -162.2 0.88 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.713 179.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -109.4 -40.86 4.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.016 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.11 -175.58 5.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.449 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 60.8 mt -61.77 -45.99 91.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -61.26 -46.77 88.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.993 0.425 . . . . 0.0 110.1 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.23 -30.49 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.413 179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.23 -31.62 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.677 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 60.9 mt-10 -70.14 -40.16 74.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.9 77.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.317 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -75.04 -37.54 61.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.811 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.9 mt -75.48 -26.04 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -7.33 47.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -112.82 -30.73 6.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.76 0.314 . . . . 0.0 111.233 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -128.21 156.1 43.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.786 -179.862 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.434 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 48.2 t80 -93.96 98.14 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 39.4 m-85 -80.44 123.54 82.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.33 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.459 ' O ' ' HA ' ' A' ' 74' ' ' SER . 87.9 Cg_endo -82.75 -21.59 4.88 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.578 2.186 . . . . 0.0 111.905 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.412 ' CG2' ' CE1' ' A' ' 117' ' ' PHE . 2.8 t -148.76 133.57 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.095 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 50' ' ' VAL . 15.3 mm -119.66 160.81 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.794 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 5' ' ' LEU . 95.1 t -153.27 99.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.42 ' CD2' HG11 ' A' ' 78' ' ' VAL . 12.6 tp -69.1 166.17 18.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.553 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -161.88 76.09 0.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.422 -179.742 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -63.42 75.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.583 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -66.94 -80.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.741 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -152.65 44.28 0.26 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.28 178.767 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.741 ' HD3' ' N ' ' A' ' 55' ' ' MET . 41.1 Cg_endo -97.96 -77.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.178 2.585 . . . . 0.0 112.368 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -170.15 -51.39 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.509 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.45 -131.64 42.74 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.946 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.59 44.08 7.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.54 67.93 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.1 t -59.35 -33.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.035 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.11 5.96 24.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.449 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 19.4 t80 -72.17 -35.26 68.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.756 0.312 . . . . 0.0 111.164 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.2 mp -51.38 -32.96 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.222 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.86 -33.36 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.553 179.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 33.7 t80 -60.19 -42.87 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.423 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.3 mp -61.32 -44.85 99.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.21 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -74.85 -22.66 58.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.54 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -67.09 -38.06 85.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.36 18.23 8.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.431 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -167.73 69.58 0.89 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.629 -179.941 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.85 -20.04 39.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.788 2.325 . . . . 0.0 112.312 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -107.26 30.9 5.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.895 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 32.3 t -108.27 -162.48 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.7 t -149.9 135.02 10.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 111.834 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.6 t -107.42 116.8 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.063 -178.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.429 ' HB ' HG23 ' A' ' 50' ' ' VAL . 17.2 mm -120.85 48.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.118 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 99' ' ' PHE . 89.3 t -45.64 134.31 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.228 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.48 HD12 HG21 ' A' ' 79' ' ' ILE . 3.3 mt -132.66 167.74 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER 66.52 156.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 179.565 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.47 173.31 32.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.391 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -59.41 -51.29 70.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -166.78 -45.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.84 167.98 9.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.837 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.7 t -87.48 66.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.096 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -115.01 -58.62 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -47.34 -34.2 6.61 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.12 0.485 . . . . 0.0 110.498 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -57.94 -59.49 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.192 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.409 ' HA ' HG12 ' A' ' 92' ' ' ILE . 25.0 m -62.03 -24.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.005 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -84.77 -18.95 33.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.356 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.05 -32.54 8.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.7 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 8.1 pt -78.19 -17.73 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.774 -179.382 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -85.68 -17.18 36.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.68 0.276 . . . . 0.0 111.209 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -80.1 -24.52 40.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.302 -179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.27 -17.73 0.37 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.297 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.39 176.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.0 0.428 . . . . 0.0 111.426 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 75.8 t80 -104.32 28.28 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.269 -179.458 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.425 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 81.63 140.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -59.48 143.96 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.105 -179.755 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -85.51 104.98 15.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.734 179.938 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -65.36 157.4 29.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.117 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.47 66.89 1.08 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.988 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.0 56.6 6.13 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.65 2.234 . . . . 0.0 112.31 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -104.42 -67.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 m -130.86 35.49 3.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.064 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.533 ' HB ' ' CG ' ' A' ' 109' ' ' PHE . 2.9 m 50.94 19.25 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.008 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.1 -52.97 30.5 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.543 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.69 -27.76 66.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.05 0.453 . . . . 0.0 110.138 179.115 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.533 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -61.22 -26.27 67.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.563 179.607 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.13 -47.56 65.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.607 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 3.5 mp -70.8 -53.02 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.422 ' CG2' ' CD1' ' A' ' 77' ' ' ILE . 54.3 m -44.49 -35.78 2.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.12 0.485 . . . . 0.0 110.151 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.473 HG13 ' CZ ' ' A' ' 109' ' ' PHE . 14.3 mm -67.17 -66.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.173 178.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -55.88 -19.52 12.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 179.581 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -90.43 -35.51 15.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.649 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.66 -53.81 16.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.173 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.474 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 29.7 m-85 -56.04 -24.55 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -61.56 -18.18 58.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.391 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -88.88 14.02 11.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.503 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.415 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 37.6 t80 -105.92 31.55 4.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 110.778 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.977 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 mtp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 9.6 mmtm -106.55 124.35 49.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.66 100.65 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 36.3 t -90.57 161.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.686 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 49' ' ' ILE . 25.8 tp -108.78 136.17 48.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 30' ' ' THR . 6.5 t -123.94 90.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.33 104.3 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.071 179.567 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.7 142.71 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.479 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.26 48.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 0.0 111.025 -179.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.469 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.8 tp10 -160.94 111.96 1.8 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.99 179.848 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 55.91 -179.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.138 179.703 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -67.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.405 ' CD1' ' CG2' ' A' ' 30' ' ' THR . 8.9 mm -98.08 162.8 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.429 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 63.2 p -90.21 145.56 24.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.737 179.012 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.0 t -57.44 133.52 55.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.028 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 15' ' ' SER . 7.0 t 84.95 -31.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.752 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.417 HD22 ' CG2' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -66.77 -59.79 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.49 -179.122 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.603 ' HA ' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -47.32 -49.73 23.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.623 -179.211 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.435 0.636 . . . . 0.0 110.122 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 HD12 ' CG2' ' A' ' 106' ' ' VAL . 45.4 mt -75.88 -65.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.723 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.632 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -55.82 -11.47 1.01 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.172 -179.181 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 6.0 mt-10 -88.07 -27.29 22.07 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.891 0.377 . . . . 0.0 110.155 178.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.86 -36.06 23.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -76.53 -29.87 56.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.247 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.36 47.9 2.49 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.179 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.567 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.0 m-85 -103.66 -172.08 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.056 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -143.56 89.9 7.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.357 179.568 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.7 Cg_endo -80.46 137.26 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.484 2.123 . . . . 0.0 112.612 -179.377 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -99.6 -1.41 38.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.574 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 29' ' ' ASP . 12.9 p 8.51 123.43 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.14 -162.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.209 178.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -117.96 -28.55 5.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.754 0.311 . . . . 0.0 111.361 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.57 -168.91 1.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.804 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 63' ' ' PHE . 29.5 mt -65.06 -43.85 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.79 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -57.67 -50.79 72.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.447 179.566 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -69.42 -29.47 67.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.717 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.51 -29.59 59.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 71.4 mt-10 -73.03 -37.37 66.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.979 0.418 . . . . 0.0 109.887 179.088 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -68.46 -35.65 77.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.167 179.223 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.16 -32.55 61.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.697 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.9 mt -86.95 -24.67 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.183 179.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -25.61 8.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.228 179.997 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.92 -61.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 122.82 15.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.9 76.38 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.877 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 74' ' ' SER . 55.6 m-85 -64.91 141.28 98.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.704 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 2.7 Cg_endo -84.48 -20.45 3.95 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.938 2.425 . . . . 0.0 111.81 179.382 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 4' ' ' VAL . 3.6 t -146.57 133.03 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 23.7 mm -116.52 157.09 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.3 t -149.76 97.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.156 0.503 . . . . 0.0 111.139 -179.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 tp -92.37 129.59 38.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.747 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.441 ' HA ' HG23 ' A' ' 80' ' ' THR . 8.2 t70 -110.49 115.67 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.668 179.693 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.482 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 4.7 m -78.52 56.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.839 -179.346 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.469 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 35.4 t-105 -63.07 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.778 179.83 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.517 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.4 ttt -147.4 44.05 0.36 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.252 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.3 Cg_endo -76.97 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.441 2.094 . . . . 0.0 112.144 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -125.27 -42.86 1.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.989 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.57 148.05 51.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -76.38 116.24 16.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.16 -30.28 63.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 t -54.18 -44.67 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 111.514 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.89 0.84 37.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.742 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.428 ' CD2' HD22 ' A' ' 34' ' ' LEU . 23.5 t80 -89.81 -34.0 16.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.891 0.377 . . . . 0.0 111.043 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.406 HG23 ' CA ' ' A' ' 95' ' ' GLY . 2.7 mp -47.74 -28.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.428 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 16.1 t0 -79.64 -32.87 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.711 179.797 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 17.2 t80 -61.87 -39.31 91.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.412 HD13 ' CE2' ' A' ' 63' ' ' PHE . 4.5 mp -63.86 -50.54 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.174 179.14 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -69.29 -26.7 64.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.404 179.205 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 17.8 tt0 -60.3 -42.51 95.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.657 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.9 18.5 13.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.9 75.12 0.48 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.337 . . . . 0.0 110.844 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -85.96 -6.71 8.46 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.202 2.601 . . . . 0.0 113.099 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -98.74 -15.62 19.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.986 0.422 . . . . 0.0 111.303 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -72.18 -153.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -179.914 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -144.48 133.59 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-O 121.335 0.588 . . . . 0.0 111.921 178.692 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 97.3 t -104.83 99.16 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.147 -179.368 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.8 mm -90.36 -56.41 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.123 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.435 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 44.7 t 49.4 85.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.495 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 109' ' ' PHE . 2.1 mt -96.31 143.0 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.044 0.45 . . . . 0.0 111.757 -179.259 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.441 HG23 ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER 162.6 -175.7 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.46 179.567 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.45 -52.71 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.532 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 61.9 t60 60.28 29.49 19.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.22 -54.23 0.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 t -137.03 -172.84 3.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.37 . . . . 0.0 110.976 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.07 41.66 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.199 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -82.25 -26.85 32.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.949 179.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.405 HG23 ' CE2' ' A' ' 99' ' ' PHE . 4.5 t -71.56 -34.78 70.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 179.392 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.504 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -56.45 -58.86 6.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.066 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 m -55.08 -24.89 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.913 179.378 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -85.85 7.42 24.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.265 179.805 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.72 -41.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.618 -179.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.44 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 11.9 pt -65.01 -18.44 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.322 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -94.67 21.79 7.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.743 179.382 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -138.33 -51.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.406 ' CA ' HG23 ' A' ' 64' ' ' ILE . . . -167.48 15.08 0.07 OUTLIER Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.802 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.559 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -89.26 175.08 7.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.602 0.701 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.549 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 67.4 t80 -94.77 -14.86 24.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.62 -179.356 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 5.5 pt-20 142.87 -13.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.523 0.729 . . . . 0.0 111.163 179.275 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.504 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER 73.71 131.66 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.912 0.387 . . . . 0.0 110.539 -179.67 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.2 OUTLIER -91.67 155.59 18.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -179.866 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -92.04 173.65 7.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.522 179.668 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 65.2 84.37 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.678 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.85 -6.8 17.83 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.748 2.299 . . . . 0.0 113.101 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -98.24 -54.82 2.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.049 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.4 p -102.82 163.96 11.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.098 -179.856 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 24.5 m -130.09 4.63 2.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.577 -179.895 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -38.34 -44.77 0.93 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.741 0.305 . . . . 0.0 111.627 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -36.22 64.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.133 179.385 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 0.9 OUTLIER -54.99 -24.16 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.696 179.278 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -44.45 86.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.508 -179.831 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 mp -54.98 -55.85 26.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.044 -179.647 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 98.1 m -60.82 -39.03 87.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.2 -179.872 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.463 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -45.91 -53.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.754 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.48 -61.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -56.66 -27.31 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.924 179.606 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.11 96.03 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.903 0.383 . . . . 0.0 110.926 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.447 ' CE1' HG23 ' A' ' 4' ' ' VAL . 19.0 m-85 -69.5 -22.4 63.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.274 -179.964 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.68 -24.02 19.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.202 -179.878 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.76 -10.88 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.432 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -143.08 29.99 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.828 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.989 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.0 mtp . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.823 0.344 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -110.64 137.18 48.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.63 126.29 15.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.913 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 24.8 t -117.72 144.37 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 110.592 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.448 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 61.7 tp -100.89 127.54 47.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.23 -179.488 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.3 t -112.71 94.99 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 179.875 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.6 117.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.505 179.596 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -159.26 149.97 19.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.947 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.22 -74.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.064 179.938 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -76.87 167.84 21.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -98.74 44.99 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.99 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 p -82.22 -43.51 17.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.7 mm -90.08 -41.32 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.044 179.907 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 p -56.97 -21.15 28.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.257 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -30.28 57.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.16 -61.61 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.961 -179.846 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 1.8 tm? -43.54 -50.8 7.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.038 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -54.27 -39.35 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.424 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.02 84.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.402 ' CG2' ' CD1' ' A' ' 110' ' ' LEU . 1.6 mp -56.61 -64.0 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.705 179.661 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -50.36 -35.43 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.122 0.487 . . . . 0.0 110.472 179.374 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -24.15 65.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.948 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.78 -37.62 26.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.41 179.877 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -69.61 -48.38 60.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 179.912 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.19 44.84 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 98.9 m-85 -113.74 -170.46 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 0.0 111.159 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -139.5 72.08 37.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.388 179.578 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 35.8 Cg_exo -57.76 136.62 76.63 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.804 2.336 . . . . 0.0 112.359 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.1 t70 -113.54 -12.95 12.82 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.694 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 29' ' ' ASP . 69.5 p 44.39 177.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.677 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.84 -165.51 1.4 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.374 179.771 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -124.84 -35.27 2.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.849 0.357 . . . . 0.0 111.064 179.883 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.36 177.06 7.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.216 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.06 -37.04 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.645 179.964 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -47.88 69.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.51 -31.58 72.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.37 -65.06 0.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.487 179.588 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -41.58 -41.23 2.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -64.43 -48.85 73.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.825 178.937 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -69.2 -25.65 64.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.543 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.417 ' HB ' ' CE2' ' A' ' 66' ' ' PHE . 7.2 mt -92.43 -20.82 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.699 0.285 . . . . 0.0 111.439 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -47.53 -26.96 1.58 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.656 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.02 -51.08 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.134 -179.779 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.11 128.75 38.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.137 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -85.57 68.83 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.653 179.64 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 26.1 m-85 -65.54 122.82 82.37 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.309 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' VAL . 77.3 Cg_endo -77.21 -28.49 5.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.629 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 t -140.39 125.66 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.496 -179.632 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.13 149.2 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.497 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.8 t -141.57 96.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.428 ' HB3' HG11 ' A' ' 78' ' ' VAL . 24.2 tp -84.63 78.35 9.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.5 t0 -73.32 83.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.503 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 3.4 m -63.1 109.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -108.12 -84.39 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.56 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -72.85 -43.43 8.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.327 179.428 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 55' ' ' MET . 78.7 Cg_endo -76.09 -167.9 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.338 2.025 . . . . 0.0 112.345 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -102.92 -33.01 9.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.93 50.36 68.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.398 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -96.78 32.48 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.71 63.59 1.9 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.341 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -51.48 -44.63 33.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -70.98 -24.57 62.43 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.418 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 67' ' ' ILE . 59.2 t80 -56.34 -46.56 79.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.288 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.405 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.3 mp -47.02 -29.04 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.108 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -37.4 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 4.4 t80 -56.43 -47.26 79.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.449 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -55.55 -42.78 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.585 179.605 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -78.61 -23.16 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.663 179.361 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.71 -41.63 83.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.987 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.86 12.78 13.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.246 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.88 66.87 2.07 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.66 179.792 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.59 -19.74 41.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.594 2.196 . . . . 0.0 112.029 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.2 18.18 18.13 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.3 t -99.39 -161.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.408 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 47' ' ' PRO . 21.4 t -151.22 135.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.314 0.578 . . . . 0.0 112.536 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 6.1 t -102.95 90.94 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.579 -179.564 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.1 mm -101.01 36.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.219 179.283 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.468 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 63.2 t -43.95 107.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.785 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 4.4 mt -101.4 147.99 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 99' ' ' PHE . 30.9 p -156.16 153.86 29.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.25 136.39 4.63 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.428 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 62.18 75.53 0.4 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.902 0.382 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.39 59.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.582 -179.998 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m 63.6 131.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -109.77 30.78 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -94.5 -41.95 9.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -53.68 -30.91 45.72 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 121.157 0.504 . . . . 0.0 109.876 179.146 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 99' ' ' PHE . . . -57.69 -60.14 4.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.33 179.096 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.9 m -63.06 -25.3 38.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.579 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.82 -29.84 25.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -88.66 -39.05 14.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.495 HG21 HD13 ' A' ' 92' ' ' ILE . 7.8 pt -72.06 -11.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.473 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.86 -35.03 22.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.926 0.393 . . . . 0.0 110.495 179.573 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -60.03 -61.61 2.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.32 28.63 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.111 179.897 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.501 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.21 176.36 6.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.928 0.364 . . . . 0.0 110.962 179.717 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -101.08 29.38 4.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.779 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 78.22 138.46 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.995 179.904 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.505 ' CD2' ' CB ' ' A' ' 88' ' ' ALA . 1.3 m-85 -66.1 126.28 28.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.715 -179.916 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.9 67.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.884 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -120.23 111.13 17.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.057 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.454 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -169.07 -63.01 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.679 179.715 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.454 ' HD3' ' CB ' ' A' ' 102' ' ' LYS . 93.1 Cg_endo -82.27 -167.37 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.504 2.136 . . . . 0.0 112.229 179.733 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.54 31.28 4.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.409 . . . . 0.0 110.744 179.695 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.8 t -152.51 -167.77 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.814 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.405 ' CG2' HD22 ' A' ' 17' ' ' LEU . 13.6 p -107.13 -31.76 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.147 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -40.2 -43.26 1.63 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.587 -179.751 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.68 -41.19 88.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 0.0 110.462 179.65 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.437 ' CE1' HG12 ' A' ' 113' ' ' ILE . 6.4 t80 -59.02 -29.08 66.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.651 179.497 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -65.92 -38.37 88.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.48 -55.57 33.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.3 m -59.94 -42.65 94.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.437 HG12 ' CE1' ' A' ' 109' ' ' PHE . 3.9 mm -44.25 -56.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.781 -179.588 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -59.88 3.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.808 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -53.65 -27.0 24.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.936 179.508 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.17 -40.75 82.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.912 0.386 . . . . 0.0 110.774 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -69.69 -24.65 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.503 -179.87 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -52.22 -25.39 9.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.286 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.34 -6.08 49.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.374 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 31.4 t80 -128.45 30.6 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.964 0.412 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.3 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.988 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ttt . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.829 0.347 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 6.2 mmtp -129.28 93.97 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.969 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.471 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -145.93 110.21 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -95.31 149.09 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 110.803 179.851 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' A' ' 29' ' ' ASP . 61.5 tp -111.33 137.06 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 0.0 111.288 -179.438 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.448 ' CG2' HD11 ' A' ' 17' ' ' LEU . 21.8 t -118.31 138.37 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.56 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 8.1 t -129.58 115.99 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.306 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.17 135.06 12.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -92.0 50.03 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.9 -45.57 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.877 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.26 -79.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.717 179.924 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 p -128.8 -82.18 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.464 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 mm -101.28 161.01 3.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.918 0.39 . . . . 0.0 110.969 179.742 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 7.2 p -90.46 136.27 33.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.919 178.795 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.4 m -51.07 131.45 27.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.995 -179.04 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' SER . 0.9 OUTLIER 85.85 -31.46 0.05 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.94 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER -57.06 -61.82 2.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.701 0.286 . . . . 0.0 111.126 -179.498 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.51 -64.98 0.55 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.474 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.86 -39.93 40.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.233 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 23' ' ' GLU . 46.3 mt -67.68 -70.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 -179.917 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.06 -30.14 4.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.056 0.455 . . . . 0.0 110.368 179.507 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.84 -30.03 71.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -78.19 -39.45 40.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.076 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -79.23 -174.25 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.355 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.28 42.84 1.83 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.119 179.852 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' CE2' ' CG2' ' A' ' 113' ' ' ILE . 22.0 m-85 -100.8 178.95 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.491 0.662 . . . . 0.0 111.731 -179.428 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.3 85.82 60.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.762 178.458 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -79.97 127.54 6.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.7 2.266 . . . . 0.0 114.041 -177.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' HB3' HD13 ' A' ' 5' ' ' LEU . 5.1 t70 -119.14 117.32 28.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.474 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.7 p -104.08 143.3 33.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 112.061 -178.558 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.2 -167.04 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.054 179.13 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -130.82 -6.55 4.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -170.72 175.13 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.765 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.43 ' N ' ' OG1' ' A' ' 33' ' ' THR . 87.6 mt -66.12 -32.98 74.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -70.11 -40.19 75.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.997 179.203 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.1 -36.17 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.344 179.375 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.51 -50.22 22.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.608 179.521 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 4.9 tt0 -47.22 -45.87 23.75 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.409 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -53.73 54.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.584 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -58.0 -24.57 58.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.823 179.498 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.4 mt -98.53 -11.77 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.589 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -73.17 -10.42 59.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.691 0.281 . . . . 0.0 111.316 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -135.78 -46.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.763 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.1 116.5 15.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.715 179.869 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.2 64.32 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.36 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 19.9 m-85 -58.12 119.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.092 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 46.4 Cg_endo -69.13 -45.1 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.696 2.264 . . . . 0.0 111.946 179.772 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.54 125.02 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.553 -179.437 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -109.26 128.29 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' A' ' 109' ' ' PHE . 62.0 t -123.02 104.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.061 0.457 . . . . 0.0 111.206 -179.872 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 36.5 tp -92.96 83.9 4.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.958 179.954 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.4 OUTLIER -72.62 75.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 -179.85 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.463 ' CG1' ' HB ' ' A' ' 80' ' ' THR . 3.2 p -55.36 84.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.459 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 25.3 t-105 -86.34 -82.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.735 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.465 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 3.4 ptm -142.04 48.46 1.14 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 111.131 179.456 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 55' ' ' MET . 72.7 Cg_endo -76.31 -168.19 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.493 2.129 . . . . 0.0 112.253 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -137.59 31.27 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.76 175.35 18.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.16 93.64 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.16 65.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.652 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.3 t -53.85 -43.6 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 111.419 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 2.75 32.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.536 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CD2' HD13 ' A' ' 67' ' ' ILE . 20.0 t80 -89.99 -43.26 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.054 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 mp -45.37 -28.84 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.652 -179.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -70.38 -56.06 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.431 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 1.5 t80 -48.57 -37.63 18.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.832 0.348 . . . . 0.0 110.557 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.448 HD13 ' CD2' ' A' ' 63' ' ' PHE . 1.5 mp -60.77 -46.44 96.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.085 179.435 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -77.31 -21.44 53.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.549 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.85 -50.6 63.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.67 12.58 21.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.379 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -158.48 66.65 3.29 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.803 0.335 . . . . 0.0 110.784 179.766 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 6.5 Cg_exo -72.72 -16.95 26.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.727 2.285 . . . . 0.0 112.205 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.71 28.41 6.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -112.07 -178.05 3.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.4 t -119.35 162.99 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.786 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 1.7 t -137.92 83.77 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mm -91.84 48.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.045 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.466 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 34.9 t -57.42 136.31 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.82 -149.0 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.365 -179.506 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.463 ' HB ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 57.76 -172.51 0.09 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 111.006 179.791 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.41 94.04 1.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -77.57 173.96 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.24 -159.63 39.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.58 169.79 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.61 63.38 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -109.54 -26.48 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.32 -32.29 62.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.909 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.79 -59.22 5.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.16 178.927 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -59.23 -23.47 24.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.013 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -90.74 40.58 1.02 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.06 -38.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.762 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.511 HG21 HD13 ' A' ' 92' ' ' ILE . 7.6 pt -76.16 -28.68 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.947 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -31.4 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.597 179.713 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -63.76 -30.26 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.67 28.31 0.12 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.265 179.792 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -90.14 178.87 6.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.901 0.35 . . . . 0.0 110.808 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 47.9 t80 -97.49 28.27 3.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER 85.11 162.75 0.1 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.556 179.583 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.56 97.01 10.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.728 179.982 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.466 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 16.1 tp -55.84 160.68 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.191 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.441 ' C ' ' HG3' ' A' ' 102' ' ' LYS . 12.7 mp0 -100.9 -37.67 8.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 179.796 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER 32.4 57.23 1.28 Allowed Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.354 179.909 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 87.9 Cg_endo -81.97 50.38 3.45 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.668 2.246 . . . . 0.0 112.461 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 103' ' ' PRO . 2.0 m-85 -175.31 40.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.34 . . . . 0.0 111.301 -179.907 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.9 OUTLIER 69.45 67.85 0.25 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 179.672 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.528 ' HA ' ' HB2' ' A' ' 102' ' ' LYS . 3.0 m 40.49 25.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.17 -51.87 58.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.338 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -60.43 -33.92 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.466 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 13.7 t80 -59.44 -33.4 71.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.415 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -44.65 91.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.772 179.116 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.92 -46.47 78.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.213 -179.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.0 m -67.84 -41.43 82.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.423 . . . . 0.0 110.366 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CG2' ' CE2' ' A' ' 26' ' ' TYR . 1.6 mm -46.96 -52.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.194 179.758 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.3 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 179.798 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -56.87 -39.93 75.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.561 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.52 -30.89 55.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.504 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 2' ' ' LYS . 52.7 m-85 -91.13 -55.44 3.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.462 -179.799 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.89 -50.26 69.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.606 -179.53 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -73.31 -6.56 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.759 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.23 45.16 2.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.907 0.384 . . . . 0.0 110.916 179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.945 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.911 0.386 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -155.4 128.7 8.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.002 -179.916 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.444 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 136.07 25.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.993 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.434 HG23 ' CZ ' ' A' ' 117' ' ' PHE . 34.4 t -128.53 150.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.984 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 49' ' ' ILE . 24.4 tp -113.75 142.52 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.038 0.447 . . . . 0.0 111.575 -179.195 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.06 143.81 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.298 179.866 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.26 119.76 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.339 179.251 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 2.8 t70 -154.59 163.5 40.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.487 -179.324 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.58 49.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.0 111.104 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -126.55 -174.19 3.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.715 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.54 -79.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' ILE . 0.5 OUTLIER -93.83 177.07 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.687 179.953 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' SER . 5.5 mm -30.79 157.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.017 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 p -90.26 125.84 35.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.229 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -45.95 142.42 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.302 -179.611 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 87.85 -36.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.768 179.799 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -48.17 46.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 -179.968 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 p -50.74 -65.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.81 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.457 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.64 -69.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.966 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.57 -31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 179.819 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.63 66.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.829 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.3 -34.49 31.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -77.57 -38.1 49.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.141 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.51 43.83 3.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.052 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 9.6 m-85 -102.29 -174.93 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.218 0.533 . . . . 0.0 111.328 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.5 80.01 16.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.904 178.381 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.45 131.78 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.756 2.304 . . . . 0.0 113.972 -178.088 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -129.24 132.35 47.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.447 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.413 HG22 ' CD1' ' A' ' 13' ' ' ILE . 17.8 p -119.97 139.24 52.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.0 112.069 -178.837 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.82 -165.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 179.313 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 31.3 mttt -117.65 -25.73 6.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.844 0.354 . . . . 0.0 111.228 -179.975 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.11 174.18 11.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.398 179.891 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.456 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 15.9 mt -58.63 -28.85 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.606 179.835 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -47.83 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -35.0 79.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.374 179.263 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.39 -53.46 48.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.478 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.417 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 28.6 mt-10 -50.83 -38.98 52.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.452 179.55 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -59.89 -43.29 94.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.721 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -73.88 -47.01 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.641 179.41 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.62 -18.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -19.82 61.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.729 0.299 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.14 -50.73 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 117.38 13.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -83.42 66.26 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.751 179.825 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.413 ' CB ' ' CD1' ' A' ' 49' ' ' ILE . 44.8 m-85 -58.62 135.84 86.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.963 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 7.4 Cg_endo -81.16 -35.19 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.512 2.141 . . . . 0.0 112.009 179.451 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.3 t -126.69 136.3 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 179.691 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 5' ' ' LEU . 1.6 mm -135.67 105.37 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.407 HG21 ' CE1' ' A' ' 109' ' ' PHE . 21.8 t -103.42 131.8 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.759 0.314 . . . . 0.0 110.632 179.519 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.5 tp -99.78 146.87 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.138 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.83 106.85 9.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.415 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.95 70.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.521 -179.482 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.416 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 4.4 t-105 -72.06 -78.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.081 179.399 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.687 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.6 ptt? -149.15 48.95 0.63 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.213 179.132 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.687 ' HD3' ' N ' ' A' ' 55' ' ' MET . 14.7 Cg_endo -92.86 -159.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.164 2.576 . . . . 0.0 112.165 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -161.22 52.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.932 179.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.86 149.79 19.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.553 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.21 108.74 10.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.17 -18.73 48.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.903 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.403 HG22 ' HD3' ' A' ' 90' ' ' LYS . 21.4 t -58.52 -58.96 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.27 -21.9 63.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 33.8 t80 -60.32 -40.46 90.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.406 HD11 ' CB ' ' A' ' 91' ' ' ALA . 3.5 mt -47.19 -28.33 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -74.76 -35.67 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.679 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.439 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 19.1 t80 -61.57 -45.14 95.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.323 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.425 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.2 mp -58.0 -41.68 80.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 179.341 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -81.44 -23.3 37.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 179.521 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.409 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 61.7 tt0 -64.36 -31.6 72.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.361 179.476 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -132.67 16.04 4.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.923 179.944 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -169.53 73.41 0.69 Allowed Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.725 179.948 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.09 -7.35 11.12 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.093 2.529 . . . . 0.0 112.604 -179.79 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.5 -6.25 27.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.63 -179.866 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.44 -172.65 4.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 -179.768 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.2 t -127.24 144.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 -179.781 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.1 t -123.12 98.08 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.06 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.2 mm -73.91 -67.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.731 -179.068 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.453 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 12.2 t 63.17 98.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mt -98.14 -144.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.623 -179.109 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.5 87.44 0.06 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.827 0.346 . . . . 0.0 110.897 -179.796 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.96 42.41 0.24 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -73.99 -44.86 53.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 110.866 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.77 -51.41 1.66 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.439 -179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -97.66 68.56 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.46 -19.09 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.286 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.28 -34.4 57.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.126 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.2 t -59.15 -33.95 71.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.969 0.414 . . . . 0.0 110.376 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.453 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -59.21 -59.11 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.248 179.355 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.43 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.5 m -58.94 -27.52 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.056 179.499 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HD3' HG22 ' A' ' 61' ' ' VAL . 4.2 ttmm -80.54 -13.25 59.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 179.962 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' CB ' HD11 ' A' ' 64' ' ' ILE . . . -109.94 -35.02 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 111.736 -179.574 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 92' ' ' ILE . 7.6 pt -77.16 -26.32 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.65 -179.484 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -66.19 -28.33 68.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.587 179.652 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -58.12 3.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.8 37.2 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -89.99 -163.77 1.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.903 179.797 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 40.1 t80 -107.99 23.37 14.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.544 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 80.56 19.89 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.755 179.449 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.453 ' CE1' ' CG1' ' A' ' 78' ' ' VAL . 0.2 OUTLIER 61.78 162.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 111.038 179.465 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -101.02 133.28 45.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.602 179.935 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -65.05 -65.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 62.27 62.12 2.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.49 0.48 9.9 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.686 2.258 . . . . 0.0 112.854 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.27 -75.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.0 110.948 -179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -155.42 -168.9 2.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 13.2 p -59.83 -33.84 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.051 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -45.69 -38.17 6.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 179.877 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.53 80.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.02 179.282 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 113' ' ' ILE . 4.7 t80 -58.52 -26.47 63.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.168 179.293 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -49.67 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.102 179.708 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.3 -54.78 35.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.083 -179.797 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 113' ' ' ILE . 66.5 m -49.48 -57.32 7.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 109' ' ' PHE . 11.3 mm -29.9 -63.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.64 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 114' ' ' LYS . 4.9 tmmm? -48.91 -58.66 4.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.792 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.415 ' CE1' ' HE3' ' A' ' 114' ' ' LYS . 98.4 m-70 -53.69 -27.72 29.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.579 178.979 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.89 -42.55 69.85 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.762 179.692 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.438 ' CE2' ' HG3' ' A' ' 2' ' ' LYS . 24.7 m-85 -59.63 -21.48 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.0 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.4 -21.09 22.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.18 27.72 2.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.166 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.445 ' CE1' ' HB3' ' A' ' 47' ' ' PRO . 11.0 t80 -110.73 28.8 8.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.835 179.794 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.969 -179.996 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.83 0.348 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HG3' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER -121.03 127.93 52.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.912 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -153.69 133.85 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 179.88 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.54 162.0 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.781 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 29' ' ' ASP . 66.8 tp -118.21 147.24 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 111.446 -179.526 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -126.42 142.56 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.058 179.775 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 7.0 t -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.301 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 3.3 t70 -150.6 153.98 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.333 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.6 48.71 1.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.841 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.25 148.09 24.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.685 179.881 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.48 163.16 24.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.047 -179.784 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m 64.29 -171.3 0.18 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.151 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.418 ' CD1' ' CG2' ' A' ' 30' ' ' THR . 20.4 mm -79.41 166.38 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 29.3 p -80.4 128.37 33.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.255 179.505 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 16' ' ' SER . 13.9 p -35.07 128.02 0.52 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 15' ' ' SER . 3.2 p 82.99 -43.84 0.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.222 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.453 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -53.23 -50.84 63.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 111.216 -179.566 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.69 -65.47 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.47 -40.65 18.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' CD1' HG23 ' A' ' 106' ' ' VAL . 37.4 mt -59.44 -67.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' CD1' ' CD1' ' A' ' 17' ' ' LEU . 1.3 mt -48.74 -31.72 7.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.805 179.525 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.16 -31.63 71.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.748 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.91 -34.89 22.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.472 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -81.29 -38.39 26.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.206 -179.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 76.8 1.32 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.168 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 39.8 m-85 -130.65 -174.43 3.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.349 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -119.84 80.8 25.47 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.17 178.798 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.22 135.03 6.14 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.771 2.314 . . . . 0.0 113.928 -178.335 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' HB3' HD13 ' A' ' 5' ' ' LEU . 16.3 t70 -123.42 128.63 50.12 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.384 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.418 ' CG2' ' CD1' ' A' ' 13' ' ' ILE . 82.7 p -98.66 146.74 25.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.87 128.9 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.433 178.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 7.7 mttm -82.48 -10.32 59.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.65 167.11 7.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.304 179.791 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.8 mt -59.18 -22.35 60.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 110.329 179.436 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -46.2 33.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.794 178.834 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.92 -30.96 71.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.135 179.176 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.69 -56.05 5.21 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.619 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 42' ' ' LYS . 54.3 mt-10 -44.81 -43.27 8.54 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.618 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.95 -53.0 61.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.74 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -60.6 -30.01 69.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.978 179.581 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.9 mt -92.23 -9.29 10.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 38' ' ' GLU . 13.7 tttt -74.3 -8.64 56.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 111.027 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.36 -47.13 0.51 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.91 118.54 16.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.708 179.764 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -76.46 62.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.757 179.856 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 25.4 m-85 -55.3 116.75 12.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.77 -31.51 10.32 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.333 2.022 . . . . 0.0 112.203 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.16 129.87 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.587 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 49' ' ' ILE . 14.3 mm -118.71 144.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.185 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.6 t -137.23 109.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.388 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 42.1 tp -98.28 93.13 6.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -77.88 91.93 4.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.398 179.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.451 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 27.9 m -62.65 79.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.793 -179.383 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -78.9 -91.05 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.249 179.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.543 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 ttm -143.36 58.72 6.79 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.639 0.257 . . . . 0.0 110.855 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.7 Cg_endo -89.51 -157.64 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.176 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -155.59 28.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.37 149.43 18.64 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 81.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.75 0.309 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.26 90.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 64' ' ' ILE . 50.8 t -62.03 -40.25 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.965 0.412 . . . . 0.0 110.909 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -15.45 62.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.39 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.403 ' CE2' HD12 ' A' ' 67' ' ' ILE . 30.4 t80 -84.33 -30.0 25.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 61' ' ' VAL . 6.4 mm -48.63 -30.57 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.092 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 69' ' ' GLU . 8.3 t0 -74.14 -47.95 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.734 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.425 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 10.2 t80 -48.25 -43.52 32.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.851 0.357 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.403 HD12 ' CE2' ' A' ' 63' ' ' PHE . 3.9 mp -59.96 -47.85 90.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.421 179.438 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.85 -16.19 59.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.964 179.576 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.468 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 12.2 tt0 -73.12 -46.69 49.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.765 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.489 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -114.41 13.72 17.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.948 -179.78 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.42 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.44 65.53 2.35 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.776 179.836 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.6 Cg_exo -76.07 -13.97 19.06 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.646 2.231 . . . . 0.0 112.192 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.06 27.63 8.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -112.28 -166.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 76' ' ' VAL . 21.4 t -129.02 139.96 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.342 0.592 . . . . 0.0 111.831 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 3.0 t -128.18 89.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.08 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.426 HD11 HG23 ' A' ' 77' ' ' ILE . 40.8 mm -79.63 -43.03 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.857 179.947 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.425 ' O ' ' CE1' ' A' ' 99' ' ' PHE . 59.7 t 45.17 89.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.445 HG22 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -99.66 179.05 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.035 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 m 76.49 151.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.054 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.24 -108.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.364 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -164.07 -68.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.842 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.06 -80.94 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.418 -179.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -66.23 173.68 3.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.765 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 m -100.52 33.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -75.93 -37.19 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -33.18 63.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.054 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.91 -59.07 5.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.109 179.032 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 92' ' ' ILE . 14.2 m -58.9 -26.08 31.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.118 179.812 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -78.03 -4.59 47.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.244 179.83 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.71 -38.67 2.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.379 -179.911 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 89' ' ' VAL . 6.1 pt -76.95 -41.65 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.133 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -57.95 -28.79 64.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -62.57 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 179.63 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.092 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.512 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -90.35 -174.7 4.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.983 0.392 . . . . 0.0 110.943 179.725 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.536 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 69.0 t80 -94.46 -23.1 17.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 11.3 pt-20 147.87 -167.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.54 0.736 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.05 107.07 10.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.708 0.29 . . . . 0.0 110.622 179.606 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.445 ' HB3' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -56.4 92.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.07 -179.908 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -59.56 88.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 179.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.48 72.3 0.15 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 -179.959 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.78 -13.3 25.8 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.669 2.246 . . . . 0.0 112.703 179.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -109.38 109.12 19.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.748 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.8 t 63.91 146.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.036 -179.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 109' ' ' PHE . 18.0 m -106.15 40.47 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.09 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.58 -52.7 28.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -31.4 70.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.431 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 15.8 t80 -57.52 -40.95 79.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.43 -48.39 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.236 179.349 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mp -54.98 -45.57 75.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.399 -179.561 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -67.12 -39.8 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.457 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 2.7 mm -47.43 -55.88 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -55.62 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 110.16 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.71 69.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.81 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.86 -37.08 83.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.798 179.793 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.425 ' CD1' ' HG3' ' A' ' 2' ' ' LYS . 49.0 m-85 -80.27 -28.6 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.058 179.862 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -56.47 -22.84 35.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.994 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -97.61 29.86 3.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -102.77 28.77 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.81 179.953 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.7 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.975 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HB2' ' HD3' ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 . . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 7.5 mmtp 56.2 97.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 111.34 179.761 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -121.23 139.99 52.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.284 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 21.3 t -128.61 158.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 110.932 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.433 HD21 ' CE2' ' A' ' 46' ' ' PHE . 16.4 tp -117.03 131.83 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.651 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.409 ' CG2' HD13 ' A' ' 17' ' ' LEU . 25.4 t -115.81 89.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.201 179.866 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.92 103.16 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.757 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.81 137.63 45.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.782 -179.769 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.07 48.65 1.67 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.042 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.438 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -178.97 179.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 179.953 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -119.83 88.67 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.93 -44.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.3 mm -79.78 -43.65 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.998 179.86 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 p -60.34 -16.93 39.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.433 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -80.13 -43.33 21.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.283 . . . . 0.0 111.146 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -60.23 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.209 -179.673 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.422 HD12 ' CD1' ' A' ' 21' ' ' LEU . 2.3 tm? -46.9 -50.95 17.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.088 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -56.67 -48.91 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.572 179.75 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.24 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 23' ' ' GLU . 57.0 mt -57.41 -66.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.822 179.755 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.02 -35.43 11.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.139 0.495 . . . . 0.0 110.468 179.615 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.51 -28.22 69.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -79.84 -35.18 38.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.079 179.469 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -4.63 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.487 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.39 56.38 1.57 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.383 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.439 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-85 -128.41 -176.16 3.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -138.9 70.8 42.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.76 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 34.9 Cg_exo -60.15 142.3 98.02 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.821 2.347 . . . . 0.0 112.581 -179.678 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -121.64 2.97 10.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.398 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 29' ' ' ASP . 13.7 p 9.86 122.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.996 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.22 -164.22 1.02 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.436 178.631 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -118.47 -30.2 5.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.122 -179.754 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.25 -172.71 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.668 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.448 ' CD2' ' CD2' ' A' ' 63' ' ' PHE . 29.8 mt -65.86 -49.5 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.516 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.84 -48.83 80.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.447 . . . . 0.0 109.852 179.195 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.1 -30.8 71.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.17 179.144 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.41 -62.92 1.23 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.253 179.337 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 22.7 mt-10 -41.88 -39.93 1.97 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -49.24 73.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 178.91 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -68.19 -32.39 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.148 179.8 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.5 mt -86.34 -15.79 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.572 -179.755 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -24.29 6.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.548 -179.741 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -122.41 -55.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 129.03 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.21 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -92.03 86.41 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.528 179.621 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' A' ' 29' ' ' ASP . 49.8 m-85 -79.32 119.31 76.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.508 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.432 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 59.7 Cg_endo -73.54 -19.45 21.66 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.474 2.116 . . . . 0.0 111.974 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 117' ' ' PHE . 3.2 t -143.44 130.15 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.724 -179.911 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mm -118.59 156.19 20.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 179.54 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.7 t -146.31 102.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.494 . . . . 0.0 110.679 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.426 ' CD2' ' HA3' ' A' ' 60' ' ' GLY . 57.0 tp -90.09 91.1 8.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.42 92.3 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.857 178.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 53' ' ' VAL . 35.4 m -64.5 72.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.14 -179.006 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.438 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 25.5 t-105 -73.39 -77.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.361 . . . . 0.0 110.324 179.35 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.487 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.2 ttm -162.23 61.99 1.29 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.4 Cg_endo -84.61 -155.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.068 2.512 . . . . 0.0 112.216 -179.825 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.82 -42.2 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.93 177.55 53.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.07 127.77 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.426 ' HA3' ' CD2' ' A' ' 51' ' ' LEU . . . -79.16 -1.55 85.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.989 -179.969 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.49 -59.75 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.989 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.4 -21.5 62.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.512 -179.856 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CD2' ' CD2' ' A' ' 34' ' ' LEU . 14.0 t80 -61.33 -36.7 80.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.468 -179.565 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.6 mt -47.64 -27.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.285 -179.853 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.56 -40.91 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 38' ' ' GLU . 17.6 t80 -57.25 -43.02 82.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.469 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.9 mp -61.41 -42.78 95.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 179.417 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -18.85 56.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.326 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.48 -42.33 68.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.551 179.701 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.93 14.15 15.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.068 -179.843 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.74 67.65 1.59 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.847 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.84 -20.24 39.67 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.673 2.249 . . . . 0.0 112.232 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -104.12 35.67 2.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.747 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -111.79 -157.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.798 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.411 HG22 ' CD2' ' A' ' 120' ' ' TYR . 41.3 t -154.53 137.94 7.95 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 111.659 179.498 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 2.5 t -117.43 100.26 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.335 -179.478 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -82.68 -51.12 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.737 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t 52.37 96.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 179.648 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.413 ' CG2' ' H ' ' A' ' 80' ' ' THR . 1.7 mt -106.12 -155.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.085 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.413 ' H ' ' CG2' ' A' ' 79' ' ' ILE . 8.3 m 71.0 115.14 0.05 OUTLIER 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 179.918 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.99 144.81 11.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.33 179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -93.39 -78.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.986 -179.803 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -159.78 45.97 0.42 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -154.03 138.45 16.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.794 0.331 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 t -106.99 39.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.05 -24.65 12.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -82.49 -38.69 23.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.019 0.437 . . . . 0.0 109.944 179.292 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -57.31 -57.38 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.142 178.991 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.1 m -58.01 -28.95 35.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.289 179.702 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -15.86 57.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.626 -179.694 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.87 -33.86 6.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 -179.546 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.434 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 2.2 pt -79.3 -34.99 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.263 -179.554 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -31.26 71.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.781 179.889 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.2 32.91 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.859 -179.956 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -90.16 -165.3 1.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 110.998 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.437 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 26.0 t80 -114.16 27.14 9.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 -179.787 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 76.01 141.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.09 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -66.0 118.33 9.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 -179.707 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.05 129.14 40.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.883 179.703 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -61.68 -67.35 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.01 57.37 4.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.31 2.0 8.82 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.619 2.213 . . . . 0.0 112.788 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -131.61 -61.98 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.72 0.295 . . . . 0.0 110.937 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.0 p -171.03 179.15 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.038 -179.985 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 109' ' ' PHE . 9.5 p -53.0 -38.36 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.227 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -38.02 -38.46 0.32 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.823 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -70.82 -41.65 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.482 . . . . 0.0 110.494 179.642 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' VAL . 6.2 t80 -57.38 -30.43 64.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.802 179.528 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -59.18 -43.77 92.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.505 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mp -53.66 -52.29 60.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.829 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.3 m -59.61 -40.98 89.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.777 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mm -49.78 -57.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.634 -179.634 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.58 -63.4 1.1 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.455 ' CD2' ' CG ' ' A' ' 119' ' ' GLU . 5.5 t-160 -50.81 -27.35 7.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.821 179.31 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.96 87.64 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.927 0.394 . . . . 0.0 110.479 179.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' A' ' 48' ' ' VAL . 23.1 m-85 -71.88 -30.03 64.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.233 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -88.47 -37.54 15.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.368 -179.686 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.455 ' CG ' ' CD2' ' A' ' 115' ' ' HIS . 1.6 mm-40 -75.55 -5.25 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.668 -179.816 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.411 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -144.06 45.0 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 110.915 179.952 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.801 0.334 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -94.05 154.87 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -164.33 125.42 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 -179.906 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 22.5 t -114.64 143.56 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.862 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.453 HD12 ' CZ ' ' A' ' 46' ' ' PHE . 59.6 tp -93.95 129.63 40.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.808 -179.875 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' CG2' ' CD1' ' A' ' 17' ' ' LEU . 17.5 t -115.44 104.71 17.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.6 124.07 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.744 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -168.9 157.75 8.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 -179.839 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -89.56 49.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.168 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -108.72 -171.99 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.721 179.807 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -69.41 -66.79 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -131.82 -79.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 179.921 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.6 mm -97.68 163.0 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.091 179.834 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.429 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 71.5 p -90.27 142.58 27.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.212 179.442 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -52.94 136.68 34.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.695 -179.213 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 84.77 -36.55 0.05 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.08 179.442 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.463 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -59.74 -52.64 64.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 -179.582 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -45.63 -67.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.588 -179.488 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.33 -40.58 35.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.495 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.417 ' CD1' ' CG2' ' A' ' 106' ' ' VAL . 60.0 mt -65.88 -67.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.37 -179.717 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.926 0.394 . . . . 0.0 111.452 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.55 -31.32 66.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 tt0 -85.0 -36.04 21.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.513 179.716 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -78.16 -39.13 41.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.43 30.28 5.98 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.632 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -89.6 -175.56 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.92 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.2 OUTLIER -140.06 94.84 8.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 179.81 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 72.1 Cg_endo -77.45 134.2 13.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.501 2.134 . . . . 0.0 112.818 -179.514 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.9 t0 -103.66 -12.01 17.3 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.414 0.626 . . . . 0.0 111.618 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' ASP . 71.5 p 44.07 175.3 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.832 179.353 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -158.75 -166.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.438 179.833 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 mtpt -129.48 -37.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 110.963 179.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 p -163.07 178.24 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.304 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.36 -41.45 98.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 110.536 179.869 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.96 48.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 178.962 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.79 -29.63 70.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.205 179.036 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.33 -22.04 57.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.946 179.535 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 13.9 mt-10 -75.46 -41.52 55.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.897 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.3 -37.38 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.061 178.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -72.52 -30.07 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 mt -89.44 -23.13 6.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.906 179.671 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -81.07 -0.29 39.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 179.941 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -117.36 -41.33 2.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.681 179.789 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.472 HD23 ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -116.26 156.03 27.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.174 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.417 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 8.1 t80 -96.55 94.95 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.726 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.472 ' CE2' HD23 ' A' ' 44' ' ' LEU . 26.3 m-85 -78.18 124.8 85.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.429 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 73.8 Cg_endo -74.72 -29.33 8.86 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.402 2.068 . . . . 0.0 111.928 179.616 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 t -142.86 129.01 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.446 -179.819 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 49' ' ' ILE . 26.8 mm -111.71 151.31 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.91 179.124 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.429 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 46.6 t -144.19 100.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.0 111.752 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.28 175.02 8.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.038 179.339 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -146.41 -52.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.568 -179.543 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t 61.82 50.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.052 0.454 . . . . 0.0 110.47 -179.562 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -71.16 -82.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.799 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.495 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -76.06 -48.64 3.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 55' ' ' MET . 96.7 Cg_endo -77.73 -173.18 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.436 2.091 . . . . 0.0 112.619 -179.518 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -158.28 47.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.671 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.03 166.77 3.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.656 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -82.97 74.05 9.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.26 -22.39 36.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.692 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.402 ' O ' HD12 ' A' ' 64' ' ' ILE . 32.7 t -54.26 -41.7 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 111.496 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.35 4.96 44.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.436 ' O ' HG12 ' A' ' 67' ' ' ILE . 8.0 t80 -90.03 -37.07 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.58 0.229 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.424 HD13 ' CB ' ' A' ' 91' ' ' ALA . 3.2 mp -45.15 -44.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.908 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.84 -47.45 83.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 42.5 t80 -55.22 -31.46 61.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.005 179.244 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 63' ' ' PHE . 3.8 mm -66.25 -53.42 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.184 179.145 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -71.93 -19.98 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.369 179.206 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 20.0 tt0 -67.08 -50.0 63.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.538 179.588 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.475 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -113.98 19.67 16.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.135 -179.812 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.35 67.92 1.05 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.42 -16.03 22.0 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.781 2.321 . . . . 0.0 112.302 -179.898 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.61 31.12 6.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -112.99 -159.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.6 t -148.07 135.68 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.371 0.605 . . . . 0.0 112.251 179.453 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 24.7 t -105.44 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.514 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.6 mm -120.23 44.25 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.997 179.677 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' CG1' ' CE1' ' A' ' 99' ' ' PHE . 57.4 t -46.52 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.665 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -74.2 -107.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.35 -179.639 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 71.24 110.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.65 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.84 -105.8 0.39 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.603 -179.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 166.91 1.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.816 0.341 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.69 -66.0 0.57 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.1 t -177.63 109.55 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 179.96 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m -62.13 -21.95 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.233 179.841 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.87 -8.55 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.473 179.997 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.62 -33.64 31.34 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.067 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . . . -60.74 -57.65 11.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.125 178.998 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.62 -22.64 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -91.29 25.89 2.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.874 0.369 . . . . 0.0 110.772 179.606 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.424 ' CB ' HD13 ' A' ' 64' ' ' ILE . . . -155.2 -40.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.818 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 98' ' ' GLU . 5.3 pt -71.86 -43.91 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.172 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 2.2 ttmt -63.13 -22.77 67.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -71.65 -28.37 63.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.076 179.901 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.01 -19.7 0.35 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.32 179.971 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 92' ' ' ILE . . . -50.73 176.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.001 0.401 . . . . 0.0 111.318 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.407 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 32.5 t80 -98.98 28.5 4.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.477 -179.582 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.521 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 79.82 147.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.135 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 1.1 m-85 -73.85 139.89 45.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.082 -179.72 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -90.32 130.23 36.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.545 179.708 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -49.93 -72.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.48 70.98 1.45 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.801 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HG2' ' CD1' ' A' ' 104' ' ' PHE . 61.3 Cg_endo -73.01 -6.84 19.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.452 2.101 . . . . 0.0 112.675 -179.837 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 103' ' ' PRO . 47.3 p90 -179.65 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.984 179.798 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 81.0 p -128.22 156.31 43.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.014 -179.874 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 109' ' ' PHE . 33.5 m -83.88 6.05 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.68 179.95 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -40.87 -47.36 2.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.819 0.342 . . . . 0.0 111.281 -179.856 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -36.11 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.0 110.011 179.188 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 1.9 t80 -56.53 -23.54 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 179.229 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.64 -43.76 95.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.353 179.937 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 mp -54.27 -57.06 12.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 -179.739 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.3 m -57.71 -43.25 85.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CG1' ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -44.35 -53.38 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.786 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.08 -61.6 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -53.64 -28.24 31.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.17 -41.47 94.63 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 179.706 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 45.3 m-85 -79.66 -29.78 41.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -55.79 -25.1 39.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 179.974 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -97.51 30.06 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 47' ' ' PRO . 6.1 t80 -102.48 28.32 6.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.988 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.848 0.356 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 3.8 mmtm 60.07 65.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.984 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.433 ' CB ' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -117.62 141.5 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 179.989 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.408 HG21 ' CE1' ' A' ' 117' ' ' PHE . 41.3 t -126.66 159.87 35.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.422 HD21 ' CE2' ' A' ' 46' ' ' PHE . 35.4 tp -113.12 129.26 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.079 -179.901 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 30' ' ' THR . 23.5 t -115.62 89.95 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.517 179.916 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 t -83.56 103.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.9 140.2 42.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.435 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 33.6 t70 -88.45 27.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.508 -179.865 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.419 ' HG3' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -156.14 -175.57 5.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.809 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -121.59 46.6 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 t -103.22 -51.78 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.043 179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.2 mm -75.7 -46.01 37.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.077 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.4 p -57.11 -21.73 34.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.18 -43.41 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.4 -57.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -46.21 -56.87 5.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -52.86 -45.11 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.769 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.13 96.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.67 179.58 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.421 ' CD1' ' CG1' ' A' ' 106' ' ' VAL . 5.9 mt -57.59 -65.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.65 -32.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.731 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.26 -29.61 69.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -79.27 -34.4 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 109.887 179.441 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.52 -12.11 59.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.114 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.06 62.71 1.16 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.892 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 46.3 m-85 -127.22 -172.69 2.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 111.38 -179.319 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -135.9 68.43 64.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.498 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.74 131.09 35.86 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.641 2.227 . . . . 0.0 111.952 179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -109.6 3.31 20.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.266 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 29' ' ' ASP . 8.7 p 1.87 123.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.74 -162.46 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.487 178.836 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -114.93 -31.63 6.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.16 -168.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.686 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -63.95 -45.38 89.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -50.68 72.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.259 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.76 -29.64 67.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.49 179.422 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.63 -26.31 54.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.95 179.793 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 30.8 mt-10 -74.74 -38.47 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.073 0.463 . . . . 0.0 109.931 179.124 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.65 77.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.903 179.036 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -74.67 -35.64 62.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.676 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.5 mt -84.11 -21.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.095 179.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -18.65 59.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.279 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -129.02 -44.82 1.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.13 120.6 25.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 71' ' ' SER . 52.1 t80 -83.27 88.66 6.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.718 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.1 m-85 -79.23 133.37 60.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 9.3 Cg_endo -84.55 -20.4 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.815 2.344 . . . . 0.0 111.947 179.204 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.408 HG23 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -145.25 131.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mm -119.04 156.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.483 179.609 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -146.86 101.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 110.764 179.787 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.8 tp -88.94 108.14 19.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.825 -179.255 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.06 91.32 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.141 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.426 HG22 ' CG2' ' A' ' 80' ' ' THR . 33.4 m -67.47 68.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.727 -179.154 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.45 ' CG ' ' N ' ' A' ' 55' ' ' MET . 29.0 t90 -67.16 -96.97 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.208 179.426 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.541 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -129.36 41.62 0.76 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.471 0.177 . . . . 0.0 111.27 179.361 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 55' ' ' MET . 91.6 Cg_endo -80.38 -165.98 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.52 2.147 . . . . 0.0 112.286 179.949 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -150.02 46.91 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.85 -179.35 16.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -104.83 95.42 5.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.97 -30.56 63.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.19 -44.74 80.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.352 -179.93 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 1.89 35.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.507 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 34' ' ' LEU . 11.9 t80 -88.5 -36.37 16.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.801 0.334 . . . . 0.0 111.098 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.2 mp -47.5 -29.33 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.147 -179.936 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -78.38 -35.62 47.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.637 179.708 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.438 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 9.0 t80 -58.64 -41.53 86.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.411 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.0 mp -61.58 -45.74 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.376 179.5 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -76.63 -20.16 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.75 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.59 -42.25 78.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.828 179.749 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.39 15.4 12.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.193 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.41 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -163.48 67.75 1.66 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.809 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.39 -20.39 36.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.737 2.291 . . . . 0.0 112.232 -179.93 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -103.13 28.02 6.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.79 179.774 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 t -107.56 -156.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.363 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -153.91 137.66 8.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.996 0.426 . . . . 0.0 111.406 179.114 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 13.1 t -119.85 108.46 23.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.373 -179.257 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mm -93.16 -53.7 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.412 HG13 ' CE1' ' A' ' 99' ' ' PHE . 24.6 t 54.31 94.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 179.702 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.414 ' CG2' ' H ' ' A' ' 80' ' ' THR . 1.8 mt -94.8 -157.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 179.679 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.426 ' CG2' HG22 ' A' ' 53' ' ' VAL . 2.4 m 64.71 82.69 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.8 -173.97 20.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.531 -179.899 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -127.43 -175.08 3.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.4 -28.15 64.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.546 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.4 -35.75 60.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.84 0.352 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.7 t 63.95 33.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.155 179.922 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -95.6 -15.51 22.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 179.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.15 -34.89 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.112 0.482 . . . . 0.0 109.734 179.104 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . . . -59.16 -58.54 8.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.117 178.895 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.7 m -57.53 -28.99 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -75.44 -6.61 50.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.442 -179.916 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.77 -44.33 1.95 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 111.387 -179.772 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 89' ' ' VAL . 2.4 pt -67.89 155.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.924 -179.723 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 81.46 -47.27 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 -179.148 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -65.13 -16.83 63.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.495 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.23 -29.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.791 -179.955 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -74.5 176.31 6.95 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 111.31 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 13.4 t80 -102.16 -8.95 20.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.048 -179.983 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 8.5 pt-20 137.03 172.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.778 0.831 . . . . 0.0 110.181 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CG ' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -103.67 96.77 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.616 179.687 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 109' ' ' PHE . 13.1 tp -54.98 90.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.282 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -113.81 -18.52 11.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.296 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.41 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 9.2 tttt -55.13 -52.82 68.0 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.122 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 102' ' ' LYS . 50.1 Cg_exo -56.8 -161.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.524 2.149 . . . . 0.0 112.465 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -154.32 -45.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.805 -180.0 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.98 -73.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 109' ' ' PHE . 7.6 p 178.78 -37.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -36.07 -44.76 0.39 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.126 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -42.36 84.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 0.0 110.734 179.798 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' VAL . 8.4 t80 -53.59 -30.88 44.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.889 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -44.2 80.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.3 -179.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mp -56.7 -55.16 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.33 -179.701 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.9 m -56.37 -41.85 76.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.409 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.1 mm -44.62 -54.48 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -48.35 -61.31 2.07 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -48.18 -31.87 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.749 179.287 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.47 83.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.978 0.418 . . . . 0.0 110.504 179.417 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 2' ' ' LYS . 48.6 m-85 -83.77 -28.29 28.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 179.853 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -54.32 -24.1 17.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.428 -179.809 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.6 -5.94 47.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.479 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -100.29 35.31 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 12.5 mmtm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.83 0.348 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.62 127.74 14.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 48' ' ' VAL . 61.3 t -126.15 163.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 29' ' ' ASP . 55.4 tp -121.28 134.95 55.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.015 0.436 . . . . 0.0 111.671 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.811 HG21 ' CD1' ' A' ' 17' ' ' LEU . 12.8 t -119.41 128.23 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.127 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.434 ' HB ' HD12 ' A' ' 51' ' ' LEU . 11.9 t -119.56 125.82 74.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.993 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.0 t0 -162.1 145.86 12.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.653 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.32 51.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.871 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 12.4 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.072 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 53.3 p . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.899 0.381 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.87 133.18 22.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 m 78.77 -14.31 0.88 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.653 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.969 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -76.77 -54.79 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.942 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.41 -64.27 0.76 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.519 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.98 -40.76 31.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.197 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.835 HG23 ' CD1' ' A' ' 110' ' ' LEU . 56.0 mt -63.14 -67.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.218 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.969 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -49.44 -31.14 9.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 110.851 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.61 -27.47 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.879 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.47 -34.91 27.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.317 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.814 ' CG ' HD21 ' A' ' 110' ' ' LEU . 21.8 mm-40 -80.38 -36.28 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.051 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.4 49.76 2.52 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.066 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 3.8 m-85 -103.8 -174.61 2.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.326 0.584 . . . . 0.0 111.429 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.13 77.13 76.95 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.938 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.647 ' HG3' HD13 ' A' ' 21' ' ' LEU . 97.3 Cg_endo -85.79 142.78 8.03 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.836 2.358 . . . . 0.0 113.851 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.884 ' O ' HD12 ' A' ' 5' ' ' LEU . 8.6 t0 -123.67 120.33 32.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.145 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.587 HG22 ' HB ' ' A' ' 6' ' ' VAL . 47.5 p -100.81 139.86 35.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.11 0.481 . . . . 0.0 112.011 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.48 -164.37 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.228 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 2.4 mttt -134.65 -7.67 2.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.36 -172.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 0.0 110.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.785 HD11 ' O ' ' A' ' 59' ' ' ASP . 96.3 mt -78.64 -28.73 45.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.473 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.49 -41.64 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -34.0 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.233 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.68 ' C ' HD12 ' A' ' 41' ' ' ILE . . . -73.51 -52.39 13.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 42' ' ' LYS . 41.3 mt-10 -46.38 -45.08 17.58 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.525 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -53.35 58.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -61.86 -23.9 66.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.075 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 ' C ' ' A' ' 37' ' ' ALA . 5.5 mt -95.82 -14.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.688 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 1.2 tmtt? -78.83 -5.32 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.645 0.26 . . . . 0.0 111.48 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -136.96 -49.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.382 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.32 116.29 16.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.783 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -74.75 64.12 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.518 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 22.9 m-85 -58.35 122.08 56.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.087 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 10.8 Cg_exo -66.1 -50.05 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.468 2.112 . . . . 0.0 112.277 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 4' ' ' VAL . 35.8 t -116.85 127.11 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.671 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 14.6 mm -113.81 127.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.273 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.861 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 84.7 t -124.3 105.93 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 78' ' ' VAL . 4.9 tp -93.52 145.36 24.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.711 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' HA ' ' HG1' ' A' ' 80' ' ' THR . 2.7 t70 -110.33 178.66 4.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.115 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.603 HG22 ' CB ' ' A' ' 80' ' ' THR . 4.8 m -149.52 42.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.155 0.502 . . . . 0.0 111.527 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 57.6 t-105 -49.9 -90.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 25.6 ttp -149.6 50.84 0.83 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.312 . . . . 0.0 111.072 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 55' ' ' MET . 73.0 Cg_endo -75.95 -168.29 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.487 2.125 . . . . 0.0 112.281 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -145.4 39.77 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -139.26 20.86 2.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.647 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.785 ' O ' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER 62.07 -159.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.612 0.244 . . . . 0.0 110.488 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.11 -39.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.641 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.753 HG21 ' HD3' ' A' ' 90' ' ' LYS . 40.3 t -56.85 -42.1 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.059 0.457 . . . . 0.0 110.756 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -20.24 64.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.674 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.964 ' CE2' HD11 ' A' ' 67' ' ' ILE . 36.0 t80 -80.53 -33.32 36.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 61' ' ' VAL . 4.6 mm -47.03 -29.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.81 0.338 . . . . 0.0 111.154 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -75.17 -47.54 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.546 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 12.2 t80 -50.02 -42.47 49.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.964 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.2 mp -60.6 -44.04 95.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.351 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -80.31 -17.45 52.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.807 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 65' ' ' ASP . 31.6 tt0 -71.4 -46.7 59.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.546 ' ND2' ' CE1' ' A' ' 66' ' ' PHE . 0.1 OUTLIER -112.49 7.51 19.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.186 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.426 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -154.63 65.38 4.79 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 110.656 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 71' ' ' SER . 2.7 Cg_exo -74.65 -15.59 21.58 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.683 2.255 . . . . 0.0 112.103 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -97.48 -9.47 27.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.216 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t -80.36 -173.95 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.584 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.683 HG21 ' HB1' ' A' ' 116' ' ' ALA . 31.1 t -120.5 157.23 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.094 0.473 . . . . 0.0 111.217 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.597 HG12 HG23 ' A' ' 78' ' ' VAL . 1.1 t -143.19 89.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.093 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.838 HD13 ' HB3' ' A' ' 97' ' ' TYR . 21.5 mm -80.5 -45.35 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.597 HG23 HG12 ' A' ' 76' ' ' VAL . 58.5 t 54.99 101.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.791 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 77' ' ' ILE . 7.7 mt -133.1 145.69 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.763 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.603 ' CB ' HG22 ' A' ' 53' ' ' VAL . 14.5 m . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.832 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.812 0.339 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.5 -12.93 62.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.5 -35.46 27.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.09 0.471 . . . . 0.0 109.798 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.09 -57.56 12.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.753 ' HD3' HG21 ' A' ' 61' ' ' VAL . 12.7 ttmt -89.75 39.92 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.019 0.438 . . . . 0.0 110.554 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.24 -42.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.9 pt -71.25 -28.08 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.263 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.53 19.83 6.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -0.63 8.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.483 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.91 11.5 1.84 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.956 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.13 -168.67 2.18 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.252 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.838 ' HB3' HD13 ' A' ' 77' ' ' ILE . 17.8 t80 -116.22 27.39 9.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.344 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.476 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 79.29 141.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.579 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -67.45 129.3 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.124 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.688 HD11 ' HB3' ' A' ' 108' ' ' ARG . 0.2 OUTLIER -71.42 106.42 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.72 HG21 HD23 ' A' ' 17' ' ' LEU . 3.1 m . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.3 -47.52 79.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.688 ' HB3' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -63.69 -34.14 77.2 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.861 ' CZ ' HG21 ' A' ' 50' ' ' VAL . 8.3 t80 -56.75 -35.26 68.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.366 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.835 ' CD1' HG23 ' A' ' 20' ' ' ILE . 1.4 tt -56.85 -53.3 59.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.031 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.98 -42.61 94.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.534 HG23 ' HE2' ' A' ' 97' ' ' TYR . 87.7 m -64.83 -40.42 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.883 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.655 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.6 mm -44.11 -52.68 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.785 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.55 -56.8 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.321 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -60.48 -32.47 71.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.683 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.57 -39.04 82.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.548 ' CE1' HG21 ' A' ' 48' ' ' VAL . 39.2 m-85 -77.78 -13.2 59.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.43 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 120.798 0.332 . . . . 0.0 111.248 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 32.3 mmtp . . . . . 0 C--O 1.225 -0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 3.5 mpt_? 64.64 108.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.8 t -123.22 159.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.911 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.709 HD23 HG23 ' A' ' 49' ' ' ILE . 42.9 tp -115.43 135.17 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.847 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.701 ' HB ' HG22 ' A' ' 30' ' ' THR . 17.2 t -117.53 89.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.696 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.47 107.55 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -143.17 140.73 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 111.301 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 34.9 t0 -64.04 -70.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.974 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.716 0.293 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.34 -43.01 67.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.2 p -101.81 -53.2 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.328 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.75 ' CD1' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -47.84 -51.84 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.081 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.726 ' HA ' HD12 ' A' ' 21' ' ' LEU . 46.0 m -50.68 -46.61 58.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.773 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.07 91.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.777 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.717 ' CD1' HG13 ' A' ' 106' ' ' VAL . 17.1 mt -55.99 -59.92 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.532 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.019 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -46.9 -40.23 13.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.854 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.22 -27.96 69.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.987 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -80.09 -34.73 37.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.982 0.42 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.759 ' HG3' HD21 ' A' ' 110' ' ' LEU . 66.2 mm-40 -76.71 -24.73 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 28.38 6.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.416 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 59.9 m-85 -98.93 -175.86 3.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -134.56 90.0 24.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 1.019 ' HB3' HD13 ' A' ' 21' ' ' LEU . 74.4 Cg_endo -78.8 132.64 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.432 2.088 . . . . 0.0 112.873 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -108.78 6.0 25.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.235 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.701 HG22 ' HB ' ' A' ' 6' ' ' VAL . 14.3 p 4.33 122.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.83 -164.17 1.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.925 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 33' ' ' THR . 13.2 tttt -115.1 -40.08 3.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 32' ' ' LYS . 12.7 p -159.23 -173.95 4.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.466 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.746 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -65.64 -45.34 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.617 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -61.67 -48.65 79.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.074 0.464 . . . . 0.0 109.749 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.06 -32.22 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.01 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -70.55 -29.77 66.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.699 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 17.6 mt-10 -68.58 -44.27 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -36.28 78.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.106 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -74.12 -43.03 59.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.491 HD12 ' O ' ' A' ' 37' ' ' ALA . 10.9 mt -73.61 -24.17 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -51.58 -25.89 7.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.277 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -124.37 -58.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.096 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.75 123.64 18.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.04 79.93 8.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.628 ' CE2' HD13 ' A' ' 5' ' ' LEU . 33.0 m-85 -73.94 116.34 51.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.025 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.549 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 74.0 Cg_endo -73.2 -16.16 25.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.524 2.149 . . . . 0.0 111.816 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.5 t -147.23 132.29 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.709 HG23 HD23 ' A' ' 5' ' ' LEU . 10.2 mm -118.18 159.96 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.11 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.403 HG13 HG13 ' A' ' 79' ' ' ILE . 62.1 t -147.97 97.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.252 0.548 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 78' ' ' VAL . 58.7 tp -80.39 130.03 34.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.468 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.62 89.71 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.033 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.715 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.8 m -67.31 66.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.875 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 69.3 t-105 -69.86 -96.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.195 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.604 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -134.66 32.16 0.21 Allowed Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.8 Cg_endo -81.97 -165.18 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.106 1.871 . . . . 0.0 112.236 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -116.29 28.54 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.866 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' CA ' HD12 ' A' ' 34' ' ' LEU . . . -85.07 -99.49 0.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.499 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 56.91 46.39 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.773 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.93 103.81 2.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.907 ' O ' HD12 ' A' ' 64' ' ' ILE . 48.1 t -61.07 -40.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 0.0 110.828 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -13.01 61.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.362 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 67' ' ' ILE . 35.6 t80 -54.3 -39.23 66.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 111.265 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.5 mt -50.01 -29.8 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' GLU . 1.5 t0 -75.81 -34.19 60.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 51.4 t80 -59.56 -47.48 85.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.015 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.873 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -58.34 -43.7 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.398 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -77.03 -22.85 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.699 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 65' ' ' ASP . 42.3 tt0 -65.0 -34.23 77.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.55 18.65 5.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.853 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.91 75.6 0.66 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.2 -8.08 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.162 2.575 . . . . 0.0 112.733 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -107.31 12.96 27.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.459 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.23 -160.15 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.98 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HB ' HG13 ' A' ' 48' ' ' VAL . 26.3 t -148.94 134.42 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 111.47 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.915 HG12 HG23 ' A' ' 78' ' ' VAL . 23.9 t -115.01 109.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.575 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.727 HD13 ' HB3' ' A' ' 97' ' ' TYR . 31.7 mm -90.36 -51.06 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.956 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.915 HG23 HG12 ' A' ' 76' ' ' VAL . 30.1 t 54.21 97.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.74 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -102.68 -170.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.315 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.74 ' H ' HG22 ' A' ' 79' ' ' ILE . 2.8 m . . . . . 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.342 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.609 0.242 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.3 -1.88 28.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.326 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.59 -37.06 14.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.825 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.55 -57.44 12.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.159 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.9 m -58.27 -29.27 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.314 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.666 ' HD3' HG21 ' A' ' 61' ' ' VAL . 3.9 ttmp? -76.86 -14.96 59.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.378 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.91 -44.8 3.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 111.528 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.87 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.2 pt -67.6 169.84 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.038 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.8 mttp 74.31 -44.01 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -16.44 63.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.077 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.95 -29.43 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.26 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.87 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -59.56 -178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.421 . . . . 0.0 111.11 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.727 ' HB3' HD13 ' A' ' 77' ' ' ILE . 85.0 t80 -115.67 27.49 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.904 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 86.65 157.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.376 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.474 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -86.16 100.27 12.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.024 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.886 HD21 ' HA ' ' A' ' 109' ' ' PHE . 39.2 tp -70.47 131.47 44.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.008 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.352 179.617 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.717 HG13 ' CD1' ' A' ' 20' ' ' ILE . 8.6 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.513 0.196 . . . . 0.0 111.498 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -45.8 -34.6 3.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -38.96 62.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.153 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.886 ' HA ' HD21 ' A' ' 100' ' ' LEU . 4.2 t80 -55.61 -28.64 56.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.41 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -47.87 -39.57 19.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.4 mp -57.97 -58.06 10.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.874 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.823 ' OG1' HD22 ' A' ' 100' ' ' LEU . 52.3 m -45.95 -43.65 14.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.626 HD12 HG21 ' A' ' 4' ' ' VAL . 18.6 mm -53.66 -66.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 110.382 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -16.21 5.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.979 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -90.19 -26.53 20.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 110.518 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.59 -40.83 40.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.018 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 38.0 m-85 -76.35 -19.03 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.699 -179.864 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 1.4 mptp? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.795 0.331 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -145.49 133.57 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 48' ' ' VAL . 20.8 t -126.2 160.66 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.695 HD23 HG23 ' A' ' 49' ' ' ILE . 40.9 tp -118.8 136.34 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.808 0.337 . . . . 0.0 110.996 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.659 ' HB ' HG22 ' A' ' 30' ' ' THR . 13.7 t -117.35 90.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.89 104.86 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.842 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -140.32 137.99 34.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -88.76 48.83 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.841 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.628 0.252 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -90.04 -26.42 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.731 0.3 . . . . 0.0 111.231 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.24 -63.03 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.199 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.003 HD13 HD11 ' A' ' 21' ' ' LEU . 2.1 tm? -52.24 -50.18 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.02 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.796 ' HA ' HD12 ' A' ' 21' ' ' LEU . 7.0 t -53.09 -59.42 4.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.217 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.0 -39.51 59.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.05 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.728 HG23 HD11 ' A' ' 110' ' ' LEU . 8.9 mt -57.41 -58.3 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.9 -39.61 19.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.408 . . . . 0.0 110.78 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.59 -28.34 68.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.6 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.37 -34.47 31.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.233 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.748 ' HG3' HD21 ' A' ' 110' ' ' LEU . 15.8 mm-40 -76.49 -70.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 149.23 57.45 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 81.0 m-85 -129.84 -169.31 2.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.53 88.04 20.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.967 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.907 ' HB3' HD13 ' A' ' 21' ' ' LEU . 66.6 Cg_endo -78.81 132.6 10.85 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.419 2.079 . . . . 0.0 113.148 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 30' ' ' THR . 17.5 t70 -111.56 8.43 20.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.221 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.659 HG22 ' HB ' ' A' ' 6' ' ' VAL . 5.9 p 0.83 123.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 -165.69 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.702 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -116.61 -33.52 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.776 HG23 ' HB3' ' A' ' 56' ' ' PRO . 0.7 OUTLIER -162.03 175.23 12.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.612 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.71 HD22 ' CD2' ' A' ' 63' ' ' PHE . 54.3 mt -55.56 -33.41 63.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.757 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -48.13 76.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.506 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.838 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.32 -36.02 63.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 83.6 mt-10 -68.48 -40.81 80.81 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.06 -35.09 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.9 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -76.65 -44.72 32.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.721 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.96 -26.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.18 -25.79 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.427 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -125.67 -45.58 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.012 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -74.66 135.06 41.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -92.25 95.47 9.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 75.8 m-85 -91.98 113.4 58.85 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.8 Cg_endo -73.43 -16.5 24.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.387 2.058 . . . . 0.0 111.886 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.8 t -148.43 131.61 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.47 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.695 HG23 HD23 ' A' ' 5' ' ' LEU . 7.3 mm -119.16 162.65 17.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.5 t -149.85 98.42 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.178 0.514 . . . . 0.0 111.454 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB3' HG22 ' A' ' 78' ' ' VAL . 37.7 tp -81.73 148.87 28.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.588 ' O ' HG21 ' A' ' 80' ' ' THR . 8.0 t70 -107.84 -19.92 13.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.484 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.681 HG22 ' HB ' ' A' ' 80' ' ' THR . 2.4 m 45.93 32.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -56.6 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.676 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.567 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 13.3 mtp -152.54 57.52 2.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.964 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.776 ' HB3' HG23 ' A' ' 33' ' ' THR . 4.9 Cg_endo -86.3 -156.38 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.061 2.507 . . . . 0.0 112.199 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -157.39 37.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.94 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.584 ' C ' HD12 ' A' ' 34' ' ' LEU . . . -127.98 -0.69 6.48 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.065 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.424 ' C ' HD11 ' A' ' 34' ' ' LEU . 19.7 m-20 58.4 105.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.18 -0.8 87.04 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.142 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.918 ' O ' HD12 ' A' ' 64' ' ' ILE . 46.4 t -67.25 -66.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 120.898 0.38 . . . . 0.0 111.161 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -67.09 -14.33 62.8 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CD2' HD22 ' A' ' 34' ' ' LEU . 21.4 t80 -63.4 -38.92 93.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.1 mt -48.35 -33.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.5 t70 -70.03 -32.8 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.29 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 6.9 t80 -62.33 -43.96 97.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.686 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mp -59.57 -44.64 93.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.41 -21.31 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.563 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' ASP . 37.4 tt0 -67.0 -31.77 72.55 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.05 18.63 3.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.044 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.86 70.06 0.88 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.24 -19.37 38.71 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.721 2.281 . . . . 0.0 112.241 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.22 29.14 3.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.978 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 48.0 t -110.87 -163.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.42 ' N ' ' OG ' ' A' ' 74' ' ' SER . 31.9 t -154.55 136.2 5.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 120.836 0.351 . . . . 0.0 111.399 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.845 HG12 HG23 ' A' ' 78' ' ' VAL . 2.0 t -115.43 109.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.412 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.564 HG21 ' CE1' ' A' ' 109' ' ' PHE . 38.3 mm -83.27 -59.68 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.913 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.845 HG23 HG12 ' A' ' 76' ' ' VAL . 55.7 t 55.48 89.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.667 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -96.21 -152.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.681 ' HB ' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.809 0.338 . . . . 0.0 110.976 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 85' ' ' VAL . 11.7 p . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.562 0.22 . . . . 0.0 111.584 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.52 -8.97 57.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -89.79 -39.29 13.21 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.571 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -56.42 -57.99 9.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.3 m -55.19 -31.1 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.772 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.555 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -76.97 -5.38 48.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.91 -38.12 3.0 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.909 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 9.1 pt -73.93 -34.52 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.435 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -65.34 -18.12 65.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.935 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -85.89 -56.27 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.045 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.29 32.03 0.05 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.043 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.909 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.27 -162.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.329 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.558 ' CE2' HG23 ' A' ' 112' ' ' THR . 81.3 t80 -111.98 23.32 13.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.439 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 0.7 OUTLIER 83.89 20.33 0.17 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.95 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER 58.43 163.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 0.0 111.453 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HB3' HG23 ' A' ' 79' ' ' ILE . 1.8 tm? -116.02 81.23 1.57 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.222 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.494 ' CG2' HD23 ' A' ' 17' ' ' LEU . 11.4 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.657 0.265 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -40.62 -40.57 1.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.913 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -39.3 74.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.765 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.564 ' CE1' HG21 ' A' ' 77' ' ' ILE . 5.5 t80 -57.23 -30.04 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.748 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -50.76 -34.92 29.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.1 mp -61.8 -51.65 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.313 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.558 HG23 ' CE2' ' A' ' 97' ' ' TYR . 87.9 m -51.51 -39.2 57.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.997 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.431 ' HA ' HD13 ' A' ' 113' ' ' ILE . 12.6 mm -53.58 -65.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.981 0.419 . . . . 0.0 110.132 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -13.45 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.716 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -90.49 -25.49 20.26 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 110.065 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.94 -47.37 13.78 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 48' ' ' VAL . 34.2 m-85 -57.93 -21.8 45.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.195 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.185 -179.93 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 23.8 mmtt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.804 0.335 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.67 135.41 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.4 t -127.12 143.92 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.824 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.723 HD23 HD11 ' A' ' 41' ' ' ILE . 15.1 tp -99.99 125.33 46.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.791 HG21 HD12 ' A' ' 17' ' ' LEU . 21.9 t -112.11 88.78 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.07 103.47 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -137.08 138.8 40.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.43 38.5 1.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 17.0 tp10 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.64 0.257 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.1 t -90.14 23.16 2.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.524 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.9 t -163.27 -53.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.583 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.791 HD12 HG21 ' A' ' 6' ' ' VAL . 1.6 tm? -57.88 -50.97 71.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.572 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 30' ' ' THR . 0.7 OUTLIER -56.99 -51.52 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.336 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.54 70.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.538 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.667 ' CD1' HG11 ' A' ' 106' ' ' VAL . 40.7 mt -58.16 -66.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.678 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.2 mt -49.7 -31.42 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.469 . . . . 0.0 110.369 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.42 -30.63 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.57 -34.89 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.037 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.805 ' HG3' HD21 ' A' ' 110' ' ' LEU . 41.9 mm-40 -75.08 -12.09 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.207 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 53.36 1.08 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.197 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.465 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 64.5 m-85 -126.38 -176.33 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 111.108 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.48 71.95 51.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 33.9 Cg_exo -60.34 138.66 82.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.776 2.318 . . . . 0.0 112.645 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.9 t70 -121.04 4.59 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.748 HG22 ' HB ' ' A' ' 6' ' ' VAL . 12.8 p 3.38 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 -163.21 0.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.391 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -118.85 -28.26 5.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.278 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -163.48 -170.12 2.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.806 0.336 . . . . 0.0 110.806 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 63' ' ' PHE . 47.0 mt -68.41 -45.87 71.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -48.56 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.67 -30.19 69.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.491 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.505 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.29 -25.32 54.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.443 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 45.7 mt-10 -75.56 -36.27 60.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -37.33 77.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.58 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -71.82 -37.48 70.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.542 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.723 HD11 HD23 ' A' ' 5' ' ' LEU . 23.7 mt -85.76 -16.86 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.387 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -52.59 -22.19 4.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.619 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -133.3 -51.66 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.824 0.345 . . . . 0.0 111.154 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 118.71 5.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -73.96 72.26 1.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 38.8 m-85 -66.41 111.24 6.23 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.476 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.408 ' HG2' ' CE2' ' A' ' 117' ' ' PHE . 72.3 Cg_endo -74.42 -20.67 18.09 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.628 2.219 . . . . 0.0 112.207 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.631 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.4 t -144.0 130.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.295 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 9.9 mm -117.7 156.99 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.407 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.15 102.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 tp -86.12 84.72 7.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.976 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.49 77.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.66 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.718 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.2 p -59.33 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.599 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 44.5 t-105 -74.46 -82.78 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.097 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.545 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.39 45.45 0.35 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.313 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 55' ' ' MET . 82.3 Cg_endo -85.12 -165.54 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.442 2.095 . . . . 0.0 112.261 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -154.55 48.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.949 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.0 -16.67 6.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.85 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 62.58 104.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.791 0.329 . . . . 0.0 110.733 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.06 18.57 57.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.895 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.68 ' O ' HD12 ' A' ' 64' ' ' ILE . 13.1 t -58.98 -58.36 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.879 0.371 . . . . 0.0 111.098 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.05 -4.79 43.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.745 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 67' ' ' ILE . 26.7 t80 -69.15 -39.99 78.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.618 0.247 . . . . 0.0 111.496 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mp -46.89 -33.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.766 0.317 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.483 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -70.04 -34.75 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 75.0 t80 -63.06 -39.92 96.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mp -62.77 -47.12 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.909 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.483 ' HG3' ' HA ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -75.41 -18.95 59.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.45 -42.75 74.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.718 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.75 18.36 11.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.054 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.85 67.11 1.09 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.81 -20.29 34.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.653 2.235 . . . . 0.0 112.218 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.41 32.72 2.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 t -113.2 -157.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.2 t -155.37 137.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 111.505 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.84 HG12 HG23 ' A' ' 78' ' ' VAL . 2.8 t -117.83 100.4 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.376 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 97' ' ' TYR . 38.2 mm -81.5 -55.12 8.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.739 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 76' ' ' VAL . 40.3 t 57.69 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -114.31 -159.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.334 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.718 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 85' ' ' VAL . 14.0 p . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.893 0.378 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.57 -22.26 28.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -79.78 -36.38 37.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.144 0.497 . . . . 0.0 109.726 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.1 -57.74 10.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.203 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 -26.17 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.948 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 61' ' ' VAL . 5.3 tttt -87.93 40.54 0.95 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.625 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.36 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.945 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.4 pt -75.08 -29.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.501 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -80.08 -19.27 47.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -23.15 58.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.76 22.88 0.14 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.595 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.945 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.36 -165.15 1.28 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 117.22 0.51 . . . . 0.0 111.147 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.452 ' HB3' HD13 ' A' ' 77' ' ' ILE . 70.3 t80 -114.11 25.14 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 79.95 139.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.562 ' H ' HG21 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -57.19 130.11 44.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.676 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -78.26 120.3 22.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.684 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.419 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.1 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.014 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.667 HG11 ' CD1' ' A' ' 20' ' ' ILE . 11.7 p . . . . . 0 CA--C 1.526 0.029 0 CA-C-O 120.614 0.245 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -38.96 -44.16 1.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.635 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -64.45 -42.33 96.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 0.0 110.345 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 8.8 t80 -59.51 -27.24 65.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.692 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.805 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -60.27 -48.15 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.404 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.9 mp -51.39 -51.52 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.227 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.91 -41.34 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 3.4 mm -50.35 -56.15 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.608 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -63.22 1.13 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -49.97 -32.56 15.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.776 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -60.92 -41.35 95.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.458 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.628 ' CE1' HG21 ' A' ' 48' ' ' VAL . 32.6 m-85 -76.13 -34.81 59.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.597 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HB3' ' CG ' ' A' ' 26' ' ' TYR . 13.3 mmtt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.905 0.383 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.4 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -148.22 121.95 9.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.633 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.577 HG13 ' HB ' ' A' ' 48' ' ' VAL . 38.0 t -127.36 158.15 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.892 HD12 ' O ' ' A' ' 29' ' ' ASP . 52.3 tp -117.96 141.55 48.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 111.43 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.69 HG21 HD12 ' A' ' 17' ' ' LEU . 16.9 t -121.24 141.65 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.158 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 14.2 t -132.84 121.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.1 t70 -159.25 159.75 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 110.621 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.53 50.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.936 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 179.765 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.633 HG21 HG11 ' A' ' 6' ' ' VAL . 30.1 p . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 16' ' ' SER . 29.6 t -54.21 132.46 43.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.955 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.684 ' HB3' HG11 ' A' ' 106' ' ' VAL . 5.7 t 83.08 -15.02 0.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.719 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.905 ' CD1' HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -77.4 -48.49 17.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.855 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -50.7 -57.0 9.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.31 80.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.655 HD11 HG13 ' A' ' 106' ' ' VAL . 81.9 mt -59.91 -70.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.905 HD11 ' CD1' ' A' ' 17' ' ' LEU . 1.2 mt -47.84 -31.17 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -73.79 -30.54 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.884 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.16 -35.53 25.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.89 -33.74 62.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.5 42.17 3.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' CG ' ' HB3' ' A' ' 2' ' ' LYS . 3.1 m-85 -104.12 -175.67 2.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.4 ' HB2' ' HG3' ' A' ' 3' ' ' ARG . 2.5 t-80 -127.59 82.27 68.62 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.05 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.664 ' HB3' HD22 ' A' ' 21' ' ' LEU . 88.0 Cg_endo -83.44 130.94 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 113.884 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.892 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -119.74 116.82 26.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.856 178.367 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.541 HG22 ' HB ' ' A' ' 6' ' ' VAL . 18.5 p -105.76 137.14 44.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 112.039 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 36' ' ' GLU . . . -106.93 -164.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.076 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -131.59 -5.84 3.68 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.7 167.66 7.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.674 HD22 ' CD2' ' A' ' 63' ' ' PHE . 33.8 mt -60.78 -29.6 69.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.848 0.356 . . . . 0.0 110.225 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -70.63 -45.98 64.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.722 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.515 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 2.5 mm-40 -62.66 -33.07 74.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.069 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.97 34.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.718 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' LYS . 49.8 mt-10 -46.17 -46.55 17.41 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -58.95 -54.45 47.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.51 -24.63 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.014 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 41' ' ' ILE . 18.2 mt -97.07 -13.49 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.22 -9.28 58.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.587 0.232 . . . . 0.0 111.288 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.03 -62.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 113.12 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.21 68.26 0.49 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.481 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 35.2 m-85 -63.28 130.18 94.04 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 5.1 Cg_endo -80.39 -45.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.393 2.062 . . . . 0.0 111.924 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 4' ' ' VAL . 23.9 t -117.37 123.41 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.91 128.35 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.785 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.64 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 60.2 t -120.35 106.27 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.068 0.461 . . . . 0.0 111.552 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.735 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.8 tp -89.07 153.84 20.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -145.68 109.03 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.742 ' H ' HG22 ' A' ' 80' ' ' THR . 79.9 t -86.75 70.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.973 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -71.96 -80.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.485 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.612 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.97 55.0 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.96 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 55' ' ' MET . 6.9 Cg_endo -88.34 -156.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.136 2.557 . . . . 0.0 112.161 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -146.34 36.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.97 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.21 129.25 3.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.447 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.49 141.99 53.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.72 -23.06 11.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.658 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.691 ' O ' HD12 ' A' ' 64' ' ' ILE . 21.7 t -53.51 -46.73 60.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.572 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -75.65 -5.39 45.29 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.1 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.901 ' CE2' HD11 ' A' ' 67' ' ' ILE . 16.4 t80 -84.43 -35.72 22.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.571 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.9 mp -45.07 -29.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.466 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.615 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 9.9 t0 -72.34 -51.45 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.12 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 8.8 t80 -50.58 -41.63 54.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.942 0.401 . . . . 0.0 110.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.901 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.1 mp -63.6 -50.19 79.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.42 -15.79 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 110.688 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -73.42 -52.09 14.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.673 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.406 ' ND2' ' OE1' ' A' ' 69' ' ' GLU . 2.4 m120 -112.14 19.75 17.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.436 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -163.67 64.29 1.3 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.684 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 71' ' ' SER . 5.0 Cg_exo -76.02 -13.5 19.33 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.602 2.201 . . . . 0.0 111.99 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 25.54 11.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.083 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.5 t -108.76 -173.3 2.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.976 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.2 t -123.9 162.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.009 0.433 . . . . 0.0 111.293 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.943 HG12 HG23 ' A' ' 78' ' ' VAL . 1.5 t -140.34 105.54 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.378 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 77' ' ' ILE . 34.4 mm -107.25 41.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.943 HG23 HG12 ' A' ' 76' ' ' VAL . 58.8 t -46.23 97.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.572 HG23 ' HB3' ' A' ' 100' ' ' LEU . 31.7 mt -71.61 -101.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.455 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.696 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.09 -14.0 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -81.33 -35.43 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 109.799 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.87 -57.59 12.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.172 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.2 m -59.38 -29.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -75.79 -12.9 60.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.57 -36.34 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.3 pt -80.31 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.917 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.4 mptp? 73.64 -46.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.613 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -21.92 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.786 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.15 -30.07 0.11 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.62 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.766 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -62.48 176.52 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.95 0.405 . . . . 0.0 111.331 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -104.82 27.43 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 79.64 142.67 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.855 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.5 m-30 -63.82 149.39 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.572 ' HB3' HG23 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -81.57 101.72 10.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.205 -179.788 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.881 HG21 HD23 ' A' ' 17' ' ' LEU . 8.0 p . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.673 0.273 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -37.58 87.81 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.81 -36.32 83.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.675 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.64 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 9.6 t80 -59.46 -37.04 77.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.643 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.599 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.53 -42.95 79.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.136 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.34 -47.07 76.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.408 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.7 m -66.15 -41.69 90.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.518 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.9 mm -45.27 -54.33 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.52 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.29 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.033 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -60.92 -30.36 70.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.989 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.612 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -60.38 -39.37 87.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.914 0.387 . . . . 0.0 110.857 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 48' ' ' VAL . 28.2 m-85 -69.6 -15.04 63.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.345 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.77 0.319 . . . . 0.0 111.428 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.835 0.35 . . . . 0.0 111.013 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.418 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -144.98 151.04 37.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.787 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' A' ' 48' ' ' VAL . 30.3 t -133.37 143.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.711 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 29' ' ' ASP . 46.3 tp -106.45 129.75 54.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.959 HG21 ' CD1' ' A' ' 17' ' ' LEU . 17.7 t -117.94 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.594 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 42.9 t -81.84 119.14 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 26.3 t0 -155.15 149.99 26.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 32.3 t70 -90.31 51.43 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.732 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.788 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.78 HG21 ' CG1' ' A' ' 6' ' ' VAL . 61.1 p . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.886 0.374 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 t -58.84 138.03 57.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.981 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.409 ' CB ' HG11 ' A' ' 106' ' ' VAL . 3.1 m 75.84 -0.89 3.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.417 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.046 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -89.96 -52.67 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.347 . . . . 0.0 110.804 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.85 -58.59 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.024 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.22 48.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.011 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.889 HD11 HG13 ' A' ' 106' ' ' VAL . 62.1 mt -68.18 -71.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.331 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.046 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -49.59 -29.72 7.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -74.32 -27.02 60.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.654 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.28 -35.07 28.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.877 ' HG3' HD21 ' A' ' 110' ' ' LEU . 20.7 mm-40 -81.17 -34.62 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.045 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.19 53.27 1.91 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.227 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.475 ' CE2' HG21 ' A' ' 113' ' ' ILE . 7.8 m-85 -112.03 -175.69 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.357 0.599 . . . . 0.0 111.259 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 82.03 31.23 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.816 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.805 ' CB ' HD13 ' A' ' 21' ' ' LEU . 78.2 Cg_endo -82.06 128.02 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.752 2.301 . . . . 0.0 113.926 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.932 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -121.67 114.23 20.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 20.3 p -95.46 128.83 42.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.009 0.433 . . . . 0.0 111.648 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -98.96 163.35 12.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.39 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 5.8 mttt -111.93 -9.15 14.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.249 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.61 152.71 3.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.576 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.2 mt -52.16 -26.64 11.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.55 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -43.45 59.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.986 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 7' ' ' VAL . . . -73.24 -48.83 31.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.479 ' HG3' ' CE2' ' A' ' 66' ' ' PHE . 4.8 tt0 -47.11 -47.39 23.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.33 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -55.39 35.64 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -58.23 -26.33 62.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 41' ' ' ILE . 14.5 mt -90.16 -13.27 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.32 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -97.53 20.71 11.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -140.89 -52.65 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -98.83 155.51 17.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.379 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.417 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 52.5 t80 -88.67 78.23 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.047 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.639 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 16.1 m-85 -66.49 120.39 70.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.7 Cg_endo -80.63 -47.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.311 2.007 . . . . 0.0 111.889 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.813 HG23 ' CE1' ' A' ' 117' ' ' PHE . 36.6 t -115.06 124.9 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.577 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 46' ' ' PHE . 29.2 mm -112.82 124.48 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.51 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.674 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 46.4 t -128.12 108.58 18.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 112.051 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD23 HG13 ' A' ' 78' ' ' VAL . 49.7 tp -82.76 157.76 23.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.408 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -140.17 89.93 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.71 66.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.154 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -77.94 -80.51 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.561 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.8 ttm -146.0 50.46 1.05 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.029 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 55' ' ' MET . 58.0 Cg_endo -92.66 -165.92 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.96 2.44 . . . . 0.0 112.377 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.01 30.6 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.82 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.67 -73.54 0.89 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.562 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 31.2 20.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.17 91.33 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.813 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.892 ' O ' HD12 ' A' ' 64' ' ' ILE . 57.8 t -58.69 -39.78 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.836 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -15.51 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.348 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.94 ' CE2' HD11 ' A' ' 67' ' ' ILE . 45.9 t80 -53.26 -47.12 69.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.892 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.8 mt -46.62 -29.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -65.72 -49.67 67.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.418 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 38' ' ' GLU . 2.0 t80 -53.92 -41.4 67.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.95 0.405 . . . . 0.0 110.138 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.94 HD11 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -62.47 -43.89 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -79.9 -17.35 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.041 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 65' ' ' ASP . 4.0 tt0 -72.07 -45.5 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -112.45 8.06 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.198 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.445 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -155.54 63.95 3.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.877 0.37 . . . . 0.0 110.57 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 71' ' ' SER . 15.0 Cg_exo -67.86 -20.87 45.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.548 2.165 . . . . 0.0 112.082 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.48 23.03 7.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.869 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.407 ' HG ' ' C ' ' A' ' 47' ' ' PRO . 34.7 t -104.81 -176.98 3.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.643 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.682 HG21 ' HB1' ' A' ' 116' ' ' ALA . 31.0 t -123.36 157.23 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.068 0.461 . . . . 0.0 111.257 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -146.2 104.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.134 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 112' ' ' THR . 43.3 mm -90.11 -42.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 HG12 ' A' ' 76' ' ' VAL . 47.2 t 45.97 88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.351 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.713 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -104.28 -177.74 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.503 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.713 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 85' ' ' VAL . 21.3 t . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.594 0.235 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.24 -17.07 62.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.344 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -74.25 -35.23 63.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 0.0 109.944 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.75 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.87 -58.78 6.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.044 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 92' ' ' ILE . 21.3 m -60.25 -25.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.101 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.551 ' HD3' HG21 ' A' ' 61' ' ' VAL . 18.4 ttmm -76.22 -17.27 59.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.78 -39.67 4.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.852 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.8 pt -72.76 -22.73 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.689 0.28 . . . . 0.0 111.53 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -68.72 -30.65 69.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.385 . . . . 0.0 110.41 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -64.76 -57.07 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 34.75 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.29 -167.77 1.93 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.158 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 75.2 t80 -107.64 -17.97 13.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.45 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 4.6 pt-20 145.17 -173.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.504 0.721 . . . . 0.0 110.066 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.512 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -121.45 94.24 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.7 tp -54.15 140.74 31.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.294 -179.816 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.889 HG13 HD11 ' A' ' 20' ' ' ILE . 8.1 p . . . . . 0 C--O 1.232 0.143 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -46.74 -35.87 6.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -39.53 80.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.941 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.742 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 18.0 t80 -55.97 -31.46 63.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.926 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.877 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.4 tt -60.55 -52.55 64.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.147 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -47.05 -40.87 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.499 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.538 HG21 HD12 ' A' ' 77' ' ' ILE . 96.7 m -64.69 -50.19 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.742 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.4 mp -45.5 -52.95 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.922 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -59.12 4.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.0 0.429 . . . . 0.0 109.962 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -31.7 70.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.838 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.682 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.63 -28.36 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.813 ' CE1' HG23 ' A' ' 48' ' ' VAL . 10.7 m-85 -86.93 -56.4 3.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.529 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.457 ' HB2' ' CG ' ' A' ' 26' ' ' TYR . 13.8 mmtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.837 0.351 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.405 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.62 122.65 12.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 48.2 t -129.89 144.81 36.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.934 HD23 HG23 ' A' ' 49' ' ' ILE . 46.5 tp -106.67 140.1 40.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.496 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.83 HG21 ' CD1' ' A' ' 17' ' ' LEU . 19.2 t -118.39 127.07 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.182 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.803 ' HB ' HD12 ' A' ' 51' ' ' LEU . 37.4 t -117.01 115.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -140.49 162.59 34.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.618 -179.256 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' CG ' ' A' ' 56' ' ' PRO . 17.4 t70 -63.54 -85.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.618 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.44 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 68.4 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.704 0.288 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -50.6 138.7 17.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.796 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.519 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.2 m 78.04 -1.98 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.283 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.897 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.12 -53.95 4.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.8 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.31 -60.59 2.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.36 -39.86 47.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.078 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.748 HG23 ' CD1' ' A' ' 110' ' ' LEU . 46.3 mt -64.26 -66.61 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.159 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.897 HD11 HD13 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -50.66 -28.78 9.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -72.61 -27.98 62.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.649 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -82.6 -35.01 27.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.281 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.735 ' HG3' HD21 ' A' ' 110' ' ' LEU . 8.9 mm-40 -80.99 -39.85 25.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.037 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.31 51.0 2.29 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.166 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' A' ' 2' ' ' LYS . 3.4 m-30 -104.1 -174.85 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.376 0.608 . . . . 0.0 111.315 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 77.47 59.45 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.722 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.774 ' HB3' HD22 ' A' ' 21' ' ' LEU . 92.1 Cg_endo -86.45 154.29 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.685 2.257 . . . . 0.0 114.585 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.485 ' O ' HD12 ' A' ' 5' ' ' LEU . 20.5 t70 -140.3 137.36 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.558 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.1 p -114.89 143.38 45.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.208 0.528 . . . . 0.0 112.135 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.89 -173.69 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.056 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 33' ' ' THR . 0.3 OUTLIER -117.65 -22.24 8.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.773 0.321 . . . . 0.0 111.288 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -166.08 167.38 16.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.379 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.785 HD22 ' CD2' ' A' ' 63' ' ' PHE . 12.1 mt -54.53 -32.51 58.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.708 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.002 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -35.42 80.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.01 -56.21 16.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 27.3 mt-10 -45.86 -42.61 12.71 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -45.89 86.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.874 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -71.73 -42.02 67.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.9 mt -71.54 -21.28 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -61.8 -20.73 63.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.125 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -126.68 -55.98 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -64.92 115.62 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -74.26 65.77 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.483 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 37.8 m-85 -63.75 128.78 93.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 11.1 Cg_endo -82.57 -27.6 2.11 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.491 2.127 . . . . 0.0 112.125 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.861 ' O ' HD13 ' A' ' 49' ' ' ILE . 10.6 t -130.48 139.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.934 HG23 HD23 ' A' ' 5' ' ' LEU . 2.0 mm -139.03 108.84 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.727 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.797 HG22 ' CG1' ' A' ' 77' ' ' ILE . 41.8 t -111.05 142.18 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 110.662 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.803 HD12 ' HB ' ' A' ' 7' ' ' VAL . 20.2 tp -101.39 159.88 14.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 6.9 t70 -141.99 79.82 1.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 53' ' ' VAL . 45.3 t -65.89 68.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.666 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 31.0 t-105 -68.57 -79.62 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.923 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.763 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.2 ptt? -144.07 40.61 0.3 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.667 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.763 ' HD3' ' N ' ' A' ' 55' ' ' MET . 57.1 Cg_endo -99.45 -162.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.201 2.601 . . . . 0.0 112.198 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -91.52 -47.27 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.451 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.06 -121.65 14.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.014 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.96 31.32 18.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.408 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -95.04 59.65 1.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.524 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 90' ' ' LYS . 57.6 t -56.39 -38.11 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.153 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.09 15.96 9.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.44 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.958 ' CE2' HD11 ' A' ' 67' ' ' ILE . 47.8 t80 -79.7 -38.42 33.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.81 0.338 . . . . 0.0 110.742 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -48.58 -28.52 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.29 -37.78 60.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 19.4 t80 -57.68 -44.87 86.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.281 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.958 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.0 mp -59.29 -41.88 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.361 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.66 -24.85 49.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.551 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.14 -41.5 94.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.71 12.86 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 68.15 1.18 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.842 0.354 . . . . 0.0 110.668 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -67.98 -20.32 44.84 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.771 2.314 . . . . 0.0 112.138 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.6 28.73 6.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 47.5 t -112.1 -176.25 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.973 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.638 HG11 ' HB1' ' A' ' 116' ' ' ALA . 47.6 t -126.03 143.59 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.125 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.738 HG22 HG21 ' A' ' 67' ' ' ILE . 3.3 t -127.06 95.84 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.726 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.797 ' CG1' HG22 ' A' ' 50' ' ' VAL . 47.9 mm -74.22 -65.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.483 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 76' ' ' VAL . 11.3 t 67.8 88.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -106.45 175.7 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.563 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.594 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.916 0.389 . . . . 0.0 110.892 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 85' ' ' VAL . 15.2 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.878 0.371 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.5 -31.56 32.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.455 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 2.6 t -63.16 -34.48 77.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.874 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.849 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.13 -59.84 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.227 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 92' ' ' ILE . 10.3 m -64.53 -23.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.019 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.519 ' O ' HG13 ' A' ' 61' ' ' VAL . 22.0 ttpt -81.25 -7.6 59.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.427 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -123.29 -40.13 2.41 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.868 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.5 pt -69.8 -40.75 79.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.288 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -56.42 -25.46 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -19.75 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.347 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.85 -3.68 3.49 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.063 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -56.52 -167.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.901 0.381 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.524 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.8 t80 -108.53 26.05 10.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.44 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 79.66 152.65 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.203 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -74.83 103.08 4.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.948 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.4 tp -80.61 53.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.654 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 111.323 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.632 HG21 HD23 ' A' ' 17' ' ' LEU . 5.4 m . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -40.95 -50.51 3.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.203 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -35.41 80.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.23 0.538 . . . . 0.0 109.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.6 ' HE2' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -58.3 -24.09 58.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.213 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.748 ' CD1' HG23 ' A' ' 20' ' ' ILE . 1.2 tt -60.27 -49.08 79.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.221 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.596 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.4 mp -56.31 -56.15 24.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.33 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.436 HG23 ' HE2' ' A' ' 97' ' ' TYR . 60.8 m -53.72 -57.95 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 7.4 mm -31.58 -62.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.5 -59.2 3.97 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -52.67 -28.33 21.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.693 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.638 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -70.27 -32.66 70.57 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS . 26.6 m-85 -68.75 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.141 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.377 -179.575 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.2 mptt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.912 0.387 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.8 132.5 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.709 HG11 ' CD1' ' A' ' 113' ' ' ILE . 7.4 t -123.75 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.63 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.6 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 43.5 tp -103.66 132.74 49.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.733 HG21 ' CD1' ' A' ' 17' ' ' LEU . 34.1 t -113.26 90.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.254 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.14 104.63 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -135.32 134.39 39.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.95 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 t0 -73.29 -40.79 64.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.41 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.7 p . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 t -76.99 -65.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.44 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m -73.16 -53.43 11.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.396 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.7 tm? -46.81 -53.94 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.246 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.533 ' OG ' HG21 ' A' ' 30' ' ' THR . 71.3 m -52.8 -43.58 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.94 96.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.424 ' CG2' ' CD1' ' A' ' 110' ' ' LEU . 55.5 mt -56.22 -67.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.59 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.527 HD21 HG13 ' A' ' 113' ' ' ILE . 1.4 mt -47.47 -33.32 6.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 110.497 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.23 -29.96 71.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.589 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -78.51 -37.07 44.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.408 ' CD ' HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -70.61 -22.27 62.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.085 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.54 58.47 0.81 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.378 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.464 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 55.7 m-85 -130.14 -177.27 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.431 . . . . 0.0 111.116 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.1 76.18 77.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.448 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 11.7 Cg_exo -67.7 137.7 42.94 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.795 2.33 . . . . 0.0 112.631 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.2 t70 -120.63 7.85 10.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 6' ' ' VAL . 13.7 p 6.04 122.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.24 -162.41 0.93 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.86 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 ttpt -117.22 -38.46 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 32' ' ' LYS . 13.9 p -161.3 -173.06 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.538 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 63' ' ' PHE . 16.5 mt -66.79 -45.75 77.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.456 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -62.85 -45.88 90.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.157 0.504 . . . . 0.0 109.937 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -32.35 71.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -72.93 -28.68 62.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.704 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mt-10 -69.76 -43.49 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -60.04 -39.9 87.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.66 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -70.37 -46.82 63.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.721 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 37' ' ' ALA . 11.7 mt -73.0 -20.43 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.567 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -57.98 -21.17 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.371 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -126.46 -43.73 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -77.76 122.93 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.044 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -81.05 85.25 6.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.6 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 61.1 m-85 -80.79 113.97 44.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.367 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 74' ' ' SER . 71.6 Cg_endo -74.17 -20.39 19.01 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.655 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.3 t -144.72 129.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.299 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 7.6 mm -117.22 157.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.251 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 109' ' ' PHE . 74.9 t -149.34 102.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 110.767 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.479 HD23 HG13 ' A' ' 78' ' ' VAL . 60.1 tp -78.42 148.17 33.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.312 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.5 OUTLIER -130.24 84.06 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.242 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.649 ' N ' HG21 ' A' ' 80' ' ' THR . 87.3 t -62.88 72.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.978 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 55' ' ' MET . 27.9 t90 -64.92 -97.15 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.623 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -135.99 38.58 0.39 Allowed Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 55' ' ' MET . 69.5 Cg_endo -85.33 -164.72 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.425 2.083 . . . . 0.0 112.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -143.96 41.45 1.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.5 179.9 36.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.388 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.97 77.46 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.83 -25.87 62.09 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.554 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.451 ' O ' HD12 ' A' ' 64' ' ' ILE . 24.4 t -54.56 -44.53 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 120.756 0.312 . . . . 0.0 111.45 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.7 6.67 40.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.472 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 67' ' ' ILE . 34.9 t80 -90.07 -37.51 14.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.7 mp -47.95 -28.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.359 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -77.15 -36.22 55.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.703 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 61.2 t80 -59.15 -42.83 91.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.974 0.416 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.869 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.5 mp -59.85 -43.27 91.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.317 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.25 -16.04 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -74.0 -34.34 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.412 . . . . 0.0 110.737 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.41 13.31 7.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.029 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.29 66.89 1.94 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.584 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.25 -20.9 42.48 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.655 2.237 . . . . 0.0 112.187 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -100.04 30.42 3.76 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 44.5 t -113.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.478 HG11 ' HB1' ' A' ' 116' ' ' ALA . 58.0 t -152.92 136.83 8.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 111.646 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.635 HG12 HG23 ' A' ' 78' ' ' VAL . 3.4 t -108.77 113.94 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.866 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 79' ' ' ILE . 47.3 mm -91.22 -65.33 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.635 HG23 HG12 ' A' ' 76' ' ' VAL . 58.0 t 52.8 97.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.134 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.695 HD13 HD23 ' A' ' 100' ' ' LEU . 17.0 mt -126.22 142.54 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.649 HG21 ' N ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.736 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.758 0.313 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -83.76 3.44 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.216 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -37.57 13.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.28 -57.66 11.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.154 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.7 m -60.96 -25.89 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.478 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 61' ' ' VAL . 6.0 tttp -81.22 -18.21 46.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.531 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.7 -30.12 8.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 88' ' ' ALA . 4.7 pt -82.17 -23.45 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.197 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -68.95 -35.37 76.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpm? -59.25 -27.51 65.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.888 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.82 35.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.934 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.83 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.06 -165.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.481 ' HE2' HG23 ' A' ' 112' ' ' THR . 59.2 t80 -110.98 25.09 12.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.303 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.8 OUTLIER 85.37 161.9 0.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.653 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.739 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -95.36 95.07 8.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.306 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.695 HD23 HD13 ' A' ' 79' ' ' ILE . 20.2 tp -49.88 98.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.541 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 106' ' ' VAL . 7.2 p . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.76 -43.66 18.07 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -62.24 -34.83 77.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.307 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.615 ' HD2' HG23 ' A' ' 106' ' ' VAL . 1.6 t80 -63.32 -46.44 86.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.167 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.424 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -48.91 -37.26 19.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.456 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.21 -45.79 72.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.328 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.661 ' CG2' HD12 ' A' ' 77' ' ' ILE . 86.8 m -46.46 -40.79 12.92 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.399 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.709 ' CD1' HG11 ' A' ' 4' ' ' VAL . 12.9 mm -62.32 -65.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.716 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -14.9 3.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.743 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.25 -30.92 18.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.112 0.482 . . . . 0.0 109.718 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -79.44 -33.94 42.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.385 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 14.8 m-85 -70.26 -29.59 66.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.815 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.52 120.26 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.609 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.653 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.9 t -116.28 159.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.772 HD11 ' HD3' ' A' ' 40' ' ' LYS . 49.8 tp -109.58 129.66 55.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.896 HG21 ' CD1' ' A' ' 17' ' ' LEU . 24.6 t -115.38 89.45 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.673 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.13 115.21 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.137 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -149.35 143.15 25.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.403 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -87.44 50.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.437 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.434 HG21 ' CG1' ' A' ' 6' ' ' VAL . 52.6 p . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.8 136.3 47.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.138 0.494 . . . . 0.0 112.028 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.653 ' CB ' HG11 ' A' ' 106' ' ' VAL . 1.4 m 74.26 0.57 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.364 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.984 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.05 -53.35 4.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.859 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 t -44.57 -55.56 5.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.29 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.935 HD11 HG13 ' A' ' 106' ' ' VAL . 64.6 mt -65.22 -69.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.984 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.97 -30.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.51 -30.32 67.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -34.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 110.273 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.845 ' HG3' HD21 ' A' ' 110' ' ' LEU . 10.1 mm-40 -83.41 -36.98 23.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.08 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.11 54.26 1.77 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.269 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -108.59 -173.3 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 111.241 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.42 88.8 33.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.219 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HG3' HD13 ' A' ' 21' ' ' LEU . 85.1 Cg_endo -80.93 130.98 7.75 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.653 2.235 . . . . 0.0 112.811 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.4 t70 -105.57 5.04 30.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.347 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.79 HG22 ' HB ' ' A' ' 6' ' ' VAL . 10.4 p 2.14 124.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.786 ' HB2' ' CD ' ' A' ' 40' ' ' LYS . . . -106.71 -163.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.625 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -118.14 -36.45 3.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -158.56 179.94 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD22 ' CD2' ' A' ' 63' ' ' PHE . 56.3 mt -60.03 -47.41 85.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.92 -45.26 86.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.542 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -70.87 -32.15 69.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -75.19 -28.97 60.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 55.4 mt-10 -72.1 -39.95 68.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -32.26 69.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.688 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.786 ' CD ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -78.31 -37.6 44.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.773 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 37' ' ' ALA . 21.7 mt -76.97 -27.16 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -5.48 30.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.776 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.03 -27.38 10.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -134.83 156.38 49.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 69.1 t80 -91.66 96.46 10.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.947 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 38.9 m-85 -79.76 122.49 83.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.341 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.71 -20.5 7.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.511 2.141 . . . . 0.0 111.934 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.9 t -148.31 133.82 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.17 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.699 HG23 HD23 ' A' ' 5' ' ' LEU . 6.2 mm -121.01 163.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 60.1 t -154.06 99.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.843 ' HB3' HG13 ' A' ' 78' ' ' VAL . 42.5 tp -79.6 163.3 24.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 8.7 t70 -151.17 88.84 1.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.224 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.9 m -67.63 66.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.652 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -58.32 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.43 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.692 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.8 OUTLIER -152.5 49.5 0.53 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.104 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.692 ' HD3' ' N ' ' A' ' 55' ' ' MET . 36.6 Cg_endo -94.53 -162.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.09 2.527 . . . . 0.0 112.293 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -152.08 43.64 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.92 -21.26 5.02 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.815 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.434 ' OD1' HG23 ' A' ' 61' ' ' VAL . 0.4 OUTLIER 63.97 123.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.758 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -94.65 11.98 69.28 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.971 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 90' ' ' LYS . 46.5 t -68.78 -41.9 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.851 0.358 . . . . 0.0 111.045 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.28 4.79 49.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.85 ' CE2' HD11 ' A' ' 67' ' ' ILE . 24.8 t80 -90.09 -36.63 14.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.285 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.518 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.2 mp -47.05 -29.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.366 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -35.35 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 29.8 t80 -59.88 -41.36 91.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.85 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.2 mp -61.57 -43.46 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.212 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -25.89 58.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.396 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -63.84 -39.98 95.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 16.38 11.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.428 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -166.56 70.13 1.09 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.817 0.341 . . . . 0.0 110.822 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.46 -18.4 29.58 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.795 2.33 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.75 27.19 9.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.989 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.7 t -104.4 -159.82 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.395 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 48' ' ' VAL . 52.4 t -150.11 135.15 10.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 111.695 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.763 HG12 HG23 ' A' ' 78' ' ' VAL . 8.2 t -110.53 116.05 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.643 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.793 HG21 HG21 ' A' ' 112' ' ' THR . 16.1 mm -118.49 50.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 51' ' ' LEU . 44.7 t -49.64 115.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.677 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -110.26 179.16 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.749 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.723 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.832 0.348 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -94.84 -19.88 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -34.31 23.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.49 -59.38 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.846 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.8 m -55.39 -28.02 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.096 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 61' ' ' VAL . 14.4 tttt -80.13 -9.16 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.414 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -120.08 -31.41 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.953 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.3 pt -79.21 -44.72 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.738 0.304 . . . . 0.0 111.417 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.42 ' N ' HG13 ' A' ' 92' ' ' ILE . 27.8 mttp -63.21 -17.93 62.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.782 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -25.87 52.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.2 -16.13 0.29 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.629 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -59.17 -179.65 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.41 0.605 . . . . 0.0 111.043 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 85.1 t80 -99.81 -7.8 24.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.785 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.561 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 17.9 pt-20 140.99 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.276 0.63 . . . . 0.0 110.663 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.563 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.41 91.11 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.751 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.662 ' HB3' HG23 ' A' ' 79' ' ' ILE . 14.6 tp -55.64 167.34 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.935 HG13 HD11 ' A' ' 20' ' ' ILE . 7.3 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.666 0.269 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -44.96 -31.94 1.46 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.939 0.4 . . . . 0.0 110.481 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.426 ' HA ' HD13 ' A' ' 111' ' ' LEU . 4.6 mmt180 -70.17 -41.44 73.79 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.679 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 3.7 t80 -55.02 -29.26 57.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.954 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -56.36 -39.74 73.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.764 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 108' ' ' ARG . 8.2 mp -59.21 -60.03 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.793 HG21 HG21 ' A' ' 77' ' ' ILE . 80.0 m -44.12 -48.38 9.07 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.148 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.679 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 40.7 mm -54.76 -73.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.603 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -17.75 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -90.13 -20.81 22.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.4 -47.24 12.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 48' ' ' VAL . 57.7 m-85 -56.8 -29.86 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.103 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 179.88 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 17.1 mmtm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.919 0.39 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.9 134.65 23.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.597 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.627 HG13 ' HB ' ' A' ' 48' ' ' VAL . 10.9 t -125.34 160.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.572 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 61.5 tp -112.93 128.59 56.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.845 HG21 HD12 ' A' ' 17' ' ' LEU . 44.4 t -108.47 90.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.865 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 19.1 t -86.89 119.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.159 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -158.93 139.67 12.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.495 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.417 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 43.4 t0 -90.24 50.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.897 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 p . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 p -63.37 140.59 58.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.9 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.734 ' HB2' HG11 ' A' ' 106' ' ' VAL . 2.5 m 79.37 -5.36 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.563 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.019 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.18 -49.06 6.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 110.922 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.2 p -47.68 -49.24 28.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.79 68.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.745 HG23 HD11 ' A' ' 110' ' ' LEU . 91.4 mt -54.2 -69.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.162 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.019 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -45.08 -33.65 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.18 -28.82 65.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -83.07 -35.65 25.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.848 ' HG3' HD21 ' A' ' 110' ' ' LEU . 69.4 mm-40 -78.21 -38.72 42.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.943 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.58 26.58 7.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.354 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 49.2 m-85 -84.25 -174.94 5.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.989 0.423 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -133.13 86.57 41.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' A' ' 21' ' ' LEU . 95.2 Cg_endo -81.38 129.54 6.69 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.663 2.242 . . . . 0.0 112.442 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.0 t70 -106.92 -4.65 18.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 112.049 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 29' ' ' ASP . 69.2 p 43.72 174.54 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.703 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.865 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -164.01 170.43 16.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.419 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -104.76 -40.75 5.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -161.86 -174.49 4.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.571 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.687 HD22 ' CD2' ' A' ' 63' ' ' PHE . 45.8 mt -65.26 -41.34 94.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.708 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -61.53 -49.29 77.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 109.989 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.86 -34.85 77.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.57 -26.85 63.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 27.4 mt-10 -69.97 -46.62 64.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.873 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -62.28 -32.96 73.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.223 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -77.95 -40.36 39.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.229 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.661 HD12 ' HZ ' ' A' ' 63' ' ' PHE . 96.6 mt -76.87 -29.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 111.308 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.27 -25.84 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.358 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.79 -60.43 1.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.082 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -59.4 129.34 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.14 80.9 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 56.8 m-85 -78.77 119.2 76.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 95.8 Cg_endo -78.97 -22.11 8.96 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.512 2.141 . . . . 0.0 111.958 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.627 ' HB ' HG13 ' A' ' 4' ' ' VAL . 4.6 t -145.43 127.6 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.623 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.546 HG23 HD23 ' A' ' 5' ' ' LEU . 11.8 mm -113.98 152.09 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.827 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.79 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 84.5 t -139.56 94.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.508 . . . . 0.0 110.682 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 78' ' ' VAL . 37.6 tp -76.75 160.27 29.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.592 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 5.1 t0 -153.55 79.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.984 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.784 HG22 ' HB ' ' A' ' 80' ' ' THR . 28.6 m -59.24 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.283 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.432 ' CG ' ' N ' ' A' ' 55' ' ' MET . 14.8 t90 -63.41 -90.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.649 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.5 tpt -148.5 51.68 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.87 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.649 ' HD3' ' N ' ' A' ' 55' ' ' MET . 44.5 Cg_endo -92.54 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.898 2.399 . . . . 0.0 112.676 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -170.22 -68.5 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.785 0.326 . . . . 0.0 111.296 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.36 159.35 3.99 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.97 23.72 14.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 10.24 8.81 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.779 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 64' ' ' ILE . 27.3 t -84.34 -44.39 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.512 0.656 . . . . 0.0 110.964 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -68.39 -13.52 62.35 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.856 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.687 ' CD2' HD22 ' A' ' 34' ' ' LEU . 4.7 t80 -86.88 -27.45 23.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.315 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 61' ' ' VAL . 15.2 mm -47.59 -46.05 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.0 111.204 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -42.42 93.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.523 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 26.6 t80 -58.71 -29.97 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.113 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 1.065 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mm -64.71 -48.44 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.491 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -82.04 -14.28 56.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.24 -39.37 68.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.917 0.389 . . . . 0.0 110.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.48 11.48 9.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -157.43 66.62 3.77 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 110.673 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.0 Cg_exo -70.17 -19.49 34.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.745 2.297 . . . . 0.0 112.207 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.39 29.74 6.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.675 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 35.1 t -111.83 -162.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.757 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' PRO . 25.8 t -151.51 134.41 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.035 0.445 . . . . 0.0 111.81 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.065 HG22 HG21 ' A' ' 67' ' ' ILE . 2.0 t -111.44 111.79 37.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.756 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.626 HD13 ' HB3' ' A' ' 97' ' ' TYR . 37.5 mm -92.83 -42.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.309 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.014 HG23 HG12 ' A' ' 76' ' ' VAL . 40.7 t 46.0 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.271 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 100' ' ' LEU . 31.8 mt -56.3 -101.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.212 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.784 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.1 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 110.752 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.764 0.316 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -89.67 -60.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.729 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.645 HG23 ' CE2' ' A' ' 99' ' ' PHE . 5.3 t -46.09 -32.77 3.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.139 0.495 . . . . 0.0 110.305 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.902 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.24 -60.27 3.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.086 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 86' ' ' ASP . 28.0 m -61.88 -24.43 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.223 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.456 ' CD ' HG21 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -81.23 -32.48 33.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.14 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.17 -34.92 14.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.48 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.902 HG23 ' O ' ' A' ' 88' ' ' ALA . 2.7 pt -80.3 157.19 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.781 0.324 . . . . 0.0 110.754 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 mttm 72.42 6.1 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.162 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.49 26.66 5.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 110.565 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.62 -18.82 5.97 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.402 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -84.96 -169.8 2.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 111.248 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 77' ' ' ILE . 82.9 t80 -125.72 29.77 5.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 80.95 138.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.921 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.655 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.6 m-85 -66.08 128.97 38.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.061 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -71.93 118.11 14.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.952 HG21 HD23 ' A' ' 17' ' ' LEU . 7.4 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.666 0.27 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -45.23 -34.1 2.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.6 -39.99 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.9 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.79 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 1.5 t80 -56.39 -30.45 62.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.961 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.848 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -51.81 -42.84 62.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.229 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.427 ' H ' HD12 ' A' ' 111' ' ' LEU . 7.3 mp -57.61 -58.76 6.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.055 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.54 HG21 HD22 ' A' ' 100' ' ' LEU . 94.0 m -46.94 -41.28 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.76 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 23.0 mm -54.13 -68.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.313 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -15.51 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.839 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -90.27 -22.3 21.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -84.31 -37.75 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.06 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.419 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -66.84 -34.42 77.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.311 -179.832 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.944 0.402 . . . . 0.0 110.931 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.5 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -143.98 139.98 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.966 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.547 HG13 ' HB ' ' A' ' 48' ' ' VAL . 78.2 t -128.56 155.18 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.959 0.409 . . . . 0.0 111.065 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.077 HD23 HG23 ' A' ' 49' ' ' ILE . 40.6 tp -115.19 134.55 55.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.75 HG21 HD12 ' A' ' 17' ' ' LEU . 14.4 t -120.35 102.61 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.986 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.463 ' HB ' HD12 ' A' ' 51' ' ' LEU . 31.9 t -93.21 117.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.576 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 23.1 t0 -159.5 157.47 30.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 26.6 t70 -89.6 51.12 2.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.181 0.515 . . . . 0.0 110.569 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.515 179.795 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.8 0.333 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 52.8 p -50.06 141.74 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.619 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.588 ' CB ' HG11 ' A' ' 106' ' ' VAL . 1.3 m 85.95 -20.93 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.196 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.094 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -86.99 -47.12 9.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -50.33 -47.42 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.32 74.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.694 HG23 ' CD1' ' A' ' 110' ' ' LEU . 97.8 mt -58.12 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.094 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -45.12 -32.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.388 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.06 -29.79 63.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -83.52 -35.76 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.563 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.874 ' HG3' HD21 ' A' ' 110' ' ' LEU . 65.1 mm-40 -75.33 -35.49 61.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.21 44.4 2.79 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.529 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 53.6 m-85 -102.97 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 81.46 67.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.429 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.631 ' HB3' HD22 ' A' ' 21' ' ' LEU . 91.8 Cg_endo -83.12 142.11 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.78 2.32 . . . . 0.0 113.468 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.639 ' O ' HD12 ' A' ' 5' ' ' LEU . 24.2 t0 -136.23 65.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.373 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 6' ' ' VAL . 10.5 p -56.14 133.29 52.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.832 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.07 -160.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.336 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 33' ' ' THR . 3.7 mttt -120.66 -30.17 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.622 0.248 . . . . 0.0 111.336 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 32' ' ' LYS . 3.1 p -163.18 179.2 7.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.724 HD22 ' CD2' ' A' ' 63' ' ' PHE . 9.0 mt -61.45 -40.2 93.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.52 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 110.093 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -61.6 -33.53 74.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.196 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.68 -57.41 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 38.3 mt-10 -46.77 -41.13 14.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.766 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -43.41 95.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -44.44 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.854 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mt -71.17 -19.83 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.41 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -22.96 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -129.92 -59.38 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.88 114.45 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -79.83 67.05 5.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 46.0 m-85 -57.63 132.53 82.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 1.1 Cg_endo -77.74 -36.0 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.544 2.163 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.568 ' O ' HD13 ' A' ' 49' ' ' ILE . 20.0 t -125.82 133.93 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.077 HG23 HD23 ' A' ' 5' ' ' LEU . 1.8 mm -132.67 102.13 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.666 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 77' ' ' ILE . 31.0 t -100.47 125.61 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.279 . . . . 0.0 110.976 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.641 ' HB3' HG13 ' A' ' 78' ' ' VAL . 37.7 tp -90.53 161.49 15.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.45 . . . . 0.0 110.842 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -152.8 93.14 1.72 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 53' ' ' VAL . 57.2 t -73.9 63.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.404 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -63.39 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.319 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 35.6 mmm -139.71 37.19 0.27 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.648 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 55' ' ' MET . 92.8 Cg_endo -79.24 -165.42 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.294 1.996 . . . . 0.0 112.278 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -134.37 27.36 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.53 -86.64 1.9 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 59.16 54.37 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.69 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.35 110.49 3.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.831 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.863 ' O ' HD12 ' A' ' 64' ' ' ILE . 99.0 t -63.22 -36.13 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -6.53 48.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.61 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.0 ' CE2' HD11 ' A' ' 67' ' ' ILE . 48.3 t80 -62.07 -38.07 87.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.698 0.285 . . . . 0.0 111.165 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.863 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mt -48.57 -30.2 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.154 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.39 -34.01 63.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.651 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 26.8 t80 -61.2 -44.27 97.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 1.0 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -60.85 -41.2 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.393 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -21.0 46.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -68.03 -37.29 81.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.33 9.04 10.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.309 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.64 67.26 2.54 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.51 -18.93 33.15 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.702 2.268 . . . . 0.0 112.233 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -102.18 30.35 4.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.714 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.4 t -117.93 -179.79 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.797 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.6 143.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.574 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 67' ' ' ILE . 2.6 t -123.01 100.31 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.888 0.375 . . . . 0.0 110.976 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.824 ' O ' HG13 ' A' ' 50' ' ' VAL . 12.2 mm -104.18 74.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.641 HG13 ' HB3' ' A' ' 51' ' ' LEU . 19.6 t -67.79 118.75 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 100' ' ' LEU . 17.1 mt -125.83 157.97 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.479 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.455 HG22 HG23 ' A' ' 53' ' ' VAL . 25.1 p . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.117 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.787 0.327 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.32 -23.64 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.092 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -35.38 76.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -55.32 -59.16 5.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' HG12 ' A' ' 92' ' ' ILE . 26.3 m -62.38 -34.74 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.996 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.618 ' HD3' HG21 ' A' ' 61' ' ' VAL . 5.7 tttm -72.67 -10.67 60.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.603 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.543 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -106.9 -27.97 10.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.906 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.3 pt -88.17 -35.75 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -61.25 -31.33 71.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.844 ' HB2' HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -60.32 -65.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.744 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 25.69 0.08 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.044 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.38 -167.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.834 0.317 . . . . 0.0 110.897 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.661 ' HB3' HD13 ' A' ' 77' ' ' ILE . 62.0 t80 -108.98 -17.56 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.31 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 13.1 pt-20 152.01 -173.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.244 0.617 . . . . 0.0 110.375 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -122.66 90.45 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.616 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.718 ' O ' HG23 ' A' ' 79' ' ' ILE . 9.1 tp -50.46 107.82 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.34 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.958 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.887 HG21 HD23 ' A' ' 17' ' ' LEU . 10.5 p . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.844 0.354 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.06 -37.03 19.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 tpt85 -68.17 -40.07 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.768 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 50' ' ' VAL . 2.0 t80 -57.46 -27.09 62.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.992 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.874 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.2 tt -57.71 -48.4 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.137 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.4 mp -52.64 -53.19 50.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.307 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 m -51.89 -58.61 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.387 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 9.0 mm -32.93 -63.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.969 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -59.58 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -51.46 -27.54 10.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.688 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -71.56 -35.34 70.58 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.817 0.341 . . . . 0.0 111.033 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.7 -39.18 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.978 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.274 -179.607 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 3.6 mptt . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 124.21 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.71 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.638 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.5 t -122.64 143.75 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.992 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.516 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 20.3 tp -90.12 132.5 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.73 HG21 ' CD1' ' A' ' 17' ' ' LEU . 14.0 t -119.3 89.59 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.66 114.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 31.6 t0 -155.09 152.1 29.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.5 48.73 1.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.677 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.501 HG23 ' CG1' ' A' ' 6' ' ' VAL . 81.3 p . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 t -71.42 131.9 44.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.961 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.452 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.8 m 77.35 -5.84 2.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.511 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.39 -55.15 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.063 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -47.07 -56.99 5.53 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.373 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.41 -39.2 64.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.05 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.879 HD12 HG23 ' A' ' 106' ' ' VAL . 45.2 mt -64.56 -66.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.304 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.953 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.62 -29.73 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -69.92 -28.82 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.902 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.79 -36.06 23.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.487 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.842 ' HG3' HD21 ' A' ' 110' ' ' LEU . 6.8 mm-40 -81.73 -39.0 24.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.39 31.89 5.97 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.177 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 4.9 m-85 -81.66 -172.79 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 88.76 25.4 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HG3' HD13 ' A' ' 21' ' ' LEU . 74.3 Cg_endo -78.63 129.35 9.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.469 2.113 . . . . 0.0 112.592 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 30' ' ' THR . 18.2 t70 -99.96 2.17 43.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.754 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.703 HG22 ' HB ' ' A' ' 6' ' ' VAL . 3.2 p 1.76 124.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.93 -160.65 0.73 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.349 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 19.0 mttp -113.65 -31.94 6.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -163.12 -175.28 4.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.745 HD22 ' CD2' ' A' ' 63' ' ' PHE . 9.6 mt -63.23 -44.23 95.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.638 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.03 -54.02 51.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.195 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.119 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.488 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.44 -28.62 64.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.772 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 19.0 mt-10 -71.47 -43.18 67.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.23 75.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.009 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -75.59 -35.35 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 37' ' ' ALA . 20.3 mt -76.03 -26.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.787 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -77.77 -5.4 50.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.26 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -101.07 -51.74 3.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.764 0.316 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.918 HD11 ' CE1' ' A' ' 46' ' ' PHE . 3.0 pp -117.69 -179.61 3.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.077 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.6 ' N ' HD12 ' A' ' 44' ' ' LEU . 1.7 t80 -107.14 111.02 23.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.918 ' CE1' HD11 ' A' ' 44' ' ' LEU . 64.0 m-85 -98.08 113.01 63.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.406 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HG2' ' CE2' ' A' ' 117' ' ' PHE . 63.6 Cg_endo -73.15 -19.38 22.78 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.659 2.239 . . . . 0.0 111.929 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.5 t -148.63 134.23 11.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.422 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.408 HD12 HD23 ' A' ' 5' ' ' LEU . 23.4 mm -116.89 157.15 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.425 HG21 ' CE1' ' A' ' 109' ' ' PHE . 43.1 t -151.42 101.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.183 0.516 . . . . 0.0 112.073 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.455 ' HB3' HG13 ' A' ' 78' ' ' VAL . 14.1 tp -75.03 168.63 19.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.797 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -127.37 -47.27 1.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.674 0.273 . . . . 0.0 111.404 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 53' ' ' VAL . 23.2 t 68.54 37.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.965 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -63.92 -82.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.53 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.704 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.2 ttm -152.1 47.69 0.42 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.358 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.704 ' HD3' ' N ' ' A' ' 55' ' ' MET . 29.3 Cg_endo -95.05 -161.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.06 2.507 . . . . 0.0 112.162 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.32 29.68 7.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.65 -97.79 2.08 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.601 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 55.36 54.21 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.418 . . . . 0.0 110.535 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' H ' HD11 ' A' ' 34' ' ' LEU . . . -100.1 106.66 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.746 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.691 HG21 ' HD2' ' A' ' 90' ' ' LYS . 97.0 t -63.69 -32.47 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.825 0.345 . . . . 0.0 111.012 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -3.77 48.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.754 ' CE2' HD11 ' A' ' 67' ' ' ILE . 23.6 t80 -60.77 -31.38 70.73 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.578 0.228 . . . . 0.0 110.987 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -46.74 -38.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.59 -53.29 56.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 20.1 t80 -51.11 -30.75 17.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 110.217 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.838 HG21 HG22 ' A' ' 76' ' ' VAL . 3.8 mm -64.87 -53.34 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -74.21 -19.05 60.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.851 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.17 -44.62 83.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.867 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.56 10.19 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.436 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.69 66.62 2.79 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.777 0.322 . . . . 0.0 110.832 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.54 -19.62 32.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.84 2.36 . . . . 0.0 112.305 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -107.33 34.66 3.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 48.5 t -116.35 -158.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' A' ' 48' ' ' VAL . 39.2 t -150.57 135.58 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-O 120.917 0.389 . . . . 0.0 111.449 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.838 HG22 HG21 ' A' ' 67' ' ' ILE . 1.7 t -112.53 106.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.414 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' A' ' 97' ' ' TYR . 36.5 mm -89.0 -49.38 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.72 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.821 HG23 HG12 ' A' ' 76' ' ' VAL . 59.3 t 52.69 81.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.363 . . . . 0.0 111.104 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 77' ' ' ILE . 2.4 mt -105.39 155.11 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.353 . . . . 0.0 111.006 -179.855 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.748 0.309 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.86 -26.47 65.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.5 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.5 t -75.55 -33.26 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -59.94 -59.28 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.99 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 92' ' ' ILE . 18.0 m -58.78 -21.48 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.018 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.691 ' HD2' HG21 ' A' ' 61' ' ' VAL . 22.3 ttpt -83.85 -9.65 58.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.591 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.32 -33.93 4.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.873 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 12.2 pt -73.05 -38.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.673 0.273 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -25.29 64.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.636 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.6 -57.54 3.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.11 33.45 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.19 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.873 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.11 -164.29 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 110.727 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.582 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.1 t80 -108.53 25.32 11.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.245 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.443 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 82.49 17.98 0.33 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.013 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.586 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 57.56 166.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.25 179.371 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -119.56 122.17 41.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.786 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.879 HG23 HD12 ' A' ' 20' ' ' ILE . 34.3 m . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.596 0.236 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -41.46 -44.7 2.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.815 0.341 . . . . 0.0 111.225 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -36.07 74.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.138 0.494 . . . . 0.0 109.816 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.639 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 1.4 t80 -56.17 -23.97 38.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.842 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -62.23 -49.2 76.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.663 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.0 mp -57.09 -57.68 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.49 HG23 ' HE2' ' A' ' 97' ' ' TYR . 97.4 m -54.47 -43.68 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -41.8 -54.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.011 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 0.0 109.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -55.87 -24.89 39.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -67.55 -37.68 83.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.049 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.572 ' CE1' HG21 ' A' ' 48' ' ' VAL . 27.4 m-85 -75.57 -17.49 60.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.956 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.257 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.457 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 6.0 mptt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.878 0.371 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 126.25 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.726 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.652 HG13 ' HB ' ' A' ' 48' ' ' VAL . 23.8 t -122.47 152.53 26.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 110.867 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.641 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 47.0 tp -103.48 135.33 45.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.856 ' HB ' HG22 ' A' ' 30' ' ' THR . 15.1 t -120.74 89.01 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.69 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.509 ' HB ' HD12 ' A' ' 51' ' ' LEU . 21.2 t -78.88 115.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.716 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 22.5 t70 -155.27 163.24 40.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.313 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -83.8 48.75 1.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.987 0.422 . . . . 0.0 111.08 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.674 179.697 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.621 HG21 ' CG1' ' A' ' 6' ' ' VAL . 60.7 p . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.5 t -83.77 134.96 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 111.679 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m 81.35 -10.38 1.19 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.306 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.938 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.15 -50.67 5.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 110.613 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.06 -54.95 7.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.86 66.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.777 HD11 HG13 ' A' ' 106' ' ' VAL . 70.8 mt -69.22 -69.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.309 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -45.72 -32.7 2.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.486 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -27.83 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.013 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -82.94 -35.56 25.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.441 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.916 ' HG3' HD21 ' A' ' 110' ' ' LEU . 2.9 mm-40 -81.31 -31.87 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.988 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.2 29.83 6.58 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.189 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CE1' ' CG ' ' A' ' 2' ' ' LYS . 46.1 m-85 -86.31 -173.97 4.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.049 0.452 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -138.25 89.36 14.3 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.037 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HB3' HD13 ' A' ' 21' ' ' LEU . 73.3 Cg_endo -77.95 132.38 11.7 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.54 2.16 . . . . 0.0 112.594 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -104.5 -4.31 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.193 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.856 HG22 ' HB ' ' A' ' 6' ' ' VAL . 43.0 p 12.95 121.75 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.38 156.35 21.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.364 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.688 ' O ' HG23 ' A' ' 33' ' ' THR . 2.2 mtmp? -80.68 -28.36 36.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -167.93 178.76 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.615 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 63' ' ' PHE . 16.6 mt -57.5 -33.12 67.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -56.32 18.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.22 -29.43 70.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.33 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -72.9 -29.02 62.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 26.5 mt-10 -71.19 -41.23 70.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 109.903 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -33.9 76.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -77.83 -35.91 50.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.854 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 37' ' ' ALA . 19.9 mt -78.47 -25.17 13.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.812 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -90.26 28.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.257 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -146.17 -46.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.531 HD22 ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -113.55 155.52 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.451 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 9.1 t80 -85.5 90.42 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.332 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.641 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 9.5 m-85 -76.66 113.82 33.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.55 -23.8 9.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.472 2.115 . . . . 0.0 112.146 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.652 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.6 t -146.58 133.41 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.625 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.582 HG23 HD23 ' A' ' 5' ' ' LEU . 23.8 mm -115.96 150.01 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.098 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.633 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 77.9 t -142.78 100.06 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.398 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.589 HD23 HG13 ' A' ' 78' ' ' VAL . 8.9 tp -86.09 149.1 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 t0 -140.2 107.15 5.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 53' ' ' VAL . 20.3 m -75.31 61.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.673 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -69.58 -79.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.801 0.334 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.697 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 6.1 ttt -153.72 49.96 0.53 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.983 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.697 ' HD3' ' N ' ' A' ' 55' ' ' MET . 19.5 Cg_endo -93.47 -159.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.143 2.562 . . . . 0.0 112.119 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -142.61 38.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.22 -82.24 1.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.34 68.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.824 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.42 93.29 0.66 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.641 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.625 HG21 ' HD3' ' A' ' 90' ' ' LYS . 81.6 t -58.96 -33.84 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.927 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.19 -0.85 42.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.682 ' CD2' HD22 ' A' ' 34' ' ' LEU . 12.6 t80 -60.15 -38.13 82.2 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.8 mp -46.44 -42.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -43.03 95.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.134 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HD1' HD13 ' A' ' 67' ' ' ILE . 12.1 t80 -57.84 -33.66 68.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.762 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mm -65.12 -53.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.266 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -72.69 -16.71 61.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.727 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.27 -44.29 72.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.53 13.07 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.326 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.42 66.57 1.86 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.37 -18.75 29.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.754 2.302 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -106.57 31.35 5.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.666 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.9 t -111.41 -158.3 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.545 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 48' ' ' VAL . 46.7 t -149.64 136.24 12.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.777 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 67' ' ' ILE . 16.4 t -114.13 115.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.674 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mm -100.95 -47.47 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.75 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.73 HG23 HG12 ' A' ' 76' ' ' VAL . 59.9 t 49.74 86.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.314 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.639 HG23 ' HB3' ' A' ' 100' ' ' LEU . 8.9 mt -94.22 162.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.915 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.497 ' HB ' HG22 ' A' ' 53' ' ' VAL . 48.4 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.792 0.329 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.79 -12.62 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.429 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.8 t -78.78 -35.45 44.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.069 0.461 . . . . 0.0 109.864 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.8 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.54 -58.55 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.091 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.32 -25.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.769 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.625 ' HD3' HG21 ' A' ' 61' ' ' VAL . 1.5 ttmp? -90.06 39.01 0.95 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.556 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.26 -39.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.99 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.9 pt -74.88 -42.46 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -21.46 63.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.781 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -73.95 -27.65 61.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.17 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.29 -18.29 0.38 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.378 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.99 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.9 176.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.152 0.476 . . . . 0.0 111.464 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 74.4 t80 -97.6 26.14 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.456 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.479 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.6 OUTLIER 77.44 146.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.652 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.9 OUTLIER -65.83 138.87 58.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.908 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 101' ' ' GLU . 1.5 tm? -68.93 137.94 54.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.502 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.881 ' N ' HD13 ' A' ' 100' ' ' LEU . 1.8 mp0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.244 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.777 HG13 HD11 ' A' ' 20' ' ' ILE . 9.5 p . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.64 0.257 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.2 -36.18 3.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.95 0.405 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HA ' HD13 ' A' ' 111' ' ' LEU . 2.1 tpm_? -67.29 -41.03 86.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.776 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.633 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 24.4 t80 -57.54 -27.27 62.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.153 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.916 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -60.07 -47.81 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.243 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.5 mp -51.79 -52.6 47.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.187 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.8 m -57.41 -45.92 84.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.14 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.9 mm -45.47 -56.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.587 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.29 -62.57 1.42 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -49.56 -27.34 4.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.926 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -67.73 -29.55 68.81 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.914 0.388 . . . . 0.0 110.782 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 61.6 m-85 -89.67 -26.45 20.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.818 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.044 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HD2' ' CD2' ' A' ' 117' ' ' PHE . 5.1 mmtm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.832 0.349 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.566 ' HB3' ' CB ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -175.43 93.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 48' ' ' VAL . 18.3 t -77.41 160.49 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 29' ' ' ASP . 60.7 tp -117.07 135.09 53.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.31 90.66 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.732 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.596 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 16.6 t -88.91 121.44 39.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.342 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -157.37 141.16 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.859 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.51 48.8 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 7.8 tp10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.801 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.748 0.309 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -26.32 65.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 t -93.27 -68.31 0.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -46.17 -56.89 5.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.487 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.81 ' HA ' HD12 ' A' ' 21' ' ' LEU . 21.3 t -41.25 -51.52 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.271 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -38.54 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.095 0.474 . . . . 0.0 110.622 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.857 HD13 HG11 ' A' ' 106' ' ' VAL . 6.1 mt -69.06 -70.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.322 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.936 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.49 -23.72 2.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.508 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.867 ' N ' HD13 ' A' ' 21' ' ' LEU . 31.5 mt-10 -78.48 -29.92 47.04 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 -37.92 58.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 109.923 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.726 ' HG3' HD21 ' A' ' 110' ' ' LEU . 19.2 mm-40 -59.34 -18.89 42.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.207 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.4 73.45 1.14 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.767 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 29.5 m-85 -147.01 -178.86 6.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 111.649 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.566 ' CB ' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -121.42 81.95 39.05 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.837 ' CG ' HD11 ' A' ' 21' ' ' LEU . 37.4 Cg_endo -89.86 137.9 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.699 2.266 . . . . 0.0 114.041 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.899 ' O ' HD12 ' A' ' 5' ' ' LEU . 13.1 t70 -126.15 125.07 41.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.6 p -97.2 135.96 38.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 111.643 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -108.44 178.5 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 mttt -122.75 -8.79 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.92 -171.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.773 HD22 ' CD2' ' A' ' 63' ' ' PHE . 75.5 mt -79.36 -32.34 43.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 0.0 110.154 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -70.9 -44.38 66.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.795 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.12 -33.81 76.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.58 -49.23 33.78 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -46.93 -45.94 21.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.365 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -54.89 41.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -57.66 -27.87 63.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.692 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 41' ' ' ILE . 42.9 mt -92.82 -8.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.55 8.22 29.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.73 0.3 . . . . 0.0 111.147 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -148.9 -48.14 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.58 116.09 21.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -69.22 71.29 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.731 ' CE2' HD13 ' A' ' 5' ' ' LEU . 13.1 m-85 -69.68 116.16 40.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.1 Cg_exo -74.56 -35.7 3.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.183 1.922 . . . . 0.0 111.44 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.913 HG23 ' CE1' ' A' ' 117' ' ' PHE . 16.5 t -124.8 126.59 71.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.784 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.574 HG23 HD23 ' A' ' 5' ' ' LEU . 15.5 mm -113.61 130.1 68.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.605 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.746 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 61.0 t -123.81 107.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.103 0.477 . . . . 0.0 111.168 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.543 ' HB3' HG22 ' A' ' 78' ' ' VAL . 13.0 tp -93.87 147.08 23.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 1.1 t70 -126.02 97.37 5.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 80' ' ' THR . 23.4 t -67.05 72.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.354 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.452 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 59.4 t-105 -80.04 -91.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 ttp -140.73 46.0 0.86 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.102 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 55' ' ' MET . 86.2 Cg_endo -77.65 -167.02 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.547 2.164 . . . . 0.0 112.4 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.8 -44.09 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.72 163.76 51.67 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.582 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.39 120.47 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.17 -20.96 80.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.57 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.498 HG21 ' HD3' ' A' ' 90' ' ' LYS . 91.4 t -57.36 -38.13 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.32 -22.09 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.773 ' CD2' HD22 ' A' ' 34' ' ' LEU . 14.9 t80 -65.01 -40.66 95.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.811 0.339 . . . . 0.0 111.057 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.451 HG23 HG11 ' A' ' 76' ' ' VAL . 3.2 mt -46.32 -28.68 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -70.48 -51.7 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -48.82 -40.67 30.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.826 0.346 . . . . 0.0 110.559 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.831 HG21 HG22 ' A' ' 76' ' ' VAL . 3.5 mp -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.412 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -76.45 -19.58 57.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.789 0.328 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.8 -50.87 54.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.712 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -112.08 14.7 20.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.372 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.2 66.86 2.65 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.9 -19.1 35.89 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.21 . . . . 0.0 112.113 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.8 28.11 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.805 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.9 t -117.31 -175.77 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.775 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.527 HG21 ' HB1' ' A' ' 116' ' ' ALA . 45.6 t -127.17 139.95 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.371 0.605 . . . . 0.0 111.783 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.831 HG22 HG21 ' A' ' 67' ' ' ILE . 1.7 t -122.96 88.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 97' ' ' TYR . 44.8 mm -73.8 -69.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.369 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 51' ' ' LEU . 38.2 t 63.15 118.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.302 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.531 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.6 mt -121.0 -142.36 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.839 0.352 . . . . 0.0 110.815 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.621 HG13 ' OE2' ' A' ' 101' ' ' GLU . 16.3 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.861 0.363 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -90.08 -24.44 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.5 t -77.48 -35.28 53.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.188 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.505 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.69 -57.52 12.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.94 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.1 m -55.72 -30.37 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.844 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.498 ' HD3' HG21 ' A' ' 61' ' ' VAL . 30.4 tttt -76.84 -13.28 60.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.088 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.45 -41.77 5.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.658 0.266 . . . . 0.0 111.433 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.846 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.3 pt -70.47 -31.36 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 111.028 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -24.32 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.18 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -84.93 -54.89 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.661 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.87 28.98 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.641 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.25 177.62 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.24 0.52 . . . . 0.0 110.565 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.695 ' HE2' HG23 ' A' ' 112' ' ' THR . 39.8 t80 -88.24 -23.34 23.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.526 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.498 ' HA ' HG21 ' A' ' 92' ' ' ILE . 2.6 pt-20 152.56 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.292 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 78' ' ' VAL . 1.5 t80 80.61 111.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.644 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.662 HD21 ' HA ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -51.95 96.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.207 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.621 ' OE2' HG13 ' A' ' 85' ' ' VAL . 4.9 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.857 HG11 HD13 ' A' ' 20' ' ' ILE . 12.5 p . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 120.63 0.252 . . . . 0.0 111.617 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -52.11 -51.11 59.86 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 110.902 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -38.69 74.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.746 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 28.0 t80 -60.58 -29.77 69.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.379 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.726 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -70.12 -46.21 65.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.038 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mp -50.23 -42.78 52.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.695 HG23 ' HE2' ' A' ' 97' ' ' TYR . 75.1 m -69.37 -46.7 66.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.891 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.526 HD13 HG11 ' A' ' 48' ' ' VAL . 6.8 mm -45.52 -59.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.727 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -55.64 7.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.78 -29.2 69.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.74 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.96 -37.65 85.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 0.0 110.853 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.913 ' CE1' HG23 ' A' ' 48' ' ' VAL . 6.4 m-85 -73.02 -17.1 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.372 179.912 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.896 0.379 . . . . 0.0 110.984 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.426 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.45 85.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.857 HG21 HD12 ' A' ' 113' ' ' ILE . 21.9 t -81.79 146.43 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.842 HD13 ' CE2' ' A' ' 46' ' ' PHE . 37.3 tp -106.96 139.77 40.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 0.0 111.218 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.752 ' HB ' HG22 ' A' ' 30' ' ' THR . 21.7 t -117.3 145.9 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.44 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.449 ' HB ' HD12 ' A' ' 51' ' ' LEU . 15.5 t -132.94 120.96 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.284 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 9.9 t0 -156.68 148.69 22.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -83.79 49.32 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.449 . . . . 0.0 111.19 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.662 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 20.3 p . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.896 0.379 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.7 m -41.01 133.82 2.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.477 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.531 ' O ' HD12 ' A' ' 20' ' ' ILE . 6.5 t 79.72 -9.05 1.49 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.486 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.979 HD23 HG21 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -90.15 -53.88 4.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.33 . . . . 0.0 111.103 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -51.52 -52.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.92 79.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.011 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.724 HG23 ' CD1' ' A' ' 110' ' ' LEU . 38.4 mt -60.54 -66.52 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.034 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.4 mt -50.98 -34.1 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -68.72 -26.75 65.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.74 -35.1 30.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.068 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.865 ' HG3' HD21 ' A' ' 110' ' ' LEU . 31.4 mm-40 -81.23 -27.97 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.057 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.12 1.21 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.233 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.455 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 6.2 m-85 -120.9 -176.18 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.307 0.575 . . . . 0.0 111.357 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.62 79.54 67.51 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.554 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.797 ' HB3' HD13 ' A' ' 21' ' ' LEU . 84.7 Cg_endo -84.34 146.86 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.864 2.376 . . . . 0.0 114.348 -177.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' O ' HD12 ' A' ' 5' ' ' LEU . 20.8 t70 -139.24 135.27 33.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.545 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.752 HG22 ' HB ' ' A' ' 6' ' ' VAL . 17.7 p -122.53 133.75 54.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 111.883 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.33 -163.14 0.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 11.0 mttm -112.76 -31.21 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -162.76 -175.04 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.678 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.4 mt -64.31 -41.16 96.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -61.42 -46.04 91.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 109.94 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.57 -38.58 89.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.3 -56.06 19.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.435 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 41.0 mt-10 -47.27 -41.4 18.75 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.756 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -59.73 -43.06 94.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.922 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -73.25 -44.03 60.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.84 -18.56 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.472 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.2 -23.6 15.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -127.17 -52.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.99 121.61 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.28 58.34 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.842 ' CE2' HD13 ' A' ' 5' ' ' LEU . 16.0 m-85 -57.73 123.35 62.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' SER . 58.5 Cg_endo -71.97 -32.56 10.99 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.548 2.165 . . . . 0.0 112.21 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.639 ' HB ' HG13 ' A' ' 4' ' ' VAL . 8.0 t -128.32 139.55 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.257 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.822 HG23 HD23 ' A' ' 5' ' ' LEU . 1.2 mm -139.77 108.34 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.299 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG22 ' CG1' ' A' ' 77' ' ' ILE . 50.9 t -105.54 133.69 49.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.769 0.318 . . . . 0.0 110.305 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.568 HD23 HG13 ' A' ' 78' ' ' VAL . 30.7 tp -101.96 136.44 41.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.88 81.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.015 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.745 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.4 p -60.58 80.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.3 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 13.6 t-105 -84.82 -78.04 0.26 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.355 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.678 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.65 50.34 0.97 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.391 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.678 ' HD3' ' N ' ' A' ' 55' ' ' MET . 15.3 Cg_endo -92.78 -159.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.163 2.575 . . . . 0.0 112.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -153.6 62.84 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.93 0.395 . . . . 0.0 111.004 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.39 162.78 29.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.541 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.542 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -85.07 116.54 23.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 110.864 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.49 -26.58 24.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.629 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.636 HG21 ' HD3' ' A' ' 90' ' ' LYS . 50.4 t -63.35 -41.21 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 111.2 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.74 -26.88 57.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 67' ' ' ILE . 16.0 t80 -61.05 -36.01 78.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.08 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.423 ' CG2' ' HA3' ' A' ' 95' ' ' GLY . 2.1 mp -45.81 -29.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.373 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -78.77 -38.67 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 38' ' ' GLU . 16.3 t80 -56.84 -41.64 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.753 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.9 mp -58.99 -46.3 91.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.382 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -75.34 -25.01 57.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -63.74 -43.68 95.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.86 16.93 13.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.04 69.44 0.98 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.81 -19.27 41.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.726 2.284 . . . . 0.0 112.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -104.99 28.24 7.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.6 t -111.72 179.99 3.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.462 ' HB ' HG13 ' A' ' 48' ' ' VAL . 61.8 t -127.15 146.11 33.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 0.0 111.206 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.678 HG22 HG21 ' A' ' 67' ' ' ILE . 3.7 t -125.43 119.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.335 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.759 ' CG1' HG22 ' A' ' 50' ' ' VAL . 42.3 mm -97.33 -63.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.592 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 76' ' ' VAL . 6.0 t 63.13 115.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 53' ' ' VAL . 1.4 mt -129.31 -145.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.879 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.745 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 121.008 0.433 . . . . 0.0 111.368 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.501 HG12 ' HB3' ' A' ' 88' ' ' ALA . 22.2 t . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 89' ' ' VAL . 39.1 t70 -100.03 -47.86 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.0 t -55.6 -31.55 62.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.966 0.413 . . . . 0.0 110.353 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.73 -60.0 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.123 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 86' ' ' ASP . 32.8 m -58.11 -24.73 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.914 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.636 ' HD3' HG21 ' A' ' 61' ' ' VAL . 8.1 ttmt -83.03 -10.92 58.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.27 -37.52 5.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.683 0.278 . . . . 0.0 111.6 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.886 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 14.1 pt -71.99 159.66 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.167 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HG2' HG13 ' A' ' 92' ' ' ILE . 7.7 mmmt 80.52 -47.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.579 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.4 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' A' ' 64' ' ' ILE . . . -175.52 -33.19 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.464 -0.875 . . . . 0.0 113.237 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.886 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -62.8 176.22 0.72 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.194 0.497 . . . . 0.0 110.671 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.562 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -100.67 -8.35 22.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 140.23 -11.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.411 0.684 . . . . 0.0 111.438 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER 77.71 120.27 0.05 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.88 0.372 . . . . 0.0 110.924 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.499 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -72.93 157.95 36.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.551 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 -179.849 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.979 HG21 HD23 ' A' ' 17' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -44.19 -42.1 6.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.952 0.406 . . . . 0.0 110.706 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -68.2 -37.51 80.98 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.889 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 5.0 t80 -58.52 -22.86 56.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.261 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.865 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.1 tt -63.8 -51.15 66.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.319 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mp -53.78 -54.49 37.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.018 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.507 HG23 ' CZ ' ' A' ' 97' ' ' TYR . 86.3 m -51.39 -56.78 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.091 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.889 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 9.9 mm -30.06 -63.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.695 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.67 -59.29 3.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.64 -24.86 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.828 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -70.87 -45.38 64.52 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 0.0 111.379 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.585 ' CE1' HG21 ' A' ' 48' ' ' VAL . 55.1 m-85 -66.53 -13.26 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.32 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.441 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 4.3 mmmm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.848 0.356 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -143.59 127.11 16.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.777 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 48' ' ' VAL . 42.7 t -115.59 154.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.61 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 37.0 tp -115.01 132.78 56.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.706 HG21 HD12 ' A' ' 17' ' ' LEU . 25.0 t -116.62 89.55 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.338 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' A' ' 37' ' ' ALA . 14.0 t -84.7 96.92 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.3 132.14 53.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.56 -65.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.763 0.316 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 t -90.28 29.41 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.565 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.3 p -157.97 -61.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.683 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.706 HD12 HG21 ' A' ' 6' ' ' VAL . 1.5 tm? -56.58 -49.73 74.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.594 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 p -54.75 -46.2 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.383 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.62 85.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.576 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.698 HG23 HD11 ' A' ' 110' ' ' LEU . 24.1 mt -57.28 -64.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.843 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 17' ' ' LEU . 1.4 mt -49.27 -32.58 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -27.43 68.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -79.01 -37.39 39.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.985 0.421 . . . . 0.0 110.013 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' HG3' HD22 ' A' ' 110' ' ' LEU . 1.1 tm-20 -70.09 -51.06 34.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 58.91 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.522 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -135.88 -173.89 3.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -136.47 75.04 52.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.066 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 50.5 Cg_exo -54.8 151.4 32.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.684 2.256 . . . . 0.0 112.638 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -132.66 6.25 4.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.662 HG22 ' HB ' ' A' ' 6' ' ' VAL . 3.5 p 0.7 126.52 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 166.14 21.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.222 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.628 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 mtpt -79.41 -163.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.38 168.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.136 0.493 . . . . 0.0 111.82 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.661 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.3 mt -36.41 -35.53 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.261 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -54.34 -63.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.056 0.455 . . . . 0.0 110.146 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 2.0 mp0 -65.18 -33.8 76.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.704 ' HB2' HG13 ' A' ' 7' ' ' VAL . . . -63.22 -65.5 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -43.13 -42.25 4.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.525 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -61.06 -51.0 71.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.63 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -34.78 79.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.191 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 41' ' ' ILE . 31.4 mt -86.07 -6.15 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.844 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.64 31.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.79 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -150.26 -52.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -103.36 154.96 18.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.926 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.441 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 42.5 t80 -93.65 87.19 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.644 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.61 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 28.6 m-85 -70.15 125.2 91.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.37 -26.2 7.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.585 2.19 . . . . 0.0 112.062 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 113' ' ' ILE . 3.0 t -139.28 130.94 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 46' ' ' PHE . 8.4 mm -120.31 153.02 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.617 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' VAL . 49.1 t -143.23 107.09 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.451 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HB3' HG22 ' A' ' 78' ' ' VAL . 43.6 tp -96.9 85.89 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.257 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.487 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.6 OUTLIER -68.02 72.52 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.527 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.3 p -53.16 85.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.716 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.453 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 21.8 t-105 -71.94 -80.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.605 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.9 54.99 0.61 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 55' ' ' MET . 5.6 Cg_endo -87.55 -155.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.172 2.581 . . . . 0.0 112.141 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -159.81 49.69 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.14 11.68 9.87 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.86 78.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.06 -20.9 63.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.888 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 90' ' ' LYS . 23.8 t -50.95 -44.82 27.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.423 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.14 -25.03 59.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.745 ' CE2' HD11 ' A' ' 67' ' ' ILE . 14.0 t80 -60.97 -39.63 90.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 91' ' ' ALA . 2.6 mp -47.02 -28.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.7 t0 -75.63 -41.46 54.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.815 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.76 -42.07 83.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.745 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.7 mp -63.92 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -81.89 -12.02 58.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.7 -40.69 47.94 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.004 0.431 . . . . 0.0 110.593 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 9.76 12.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.983 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.409 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.07 66.23 3.38 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.866 0.365 . . . . 0.0 110.787 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.4 Cg_exo -76.03 -14.32 19.03 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 112.22 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -109.53 29.55 7.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.813 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -106.96 -155.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.62 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.669 HG21 ' HB1' ' A' ' 116' ' ' ALA . 36.8 t -147.2 137.96 17.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 121.039 0.447 . . . . 0.0 112.018 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.779 HG12 HG23 ' A' ' 78' ' ' VAL . 1.2 t -123.39 112.08 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.448 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.616 HG21 ' CE1' ' A' ' 109' ' ' PHE . 32.2 mm -113.63 44.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.506 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.779 HG23 HG12 ' A' ' 76' ' ' VAL . 49.0 t -45.43 116.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.261 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.643 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.6 mt -106.43 -148.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.194 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.7 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.55 -17.31 15.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -36.16 30.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.27 -59.36 5.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.968 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.608 ' HA ' HG12 ' A' ' 92' ' ' ILE . 12.4 m -58.99 -30.77 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.949 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.479 ' O ' HG13 ' A' ' 61' ' ' VAL . 13.6 ttmt -75.04 -8.5 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.347 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.485 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -118.27 -35.54 3.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.475 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 88' ' ' ALA . 8.7 pt -80.02 158.07 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.192 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' CG ' HG13 ' A' ' 92' ' ' ILE . 9.2 mmtt 80.77 -45.83 0.25 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -22.97 64.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.97 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.03 -29.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.187 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -79.77 175.82 10.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.082 0.441 . . . . 0.0 111.009 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.524 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 56.0 t80 -100.69 -12.06 19.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.323 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 147.54 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.158 0.583 . . . . 0.0 110.368 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.56 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -118.97 131.09 56.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.534 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -93.88 44.81 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.822 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.265 -179.805 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' CD1' ' A' ' 20' ' ' ILE . 10.4 p . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.596 0.236 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -47.52 76.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.861 0.362 . . . . 0.0 110.367 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.29 -33.61 69.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.071 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.616 ' CE1' HG21 ' A' ' 77' ' ' ILE . 10.1 t80 -64.44 -37.8 88.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.183 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.698 HD11 HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -55.33 -48.21 74.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -44.71 83.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.1 m -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.75 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.7 mm -57.22 -53.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -59.46 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -55.75 -30.79 61.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.738 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.61 -38.77 88.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.505 ' CE2' HG21 ' A' ' 48' ' ' VAL . 31.0 m-85 -75.23 -28.75 60.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.906 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmmp? . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.775 0.321 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -136.06 142.22 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.629 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.5 t -125.96 163.9 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.857 HD22 ' CD2' ' A' ' 46' ' ' PHE . 34.0 tp -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.2 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.959 HG21 ' CD1' ' A' ' 17' ' ' LEU . 27.6 t -115.28 97.33 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.95 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.748 HG22 ' HB3' ' A' ' 31' ' ' ALA . 40.7 t -83.23 119.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.797 0.332 . . . . 0.0 110.985 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -154.35 131.57 11.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.9 46.77 1.39 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.29 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 110.99 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.652 HG21 ' CG1' ' A' ' 6' ' ' VAL . 76.0 p . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -65.43 141.91 58.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.158 0.504 . . . . 0.0 112.259 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.426 ' O ' HD12 ' A' ' 20' ' ' ILE . 28.2 m 65.1 9.39 5.48 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.721 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.057 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -90.49 -53.07 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.483 179.46 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -45.88 -59.67 2.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.23 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.52 53.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.08 0.467 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.769 HG23 ' CD1' ' A' ' 110' ' ' LEU . 75.1 mt -68.29 -70.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.057 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.73 -30.36 3.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.044 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -73.42 -29.67 62.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.845 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -81.08 -34.84 32.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 110.12 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.783 ' CG ' HD21 ' A' ' 110' ' ' LEU . 5.7 mm-40 -81.48 -35.0 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.4 47.75 2.72 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.221 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 2' ' ' LYS . 44.3 m-85 -105.23 -173.26 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.127 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.56 85.68 47.16 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.814 ' HG3' HD13 ' A' ' 21' ' ' LEU . 91.4 Cg_endo -82.45 127.71 5.2 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.689 2.259 . . . . 0.0 111.953 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -105.65 -1.01 25.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.482 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.625 ' O ' ' O ' ' A' ' 29' ' ' ASP . 58.7 p 24.49 122.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB3' HG22 ' A' ' 7' ' ' VAL . . . -105.82 167.72 9.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.549 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -88.29 -46.06 9.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.821 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.436 HG23 ' HB3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -158.47 -167.03 2.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.606 HD22 ' CD2' ' A' ' 63' ' ' PHE . 58.1 mt -67.44 -46.53 72.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -63.1 -45.47 91.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.044 0.45 . . . . 0.0 109.873 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -32.2 70.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.38 -28.82 63.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.686 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 13.6 mt-10 -70.85 -42.03 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -63.77 -35.33 80.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.009 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -75.68 -42.41 51.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.898 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.77 -27.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.031 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -52.03 -25.98 9.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -120.72 -55.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.19 133.57 50.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -95.28 102.04 13.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.857 ' CD2' HD22 ' A' ' 5' ' ' LEU . 40.7 m-85 -102.74 122.04 47.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 74' ' ' SER . 65.4 Cg_endo -73.68 -19.16 21.63 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.331 2.021 . . . . 0.0 111.788 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.629 ' HB ' HG13 ' A' ' 4' ' ' VAL . 10.8 t -143.7 120.53 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.494 HD11 ' HB2' ' A' ' 46' ' ' PHE . 6.5 mm -107.18 153.75 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.83 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 51' ' ' LEU . 7.4 t -135.49 174.59 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.651 ' H ' HG12 ' A' ' 50' ' ' VAL . 29.2 tp -159.92 117.27 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.548 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.46 89.62 3.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.141 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 53' ' ' VAL . 35.2 m -58.68 82.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.834 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -81.52 -83.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.402 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.504 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 3.2 mtt -148.45 44.78 0.37 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 55' ' ' MET . 85.4 Cg_endo -80.19 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.461 2.107 . . . . 0.0 112.226 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -137.99 49.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 110.97 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.47 139.85 6.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.445 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.44 144.27 37.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.641 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -93.63 -15.94 47.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.892 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 90' ' ' LYS . 26.2 t -53.81 -52.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.014 0.435 . . . . 0.0 111.209 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.7 -6.29 47.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.765 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.829 ' CE2' HD11 ' A' ' 67' ' ' ILE . 22.3 t80 -85.67 -36.52 20.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.645 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.028 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.0 mp -49.52 -31.95 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.681 0.277 . . . . 0.0 111.084 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.3 t70 -79.41 -25.26 42.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.572 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 48.1 t80 -67.85 -42.32 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.829 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.8 mp -60.03 -43.23 92.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.035 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.88 -20.96 52.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 33.7 tt0 -68.72 -34.8 76.25 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.407 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -126.39 14.58 7.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.034 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.49 67.39 1.38 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.889 0.376 . . . . 0.0 110.579 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.02 -20.79 50.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.65 2.233 . . . . 0.0 112.064 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.29 25.5 6.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.055 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 33.5 t -113.37 -166.18 1.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -148.67 131.56 7.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 121.248 0.547 . . . . 0.0 112.428 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 38.9 t -100.89 113.65 37.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.63 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.731 HD12 ' CG2' ' A' ' 112' ' ' THR . 44.8 mm -94.01 -62.35 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.915 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 HD23 ' A' ' 51' ' ' LEU . 99.4 t 59.15 111.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.718 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.8 mt -122.48 178.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.641 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.8 m . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 85' ' ' VAL . 7.2 p . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.862 0.363 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.725 ' O ' HG22 ' A' ' 89' ' ' VAL . 23.9 t0 -139.2 -60.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.842 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 t -48.8 -30.74 6.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.261 0.553 . . . . 0.0 110.1 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.847 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.26 -59.72 5.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.156 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 86' ' ' ASP . 30.2 m -61.61 -21.96 26.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.325 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 61' ' ' VAL . 15.7 ttmt -87.32 -14.22 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.673 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 1.028 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -114.8 -31.82 6.01 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.942 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 8.7 pt -74.63 -21.88 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.692 0.282 . . . . 0.0 111.625 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.65 15.38 16.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.22 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -119.64 -21.2 7.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.555 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.39 -24.2 0.16 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.937 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.942 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -55.13 176.26 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.584 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.458 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 56.4 t80 -108.5 27.37 9.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.9 OUTLIER 85.61 138.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.187 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.619 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -71.38 94.77 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.608 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 109' ' ' PHE . 28.3 tp -54.94 146.69 17.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.653 ' H ' HD12 ' A' ' 100' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 20' ' ' ILE . 7.4 p . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.641 0.258 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -46.22 -35.45 5.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.496 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -71.65 -35.78 70.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.934 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.913 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 29.3 t80 -58.16 -30.82 66.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.783 HD21 ' CG ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -50.0 -43.33 50.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.318 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 108' ' ' ARG . 3.7 mp -59.3 -60.21 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.121 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.731 ' CG2' HD12 ' A' ' 77' ' ' ILE . 97.8 m -44.12 -39.14 4.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.343 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 29.2 mm -56.23 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -54.16 -21.09 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.739 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -85.66 -24.73 26.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.695 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -80.55 -30.86 37.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -78.29 -20.08 52.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.365 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.658 -179.58 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 7.8 mmmt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.494 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 131.18 20.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.718 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 48' ' ' VAL . 27.0 t -121.31 144.15 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.823 HD13 ' CE2' ' A' ' 46' ' ' PHE . 29.9 tp -107.2 137.7 44.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 0.0 111.214 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.873 HG21 HD12 ' A' ' 17' ' ' LEU . 3.8 t -116.3 123.88 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.528 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.558 ' HB ' HD12 ' A' ' 51' ' ' LEU . 44.4 t -114.29 110.38 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.24 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 40.8 t0 -158.76 160.63 36.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.057 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.4 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 25.5 t70 -89.16 49.45 1.77 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.05 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.771 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.63 HG21 HG11 ' A' ' 6' ' ' VAL . 72.3 p . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 16' ' ' SER . 73.5 m -43.0 136.44 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.775 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.4 m 88.16 -36.35 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.161 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.927 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.89 -50.82 63.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 110.93 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.5 -64.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.463 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.27 60.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 111.443 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.611 HG23 HD11 ' A' ' 110' ' ' LEU . 91.5 mt -65.72 -70.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.927 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -46.94 -31.03 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.938 0.399 . . . . 0.0 111.071 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.46 -31.67 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.707 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -83.0 -35.21 26.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.877 ' HG3' HD21 ' A' ' 110' ' ' LEU . 43.9 mm-40 -75.1 -29.98 60.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.046 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.88 1.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.227 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 43.2 m-85 -131.76 -176.3 4.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.243 0.544 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.41 80.74 46.04 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.837 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.662 ' HB3' HD13 ' A' ' 21' ' ' LEU . 88.0 Cg_endo -82.5 141.53 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.838 2.359 . . . . 0.0 113.759 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' O ' HD12 ' A' ' 5' ' ' LEU . 6.5 t0 -138.54 136.18 35.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.868 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.496 HG22 ' HB ' ' A' ' 6' ' ' VAL . 14.7 p -121.62 132.58 54.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.114 0.483 . . . . 0.0 111.745 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.69 -121.57 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.226 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 13.8 mttp -157.63 -41.75 0.07 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.937 0.399 . . . . 0.0 110.59 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 p -152.83 175.66 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.622 HD22 ' CD2' ' A' ' 63' ' ' PHE . 39.8 mt -58.14 -37.34 74.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -44.83 78.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -35.81 82.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.336 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.27 61.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 34.1 mt-10 -49.16 -44.21 42.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.533 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -56.43 -44.6 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.063 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -73.23 -44.39 59.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.979 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.3 mt -70.32 -17.75 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.556 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -21.25 41.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.218 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.99 -63.46 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.12 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -55.35 132.42 48.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 45' ' ' PHE . 60.4 t80 -97.2 59.56 1.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.77 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.823 ' CE2' HD13 ' A' ' 5' ' ' LEU . 44.2 m-85 -57.93 126.53 77.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.494 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 53.1 Cg_endo -70.93 -28.79 19.21 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.318 2.012 . . . . 0.0 111.66 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.611 HG21 ' CE1' ' A' ' 117' ' ' PHE . 15.2 t -128.66 136.59 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.567 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 46' ' ' PHE . 5.9 mm -135.78 103.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.63 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 77' ' ' ILE . 59.8 t -101.79 129.81 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.596 HD23 HG13 ' A' ' 78' ' ' VAL . 28.6 tp -92.13 162.84 14.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.334 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -153.81 69.96 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.806 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 80' ' ' THR . 2.4 p -59.79 81.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.683 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 52' ' ' ASP . 65.3 t-105 -86.41 -92.23 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.772 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.576 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mtt -64.25 -52.09 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.075 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 55' ' ' MET . 39.7 Cg_endo -65.97 -169.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.37 2.047 . . . . 0.0 112.37 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.92 -24.07 7.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.84 -89.13 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.428 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 48.69 30.76 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.2 72.28 2.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.562 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 64' ' ' ILE . 58.2 t -58.11 -39.65 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -75.0 -11.79 60.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.523 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.027 ' CE2' HD11 ' A' ' 67' ' ' ILE . 50.4 t80 -64.36 -43.77 93.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.734 0.302 . . . . 0.0 111.429 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mp -48.24 -28.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -77.58 -30.85 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 4.5 t80 -63.73 -44.76 92.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 1.027 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -61.21 -43.62 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.21 -22.52 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.667 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 21.6 tt0 -62.91 -39.81 95.67 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.073 0.463 . . . . 0.0 110.222 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.53 15.68 9.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.26 71.21 0.6 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.71 -7.71 11.43 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.039 2.493 . . . . 0.0 112.56 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.03 -3.06 30.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.558 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -170.31 2.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 0.0 111.302 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.737 HG11 ' HB1' ' A' ' 116' ' ' ALA . 50.1 t -127.34 147.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.025 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 67' ' ' ILE . 3.3 t -126.7 100.45 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.87 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.0 mm -101.62 71.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.145 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.622 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 32.1 t -67.09 133.31 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.176 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 80' ' ' THR . 2.1 mt -142.4 175.64 4.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.901 0.381 . . . . 0.0 111.163 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 85' ' ' VAL . 14.4 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.882 0.373 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 89' ' ' VAL . 13.4 p-10 -115.51 -34.29 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.82 -31.1 70.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.745 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.28 -59.62 5.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 86' ' ' ASP . 22.1 m -62.75 -23.33 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.931 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.546 ' HD3' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.73 27.68 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.6 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.53 -41.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.035 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.006 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.8 pt -69.17 -21.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.505 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.53 26.47 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -133.8 7.27 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.517 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.25 -23.26 3.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.912 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 1.006 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -60.48 -177.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.373 . . . . 0.0 111.266 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.758 ' HB3' HD13 ' A' ' 77' ' ' ILE . 48.9 t80 -117.21 29.14 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.269 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 87.89 158.13 0.07 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.227 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.622 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -91.97 103.91 16.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.078 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.578 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.4 tp -57.97 160.9 4.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.041 -179.628 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.926 HG21 HD23 ' A' ' 17' ' ' LEU . 1.2 m . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -45.78 44.77 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.919 0.39 . . . . 0.0 110.608 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.445 ' HA ' HD13 ' A' ' 111' ' ' LEU . 7.5 tpt85 -66.59 -36.67 83.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.819 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.842 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 7.2 t80 -59.82 -27.81 66.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.245 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.877 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -60.11 -44.25 95.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.364 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.525 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.5 mp -54.38 -56.64 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' ILE . 92.4 m -51.73 -59.53 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.342 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.842 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 13.6 mm -31.05 -64.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.891 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -58.1 5.76 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -27.32 15.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.737 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -73.41 -36.57 66.01 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.611 ' CE1' HG21 ' A' ' 48' ' ' VAL . 27.2 m-85 -66.85 -14.93 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.257 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--N 1.332 -0.181 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.468 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 21.1 mmtt . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.85 0.357 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.445 ' HD2' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 73.95 113.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.044 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.613 HG13 ' HB ' ' A' ' 48' ' ' VAL . 43.6 t -118.99 158.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.489 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.623 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 56.2 tp -112.65 127.98 56.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 111.394 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.26 91.97 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.317 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.784 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 33.2 t -85.02 117.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.483 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -156.51 147.03 21.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.914 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.43 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 36.3 t70 -72.62 -73.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.096 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 1.6 tm-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.115 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -66.06 -32.95 74.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 t -102.13 -59.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.792 HD23 HG21 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -47.04 -57.21 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.428 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.832 ' HA ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -41.41 -54.66 3.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.158 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.96 -36.62 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.508 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 17' ' ' LEU . 14.3 mt -72.92 -70.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.84 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.957 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -52.56 -28.51 21.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.465 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.957 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -79.73 -23.67 42.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.814 0.34 . . . . 0.0 110.667 178.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -78.82 -39.08 36.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.903 0.383 . . . . 0.0 110.026 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.66 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.7 mm-40 -55.91 -43.73 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 60.68 0.16 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.32 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 61.7 m-85 -132.31 -171.51 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 111.061 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.39 82.9 56.33 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.926 ' HG3' HD21 ' A' ' 21' ' ' LEU . 21.3 Cg_exo -65.28 143.44 77.12 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.682 2.254 . . . . 0.0 112.634 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 30' ' ' THR . 6.2 t70 -116.78 -10.72 11.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.139 0.495 . . . . 0.0 111.983 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 29' ' ' ASP . 41.9 p 43.12 176.05 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.289 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.784 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -165.57 174.81 9.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.908 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 33' ' ' THR . 0.5 OUTLIER -112.82 -26.65 8.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.801 0.334 . . . . 0.0 111.236 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.12 -178.33 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.62 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.743 HD12 ' HA3' ' A' ' 58' ' ' GLY . 96.5 mt -61.01 -39.2 88.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -50.34 71.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.031 0.443 . . . . 0.0 109.831 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -33.16 75.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.172 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.524 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.07 -20.2 57.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 4.3 mt-10 -77.56 -38.31 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 109.85 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.41 -39.14 81.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.661 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mmtm -71.22 -36.19 71.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.769 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 37' ' ' ALA . 36.5 mt -86.19 -17.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.201 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -58.38 -19.09 32.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.441 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -134.8 -53.76 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.062 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -58.45 118.22 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.052 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -74.11 64.52 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.438 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.623 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 31.2 m-85 -56.65 113.69 6.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.297 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 60.3 Cg_endo -73.14 -27.38 13.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 112.032 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HB ' HG13 ' A' ' 4' ' ' VAL . 4.0 t -139.75 128.29 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.479 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.413 HG23 HD23 ' A' ' 5' ' ' LEU . 9.4 mm -112.59 146.85 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.68 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 5' ' ' LEU . 97.6 t -139.06 98.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.488 . . . . 0.0 110.576 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.426 ' HB3' HG13 ' A' ' 78' ' ' VAL . 24.7 tp -77.16 166.25 23.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.89 93.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.252 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.786 HG22 ' HB ' ' A' ' 80' ' ' THR . 6.8 m -76.71 57.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.55 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.446 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 55.7 t-105 -61.54 -90.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.652 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.666 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -90.64 -27.09 0.3 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 55' ' ' MET . 62.3 Cg_endo -85.93 -168.29 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.341 2.027 . . . . 0.0 113.021 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -147.59 -47.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.411 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.743 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . 46.79 -171.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.948 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.57 48.29 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.634 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -47.78 -34.38 10.7 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.452 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 90' ' ' LYS . 6.6 t -63.87 -49.91 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.942 0.401 . . . . 0.0 110.65 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.54 8.34 34.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.384 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.902 ' CE2' HD11 ' A' ' 67' ' ' ILE . 36.1 t80 -84.55 -41.83 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.772 0.32 . . . . 0.0 111.224 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.772 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.4 mp -46.01 -30.44 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.242 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -40.62 66.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.565 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 68.5 t80 -55.97 -43.36 77.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.902 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.0 mp -61.79 -44.37 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.462 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -78.95 -14.52 59.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.833 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.3 -43.07 58.31 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.968 0.413 . . . . 0.0 110.593 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -116.68 12.46 14.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.08 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.54 66.79 2.51 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.728 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.68 -19.04 32.23 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.616 2.211 . . . . 0.0 112.232 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -103.97 32.39 3.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.673 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 t -113.63 -158.45 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.689 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.491 HG21 ' HB1' ' A' ' 116' ' ' ALA . 39.2 t -147.49 136.2 15.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.812 HG12 HG23 ' A' ' 78' ' ' VAL . 18.3 t -114.25 110.99 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.608 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 79' ' ' ILE . 44.5 mm -99.23 -39.91 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.558 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.812 HG23 HG12 ' A' ' 76' ' ' VAL . 59.1 t 45.25 77.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.564 HG23 ' HB3' ' A' ' 100' ' ' LEU . 4.2 mt -93.45 148.51 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.579 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.786 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.4 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.025 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.929 0.395 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -111.52 -24.21 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.192 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -32.08 22.67 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.798 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.96 -57.27 12.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.897 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.6 m -58.08 -26.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.016 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.576 ' O ' HG13 ' A' ' 61' ' ' VAL . 3.1 ttmm -81.76 -9.25 59.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.772 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -121.96 -26.45 4.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.877 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.5 pt -83.32 -42.16 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -23.73 41.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.679 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -25.06 65.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.94 -16.1 1.05 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.106 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -51.9 177.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.97 0.385 . . . . 0.0 111.464 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 72.3 t80 -95.29 28.55 2.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.501 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 1.2 tt0 70.09 139.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.208 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.608 ' H ' HG21 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -55.11 146.07 19.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.564 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -87.23 109.65 19.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.059 -179.87 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.792 HG21 HD23 ' A' ' 17' ' ' LEU . 32.8 m . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.971 0.415 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.15 -60.67 2.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -30.55 53.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.824 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 80.8 t80 -61.91 -40.57 95.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.607 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.66 HD21 ' HG2' ' A' ' 24' ' ' GLU . 2.1 tt -52.41 -59.09 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.395 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.581 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.3 mp -66.23 -44.46 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.544 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.3 m -60.2 -37.8 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.125 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.824 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -49.02 -52.36 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.482 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -56.56 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.042 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.55 -36.49 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -58.9 -38.54 79.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 110.57 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 34.7 m-85 -82.73 -17.18 45.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.792 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.911 0.386 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -149.2 140.87 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.7 t -124.67 162.27 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.978 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.976 HD22 ' CD2' ' A' ' 46' ' ' PHE . 57.5 tp -119.8 121.82 39.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 110.588 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.859 HG21 ' CD1' ' A' ' 17' ' ' LEU . 40.0 t -102.77 122.88 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.19 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 41.3 t -111.41 105.26 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.866 0.365 . . . . 0.0 111.191 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -117.57 151.76 36.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.934 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 54' ' ' TRP . 32.3 t70 -81.27 49.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 111.667 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.361 179.241 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.525 ' CG2' HG11 ' A' ' 6' ' ' VAL . 2.3 p . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 m -54.68 145.94 18.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.512 ' O ' HD12 ' A' ' 20' ' ' ILE . 42.1 t 66.03 10.86 7.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.839 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.079 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.22 -52.23 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.443 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 t -50.08 -55.26 15.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.06 73.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.968 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.72 HG23 ' CD1' ' A' ' 110' ' ' LEU . 54.3 mt -62.19 -66.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.079 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -49.38 -28.62 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.44 -27.68 61.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.79 -34.46 30.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.149 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.672 ' HG3' HD21 ' A' ' 110' ' ' LEU . 30.5 mm-40 -87.18 -30.58 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 60.53 1.48 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.45 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 44.8 m-85 -113.09 -173.67 2.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.25 83.83 54.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.882 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.882 ' HG3' HD13 ' A' ' 21' ' ' LEU . 92.2 Cg_endo -84.74 117.62 2.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.79 2.326 . . . . 0.0 111.636 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.26 -9.2 33.84 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.403 0.62 . . . . 0.0 112.046 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 71.5 p 49.66 173.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.216 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -158.55 -154.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.493 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 27.3 mttt -143.65 -42.96 0.28 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.0 170.07 20.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.591 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.678 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.3 mt -61.41 -26.77 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.51 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -76.2 -43.59 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.083 0.468 . . . . 0.0 109.819 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -25.98 59.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.607 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.506 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.52 -34.03 58.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.634 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 44.8 mt-10 -69.75 -41.46 75.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -61.83 -37.98 86.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.837 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -72.41 -47.03 52.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.615 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 37' ' ' ALA . 10.1 mt -68.71 -27.97 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.976 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -47.55 -29.12 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -116.82 -44.21 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.63 112.75 18.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -75.13 63.94 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.976 ' CD2' HD22 ' A' ' 5' ' ' LEU . 42.4 m-85 -56.03 125.58 63.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.526 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 72.2 Cg_endo -76.45 -34.04 2.9 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.307 2.004 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.865 HG13 ' HB ' ' A' ' 75' ' ' VAL . 23.5 t -130.16 111.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.007 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.468 HG23 HD23 ' A' ' 5' ' ' LEU . 2.3 mm -97.01 142.38 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.795 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.768 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.6 t -128.66 165.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 7' ' ' VAL . 16.2 tp -142.41 157.69 44.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.119 0.485 . . . . 0.0 111.539 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -141.93 79.95 1.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.011 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.694 HG22 ' HB ' ' A' ' 80' ' ' THR . 31.0 m -65.67 66.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.188 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.412 ' N ' ' O ' ' A' ' 52' ' ' ASP . 26.7 t-105 -67.16 -74.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.651 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 31.4 mtt -147.54 52.75 1.37 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.763 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.4 Cg_endo -89.72 -156.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -136.89 -43.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.246 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.44 148.37 34.11 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.647 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 127.53 43.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.71 -13.8 83.17 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.823 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 90' ' ' LYS . 21.7 t -53.57 -45.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.789 0.328 . . . . 0.0 111.339 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 -5.9 55.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.537 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.678 ' CD2' HD22 ' A' ' 34' ' ' LEU . 15.7 t80 -74.15 -37.74 63.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.347 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.521 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.5 mp -49.7 -27.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -39.45 69.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.632 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 18.8 t80 -60.3 -43.35 96.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.061 0.458 . . . . 0.0 109.914 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.626 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -57.33 -41.76 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -81.64 -24.16 36.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.0 110.638 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -66.39 -26.18 67.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.444 ' ND2' ' CE1' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -138.0 16.58 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.026 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.15 69.17 0.82 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.864 0.364 . . . . 0.0 110.748 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.44 -20.26 48.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.76 2.307 . . . . 0.0 112.11 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.78 39.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.853 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.8 t -119.61 177.59 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.865 ' HB ' HG13 ' A' ' 48' ' ' VAL . 2.7 t -107.9 178.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.754 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -157.52 79.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.898 0.38 . . . . 0.0 110.146 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.768 ' HB ' HG13 ' A' ' 50' ' ' VAL . 31.2 mm -62.21 -53.02 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.364 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.659 ' CG2' HG12 ' A' ' 76' ' ' VAL . 5.2 t 45.39 89.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.714 HG23 ' HB3' ' A' ' 100' ' ' LEU . 13.8 mt -104.21 167.2 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.614 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.694 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.6 m . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.425 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.793 0.33 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.595 ' O ' HG22 ' A' ' 89' ' ' VAL . 8.3 t0 -62.81 -32.91 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.39 -34.76 49.49 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.19 0.519 . . . . 0.0 109.954 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.885 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.41 -61.27 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.315 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 86' ' ' ASP . 33.4 m -61.92 -22.73 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.243 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.415 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 15.8 tttt -85.52 -25.13 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -98.91 -26.1 14.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.885 HG23 ' O ' ' A' ' 88' ' ' ALA . 4.2 pt -89.32 -17.0 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.436 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -71.71 -32.66 68.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 110.43 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -64.78 -61.99 1.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.84 33.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.986 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.11 -179.0 5.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.815 ' CE2' HG23 ' A' ' 112' ' ' THR . 26.4 t80 -98.52 28.54 4.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.452 . . . . 0.0 111.062 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.643 ' CD ' HD12 ' A' ' 92' ' ' ILE . 2.7 tp10 67.47 134.15 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.193 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.659 ' H ' HG21 ' A' ' 92' ' ' ILE . 2.3 m-85 -61.64 131.48 50.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.014 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.714 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -74.81 80.81 2.1 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.412 -179.681 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.646 HG13 HD11 ' A' ' 20' ' ' ILE . 7.6 p . . . . . 0 CA--C 1.526 0.039 0 CA-C-O 120.69 0.281 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -46.51 -33.92 4.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 110.838 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -36.25 69.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.933 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.891 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 3.4 t80 -59.64 -31.16 69.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.181 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.72 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -49.16 -49.21 43.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.29 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.6 mp -56.93 -57.56 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.75 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.815 HG23 ' CE2' ' A' ' 97' ' ' TYR . 93.0 m -44.68 -39.28 4.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.301 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.891 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 24.1 mm -59.13 -70.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.517 ' HE3' ' CD2' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -55.24 -23.07 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.563 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.517 ' CD2' ' HE3' ' A' ' 114' ' ' LYS . 31.9 m170 -84.75 -20.62 30.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.668 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.587 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -87.19 -45.22 10.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.45 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -60.44 -22.53 63.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.271 -179.965 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.746 0.308 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.477 ' HA ' ' H ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -111.71 135.07 52.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.862 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.66 HG13 ' HB ' ' A' ' 48' ' ' VAL . 24.0 t -126.5 154.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.411 -179.093 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.675 HD23 HD11 ' A' ' 41' ' ' ILE . 28.8 tp -105.73 127.98 53.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.709 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.673 HG21 ' CD1' ' A' ' 17' ' ' LEU . 45.2 t -107.52 90.1 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.716 HG13 ' HB2' ' A' ' 37' ' ' ALA . 5.1 t -85.08 105.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -138.36 143.04 39.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.037 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.873 ' HB2' HG23 ' A' ' 33' ' ' THR . 33.1 t70 -91.9 50.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.674 0.273 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.51 -45.85 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 111.258 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 p -73.58 -68.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.085 HD23 HG21 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -44.78 -42.86 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.574 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.1 m -57.15 -44.18 83.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.43 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.69 78.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.431 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.917 HD13 HG22 ' A' ' 106' ' ' VAL . 1.5 mt -59.76 -57.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.587 179.539 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.622 HD11 HD11 ' A' ' 17' ' ' LEU . 1.4 mt -50.33 -33.49 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.664 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.02 -24.59 66.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.794 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.38 -36.61 45.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.752 ' HG2' HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -78.34 -19.12 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.157 179.693 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.17 52.95 2.11 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.186 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.1 m-85 -112.07 -172.21 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 0.0 111.163 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.477 ' H ' ' HA ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -131.41 69.41 81.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.805 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -62.61 143.26 92.35 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.628 2.218 . . . . 0.0 111.931 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.8 t70 -126.56 -9.11 6.24 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.625 ' O ' ' O ' ' A' ' 29' ' ' ASP . 29.9 p 41.9 163.68 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -170.61 142.87 2.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.778 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 41.5 mttt -74.01 -166.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.873 HG23 ' HB2' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -47.73 156.24 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 111.705 -178.101 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.85 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.2 mt -27.36 -43.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.833 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -50.56 -59.59 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.083 0.468 . . . . 0.0 110.333 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 1.4 tp10 -66.07 -39.1 89.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.716 ' HB2' HG13 ' A' ' 7' ' ' VAL . . . -60.15 -60.5 3.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.595 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.44 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 19.7 mt-10 -45.67 -42.18 11.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -60.8 -52.75 63.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -62.44 -34.59 77.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.328 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.675 HD11 HD23 ' A' ' 5' ' ' LEU . 48.6 mt -89.54 -6.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.52 -16.56 48.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.633 0.254 . . . . 0.0 111.262 179.901 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -132.95 -52.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.769 0.318 . . . . 0.0 111.093 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.95 133.25 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.073 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -96.52 63.89 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.706 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.647 ' CD2' HD22 ' A' ' 5' ' ' LEU . 45.2 m-85 -58.27 125.23 74.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.036 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.74 -24.78 17.83 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.317 2.011 . . . . 0.0 111.892 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.698 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.8 t -141.59 134.12 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.524 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 46' ' ' PHE . 21.8 mm -119.24 148.18 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.547 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.445 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 82.9 t -136.59 105.62 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.587 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.04 84.11 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.751 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 1.2 t70 -66.35 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG13 ' HB ' ' A' ' 80' ' ' THR . 2.5 p -53.24 88.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ASP . 34.0 t-105 -88.47 -80.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.49 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 mmt -147.22 47.27 0.55 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 55' ' ' MET . 97.8 Cg_endo -78.6 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.562 2.175 . . . . 0.0 112.323 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -152.2 30.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.57 -147.17 18.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.411 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.471 ' H ' HD12 ' A' ' 34' ' ' LEU . 50.0 m-20 -129.49 81.2 2.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.863 0.363 . . . . 0.0 110.9 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.9 92.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 90' ' ' LYS . 78.0 t -59.87 -38.64 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -23.41 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.108 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.85 ' CD2' HD22 ' A' ' 34' ' ' LEU . 13.4 t80 -75.35 -30.22 60.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.819 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 61' ' ' VAL . 7.9 mm -47.8 -37.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' GLU . 39.1 t70 -70.07 -42.93 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.554 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 23.4 t80 -50.99 -39.91 56.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.935 0.398 . . . . 0.0 110.651 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.846 HG21 HG22 ' A' ' 76' ' ' VAL . 2.7 mp -62.74 -52.08 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -74.63 -9.51 58.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.701 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 65' ' ' ASP . 18.0 tt0 -77.1 -48.04 18.86 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.554 ' ND2' ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -114.33 16.83 17.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.925 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.66 67.54 1.6 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.2 -18.59 34.86 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.672 2.248 . . . . 0.0 112.156 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.75 40.66 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.66 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.0 t -119.06 -157.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.698 ' HB ' HG13 ' A' ' 48' ' ' VAL . 41.1 t -147.01 139.0 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 112.102 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.846 HG22 HG21 ' A' ' 67' ' ' ILE . 2.1 t -120.74 94.16 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.175 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.521 HG21 ' HE1' ' A' ' 109' ' ' PHE . 39.6 mm -73.63 -57.11 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.917 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.832 HG23 HG12 ' A' ' 76' ' ' VAL . 21.7 t 52.59 94.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.699 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.7 mt -108.45 -148.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.326 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.723 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.829 0.347 . . . . 0.0 111.106 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.687 0.28 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.0 -24.77 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.288 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -33.56 26.62 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.867 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.1 -57.09 13.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.116 178.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 92' ' ' ILE . 13.4 m -59.94 -28.22 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.43 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 61' ' ' VAL . 10.3 ttmt -78.74 -2.26 38.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.606 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.05 -35.04 1.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.93 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 4.7 pt -73.69 -43.59 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 111.413 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -59.42 -31.44 69.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -64.71 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.736 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.34 29.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.845 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.25 -166.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.722 0.296 . . . . 0.0 111.135 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 20.9 t80 -113.51 26.71 10.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.5 OUTLIER 79.5 147.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.229 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.652 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -79.31 88.3 4.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.802 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 79' ' ' ILE . 13.8 tp -59.06 148.23 31.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.01 -179.986 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.085 HG21 HD23 ' A' ' 17' ' ' LEU . 32.4 m . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -62.19 1.53 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.436 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -55.3 -29.32 57.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.163 0.506 . . . . 0.0 109.69 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.699 ' CE1' HD11 ' A' ' 79' ' ' ILE . 43.3 t80 -61.62 -44.18 97.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.985 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.752 HD22 ' HG2' ' A' ' 24' ' ' GLU . 1.8 mt -52.5 -31.17 33.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.465 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.656 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 4.1 mp -79.75 -36.05 37.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 m -69.16 -36.88 77.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.491 . . . . 0.0 109.811 179.509 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.651 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.7 mm -67.17 -51.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.068 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -47.26 -57.2 5.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.311 -179.018 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -34.76 69.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.818 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -54.92 -32.42 61.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' A' ' 48' ' ' VAL . 29.8 m-85 -74.6 -46.11 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.076 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.658 -179.762 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 8.5 mmtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.812 0.339 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.445 ' HD2' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 75.53 105.96 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.093 -179.781 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 48' ' ' VAL . 44.4 t -112.78 162.51 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 29' ' ' ASP . 59.5 tp -119.81 139.12 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.687 HG21 HD12 ' A' ' 17' ' ' LEU . 10.5 t -121.05 117.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.133 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 32' ' ' LYS . 61.9 t -105.75 111.6 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.361 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.01 157.21 38.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB2' ' CD ' ' A' ' 56' ' ' PRO . 8.4 t0 -83.5 -70.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.423 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.0 mm-40 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 111.241 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.523 ' HB ' HG21 ' A' ' 30' ' ' THR . 81.3 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.753 0.311 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -82.1 58.56 4.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.065 0.459 . . . . 0.0 110.966 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 170.6 -56.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.415 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.687 HD12 HG21 ' A' ' 6' ' ' VAL . 1.4 tm? -59.81 -55.87 28.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 m -54.66 -41.8 70.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 179.425 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.474 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 17' ' ' LEU . 33.1 mt -57.64 -64.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.69 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.674 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -47.73 -36.46 11.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.51 179.518 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -29.39 70.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.97 -35.06 57.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HG3' HD21 ' A' ' 110' ' ' LEU . 18.5 mm-40 -77.48 -8.58 57.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.161 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.14 51.93 1.99 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.964 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 51.0 m-85 -124.04 -175.92 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 111.345 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -140.23 77.92 24.07 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.061 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HB3' HD13 ' A' ' 21' ' ' LEU . 71.8 Cg_endo -84.05 148.91 12.09 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.582 2.188 . . . . 0.0 113.617 -178.312 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.681 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -131.88 134.1 45.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.719 179.331 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.523 HG21 ' HB ' ' A' ' 14' ' ' THR . 44.4 p -99.36 147.4 25.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.909 0.385 . . . . 0.0 111.166 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -147.24 145.77 29.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.721 ' O ' HG13 ' A' ' 7' ' ' VAL . 13.7 mttt -62.83 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.0 p -48.65 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.255 0.55 . . . . 0.0 111.817 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.775 HD22 ' CD2' ' A' ' 63' ' ' PHE . 10.9 mt -45.51 -30.47 1.44 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.959 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -59.92 -61.67 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 4.3 tp10 -58.76 -38.46 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.86 178.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.02 75.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.06 -48.66 22.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.964 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -55.73 31.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.423 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -26.38 61.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.172 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 41' ' ' ILE . 10.0 mt -97.17 -6.87 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.75 25.21 5.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.359 . . . . 0.0 110.805 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.34 -58.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.489 HD22 ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -100.04 153.52 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.459 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 18.0 t80 -86.93 81.68 8.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.604 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 14.6 m-85 -67.88 117.17 45.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 56.8 Cg_endo -72.4 -38.88 3.17 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.493 2.128 . . . . 0.0 112.325 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.611 ' HB ' HG13 ' A' ' 4' ' ' VAL . 17.2 t -124.83 125.92 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.96 0.409 . . . . 0.0 111.79 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 7.9 mm -115.2 134.29 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.644 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 66.8 t -131.42 109.71 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 111.841 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' HB3' HG13 ' A' ' 78' ' ' VAL . 12.3 tp -78.44 170.58 16.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.423 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -134.63 -54.91 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.455 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.543 HG13 ' HA ' ' A' ' 57' ' ' ASP . 15.4 t 59.82 41.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.763 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 60.5 t-105 -62.73 -91.18 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.095 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.557 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -71.02 -48.76 13.55 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.438 -179.771 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 55' ' ' MET . 64.8 Cg_endo -72.52 -167.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.242 1.962 . . . . 0.0 112.283 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' HA ' HG13 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -163.07 55.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.833 179.856 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.02 115.89 8.54 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -92.84 31.19 1.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.806 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.09 64.37 0.95 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.365 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.861 ' O ' HD12 ' A' ' 64' ' ' ILE . 25.7 t -49.0 -43.02 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.939 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.54 -18.43 40.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.934 ' CE2' HD11 ' A' ' 67' ' ' ILE . 45.8 t80 -49.96 -43.32 50.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.569 0.223 . . . . 0.0 111.227 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.861 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mt -48.07 -30.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.056 0.455 . . . . 0.0 110.604 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -67.6 -53.25 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.184 179.373 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.411 ' CE1' ' HB ' ' A' ' 41' ' ' ILE . 6.7 t80 -46.26 -44.2 16.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.795 0.331 . . . . 0.0 110.863 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.934 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.6 mp -61.94 -47.8 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -14.32 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.886 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' ASP . 28.0 tt0 -73.23 -51.43 17.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.013 0.435 . . . . 0.0 110.546 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.33 14.14 22.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.086 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.417 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -159.49 65.14 2.6 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.648 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 71' ' ' SER . 14.8 Cg_exo -67.75 -20.88 45.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.647 2.231 . . . . 0.0 112.091 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -104.68 33.1 3.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.617 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.8 t -110.63 -178.22 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.561 HG21 ' HB1' ' A' ' 116' ' ' ALA . 40.5 t -129.11 139.64 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.826 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.913 HG12 HG23 ' A' ' 78' ' ' VAL . 2.9 t -125.68 104.74 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.444 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -91.35 -43.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.566 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.913 HG23 HG12 ' A' ' 76' ' ' VAL . 40.2 t 48.15 96.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.721 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 100' ' ' LEU . 6.1 mt -118.62 149.45 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.54 179.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.62 0.247 . . . . 0.0 111.267 -179.92 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.683 0.278 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -88.84 -15.43 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.459 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.98 -34.43 26.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -60.02 -61.28 2.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.93 178.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 92' ' ' ILE . 11.1 m -58.59 -29.11 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.849 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.54 -3.33 43.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.492 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -119.25 -39.88 2.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.373 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.947 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.9 pt -74.35 -46.26 44.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.435 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -60.49 -26.92 67.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.536 179.729 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.688 ' CB ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.59 -62.82 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 179.687 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.5 19.09 0.07 OUTLIER Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.537 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.947 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.41 -169.68 2.48 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.285 0.542 . . . . 0.0 110.961 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.511 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 62.0 t80 -103.91 -18.95 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.534 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 9.0 pt-20 151.28 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.34 0.656 . . . . 0.0 110.003 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -133.49 98.51 4.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.93 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 79' ' ' ILE . 9.8 tp -64.11 169.78 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.995 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.011 179.948 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.434 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.8 p . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.718 0.294 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.65 -42.23 92.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.778 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -63.8 -34.73 78.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.244 179.465 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.644 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 9.7 t80 -60.66 -39.52 88.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.174 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.531 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -55.85 -36.46 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.187 179.871 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 108' ' ' ARG . 1.2 mt -60.44 -42.71 96.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.167 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.9 m -70.97 -46.67 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.549 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 5.1 mm -43.68 -58.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.508 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -47.41 -54.51 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.079 0.466 . . . . 0.0 110.123 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.07 66.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -66.41 -34.68 78.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.945 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE1' ' CA ' ' A' ' 2' ' ' LYS . 25.8 m-85 -74.45 -13.74 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.823 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 . . . . . 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.282 . . . . 0.0 111.358 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HD3' ' CD2' ' A' ' 117' ' ' PHE . 9.8 mmtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.836 0.35 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -147.84 83.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.774 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.624 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.9 t -68.94 160.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 46' ' ' PHE . 55.3 tp -118.94 135.86 54.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 17' ' ' LEU . 14.2 t -118.17 139.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.052 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.775 ' HB ' HD12 ' A' ' 51' ' ' LEU . 24.3 t -125.85 119.27 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.496 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 52' ' ' ASP . 22.9 t0 -170.32 160.68 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -179.365 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 27.4 t70 -88.27 50.53 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.586 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.711 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 54.7 p . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 16' ' ' SER . 1.6 m -55.77 133.79 51.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.851 0.357 . . . . 0.0 111.771 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.692 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER 82.36 -43.55 0.14 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.328 179.159 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -52.21 -53.92 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.755 0.312 . . . . 0.0 111.367 -179.33 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.4 t -46.47 -71.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.54 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.3 -40.63 11.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 0.0 111.482 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.699 HD13 ' CG2' ' A' ' 106' ' ' VAL . 16.3 mt -64.18 -68.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.155 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.042 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.62 -29.92 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.89 -24.0 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.998 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.52 -37.46 27.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.234 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.09 -25.44 43.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.7 2.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.267 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CE2' HG21 ' A' ' 113' ' ' ILE . 11.2 m-30 -112.4 -178.01 3.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 111.366 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.12 78.75 72.37 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.539 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.715 ' HG3' HD13 ' A' ' 21' ' ' LEU . 84.3 Cg_endo -84.27 139.29 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.862 2.375 . . . . 0.0 113.889 -177.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.837 ' O ' HD12 ' A' ' 5' ' ' LEU . 11.1 t0 -121.97 118.27 28.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.342 178.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.819 HG22 ' HB ' ' A' ' 6' ' ' VAL . 72.8 p -102.34 127.05 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.93 0.395 . . . . 0.0 111.627 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.73 -165.18 1.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.526 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -127.43 -5.68 5.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.639 -179.834 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -170.58 -176.28 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.725 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.813 HD22 ' CD2' ' A' ' 63' ' ' PHE . 24.8 mt -77.36 -31.49 54.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.731 0.301 . . . . 0.0 110.339 179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -45.64 67.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -35.72 80.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.075 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.432 ' HB1' HD11 ' A' ' 41' ' ' ILE . . . -69.96 -48.18 59.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 82.4 mt-10 -46.42 -48.36 18.82 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.905 0.383 . . . . 0.0 110.503 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.84 -52.79 64.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.712 178.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.891 ' O ' HD22 ' A' ' 44' ' ' LEU . 9.8 mttt -63.71 -23.47 67.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.283 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.432 HD11 ' HB1' ' A' ' 37' ' ' ALA . 21.0 mt -93.33 -16.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -100.86 22.26 12.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 179.552 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.634 ' C ' HD13 ' A' ' 44' ' ' LEU . 26.7 mt-10 -143.22 -52.98 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.02 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -99.64 12.95 35.2 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.413 0.625 . . . . 0.0 109.818 179.691 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 44' ' ' LEU . 16.1 t80 23.72 86.19 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.748 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.939 ' CE2' HD13 ' A' ' 5' ' ' LEU . 49.3 m-85 -68.42 148.57 98.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.407 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' C ' ' HG ' ' A' ' 74' ' ' SER . 8.4 Cg_endo -83.67 -47.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.792 2.328 . . . . 0.0 111.88 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.624 ' HB ' HG13 ' A' ' 4' ' ' VAL . 24.7 t -116.94 126.79 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.628 HD12 HD23 ' A' ' 5' ' ' LEU . 21.5 mm -111.97 125.68 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.853 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.668 HG21 ' CE1' ' A' ' 109' ' ' PHE . 52.9 t -127.16 106.31 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.08 0.467 . . . . 0.0 112.031 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.775 HD12 ' HB ' ' A' ' 7' ' ' VAL . 42.9 tp -79.04 165.11 23.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.304 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 42.4 t0 -127.59 -56.79 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.668 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.411 HG23 ' HG ' ' A' ' 51' ' ' LEU . 18.1 t 67.96 66.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.935 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.422 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 26.8 t-105 -96.54 -82.93 0.39 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 111.442 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.607 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.2 mtt -83.68 -31.76 0.5 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 55' ' ' MET . 87.7 Cg_endo -83.05 -174.25 1.96 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.099 1.866 . . . . 0.0 112.922 -179.225 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -170.19 58.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.563 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.71 12.69 60.74 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.955 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.45 92.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.792 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.33 -9.05 60.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.852 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 90' ' ' LYS . 18.0 t -51.32 -49.72 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.403 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.58 -3.9 40.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.941 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.813 ' CD2' HD22 ' A' ' 34' ' ' LEU . 12.2 t80 -88.64 -42.09 12.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.538 0.209 . . . . 0.0 111.504 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.511 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.8 mp -43.84 -30.07 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.771 0.319 . . . . 0.0 111.272 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -67.24 -54.63 19.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -48.15 -40.6 24.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 110.52 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.634 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mp -60.45 -48.34 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.511 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -77.24 -18.97 57.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.971 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.89 -50.68 54.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.956 0.408 . . . . 0.0 110.716 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.07 17.26 16.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.6 OUTLIER -161.26 68.33 2.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.771 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.11 -16.63 25.28 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.764 2.309 . . . . 0.0 112.297 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.07 -2.45 34.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.377 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.463 ' HG ' ' C ' ' A' ' 47' ' ' PRO . 46.6 t -82.37 176.82 9.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.051 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.744 HG21 ' HB1' ' A' ' 116' ' ' ALA . 47.0 t -114.61 159.25 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.88 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.756 HG12 ' CG2' ' A' ' 78' ' ' VAL . 1.1 t -143.54 83.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.571 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.699 HD13 ' HB3' ' A' ' 97' ' ' TYR . 37.4 mm -71.53 -45.32 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.656 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.756 ' CG2' HG12 ' A' ' 76' ' ' VAL . 6.8 t 48.67 85.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.489 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 7.6 mt -107.19 152.5 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 -179.977 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.66 0.267 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.3 -22.17 66.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.315 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.7 39.48 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.51 -58.58 7.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.004 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.12 -23.43 27.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.842 179.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.507 ' O ' HG22 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -91.09 39.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.376 179.566 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.511 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -170.16 -38.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.083 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.919 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -74.36 -30.03 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -29.84 67.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.7 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.69 65.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.144 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.77 -2.18 3.31 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.231 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.919 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -56.99 -168.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.046 0.423 . . . . 0.0 111.111 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.699 ' HB3' HD13 ' A' ' 77' ' ' ILE . 6.8 t80 -110.73 27.87 9.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 80.67 156.78 0.14 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.434 179.705 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.727 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -88.54 110.26 20.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 -179.993 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.42 HD23 HD13 ' A' ' 79' ' ' ILE . 8.3 tp -63.72 149.42 46.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.862 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.875 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.941 HG21 HD23 ' A' ' 17' ' ' LEU . 32.8 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.024 0.44 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.7 -55.64 18.7 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.14 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -60.94 -31.54 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.807 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.671 ' CE1' HD11 ' A' ' 113' ' ' ILE . 27.8 t80 -57.65 -39.28 76.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.893 179.065 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.644 HD11 HG23 ' A' ' 20' ' ' ILE . 1.5 mt -60.45 -51.03 71.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.174 179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -57.29 -46.13 83.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.549 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 m -69.27 -44.96 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 0.0 110.959 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.671 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.6 mm -40.63 -52.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.78 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.19 12.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.651 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -62.08 -36.21 80.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.744 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.92 -39.46 85.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.445 ' CE1' HG22 ' A' ' 4' ' ' VAL . 19.5 m-85 -65.36 -19.42 65.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.291 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.333 -179.878 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -142.35 118.09 10.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.967 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.65 HG13 ' HB ' ' A' ' 48' ' ' VAL . 14.3 t -118.6 160.81 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.655 HD22 ' CD2' ' A' ' 46' ' ' PHE . 42.5 tp -114.74 133.44 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.871 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.728 ' HB ' HG22 ' A' ' 30' ' ' THR . 24.5 t -113.58 90.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.407 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 t -82.2 111.85 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.87 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -147.73 137.54 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 13.2 t0 -61.38 -80.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.995 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 p . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.722 0.296 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -80.43 -54.54 5.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.024 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -69.62 -63.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -45.21 -46.17 12.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.315 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.813 ' HA ' HD12 ' A' ' 21' ' ' LEU . 5.7 t -44.73 -37.76 3.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.2 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.238 0.542 . . . . 0.0 110.391 179.301 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.65 ' CD1' HG11 ' A' ' 106' ' ' VAL . 3.0 mp -68.54 -68.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.144 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -48.51 -27.24 2.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.316 179.438 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.946 ' N ' HD13 ' A' ' 21' ' ' LEU . 15.5 mt-10 -73.71 -28.44 61.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.711 0.291 . . . . 0.0 111.011 179.129 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.31 -36.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.826 0.346 . . . . 0.0 110.511 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -64.46 -17.37 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 -179.98 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.99 65.51 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.22 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 24' ' ' GLU . 20.3 m-85 -137.69 -176.92 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.217 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.84 91.89 43.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.716 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.837 ' HG3' HD11 ' A' ' 21' ' ' LEU . 72.7 Cg_endo -84.3 133.3 5.45 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.625 2.216 . . . . 0.0 112.91 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.549 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -110.26 7.23 23.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.344 -179.731 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.728 HG22 ' HB ' ' A' ' 6' ' ' VAL . 15.4 p 6.5 122.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 -170.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.116 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 18.9 tttt -104.39 -43.33 5.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -161.15 -168.28 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.317 179.535 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.596 HD22 ' CD2' ' A' ' 63' ' ' PHE . 32.1 mt -67.19 -52.9 35.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -57.36 -45.78 84.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.58 -35.16 75.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.36 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.483 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -68.45 -34.73 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 77.5 mt-10 -64.51 -43.38 94.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -39.11 78.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -72.36 -49.93 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.687 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 37' ' ' ALA . 6.0 mt -64.19 -27.33 42.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -27.92 5.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -124.2 -42.34 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.08 115.01 19.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -80.34 101.34 8.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.709 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CD2' HD22 ' A' ' 5' ' ' LEU . 35.2 m-85 -97.25 119.15 63.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.0 Cg_endo -73.06 -17.69 24.63 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.477 2.118 . . . . 0.0 111.899 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.679 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -147.85 132.21 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.565 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.501 HD12 HD23 ' A' ' 5' ' ' LEU . 15.5 mm -115.77 160.1 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 178.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.677 ' CG1' HD11 ' A' ' 79' ' ' ILE . 60.0 t -152.67 99.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.206 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -71.39 164.56 25.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' TRP . 4.8 t70 -152.61 57.6 0.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -44.43 91.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.04 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.414 ' N ' ' O ' ' A' ' 52' ' ' ASP . 30.3 t-105 -88.16 -75.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.828 179.257 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.736 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 7.8 ttp -147.18 46.22 0.48 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.161 179.002 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.736 ' HD3' ' N ' ' A' ' 55' ' ' MET . 28.1 Cg_endo -95.48 -160.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.235 2.623 . . . . 0.0 112.204 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -149.54 60.03 1.01 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.03 131.24 4.49 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.508 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.44 ' O ' HD13 ' A' ' 34' ' ' LEU . 11.8 p-10 -74.23 144.94 44.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -103.79 -18.95 12.69 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.766 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.0 t -52.94 -40.61 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.16 -11.44 49.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.84 ' CE2' HD11 ' A' ' 67' ' ' ILE . 26.5 t80 -78.76 -39.64 35.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.371 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.709 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.7 mp -47.57 -32.79 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.359 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.64 -32.96 60.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.662 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 48.3 t80 -61.29 -44.96 96.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.84 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.1 mp -58.02 -42.64 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.271 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -80.25 -19.23 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.15 -30.92 67.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.947 0.403 . . . . 0.0 110.703 179.719 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.437 HD21 HG22 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -132.37 17.21 4.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 180.0 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.57 68.73 1.05 Allowed Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.59 -21.25 46.16 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.77 2.313 . . . . 0.0 112.183 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.67 31.09 3.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.9 t -112.65 -163.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' HB ' HG13 ' A' ' 48' ' ' VAL . 45.8 t -152.58 135.85 7.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-O 121.025 0.441 . . . . 0.0 111.421 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.944 HG12 HG23 ' A' ' 78' ' ' VAL . 2.5 t -107.89 109.85 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.723 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.85 HD12 ' CG2' ' A' ' 112' ' ' THR . 33.7 mm -87.75 -56.32 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 179.388 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.944 HG23 HG12 ' A' ' 76' ' ' VAL . 20.3 t 53.65 103.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.518 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -102.98 -173.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.227 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.716 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.85 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.763 0.316 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 89' ' ' VAL . 38.8 m-20 -78.85 -52.93 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.694 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.407 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.2 t -47.29 -32.5 4.73 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.205 0.526 . . . . 0.0 110.062 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.99 -60.04 4.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.16 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 86' ' ' ASP . 17.5 m -66.32 -24.66 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.118 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -83.63 -20.23 34.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.258 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.709 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -102.52 -39.14 7.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.662 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.91 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.8 pt -69.32 -27.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.408 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -32.08 64.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.697 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -64.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 29.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.916 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.91 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.18 -167.22 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 84.1 t80 -117.67 26.03 9.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.1 pt-20 85.74 146.43 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.415 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -78.8 105.39 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.772 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 79' ' ' ILE . 10.5 tp -57.59 167.01 1.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.05 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 179.942 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.65 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.4 p . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.764 0.316 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -39.87 -38.31 0.66 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.04 -39.77 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.413 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.714 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 21.0 t80 -57.14 -28.32 62.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.74 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -48.03 67.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.331 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.4 mp -66.73 -52.19 47.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.973 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.85 ' CG2' HD12 ' A' ' 77' ' ' ILE . 28.8 m -46.36 -32.61 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 0.0 110.728 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.714 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 22.1 mm -78.18 -67.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.488 ' HZ1' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -50.42 -19.66 0.91 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.941 -179.939 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.41 ' CG ' ' OH ' ' A' ' 97' ' ' TYR . 1.8 t-80 -89.58 -27.84 19.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 110.754 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.01 -35.49 57.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 48' ' ' VAL . 63.7 m-85 -79.73 -45.77 18.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.783 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.912 0.386 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.466 ' HB3' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -162.37 127.66 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.721 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' A' ' 48' ' ' VAL . 39.5 t -116.86 143.72 26.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.727 0.298 . . . . 0.0 110.685 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.599 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 19.1 tp -96.88 132.3 42.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.061 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.874 ' HB ' HG22 ' A' ' 30' ' ' THR . 21.9 t -116.35 89.0 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 32' ' ' LYS . 23.9 t -84.88 112.74 22.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.104 0.478 . . . . 0.0 111.167 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -146.12 136.51 23.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.565 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -51.27 -24.31 4.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.688 179.621 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.494 HG21 ' CG1' ' A' ' 6' ' ' VAL . 72.0 p . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -68.2 137.11 54.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.601 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.529 ' CB ' HG11 ' A' ' 106' ' ' VAL . 0.8 OUTLIER 83.59 -16.94 0.52 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.28 179.316 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.005 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -86.39 -50.18 7.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 110.796 -179.899 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.15 -53.67 12.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.884 HD11 HG13 ' A' ' 106' ' ' VAL . 85.9 mt -67.85 -69.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.005 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.94 -30.23 1.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.98 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.87 -30.59 69.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.734 179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.47 -35.29 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.014 179.486 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.887 ' HG3' HD21 ' A' ' 110' ' ' LEU . 23.4 mm-40 -85.06 178.56 7.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.662 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.25 31.58 6.93 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.219 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.36 -175.55 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.199 0.523 . . . . 0.0 111.301 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.9 OUTLIER -151.05 95.79 3.35 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.811 179.61 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.547 ' HB3' HD13 ' A' ' 21' ' ' LEU . 57.6 Cg_endo -72.94 140.51 31.77 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.251 1.968 . . . . 0.0 112.481 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -115.42 -1.31 12.87 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.874 HG22 ' HB ' ' A' ' 6' ' ' VAL . 48.9 p 12.66 122.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -132.38 159.96 37.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.444 178.795 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.737 ' O ' HG13 ' A' ' 7' ' ' VAL . 31.5 mttt -73.48 -168.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 56' ' ' PRO . 16.8 p -48.04 161.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 111.909 -178.212 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.68 HD22 ' CD2' ' A' ' 63' ' ' PHE . 10.4 mt -27.24 -44.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.648 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.18 -62.36 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.318 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 2.1 tp10 -65.38 -34.73 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.507 ' C ' HD12 ' A' ' 41' ' ' ILE . . . -61.22 -63.14 1.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -44.67 -40.7 6.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.382 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -52.62 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.42 -34.28 76.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.835 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.507 HD12 ' C ' ' A' ' 37' ' ' ALA . 4.3 mt -85.27 -5.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.667 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -93.02 29.18 1.9 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.959 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -147.69 -53.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.953 HD11 ' CE1' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -99.31 -174.63 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -122.48 111.16 16.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.953 ' CE1' HD11 ' A' ' 44' ' ' LEU . 67.6 m-85 -98.58 125.59 42.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.41 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 4.3 Cg_endo -81.44 -23.97 4.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.711 2.274 . . . . 0.0 111.485 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.626 HG21 ' CE1' ' A' ' 117' ' ' PHE . 6.2 t -141.55 131.06 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.567 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 46' ' ' PHE . 8.8 mm -118.25 152.08 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.344 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.52 102.29 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.036 0.445 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.739 ' HB3' HG22 ' A' ' 78' ' ' VAL . 8.8 tp -94.3 129.62 40.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.063 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -113.33 113.15 24.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.417 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.816 HG22 ' CB ' ' A' ' 80' ' ' THR . 5.2 m -76.08 56.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.41 . . . . 0.0 111.542 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -64.76 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.489 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.677 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 35.1 mtm -149.01 51.78 1.03 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.949 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.5 Cg_exo -81.12 -153.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -163.19 30.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.23 134.51 7.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -58.64 105.79 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.89 -33.82 70.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.598 HG13 ' HG3' ' A' ' 94' ' ' LYS . 57.4 t -55.49 -39.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.014 0.435 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -23.64 59.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.183 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.839 ' CE2' HD11 ' A' ' 67' ' ' ILE . 39.7 t80 -75.35 -30.16 60.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 61' ' ' VAL . 5.4 mm -50.65 -33.74 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 69' ' ' GLU . 27.3 t70 -71.56 -39.57 70.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.53 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 14.7 t80 -55.19 -43.68 74.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.845 HG21 HG22 ' A' ' 76' ' ' VAL . 4.0 mp -59.57 -46.28 93.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.397 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -79.31 -13.27 59.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.748 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 65' ' ' ASP . 43.2 tt0 -74.38 -43.15 57.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.113 0.483 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.53 ' ND2' ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -118.55 13.61 13.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.037 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.89 66.43 2.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.925 0.393 . . . . 0.0 110.72 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.4 Cg_exo -69.13 -19.63 38.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.632 2.221 . . . . 0.0 112.243 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.29 27.3 7.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -109.68 -157.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 116' ' ' ALA . 60.7 t -150.23 137.54 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.064 0.459 . . . . 0.0 111.726 179.212 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.845 HG22 HG21 ' A' ' 67' ' ' ILE . 1.6 t -116.35 91.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.445 HG22 ' CG1' ' A' ' 79' ' ' ILE . 27.6 mm -72.38 -59.26 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.114 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 51' ' ' LEU . 47.9 t 51.63 92.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.837 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.936 HG23 ' O ' ' A' ' 100' ' ' LEU . 3.0 mt -116.42 145.71 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.992 0.425 . . . . 0.0 111.558 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.816 ' CB ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.686 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 85' ' ' VAL . 29.3 m . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.948 0.404 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -103.92 -28.78 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -85.47 -31.81 22.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 109.953 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.536 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -61.55 -56.59 18.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.777 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.8 m -52.58 -30.71 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.888 179.445 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.583 ' CD ' HG21 ' A' ' 61' ' ' VAL . 8.2 ttmt -75.98 -22.34 55.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.48 -40.72 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.87 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.892 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 9.2 pt -70.91 -42.94 77.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.321 -179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -23.38 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.554 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.598 ' HG3' HG13 ' A' ' 61' ' ' VAL . 4.1 mmpt? -79.76 -57.83 3.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.61 28.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.495 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.18 -164.52 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.12 0.46 . . . . 0.0 110.68 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.519 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 54.8 t80 -101.87 -23.18 14.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.6 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 3.8 pt-20 150.07 -11.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.603 0.565 . . . . 0.0 111.932 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.625 ' CE1' HG12 ' A' ' 78' ' ' VAL . 1.5 t80 69.98 71.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.121 0.486 . . . . 0.0 110.085 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.936 ' O ' HG23 ' A' ' 79' ' ' ILE . 66.1 tp -49.77 165.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.189 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.456 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 7.7 mt-10 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.884 HG13 HD11 ' A' ' 20' ' ' ILE . 7.1 p . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.632 0.254 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.93 -41.91 77.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -60.83 -34.85 75.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.455 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.613 ' HA ' HD21 ' A' ' 100' ' ' LEU . 6.2 t80 -61.35 -39.78 91.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.429 178.826 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.887 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.2 tt -48.72 -51.71 27.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.31 179.379 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -57.35 -46.57 83.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.4 m -60.8 -40.17 91.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.223 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.0 mm -47.97 -54.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.535 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.91 -59.15 3.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -51.73 -29.46 18.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.867 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -65.33 -33.94 77.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.965 0.412 . . . . 0.0 110.672 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.626 ' CE1' HG21 ' A' ' 48' ' ' VAL . 35.1 m-85 -78.45 -23.01 46.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.291 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.808 0.337 . . . . 0.0 111.186 179.969 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmtp . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.866 0.365 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.33 133.57 24.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.842 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 48' ' ' VAL . 18.6 t -128.03 161.08 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.799 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.697 HD22 ' CD2' ' A' ' 46' ' ' PHE . 28.0 tp -112.51 134.64 53.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.718 ' HB ' HG22 ' A' ' 30' ' ' THR . 22.0 t -116.23 90.28 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.823 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.6 106.02 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.772 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 14' ' ' THR . 10.0 t70 -136.66 133.11 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.989 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 16.8 t70 -51.85 -45.1 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.277 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.661 -179.99 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.472 HG22 ' HB ' ' A' ' 30' ' ' THR . 12.1 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.639 0.257 . . . . 0.0 111.63 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -90.11 -47.02 8.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.544 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -74.88 -69.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.661 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.891 HD13 ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -40.71 -48.02 2.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.68 -179.393 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.68 ' O ' HD22 ' A' ' 21' ' ' LEU . 6.6 t -51.17 -41.73 60.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 110.924 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.35 74.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.313 0.577 . . . . 0.0 109.892 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.846 ' CD1' HG11 ' A' ' 106' ' ' VAL . 2.0 mp -75.51 -63.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.965 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.891 ' CD1' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.11 -13.35 1.17 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.088 -179.241 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.68 ' N ' HD23 ' A' ' 21' ' ' LEU . 3.6 mt-10 -85.07 -26.03 27.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.79 0.329 . . . . 0.0 110.313 179.034 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -35.55 26.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.394 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.868 ' HG2' HD21 ' A' ' 110' ' ' LEU . 3.3 mp0 -73.98 -50.37 20.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.67 57.05 0.22 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.194 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 82.1 m-85 -120.24 -174.74 2.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.072 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.77 89.17 40.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.058 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 85.2 Cg_endo -81.32 124.95 4.97 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.522 2.148 . . . . 0.0 113.062 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.97 7.52 46.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.718 HG22 ' HB ' ' A' ' 6' ' ' VAL . 11.7 p 4.42 122.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.2 168.18 10.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.428 178.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' ASP . 37.1 mttm -88.93 -37.89 14.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -155.95 -179.5 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.734 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.542 HD22 ' CG ' ' A' ' 63' ' ' PHE . 11.2 mt -61.88 -33.89 75.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.549 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -48.19 71.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.191 179.293 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.51 -30.15 68.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.498 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.4 -33.9 69.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 33.7 mt-10 -67.84 -42.56 81.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -33.73 76.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.088 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -75.83 -42.81 48.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.509 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.498 HD12 ' O ' ' A' ' 37' ' ' ALA . 9.3 mt -72.49 -26.95 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.109 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -26.76 13.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -122.27 -42.5 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 139.83 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -103.72 101.93 11.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.77 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.697 ' CD2' HD22 ' A' ' 5' ' ' LEU . 25.8 m-85 -94.82 120.09 65.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.9 Cg_endo -73.64 -12.38 24.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.43 2.087 . . . . 0.0 111.759 179.096 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.649 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.4 t -151.94 135.11 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.43 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 12.3 mm -115.83 161.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.633 178.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' LEU . 60.7 t -149.72 94.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.542 . . . . 0.0 111.642 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.884 ' HB3' HG13 ' A' ' 78' ' ' VAL . 11.6 tp -77.59 171.1 15.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.289 179.624 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 6.4 t70 -139.65 -46.43 0.45 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.395 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 53' ' ' VAL . 21.5 t 66.24 40.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -57.79 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.525 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.676 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.7 mmm -148.05 51.36 1.03 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.059 179.241 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.676 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.8 Cg_endo -87.56 -155.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.036 2.49 . . . . 0.0 112.021 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -148.67 38.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.02 168.87 22.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.515 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.0 111.58 24.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.38 -19.4 66.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.752 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.574 ' O ' HD12 ' A' ' 64' ' ' ILE . 18.8 t -53.12 -48.85 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.859 0.362 . . . . 0.0 111.357 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -14.08 58.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.299 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 67' ' ' ILE . 44.6 t80 -71.87 -37.7 70.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.683 0.277 . . . . 0.0 111.225 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mt -47.89 -28.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.285 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -34.24 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 72.6 t80 -60.12 -38.68 83.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.139 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -60.32 -45.97 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 179.369 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -77.91 -24.24 48.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -64.57 -33.61 76.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.0 17.52 5.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.182 -179.836 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.82 70.02 1.04 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.823 0.344 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.2 -18.79 34.73 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.842 2.361 . . . . 0.0 112.254 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -98.89 30.42 3.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.824 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 41.6 t -114.71 -162.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.641 ' HB ' HG13 ' A' ' 48' ' ' VAL . 30.8 t -154.31 136.5 6.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.68 0.276 . . . . 0.0 111.284 179.201 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.953 HG12 HG23 ' A' ' 78' ' ' VAL . 4.9 t -110.38 110.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.837 -179.036 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 77' ' ' ILE . 28.1 mm -111.11 43.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.662 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.953 HG23 HG12 ' A' ' 76' ' ' VAL . 47.7 t -43.36 121.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.587 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.521 HG23 ' HB3' ' A' ' 100' ' ' LEU . 3.8 mt -121.34 150.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.805 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.478 HG22 ' CG2' ' A' ' 53' ' ' VAL . 30.5 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -111.25 -10.36 14.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.401 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.5 t -89.38 -36.5 15.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.013 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -57.62 -58.21 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.843 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.406 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.1 m -55.14 -27.11 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.578 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HE3' HG22 ' A' ' 61' ' ' VAL . 31.0 ttpt -82.21 -20.35 37.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.134 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.59 -40.3 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.498 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.939 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 12.5 pt -68.71 -31.52 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -26.4 67.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.697 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -73.74 -59.59 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 31.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.332 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.939 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.09 -164.67 1.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.025 0.412 . . . . 0.0 110.438 179.3 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.555 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.6 t80 -105.22 -22.02 13.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.53 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 144.52 14.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.733 0.645 . . . . 0.0 111.773 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER 62.15 163.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 110.643 -179.881 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -107.48 97.04 6.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.649 179.856 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.032 -179.889 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 20' ' ' ILE . 12.4 p . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.746 0.308 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -45.94 -41.82 12.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.936 0.398 . . . . 0.0 110.909 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.467 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -64.04 -34.79 78.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.166 179.362 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.631 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 6.3 t80 -68.03 -28.93 67.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.522 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.868 HD21 ' HG2' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -50.67 -42.69 56.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.068 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 108' ' ' ARG . 3.3 mp -56.37 -56.2 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.836 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.418 ' CG2' HD12 ' A' ' 77' ' ' ILE . 90.9 m -46.62 -44.06 17.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.055 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.631 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 24.2 mm -54.53 -69.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.037 0.446 . . . . 0.0 110.43 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.418 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -54.9 -17.9 4.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.876 179.111 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -89.8 -21.23 22.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.34 -37.34 18.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.971 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 48' ' ' VAL . 35.0 m-85 -73.09 -39.29 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.294 -179.741 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 25.4 mmtt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.861 0.362 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.405 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -147.99 124.75 11.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 48' ' ' VAL . 25.2 t -119.6 159.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.707 HD23 HG23 ' A' ' 49' ' ' ILE . 41.7 tp -114.04 136.29 53.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.579 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.777 HG21 HD12 ' A' ' 17' ' ' LEU . 3.6 t -120.79 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 37' ' ' ALA . 30.2 t -78.14 119.47 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.567 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 12.3 t0 -163.75 154.74 16.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.747 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -85.23 48.99 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.653 179.707 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.429 HG22 ' OD2' ' A' ' 8' ' ' ASP . 64.2 p . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.721 ' HB3' HG13 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -91.46 -155.13 0.39 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.745 0.307 . . . . 0.0 111.523 -179.591 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' LEU . 52.6 m -47.53 -22.23 0.45 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.869 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.977 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -32.14 -49.55 0.2 Allowed 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 110.482 179.238 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 t -47.78 -67.14 0.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.111 179.289 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.53 75.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.693 ' CD1' HG23 ' A' ' 106' ' ' VAL . 13.7 mt -61.59 -63.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.346 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.977 HD11 HD13 ' A' ' 17' ' ' LEU . 1.5 mt -45.07 -36.18 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.329 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -27.85 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.136 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' ILE . 12.3 tt0 -87.1 -41.98 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.507 ' OE2' HD21 ' A' ' 110' ' ' LEU . 5.3 mm-40 -75.31 -43.33 51.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.75 32.71 5.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.558 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.698 ' HB2' HD23 ' A' ' 21' ' ' LEU . 48.9 m-85 -81.42 -174.63 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.894 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.98 86.05 53.1 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.031 179.332 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.546 ' HG3' HD13 ' A' ' 21' ' ' LEU . 94.0 Cg_endo -81.46 136.82 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 112.505 -179.363 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 30' ' ' THR . 7.2 t70 -113.53 3.02 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.03 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.731 HG22 ' HB ' ' A' ' 6' ' ' VAL . 26.4 p 9.84 121.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.12 -178.54 3.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.699 179.041 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 30.7 tttp -95.39 -38.62 10.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.667 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 6.2 t -165.76 -162.47 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.899 HD11 ' O ' ' A' ' 59' ' ' ASP . 14.9 mt -68.4 -47.36 67.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.657 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -60.78 -45.63 93.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 109.989 179.167 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -34.13 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 7' ' ' VAL . . . -70.29 -35.06 73.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.705 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG2' ' CD1' ' A' ' 66' ' ' PHE . 90.3 mt-10 -65.92 -41.31 91.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -38.07 85.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.601 178.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -74.06 -49.94 21.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.873 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.57 HG22 HD21 ' A' ' 70' ' ' ASN . 11.6 mt -66.9 -27.75 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.145 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -62.85 -23.99 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.095 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.06 -42.89 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.247 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 129.16 38.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -82.18 62.39 5.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.461 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.564 ' HB2' HD11 ' A' ' 49' ' ' ILE . 60.0 m-85 -55.34 121.31 36.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.475 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.446 ' O ' ' HA ' ' A' ' 74' ' ' SER . 61.0 Cg_endo -72.9 -22.92 19.35 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.435 2.09 . . . . 0.0 111.805 179.318 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 117' ' ' PHE . 4.5 t -142.68 125.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.316 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.707 HG23 HD23 ' A' ' 5' ' ' LEU . 8.3 mm -111.91 152.52 13.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.029 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 51' ' ' LEU . 4.9 t -134.87 177.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.432 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.875 ' HB3' HG13 ' A' ' 78' ' ' VAL . 29.4 tp -161.74 78.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.072 0.463 . . . . 0.0 111.101 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 8.6 t70 -70.72 67.84 0.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.517 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' A' ' 51' ' ' LEU . 50.4 t -47.12 92.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.474 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -79.19 -80.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.502 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.681 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -152.5 50.6 0.64 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.13 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.681 ' HD3' ' N ' ' A' ' 55' ' ' MET . 10.1 Cg_endo -90.57 -158.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.043 2.495 . . . . 0.0 112.015 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -157.74 58.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.096 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.48 10.79 4.06 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.788 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.899 ' O ' HD11 ' A' ' 34' ' ' LEU . 3.3 m-20 52.98 -162.02 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.717 0.258 . . . . 0.0 110.679 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.23 28.96 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.674 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.632 HG21 ' HD3' ' A' ' 90' ' ' LYS . 17.6 t -89.44 -44.91 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.13 9.56 27.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.569 -179.693 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.774 ' CE2' HD11 ' A' ' 67' ' ' ILE . 17.6 t80 -90.03 -36.88 14.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.704 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.6 mp -46.79 -28.97 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.403 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -35.89 65.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.539 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 12.3 t80 -62.74 -44.2 96.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.422 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.774 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.0 mp -59.27 -37.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.321 179.411 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -85.7 -20.19 29.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.719 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -69.59 -29.26 66.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.57 HD21 HG22 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -131.93 9.05 4.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.251 -179.873 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.03 67.79 3.21 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.854 0.359 . . . . 0.0 110.745 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.65 -15.37 21.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.799 2.333 . . . . 0.0 112.285 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.35 27.35 9.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.067 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 39.8 t -107.18 -163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.489 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.869 HG21 ' HB1' ' A' ' 116' ' ' ALA . 21.2 t -146.36 131.64 12.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 121.239 0.542 . . . . 0.0 112.457 179.338 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.006 HG12 HG23 ' A' ' 78' ' ' VAL . 1.3 t -105.25 110.72 31.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.094 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.704 HD12 ' CG2' ' A' ' 112' ' ' THR . 29.2 mm -109.25 38.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.137 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.006 HG23 HG12 ' A' ' 76' ' ' VAL . 60.0 t -42.63 115.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.295 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.896 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -105.64 179.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.87 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.692 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 111.289 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.935 0.398 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -104.12 -18.92 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -90.84 -36.16 14.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.393 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.78 -57.27 13.17 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.84 178.794 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -51.76 -26.86 7.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.632 ' HD3' HG21 ' A' ' 61' ' ' VAL . 8.9 tttt -89.09 36.74 0.83 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.22 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.704 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -170.31 -42.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.614 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -75.47 157.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.808 179.997 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.16 -3.2 2.52 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.102 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -112.6 -25.33 9.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.31 -34.92 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.25 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -68.91 177.63 2.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.773 0.321 . . . . 0.0 111.151 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.46 ' HB3' HD13 ' A' ' 77' ' ' ILE . 45.4 t80 -108.77 29.94 6.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.486 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.1 OUTLIER 80.15 142.71 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.932 179.773 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.61 ' CG ' ' HB2' ' A' ' 88' ' ' ALA . 1.6 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.38 -179.605 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.896 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -89.94 89.46 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.593 179.655 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.26 -179.882 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.755 HG21 HD23 ' A' ' 17' ' ' LEU . 33.3 m . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -45.93 -47.85 16.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.664 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -70.45 -30.34 67.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.987 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.508 ' CE2' HG21 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -65.71 -25.15 67.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.447 179.522 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.507 HD21 ' OE2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -47.44 -50.15 23.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.883 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.608 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.5 mp -55.63 -47.56 76.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.476 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.704 ' CG2' HD12 ' A' ' 77' ' ' ILE . 97.7 m -49.29 -38.36 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.632 179.58 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.472 HG23 ' CE1' ' A' ' 117' ' ' PHE . 8.3 mm -66.48 -62.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.16 179.237 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.478 ' CG ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -55.56 -14.94 2.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.456 179.402 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.416 ' N ' ' HD3' ' A' ' 114' ' ' LYS . 2.0 m80 -90.41 -19.69 23.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.072 0.463 . . . . 0.0 110.266 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.869 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -89.98 -49.1 6.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.963 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 48' ' ' VAL . 36.9 m-85 -56.8 -30.8 64.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.985 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 19.9 mmtt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.836 0.351 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -143.64 128.04 17.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.651 179.948 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.2 t -121.5 151.45 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 -179.806 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.58 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 33.5 tp -101.24 136.53 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.752 0.31 . . . . 0.0 110.516 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.819 HG21 HD12 ' A' ' 17' ' ' LEU . 8.4 t -117.14 95.57 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 32' ' ' LYS . 87.6 t -89.34 116.22 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 0.0 111.243 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -145.37 112.68 6.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.879 179.841 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.537 ' HB2' HG23 ' A' ' 33' ' ' THR . 4.8 t70 -50.42 -79.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -178.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.915 0.388 . . . . 0.0 111.244 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.52 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 2.7 p . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -42.57 140.92 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.285 -178.733 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.57 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.6 m 85.56 -17.57 0.41 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.62 179.054 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.991 HD23 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.66 -54.45 11.87 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.052 -179.672 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.0 -67.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.676 -179.562 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.65 -40.36 27.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.496 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.882 HG23 HD11 ' A' ' 110' ' ' LEU . 60.3 mt -64.72 -66.27 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.918 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.65 -29.44 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.13 -25.09 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.09 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -81.89 -41.11 21.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.869 0.366 . . . . 0.0 110.246 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.612 ' HG2' HD22 ' A' ' 110' ' ' LEU . 1.6 mp0 -75.85 -32.09 59.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.059 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.74 31.17 6.46 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 51.1 m-85 -88.27 -174.69 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -139.01 91.61 11.38 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.635 179.858 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 66.9 Cg_endo -76.88 145.49 25.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.18 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.9 t70 -120.09 -4.61 10.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.703 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.613 ' O ' ' O ' ' A' ' 29' ' ' ASP . 10.2 p 23.54 123.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.64 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -131.74 145.69 51.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.297 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.646 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -58.61 -173.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.521 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -48.36 167.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 111.654 -178.591 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 63' ' ' PHE . 11.8 mt -31.44 -39.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.481 -178.952 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -62.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.149 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.463 ' CB ' ' CB ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -64.81 -27.25 68.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.865 179.568 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.45 -57.39 4.47 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.391 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.472 ' HG3' ' CE1' ' A' ' 63' ' ' PHE . 64.5 mt-10 -46.31 -41.34 13.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -61.0 -53.28 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.541 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HD2' ' HB2' ' A' ' 31' ' ' ALA . 20.1 mttm -59.66 -35.03 73.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.129 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.731 HD12 ' HZ ' ' A' ' 63' ' ' PHE . 47.3 mt -92.3 -5.23 10.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLU . 2.8 tmtm? -56.75 -19.61 17.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.299 -179.813 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -139.43 -46.23 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 121.07 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -87.14 75.22 9.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 27.2 m-85 -66.09 132.33 94.56 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 74.1 Cg_endo -75.23 -30.38 6.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.411 2.074 . . . . 0.0 111.878 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.778 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.4 t -140.32 132.98 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.537 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 46' ' ' PHE . 20.9 mm -115.47 145.23 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.453 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 44.1 t -130.3 105.74 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 111.446 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 ' HA3' ' A' ' 60' ' ' GLY . 45.7 tp -100.33 147.88 25.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.3 179.398 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.704 ' C ' HG22 ' A' ' 80' ' ' THR . 7.4 t0 -119.11 -31.76 4.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.563 -179.38 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 53' ' ' VAL . 88.5 t 60.64 63.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.73 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.455 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 37.1 t-105 -58.83 -81.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.834 0.349 . . . . 0.0 110.383 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.71 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 ttt -151.97 48.82 0.5 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.085 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.8 Cg_exo -76.87 -150.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.789 2.326 . . . . 0.0 112.032 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -135.18 21.48 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.212 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.67 -3.71 4.98 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.029 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 61' ' ' VAL . 16.4 m-20 52.64 25.1 3.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.018 0.437 . . . . 0.0 111.167 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.668 ' HA3' HD21 ' A' ' 51' ' ' LEU . . . 49.6 18.63 1.73 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.623 179.637 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 90' ' ' LYS . 23.2 t -87.25 -45.1 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 117.149 0.474 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -65.78 -16.16 63.53 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 34' ' ' LEU . 3.7 t80 -85.65 -29.05 24.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.564 ' CD1' ' HB1' ' A' ' 91' ' ' ALA . 20.2 mm -46.59 -43.47 6.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.327 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -44.91 70.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 21.1 t80 -49.4 -41.06 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.975 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.792 HG21 HG22 ' A' ' 76' ' ' VAL . 2.1 mp -62.61 -49.97 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -12.09 60.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.466 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.92 -49.37 20.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.059 0.457 . . . . 0.0 110.394 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -114.18 17.04 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.05 67.2 2.05 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.736 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.22 -15.77 22.66 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.776 2.317 . . . . 0.0 112.265 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -112.61 32.91 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.83 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -111.89 -159.83 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.878 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.833 HG11 ' HB1' ' A' ' 116' ' ' ALA . 41.2 t -138.08 138.98 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.309 0.576 . . . . 0.0 112.293 179.728 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.874 HG12 HG23 ' A' ' 78' ' ' VAL . 6.2 t -114.41 99.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.317 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.641 HG21 ' CD1' ' A' ' 109' ' ' PHE . 35.0 mm -103.41 43.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.874 HG23 HG12 ' A' ' 76' ' ' VAL . 98.9 t -54.72 87.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.652 HG23 ' HB3' ' A' ' 100' ' ' LEU . 19.2 mt -66.25 -101.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.704 HG22 ' C ' ' A' ' 52' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.237 . . . . 0.0 111.041 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 C--O 1.231 0.094 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.72 -27.06 68.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.685 0.279 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.52 -34.24 54.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.8 -57.81 11.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.018 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 m -56.84 -22.83 16.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.956 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.523 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -80.41 2.81 23.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.248 179.753 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . -138.71 -40.53 0.5 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 1.6 pt -70.84 -24.59 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -71.74 -35.58 70.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -59.77 -59.21 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.65 31.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.995 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.24 -178.74 5.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.471 ' HB3' HD13 ' A' ' 77' ' ' ILE . 18.9 t80 -101.25 27.91 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.426 -179.758 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 77.64 151.96 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.971 179.927 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -74.19 139.26 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.652 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -83.64 92.11 7.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.556 179.869 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.066 -179.823 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.991 HG21 HD23 ' A' ' 17' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.465 0.304 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.1 -50.86 29.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HA ' HD13 ' A' ' 111' ' ' LEU . 13.8 tpt180 -61.94 -29.63 70.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.417 178.514 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CD1' HG21 ' A' ' 77' ' ' ILE . 24.0 t80 -62.12 -40.71 96.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.712 178.804 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.882 HD11 HG23 ' A' ' 20' ' ' ILE . 2.0 mt -54.65 -48.83 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.263 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.482 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.4 mp -59.54 -50.45 73.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.028 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.0 m -61.5 -37.55 84.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.707 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.502 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 1.6 mm -55.76 -53.13 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.375 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -60.0 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 109.853 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -58.4 -26.13 62.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.998 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.833 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -66.14 -38.35 87.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.926 0.393 . . . . 0.0 110.977 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.597 ' CE2' HG21 ' A' ' 48' ' ' VAL . 20.7 m-85 -68.84 -20.04 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.632 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.961 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.486 ' HG3' ' CD2' ' A' ' 117' ' ' PHE . 2.0 mptt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.909 0.385 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -111.39 124.73 52.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.458 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.671 HG13 ' HB ' ' A' ' 48' ' ' VAL . 26.9 t -124.33 144.33 34.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.329 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.654 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 46.8 tp -95.02 128.76 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.321 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.555 HG21 ' CD1' ' A' ' 17' ' ' LEU . 18.9 t -112.91 92.56 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.482 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 32' ' ' LYS . 60.1 t -89.99 118.72 35.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.029 0.442 . . . . 0.0 111.082 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -153.63 125.12 7.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.681 ' HB2' HG22 ' A' ' 33' ' ' THR . 21.2 t0 -85.73 47.59 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.329 -179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' CG ' ' CD1' ' A' ' 54' ' ' TRP . 4.0 tm-20 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.676 179.727 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.438 HG23 ' CG1' ' A' ' 6' ' ' VAL . 65.6 p . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.799 0.333 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -52.19 139.46 23.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 0.0 112.185 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.752 ' O ' HD12 ' A' ' 20' ' ' ILE . 8.7 t 73.54 0.72 3.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.449 179.109 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.36 -59.45 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.157 -179.918 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.63 ' O ' HD22 ' A' ' 21' ' ' LEU . 7.8 t -46.5 -45.94 18.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.591 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.14 73.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.376 0.607 . . . . 0.0 110.17 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 110' ' ' LEU . 41.7 mt -76.14 -64.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.774 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.771 ' CD1' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -56.74 -10.46 1.04 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.978 -179.186 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.571 ' N ' HD23 ' A' ' 21' ' ' LEU . 17.4 mt-10 -89.23 -28.6 19.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.033 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -36.1 32.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.013 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.769 ' CG ' HD21 ' A' ' 110' ' ' LEU . 30.5 mm-40 -77.77 -31.33 51.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.019 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 42.89 3.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.512 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 7.2 m-85 -95.83 -170.31 2.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 -179.066 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.08 93.47 5.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.455 ' HD3' ' HG ' ' A' ' 21' ' ' LEU . 73.3 Cg_endo -79.67 146.78 19.17 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.384 2.056 . . . . 0.0 112.011 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.658 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -115.76 -7.26 12.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 29' ' ' ASP . 11.7 p 25.51 124.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -141.89 141.88 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.901 178.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.844 ' O ' HG13 ' A' ' 7' ' ' VAL . 39.4 mtmt -58.79 -165.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.56 0.219 . . . . 0.0 110.564 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.681 HG22 ' HB2' ' A' ' 9' ' ' ASP . 14.9 p -47.89 168.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 112.149 -177.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.815 HD11 ' O ' ' A' ' 59' ' ' ASP . 22.5 mt -40.81 -31.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.97 -179.075 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -64.3 0.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.14 0.495 . . . . 0.0 109.84 179.181 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.5 -33.72 76.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.461 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 34' ' ' LEU . . . -64.88 -61.66 2.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.729 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 7.5 mt-10 -44.05 -42.12 5.93 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -61.44 -51.74 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -63.35 -33.95 76.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.336 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 41' ' ' ILE . 8.3 mt -88.95 -9.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -57.67 -19.42 26.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.501 -179.735 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -134.64 -47.25 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 124.72 20.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -84.96 72.0 10.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.654 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 25.0 m-85 -65.79 126.77 92.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.79 -27.62 3.84 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.508 2.139 . . . . 0.0 112.074 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.717 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.8 t -140.51 132.62 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.346 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.448 HD11 ' CB ' ' A' ' 46' ' ' PHE . 18.5 mm -118.73 148.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.138 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 49.0 t -136.86 104.57 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.488 179.532 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp -98.99 97.68 8.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -83.42 92.79 7.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.953 178.936 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.761 HG22 ' HB ' ' A' ' 80' ' ' THR . 28.0 m -63.87 74.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.789 -179.211 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.442 ' CD1' ' CG ' ' A' ' 10' ' ' GLU . 30.3 t-105 -81.75 -80.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.514 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.498 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 21.9 mmt -145.67 61.4 7.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.809 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 55' ' ' MET . 11.1 Cg_endo -89.2 -159.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.128 2.552 . . . . 0.0 112.32 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -153.77 25.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.141 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.96 10.66 5.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.629 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.815 ' O ' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 55.92 -157.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.788 0.294 . . . . 0.0 110.212 -179.703 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.7 22.04 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.898 ' O ' HD12 ' A' ' 64' ' ' ILE . 20.4 t -86.83 -45.15 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 110.879 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -1.16 50.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CD2' HD11 ' A' ' 67' ' ' ILE . 6.5 t80 -76.32 -41.14 49.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.4 mt -43.81 -38.42 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.329 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.32 -51.37 57.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.427 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 34.0 t80 -53.68 -28.5 33.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.097 179.289 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.984 HG21 HG22 ' A' ' 76' ' ' VAL . 2.9 mm -68.25 -54.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -71.3 -22.06 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.557 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.93 -52.89 61.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.701 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -112.62 18.0 18.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.161 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.4 68.15 1.71 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 110.801 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.35 -19.33 33.45 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.804 2.336 . . . . 0.0 112.361 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -113.17 35.96 3.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -112.64 -156.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.809 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.717 ' HB ' HG13 ' A' ' 48' ' ' VAL . 50.0 t -146.49 138.72 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.436 0.636 . . . . 0.0 112.16 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 67' ' ' ILE . 2.8 t -118.35 80.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.149 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -65.56 -54.93 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.78 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.809 HG23 HG12 ' A' ' 76' ' ' VAL . 34.4 t 49.44 89.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.32 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.749 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -99.33 -173.96 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.761 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.7 m . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.352 . . . . 0.0 110.963 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.6 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.618 0.247 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.49 -15.87 28.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.099 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.13 -32.86 38.92 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.51 -57.95 10.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.099 178.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 92' ' ' ILE . 17.5 m -61.84 -27.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.207 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.528 ' O ' HG13 ' A' ' 61' ' ' VAL . 4.8 ttmt -80.56 -12.91 59.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.647 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.663 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -114.1 -24.34 9.05 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.834 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 4.9 pt -90.1 -15.05 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.272 . . . . 0.0 111.635 -179.564 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.69 -42.74 67.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.737 0.303 . . . . 0.0 111.123 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.611 ' HB3' HD13 ' A' ' 64' ' ' ILE . 9.4 ttmt -54.82 -35.1 63.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.77 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.157 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.1 -167.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.33 . . . . 0.0 110.899 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 9.3 t80 -108.44 27.28 9.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.219 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.9 OUTLIER 80.66 159.7 0.16 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.154 179.759 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.734 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -92.13 104.39 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.827 -179.962 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HB3' HG23 ' A' ' 79' ' ' ILE . 9.9 tp -57.78 147.33 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.992 -179.974 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.722 HG21 HD23 ' A' ' 17' ' ' LEU . 3.5 m . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -70.72 -51.89 24.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -58.64 -32.22 68.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.583 ' CE1' HD11 ' A' ' 113' ' ' ILE . 28.4 t80 -61.54 -36.92 81.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.267 178.557 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.833 ' CD1' HG23 ' A' ' 20' ' ' ILE . 3.2 tt -55.61 -60.09 3.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.1 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.421 ' H ' HD12 ' A' ' 111' ' ' LEU . 3.5 mp -60.29 -46.98 87.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.628 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.6 m -61.19 -40.07 92.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.583 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.7 mm -50.28 -52.38 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.657 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -55.52 7.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.115 0.483 . . . . 0.0 110.323 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -56.03 -27.37 52.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.949 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.696 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -65.94 -36.19 82.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.98 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.675 ' CE1' HG21 ' A' ' 48' ' ' VAL . 50.9 m-85 -80.82 -35.23 33.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.229 -179.63 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.849 0.356 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.01 134.21 21.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.667 HG13 ' HB ' ' A' ' 48' ' ' VAL . 5.6 t -124.16 152.6 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.905 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 52.4 tp -105.03 127.93 53.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.166 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.908 HG21 ' CD1' ' A' ' 17' ' ' LEU . 21.5 t -113.42 92.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.372 . . . . 0.0 111.604 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.653 ' HB ' HD12 ' A' ' 51' ' ' LEU . 43.8 t -78.97 115.24 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 34.5 t70 -157.31 155.53 30.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.806 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -88.27 49.33 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.969 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.983 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 37.5 p . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.19 127.11 31.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 t 80.41 -39.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.52 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.908 ' CD1' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -46.04 -61.13 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.145 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.823 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -39.79 -61.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.7 -178.703 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.98 12.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.277 0.561 . . . . 0.0 110.88 179.427 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.619 HD13 HG22 ' A' ' 106' ' ' VAL . 10.4 mt -76.04 -71.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.019 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -50.49 -30.25 12.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.416 -179.558 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.946 ' N ' HD13 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -74.22 -25.95 59.97 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.764 0.316 . . . . 0.0 110.705 178.945 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.75 -37.13 30.99 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.171 179.43 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.635 ' CD ' HD21 ' A' ' 110' ' ' LEU . 16.5 mm-40 -66.84 -28.82 68.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.46 42.91 3.31 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.377 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 72.5 m-85 -113.82 -177.61 3.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 111.156 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.95 106.7 28.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.776 179.124 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.671 ' HD3' HD21 ' A' ' 21' ' ' LEU . 98.3 Cg_endo -92.9 128.32 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.809 2.34 . . . . 0.0 113.218 -178.806 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.1 t70 -107.32 6.55 28.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.794 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.638 HG22 ' HB ' ' A' ' 6' ' ' VAL . 1.7 p -2.74 125.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.31 -162.2 0.88 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.713 179.16 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -109.4 -40.86 4.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.016 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.11 -175.58 5.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.7 HD22 ' CD2' ' A' ' 63' ' ' PHE . 60.8 mt -61.77 -45.99 91.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -61.26 -46.77 88.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.993 0.425 . . . . 0.0 110.1 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.23 -30.49 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.413 179.414 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.46 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.23 -31.62 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.677 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 60.9 mt-10 -70.14 -40.16 74.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.9 77.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.317 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -75.04 -37.54 61.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.811 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 37' ' ' ALA . 12.9 mt -75.48 -26.04 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -7.33 47.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -112.82 -30.73 6.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.76 0.314 . . . . 0.0 111.233 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.622 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -128.21 156.1 43.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.786 -179.862 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 48.2 t80 -93.96 98.14 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 39.4 m-85 -80.44 123.54 82.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.33 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.476 ' O ' ' HA ' ' A' ' 74' ' ' SER . 87.9 Cg_endo -82.75 -21.59 4.88 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.578 2.186 . . . . 0.0 111.905 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.667 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.8 t -148.76 133.57 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.095 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.536 HD12 HD23 ' A' ' 5' ' ' LEU . 15.3 mm -119.66 160.81 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.794 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 79' ' ' ILE . 95.1 t -153.27 99.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.653 HD12 ' HB ' ' A' ' 7' ' ' VAL . 12.6 tp -69.1 166.17 18.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.565 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -161.88 76.09 0.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.422 -179.742 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -63.42 75.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.583 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -66.94 -80.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.21 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.749 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -152.65 44.28 0.26 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.28 178.767 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.749 ' HD3' ' N ' ' A' ' 55' ' ' MET . 41.1 Cg_endo -97.96 -77.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.178 2.585 . . . . 0.0 112.368 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -170.15 -51.39 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.509 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.45 -131.64 42.74 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.946 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.59 44.08 7.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.54 67.93 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.839 ' O ' HD12 ' A' ' 64' ' ' ILE . 80.1 t -59.35 -33.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.035 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.11 5.96 24.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.7 ' CD2' HD22 ' A' ' 34' ' ' LEU . 19.4 t80 -72.17 -35.26 68.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.756 0.312 . . . . 0.0 111.164 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.2 mp -51.38 -32.96 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.222 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.86 -33.36 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.553 179.673 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 33.7 t80 -60.19 -42.87 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.3 mp -61.32 -44.85 99.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.21 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -74.85 -22.66 58.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.54 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -67.09 -38.06 85.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.36 18.23 8.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.442 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -167.73 69.58 0.89 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.629 -179.941 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.85 -20.04 39.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.788 2.325 . . . . 0.0 112.312 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -107.26 30.9 5.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.895 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 32.3 t -108.27 -162.48 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HB ' HG13 ' A' ' 48' ' ' VAL . 63.7 t -149.9 135.02 10.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 111.834 179.249 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.644 HG12 HG23 ' A' ' 78' ' ' VAL . 22.6 t -107.42 116.8 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.063 -178.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.69 HD12 ' CG2' ' A' ' 112' ' ' THR . 17.2 mm -120.85 48.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.118 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.65 HG13 HD23 ' A' ' 51' ' ' LEU . 89.3 t -45.64 134.31 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.228 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.561 HD11 HG13 ' A' ' 50' ' ' VAL . 3.3 mt -132.66 167.74 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 179.565 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.7 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 89' ' ' VAL . 33.5 t70 -115.01 -58.62 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -47.34 -34.2 6.61 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.12 0.485 . . . . 0.0 110.498 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.831 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.94 -59.49 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.192 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 86' ' ' ASP . 25.0 m -62.03 -24.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.005 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.591 ' HD3' HG21 ' A' ' 61' ' ' VAL . 7.5 ttmm -84.77 -18.95 33.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.356 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.05 -32.54 8.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.7 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.908 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 8.1 pt -78.19 -17.73 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.774 -179.382 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -85.68 -17.18 36.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.68 0.276 . . . . 0.0 111.209 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.623 ' HB3' HD13 ' A' ' 64' ' ' ILE . 8.7 tttp -80.1 -24.52 40.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.302 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.27 -17.73 0.37 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.297 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.908 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.39 176.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.0 0.428 . . . . 0.0 111.426 -179.759 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.636 ' HB3' HD13 ' A' ' 77' ' ' ILE . 75.8 t80 -104.32 28.28 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.269 -179.458 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 81.63 140.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -59.48 143.96 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.105 -179.755 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.867 HD21 ' HA ' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -85.51 104.98 15.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.734 179.938 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.117 -179.8 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.776 HG21 HD23 ' A' ' 17' ' ' LEU . 2.9 m . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.1 -52.97 30.5 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.543 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.69 -27.76 66.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.05 0.453 . . . . 0.0 110.138 179.115 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.867 ' HA ' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -61.22 -26.27 67.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.563 179.607 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.635 HD21 ' CD ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -52.13 -47.56 65.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 179.963 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.615 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 3.5 mp -70.8 -53.02 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.69 ' CG2' HD12 ' A' ' 77' ' ' ILE . 54.3 m -44.49 -35.78 2.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.12 0.485 . . . . 0.0 110.151 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 4' ' ' VAL . 14.3 mm -67.17 -66.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.173 178.824 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -55.88 -19.52 12.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 179.581 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -90.43 -35.51 15.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.649 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -69.66 -53.81 16.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.173 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.49 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 29.7 m-85 -56.04 -24.55 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.391 179.896 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.447 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 9.6 mmtm . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.802 0.334 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.44 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.66 100.65 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.639 HG13 ' HB ' ' A' ' 48' ' ' VAL . 36.3 t -90.57 161.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.686 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.591 HD13 ' CE2' ' A' ' 46' ' ' PHE . 25.8 tp -108.78 136.17 48.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG21 HD12 ' A' ' 17' ' ' LEU . 6.5 t -123.94 90.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 37' ' ' ALA . 25.4 t -89.33 104.3 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.071 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.7 142.71 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.479 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.26 48.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 0.0 111.025 -179.759 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.8 tp10 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.99 179.848 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.515 HG23 ' CG1' ' A' ' 6' ' ' VAL . 63.2 p . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.0 t -57.44 133.52 55.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.028 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.457 ' O ' HD12 ' A' ' 20' ' ' ILE . 7.0 t 84.95 -31.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.752 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.926 HD23 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -66.77 -59.79 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.49 -179.122 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.634 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -47.32 -49.73 23.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.623 -179.211 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.435 0.636 . . . . 0.0 110.122 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.638 HD13 HG23 ' A' ' 106' ' ' VAL . 45.4 mt -75.88 -65.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.723 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.907 HD12 HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.82 -11.47 1.01 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.172 -179.181 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.619 ' N ' HD23 ' A' ' 21' ' ' LEU . 6.0 mt-10 -88.07 -27.29 22.07 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.891 0.377 . . . . 0.0 110.155 178.954 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.86 -36.06 23.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.918 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.6 mp0 -76.53 -29.87 56.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.247 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.36 47.9 2.49 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.179 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.61 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.0 m-85 -103.66 -172.08 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.056 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -143.56 89.9 7.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.357 179.568 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.7 Cg_endo -80.46 137.26 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.484 2.123 . . . . 0.0 112.612 -179.377 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -99.6 -1.41 38.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.574 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.664 HG22 ' HB ' ' A' ' 6' ' ' VAL . 12.9 p 8.51 123.43 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.14 -162.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.209 178.434 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -117.96 -28.55 5.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.754 0.311 . . . . 0.0 111.361 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.57 -168.91 1.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.804 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.63 HD22 ' CD2' ' A' ' 63' ' ' PHE . 29.5 mt -65.06 -43.85 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.79 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -57.67 -50.79 72.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.447 179.566 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -69.42 -29.47 67.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.717 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CB ' HG21 ' A' ' 7' ' ' VAL . . . -75.51 -29.59 59.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 71.4 mt-10 -73.03 -37.37 66.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.979 0.418 . . . . 0.0 109.887 179.088 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -68.46 -35.65 77.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.167 179.223 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.16 -32.55 61.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.697 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 37' ' ' ALA . 23.9 mt -86.95 -24.67 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.183 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -25.61 8.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.228 179.997 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.92 -61.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 122.82 15.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.9 76.38 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.877 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CE2' HD13 ' A' ' 5' ' ' LEU . 55.6 m-85 -64.91 141.28 98.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.704 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 2.7 Cg_endo -84.48 -20.45 3.95 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.938 2.425 . . . . 0.0 111.81 179.382 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.67 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.6 t -146.57 133.03 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 46' ' ' PHE . 23.7 mm -116.52 157.09 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.419 HG13 HG13 ' A' ' 79' ' ' ILE . 84.3 t -149.76 97.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.156 0.503 . . . . 0.0 111.139 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HB3' HG22 ' A' ' 78' ' ' VAL . 5.4 tp -92.37 129.59 38.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.747 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -110.49 115.67 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.668 179.693 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 53' ' ' VAL . 4.7 m -78.52 56.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.839 -179.346 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.472 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 35.4 t-105 -63.07 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.778 179.83 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.517 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.4 ttt -147.4 44.05 0.36 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.252 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.3 Cg_endo -76.97 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.441 2.094 . . . . 0.0 112.144 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -125.27 -42.86 1.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.989 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.57 148.05 51.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -76.38 116.24 16.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.16 -30.28 63.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.604 ' O ' HD12 ' A' ' 64' ' ' ILE . 22.8 t -54.18 -44.67 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 111.514 -179.9 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.89 0.84 37.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.742 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.796 ' CE2' HD11 ' A' ' 67' ' ' ILE . 23.5 t80 -89.81 -34.0 16.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.891 0.377 . . . . 0.0 111.043 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.644 HG23 HG11 ' A' ' 76' ' ' VAL . 2.7 mp -47.74 -28.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.428 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 16.1 t0 -79.64 -32.87 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.711 179.797 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 17.2 t80 -61.87 -39.31 91.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.796 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.5 mp -63.86 -50.54 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.174 179.14 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -69.29 -26.7 64.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.404 179.205 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 17.8 tt0 -60.3 -42.51 95.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.657 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.9 18.5 13.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.9 75.12 0.48 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.337 . . . . 0.0 110.844 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -85.96 -6.71 8.46 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.202 2.601 . . . . 0.0 113.099 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -98.74 -15.62 19.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.986 0.422 . . . . 0.0 111.303 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -72.18 -153.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -179.914 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' HG13 ' A' ' 48' ' ' VAL . 47.1 t -144.48 133.59 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-O 121.335 0.588 . . . . 0.0 111.921 178.692 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.644 HG11 HG23 ' A' ' 64' ' ' ILE . 97.3 t -104.83 99.16 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.147 -179.368 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.514 HG22 HG12 ' A' ' 79' ' ' ILE . 45.8 mm -90.36 -56.41 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.755 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 44.7 t 49.4 85.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.495 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.894 HD11 ' CD1' ' A' ' 109' ' ' PHE . 2.1 mt -96.31 143.0 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.044 0.45 . . . . 0.0 111.757 -179.259 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.634 HG21 ' N ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.46 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 88' ' ' ALA . 20.9 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.888 0.375 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.494 ' O ' HG22 ' A' ' 89' ' ' VAL . 23.6 p30 -82.25 -26.85 32.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.949 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CE2' ' A' ' 99' ' ' PHE . 4.5 t -71.56 -34.78 70.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 179.392 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -56.45 -58.86 6.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.066 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 86' ' ' ASP . 35.9 m -55.08 -24.89 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.913 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 61' ' ' VAL . 12.4 ttmt -85.85 7.42 24.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.265 179.805 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.72 -41.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.618 -179.82 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.903 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.9 pt -65.01 -18.44 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.322 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -94.67 21.79 7.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.743 179.382 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -138.33 -51.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.48 15.08 0.07 OUTLIER Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.802 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.903 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -89.26 175.08 7.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.602 0.701 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.549 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 67.4 t80 -94.77 -14.86 24.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.62 -179.356 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 5.5 pt-20 142.87 -13.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.523 0.729 . . . . 0.0 111.163 179.275 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.755 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 73.71 131.66 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.912 0.387 . . . . 0.0 110.539 -179.67 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -91.67 155.59 18.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -179.866 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.522 179.668 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.926 HG21 HD23 ' A' ' 17' ' ' LEU . 24.5 m . . . . . 0 CA--C 1.53 0.177 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -38.34 -44.77 0.93 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.741 0.305 . . . . 0.0 111.627 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -74.01 -36.22 64.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.133 179.385 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.894 ' CD1' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -54.99 -24.16 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.696 179.278 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -65.72 -44.45 86.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.508 -179.831 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.47 ' H ' HD12 ' A' ' 111' ' ' LEU . 7.0 mp -54.98 -55.85 26.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.044 -179.647 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 98.1 m -60.82 -39.03 87.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.2 -179.872 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -45.91 -53.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.754 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.48 -61.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -56.66 -27.31 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.924 179.606 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -64.5 -42.11 96.03 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.903 0.383 . . . . 0.0 110.926 179.833 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.67 ' CE1' HG21 ' A' ' 48' ' ' VAL . 19.0 m-85 -69.5 -22.4 63.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.274 -179.964 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.202 -179.878 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.424 ' HD2' ' CD1' ' A' ' 117' ' ' PHE . 6.5 mmtt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.836 0.351 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.404 ' CG ' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -144.63 126.29 15.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.913 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 48' ' ' VAL . 24.8 t -117.72 144.37 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 110.592 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 61.7 tp -100.89 127.54 47.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.23 -179.488 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.698 HG21 ' CD1' ' A' ' 17' ' ' LEU . 29.3 t -112.71 94.99 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 179.875 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.915 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 84.4 t -85.6 117.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.505 179.596 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -159.26 149.97 19.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.947 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 25.5 t70 -70.22 -74.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.064 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.91 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.616 0.246 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -30.28 57.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.16 -61.61 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.961 -179.846 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.698 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.8 tm? -43.54 -50.8 7.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.038 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -54.27 -39.35 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.424 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.02 84.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.903 ' CD1' HG11 ' A' ' 106' ' ' VAL . 1.6 mp -56.61 -64.0 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.705 179.661 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -50.36 -35.43 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.122 0.487 . . . . 0.0 110.472 179.374 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -24.15 65.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.948 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.78 -37.62 26.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.41 179.877 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -69.61 -48.38 60.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 179.912 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.19 44.84 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 98.9 m-85 -113.74 -170.46 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 0.0 111.159 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 3' ' ' ARG . 0.7 OUTLIER -139.5 72.08 37.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.388 179.578 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 35.8 Cg_exo -57.76 136.62 76.63 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.804 2.336 . . . . 0.0 112.359 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.1 t70 -113.54 -12.95 12.82 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.694 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 29' ' ' ASP . 69.5 p 44.39 177.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.677 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.915 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -160.84 -165.51 1.4 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.374 179.771 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' HG23 ' A' ' 33' ' ' THR . 7.7 mttm -124.84 -35.27 2.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.849 0.357 . . . . 0.0 111.064 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -166.36 177.06 7.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.216 179.904 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.09 HD21 HD22 ' A' ' 51' ' ' LEU . 26.5 mt -61.06 -37.04 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.645 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -47.88 69.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.918 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.51 -31.58 72.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB2' ' CG2' ' A' ' 7' ' ' VAL . . . -69.37 -65.06 0.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.487 179.588 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -41.58 -41.23 2.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -64.43 -48.85 73.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.825 178.937 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -69.2 -25.65 64.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.543 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 37' ' ' ALA . 7.2 mt -92.43 -20.82 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.699 0.285 . . . . 0.0 111.439 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -47.53 -26.96 1.58 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.656 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.02 -51.08 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.134 -179.779 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.11 128.75 38.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.137 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -85.57 68.83 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.653 179.64 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 26.1 m-85 -65.54 122.82 82.37 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.309 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' VAL . 77.3 Cg_endo -77.21 -28.49 5.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.629 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 4' ' ' VAL . 6.3 t -140.39 125.66 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.496 -179.632 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.13 149.2 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.497 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 79' ' ' ILE . 86.8 t -141.57 96.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 179.927 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.09 HD22 HD21 ' A' ' 34' ' ' LEU . 24.2 tp -84.63 78.35 9.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.5 t0 -73.32 83.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 53' ' ' VAL . 3.4 m -63.1 109.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -108.12 -84.39 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.585 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -72.85 -43.43 8.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.327 179.428 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 55' ' ' MET . 78.7 Cg_endo -76.09 -167.9 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.338 2.025 . . . . 0.0 112.345 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -102.92 -33.01 9.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.93 50.36 68.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.398 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -96.78 32.48 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -73.71 63.59 1.9 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.341 179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -51.48 -44.63 33.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -70.98 -24.57 62.43 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.418 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.003 ' CE2' HD11 ' A' ' 67' ' ' ILE . 59.2 t80 -56.34 -46.56 79.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.288 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.708 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.3 mp -47.02 -29.04 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.108 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -37.4 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 4.4 t80 -56.43 -47.26 79.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 1.003 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -55.55 -42.78 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.585 179.605 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -78.61 -23.16 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.663 179.361 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.71 -41.63 83.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.987 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.86 12.78 13.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.246 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.88 66.87 2.07 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.66 179.792 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.59 -19.74 41.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.594 2.196 . . . . 0.0 112.029 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.2 18.18 18.13 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.3 t -99.39 -161.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.408 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 47' ' ' PRO . 21.4 t -151.22 135.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.314 0.578 . . . . 0.0 112.536 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 78' ' ' VAL . 6.1 t -102.95 90.94 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.579 -179.564 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.665 HG21 ' HE1' ' A' ' 109' ' ' PHE . 24.1 mm -101.01 36.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.219 179.283 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 76' ' ' VAL . 63.2 t -43.95 107.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.785 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 100' ' ' LEU . 4.4 mt -101.4 147.99 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.587 ' HB ' HG22 ' A' ' 53' ' ' VAL . 30.9 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.777 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.87 0.367 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 89' ' ' VAL . 46.1 t0 -94.5 -41.95 9.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.991 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -53.68 -30.91 45.72 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 121.157 0.504 . . . . 0.0 109.876 179.146 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.841 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.69 -60.14 4.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.33 179.096 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 86' ' ' ASP . 32.9 m -63.06 -25.3 38.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.579 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.82 -29.84 25.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -88.66 -39.05 14.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.906 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.8 pt -72.06 -11.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.473 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.86 -35.03 22.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.926 0.393 . . . . 0.0 110.495 179.573 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -60.03 -61.61 2.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.32 28.63 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.111 179.897 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.21 176.36 6.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.928 0.364 . . . . 0.0 110.962 179.717 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.448 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.6 t80 -101.08 29.38 4.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.779 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 78.22 138.46 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.995 179.904 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.3 m-85 -66.1 126.28 28.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.715 -179.916 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -69.9 67.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.884 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.057 -179.816 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.903 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.6 p . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.612 0.244 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -40.2 -43.26 1.63 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.587 -179.751 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.68 -41.19 88.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 0.0 110.462 179.65 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.665 ' HE1' HG21 ' A' ' 77' ' ' ILE . 6.4 t80 -59.02 -29.08 66.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.651 179.497 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.448 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -65.92 -38.37 88.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.48 -55.57 33.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.969 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.3 m -59.94 -42.65 94.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.625 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 3.9 mm -44.25 -56.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.781 -179.588 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -59.88 3.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.808 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -53.65 -27.0 24.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.936 179.508 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -68.17 -40.75 82.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.912 0.386 . . . . 0.0 110.774 179.721 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 19.6 m-85 -69.69 -24.65 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.503 -179.87 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.286 -179.895 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.442 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 6.2 mmtp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.884 0.374 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -145.93 110.21 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.502 HG13 ' HB ' ' A' ' 48' ' ' VAL . 12.2 t -95.31 149.09 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 29' ' ' ASP . 61.5 tp -111.33 137.06 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 0.0 111.288 -179.438 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.866 HG21 ' CD1' ' A' ' 17' ' ' LEU . 21.8 t -118.31 138.37 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.56 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' HD12 ' A' ' 51' ' ' LEU . 8.1 t -129.58 115.99 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.306 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.17 135.06 12.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -92.0 50.03 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.877 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.503 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 7.2 p . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.4 m -51.07 131.45 27.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.995 -179.04 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.54 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER 85.85 -31.46 0.05 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.94 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.979 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -57.06 -61.82 2.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.701 0.286 . . . . 0.0 111.126 -179.498 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.51 -64.98 0.55 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.474 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.86 -39.93 40.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.233 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.608 HG23 ' CD1' ' A' ' 110' ' ' LEU . 46.3 mt -67.68 -70.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 -179.917 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.979 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -48.06 -30.14 4.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.056 0.455 . . . . 0.0 110.368 179.507 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.84 -30.03 71.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -78.19 -39.45 40.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.076 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.815 ' HG3' HD21 ' A' ' 110' ' ' LEU . 70.5 mm-40 -79.23 -174.25 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.355 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.28 42.84 1.83 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.119 179.852 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.572 ' CE2' HG21 ' A' ' 113' ' ' ILE . 22.0 m-85 -100.8 178.95 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.491 0.662 . . . . 0.0 111.731 -179.428 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.3 85.82 60.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.762 178.458 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.684 ' HB3' HD22 ' A' ' 21' ' ' LEU . 80.6 Cg_endo -79.97 127.54 6.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.7 2.266 . . . . 0.0 114.041 -177.939 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.854 ' O ' HD12 ' A' ' 5' ' ' LEU . 5.1 t70 -119.14 117.32 28.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.474 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.533 HG22 ' HB ' ' A' ' 6' ' ' VAL . 27.7 p -104.08 143.3 33.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 112.061 -178.558 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.2 -167.04 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.054 179.13 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -130.82 -6.55 4.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -170.72 175.13 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.765 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 63' ' ' PHE . 87.6 mt -66.12 -32.98 74.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -70.11 -40.19 75.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.997 179.203 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.1 -36.17 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.344 179.375 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.51 -50.22 22.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.608 179.521 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 4.9 tt0 -47.22 -45.87 23.75 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.409 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -53.73 54.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.584 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 7.6 mmtp -58.0 -24.57 58.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.823 179.498 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 41' ' ' ILE . 16.4 mt -98.53 -11.77 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.589 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -73.17 -10.42 59.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.691 0.281 . . . . 0.0 111.316 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -135.78 -46.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.763 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -75.1 116.5 15.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.715 179.869 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.2 64.32 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.36 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 19.9 m-85 -58.12 119.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.092 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 46.4 Cg_endo -69.13 -45.1 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.696 2.264 . . . . 0.0 111.946 179.772 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.502 ' HB ' HG13 ' A' ' 4' ' ' VAL . 21.3 t -118.54 125.02 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.553 -179.437 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -109.26 128.29 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG21 ' CE1' ' A' ' 109' ' ' PHE . 62.0 t -123.02 104.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.061 0.457 . . . . 0.0 111.206 -179.872 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.472 HD12 ' HB ' ' A' ' 7' ' ' VAL . 36.5 tp -92.96 83.9 4.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.958 179.954 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.468 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.4 OUTLIER -72.62 75.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 -179.85 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.711 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.2 p -55.36 84.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.474 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 25.3 t-105 -86.34 -82.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.735 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.474 ' HG2' ' CD1' ' A' ' 54' ' ' TRP . 3.4 ptm -142.04 48.46 1.14 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 111.131 179.456 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 55' ' ' MET . 72.7 Cg_endo -76.31 -168.19 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.493 2.129 . . . . 0.0 112.253 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -137.59 31.27 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.76 175.35 18.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.16 93.64 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.16 65.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.652 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 64' ' ' ILE . 26.3 t -53.85 -43.6 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 111.419 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 2.75 32.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.536 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.806 ' CE2' HD11 ' A' ' 67' ' ' ILE . 20.0 t80 -89.99 -43.26 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.054 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 91' ' ' ALA . 2.3 mp -45.37 -28.84 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.652 -179.808 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -70.38 -56.06 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.579 ' HD1' HD12 ' A' ' 67' ' ' ILE . 1.5 t80 -48.57 -37.63 18.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.832 0.348 . . . . 0.0 110.557 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.806 HD11 ' CE2' ' A' ' 63' ' ' PHE . 1.5 mp -60.77 -46.44 96.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.085 179.435 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -77.31 -21.44 53.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.549 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.85 -50.6 63.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.67 12.58 21.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.379 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -158.48 66.65 3.29 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.803 0.335 . . . . 0.0 110.784 179.766 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 6.5 Cg_exo -72.72 -16.95 26.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.727 2.285 . . . . 0.0 112.205 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.71 28.41 6.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -112.07 -178.05 3.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 76' ' ' VAL . 16.4 t -119.35 162.99 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.786 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.889 HG12 HG23 ' A' ' 78' ' ' VAL . 1.7 t -137.92 83.77 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 77' ' ' ILE . 16.5 mm -91.84 48.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.889 HG23 HG12 ' A' ' 76' ' ' VAL . 34.9 t -57.42 136.31 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -134.82 -149.0 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.365 -179.506 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.711 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 111.006 179.791 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.924 0.392 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -109.54 -26.48 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.436 HG23 ' CE2' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -74.32 -32.29 62.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.909 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.724 ' HB1' ' HB2' ' A' ' 99' ' ' PHE . . . -59.79 -59.22 5.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.16 178.927 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -59.23 -23.47 24.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.013 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -90.74 40.58 1.02 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -170.06 -38.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -76.16 -28.68 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.947 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -31.4 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.597 179.713 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -63.76 -30.26 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.67 28.31 0.12 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.265 179.792 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.14 178.87 6.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.901 0.35 . . . . 0.0 110.808 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 47.9 t80 -97.49 28.27 3.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER 85.11 162.75 0.1 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.556 179.583 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.724 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.56 97.01 10.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.728 179.982 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 16.1 tp -55.84 160.68 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.191 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 179.796 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.941 HG21 HD23 ' A' ' 17' ' ' LEU . 3.0 m . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.4 tt0 -65.17 -51.87 58.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.338 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -60.43 -33.92 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.623 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.526 ' CE1' HD11 ' A' ' 113' ' ' ILE . 13.7 t80 -59.44 -33.4 71.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.415 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.815 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -64.03 -44.65 91.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.772 179.116 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 107' ' ' GLU . 3.9 mp -65.92 -46.47 78.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.213 -179.802 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.0 m -67.84 -41.43 82.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.423 . . . . 0.0 110.366 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.572 HG21 ' CE2' ' A' ' 26' ' ' TYR . 1.6 mm -46.96 -52.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.194 179.758 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.3 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 179.798 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -56.87 -39.93 75.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.561 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -54.52 -30.89 55.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.504 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.489 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 52.7 m-85 -91.13 -55.44 3.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.462 -179.799 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.606 -179.53 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.846 0.355 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 136.07 25.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.993 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 48' ' ' VAL . 34.4 t -128.53 150.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.984 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.019 HD23 HG23 ' A' ' 49' ' ' ILE . 24.4 tp -113.75 142.52 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.038 0.447 . . . . 0.0 111.575 -179.195 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.762 HG21 HD12 ' A' ' 17' ' ' LEU . 21.9 t -117.06 143.81 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.298 179.866 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.609 ' HB ' HD12 ' A' ' 51' ' ' LEU . 17.6 t -133.26 119.76 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.339 179.251 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 2.8 t70 -154.59 163.5 40.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.487 -179.324 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.58 49.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.0 111.104 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.715 179.706 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -45.95 142.42 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.302 -179.611 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 87.85 -36.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.768 179.799 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.081 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -71.99 -48.17 46.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 -179.968 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 p -50.74 -65.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.81 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.457 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.69 HG23 ' CD1' ' A' ' 110' ' ' LEU . 71.2 mt -63.64 -69.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.966 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.081 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -48.57 -31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 179.819 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.63 66.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.829 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.3 -34.49 31.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.763 ' HG3' HD21 ' A' ' 110' ' ' LEU . 68.4 mm-40 -77.57 -38.1 49.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.141 -179.913 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.51 43.83 3.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.052 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 9.6 m-85 -102.29 -174.93 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.218 0.533 . . . . 0.0 111.328 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.5 80.01 16.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.904 178.381 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.694 ' CB ' HD13 ' A' ' 21' ' ' LEU . 91.6 Cg_endo -84.45 131.78 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.756 2.304 . . . . 0.0 113.972 -178.088 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.477 ' O ' HD12 ' A' ' 5' ' ' LEU . 11.4 t70 -129.24 132.35 47.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.447 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.682 HG22 ' HB ' ' A' ' 6' ' ' VAL . 17.8 p -119.97 139.24 52.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.0 112.069 -178.837 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 36' ' ' GLU . . . -110.82 -165.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 179.313 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 31.3 mttt -117.65 -25.73 6.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.844 0.354 . . . . 0.0 111.228 -179.975 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -164.11 174.18 11.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.398 179.891 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.853 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.9 mt -58.63 -28.85 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.606 179.835 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -47.83 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.649 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -64.45 -35.0 79.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.374 179.263 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.39 -53.46 48.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.478 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 28.6 mt-10 -50.83 -38.98 52.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.452 179.55 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -59.89 -43.29 94.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.721 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -73.88 -47.01 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.641 179.41 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.62 -18.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -19.82 61.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.729 0.299 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.14 -50.73 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 117.38 13.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -83.42 66.26 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.751 179.825 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 5' ' ' LEU . 44.8 m-85 -58.62 135.84 86.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.963 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 7.4 Cg_endo -81.16 -35.19 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.512 2.141 . . . . 0.0 112.009 179.451 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.607 ' O ' HD13 ' A' ' 49' ' ' ILE . 18.3 t -126.69 136.3 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 179.691 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.019 HG23 HD23 ' A' ' 5' ' ' LEU . 1.6 mm -135.67 105.37 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.834 HG22 ' CG1' ' A' ' 77' ' ' ILE . 21.8 t -103.42 131.8 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.759 0.314 . . . . 0.0 110.632 179.519 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 7' ' ' VAL . 11.5 tp -99.78 146.87 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.138 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.83 106.85 9.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.415 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.454 ' C ' HG21 ' A' ' 80' ' ' THR . 23.7 t -80.95 70.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.521 -179.482 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.41 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 4.4 t-105 -72.06 -78.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.081 179.399 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.6 ptt? -149.15 48.95 0.63 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.213 179.132 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 55' ' ' MET . 14.7 Cg_endo -92.86 -159.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.164 2.576 . . . . 0.0 112.165 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -161.22 52.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.932 179.786 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.86 149.79 19.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.553 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.21 108.74 10.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.17 -18.73 48.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.903 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.727 ' O ' HD12 ' A' ' 64' ' ' ILE . 21.4 t -58.52 -58.96 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.27 -21.9 63.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.915 ' CE2' HD11 ' A' ' 67' ' ' ILE . 33.8 t80 -60.32 -40.46 90.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.5 mt -47.19 -28.33 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -74.76 -35.67 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.679 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CE1' ' HG2' ' A' ' 38' ' ' GLU . 19.1 t80 -61.57 -45.14 95.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.323 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.915 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -58.0 -41.68 80.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 179.341 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -81.44 -23.3 37.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 179.521 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -64.36 -31.6 72.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.361 179.476 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.67 16.04 4.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.923 179.944 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -169.53 73.41 0.69 Allowed Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.725 179.948 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.09 -7.35 11.12 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.093 2.529 . . . . 0.0 112.604 -179.79 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.5 -6.25 27.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.63 -179.866 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.44 -172.65 4.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 -179.768 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.437 HG11 ' HB1' ' A' ' 116' ' ' ALA . 67.2 t -127.24 144.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 -179.781 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG12 HG23 ' A' ' 78' ' ' VAL . 2.1 t -123.12 98.08 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.06 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.834 ' CG1' HG22 ' A' ' 50' ' ' VAL . 44.2 mm -73.91 -67.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.731 -179.068 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.549 HG13 HD23 ' A' ' 51' ' ' LEU . 12.2 t 63.17 98.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -98.14 -144.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.623 -179.109 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.466 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.827 0.346 . . . . 0.0 110.897 -179.796 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.64 0.257 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.6 ' O ' HG22 ' A' ' 89' ' ' VAL . 1.6 m-20 -53.28 -34.4 57.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.126 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.452 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 2.2 t -59.15 -33.95 71.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.969 0.414 . . . . 0.0 110.376 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.21 -59.11 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.248 179.355 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 86' ' ' ASP . 33.5 m -58.94 -27.52 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.056 179.499 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -80.54 -13.25 59.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.94 -35.02 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 111.736 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.891 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -77.16 -26.32 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.65 -179.484 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -66.19 -28.33 68.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.587 179.652 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -58.12 3.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.8 37.2 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -89.99 -163.77 1.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.903 179.797 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 40.1 t80 -107.99 23.37 14.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.544 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.425 ' HA ' HG21 ' A' ' 92' ' ' ILE . 0.4 OUTLIER 80.56 19.89 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.755 179.449 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 61.78 162.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 111.038 179.465 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 101' ' ' GLU . 1.1 tm? -101.02 133.28 45.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.82 ' N ' HD13 ' A' ' 100' ' ' LEU . 1.6 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.867 HG21 HD23 ' A' ' 17' ' ' LEU . 13.2 p . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.721 0.296 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -45.69 -38.17 6.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 179.877 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.53 80.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.02 179.282 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 4.7 t80 -58.52 -26.47 63.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.168 179.293 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.763 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -58.75 -49.67 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.102 179.708 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.3 -54.78 35.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.083 -179.797 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 113' ' ' ILE . 66.5 m -49.48 -57.32 7.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.878 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 11.3 mm -29.9 -63.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.64 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 114' ' ' LYS . 4.9 tmmm? -48.91 -58.66 4.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.792 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -53.69 -27.72 29.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.579 178.979 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -70.89 -42.55 69.85 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.762 179.692 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.53 ' CE1' HG21 ' A' ' 48' ' ' VAL . 24.7 m-85 -59.63 -21.48 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.0 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.943 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.907 0.384 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -153.69 133.85 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 179.88 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 48' ' ' VAL . 45.6 t -116.54 162.0 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.781 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 29' ' ' ASP . 66.8 tp -118.21 147.24 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 111.446 -179.526 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.643 HG11 HG23 ' A' ' 14' ' ' THR . 4.0 t -126.42 142.56 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.058 179.775 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 7.0 t -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.301 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 3.3 t70 -150.6 153.98 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.333 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.6 48.71 1.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.841 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.685 179.881 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.643 HG23 HG11 ' A' ' 6' ' ' VAL . 29.3 p . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.797 0.332 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 16' ' ' SER . 13.9 p -35.07 128.02 0.52 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 15' ' ' SER . 3.2 p 82.99 -43.84 0.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.222 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.893 HD13 HD11 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -53.23 -50.84 63.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 111.216 -179.566 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.69 -65.47 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.47 -40.65 18.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.757 HG23 ' CD1' ' A' ' 110' ' ' LEU . 37.4 mt -59.44 -67.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.893 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -48.74 -31.72 7.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.805 179.525 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.16 -31.63 71.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.748 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.91 -34.89 22.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.472 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.667 ' CD ' HD21 ' A' ' 110' ' ' LEU . 52.9 mm-40 -81.29 -38.39 26.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.206 -179.795 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 76.8 1.32 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.168 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 39.8 m-85 -130.65 -174.43 3.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.349 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -119.84 80.8 25.47 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.17 178.798 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 97.6 Cg_endo -84.22 135.03 6.14 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.771 2.314 . . . . 0.0 113.928 -178.335 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.804 ' O ' HD12 ' A' ' 5' ' ' LEU . 16.3 t70 -123.42 128.63 50.12 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.384 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.7 p -98.66 146.74 25.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -126.87 128.9 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.433 178.93 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 33' ' ' THR . 7.7 mttm -82.48 -10.32 59.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.65 167.11 7.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.304 179.791 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.722 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.8 mt -59.18 -22.35 60.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 110.329 179.436 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -46.2 33.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.794 178.834 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.92 -30.96 71.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.135 179.176 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.69 -56.05 5.21 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.619 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HG3' ' CE1' ' A' ' 63' ' ' PHE . 54.3 mt-10 -44.81 -43.27 8.54 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.618 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.95 -53.0 61.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.74 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 4.5 mmtt -60.6 -30.01 69.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.978 179.581 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 41' ' ' ILE . 50.9 mt -92.23 -9.29 10.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 38' ' ' GLU . 13.7 tttt -74.3 -8.64 56.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 111.027 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.36 -47.13 0.51 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -73.91 118.54 16.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.708 179.764 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -76.46 62.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.757 179.856 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.702 ' CD2' HD22 ' A' ' 5' ' ' LEU . 25.4 m-85 -55.3 116.75 12.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.77 -31.51 10.32 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.333 2.022 . . . . 0.0 112.203 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.63 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.8 t -132.16 129.87 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.587 -179.791 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.711 HD12 HD23 ' A' ' 5' ' ' LEU . 14.3 mm -118.71 144.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.185 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.481 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 60.6 t -137.23 109.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.388 -179.98 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 42.1 tp -98.28 93.13 6.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . 6.6 t0 -77.88 91.93 4.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.398 179.275 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 53' ' ' VAL . 27.9 m -62.65 79.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.793 -179.383 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -78.9 -91.05 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.249 179.599 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.544 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 ttm -143.36 58.72 6.79 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.639 0.257 . . . . 0.0 110.855 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.7 Cg_endo -89.51 -157.64 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.176 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -155.59 28.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.37 149.43 18.64 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 81.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.75 0.309 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.26 90.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 90' ' ' LYS . 50.8 t -62.03 -40.25 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.965 0.412 . . . . 0.0 110.909 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -15.45 62.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.39 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.903 ' CE2' HD11 ' A' ' 67' ' ' ILE . 30.4 t80 -84.33 -30.0 25.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 61' ' ' VAL . 6.4 mm -48.63 -30.57 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.092 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.3 t0 -74.14 -47.95 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.734 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.575 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 10.2 t80 -48.25 -43.52 32.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.851 0.357 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.903 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.9 mp -59.96 -47.85 90.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.421 179.438 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.85 -16.19 59.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.964 179.576 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 65' ' ' ASP . 12.2 tt0 -73.12 -46.69 49.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.765 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.575 ' ND2' ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -114.41 13.72 17.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.948 -179.78 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.422 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.44 65.53 2.35 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.776 179.836 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.6 Cg_exo -76.07 -13.97 19.06 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.646 2.231 . . . . 0.0 112.192 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.06 27.63 8.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -112.28 -166.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 48' ' ' VAL . 21.4 t -129.02 139.96 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.342 0.592 . . . . 0.0 111.831 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.829 HG12 HG23 ' A' ' 78' ' ' VAL . 3.0 t -128.18 89.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.08 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.8 mm -79.63 -43.03 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.857 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.829 HG23 HG12 ' A' ' 76' ' ' VAL . 59.7 t 45.17 89.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.813 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.8 mt -99.66 179.05 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.035 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.655 ' H ' HG22 ' A' ' 79' ' ' ILE . 6.6 m . . . . . 0 C--N 1.332 -0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.054 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 89' ' ' VAL . 11.4 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.798 0.332 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -75.93 -37.19 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.945 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -33.18 63.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.054 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 99' ' ' PHE . . . -60.91 -59.07 5.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.109 179.032 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 92' ' ' ILE . 14.2 m -58.9 -26.08 31.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.118 179.812 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 61' ' ' VAL . 7.5 ttmt -78.03 -4.59 47.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.244 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.71 -38.67 2.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.379 -179.911 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.924 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 6.1 pt -76.95 -41.65 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.133 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -57.95 -28.79 64.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -62.57 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 179.63 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.092 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.924 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.35 -174.7 4.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.983 0.392 . . . . 0.0 110.943 179.725 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.531 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 69.0 t80 -94.46 -23.1 17.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 11.3 pt-20 147.87 -167.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.54 0.736 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.05 107.07 10.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.708 0.29 . . . . 0.0 110.622 179.606 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.532 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -56.4 92.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.07 -179.908 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 179.951 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.84 HG21 HD23 ' A' ' 17' ' ' LEU . 18.0 m . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.05 0.452 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.58 -52.7 28.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -31.4 70.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.431 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.813 ' CD1' HD11 ' A' ' 79' ' ' ILE . 15.8 t80 -57.52 -40.95 79.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.757 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -48.43 -48.39 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.236 179.349 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mp -54.98 -45.57 75.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.399 -179.561 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -67.12 -39.8 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 2.7 mm -47.43 -55.88 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -55.62 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 110.16 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.71 69.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.81 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.582 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.86 -37.08 83.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.798 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 48' ' ' VAL . 49.0 m-85 -80.27 -28.6 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.058 179.862 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.994 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 7.5 mmtp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.867 0.365 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -121.23 139.99 52.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.284 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 48' ' ' VAL . 21.3 t -128.61 158.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 110.932 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.65 HD22 ' CD2' ' A' ' 46' ' ' PHE . 16.4 tp -117.03 131.83 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.651 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.751 HG21 HD12 ' A' ' 17' ' ' LEU . 25.4 t -115.81 89.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.201 179.866 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.92 103.16 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.757 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.81 137.63 45.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.782 -179.769 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.07 48.65 1.67 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.042 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.542 ' HB ' HG21 ' A' ' 30' ' ' THR . 10.2 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.54 0.209 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -80.13 -43.33 21.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.283 . . . . 0.0 111.146 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -60.23 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.209 -179.673 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.751 HD12 HG21 ' A' ' 6' ' ' VAL . 2.3 tm? -46.9 -50.95 17.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.088 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -56.67 -48.91 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.572 179.75 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.24 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.684 ' CD1' HG11 ' A' ' 106' ' ' VAL . 57.0 mt -57.41 -66.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.822 179.755 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.02 -35.43 11.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.139 0.495 . . . . 0.0 110.468 179.615 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.51 -28.22 69.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.84 -35.18 38.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.079 179.469 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -4.63 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.487 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.39 56.38 1.57 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.383 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-85 -128.41 -176.16 3.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 3' ' ' ARG . 4.1 t60 -138.9 70.8 42.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.76 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 34.9 Cg_exo -60.15 142.3 98.02 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.821 2.347 . . . . 0.0 112.581 -179.678 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -121.64 2.97 10.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.398 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.712 HG22 ' HB ' ' A' ' 6' ' ' VAL . 13.7 p 9.86 122.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.996 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.22 -164.22 1.02 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.436 178.631 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 33' ' ' THR . 9.6 ttmt -118.47 -30.2 5.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.122 -179.754 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -170.25 -172.71 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.668 179.96 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.775 HD22 ' CD2' ' A' ' 63' ' ' PHE . 29.8 mt -65.86 -49.5 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.516 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.84 -48.83 80.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.447 . . . . 0.0 109.852 179.195 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.1 -30.8 71.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.17 179.144 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HB1' HD11 ' A' ' 41' ' ' ILE . . . -71.41 -62.92 1.23 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.253 179.337 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 22.7 mt-10 -41.88 -39.93 1.97 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -49.24 73.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 178.91 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -68.19 -32.39 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.148 179.8 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.402 HD11 ' HB1' ' A' ' 37' ' ' ALA . 11.5 mt -86.34 -15.79 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -24.29 6.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.548 -179.741 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -122.41 -55.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 129.03 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.21 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -92.03 86.41 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.528 179.621 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.65 ' CD2' HD22 ' A' ' 5' ' ' LEU . 49.8 m-85 -79.32 119.31 76.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.508 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 59.7 Cg_endo -73.54 -19.45 21.66 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.474 2.116 . . . . 0.0 111.974 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.636 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.2 t -143.44 130.15 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.724 -179.911 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 46' ' ' PHE . 10.7 mm -118.59 156.19 20.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 179.54 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.7 t -146.31 102.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.494 . . . . 0.0 110.679 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.443 ' CD2' ' HA3' ' A' ' 60' ' ' GLY . 57.0 tp -90.09 91.1 8.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.42 92.3 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.857 178.728 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.704 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.4 m -64.5 72.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.14 -179.006 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 25.5 t-105 -73.39 -77.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.361 . . . . 0.0 110.324 179.35 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.483 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.2 ttm -162.23 61.99 1.29 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.4 Cg_endo -84.61 -155.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.068 2.512 . . . . 0.0 112.216 -179.825 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.82 -42.2 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.93 177.55 53.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.07 127.77 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' CD2' ' A' ' 51' ' ' LEU . . . -79.16 -1.55 85.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.989 -179.969 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.9 ' O ' HD12 ' A' ' 64' ' ' ILE . 45.8 t -61.49 -59.75 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.989 -179.922 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.4 -21.5 62.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.512 -179.856 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.775 ' CD2' HD22 ' A' ' 34' ' ' LEU . 14.0 t80 -61.33 -36.7 80.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.468 -179.565 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.6 mt -47.64 -27.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.285 -179.853 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.56 -40.91 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 38' ' ' GLU . 17.6 t80 -57.25 -43.02 82.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.469 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.674 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.9 mp -61.41 -42.78 95.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 179.417 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -18.85 56.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.326 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.48 -42.33 68.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.551 179.701 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.93 14.15 15.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.068 -179.843 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.74 67.65 1.59 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.847 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.84 -20.24 39.67 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.673 2.249 . . . . 0.0 112.232 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -104.12 35.67 2.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.747 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -111.79 -157.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.798 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -154.53 137.94 7.95 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 111.659 179.498 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.883 HG12 HG23 ' A' ' 78' ' ' VAL . 2.5 t -117.43 100.26 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.335 -179.478 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 97' ' ' TYR . 36.1 mm -82.68 -51.12 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.737 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.883 HG23 HG12 ' A' ' 76' ' ' VAL . 78.0 t 52.37 96.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.644 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -106.12 -155.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.085 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.704 ' HB ' HG22 ' A' ' 53' ' ' VAL . 8.3 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 179.918 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.1 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.872 0.368 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.05 -24.65 12.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -82.49 -38.69 23.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.019 0.437 . . . . 0.0 109.944 179.292 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.863 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.31 -57.38 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.142 178.991 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HA ' HG12 ' A' ' 92' ' ' ILE . 13.1 m -58.01 -28.95 35.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.289 179.702 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HD3' HG21 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -78.9 -15.86 57.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.626 -179.694 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.87 -33.86 6.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 -179.546 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.904 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.2 pt -79.3 -34.99 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.263 -179.554 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -31.26 71.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.781 179.889 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.2 32.91 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.859 -179.956 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.16 -165.3 1.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 110.998 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.632 ' HB3' HD13 ' A' ' 77' ' ' ILE . 26.0 t80 -114.16 27.14 9.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 -179.787 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 76.01 141.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.09 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -66.0 118.33 9.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 -179.707 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -59.05 129.14 40.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.883 179.703 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 -179.993 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.684 HG11 ' CD1' ' A' ' 20' ' ' ILE . 9.5 p . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.558 0.218 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -38.02 -38.46 0.32 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.823 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -70.82 -41.65 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.482 . . . . 0.0 110.494 179.642 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.542 ' CZ ' HD11 ' A' ' 79' ' ' ILE . 6.2 t80 -57.38 -30.43 64.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.802 179.528 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.626 HD11 ' CG2' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -59.18 -43.77 92.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.505 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mp -53.66 -52.29 60.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.829 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.566 HG23 ' HE2' ' A' ' 97' ' ' TYR . 99.3 m -59.61 -40.98 89.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.777 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.617 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 4.6 mm -49.78 -57.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.634 -179.634 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.58 -63.4 1.1 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -50.81 -27.35 7.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.821 179.31 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -66.88 -39.96 87.64 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.927 0.394 . . . . 0.0 110.479 179.432 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.636 ' CE1' HG21 ' A' ' 48' ' ' VAL . 23.1 m-85 -71.88 -30.03 64.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.233 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.368 -179.686 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.685 ' NH1' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -164.33 125.42 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 -179.906 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.634 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.5 t -114.64 143.56 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.862 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.682 HD23 HD12 ' A' ' 49' ' ' ILE . 59.6 tp -93.95 129.63 40.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.808 -179.875 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.822 HG21 ' CD1' ' A' ' 17' ' ' LEU . 17.5 t -115.44 104.71 17.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.797 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 42.4 t -91.6 124.07 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.744 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -168.9 157.75 8.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 -179.839 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -89.56 49.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.168 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.721 179.807 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.484 ' CG2' HG11 ' A' ' 6' ' ' VAL . 71.5 p . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -52.94 136.68 34.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.695 -179.213 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 84.77 -36.55 0.05 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.08 179.442 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.927 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -59.74 -52.64 64.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 -179.582 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -45.63 -67.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.588 -179.488 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.33 -40.58 35.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.495 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.656 ' CD1' HG23 ' A' ' 106' ' ' VAL . 60.0 mt -65.88 -67.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.37 -179.717 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.927 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.926 0.394 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.55 -31.32 66.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 tt0 -85.0 -36.04 21.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.513 179.716 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.649 ' CD ' HD21 ' A' ' 110' ' ' LEU . 78.5 mm-40 -78.16 -39.13 41.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.918 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.43 30.28 5.98 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.632 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.411 ' HB2' HD23 ' A' ' 21' ' ' LEU . 40.1 m-85 -89.6 -175.56 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.2 OUTLIER -140.06 94.84 8.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 179.81 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.702 ' HG3' HD13 ' A' ' 21' ' ' LEU . 72.1 Cg_endo -77.45 134.2 13.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.501 2.134 . . . . 0.0 112.818 -179.514 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.9 t0 -103.66 -12.01 17.3 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.414 0.626 . . . . 0.0 111.618 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' ASP . 71.5 p 44.07 175.3 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.832 179.353 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.797 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -158.75 -166.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.438 179.833 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 33' ' ' THR . 22.9 mtpt -129.48 -37.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 32' ' ' LYS . 4.2 p -163.07 178.24 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.304 179.828 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.743 HD22 ' CD2' ' A' ' 63' ' ' PHE . 85.6 mt -62.36 -41.45 98.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 110.536 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.96 48.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 178.962 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.79 -29.63 70.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.205 179.036 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -75.33 -22.04 57.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.946 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 13.9 mt-10 -75.46 -41.52 55.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.897 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.3 -37.38 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.061 178.995 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -72.52 -30.07 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.646 HG22 HD21 ' A' ' 70' ' ' ASN . 36.9 mt -89.44 -23.13 6.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.906 179.671 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -81.07 -0.29 39.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 179.941 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -117.36 -41.33 2.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.681 179.789 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.685 HD11 ' NH1' ' A' ' 3' ' ' ARG . 0.3 OUTLIER -116.26 156.03 27.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.174 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.421 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 8.1 t80 -96.55 94.95 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.726 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.626 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 26.3 m-85 -78.18 124.8 85.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.72 -29.33 8.86 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.402 2.068 . . . . 0.0 111.928 179.616 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.634 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.7 t -142.86 129.01 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.446 -179.819 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.682 HD12 HD23 ' A' ' 5' ' ' LEU . 26.8 mm -111.71 151.31 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.91 179.124 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.46 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 46.6 t -144.19 100.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.0 111.752 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HB3' HG13 ' A' ' 78' ' ' VAL . 7.2 tp -75.28 175.02 8.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.038 179.339 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.631 ' C ' HG22 ' A' ' 80' ' ' THR . 2.6 t70 -146.41 -52.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.568 -179.543 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 53' ' ' VAL . 61.5 t 61.82 50.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.052 0.454 . . . . 0.0 110.47 -179.562 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -71.16 -82.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.799 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.514 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -76.06 -48.64 3.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 55' ' ' MET . 96.7 Cg_endo -77.73 -173.18 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.436 2.091 . . . . 0.0 112.619 -179.518 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HA ' HG13 ' A' ' 53' ' ' VAL . 67.4 m-20 -158.28 47.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.671 179.844 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.03 166.77 3.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.656 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -82.97 74.05 9.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.26 -22.39 36.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.692 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 90' ' ' LYS . 32.7 t -54.26 -41.7 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 111.496 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.35 4.96 44.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.743 ' CD2' HD22 ' A' ' 34' ' ' LEU . 8.0 t80 -90.03 -37.07 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.58 0.229 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -45.15 -44.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.908 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.84 -47.45 83.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.556 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 42.5 t80 -55.22 -31.46 61.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.005 179.244 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.834 HG21 HG22 ' A' ' 76' ' ' VAL . 3.8 mm -66.25 -53.42 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.184 179.145 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -71.93 -19.98 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.369 179.206 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -67.08 -50.0 63.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.538 179.588 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.646 HD21 HG22 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -113.98 19.67 16.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.135 -179.812 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.35 67.92 1.05 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.42 -16.03 22.0 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.781 2.321 . . . . 0.0 112.302 -179.898 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.61 31.12 6.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -112.99 -159.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.523 ' HB ' HG13 ' A' ' 48' ' ' VAL . 52.6 t -148.07 135.68 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.371 0.605 . . . . 0.0 112.251 179.453 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.834 HG22 HG21 ' A' ' 67' ' ' ILE . 24.7 t -105.44 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.514 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 97' ' ' TYR . 16.6 mm -120.23 44.25 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.997 179.677 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.636 HG23 HG12 ' A' ' 76' ' ' VAL . 57.4 t -46.52 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.665 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.638 HG23 ' HB3' ' A' ' 100' ' ' LEU . 20.8 mt -74.2 -107.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.35 -179.639 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.631 HG22 ' C ' ' A' ' 52' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.65 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.715 0.293 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.87 -8.55 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.473 179.997 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.42 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -81.62 -33.64 31.34 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.067 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.819 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.74 -57.65 11.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.125 178.998 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.62 -22.64 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.538 ' O ' HG13 ' A' ' 61' ' ' VAL . 5.1 ttmt -91.29 25.89 2.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.874 0.369 . . . . 0.0 110.772 179.606 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.2 -40.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.818 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.931 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.3 pt -71.86 -43.91 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.172 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 2.2 ttmt -63.13 -22.77 67.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -71.65 -28.37 63.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.076 179.901 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.01 -19.7 0.35 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.32 179.971 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.73 176.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.001 0.401 . . . . 0.0 111.318 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.704 ' HE2' HG23 ' A' ' 112' ' ' THR . 32.5 t80 -98.98 28.5 4.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.477 -179.582 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.518 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 79.82 147.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.135 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.1 m-85 -73.85 139.89 45.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.082 -179.72 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.638 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -90.32 130.23 36.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.545 179.708 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.532 ' N ' HD13 ' A' ' 100' ' ' LEU . 9.6 mt-10 . . . . . 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.814 HG21 HD23 ' A' ' 17' ' ' LEU . 33.5 m . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -40.87 -47.36 2.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.819 0.342 . . . . 0.0 111.281 -179.856 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -68.93 -36.11 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.0 110.011 179.188 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.61 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 1.9 t80 -56.53 -23.54 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 179.229 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.649 HD21 ' CD ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -63.64 -43.76 95.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.353 179.937 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.8 mp -54.27 -57.06 12.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 -179.739 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.704 HG23 ' HE2' ' A' ' 97' ' ' TYR . 97.3 m -57.71 -43.25 85.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.61 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -44.35 -53.38 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.786 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.08 -61.6 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -53.64 -28.24 31.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -65.17 -41.47 94.63 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 45.3 m-85 -79.66 -29.78 41.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 179.974 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 3.8 mmtm . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.459 ' HA ' ' H ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -117.62 141.5 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 179.989 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 48' ' ' VAL . 41.3 t -126.66 159.87 35.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.942 HD22 ' CD2' ' A' ' 46' ' ' PHE . 35.4 tp -113.12 129.26 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.079 -179.901 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.696 ' HB ' HG22 ' A' ' 30' ' ' THR . 23.5 t -115.62 89.95 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.517 179.916 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 t -83.56 103.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.9 140.2 42.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.435 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 33.6 t70 -88.45 27.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.508 -179.865 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HG3' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.809 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.704 0.288 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.18 -43.41 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.4 -57.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.676 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.8 tm? -46.21 -56.87 5.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -52.86 -45.11 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.769 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.13 96.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.67 179.58 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.771 ' CD1' HG11 ' A' ' 106' ' ' VAL . 5.9 mt -57.59 -65.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.65 -32.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.731 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.26 -29.61 69.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -79.27 -34.4 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 109.887 179.441 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.788 ' HG3' HD21 ' A' ' 110' ' ' LEU . 53.4 mm-40 -77.52 -12.11 59.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.114 179.722 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.06 62.71 1.16 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.892 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.46 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 46.3 m-85 -127.22 -172.69 2.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 111.38 -179.319 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.459 ' H ' ' HA ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -135.9 68.43 64.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.498 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 27.1 Cg_exo -60.74 131.09 35.86 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.641 2.227 . . . . 0.0 111.952 179.952 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -109.6 3.31 20.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.266 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.696 HG22 ' HB ' ' A' ' 6' ' ' VAL . 8.7 p 1.87 123.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.74 -162.46 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.487 178.836 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -114.93 -31.63 6.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.16 -168.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.686 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.604 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -63.95 -45.38 89.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -50.68 72.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.259 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.76 -29.64 67.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.49 179.422 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.63 -26.31 54.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.95 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 30.8 mt-10 -74.74 -38.47 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.073 0.463 . . . . 0.0 109.931 179.124 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.65 77.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.903 179.036 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -74.67 -35.64 62.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.676 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.519 HD12 ' O ' ' A' ' 37' ' ' ALA . 28.5 mt -84.11 -21.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -18.65 59.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.279 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -129.02 -44.82 1.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.13 120.6 25.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 71' ' ' SER . 52.1 t80 -83.27 88.66 6.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.718 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.942 ' CD2' HD22 ' A' ' 5' ' ' LEU . 20.1 m-85 -79.23 133.37 60.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 9.3 Cg_endo -84.55 -20.4 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.815 2.344 . . . . 0.0 111.947 179.204 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.646 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -145.25 131.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.59 HG23 HD23 ' A' ' 5' ' ' LEU . 5.1 mm -119.04 156.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.483 179.609 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -146.86 101.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 110.764 179.787 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.729 ' HB3' HG13 ' A' ' 78' ' ' VAL . 59.8 tp -88.94 108.14 19.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.825 -179.255 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.06 91.32 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.141 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.699 HG22 ' HB ' ' A' ' 80' ' ' THR . 33.4 m -67.47 68.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.727 -179.154 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.45 ' CG ' ' N ' ' A' ' 55' ' ' MET . 29.0 t90 -67.16 -96.97 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.208 179.426 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.541 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -129.36 41.62 0.76 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.471 0.177 . . . . 0.0 111.27 179.361 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 55' ' ' MET . 91.6 Cg_endo -80.38 -165.98 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.52 2.147 . . . . 0.0 112.286 179.949 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -150.02 46.91 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.85 -179.35 16.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -104.83 95.42 5.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.97 -30.56 63.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 90' ' ' LYS . 21.8 t -56.19 -44.74 80.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.352 -179.93 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 1.89 35.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.507 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 67' ' ' ILE . 11.9 t80 -88.5 -36.37 16.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.801 0.334 . . . . 0.0 111.098 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -47.5 -29.33 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.147 -179.936 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -78.38 -35.62 47.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.637 179.708 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.423 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 9.0 t80 -58.64 -41.53 86.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.709 HG21 HG22 ' A' ' 76' ' ' VAL . 3.0 mp -61.58 -45.74 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.376 179.5 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -76.63 -20.16 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.75 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.59 -42.25 78.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.828 179.749 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.39 15.4 12.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.193 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.419 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -163.48 67.75 1.66 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.809 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.39 -20.39 36.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.737 2.291 . . . . 0.0 112.232 -179.93 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -103.13 28.02 6.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.79 179.774 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 t -107.56 -156.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.363 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -153.91 137.66 8.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.996 0.426 . . . . 0.0 111.406 179.114 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.784 HG12 HG23 ' A' ' 78' ' ' VAL . 13.1 t -119.85 108.46 23.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.373 -179.257 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mm -93.16 -53.7 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.784 HG23 HG12 ' A' ' 76' ' ' VAL . 24.6 t 54.31 94.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 179.702 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.678 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -94.8 -157.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 179.679 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.699 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.4 m . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.877 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 85' ' ' VAL . 15.7 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.778 0.323 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -95.6 -15.51 22.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 179.864 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.15 -34.89 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.112 0.482 . . . . 0.0 109.734 179.104 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.16 -58.54 8.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.117 178.895 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.483 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.7 m -57.53 -28.99 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.575 ' O ' HG13 ' A' ' 61' ' ' VAL . 1.5 ttmp? -75.44 -6.61 50.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.442 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.77 -44.33 1.95 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 111.387 -179.772 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.789 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.4 pt -67.89 155.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.924 -179.723 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.454 ' CG ' HG13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER 81.46 -47.27 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 -179.148 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -65.13 -16.83 63.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.495 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.23 -29.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.791 -179.955 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -74.5 176.31 6.95 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 111.31 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 13.4 t80 -102.16 -8.95 20.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.048 -179.983 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 8.5 pt-20 137.03 172.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.778 0.831 . . . . 0.0 110.181 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.552 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -103.67 96.77 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.616 179.687 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 79' ' ' ILE . 13.1 tp -54.98 90.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.282 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.296 -179.84 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.771 HG11 ' CD1' ' A' ' 20' ' ' ILE . 7.6 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.702 0.287 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -36.07 -44.76 0.39 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.126 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -42.36 84.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 0.0 110.734 179.798 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' VAL . 8.4 t80 -53.59 -30.88 44.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.889 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.788 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -56.55 -44.2 80.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.3 -179.972 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mp -56.7 -55.16 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.33 -179.701 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.9 m -56.37 -41.85 76.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.409 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.1 mm -44.62 -54.48 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 -179.506 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -48.35 -61.31 2.07 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -48.18 -31.87 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.749 179.287 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -63.56 -36.47 83.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.978 0.418 . . . . 0.0 110.504 179.417 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.646 ' CE1' HG21 ' A' ' 48' ' ' VAL . 48.6 m-85 -83.77 -28.29 28.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 179.853 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.428 -179.809 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.871 0.367 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 12.5 mmtm -120.98 124.15 44.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.982 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.62 127.74 14.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 48' ' ' VAL . 61.3 t -126.15 163.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 29' ' ' ASP . 55.4 tp -121.28 134.95 55.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.015 0.436 . . . . 0.0 111.671 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.811 HG21 ' CD1' ' A' ' 17' ' ' LEU . 12.8 t -119.41 128.23 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.127 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.434 ' HB ' HD12 ' A' ' 51' ' ' LEU . 11.9 t -119.56 125.82 74.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.993 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.0 t0 -162.1 145.86 12.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.653 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.32 51.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.871 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 12.4 pt-20 -173.58 127.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.072 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 58.82 160.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.049 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -69.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.553 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.645 ' HA ' HG21 ' A' ' 30' ' ' THR . 9.7 mm -96.96 164.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 13' ' ' ILE . 53.3 p -89.25 130.86 35.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.354 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.87 133.18 22.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.403 ' CB ' ' HA ' ' A' ' 105' ' ' SER . 11.7 m 78.77 -14.31 0.88 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.653 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.969 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -76.77 -54.79 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.942 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.41 -64.27 0.76 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.519 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.98 -40.76 31.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.197 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.835 HG23 ' CD1' ' A' ' 110' ' ' LEU . 56.0 mt -63.14 -67.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.218 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.969 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -49.44 -31.14 9.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 110.851 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.61 -27.47 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.879 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.47 -34.91 27.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.317 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.814 ' CG ' HD21 ' A' ' 110' ' ' LEU . 21.8 mm-40 -80.38 -36.28 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.051 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.4 49.76 2.52 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.066 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 3.8 m-85 -103.8 -174.61 2.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.326 0.584 . . . . 0.0 111.429 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.13 77.13 76.95 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.938 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.647 ' HG3' HD13 ' A' ' 21' ' ' LEU . 97.3 Cg_endo -85.79 142.78 8.03 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.836 2.358 . . . . 0.0 113.851 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.884 ' O ' HD12 ' A' ' 5' ' ' LEU . 8.6 t0 -123.67 120.33 32.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.145 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.645 HG21 ' HA ' ' A' ' 13' ' ' ILE . 47.5 p -100.81 139.86 35.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.11 0.481 . . . . 0.0 112.011 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.48 -164.37 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.228 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 2.4 mttt -134.65 -7.67 2.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.36 -172.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 0.0 110.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.785 HD11 ' O ' ' A' ' 59' ' ' ASP . 96.3 mt -78.64 -28.73 45.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.473 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.49 -41.64 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -34.0 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.233 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.68 ' C ' HD12 ' A' ' 41' ' ' ILE . . . -73.51 -52.39 13.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 42' ' ' LYS . 41.3 mt-10 -46.38 -45.08 17.58 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.525 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -53.35 58.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -61.86 -23.9 66.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.075 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 ' C ' ' A' ' 37' ' ' ALA . 5.5 mt -95.82 -14.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.688 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 1.2 tmtt? -78.83 -5.32 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.645 0.26 . . . . 0.0 111.48 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -136.96 -49.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.382 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.32 116.29 16.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.783 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -74.75 64.12 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.518 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 22.9 m-85 -58.35 122.08 56.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.087 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 10.8 Cg_exo -66.1 -50.05 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.468 2.112 . . . . 0.0 112.277 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 4' ' ' VAL . 35.8 t -116.85 127.11 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.671 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 14.6 mm -113.81 127.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.273 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.861 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 84.7 t -124.3 105.93 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 78' ' ' VAL . 4.9 tp -93.52 145.36 24.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.711 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' HA ' ' HG1' ' A' ' 80' ' ' THR . 2.7 t70 -110.33 178.66 4.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.115 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.603 HG22 ' CB ' ' A' ' 80' ' ' THR . 4.8 m -149.52 42.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.155 0.502 . . . . 0.0 111.527 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 57.6 t-105 -49.9 -90.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 25.6 ttp -149.6 50.84 0.83 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.312 . . . . 0.0 111.072 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 55' ' ' MET . 73.0 Cg_endo -75.95 -168.29 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.487 2.125 . . . . 0.0 112.281 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -145.4 39.77 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -139.26 20.86 2.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.647 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.785 ' O ' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER 62.07 -159.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.612 0.244 . . . . 0.0 110.488 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.11 -39.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.641 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.753 HG21 ' HD3' ' A' ' 90' ' ' LYS . 40.3 t -56.85 -42.1 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.059 0.457 . . . . 0.0 110.756 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -20.24 64.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.674 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.964 ' CE2' HD11 ' A' ' 67' ' ' ILE . 36.0 t80 -80.53 -33.32 36.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 61' ' ' VAL . 4.6 mm -47.03 -29.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.81 0.338 . . . . 0.0 111.154 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -75.17 -47.54 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.546 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 12.2 t80 -50.02 -42.47 49.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.964 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.2 mp -60.6 -44.04 95.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.351 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -80.31 -17.45 52.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.807 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 65' ' ' ASP . 31.6 tt0 -71.4 -46.7 59.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.546 ' ND2' ' CE1' ' A' ' 66' ' ' PHE . 0.1 OUTLIER -112.49 7.51 19.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.186 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.426 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -154.63 65.38 4.79 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 110.656 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 71' ' ' SER . 2.7 Cg_exo -74.65 -15.59 21.58 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.683 2.255 . . . . 0.0 112.103 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -97.48 -9.47 27.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.216 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t -80.36 -173.95 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.584 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.683 HG21 ' HB1' ' A' ' 116' ' ' ALA . 31.1 t -120.5 157.23 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.094 0.473 . . . . 0.0 111.217 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.597 HG12 HG23 ' A' ' 78' ' ' VAL . 1.1 t -143.19 89.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.093 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.838 HD13 ' HB3' ' A' ' 97' ' ' TYR . 21.5 mm -80.5 -45.35 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.597 HG23 HG12 ' A' ' 76' ' ' VAL . 58.5 t 54.99 101.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.791 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 77' ' ' ILE . 7.7 mt -133.1 145.69 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.763 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.603 ' CB ' HG22 ' A' ' 53' ' ' VAL . 14.5 m -166.53 163.63 17.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.832 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.442 ' N ' HG22 ' A' ' 80' ' ' THR . . . -120.72 34.59 4.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.47 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -156.4 101.34 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 110.84 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 166.57 -110.31 0.4 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 87' ' ' THR . 31.1 t -174.39 154.14 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.91 -26.27 27.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.253 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.5 -12.93 62.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -82.5 -35.46 27.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.09 0.471 . . . . 0.0 109.798 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.09 -57.56 12.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.753 ' HD3' HG21 ' A' ' 61' ' ' VAL . 12.7 ttmt -89.75 39.92 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.019 0.438 . . . . 0.0 110.554 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.24 -42.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.9 pt -71.25 -28.08 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.263 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.53 19.83 6.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -0.63 8.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.483 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.91 11.5 1.84 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.956 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.13 -168.67 2.18 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.252 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.838 ' HB3' HD13 ' A' ' 77' ' ' ILE . 17.8 t80 -116.22 27.39 9.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.344 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.476 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 79.29 141.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.579 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -67.45 129.3 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.124 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.688 HD11 ' HB3' ' A' ' 108' ' ' ARG . 0.2 OUTLIER -71.42 106.42 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.05 69.25 4.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.444 ' HB3' ' HZ3' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -179.49 58.7 0.1 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.813 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.64 176.03 9.91 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.563 2.176 . . . . 0.0 112.407 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.433 ' CE2' ' HA3' ' A' ' 81' ' ' GLY . 60.4 m-85 58.92 38.11 24.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 0.9 OUTLIER 171.7 -28.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.394 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.72 HG21 HD23 ' A' ' 17' ' ' LEU . 3.1 m 41.12 28.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.3 -47.52 79.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.688 ' HB3' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -63.69 -34.14 77.2 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.861 ' CZ ' HG21 ' A' ' 50' ' ' VAL . 8.3 t80 -56.75 -35.26 68.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.366 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.835 ' CD1' HG23 ' A' ' 20' ' ' ILE . 1.4 tt -56.85 -53.3 59.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.031 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.98 -42.61 94.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.534 HG23 ' HE2' ' A' ' 97' ' ' TYR . 87.7 m -64.83 -40.42 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.883 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.655 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.6 mm -44.11 -52.68 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.785 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.55 -56.8 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.321 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -60.48 -32.47 71.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.683 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.57 -39.04 82.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.548 ' CE1' HG21 ' A' ' 48' ' ' VAL . 39.2 m-85 -77.78 -13.2 59.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.43 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -55.91 -30.75 62.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.798 0.332 . . . . 0.0 111.248 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 82.6 mm-40 -75.24 -6.48 49.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.447 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -140.83 24.72 2.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.97 179.918 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.765 0.316 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 32.3 mmtp 59.66 -170.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.949 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 3.5 mpt_? 64.64 108.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.8 t -123.22 159.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.911 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.709 HD23 HG23 ' A' ' 49' ' ' ILE . 42.9 tp -115.43 135.17 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.847 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.701 ' HB ' HG22 ' A' ' 30' ' ' THR . 17.2 t -117.53 89.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.696 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.47 107.55 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -143.17 140.73 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 111.301 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 34.9 t0 -64.04 -70.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -81.47 -174.38 4.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.974 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -114.18 69.38 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -108.63 -49.48 3.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.583 HG22 ' CB ' ' A' ' 17' ' ' LEU . 38.9 mm -82.36 -41.44 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p -56.26 -22.06 27.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.317 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.34 -43.01 67.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.2 p -101.81 -53.2 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.328 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.75 ' CD1' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -47.84 -51.84 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.081 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.726 ' HA ' HD12 ' A' ' 21' ' ' LEU . 46.0 m -50.68 -46.61 58.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.773 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.07 91.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.777 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.717 ' CD1' HG13 ' A' ' 106' ' ' VAL . 17.1 mt -55.99 -59.92 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.532 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.019 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -46.9 -40.23 13.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.854 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.22 -27.96 69.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.987 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -80.09 -34.73 37.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.982 0.42 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.759 ' HG3' HD21 ' A' ' 110' ' ' LEU . 66.2 mm-40 -76.71 -24.73 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 28.38 6.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.416 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 59.9 m-85 -98.93 -175.86 3.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -134.56 90.0 24.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 1.019 ' HB3' HD13 ' A' ' 21' ' ' LEU . 74.4 Cg_endo -78.8 132.64 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.432 2.088 . . . . 0.0 112.873 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -108.78 6.0 25.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.235 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.701 HG22 ' HB ' ' A' ' 6' ' ' VAL . 14.3 p 4.33 122.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.83 -164.17 1.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.925 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 33' ' ' THR . 13.2 tttt -115.1 -40.08 3.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 32' ' ' LYS . 12.7 p -159.23 -173.95 4.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.466 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.746 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -65.64 -45.34 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.617 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -61.67 -48.65 79.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.074 0.464 . . . . 0.0 109.749 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.06 -32.22 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.01 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -70.55 -29.77 66.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.699 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 17.6 mt-10 -68.58 -44.27 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -36.28 78.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.106 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -74.12 -43.03 59.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.491 HD12 ' O ' ' A' ' 37' ' ' ALA . 10.9 mt -73.61 -24.17 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -51.58 -25.89 7.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.277 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -124.37 -58.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.096 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.75 123.64 18.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.04 79.93 8.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.628 ' CE2' HD13 ' A' ' 5' ' ' LEU . 33.0 m-85 -73.94 116.34 51.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.025 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.549 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 74.0 Cg_endo -73.2 -16.16 25.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.524 2.149 . . . . 0.0 111.816 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.5 t -147.23 132.29 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.709 HG23 HD23 ' A' ' 5' ' ' LEU . 10.2 mm -118.18 159.96 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.11 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.403 HG13 HG13 ' A' ' 79' ' ' ILE . 62.1 t -147.97 97.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.252 0.548 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 78' ' ' VAL . 58.7 tp -80.39 130.03 34.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.468 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.62 89.71 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.033 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.715 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.8 m -67.31 66.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.875 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 69.3 t-105 -69.86 -96.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.195 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.604 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -134.66 32.16 0.21 Allowed Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.8 Cg_endo -81.97 -165.18 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.106 1.871 . . . . 0.0 112.236 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -116.29 28.54 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.866 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' CA ' HD12 ' A' ' 34' ' ' LEU . . . -85.07 -99.49 0.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.499 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 56.91 46.39 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.773 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.93 103.81 2.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.907 ' O ' HD12 ' A' ' 64' ' ' ILE . 48.1 t -61.07 -40.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 0.0 110.828 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -13.01 61.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.362 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 67' ' ' ILE . 35.6 t80 -54.3 -39.23 66.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 111.265 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.5 mt -50.01 -29.8 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' GLU . 1.5 t0 -75.81 -34.19 60.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 51.4 t80 -59.56 -47.48 85.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.015 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.873 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -58.34 -43.7 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.398 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -77.03 -22.85 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.699 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 65' ' ' ASP . 42.3 tt0 -65.0 -34.23 77.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.55 18.65 5.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.853 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.91 75.6 0.66 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.2 -8.08 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.162 2.575 . . . . 0.0 112.733 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' OD2' ' CE2' ' A' ' 120' ' ' TYR . 5.8 t0 -107.31 12.96 27.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.459 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.23 -160.15 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.98 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HB ' HG13 ' A' ' 48' ' ' VAL . 26.3 t -148.94 134.42 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 111.47 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.915 HG12 HG23 ' A' ' 78' ' ' VAL . 23.9 t -115.01 109.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.575 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.727 HD13 ' HB3' ' A' ' 97' ' ' TYR . 31.7 mm -90.36 -51.06 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.956 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.915 HG23 HG12 ' A' ' 76' ' ' VAL . 30.1 t 54.21 97.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.74 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -102.68 -170.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.315 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.74 ' H ' HG22 ' A' ' 79' ' ' ILE . 2.8 m 74.98 114.25 0.06 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.342 . . . . 0.0 110.878 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.12 75.51 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.431 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.13 -54.29 3.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.795 0.331 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.37 46.15 2.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 p -178.13 86.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.888 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.46 9.15 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.498 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.3 -1.88 28.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.326 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.59 -37.06 14.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.825 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.55 -57.44 12.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.159 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.9 m -58.27 -29.27 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.314 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.666 ' HD3' HG21 ' A' ' 61' ' ' VAL . 3.9 ttmp? -76.86 -14.96 59.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.378 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.91 -44.8 3.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 111.528 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.87 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.2 pt -67.6 169.84 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.038 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.8 mttp 74.31 -44.01 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -16.44 63.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.077 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.95 -29.43 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.26 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.87 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -59.56 -178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.421 . . . . 0.0 111.11 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.727 ' HB3' HD13 ' A' ' 77' ' ' ILE . 85.0 t80 -115.67 27.49 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.904 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 86.65 157.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.376 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.474 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -86.16 100.27 12.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.024 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.886 HD21 ' HA ' ' A' ' 109' ' ' PHE . 39.2 tp -70.47 131.47 44.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.008 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.426 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 2.2 mm-40 -65.17 -169.84 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.352 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.728 ' HE2' HG21 ' A' ' 79' ' ' ILE . 1.2 mmpm? -135.63 45.3 1.31 Allowed Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 92.8 Cg_endo -78.38 138.85 16.05 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.5 2.133 . . . . 0.0 112.151 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 58.18 36.93 26.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.048 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.75 -169.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.184 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.717 HG13 ' CD1' ' A' ' 20' ' ' ILE . 8.6 p -62.92 -19.69 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.498 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -45.8 -34.6 3.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.406 ' NH2' ' HG3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -74.62 -38.96 62.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.153 179.281 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.886 ' HA ' HD21 ' A' ' 100' ' ' LEU . 4.2 t80 -55.61 -28.64 56.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.41 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -47.87 -39.57 19.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.4 mp -57.97 -58.06 10.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.874 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.823 ' OG1' HD22 ' A' ' 100' ' ' LEU . 52.3 m -45.95 -43.65 14.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.626 HD12 HG21 ' A' ' 4' ' ' VAL . 18.6 mm -53.66 -66.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 110.382 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -16.21 5.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.979 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -90.19 -26.53 20.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 110.518 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.59 -40.83 40.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.018 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 38.0 m-85 -76.35 -19.03 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -72.2 -6.85 45.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.699 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.59 42.38 1.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.402 ' CE2' ' OD2' ' A' ' 73' ' ' ASP . 5.2 t80 -168.26 31.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.989 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ptp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.957 0.408 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 1.4 mptp? -160.53 122.48 3.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.976 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -145.49 133.57 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 48' ' ' VAL . 20.8 t -126.2 160.66 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.695 HD23 HG23 ' A' ' 49' ' ' ILE . 40.9 tp -118.8 136.34 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.808 0.337 . . . . 0.0 110.996 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.659 ' HB ' HG22 ' A' ' 30' ' ' THR . 13.7 t -117.35 90.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.89 104.86 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.842 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -140.32 137.99 34.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -88.76 48.83 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.841 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 179.89 167.4 1.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.35 54.12 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 m -111.31 -56.02 2.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.971 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 13' ' ' ILE . 1.6 mp -79.69 -33.14 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.756 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p -59.85 -19.73 52.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -90.04 -26.42 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.731 0.3 . . . . 0.0 111.231 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.24 -63.03 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.199 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.003 HD13 HD11 ' A' ' 21' ' ' LEU . 2.1 tm? -52.24 -50.18 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.02 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.796 ' HA ' HD12 ' A' ' 21' ' ' LEU . 7.0 t -53.09 -59.42 4.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.217 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.0 -39.51 59.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.05 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.728 HG23 HD11 ' A' ' 110' ' ' LEU . 8.9 mt -57.41 -58.3 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.9 -39.61 19.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.408 . . . . 0.0 110.78 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.59 -28.34 68.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.6 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.37 -34.47 31.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.233 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.748 ' HG3' HD21 ' A' ' 110' ' ' LEU . 15.8 mm-40 -76.49 -70.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 149.23 57.45 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 81.0 m-85 -129.84 -169.31 2.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.53 88.04 20.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.967 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.907 ' HB3' HD13 ' A' ' 21' ' ' LEU . 66.6 Cg_endo -78.81 132.6 10.85 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.419 2.079 . . . . 0.0 113.148 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 30' ' ' THR . 17.5 t70 -111.56 8.43 20.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.221 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.659 HG22 ' HB ' ' A' ' 6' ' ' VAL . 5.9 p 0.83 123.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 -165.69 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.702 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -116.61 -33.52 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.776 HG23 ' HB3' ' A' ' 56' ' ' PRO . 0.7 OUTLIER -162.03 175.23 12.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.612 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.71 HD22 ' CD2' ' A' ' 63' ' ' PHE . 54.3 mt -55.56 -33.41 63.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.757 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -48.13 76.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.506 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.838 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.32 -36.02 63.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 83.6 mt-10 -68.48 -40.81 80.81 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.06 -35.09 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.9 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -76.65 -44.72 32.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.721 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.96 -26.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.18 -25.79 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.427 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -125.67 -45.58 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.012 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -74.66 135.06 41.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -92.25 95.47 9.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 75.8 m-85 -91.98 113.4 58.85 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.8 Cg_endo -73.43 -16.5 24.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.387 2.058 . . . . 0.0 111.886 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.8 t -148.43 131.61 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.47 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.695 HG23 HD23 ' A' ' 5' ' ' LEU . 7.3 mm -119.16 162.65 17.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.5 t -149.85 98.42 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.178 0.514 . . . . 0.0 111.454 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB3' HG22 ' A' ' 78' ' ' VAL . 37.7 tp -81.73 148.87 28.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.588 ' O ' HG21 ' A' ' 80' ' ' THR . 8.0 t70 -107.84 -19.92 13.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.484 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.681 HG22 ' HB ' ' A' ' 80' ' ' THR . 2.4 m 45.93 32.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -56.6 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.676 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.567 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 13.3 mtp -152.54 57.52 2.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.964 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.776 ' HB3' HG23 ' A' ' 33' ' ' THR . 4.9 Cg_endo -86.3 -156.38 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.061 2.507 . . . . 0.0 112.199 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -157.39 37.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.94 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.584 ' C ' HD12 ' A' ' 34' ' ' LEU . . . -127.98 -0.69 6.48 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.065 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.424 ' C ' HD11 ' A' ' 34' ' ' LEU . 19.7 m-20 58.4 105.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.18 -0.8 87.04 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.142 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.918 ' O ' HD12 ' A' ' 64' ' ' ILE . 46.4 t -67.25 -66.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 120.898 0.38 . . . . 0.0 111.161 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -67.09 -14.33 62.8 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CD2' HD22 ' A' ' 34' ' ' LEU . 21.4 t80 -63.4 -38.92 93.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.1 mt -48.35 -33.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.5 t70 -70.03 -32.8 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.29 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 6.9 t80 -62.33 -43.96 97.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.686 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mp -59.57 -44.64 93.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.41 -21.31 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.563 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' ASP . 37.4 tt0 -67.0 -31.77 72.55 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.05 18.63 3.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.044 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.86 70.06 0.88 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.24 -19.37 38.71 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.721 2.281 . . . . 0.0 112.241 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.22 29.14 3.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.978 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 48.0 t -110.87 -163.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.42 ' N ' ' OG ' ' A' ' 74' ' ' SER . 31.9 t -154.55 136.2 5.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 120.836 0.351 . . . . 0.0 111.399 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.845 HG12 HG23 ' A' ' 78' ' ' VAL . 2.0 t -115.43 109.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.412 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.564 HG21 ' CE1' ' A' ' 109' ' ' PHE . 38.3 mm -83.27 -59.68 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.913 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.845 HG23 HG12 ' A' ' 76' ' ' VAL . 55.7 t 55.48 89.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.667 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -96.21 -152.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.681 ' HB ' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER 69.16 139.86 0.04 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.809 0.338 . . . . 0.0 110.976 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.04 37.92 0.67 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.435 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -69.89 71.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.825 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.9 -33.96 0.14 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.431 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 m -129.43 106.18 8.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 110.865 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 85' ' ' VAL . 11.7 p -81.21 -0.1 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.584 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.52 -8.97 57.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -89.79 -39.29 13.21 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.571 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -56.42 -57.99 9.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.3 m -55.19 -31.1 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.772 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.555 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -76.97 -5.38 48.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.91 -38.12 3.0 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.909 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 9.1 pt -73.93 -34.52 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.435 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -65.34 -18.12 65.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.935 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -85.89 -56.27 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.045 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.29 32.03 0.05 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.043 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.909 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.27 -162.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.329 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.558 ' CE2' HG23 ' A' ' 112' ' ' THR . 81.3 t80 -111.98 23.32 13.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.439 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 0.7 OUTLIER 83.89 20.33 0.17 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.95 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER 58.43 163.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 0.0 111.453 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HB3' HG23 ' A' ' 79' ' ' ILE . 1.8 tm? -116.02 81.23 1.57 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -115.12 112.42 22.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.222 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.637 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 0.3 OUTLIER 177.21 -54.42 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.944 179.599 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 102' ' ' LYS . 89.9 Cg_endo -81.04 -168.03 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.383 2.055 . . . . 0.0 112.601 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -145.84 25.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.8 t -149.38 -84.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.966 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' CG2' HD23 ' A' ' 17' ' ' LEU . 11.4 p 178.7 -39.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.657 0.265 . . . . 0.0 111.313 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -40.62 -40.57 1.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.913 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.442 ' CB ' ' HB3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -70.43 -39.3 74.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.765 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.564 ' CE1' HG21 ' A' ' 77' ' ' ILE . 5.5 t80 -57.23 -30.04 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.748 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -50.76 -34.92 29.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.1 mp -61.8 -51.65 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.313 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.558 HG23 ' CE2' ' A' ' 97' ' ' TYR . 87.9 m -51.51 -39.2 57.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.997 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.431 ' HA ' HD13 ' A' ' 113' ' ' ILE . 12.6 mm -53.58 -65.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.981 0.419 . . . . 0.0 110.132 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -13.45 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.716 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -90.49 -25.49 20.26 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 110.065 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.94 -47.37 13.78 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 48' ' ' VAL . 34.2 m-85 -57.93 -21.8 45.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.195 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -49.53 -28.01 5.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.185 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -98.32 31.08 2.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -149.41 31.26 0.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.737 0.303 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 23.8 mmtt -146.77 96.07 2.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.979 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.67 135.41 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.4 t -127.12 143.92 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.824 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.723 HD23 HD11 ' A' ' 41' ' ' ILE . 15.1 tp -99.99 125.33 46.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.791 HG21 HD12 ' A' ' 17' ' ' LEU . 21.9 t -112.11 88.78 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.07 103.47 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -137.08 138.8 40.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.43 38.5 1.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 17.0 tp10 -150.21 164.84 34.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.4 -36.13 58.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.009 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 14' ' ' THR . 38.4 t -59.08 -173.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 14' ' ' THR . 11.8 mm 62.52 -72.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.194 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.455 ' N ' HG22 ' A' ' 13' ' ' ILE . 31.4 p -53.8 -22.75 10.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.353 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.1 t -90.14 23.16 2.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.524 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.9 t -163.27 -53.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.583 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.791 HD12 HG21 ' A' ' 6' ' ' VAL . 1.6 tm? -57.88 -50.97 71.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.572 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 30' ' ' THR . 0.7 OUTLIER -56.99 -51.52 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.336 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.54 70.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.538 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.667 ' CD1' HG11 ' A' ' 106' ' ' VAL . 40.7 mt -58.16 -66.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.678 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.2 mt -49.7 -31.42 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.469 . . . . 0.0 110.369 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.42 -30.63 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.57 -34.89 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.037 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.805 ' HG3' HD21 ' A' ' 110' ' ' LEU . 41.9 mm-40 -75.08 -12.09 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.207 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 53.36 1.08 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.197 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.465 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 64.5 m-85 -126.38 -176.33 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 111.108 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.48 71.95 51.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 33.9 Cg_exo -60.34 138.66 82.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.776 2.318 . . . . 0.0 112.645 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.9 t70 -121.04 4.59 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.748 HG22 ' HB ' ' A' ' 6' ' ' VAL . 12.8 p 3.38 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 -163.21 0.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.391 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -118.85 -28.26 5.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.278 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -163.48 -170.12 2.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.806 0.336 . . . . 0.0 110.806 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 63' ' ' PHE . 47.0 mt -68.41 -45.87 71.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -48.56 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.67 -30.19 69.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.491 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.505 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.29 -25.32 54.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.443 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 45.7 mt-10 -75.56 -36.27 60.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -37.33 77.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.58 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -71.82 -37.48 70.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.542 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.723 HD11 HD23 ' A' ' 5' ' ' LEU . 23.7 mt -85.76 -16.86 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.387 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -52.59 -22.19 4.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.619 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -133.3 -51.66 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.824 0.345 . . . . 0.0 111.154 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 118.71 5.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -73.96 72.26 1.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 38.8 m-85 -66.41 111.24 6.23 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.476 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.408 ' HG2' ' CE2' ' A' ' 117' ' ' PHE . 72.3 Cg_endo -74.42 -20.67 18.09 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.628 2.219 . . . . 0.0 112.207 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.631 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.4 t -144.0 130.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.295 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 9.9 mm -117.7 156.99 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.407 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.15 102.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 tp -86.12 84.72 7.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.976 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.49 77.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.66 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.718 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.2 p -59.33 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.599 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 44.5 t-105 -74.46 -82.78 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.097 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.545 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.39 45.45 0.35 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.313 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 55' ' ' MET . 82.3 Cg_endo -85.12 -165.54 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.442 2.095 . . . . 0.0 112.261 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -154.55 48.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.949 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.0 -16.67 6.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.85 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 62.58 104.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.791 0.329 . . . . 0.0 110.733 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.06 18.57 57.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.895 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.68 ' O ' HD12 ' A' ' 64' ' ' ILE . 13.1 t -58.98 -58.36 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.879 0.371 . . . . 0.0 111.098 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.05 -4.79 43.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.745 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 67' ' ' ILE . 26.7 t80 -69.15 -39.99 78.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.618 0.247 . . . . 0.0 111.496 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mp -46.89 -33.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.766 0.317 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.483 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -70.04 -34.75 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 75.0 t80 -63.06 -39.92 96.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mp -62.77 -47.12 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.909 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.483 ' HG3' ' HA ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -75.41 -18.95 59.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.45 -42.75 74.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.718 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.75 18.36 11.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.054 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.85 67.11 1.09 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.81 -20.29 34.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.653 2.235 . . . . 0.0 112.218 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.41 32.72 2.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 t -113.2 -157.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.439 HG22 ' CD2' ' A' ' 120' ' ' TYR . 39.2 t -155.37 137.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 111.505 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.84 HG12 HG23 ' A' ' 78' ' ' VAL . 2.8 t -117.83 100.4 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.376 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 97' ' ' TYR . 38.2 mm -81.5 -55.12 8.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.739 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 76' ' ' VAL . 40.3 t 57.69 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -114.31 -159.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.334 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.718 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 57.36 165.04 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.21 43.16 0.41 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.413 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -59.17 139.57 56.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.49 99.05 1.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m 63.06 146.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 85' ' ' VAL . 14.0 p -105.96 37.79 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.047 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.57 -22.26 28.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -79.78 -36.38 37.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.144 0.497 . . . . 0.0 109.726 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.1 -57.74 10.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.203 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 -26.17 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.948 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 61' ' ' VAL . 5.3 tttt -87.93 40.54 0.95 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.625 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.36 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.945 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.4 pt -75.08 -29.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.501 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -80.08 -19.27 47.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -23.15 58.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.76 22.88 0.14 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.595 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.945 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.36 -165.15 1.28 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 117.22 0.51 . . . . 0.0 111.147 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.452 ' HB3' HD13 ' A' ' 77' ' ' ILE . 70.3 t80 -114.11 25.14 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 79.95 139.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.562 ' H ' HG21 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -57.19 130.11 44.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.676 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -78.26 120.3 22.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.684 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.419 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.1 mt-10 -58.49 -168.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.014 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -150.52 53.62 1.27 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.857 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.17 -2.32 12.16 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.592 2.194 . . . . 0.0 112.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.96 -75.72 0.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.737 0.303 . . . . 0.0 110.845 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.7 t 178.15 -51.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.667 HG11 ' CD1' ' A' ' 20' ' ' ILE . 11.7 p -155.79 -44.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -38.96 -44.16 1.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.635 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -64.45 -42.33 96.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 0.0 110.345 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 8.8 t80 -59.51 -27.24 65.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.692 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.805 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -60.27 -48.15 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.404 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.9 mp -51.39 -51.52 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.227 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.91 -41.34 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 3.4 mm -50.35 -56.15 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.608 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -63.22 1.13 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -49.97 -32.56 15.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.776 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -60.92 -41.35 95.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.458 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.628 ' CE1' HG21 ' A' ' 48' ' ' VAL . 32.6 m-85 -76.13 -34.81 59.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 -77.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.597 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 -21.44 12.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.788 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.439 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -127.3 54.95 1.62 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.88 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttm . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.9 0.381 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HB3' ' CG ' ' A' ' 26' ' ' TYR . 13.3 mmtt 65.39 100.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.4 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -148.22 121.95 9.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.633 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.577 HG13 ' HB ' ' A' ' 48' ' ' VAL . 38.0 t -127.36 158.15 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.892 HD12 ' O ' ' A' ' 29' ' ' ASP . 52.3 tp -117.96 141.55 48.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 111.43 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.69 HG21 HD12 ' A' ' 17' ' ' LEU . 16.9 t -121.24 141.65 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.158 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 14.2 t -132.84 121.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.1 t70 -159.25 159.75 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 110.621 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.53 50.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.936 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -138.55 123.9 19.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -88.12 53.8 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -164.56 36.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.798 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.74 HD13 ' OG1' ' A' ' 30' ' ' THR . 23.2 mm 55.71 168.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 121.116 0.484 . . . . 0.0 110.923 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.633 HG21 HG11 ' A' ' 6' ' ' VAL . 30.1 p -86.1 122.15 29.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.129 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 16' ' ' SER . 29.6 t -54.21 132.46 43.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.955 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.684 ' HB3' HG11 ' A' ' 106' ' ' VAL . 5.7 t 83.08 -15.02 0.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.719 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.905 ' CD1' HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -77.4 -48.49 17.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.855 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -50.7 -57.0 9.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.31 80.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.655 HD11 HG13 ' A' ' 106' ' ' VAL . 81.9 mt -59.91 -70.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.905 HD11 ' CD1' ' A' ' 17' ' ' LEU . 1.2 mt -47.84 -31.17 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -73.79 -30.54 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.884 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.16 -35.53 25.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.89 -33.74 62.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.5 42.17 3.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' CG ' ' HB3' ' A' ' 2' ' ' LYS . 3.1 m-85 -104.12 -175.67 2.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.4 ' HB2' ' HG3' ' A' ' 3' ' ' ARG . 2.5 t-80 -127.59 82.27 68.62 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.05 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.664 ' HB3' HD22 ' A' ' 21' ' ' LEU . 88.0 Cg_endo -83.44 130.94 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 113.884 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.892 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -119.74 116.82 26.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.856 178.367 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.74 ' OG1' HD13 ' A' ' 13' ' ' ILE . 18.5 p -105.76 137.14 44.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 112.039 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 36' ' ' GLU . . . -106.93 -164.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.076 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -131.59 -5.84 3.68 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.7 167.66 7.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.674 HD22 ' CD2' ' A' ' 63' ' ' PHE . 33.8 mt -60.78 -29.6 69.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.848 0.356 . . . . 0.0 110.225 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -70.63 -45.98 64.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.722 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.515 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 2.5 mm-40 -62.66 -33.07 74.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.069 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.97 34.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.718 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' LYS . 49.8 mt-10 -46.17 -46.55 17.41 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -58.95 -54.45 47.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.51 -24.63 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.014 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 41' ' ' ILE . 18.2 mt -97.07 -13.49 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.22 -9.28 58.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.587 0.232 . . . . 0.0 111.288 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.03 -62.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 113.12 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.21 68.26 0.49 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.481 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 35.2 m-85 -63.28 130.18 94.04 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 5.1 Cg_endo -80.39 -45.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.393 2.062 . . . . 0.0 111.924 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 4' ' ' VAL . 23.9 t -117.37 123.41 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.91 128.35 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.785 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.64 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 60.2 t -120.35 106.27 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.068 0.461 . . . . 0.0 111.552 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.735 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.8 tp -89.07 153.84 20.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -145.68 109.03 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.742 ' H ' HG22 ' A' ' 80' ' ' THR . 79.9 t -86.75 70.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.973 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -71.96 -80.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.485 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.612 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.97 55.0 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.96 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 55' ' ' MET . 6.9 Cg_endo -88.34 -156.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.136 2.557 . . . . 0.0 112.161 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -146.34 36.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.97 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.21 129.25 3.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.447 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.49 141.99 53.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.72 -23.06 11.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.658 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.691 ' O ' HD12 ' A' ' 64' ' ' ILE . 21.7 t -53.51 -46.73 60.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.572 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -75.65 -5.39 45.29 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.1 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.901 ' CE2' HD11 ' A' ' 67' ' ' ILE . 16.4 t80 -84.43 -35.72 22.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.571 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.9 mp -45.07 -29.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.466 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.615 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 9.9 t0 -72.34 -51.45 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.12 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 8.8 t80 -50.58 -41.63 54.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.942 0.401 . . . . 0.0 110.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.901 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.1 mp -63.6 -50.19 79.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.42 -15.79 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 110.688 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -73.42 -52.09 14.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.673 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.406 ' ND2' ' OE1' ' A' ' 69' ' ' GLU . 2.4 m120 -112.14 19.75 17.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.436 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -163.67 64.29 1.3 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.684 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 71' ' ' SER . 5.0 Cg_exo -76.02 -13.5 19.33 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.602 2.201 . . . . 0.0 111.99 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 25.54 11.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.083 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.5 t -108.76 -173.3 2.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.976 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.2 t -123.9 162.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.009 0.433 . . . . 0.0 111.293 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.943 HG12 HG23 ' A' ' 78' ' ' VAL . 1.5 t -140.34 105.54 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.378 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 77' ' ' ILE . 34.4 mm -107.25 41.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.943 HG23 HG12 ' A' ' 76' ' ' VAL . 58.8 t -46.23 97.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.572 HG23 ' HB3' ' A' ' 100' ' ' LEU . 31.7 mt -71.61 -101.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.455 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER 69.8 130.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.696 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.79 -111.2 1.79 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.58 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 62.92 -79.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 111.061 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.77 51.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.565 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.633 ' O ' HG22 ' A' ' 87' ' ' THR . 0.5 OUTLIER -129.41 80.59 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.74 0.305 . . . . 0.0 110.916 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.59 -30.73 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.09 -14.0 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -81.33 -35.43 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 109.799 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.87 -57.59 12.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.172 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.2 m -59.38 -29.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -75.79 -12.9 60.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.57 -36.34 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.3 pt -80.31 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.917 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.4 mptp? 73.64 -46.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.613 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -21.92 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.786 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.15 -30.07 0.11 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.62 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.766 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -62.48 176.52 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.95 0.405 . . . . 0.0 111.331 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -104.82 27.43 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 79.64 142.67 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.855 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.5 m-30 -63.82 149.39 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.572 ' HB3' HG23 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -81.57 101.72 10.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -53.27 154.61 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.205 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.39 72.48 0.67 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.63 61.59 3.63 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.576 2.184 . . . . 0.0 112.303 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -147.56 -47.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 p -96.88 136.37 37.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.881 HG21 HD23 ' A' ' 17' ' ' LEU . 8.0 p -100.26 -15.73 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.235 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -37.58 87.81 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.81 -36.32 83.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.675 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.64 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 9.6 t80 -59.46 -37.04 77.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.643 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.599 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.53 -42.95 79.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.136 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.34 -47.07 76.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.408 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.7 m -66.15 -41.69 90.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.518 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.9 mm -45.27 -54.33 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.52 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.29 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.033 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -60.92 -30.36 70.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.989 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.612 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -60.38 -39.37 87.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.914 0.387 . . . . 0.0 110.857 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 48' ' ' VAL . 28.2 m-85 -69.6 -15.04 63.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.345 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.25 -25.4 9.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.77 0.319 . . . . 0.0 111.428 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.76 40.84 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -166.19 32.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.837 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.881 0.372 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -109.16 135.09 50.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.013 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.418 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -144.98 151.04 37.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.787 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' A' ' 48' ' ' VAL . 30.3 t -133.37 143.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.711 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 29' ' ' ASP . 46.3 tp -106.45 129.75 54.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.959 HG21 ' CD1' ' A' ' 17' ' ' LEU . 17.7 t -117.94 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.594 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 42.9 t -81.84 119.14 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 26.3 t0 -155.15 149.99 26.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 32.3 t70 -90.31 51.43 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.732 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.43 -165.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.788 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.99 -67.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.984 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 m -129.3 105.25 8.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 14' ' ' THR . 15.1 mm 55.54 168.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.78 HG21 ' CG1' ' A' ' 6' ' ' VAL . 61.1 p -90.36 128.58 36.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.203 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 t -58.84 138.03 57.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.981 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.409 ' CB ' HG11 ' A' ' 106' ' ' VAL . 3.1 m 75.84 -0.89 3.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.417 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.046 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -89.96 -52.67 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.347 . . . . 0.0 110.804 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.85 -58.59 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.024 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.22 48.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.011 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.889 HD11 HG13 ' A' ' 106' ' ' VAL . 62.1 mt -68.18 -71.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.331 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.046 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -49.59 -29.72 7.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -74.32 -27.02 60.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.654 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.28 -35.07 28.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.877 ' HG3' HD21 ' A' ' 110' ' ' LEU . 20.7 mm-40 -81.17 -34.62 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.045 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.19 53.27 1.91 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.227 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.475 ' CE2' HG21 ' A' ' 113' ' ' ILE . 7.8 m-85 -112.03 -175.69 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.357 0.599 . . . . 0.0 111.259 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 82.03 31.23 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.816 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.805 ' CB ' HD13 ' A' ' 21' ' ' LEU . 78.2 Cg_endo -82.06 128.02 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.752 2.301 . . . . 0.0 113.926 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.932 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -121.67 114.23 20.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 13' ' ' ILE . 20.3 p -95.46 128.83 42.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.009 0.433 . . . . 0.0 111.648 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -98.96 163.35 12.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.39 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 5.8 mttt -111.93 -9.15 14.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.249 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.61 152.71 3.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.576 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.2 mt -52.16 -26.64 11.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.55 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -43.45 59.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.986 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 7' ' ' VAL . . . -73.24 -48.83 31.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.479 ' HG3' ' CE2' ' A' ' 66' ' ' PHE . 4.8 tt0 -47.11 -47.39 23.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.33 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -55.39 35.64 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -58.23 -26.33 62.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 41' ' ' ILE . 14.5 mt -90.16 -13.27 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.32 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -97.53 20.71 11.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -140.89 -52.65 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -98.83 155.51 17.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.379 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.417 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 52.5 t80 -88.67 78.23 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.047 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.639 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 16.1 m-85 -66.49 120.39 70.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.7 Cg_endo -80.63 -47.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.311 2.007 . . . . 0.0 111.889 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.813 HG23 ' CE1' ' A' ' 117' ' ' PHE . 36.6 t -115.06 124.9 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.577 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 46' ' ' PHE . 29.2 mm -112.82 124.48 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.51 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.674 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 46.4 t -128.12 108.58 18.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 112.051 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD23 HG13 ' A' ' 78' ' ' VAL . 49.7 tp -82.76 157.76 23.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.408 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -140.17 89.93 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.71 66.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.154 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -77.94 -80.51 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.561 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.8 ttm -146.0 50.46 1.05 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.029 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 55' ' ' MET . 58.0 Cg_endo -92.66 -165.92 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.96 2.44 . . . . 0.0 112.377 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.01 30.6 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.82 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.67 -73.54 0.89 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.562 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 31.2 20.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.17 91.33 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.813 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.892 ' O ' HD12 ' A' ' 64' ' ' ILE . 57.8 t -58.69 -39.78 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.836 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -15.51 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.348 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.94 ' CE2' HD11 ' A' ' 67' ' ' ILE . 45.9 t80 -53.26 -47.12 69.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.892 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.8 mt -46.62 -29.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -65.72 -49.67 67.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.418 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 38' ' ' GLU . 2.0 t80 -53.92 -41.4 67.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.95 0.405 . . . . 0.0 110.138 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.94 HD11 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -62.47 -43.89 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -79.9 -17.35 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.041 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 65' ' ' ASP . 4.0 tt0 -72.07 -45.5 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -112.45 8.06 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.198 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.445 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -155.54 63.95 3.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.877 0.37 . . . . 0.0 110.57 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 71' ' ' SER . 15.0 Cg_exo -67.86 -20.87 45.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.548 2.165 . . . . 0.0 112.082 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.48 23.03 7.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.869 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.407 ' HG ' ' C ' ' A' ' 47' ' ' PRO . 34.7 t -104.81 -176.98 3.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.643 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.682 HG21 ' HB1' ' A' ' 116' ' ' ALA . 31.0 t -123.36 157.23 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.068 0.461 . . . . 0.0 111.257 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -146.2 104.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.134 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 112' ' ' THR . 43.3 mm -90.11 -42.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 HG12 ' A' ' 76' ' ' VAL . 47.2 t 45.97 88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.351 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.713 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -104.28 -177.74 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.503 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.713 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 78.37 143.52 0.08 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.29 -116.6 0.41 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.365 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 179.25 -50.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.68 -41.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.482 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 t -81.41 124.52 29.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 110.99 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 85' ' ' VAL . 21.3 t -83.56 -5.59 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.455 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.24 -17.07 62.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.344 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -74.25 -35.23 63.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 0.0 109.944 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.75 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.87 -58.78 6.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.044 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 92' ' ' ILE . 21.3 m -60.25 -25.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.101 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.551 ' HD3' HG21 ' A' ' 61' ' ' VAL . 18.4 ttmm -76.22 -17.27 59.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.78 -39.67 4.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.852 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.8 pt -72.76 -22.73 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.689 0.28 . . . . 0.0 111.53 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -68.72 -30.65 69.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.385 . . . . 0.0 110.41 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -64.76 -57.07 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 34.75 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.29 -167.77 1.93 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.158 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 75.2 t80 -107.64 -17.97 13.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.45 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 4.6 pt-20 145.17 -173.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.504 0.721 . . . . 0.0 110.066 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.512 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -121.45 94.24 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.7 tp -54.15 140.74 31.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.75 16.49 12.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.294 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.568 ' N ' ' HD3' ' A' ' 103' ' ' PRO . 9.1 tttt 50.81 54.38 15.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.277 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 102' ' ' LYS . 39.3 Cg_exo -59.99 138.96 85.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.309 2.006 . . . . 0.0 112.114 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 63.98 -76.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.8 p -166.23 -39.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.2 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.889 HG13 HD11 ' A' ' 20' ' ' ILE . 8.1 p -176.66 -27.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.814 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -46.74 -35.87 6.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.402 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.61 -39.53 80.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.941 179.229 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.742 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 18.0 t80 -55.97 -31.46 63.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.926 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.877 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.4 tt -60.55 -52.55 64.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.147 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -47.05 -40.87 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.499 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.538 HG21 HD12 ' A' ' 77' ' ' ILE . 96.7 m -64.69 -50.19 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.742 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.4 mp -45.5 -52.95 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.922 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -59.12 4.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.0 0.429 . . . . 0.0 109.962 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -31.7 70.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.838 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.682 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.63 -28.36 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.813 ' CE1' HG23 ' A' ' 48' ' ' VAL . 10.7 m-85 -86.93 -56.4 3.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -48.82 79.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.529 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.17 -5.21 43.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.774 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.589 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -140.05 39.36 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 111.035 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.93 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.844 0.354 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.457 ' HB2' ' CG ' ' A' ' 26' ' ' TYR . 13.8 mmtm -132.3 161.66 32.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.405 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.62 122.65 12.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 48.2 t -129.89 144.81 36.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.934 HD23 HG23 ' A' ' 49' ' ' ILE . 46.5 tp -106.67 140.1 40.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.496 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.83 HG21 ' CD1' ' A' ' 17' ' ' LEU . 19.2 t -118.39 127.07 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.182 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.803 ' HB ' HD12 ' A' ' 51' ' ' LEU . 37.4 t -117.01 115.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -140.49 162.59 34.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.618 -179.256 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' CG ' ' A' ' 56' ' ' PRO . 17.4 t70 -63.54 -85.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.618 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.13 -164.94 1.25 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.44 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 74.86 126.03 0.04 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t -54.61 109.98 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.006 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 14' ' ' THR . 26.2 mm 58.13 166.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.593 ' N ' HG22 ' A' ' 13' ' ' ILE . 68.4 p -90.27 117.64 29.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.233 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -50.6 138.7 17.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.796 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.519 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.2 m 78.04 -1.98 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.283 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.897 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.12 -53.95 4.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.8 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.31 -60.59 2.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.36 -39.86 47.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.078 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.748 HG23 ' CD1' ' A' ' 110' ' ' LEU . 46.3 mt -64.26 -66.61 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.159 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.897 HD11 HD13 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -50.66 -28.78 9.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -72.61 -27.98 62.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.649 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -82.6 -35.01 27.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.281 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.735 ' HG3' HD21 ' A' ' 110' ' ' LEU . 8.9 mm-40 -80.99 -39.85 25.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.037 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.31 51.0 2.29 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.166 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' A' ' 2' ' ' LYS . 3.4 m-30 -104.1 -174.85 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.376 0.608 . . . . 0.0 111.315 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 77.47 59.45 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.722 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.774 ' HB3' HD22 ' A' ' 21' ' ' LEU . 92.1 Cg_endo -86.45 154.29 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.685 2.257 . . . . 0.0 114.585 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.485 ' O ' HD12 ' A' ' 5' ' ' LEU . 20.5 t70 -140.3 137.36 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.558 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.405 HG21 ' CD1' ' A' ' 13' ' ' ILE . 16.1 p -114.89 143.38 45.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.208 0.528 . . . . 0.0 112.135 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.89 -173.69 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.056 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 33' ' ' THR . 0.3 OUTLIER -117.65 -22.24 8.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.773 0.321 . . . . 0.0 111.288 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -166.08 167.38 16.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.379 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.785 HD22 ' CD2' ' A' ' 63' ' ' PHE . 12.1 mt -54.53 -32.51 58.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.708 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.002 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -35.42 80.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.01 -56.21 16.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 27.3 mt-10 -45.86 -42.61 12.71 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -45.89 86.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.874 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -71.73 -42.02 67.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.9 mt -71.54 -21.28 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -61.8 -20.73 63.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.125 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -126.68 -55.98 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -64.92 115.62 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -74.26 65.77 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.483 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 37.8 m-85 -63.75 128.78 93.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 11.1 Cg_endo -82.57 -27.6 2.11 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.491 2.127 . . . . 0.0 112.125 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.861 ' O ' HD13 ' A' ' 49' ' ' ILE . 10.6 t -130.48 139.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.934 HG23 HD23 ' A' ' 5' ' ' LEU . 2.0 mm -139.03 108.84 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.727 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.797 HG22 ' CG1' ' A' ' 77' ' ' ILE . 41.8 t -111.05 142.18 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 110.662 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.803 HD12 ' HB ' ' A' ' 7' ' ' VAL . 20.2 tp -101.39 159.88 14.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 6.9 t70 -141.99 79.82 1.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 53' ' ' VAL . 45.3 t -65.89 68.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.666 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 31.0 t-105 -68.57 -79.62 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.923 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.763 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.2 ptt? -144.07 40.61 0.3 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.667 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.763 ' HD3' ' N ' ' A' ' 55' ' ' MET . 57.1 Cg_endo -99.45 -162.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.201 2.601 . . . . 0.0 112.198 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -91.52 -47.27 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.451 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.06 -121.65 14.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.014 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.96 31.32 18.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -95.04 59.65 1.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.524 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 90' ' ' LYS . 57.6 t -56.39 -38.11 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.153 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.09 15.96 9.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.44 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.958 ' CE2' HD11 ' A' ' 67' ' ' ILE . 47.8 t80 -79.7 -38.42 33.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.81 0.338 . . . . 0.0 110.742 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -48.58 -28.52 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.29 -37.78 60.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 19.4 t80 -57.68 -44.87 86.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.281 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.958 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.0 mp -59.29 -41.88 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.361 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.66 -24.85 49.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.551 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.14 -41.5 94.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.71 12.86 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 68.15 1.18 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.842 0.354 . . . . 0.0 110.668 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -67.98 -20.32 44.84 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.771 2.314 . . . . 0.0 112.138 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.6 28.73 6.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 47.5 t -112.1 -176.25 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.973 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.638 HG11 ' HB1' ' A' ' 116' ' ' ALA . 47.6 t -126.03 143.59 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.125 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.738 HG22 HG21 ' A' ' 67' ' ' ILE . 3.3 t -127.06 95.84 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.726 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.797 ' CG1' HG22 ' A' ' 50' ' ' VAL . 47.9 mm -74.22 -65.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.483 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 76' ' ' VAL . 11.3 t 67.8 88.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -106.45 175.7 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.563 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.594 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 72.24 121.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.916 0.389 . . . . 0.0 110.892 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.09 150.08 11.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.475 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -128.81 -178.15 4.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.357 . . . . 0.0 110.956 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.39 -139.73 16.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.7 m -98.42 29.52 3.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 85' ' ' VAL . 15.2 t 58.28 30.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.073 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.5 -31.56 32.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.455 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 2.6 t -63.16 -34.48 77.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.874 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.849 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.13 -59.84 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.227 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 92' ' ' ILE . 10.3 m -64.53 -23.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.019 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.519 ' O ' HG13 ' A' ' 61' ' ' VAL . 22.0 ttpt -81.25 -7.6 59.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.427 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -123.29 -40.13 2.41 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.868 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.5 pt -69.8 -40.75 79.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.288 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -56.42 -25.46 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -19.75 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.347 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.85 -3.68 3.49 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.063 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -56.52 -167.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.901 0.381 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.524 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.8 t80 -108.53 26.05 10.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.44 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 79.66 152.65 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.203 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -74.83 103.08 4.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.948 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.4 tp -80.61 53.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.654 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.34 133.24 55.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 111.323 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.3 OUTLIER 175.41 -58.0 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 102' ' ' LYS . 97.2 Cg_endo -84.19 6.21 5.89 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.761 2.307 . . . . 0.0 112.743 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 61.88 171.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.704 0.288 . . . . 0.0 110.754 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m 59.06 -166.17 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.684 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.632 HG21 HD23 ' A' ' 17' ' ' LEU . 5.4 m -116.4 -11.82 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.648 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -40.95 -50.51 3.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.203 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -35.41 80.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.23 0.538 . . . . 0.0 109.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.6 ' HE2' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -58.3 -24.09 58.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.213 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.748 ' CD1' HG23 ' A' ' 20' ' ' ILE . 1.2 tt -60.27 -49.08 79.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.221 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.596 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.4 mp -56.31 -56.15 24.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.33 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.436 HG23 ' HE2' ' A' ' 97' ' ' TYR . 60.8 m -53.72 -57.95 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 7.4 mm -31.58 -62.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.5 -59.2 3.97 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -52.67 -28.33 21.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.693 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.638 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -70.27 -32.66 70.57 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS . 26.6 m-85 -68.75 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.141 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -60.32 -41.23 93.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.377 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -72.28 -8.35 54.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.583 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.62 39.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.2 mptt 63.53 95.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.257 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.8 132.5 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.709 HG11 ' CD1' ' A' ' 113' ' ' ILE . 7.4 t -123.75 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.63 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.6 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 43.5 tp -103.66 132.74 49.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.733 HG21 ' CD1' ' A' ' 17' ' ' LEU . 34.1 t -113.26 90.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.254 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.14 104.63 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -135.32 134.39 39.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.95 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 t0 -73.29 -40.79 64.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.41 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -178.72 120.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.403 ' HB3' HD13 ' A' ' 13' ' ' ILE . 3.2 tt0 179.73 -179.04 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.26 19.34 10.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.116 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 2.0 mp -80.69 -59.38 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.366 . . . . 0.0 110.716 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.7 p -46.0 -26.7 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.799 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 t -76.99 -65.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.44 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m -73.16 -53.43 11.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.396 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.7 tm? -46.81 -53.94 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.246 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.533 ' OG ' HG21 ' A' ' 30' ' ' THR . 71.3 m -52.8 -43.58 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.94 96.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.424 ' CG2' ' CD1' ' A' ' 110' ' ' LEU . 55.5 mt -56.22 -67.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.59 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.527 HD21 HG13 ' A' ' 113' ' ' ILE . 1.4 mt -47.47 -33.32 6.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 110.497 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.23 -29.96 71.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.589 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -78.51 -37.07 44.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' CD ' HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -70.61 -22.27 62.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.085 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.54 58.47 0.81 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.378 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.464 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 55.7 m-85 -130.14 -177.27 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.431 . . . . 0.0 111.116 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.1 76.18 77.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.448 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 11.7 Cg_exo -67.7 137.7 42.94 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.795 2.33 . . . . 0.0 112.631 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.2 t70 -120.63 7.85 10.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 6' ' ' VAL . 13.7 p 6.04 122.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.24 -162.41 0.93 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.86 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 ttpt -117.22 -38.46 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 32' ' ' LYS . 13.9 p -161.3 -173.06 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.538 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 63' ' ' PHE . 16.5 mt -66.79 -45.75 77.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.456 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -62.85 -45.88 90.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.157 0.504 . . . . 0.0 109.937 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -32.35 71.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -72.93 -28.68 62.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.704 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mt-10 -69.76 -43.49 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -60.04 -39.9 87.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.66 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -70.37 -46.82 63.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.721 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 37' ' ' ALA . 11.7 mt -73.0 -20.43 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.567 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -57.98 -21.17 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.371 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -126.46 -43.73 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -77.76 122.93 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.044 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -81.05 85.25 6.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.6 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 61.1 m-85 -80.79 113.97 44.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.367 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 74' ' ' SER . 71.6 Cg_endo -74.17 -20.39 19.01 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.655 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.3 t -144.72 129.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.299 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 7.6 mm -117.22 157.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.251 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 109' ' ' PHE . 74.9 t -149.34 102.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 110.767 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.479 HD23 HG13 ' A' ' 78' ' ' VAL . 60.1 tp -78.42 148.17 33.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.312 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.5 OUTLIER -130.24 84.06 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.242 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.649 ' N ' HG21 ' A' ' 80' ' ' THR . 87.3 t -62.88 72.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.978 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 55' ' ' MET . 27.9 t90 -64.92 -97.15 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.623 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -135.99 38.58 0.39 Allowed Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 55' ' ' MET . 69.5 Cg_endo -85.33 -164.72 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.425 2.083 . . . . 0.0 112.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -143.96 41.45 1.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.5 179.9 36.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.388 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.97 77.46 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.83 -25.87 62.09 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.554 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.451 ' O ' HD12 ' A' ' 64' ' ' ILE . 24.4 t -54.56 -44.53 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 120.756 0.312 . . . . 0.0 111.45 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.7 6.67 40.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.472 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 67' ' ' ILE . 34.9 t80 -90.07 -37.51 14.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.7 mp -47.95 -28.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.359 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -77.15 -36.22 55.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.703 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 61.2 t80 -59.15 -42.83 91.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.974 0.416 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.869 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.5 mp -59.85 -43.27 91.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.317 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.25 -16.04 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -74.0 -34.34 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.412 . . . . 0.0 110.737 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.41 13.31 7.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.029 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.29 66.89 1.94 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.584 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.25 -20.9 42.48 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.655 2.237 . . . . 0.0 112.187 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -100.04 30.42 3.76 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 44.5 t -113.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG22 ' CG ' ' A' ' 120' ' ' TYR . 58.0 t -152.92 136.83 8.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 111.646 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.635 HG12 HG23 ' A' ' 78' ' ' VAL . 3.4 t -108.77 113.94 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.866 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 79' ' ' ILE . 47.3 mm -91.22 -65.33 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.635 HG23 HG12 ' A' ' 76' ' ' VAL . 58.0 t 52.8 97.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.134 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.695 HD13 HD23 ' A' ' 100' ' ' LEU . 17.0 mt -126.22 142.54 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.649 HG21 ' N ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 173.42 111.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.736 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.16 86.21 0.41 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.579 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -122.21 31.43 6.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.1 40.27 3.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.9 p -142.91 103.53 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 m -99.24 -27.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -83.76 3.44 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.216 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -37.57 13.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.28 -57.66 11.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.154 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.7 m -60.96 -25.89 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.478 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 61' ' ' VAL . 6.0 tttp -81.22 -18.21 46.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.531 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.7 -30.12 8.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 88' ' ' ALA . 4.7 pt -82.17 -23.45 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.197 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -68.95 -35.37 76.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpm? -59.25 -27.51 65.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.888 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.82 35.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.934 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.83 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.06 -165.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.481 ' HE2' HG23 ' A' ' 112' ' ' THR . 59.2 t80 -110.98 25.09 12.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.303 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.8 OUTLIER 85.37 161.9 0.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.653 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.739 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -95.36 95.07 8.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.306 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.695 HD23 HD13 ' A' ' 79' ' ' ILE . 20.2 tp -49.88 98.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.541 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.62 75.82 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -151.58 59.26 3.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.76 90.42 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.604 2.203 . . . . 0.0 112.411 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.32 -71.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.47 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 15.3 p -159.85 42.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.61 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 106' ' ' VAL . 7.2 p 48.01 15.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.473 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.76 -43.66 18.07 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -62.24 -34.83 77.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.307 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.615 ' HD2' HG23 ' A' ' 106' ' ' VAL . 1.6 t80 -63.32 -46.44 86.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.167 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.424 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -48.91 -37.26 19.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.456 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.21 -45.79 72.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.328 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.661 ' CG2' HD12 ' A' ' 77' ' ' ILE . 86.8 m -46.46 -40.79 12.92 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.399 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.709 ' CD1' HG11 ' A' ' 4' ' ' VAL . 12.9 mm -62.32 -65.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.716 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -14.9 3.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.743 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.442 ' CD2' ' HG3' ' A' ' 119' ' ' GLU . 1.9 t-160 -89.25 -30.92 18.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.112 0.482 . . . . 0.0 109.718 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -79.44 -33.94 42.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.385 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 14.8 m-85 -70.26 -29.59 66.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.59 -35.67 9.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.815 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.442 ' HG3' ' CD2' ' A' ' 115' ' ' HIS . 2.0 mm-40 -91.61 18.78 6.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.653 0.263 . . . . 0.0 111.593 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.498 ' CG ' HG22 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -154.65 38.11 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 110.83 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.816 0.341 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 61.88 108.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.52 120.26 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.609 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.653 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.9 t -116.28 159.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.772 HD11 ' HD3' ' A' ' 40' ' ' LYS . 49.8 tp -109.58 129.66 55.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.896 HG21 ' CD1' ' A' ' 17' ' ' LEU . 24.6 t -115.38 89.45 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.673 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.13 115.21 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.137 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -149.35 143.15 25.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.403 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -87.44 50.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.99 5.43 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.437 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.6 148.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.809 0.338 . . . . 0.0 110.976 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m 54.03 178.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.936 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.582 HG23 HG21 ' A' ' 30' ' ' THR . 10.6 mm -52.93 163.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.867 0.365 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.508 ' N ' HG22 ' A' ' 13' ' ' ILE . 52.6 p -86.09 158.23 19.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.015 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.8 136.3 47.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.138 0.494 . . . . 0.0 112.028 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.653 ' CB ' HG11 ' A' ' 106' ' ' VAL . 1.4 m 74.26 0.57 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.364 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.984 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.05 -53.35 4.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.859 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 t -44.57 -55.56 5.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.29 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.935 HD11 HG13 ' A' ' 106' ' ' VAL . 64.6 mt -65.22 -69.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.984 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.97 -30.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.51 -30.32 67.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -34.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 110.273 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.845 ' HG3' HD21 ' A' ' 110' ' ' LEU . 10.1 mm-40 -83.41 -36.98 23.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.08 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.11 54.26 1.77 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.269 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -108.59 -173.3 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 111.241 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.42 88.8 33.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.219 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HG3' HD13 ' A' ' 21' ' ' LEU . 85.1 Cg_endo -80.93 130.98 7.75 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.653 2.235 . . . . 0.0 112.811 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.4 t70 -105.57 5.04 30.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.347 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.79 HG22 ' HB ' ' A' ' 6' ' ' VAL . 10.4 p 2.14 124.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.786 ' HB2' ' CD ' ' A' ' 40' ' ' LYS . . . -106.71 -163.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.625 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -118.14 -36.45 3.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -158.56 179.94 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD22 ' CD2' ' A' ' 63' ' ' PHE . 56.3 mt -60.03 -47.41 85.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.92 -45.26 86.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.542 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -70.87 -32.15 69.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -75.19 -28.97 60.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 55.4 mt-10 -72.1 -39.95 68.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -32.26 69.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.688 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.786 ' CD ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -78.31 -37.6 44.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.773 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 37' ' ' ALA . 21.7 mt -76.97 -27.16 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -5.48 30.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.776 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.03 -27.38 10.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -134.83 156.38 49.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 69.1 t80 -91.66 96.46 10.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.947 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 38.9 m-85 -79.76 122.49 83.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.341 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.71 -20.5 7.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.511 2.141 . . . . 0.0 111.934 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.9 t -148.31 133.82 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.17 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.699 HG23 HD23 ' A' ' 5' ' ' LEU . 6.2 mm -121.01 163.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 60.1 t -154.06 99.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.843 ' HB3' HG13 ' A' ' 78' ' ' VAL . 42.5 tp -79.6 163.3 24.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 8.7 t70 -151.17 88.84 1.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.224 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.9 m -67.63 66.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.652 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -58.32 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.43 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.692 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.8 OUTLIER -152.5 49.5 0.53 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.104 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.692 ' HD3' ' N ' ' A' ' 55' ' ' MET . 36.6 Cg_endo -94.53 -162.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.09 2.527 . . . . 0.0 112.293 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -152.08 43.64 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.92 -21.26 5.02 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.815 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.434 ' OD1' HG23 ' A' ' 61' ' ' VAL . 0.4 OUTLIER 63.97 123.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.758 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -94.65 11.98 69.28 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.971 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 90' ' ' LYS . 46.5 t -68.78 -41.9 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.851 0.358 . . . . 0.0 111.045 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.28 4.79 49.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.85 ' CE2' HD11 ' A' ' 67' ' ' ILE . 24.8 t80 -90.09 -36.63 14.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.285 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.518 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.2 mp -47.05 -29.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.366 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -35.35 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 29.8 t80 -59.88 -41.36 91.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.85 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.2 mp -61.57 -43.46 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.212 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -25.89 58.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.396 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -63.84 -39.98 95.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 16.38 11.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.428 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -166.56 70.13 1.09 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.817 0.341 . . . . 0.0 110.822 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.46 -18.4 29.58 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.795 2.33 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.75 27.19 9.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.989 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.7 t -104.4 -159.82 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.395 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 48' ' ' VAL . 52.4 t -150.11 135.15 10.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 111.695 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.763 HG12 HG23 ' A' ' 78' ' ' VAL . 8.2 t -110.53 116.05 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.643 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.793 HG21 HG21 ' A' ' 112' ' ' THR . 16.1 mm -118.49 50.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 51' ' ' LEU . 44.7 t -49.64 115.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.677 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -110.26 179.16 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.749 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.723 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.4 m 81.73 110.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.832 0.348 . . . . 0.0 110.995 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.62 109.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.49 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -95.74 162.54 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.35 -153.87 31.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.523 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -59.76 129.93 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 m -71.74 64.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -94.84 -19.88 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -34.31 23.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.49 -59.38 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.846 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.8 m -55.39 -28.02 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.096 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 61' ' ' VAL . 14.4 tttt -80.13 -9.16 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.414 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -120.08 -31.41 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.953 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.3 pt -79.21 -44.72 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.738 0.304 . . . . 0.0 111.417 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.42 ' N ' HG13 ' A' ' 92' ' ' ILE . 27.8 mttp -63.21 -17.93 62.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.782 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -25.87 52.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.2 -16.13 0.29 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.629 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -59.17 -179.65 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.41 0.605 . . . . 0.0 111.043 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 85.1 t80 -99.81 -7.8 24.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.785 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.561 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 17.9 pt-20 140.99 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.276 0.63 . . . . 0.0 110.663 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.563 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.41 91.11 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.751 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.662 ' HB3' HG23 ' A' ' 79' ' ' ILE . 14.6 tp -55.64 167.34 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -93.0 116.21 28.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -57.58 -58.09 20.71 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.089 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 28.6 Cg_endo -62.7 -164.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.385 2.057 . . . . 0.0 112.141 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 74.95 -72.99 0.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.0 t 174.46 164.2 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.985 0.422 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.935 HG13 HD11 ' A' ' 20' ' ' ILE . 7.3 p -88.66 -28.82 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.8 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -44.96 -31.94 1.46 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.939 0.4 . . . . 0.0 110.481 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.426 ' HA ' HD13 ' A' ' 111' ' ' LEU . 4.6 mmt180 -70.17 -41.44 73.79 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.679 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 3.7 t80 -55.02 -29.26 57.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.954 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -56.36 -39.74 73.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.764 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 108' ' ' ARG . 8.2 mp -59.21 -60.03 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.793 HG21 HG21 ' A' ' 77' ' ' ILE . 80.0 m -44.12 -48.38 9.07 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.148 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.679 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 40.7 mm -54.76 -73.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.603 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -17.75 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -90.13 -20.81 22.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.4 -47.24 12.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 48' ' ' VAL . 57.7 m-85 -56.8 -29.86 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.103 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -57.48 -22.3 42.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -97.03 29.97 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 20.9 t80 -119.75 29.43 7.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.756 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.797 0.332 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 17.1 mmtm 61.59 99.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.072 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.9 134.65 23.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.597 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.627 HG13 ' HB ' ' A' ' 48' ' ' VAL . 10.9 t -125.34 160.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.572 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 61.5 tp -112.93 128.59 56.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.845 HG21 HD12 ' A' ' 17' ' ' LEU . 44.4 t -108.47 90.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.865 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 19.1 t -86.89 119.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.159 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -158.93 139.67 12.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.495 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.417 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 43.4 t0 -90.24 50.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.897 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -152.23 104.48 2.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 61.15 167.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.059 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.3 p -58.16 -56.65 19.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.851 ' CD1' HG21 ' A' ' 30' ' ' THR . 7.6 mm -112.4 161.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.047 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.485 ' N ' HG22 ' A' ' 13' ' ' ILE . 57.4 p -90.51 138.44 31.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.577 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 p -63.37 140.59 58.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.9 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.734 ' HB2' HG11 ' A' ' 106' ' ' VAL . 2.5 m 79.37 -5.36 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.563 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.019 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.18 -49.06 6.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 110.922 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.2 p -47.68 -49.24 28.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.79 68.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.745 HG23 HD11 ' A' ' 110' ' ' LEU . 91.4 mt -54.2 -69.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.162 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.019 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -45.08 -33.65 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.18 -28.82 65.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -83.07 -35.65 25.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.848 ' HG3' HD21 ' A' ' 110' ' ' LEU . 69.4 mm-40 -78.21 -38.72 42.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.943 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.58 26.58 7.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.354 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 49.2 m-85 -84.25 -174.94 5.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.989 0.423 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -133.13 86.57 41.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' A' ' 21' ' ' LEU . 95.2 Cg_endo -81.38 129.54 6.69 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.663 2.242 . . . . 0.0 112.442 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.0 t70 -106.92 -4.65 18.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 112.049 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.851 HG21 ' CD1' ' A' ' 13' ' ' ILE . 69.2 p 43.72 174.54 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.703 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.865 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -164.01 170.43 16.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.419 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -104.76 -40.75 5.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -161.86 -174.49 4.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.571 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.687 HD22 ' CD2' ' A' ' 63' ' ' PHE . 45.8 mt -65.26 -41.34 94.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.708 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -61.53 -49.29 77.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 109.989 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.86 -34.85 77.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.57 -26.85 63.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 27.4 mt-10 -69.97 -46.62 64.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.873 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -62.28 -32.96 73.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.223 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -77.95 -40.36 39.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.229 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.661 HD12 ' HZ ' ' A' ' 63' ' ' PHE . 96.6 mt -76.87 -29.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 111.308 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.27 -25.84 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.358 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.79 -60.43 1.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.082 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -59.4 129.34 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.14 80.9 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 56.8 m-85 -78.77 119.2 76.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 95.8 Cg_endo -78.97 -22.11 8.96 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.512 2.141 . . . . 0.0 111.958 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.627 ' HB ' HG13 ' A' ' 4' ' ' VAL . 4.6 t -145.43 127.6 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.623 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.546 HG23 HD23 ' A' ' 5' ' ' LEU . 11.8 mm -113.98 152.09 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.827 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.79 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 84.5 t -139.56 94.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.508 . . . . 0.0 110.682 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 78' ' ' VAL . 37.6 tp -76.75 160.27 29.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.592 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 5.1 t0 -153.55 79.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.984 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.784 HG22 ' HB ' ' A' ' 80' ' ' THR . 28.6 m -59.24 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.283 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.432 ' CG ' ' N ' ' A' ' 55' ' ' MET . 14.8 t90 -63.41 -90.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.649 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.5 tpt -148.5 51.68 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.87 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.649 ' HD3' ' N ' ' A' ' 55' ' ' MET . 44.5 Cg_endo -92.54 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.898 2.399 . . . . 0.0 112.676 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -170.22 -68.5 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.785 0.326 . . . . 0.0 111.296 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.36 159.35 3.99 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.97 23.72 14.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 10.24 8.81 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.779 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 64' ' ' ILE . 27.3 t -84.34 -44.39 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.512 0.656 . . . . 0.0 110.964 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -68.39 -13.52 62.35 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.856 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.687 ' CD2' HD22 ' A' ' 34' ' ' LEU . 4.7 t80 -86.88 -27.45 23.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.315 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 61' ' ' VAL . 15.2 mm -47.59 -46.05 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.0 111.204 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -42.42 93.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.523 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 26.6 t80 -58.71 -29.97 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.113 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 1.065 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mm -64.71 -48.44 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.491 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -82.04 -14.28 56.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.24 -39.37 68.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.917 0.389 . . . . 0.0 110.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.48 11.48 9.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -157.43 66.62 3.77 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 110.673 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.0 Cg_exo -70.17 -19.49 34.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.745 2.297 . . . . 0.0 112.207 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.39 29.74 6.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.675 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 35.1 t -111.83 -162.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.757 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.44 HG22 ' CD2' ' A' ' 120' ' ' TYR . 25.8 t -151.51 134.41 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.035 0.445 . . . . 0.0 111.81 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.065 HG22 HG21 ' A' ' 67' ' ' ILE . 2.0 t -111.44 111.79 37.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.756 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.626 HD13 ' HB3' ' A' ' 97' ' ' TYR . 37.5 mm -92.83 -42.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.309 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.014 HG23 HG12 ' A' ' 76' ' ' VAL . 40.7 t 46.0 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.271 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 100' ' ' LEU . 31.8 mt -56.3 -101.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.212 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.784 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.1 p 68.87 -168.93 0.18 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 110.752 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.54 -151.02 18.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.557 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.0 43.2 9.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.389 . . . . 0.0 110.903 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 175.28 -62.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 m -130.85 -173.59 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.761 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.9 m -152.01 28.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.258 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -89.67 -60.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.729 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.645 HG23 ' CE2' ' A' ' 99' ' ' PHE . 5.3 t -46.09 -32.77 3.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.139 0.495 . . . . 0.0 110.305 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.902 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.24 -60.27 3.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.086 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 86' ' ' ASP . 28.0 m -61.88 -24.43 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.223 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.456 ' CD ' HG21 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -81.23 -32.48 33.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.14 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.17 -34.92 14.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.48 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.902 HG23 ' O ' ' A' ' 88' ' ' ALA . 2.7 pt -80.3 157.19 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.781 0.324 . . . . 0.0 110.754 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 mttm 72.42 6.1 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.162 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.49 26.66 5.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 110.565 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.62 -18.82 5.97 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.402 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -84.96 -169.8 2.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 111.248 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 77' ' ' ILE . 82.9 t80 -125.72 29.77 5.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 80.95 138.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.921 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.655 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.6 m-85 -66.08 128.97 38.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.061 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -71.93 118.11 14.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.92 171.86 14.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.503 ' N ' ' HD3' ' A' ' 103' ' ' PRO . 25.9 mmtt 63.44 60.29 1.9 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.034 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 102' ' ' LYS . 17.7 Cg_exo -65.24 -10.67 26.75 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.597 2.198 . . . . 0.0 112.721 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -73.64 -56.65 4.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -95.62 119.11 33.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.952 HG21 HD23 ' A' ' 17' ' ' LEU . 7.4 p -78.32 -30.26 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -45.23 -34.1 2.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.6 -39.99 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.9 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.79 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 1.5 t80 -56.39 -30.45 62.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.961 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.848 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -51.81 -42.84 62.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.229 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.427 ' H ' HD12 ' A' ' 111' ' ' LEU . 7.3 mp -57.61 -58.76 6.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.055 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.54 HG21 HD22 ' A' ' 100' ' ' LEU . 94.0 m -46.94 -41.28 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.76 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 23.0 mm -54.13 -68.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.313 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -15.51 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.839 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -90.27 -22.3 21.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -84.31 -37.75 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.06 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.419 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -66.84 -34.42 77.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -81.43 -22.49 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.311 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -88.99 11.38 18.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.598 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.44 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -154.27 38.99 0.45 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 0.0 110.886 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.78 0.324 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -157.3 121.61 4.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.931 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.5 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -143.98 139.98 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.966 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.547 HG13 ' HB ' ' A' ' 48' ' ' VAL . 78.2 t -128.56 155.18 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.959 0.409 . . . . 0.0 111.065 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.077 HD23 HG23 ' A' ' 49' ' ' ILE . 40.6 tp -115.19 134.55 55.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.75 HG21 HD12 ' A' ' 17' ' ' LEU . 14.4 t -120.35 102.61 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.986 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.463 ' HB ' HD12 ' A' ' 51' ' ' LEU . 31.9 t -93.21 117.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.576 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 23.1 t0 -159.5 157.47 30.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 26.6 t70 -89.6 51.12 2.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.181 0.515 . . . . 0.0 110.569 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.71 137.54 50.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.515 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.94 154.19 20.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.93 53.17 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.204 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.641 HG23 HG21 ' A' ' 30' ' ' THR . 21.3 mm 57.1 168.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.588 ' N ' HG22 ' A' ' 13' ' ' ILE . 20.6 p -90.26 118.61 29.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.225 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 52.8 p -50.06 141.74 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.619 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.588 ' CB ' HG11 ' A' ' 106' ' ' VAL . 1.3 m 85.95 -20.93 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.196 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.094 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -86.99 -47.12 9.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -50.33 -47.42 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.32 74.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.694 HG23 ' CD1' ' A' ' 110' ' ' LEU . 97.8 mt -58.12 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.094 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -45.12 -32.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.388 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.06 -29.79 63.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -83.52 -35.76 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.563 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.874 ' HG3' HD21 ' A' ' 110' ' ' LEU . 65.1 mm-40 -75.33 -35.49 61.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.21 44.4 2.79 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.529 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 53.6 m-85 -102.97 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 81.46 67.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.429 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.631 ' HB3' HD22 ' A' ' 21' ' ' LEU . 91.8 Cg_endo -83.12 142.11 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.78 2.32 . . . . 0.0 113.468 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.639 ' O ' HD12 ' A' ' 5' ' ' LEU . 24.2 t0 -136.23 65.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.373 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 6' ' ' VAL . 10.5 p -56.14 133.29 52.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.832 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.07 -160.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.336 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 33' ' ' THR . 3.7 mttt -120.66 -30.17 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.622 0.248 . . . . 0.0 111.336 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 32' ' ' LYS . 3.1 p -163.18 179.2 7.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.724 HD22 ' CD2' ' A' ' 63' ' ' PHE . 9.0 mt -61.45 -40.2 93.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.52 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 110.093 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -61.6 -33.53 74.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.196 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.68 -57.41 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 38.3 mt-10 -46.77 -41.13 14.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.766 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -43.41 95.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -44.44 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.854 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mt -71.17 -19.83 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.41 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -22.96 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -129.92 -59.38 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.88 114.45 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -79.83 67.05 5.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 46.0 m-85 -57.63 132.53 82.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 1.1 Cg_endo -77.74 -36.0 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.544 2.163 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.568 ' O ' HD13 ' A' ' 49' ' ' ILE . 20.0 t -125.82 133.93 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.077 HG23 HD23 ' A' ' 5' ' ' LEU . 1.8 mm -132.67 102.13 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.666 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 77' ' ' ILE . 31.0 t -100.47 125.61 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.279 . . . . 0.0 110.976 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.641 ' HB3' HG13 ' A' ' 78' ' ' VAL . 37.7 tp -90.53 161.49 15.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.45 . . . . 0.0 110.842 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -152.8 93.14 1.72 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 53' ' ' VAL . 57.2 t -73.9 63.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.404 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -63.39 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.319 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 35.6 mmm -139.71 37.19 0.27 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.648 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 55' ' ' MET . 92.8 Cg_endo -79.24 -165.42 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.294 1.996 . . . . 0.0 112.278 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -134.37 27.36 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.53 -86.64 1.9 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 59.16 54.37 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.69 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.35 110.49 3.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.831 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.863 ' O ' HD12 ' A' ' 64' ' ' ILE . 99.0 t -63.22 -36.13 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -6.53 48.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.61 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.0 ' CE2' HD11 ' A' ' 67' ' ' ILE . 48.3 t80 -62.07 -38.07 87.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.698 0.285 . . . . 0.0 111.165 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.863 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mt -48.57 -30.2 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.154 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.39 -34.01 63.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.651 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 26.8 t80 -61.2 -44.27 97.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 1.0 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -60.85 -41.2 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.393 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -21.0 46.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -68.03 -37.29 81.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.33 9.04 10.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.309 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.64 67.26 2.54 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.51 -18.93 33.15 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.702 2.268 . . . . 0.0 112.233 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -102.18 30.35 4.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.714 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.4 t -117.93 -179.79 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.797 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.6 143.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.574 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 67' ' ' ILE . 2.6 t -123.01 100.31 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.888 0.375 . . . . 0.0 110.976 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.824 ' O ' HG13 ' A' ' 50' ' ' VAL . 12.2 mm -104.18 74.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.641 HG13 ' HB3' ' A' ' 51' ' ' LEU . 19.6 t -67.79 118.75 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 100' ' ' LEU . 17.1 mt -125.83 157.97 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.479 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.455 HG22 HG23 ' A' ' 53' ' ' VAL . 25.1 p -156.55 28.22 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.117 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.45 ' H ' HG22 ' A' ' 79' ' ' ILE . . . 54.58 -125.02 33.44 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.652 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.3 136.5 42.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.827 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.74 147.85 8.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m 59.89 85.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.15 -31.29 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.32 -23.64 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.092 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -35.38 76.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -55.32 -59.16 5.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' HG12 ' A' ' 92' ' ' ILE . 26.3 m -62.38 -34.74 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.996 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.618 ' HD3' HG21 ' A' ' 61' ' ' VAL . 5.7 tttm -72.67 -10.67 60.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.603 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.543 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -106.9 -27.97 10.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.906 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.3 pt -88.17 -35.75 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -61.25 -31.33 71.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.844 ' HB2' HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -60.32 -65.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.744 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 25.69 0.08 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.044 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.38 -167.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.834 0.317 . . . . 0.0 110.897 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.661 ' HB3' HD13 ' A' ' 77' ' ' ILE . 62.0 t80 -108.98 -17.56 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.31 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 13.1 pt-20 152.01 -173.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.244 0.617 . . . . 0.0 110.375 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -122.66 90.45 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.616 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.718 ' O ' HG23 ' A' ' 79' ' ' ILE . 9.1 tp -50.46 107.82 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.34 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -95.09 -170.37 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.1 mttt 60.71 80.13 0.27 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.26 -177.1 1.87 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.506 2.138 . . . . 0.0 112.221 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 59.99 31.41 20.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.3 m -160.69 76.38 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.887 HG21 HD23 ' A' ' 17' ' ' LEU . 10.5 p -76.62 -28.61 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.06 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.06 -37.03 19.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 tpt85 -68.17 -40.07 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.768 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 50' ' ' VAL . 2.0 t80 -57.46 -27.09 62.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.992 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.874 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.2 tt -57.71 -48.4 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.137 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.4 mp -52.64 -53.19 50.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.307 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 m -51.89 -58.61 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.387 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 9.0 mm -32.93 -63.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.969 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -59.58 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -51.46 -27.54 10.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.688 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -71.56 -35.34 70.58 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.817 0.341 . . . . 0.0 111.033 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.7 -39.18 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.978 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.37 -36.63 33.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.274 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -74.11 -6.46 47.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.634 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.37 42.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 110.869 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.853 0.358 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 3.6 mptt -121.56 125.17 46.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 124.21 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.71 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.638 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.5 t -122.64 143.75 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.992 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.516 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 20.3 tp -90.12 132.5 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.73 HG21 ' CD1' ' A' ' 17' ' ' LEU . 14.0 t -119.3 89.59 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.66 114.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 31.6 t0 -155.09 152.1 29.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.5 48.73 1.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.85 -167.16 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.677 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -74.03 -46.67 41.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.829 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.33 -78.45 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.069 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.622 HD13 HG21 ' A' ' 30' ' ' THR . 9.4 mm -95.34 163.24 2.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.306 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.501 HG23 ' CG1' ' A' ' 6' ' ' VAL . 81.3 p -90.14 164.9 14.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.218 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 t -71.42 131.9 44.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.961 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.452 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.8 m 77.35 -5.84 2.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.511 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.39 -55.15 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.063 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.458 ' CB ' HG21 ' A' ' 13' ' ' ILE . 1.5 t -47.07 -56.99 5.53 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.373 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.41 -39.2 64.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.05 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.879 HD12 HG23 ' A' ' 106' ' ' VAL . 45.2 mt -64.56 -66.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.304 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.953 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.62 -29.73 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -69.92 -28.82 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.902 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.79 -36.06 23.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.487 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.842 ' HG3' HD21 ' A' ' 110' ' ' LEU . 6.8 mm-40 -81.73 -39.0 24.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.39 31.89 5.97 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.177 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 4.9 m-85 -81.66 -172.79 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 88.76 25.4 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HG3' HD13 ' A' ' 21' ' ' LEU . 74.3 Cg_endo -78.63 129.35 9.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.469 2.113 . . . . 0.0 112.592 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 30' ' ' THR . 18.2 t70 -99.96 2.17 43.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.754 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.703 HG22 ' HB ' ' A' ' 6' ' ' VAL . 3.2 p 1.76 124.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.93 -160.65 0.73 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.349 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 19.0 mttp -113.65 -31.94 6.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -163.12 -175.28 4.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.745 HD22 ' CD2' ' A' ' 63' ' ' PHE . 9.6 mt -63.23 -44.23 95.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.638 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.03 -54.02 51.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.195 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.119 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.488 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.44 -28.62 64.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.772 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 19.0 mt-10 -71.47 -43.18 67.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.23 75.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.009 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -75.59 -35.35 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 37' ' ' ALA . 20.3 mt -76.03 -26.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.787 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -77.77 -5.4 50.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.26 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -101.07 -51.74 3.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.764 0.316 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.918 HD11 ' CE1' ' A' ' 46' ' ' PHE . 3.0 pp -117.69 -179.61 3.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.077 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.6 ' N ' HD12 ' A' ' 44' ' ' LEU . 1.7 t80 -107.14 111.02 23.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.918 ' CE1' HD11 ' A' ' 44' ' ' LEU . 64.0 m-85 -98.08 113.01 63.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.406 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HG2' ' CE2' ' A' ' 117' ' ' PHE . 63.6 Cg_endo -73.15 -19.38 22.78 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.659 2.239 . . . . 0.0 111.929 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.5 t -148.63 134.23 11.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.422 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.408 HD12 HD23 ' A' ' 5' ' ' LEU . 23.4 mm -116.89 157.15 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.425 HG21 ' CE1' ' A' ' 109' ' ' PHE . 43.1 t -151.42 101.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.183 0.516 . . . . 0.0 112.073 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.455 ' HB3' HG13 ' A' ' 78' ' ' VAL . 14.1 tp -75.03 168.63 19.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.797 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -127.37 -47.27 1.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.674 0.273 . . . . 0.0 111.404 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 53' ' ' VAL . 23.2 t 68.54 37.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.965 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -63.92 -82.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.53 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.704 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.2 ttm -152.1 47.69 0.42 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.358 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.704 ' HD3' ' N ' ' A' ' 55' ' ' MET . 29.3 Cg_endo -95.05 -161.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.06 2.507 . . . . 0.0 112.162 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.32 29.68 7.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.65 -97.79 2.08 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.601 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 55.36 54.21 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.418 . . . . 0.0 110.535 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' H ' HD11 ' A' ' 34' ' ' LEU . . . -100.1 106.66 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.746 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.691 HG21 ' HD2' ' A' ' 90' ' ' LYS . 97.0 t -63.69 -32.47 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.825 0.345 . . . . 0.0 111.012 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -3.77 48.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.754 ' CE2' HD11 ' A' ' 67' ' ' ILE . 23.6 t80 -60.77 -31.38 70.73 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.578 0.228 . . . . 0.0 110.987 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -46.74 -38.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.59 -53.29 56.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 20.1 t80 -51.11 -30.75 17.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 110.217 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.838 HG21 HG22 ' A' ' 76' ' ' VAL . 3.8 mm -64.87 -53.34 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -74.21 -19.05 60.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.851 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.17 -44.62 83.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.867 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.56 10.19 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.436 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.69 66.62 2.79 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.777 0.322 . . . . 0.0 110.832 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.54 -19.62 32.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.84 2.36 . . . . 0.0 112.305 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -107.33 34.66 3.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 48.5 t -116.35 -158.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' A' ' 48' ' ' VAL . 39.2 t -150.57 135.58 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-O 120.917 0.389 . . . . 0.0 111.449 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.838 HG22 HG21 ' A' ' 67' ' ' ILE . 1.7 t -112.53 106.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.414 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' A' ' 97' ' ' TYR . 36.5 mm -89.0 -49.38 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.72 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.821 HG23 HG12 ' A' ' 76' ' ' VAL . 59.3 t 52.69 81.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.363 . . . . 0.0 111.104 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 77' ' ' ILE . 2.4 mt -105.39 155.11 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.1 p -149.95 122.88 8.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.353 . . . . 0.0 111.006 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.6 95.17 2.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.604 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -165.78 -44.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.26 55.25 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.536 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 p -131.47 124.91 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 0.0 110.921 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.09 -30.44 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.221 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.86 -26.47 65.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.5 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.5 t -75.55 -33.26 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -59.94 -59.28 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.99 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 92' ' ' ILE . 18.0 m -58.78 -21.48 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.018 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.691 ' HD2' HG21 ' A' ' 61' ' ' VAL . 22.3 ttpt -83.85 -9.65 58.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.591 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.32 -33.93 4.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.873 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 12.2 pt -73.05 -38.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.673 0.273 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -25.29 64.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.636 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.6 -57.54 3.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.11 33.45 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.19 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.873 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.11 -164.29 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 110.727 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.582 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.1 t80 -108.53 25.32 11.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.245 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.443 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 82.49 17.98 0.33 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.013 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.586 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 57.56 166.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.25 179.371 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -119.56 122.17 41.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -170.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.786 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.0 80.41 0.24 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.784 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.36 -2.95 12.49 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.723 2.282 . . . . 0.0 113.004 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.75 -57.11 4.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.097 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -143.5 168.26 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.053 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.879 HG23 HD12 ' A' ' 20' ' ' ILE . 34.3 m -91.31 3.63 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.562 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -41.46 -44.7 2.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.815 0.341 . . . . 0.0 111.225 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -36.07 74.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.138 0.494 . . . . 0.0 109.816 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.639 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 1.4 t80 -56.17 -23.97 38.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.842 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -62.23 -49.2 76.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.663 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.0 mp -57.09 -57.68 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.49 HG23 ' HE2' ' A' ' 97' ' ' TYR . 97.4 m -54.47 -43.68 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -41.8 -54.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.011 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 0.0 109.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -55.87 -24.89 39.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -67.55 -37.68 83.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.049 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.572 ' CE1' HG21 ' A' ' 48' ' ' VAL . 27.4 m-85 -75.57 -17.49 60.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.956 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -109.86 -27.78 9.1 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -75.73 -4.68 41.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.706 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.447 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -131.9 38.24 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.021 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.771 0.319 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.457 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 6.0 mptt 61.08 99.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 126.25 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.726 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.652 HG13 ' HB ' ' A' ' 48' ' ' VAL . 23.8 t -122.47 152.53 26.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 110.867 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.641 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 47.0 tp -103.48 135.33 45.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.856 ' HB ' HG22 ' A' ' 30' ' ' THR . 15.1 t -120.74 89.01 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.69 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.509 ' HB ' HD12 ' A' ' 51' ' ' LEU . 21.2 t -78.88 115.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.716 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 22.5 t70 -155.27 163.24 40.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.313 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -83.8 48.75 1.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.987 0.422 . . . . 0.0 111.08 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -117.16 167.71 10.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.674 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.48 -81.52 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.054 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 13' ' ' ILE . 10.4 m -107.11 113.76 27.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.723 ' HA ' HG21 ' A' ' 30' ' ' THR . 14.0 mm 49.62 163.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.508 0.671 . . . . 0.0 112.312 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.621 HG21 ' CG1' ' A' ' 6' ' ' VAL . 60.7 p -90.91 165.53 13.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.302 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.5 t -83.77 134.96 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 111.679 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m 81.35 -10.38 1.19 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.306 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.938 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.15 -50.67 5.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 110.613 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.06 -54.95 7.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.86 66.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.777 HD11 HG13 ' A' ' 106' ' ' VAL . 70.8 mt -69.22 -69.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.309 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -45.72 -32.7 2.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.486 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -27.83 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.013 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -82.94 -35.56 25.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.441 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.916 ' HG3' HD21 ' A' ' 110' ' ' LEU . 2.9 mm-40 -81.31 -31.87 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.988 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.2 29.83 6.58 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.189 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CE1' ' CG ' ' A' ' 2' ' ' LYS . 46.1 m-85 -86.31 -173.97 4.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.049 0.452 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -138.25 89.36 14.3 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.037 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HB3' HD13 ' A' ' 21' ' ' LEU . 73.3 Cg_endo -77.95 132.38 11.7 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.54 2.16 . . . . 0.0 112.594 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -104.5 -4.31 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.193 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.856 HG22 ' HB ' ' A' ' 6' ' ' VAL . 43.0 p 12.95 121.75 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.38 156.35 21.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.364 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.688 ' O ' HG23 ' A' ' 33' ' ' THR . 2.2 mtmp? -80.68 -28.36 36.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -167.93 178.76 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.615 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 63' ' ' PHE . 16.6 mt -57.5 -33.12 67.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -56.32 18.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.22 -29.43 70.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.33 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -72.9 -29.02 62.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 26.5 mt-10 -71.19 -41.23 70.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 109.903 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -33.9 76.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -77.83 -35.91 50.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.854 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 37' ' ' ALA . 19.9 mt -78.47 -25.17 13.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.812 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -90.26 28.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.257 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -146.17 -46.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.531 HD22 ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -113.55 155.52 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.451 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 9.1 t80 -85.5 90.42 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.332 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.641 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 9.5 m-85 -76.66 113.82 33.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.55 -23.8 9.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.472 2.115 . . . . 0.0 112.146 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.652 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.6 t -146.58 133.41 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.625 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.582 HG23 HD23 ' A' ' 5' ' ' LEU . 23.8 mm -115.96 150.01 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.098 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.633 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 77.9 t -142.78 100.06 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.398 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.589 HD23 HG13 ' A' ' 78' ' ' VAL . 8.9 tp -86.09 149.1 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 t0 -140.2 107.15 5.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 53' ' ' VAL . 20.3 m -75.31 61.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.673 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -69.58 -79.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.801 0.334 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.697 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 6.1 ttt -153.72 49.96 0.53 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.983 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.697 ' HD3' ' N ' ' A' ' 55' ' ' MET . 19.5 Cg_endo -93.47 -159.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.143 2.562 . . . . 0.0 112.119 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -142.61 38.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.22 -82.24 1.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.34 68.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.824 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.42 93.29 0.66 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.641 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.625 HG21 ' HD3' ' A' ' 90' ' ' LYS . 81.6 t -58.96 -33.84 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.927 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.19 -0.85 42.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.682 ' CD2' HD22 ' A' ' 34' ' ' LEU . 12.6 t80 -60.15 -38.13 82.2 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.8 mp -46.44 -42.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -43.03 95.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.134 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HD1' HD13 ' A' ' 67' ' ' ILE . 12.1 t80 -57.84 -33.66 68.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.762 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mm -65.12 -53.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.266 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -72.69 -16.71 61.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.727 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.27 -44.29 72.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.53 13.07 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.326 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.42 66.57 1.86 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.37 -18.75 29.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.754 2.302 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -106.57 31.35 5.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.666 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.9 t -111.41 -158.3 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.545 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 48' ' ' VAL . 46.7 t -149.64 136.24 12.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.777 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 67' ' ' ILE . 16.4 t -114.13 115.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.674 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mm -100.95 -47.47 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.75 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG23 HG12 ' A' ' 76' ' ' VAL . 59.9 t 49.74 86.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.314 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.639 HG23 ' HB3' ' A' ' 100' ' ' LEU . 8.9 mt -94.22 162.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.915 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.497 ' HB ' HG22 ' A' ' 53' ' ' VAL . 48.4 p -156.52 156.49 33.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.09 -169.3 11.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.474 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.04 -77.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.777 0.322 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -159.15 108.09 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.519 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -170.43 119.17 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 0.0 110.929 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.44 -52.09 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.074 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.79 -12.62 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.429 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.8 t -78.78 -35.45 44.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.069 0.461 . . . . 0.0 109.864 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.8 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.54 -58.55 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.091 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.32 -25.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.769 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.625 ' HD3' HG21 ' A' ' 61' ' ' VAL . 1.5 ttmp? -90.06 39.01 0.95 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.556 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.26 -39.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.99 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.9 pt -74.88 -42.46 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -21.46 63.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.781 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -73.95 -27.65 61.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.17 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.29 -18.29 0.38 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.378 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.99 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.9 176.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.152 0.476 . . . . 0.0 111.464 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 74.4 t80 -97.6 26.14 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.456 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.479 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.6 OUTLIER 77.44 146.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.652 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.9 OUTLIER -65.83 138.87 58.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.908 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 101' ' ' GLU . 1.5 tm? -68.93 137.94 54.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.502 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.881 ' N ' HD13 ' A' ' 100' ' ' LEU . 1.8 mp0 -49.89 123.71 8.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.244 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.3 mptp? -57.02 -55.04 48.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.337 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 19.8 Cg_endo -58.71 -178.07 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.359 2.039 . . . . 0.0 112.111 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 62.22 147.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.724 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 t -73.5 171.29 13.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.777 HG13 HD11 ' A' ' 20' ' ' ILE . 9.5 p -55.42 -32.08 28.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.081 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.2 -36.18 3.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.95 0.405 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HA ' HD13 ' A' ' 111' ' ' LEU . 2.1 tpm_? -67.29 -41.03 86.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.776 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.633 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 24.4 t80 -57.54 -27.27 62.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.153 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.916 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -60.07 -47.81 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.243 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.5 mp -51.79 -52.6 47.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.187 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.8 m -57.41 -45.92 84.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.14 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.9 mm -45.47 -56.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.587 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.29 -62.57 1.42 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -49.56 -27.34 4.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.926 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -67.73 -29.55 68.81 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.914 0.388 . . . . 0.0 110.782 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 61.6 m-85 -89.67 -26.45 20.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.818 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.36 -41.35 7.87 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -91.41 27.16 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.685 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.633 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -161.85 38.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 0.0 110.872 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.831 0.348 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HD2' ' CD2' ' A' ' 117' ' ' PHE . 5.1 mmtm -138.22 140.0 39.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.566 ' HB3' ' CB ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -175.43 93.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 48' ' ' VAL . 18.3 t -77.41 160.49 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 29' ' ' ASP . 60.7 tp -117.07 135.09 53.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.31 90.66 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.732 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.596 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 16.6 t -88.91 121.44 39.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.342 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -157.37 141.16 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.859 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.51 48.8 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 7.8 tp10 -176.72 163.89 2.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.801 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.48 43.51 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.94 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.65 -86.21 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.425 HG22 ' HB3' ' A' ' 17' ' ' LEU . 48.8 mm -54.53 -40.45 49.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.749 0.309 . . . . 0.0 111.357 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.0 p -44.58 -46.58 10.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.456 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -26.32 65.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 t -93.27 -68.31 0.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -46.17 -56.89 5.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.487 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.81 ' HA ' HD12 ' A' ' 21' ' ' LEU . 21.3 t -41.25 -51.52 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.271 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -38.54 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.095 0.474 . . . . 0.0 110.622 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.857 HD13 HG11 ' A' ' 106' ' ' VAL . 6.1 mt -69.06 -70.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.322 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.936 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.49 -23.72 2.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.508 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.867 ' N ' HD13 ' A' ' 21' ' ' LEU . 31.5 mt-10 -78.48 -29.92 47.04 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 -37.92 58.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 109.923 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.726 ' HG3' HD21 ' A' ' 110' ' ' LEU . 19.2 mm-40 -59.34 -18.89 42.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.207 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.4 73.45 1.14 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.767 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 29.5 m-85 -147.01 -178.86 6.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 111.649 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.566 ' CB ' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -121.42 81.95 39.05 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.837 ' CG ' HD11 ' A' ' 21' ' ' LEU . 37.4 Cg_endo -89.86 137.9 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.699 2.266 . . . . 0.0 114.041 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.899 ' O ' HD12 ' A' ' 5' ' ' LEU . 13.1 t70 -126.15 125.07 41.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.6 p -97.2 135.96 38.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 111.643 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -108.44 178.5 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 mttt -122.75 -8.79 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.92 -171.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.773 HD22 ' CD2' ' A' ' 63' ' ' PHE . 75.5 mt -79.36 -32.34 43.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 0.0 110.154 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -70.9 -44.38 66.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.795 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.12 -33.81 76.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.58 -49.23 33.78 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -46.93 -45.94 21.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.365 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -54.89 41.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -57.66 -27.87 63.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.692 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 41' ' ' ILE . 42.9 mt -92.82 -8.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.55 8.22 29.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.73 0.3 . . . . 0.0 111.147 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -148.9 -48.14 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.58 116.09 21.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -69.22 71.29 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.731 ' CE2' HD13 ' A' ' 5' ' ' LEU . 13.1 m-85 -69.68 116.16 40.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.1 Cg_exo -74.56 -35.7 3.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.183 1.922 . . . . 0.0 111.44 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.913 HG23 ' CE1' ' A' ' 117' ' ' PHE . 16.5 t -124.8 126.59 71.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.784 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.574 HG23 HD23 ' A' ' 5' ' ' LEU . 15.5 mm -113.61 130.1 68.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.605 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.746 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 61.0 t -123.81 107.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.103 0.477 . . . . 0.0 111.168 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.543 ' HB3' HG22 ' A' ' 78' ' ' VAL . 13.0 tp -93.87 147.08 23.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 1.1 t70 -126.02 97.37 5.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 80' ' ' THR . 23.4 t -67.05 72.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.354 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.452 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 59.4 t-105 -80.04 -91.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 ttp -140.73 46.0 0.86 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.102 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 55' ' ' MET . 86.2 Cg_endo -77.65 -167.02 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.547 2.164 . . . . 0.0 112.4 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.8 -44.09 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.72 163.76 51.67 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.582 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.39 120.47 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.17 -20.96 80.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.57 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.498 HG21 ' HD3' ' A' ' 90' ' ' LYS . 91.4 t -57.36 -38.13 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.32 -22.09 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.773 ' CD2' HD22 ' A' ' 34' ' ' LEU . 14.9 t80 -65.01 -40.66 95.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.811 0.339 . . . . 0.0 111.057 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.451 HG23 HG11 ' A' ' 76' ' ' VAL . 3.2 mt -46.32 -28.68 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -70.48 -51.7 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -48.82 -40.67 30.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.826 0.346 . . . . 0.0 110.559 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.831 HG21 HG22 ' A' ' 76' ' ' VAL . 3.5 mp -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.412 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -76.45 -19.58 57.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.789 0.328 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.8 -50.87 54.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.712 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -112.08 14.7 20.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.372 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.2 66.86 2.65 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.9 -19.1 35.89 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.21 . . . . 0.0 112.113 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.8 28.11 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.805 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.9 t -117.31 -175.77 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.775 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.527 HG21 ' HB1' ' A' ' 116' ' ' ALA . 45.6 t -127.17 139.95 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.371 0.605 . . . . 0.0 111.783 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.831 HG22 HG21 ' A' ' 67' ' ' ILE . 1.7 t -122.96 88.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 97' ' ' TYR . 44.8 mm -73.8 -69.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.369 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 51' ' ' LEU . 38.2 t 63.15 118.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.302 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.531 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.6 mt -121.0 -142.36 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER 64.31 101.44 0.04 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.839 0.352 . . . . 0.0 110.815 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.52 39.14 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.389 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.57 88.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.72 -29.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -161.06 139.08 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.621 HG13 ' OE2' ' A' ' 101' ' ' GLU . 16.3 t -97.7 33.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.048 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -90.08 -24.44 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.5 t -77.48 -35.28 53.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.188 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.505 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.69 -57.52 12.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.94 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.1 m -55.72 -30.37 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.844 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.498 ' HD3' HG21 ' A' ' 61' ' ' VAL . 30.4 tttt -76.84 -13.28 60.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.088 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.45 -41.77 5.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.658 0.266 . . . . 0.0 111.433 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.846 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.3 pt -70.47 -31.36 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 111.028 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -24.32 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.18 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -84.93 -54.89 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.661 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.87 28.98 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.641 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.25 177.62 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.24 0.52 . . . . 0.0 110.565 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.695 ' HE2' HG23 ' A' ' 112' ' ' THR . 39.8 t80 -88.24 -23.34 23.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.526 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.498 ' HA ' HG21 ' A' ' 92' ' ' ILE . 2.6 pt-20 152.56 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.292 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 78' ' ' VAL . 1.5 t80 80.61 111.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.644 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.662 HD21 ' HA ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -51.95 96.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.207 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.621 ' OE2' HG13 ' A' ' 85' ' ' VAL . 4.9 mm-40 -95.09 161.73 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.402 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 8.3 ttmt 60.07 53.19 3.63 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 68.8 Cg_endo -74.15 105.48 2.04 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.633 2.222 . . . . 0.0 112.322 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -85.17 -31.33 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.6 t -176.96 -57.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.991 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.857 HG11 HD13 ' A' ' 20' ' ' ILE . 12.5 p 179.11 -26.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.617 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -52.11 -51.11 59.86 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 110.902 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -38.69 74.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.746 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 28.0 t80 -60.58 -29.77 69.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.379 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.726 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -70.12 -46.21 65.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.038 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mp -50.23 -42.78 52.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.695 HG23 ' HE2' ' A' ' 97' ' ' TYR . 75.1 m -69.37 -46.7 66.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.891 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.526 HD13 HG11 ' A' ' 48' ' ' VAL . 6.8 mm -45.52 -59.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.727 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -55.64 7.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.78 -29.2 69.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.74 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.96 -37.65 85.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 0.0 110.853 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.913 ' CE1' HG23 ' A' ' 48' ' ' VAL . 6.4 m-85 -73.02 -17.1 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -57.3 -21.47 35.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.372 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -95.47 35.18 1.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.839 0.352 . . . . 0.0 111.078 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 13.6 t80 -135.85 26.98 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.797 0.332 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER 61.13 99.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.426 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.45 85.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.857 HG21 HD12 ' A' ' 113' ' ' ILE . 21.9 t -81.79 146.43 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.842 HD13 ' CE2' ' A' ' 46' ' ' PHE . 37.3 tp -106.96 139.77 40.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 0.0 111.218 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.752 ' HB ' HG22 ' A' ' 30' ' ' THR . 21.7 t -117.3 145.9 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.44 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.449 ' HB ' HD12 ' A' ' 51' ' ' LEU . 15.5 t -132.94 120.96 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.284 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 9.9 t0 -156.68 148.69 22.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -83.79 49.32 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.449 . . . . 0.0 111.19 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.78 -167.39 1.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.662 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -112.7 132.31 55.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' ILE . 16.8 p 58.01 164.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.718 ' HA ' HG21 ' A' ' 30' ' ' THR . 6.4 mm -31.32 158.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.483 ' N ' HG22 ' A' ' 13' ' ' ILE . 20.3 p -86.31 124.31 32.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.295 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.7 m -41.01 133.82 2.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.477 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.531 ' O ' HD12 ' A' ' 20' ' ' ILE . 6.5 t 79.72 -9.05 1.49 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.486 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.979 HD23 HG21 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -90.15 -53.88 4.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.33 . . . . 0.0 111.103 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.493 ' HB2' HG21 ' A' ' 13' ' ' ILE . 1.4 t -51.52 -52.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.92 79.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.011 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.724 HG23 ' CD1' ' A' ' 110' ' ' LEU . 38.4 mt -60.54 -66.52 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.034 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.4 mt -50.98 -34.1 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -68.72 -26.75 65.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.74 -35.1 30.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.068 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.865 ' HG3' HD21 ' A' ' 110' ' ' LEU . 31.4 mm-40 -81.23 -27.97 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.057 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.12 1.21 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.233 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.455 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 6.2 m-85 -120.9 -176.18 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.307 0.575 . . . . 0.0 111.357 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.62 79.54 67.51 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.554 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.797 ' HB3' HD13 ' A' ' 21' ' ' LEU . 84.7 Cg_endo -84.34 146.86 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.864 2.376 . . . . 0.0 114.348 -177.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' O ' HD12 ' A' ' 5' ' ' LEU . 20.8 t70 -139.24 135.27 33.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.545 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.752 HG22 ' HB ' ' A' ' 6' ' ' VAL . 17.7 p -122.53 133.75 54.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 111.883 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.33 -163.14 0.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 11.0 mttm -112.76 -31.21 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -162.76 -175.04 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.678 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.4 mt -64.31 -41.16 96.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -61.42 -46.04 91.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 109.94 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.57 -38.58 89.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.3 -56.06 19.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.435 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 41.0 mt-10 -47.27 -41.4 18.75 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.756 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -59.73 -43.06 94.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.922 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -73.25 -44.03 60.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.84 -18.56 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.472 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.2 -23.6 15.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -127.17 -52.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.99 121.61 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.28 58.34 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.842 ' CE2' HD13 ' A' ' 5' ' ' LEU . 16.0 m-85 -57.73 123.35 62.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' SER . 58.5 Cg_endo -71.97 -32.56 10.99 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.548 2.165 . . . . 0.0 112.21 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.639 ' HB ' HG13 ' A' ' 4' ' ' VAL . 8.0 t -128.32 139.55 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.257 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.822 HG23 HD23 ' A' ' 5' ' ' LEU . 1.2 mm -139.77 108.34 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.299 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG22 ' CG1' ' A' ' 77' ' ' ILE . 50.9 t -105.54 133.69 49.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.769 0.318 . . . . 0.0 110.305 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.568 HD23 HG13 ' A' ' 78' ' ' VAL . 30.7 tp -101.96 136.44 41.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.88 81.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.015 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.745 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.4 p -60.58 80.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.3 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 13.6 t-105 -84.82 -78.04 0.26 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.355 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.678 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.65 50.34 0.97 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.391 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.678 ' HD3' ' N ' ' A' ' 55' ' ' MET . 15.3 Cg_endo -92.78 -159.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.163 2.575 . . . . 0.0 112.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -153.6 62.84 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.93 0.395 . . . . 0.0 111.004 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.39 162.78 29.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.541 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.542 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -85.07 116.54 23.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 110.864 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.49 -26.58 24.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.629 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.636 HG21 ' HD3' ' A' ' 90' ' ' LYS . 50.4 t -63.35 -41.21 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 111.2 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.74 -26.88 57.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 67' ' ' ILE . 16.0 t80 -61.05 -36.01 78.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.08 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.423 ' CG2' ' HA3' ' A' ' 95' ' ' GLY . 2.1 mp -45.81 -29.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.373 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -78.77 -38.67 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 38' ' ' GLU . 16.3 t80 -56.84 -41.64 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.753 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.9 mp -58.99 -46.3 91.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.382 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -75.34 -25.01 57.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -63.74 -43.68 95.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.86 16.93 13.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.04 69.44 0.98 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.81 -19.27 41.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.726 2.284 . . . . 0.0 112.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -104.99 28.24 7.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.6 t -111.72 179.99 3.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.462 ' HB ' HG13 ' A' ' 48' ' ' VAL . 61.8 t -127.15 146.11 33.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 0.0 111.206 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.678 HG22 HG21 ' A' ' 67' ' ' ILE . 3.7 t -125.43 119.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.335 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.759 ' CG1' HG22 ' A' ' 50' ' ' VAL . 42.3 mm -97.33 -63.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.592 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 76' ' ' VAL . 6.0 t 63.13 115.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 53' ' ' VAL . 1.4 mt -129.31 -145.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.879 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.745 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 51.32 179.87 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.008 0.433 . . . . 0.0 111.368 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.32 176.38 28.36 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.264 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.93 43.91 3.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.361 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.34 156.33 32.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.532 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.3 t 59.93 99.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.833 0.349 . . . . 0.0 111.007 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG12 ' HB3' ' A' ' 88' ' ' ALA . 22.2 t -70.39 65.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 89' ' ' VAL . 39.1 t70 -100.03 -47.86 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.0 t -55.6 -31.55 62.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.966 0.413 . . . . 0.0 110.353 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.73 -60.0 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.123 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 86' ' ' ASP . 32.8 m -58.11 -24.73 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.914 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.636 ' HD3' HG21 ' A' ' 61' ' ' VAL . 8.1 ttmt -83.03 -10.92 58.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.27 -37.52 5.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.683 0.278 . . . . 0.0 111.6 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.886 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 14.1 pt -71.99 159.66 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.167 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HG2' HG13 ' A' ' 92' ' ' ILE . 7.7 mmmt 80.52 -47.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.579 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.4 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' A' ' 64' ' ' ILE . . . -175.52 -33.19 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.464 -0.875 . . . . 0.0 113.237 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.886 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -62.8 176.22 0.72 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.194 0.497 . . . . 0.0 110.671 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.562 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -100.67 -8.35 22.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 140.23 -11.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.411 0.684 . . . . 0.0 111.438 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER 77.71 120.27 0.05 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.88 0.372 . . . . 0.0 110.924 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.499 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -72.93 157.95 36.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.551 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -117.28 153.86 32.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt 65.1 80.49 0.23 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 61.1 Cg_endo -72.62 60.08 3.43 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.634 2.223 . . . . 0.0 112.428 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -150.28 121.63 7.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.517 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.87 ' O ' HG22 ' A' ' 106' ' ' VAL . 1.7 p 81.4 -47.44 0.23 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.979 HG21 HD23 ' A' ' 17' ' ' LEU . 1.0 OUTLIER 76.71 1.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.877 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -44.19 -42.1 6.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.952 0.406 . . . . 0.0 110.706 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -68.2 -37.51 80.98 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.889 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 5.0 t80 -58.52 -22.86 56.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.261 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.865 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.1 tt -63.8 -51.15 66.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.319 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mp -53.78 -54.49 37.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.018 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.507 HG23 ' CZ ' ' A' ' 97' ' ' TYR . 86.3 m -51.39 -56.78 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.091 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.889 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 9.9 mm -30.06 -63.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.695 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.67 -59.29 3.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.64 -24.86 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.828 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -70.87 -45.38 64.52 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 0.0 111.379 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.585 ' CE1' HG21 ' A' ' 48' ' ' VAL . 55.1 m-85 -66.53 -13.26 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.32 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.24 -17.38 27.73 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.441 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -92.08 36.43 0.98 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.787 0.327 . . . . 0.0 111.269 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.94 22.93 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.954 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.883 179.986 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.783 0.325 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 4.3 mmmm -99.06 95.25 7.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.141 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -143.59 127.11 16.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.777 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 48' ' ' VAL . 42.7 t -115.59 154.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.61 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 37.0 tp -115.01 132.78 56.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.706 HG21 HD12 ' A' ' 17' ' ' LEU . 25.0 t -116.62 89.55 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.338 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' A' ' 37' ' ' ALA . 14.0 t -84.7 96.92 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.3 132.14 53.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.56 -65.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.45 115.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.474 ' CD ' HD13 ' A' ' 13' ' ' ILE . 1.3 pt-20 -162.35 -89.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -178.8 23.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 13' ' ' ILE . 1.4 mp -84.38 -36.5 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.783 0.325 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p -59.84 -33.24 71.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.976 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 t -90.28 29.41 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.565 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.3 p -157.97 -61.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.683 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.706 HD12 HG21 ' A' ' 6' ' ' VAL . 1.5 tm? -56.58 -49.73 74.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.594 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 p -54.75 -46.2 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.383 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.62 85.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.576 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.698 HG23 HD11 ' A' ' 110' ' ' LEU . 24.1 mt -57.28 -64.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.843 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 17' ' ' LEU . 1.4 mt -49.27 -32.58 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -27.43 68.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -79.01 -37.39 39.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.985 0.421 . . . . 0.0 110.013 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' HG3' HD22 ' A' ' 110' ' ' LEU . 1.1 tm-20 -70.09 -51.06 34.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 58.91 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.522 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -135.88 -173.89 3.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -136.47 75.04 52.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.066 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 50.5 Cg_exo -54.8 151.4 32.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.684 2.256 . . . . 0.0 112.638 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -132.66 6.25 4.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.662 HG22 ' HB ' ' A' ' 6' ' ' VAL . 3.5 p 0.7 126.52 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 166.14 21.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.222 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.628 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 mtpt -79.41 -163.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.38 168.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.136 0.493 . . . . 0.0 111.82 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.661 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.3 mt -36.41 -35.53 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.261 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -54.34 -63.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.056 0.455 . . . . 0.0 110.146 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 2.0 mp0 -65.18 -33.8 76.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.704 ' HB2' HG13 ' A' ' 7' ' ' VAL . . . -63.22 -65.5 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -43.13 -42.25 4.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.525 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -61.06 -51.0 71.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.63 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -34.78 79.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.191 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 41' ' ' ILE . 31.4 mt -86.07 -6.15 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.844 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.64 31.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.79 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -150.26 -52.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -103.36 154.96 18.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.926 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.441 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 42.5 t80 -93.65 87.19 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.644 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.61 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 28.6 m-85 -70.15 125.2 91.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 83.2 Cg_endo -77.37 -26.2 7.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.585 2.19 . . . . 0.0 112.062 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 113' ' ' ILE . 3.0 t -139.28 130.94 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 46' ' ' PHE . 8.4 mm -120.31 153.02 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.617 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' VAL . 49.1 t -143.23 107.09 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.451 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HB3' HG22 ' A' ' 78' ' ' VAL . 43.6 tp -96.9 85.89 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.257 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.487 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.6 OUTLIER -68.02 72.52 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.527 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.3 p -53.16 85.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.716 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.453 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 21.8 t-105 -71.94 -80.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.605 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.9 54.99 0.61 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 55' ' ' MET . 5.6 Cg_endo -87.55 -155.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.172 2.581 . . . . 0.0 112.141 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -159.81 49.69 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.14 11.68 9.87 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.86 78.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.06 -20.9 63.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.888 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 90' ' ' LYS . 23.8 t -50.95 -44.82 27.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.423 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.14 -25.03 59.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.745 ' CE2' HD11 ' A' ' 67' ' ' ILE . 14.0 t80 -60.97 -39.63 90.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 91' ' ' ALA . 2.6 mp -47.02 -28.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.7 t0 -75.63 -41.46 54.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.815 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.76 -42.07 83.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.745 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.7 mp -63.92 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -81.89 -12.02 58.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.7 -40.69 47.94 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.004 0.431 . . . . 0.0 110.593 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 9.76 12.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.983 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.409 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.07 66.23 3.38 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.866 0.365 . . . . 0.0 110.787 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.4 Cg_exo -76.03 -14.32 19.03 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 112.22 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -109.53 29.55 7.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.813 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -106.96 -155.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.62 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.669 HG21 ' HB1' ' A' ' 116' ' ' ALA . 36.8 t -147.2 137.96 17.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 121.039 0.447 . . . . 0.0 112.018 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.779 HG12 HG23 ' A' ' 78' ' ' VAL . 1.2 t -123.39 112.08 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.448 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.616 HG21 ' CE1' ' A' ' 109' ' ' PHE . 32.2 mm -113.63 44.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.506 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.779 HG23 HG12 ' A' ' 76' ' ' VAL . 49.0 t -45.43 116.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.261 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.643 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.6 mt -106.43 -148.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.194 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.7 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER 56.46 173.67 0.04 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.74 76.81 1.07 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.476 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -98.27 28.8 3.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.74 -38.81 2.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.421 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 80.2 p -178.72 173.56 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.839 0.352 . . . . 0.0 110.797 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m -97.82 31.65 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.0 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.55 -17.31 15.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -36.16 30.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.27 -59.36 5.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.968 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.608 ' HA ' HG12 ' A' ' 92' ' ' ILE . 12.4 m -58.99 -30.77 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.949 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.479 ' O ' HG13 ' A' ' 61' ' ' VAL . 13.6 ttmt -75.04 -8.5 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.347 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.485 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -118.27 -35.54 3.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.475 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 88' ' ' ALA . 8.7 pt -80.02 158.07 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.192 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' CG ' HG13 ' A' ' 92' ' ' ILE . 9.2 mmtt 80.77 -45.83 0.25 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -22.97 64.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.97 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.03 -29.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.187 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -79.77 175.82 10.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.082 0.441 . . . . 0.0 111.009 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.524 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 56.0 t80 -100.69 -12.06 19.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.323 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 147.54 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.158 0.583 . . . . 0.0 110.368 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.56 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -118.97 131.09 56.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.534 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -93.88 44.81 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.822 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.33 -17.58 17.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.265 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.06 -58.8 8.43 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.69 -168.52 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.525 2.15 . . . . 0.0 112.299 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -137.2 31.2 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.825 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.7 m -144.33 -171.91 3.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' CD1' ' A' ' 20' ' ' ILE . 10.4 p -118.0 -8.65 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.524 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -47.52 76.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.861 0.362 . . . . 0.0 110.367 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.29 -33.61 69.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.071 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.616 ' CE1' HG21 ' A' ' 77' ' ' ILE . 10.1 t80 -64.44 -37.8 88.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.183 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.698 HD11 HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -55.33 -48.21 74.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -44.71 83.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.1 m -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.75 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.7 mm -57.22 -53.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -59.46 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -55.75 -30.79 61.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.738 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.61 -38.77 88.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.505 ' CE2' HG21 ' A' ' 48' ' ' VAL . 31.0 m-85 -75.23 -28.75 60.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.906 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.13 -28.77 62.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -97.41 30.08 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 47' ' ' PRO . 64.2 t80 -107.63 27.95 8.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.77 0.319 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmmp? -112.01 92.87 4.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -136.06 142.22 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.629 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.5 t -125.96 163.9 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.857 HD22 ' CD2' ' A' ' 46' ' ' PHE . 34.0 tp -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.2 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.959 HG21 ' CD1' ' A' ' 17' ' ' LEU . 27.6 t -115.28 97.33 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.95 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.748 HG22 ' HB3' ' A' ' 31' ' ' ALA . 40.7 t -83.23 119.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.797 0.332 . . . . 0.0 110.985 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -154.35 131.57 11.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.9 46.77 1.39 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.29 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -50.72 2.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 110.99 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.36 -168.21 1.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 t -57.34 -58.43 8.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.817 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.675 HG23 HG21 ' A' ' 30' ' ' THR . 8.4 mm -116.96 163.0 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.652 HG21 ' CG1' ' A' ' 6' ' ' VAL . 76.0 p -90.1 145.55 24.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.79 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -65.43 141.91 58.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.158 0.504 . . . . 0.0 112.259 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.426 ' O ' HD12 ' A' ' 20' ' ' ILE . 28.2 m 65.1 9.39 5.48 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.721 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.057 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -90.49 -53.07 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.483 179.46 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -45.88 -59.67 2.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.23 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.52 53.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.08 0.467 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.769 HG23 ' CD1' ' A' ' 110' ' ' LEU . 75.1 mt -68.29 -70.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.057 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.73 -30.36 3.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.044 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -73.42 -29.67 62.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.845 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -81.08 -34.84 32.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 110.12 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.783 ' CG ' HD21 ' A' ' 110' ' ' LEU . 5.7 mm-40 -81.48 -35.0 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.4 47.75 2.72 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.221 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 2' ' ' LYS . 44.3 m-85 -105.23 -173.26 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.127 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.56 85.68 47.16 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.814 ' HG3' HD13 ' A' ' 21' ' ' LEU . 91.4 Cg_endo -82.45 127.71 5.2 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.689 2.259 . . . . 0.0 111.953 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -105.65 -1.01 25.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.482 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.675 HG21 HG23 ' A' ' 13' ' ' ILE . 58.7 p 24.49 122.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB3' HG22 ' A' ' 7' ' ' VAL . . . -105.82 167.72 9.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.549 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -88.29 -46.06 9.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.821 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.436 HG23 ' HB3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -158.47 -167.03 2.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.606 HD22 ' CD2' ' A' ' 63' ' ' PHE . 58.1 mt -67.44 -46.53 72.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -63.1 -45.47 91.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.044 0.45 . . . . 0.0 109.873 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -32.2 70.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.38 -28.82 63.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.686 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 13.6 mt-10 -70.85 -42.03 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -63.77 -35.33 80.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.009 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -75.68 -42.41 51.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.898 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.77 -27.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.031 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -52.03 -25.98 9.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -120.72 -55.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.19 133.57 50.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -95.28 102.04 13.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.857 ' CD2' HD22 ' A' ' 5' ' ' LEU . 40.7 m-85 -102.74 122.04 47.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 74' ' ' SER . 65.4 Cg_endo -73.68 -19.16 21.63 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.331 2.021 . . . . 0.0 111.788 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.629 ' HB ' HG13 ' A' ' 4' ' ' VAL . 10.8 t -143.7 120.53 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.494 HD11 ' HB2' ' A' ' 46' ' ' PHE . 6.5 mm -107.18 153.75 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.83 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 51' ' ' LEU . 7.4 t -135.49 174.59 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.651 ' H ' HG12 ' A' ' 50' ' ' VAL . 29.2 tp -159.92 117.27 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.548 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.46 89.62 3.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.141 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 53' ' ' VAL . 35.2 m -58.68 82.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.834 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -81.52 -83.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.402 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.504 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 3.2 mtt -148.45 44.78 0.37 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 55' ' ' MET . 85.4 Cg_endo -80.19 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.461 2.107 . . . . 0.0 112.226 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -137.99 49.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 110.97 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.47 139.85 6.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.445 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.44 144.27 37.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.641 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -93.63 -15.94 47.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.892 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 90' ' ' LYS . 26.2 t -53.81 -52.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.014 0.435 . . . . 0.0 111.209 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.7 -6.29 47.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.765 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.829 ' CE2' HD11 ' A' ' 67' ' ' ILE . 22.3 t80 -85.67 -36.52 20.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.645 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.028 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.0 mp -49.52 -31.95 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.681 0.277 . . . . 0.0 111.084 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.3 t70 -79.41 -25.26 42.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.572 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 48.1 t80 -67.85 -42.32 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.829 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.8 mp -60.03 -43.23 92.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.035 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.88 -20.96 52.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 33.7 tt0 -68.72 -34.8 76.25 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.407 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -126.39 14.58 7.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.034 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.49 67.39 1.38 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.889 0.376 . . . . 0.0 110.579 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.02 -20.79 50.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.65 2.233 . . . . 0.0 112.064 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.29 25.5 6.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.055 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 33.5 t -113.37 -166.18 1.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -148.67 131.56 7.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 121.248 0.547 . . . . 0.0 112.428 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 38.9 t -100.89 113.65 37.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.63 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.731 HD12 ' CG2' ' A' ' 112' ' ' THR . 44.8 mm -94.01 -62.35 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.915 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 HD23 ' A' ' 51' ' ' LEU . 99.4 t 59.15 111.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.718 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.8 mt -122.48 178.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.641 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.8 m 73.59 155.25 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.479 ' HA2' HG21 ' A' ' 53' ' ' VAL . . . -163.65 141.83 7.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.396 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -124.75 37.52 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.929 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.21 46.26 0.39 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.422 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.91 -78.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.726 0.298 . . . . 0.0 110.922 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 85' ' ' VAL . 7.2 p -178.95 85.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.131 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.725 ' O ' HG22 ' A' ' 89' ' ' VAL . 23.9 t0 -139.2 -60.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.842 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 t -48.8 -30.74 6.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.261 0.553 . . . . 0.0 110.1 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.847 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.26 -59.72 5.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.156 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 86' ' ' ASP . 30.2 m -61.61 -21.96 26.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.325 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 61' ' ' VAL . 15.7 ttmt -87.32 -14.22 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.673 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.028 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -114.8 -31.82 6.01 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.942 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 8.7 pt -74.63 -21.88 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.692 0.282 . . . . 0.0 111.625 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.65 15.38 16.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.22 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -119.64 -21.2 7.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.555 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.39 -24.2 0.16 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.937 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.942 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -55.13 176.26 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.584 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.458 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 56.4 t80 -108.5 27.37 9.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.9 OUTLIER 85.61 138.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.187 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.619 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -71.38 94.77 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.608 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 109' ' ' PHE . 28.3 tp -54.94 146.69 17.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.653 ' H ' HD12 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -85.06 163.8 18.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -165.15 54.25 0.35 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.773 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.88 1.52 9.06 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.517 2.145 . . . . 0.0 112.897 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.26 -68.08 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.737 0.303 . . . . 0.0 111.084 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.1 t -159.82 -178.24 6.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.411 . . . . 0.0 111.334 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 20' ' ' ILE . 7.4 p -73.93 -16.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.417 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -46.22 -35.45 5.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.496 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -71.65 -35.78 70.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.934 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.913 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 29.3 t80 -58.16 -30.82 66.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.783 HD21 ' CG ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -50.0 -43.33 50.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.318 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 108' ' ' ARG . 3.7 mp -59.3 -60.21 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.121 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.731 ' CG2' HD12 ' A' ' 77' ' ' ILE . 97.8 m -44.12 -39.14 4.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.343 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 29.2 mm -56.23 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -54.16 -21.09 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.739 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -85.66 -24.73 26.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.695 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -80.55 -30.86 37.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -78.29 -20.08 52.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.365 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -105.22 -20.4 13.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.658 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -95.46 34.38 1.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.736 0.303 . . . . 0.0 111.296 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.407 ' CE2' ' O ' ' A' ' 74' ' ' SER . 1.5 t80 -162.17 36.73 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.928 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 -179.998 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 tpp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.82 0.343 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 7.8 mmmt -117.45 112.81 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.494 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 131.18 20.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.718 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 48' ' ' VAL . 27.0 t -121.31 144.15 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.823 HD13 ' CE2' ' A' ' 46' ' ' PHE . 29.9 tp -107.2 137.7 44.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 0.0 111.214 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.873 HG21 HD12 ' A' ' 17' ' ' LEU . 3.8 t -116.3 123.88 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.528 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.558 ' HB ' HD12 ' A' ' 51' ' ' LEU . 44.4 t -114.29 110.38 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.24 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 40.8 t0 -158.76 160.63 36.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.057 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 25.5 t70 -89.16 49.45 1.77 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.05 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -109.01 -176.24 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.771 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -127.97 134.82 49.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.056 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t 58.12 71.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.627 ' HA ' HG21 ' A' ' 30' ' ' THR . 23.5 mm 57.91 166.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.63 HG21 HG11 ' A' ' 6' ' ' VAL . 72.3 p -90.37 114.4 26.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.045 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 16' ' ' SER . 73.5 m -43.0 136.44 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.775 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.4 m 88.16 -36.35 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.161 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.927 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.89 -50.82 63.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 110.93 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.5 -64.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.463 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.27 60.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 111.443 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.611 HG23 HD11 ' A' ' 110' ' ' LEU . 91.5 mt -65.72 -70.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.927 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -46.94 -31.03 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.938 0.399 . . . . 0.0 111.071 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.46 -31.67 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.707 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -83.0 -35.21 26.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.877 ' HG3' HD21 ' A' ' 110' ' ' LEU . 43.9 mm-40 -75.1 -29.98 60.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.046 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.88 1.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.227 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 43.2 m-85 -131.76 -176.3 4.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.243 0.544 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.41 80.74 46.04 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.837 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.662 ' HB3' HD13 ' A' ' 21' ' ' LEU . 88.0 Cg_endo -82.5 141.53 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.838 2.359 . . . . 0.0 113.759 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' O ' HD12 ' A' ' 5' ' ' LEU . 6.5 t0 -138.54 136.18 35.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.868 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.627 HG21 ' HA ' ' A' ' 13' ' ' ILE . 14.7 p -121.62 132.58 54.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.114 0.483 . . . . 0.0 111.745 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.69 -121.57 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.226 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 13.8 mttp -157.63 -41.75 0.07 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.937 0.399 . . . . 0.0 110.59 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 p -152.83 175.66 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.622 HD22 ' CD2' ' A' ' 63' ' ' PHE . 39.8 mt -58.14 -37.34 74.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -44.83 78.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -35.81 82.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.336 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.27 61.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 34.1 mt-10 -49.16 -44.21 42.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.533 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -56.43 -44.6 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.063 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -73.23 -44.39 59.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.979 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.3 mt -70.32 -17.75 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.556 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -21.25 41.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.218 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.99 -63.46 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.12 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -55.35 132.42 48.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 45' ' ' PHE . 60.4 t80 -97.2 59.56 1.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.77 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.823 ' CE2' HD13 ' A' ' 5' ' ' LEU . 44.2 m-85 -57.93 126.53 77.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.494 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 53.1 Cg_endo -70.93 -28.79 19.21 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.318 2.012 . . . . 0.0 111.66 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.611 HG21 ' CE1' ' A' ' 117' ' ' PHE . 15.2 t -128.66 136.59 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.567 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 46' ' ' PHE . 5.9 mm -135.78 103.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.63 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 77' ' ' ILE . 59.8 t -101.79 129.81 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.596 HD23 HG13 ' A' ' 78' ' ' VAL . 28.6 tp -92.13 162.84 14.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.334 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -153.81 69.96 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.806 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 80' ' ' THR . 2.4 p -59.79 81.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.683 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 52' ' ' ASP . 65.3 t-105 -86.41 -92.23 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.772 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.576 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mtt -64.25 -52.09 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.075 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 55' ' ' MET . 39.7 Cg_endo -65.97 -169.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.37 2.047 . . . . 0.0 112.37 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.92 -24.07 7.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.84 -89.13 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.428 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 48.69 30.76 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.2 72.28 2.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.562 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 64' ' ' ILE . 58.2 t -58.11 -39.65 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -75.0 -11.79 60.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.523 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.027 ' CE2' HD11 ' A' ' 67' ' ' ILE . 50.4 t80 -64.36 -43.77 93.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.734 0.302 . . . . 0.0 111.429 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mp -48.24 -28.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -77.58 -30.85 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 4.5 t80 -63.73 -44.76 92.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 1.027 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -61.21 -43.62 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.21 -22.52 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.667 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 21.6 tt0 -62.91 -39.81 95.67 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.073 0.463 . . . . 0.0 110.222 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.53 15.68 9.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.26 71.21 0.6 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.71 -7.71 11.43 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.039 2.493 . . . . 0.0 112.56 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.03 -3.06 30.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.558 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -170.31 2.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 0.0 111.302 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.737 HG11 ' HB1' ' A' ' 116' ' ' ALA . 50.1 t -127.34 147.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.025 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 67' ' ' ILE . 3.3 t -126.7 100.45 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.87 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.0 mm -101.62 71.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.145 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.622 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 32.1 t -67.09 133.31 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.176 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 80' ' ' THR . 2.1 mt -142.4 175.64 4.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 79.55 148.92 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.901 0.381 . . . . 0.0 111.163 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.61 82.21 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.379 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -58.73 110.35 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.828 0.347 . . . . 0.0 111.177 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.13 59.8 9.41 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.666 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 m -167.49 101.67 0.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.83 0.348 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 85' ' ' VAL . 14.4 p -109.79 30.62 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.0 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 89' ' ' VAL . 13.4 p-10 -115.51 -34.29 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.82 -31.1 70.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.745 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.28 -59.62 5.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 86' ' ' ASP . 22.1 m -62.75 -23.33 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.931 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.546 ' HD3' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.73 27.68 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.6 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.53 -41.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.035 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.006 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.8 pt -69.17 -21.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.505 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.53 26.47 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -133.8 7.27 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.517 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.25 -23.26 3.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.912 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 1.006 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -60.48 -177.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.373 . . . . 0.0 111.266 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.758 ' HB3' HD13 ' A' ' 77' ' ' ILE . 48.9 t80 -117.21 29.14 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.269 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 87.89 158.13 0.07 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.227 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.622 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -91.97 103.91 16.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.078 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.578 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.4 tp -57.97 160.9 4.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -58.02 -108.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.041 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -178.94 52.61 0.06 OUTLIER Pre-proline 0 C--O 1.232 0.155 0 CA-C-O 120.77 0.319 . . . . 0.0 110.79 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 14.9 Cg_endo -56.93 159.95 13.48 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.749 2.299 . . . . 0.0 112.242 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.83 -53.27 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.797 ' O ' HG22 ' A' ' 106' ' ' VAL . 30.3 t -96.12 6.93 47.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.358 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.926 HG21 HD23 ' A' ' 17' ' ' LEU . 1.2 m 61.17 12.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -45.78 44.77 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.919 0.39 . . . . 0.0 110.608 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.445 ' HA ' HD13 ' A' ' 111' ' ' LEU . 7.5 tpt85 -66.59 -36.67 83.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.819 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.842 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 7.2 t80 -59.82 -27.81 66.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.245 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.877 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -60.11 -44.25 95.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.364 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.525 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.5 mp -54.38 -56.64 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' ILE . 92.4 m -51.73 -59.53 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.342 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.842 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 13.6 mm -31.05 -64.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.891 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -58.1 5.76 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -27.32 15.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.737 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -73.41 -36.57 66.01 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.611 ' CE1' HG21 ' A' ' 48' ' ' VAL . 27.2 m-85 -66.85 -14.93 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.257 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -57.57 -20.13 30.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.468 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -91.76 44.38 1.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.011 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.407 ' CD2' ' O ' ' A' ' 120' ' ' TYR . 22.6 t80 -140.29 16.56 2.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.975 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.403 ' O ' ' HD2' ' A' ' 3' ' ' ARG . 3.4 mtt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.816 0.341 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 21.1 mmtt 63.72 -179.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.445 ' HD2' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 73.95 113.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.044 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.613 HG13 ' HB ' ' A' ' 48' ' ' VAL . 43.6 t -118.99 158.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.489 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.623 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 56.2 tp -112.65 127.98 56.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 111.394 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.26 91.97 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.317 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.784 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 33.2 t -85.02 117.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.483 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -156.51 147.03 21.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.914 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.43 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 36.3 t70 -72.62 -73.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.096 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 1.6 tm-20 -88.87 172.07 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.115 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -85.04 61.95 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.4 m -89.5 -65.73 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.625 HG22 ' CB ' ' A' ' 17' ' ' LEU . 32.7 mm -84.3 -43.72 17.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.289 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p -46.47 -35.3 5.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.524 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -66.06 -32.95 74.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 t -102.13 -59.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.792 HD23 HG21 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -47.04 -57.21 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.428 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.832 ' HA ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -41.41 -54.66 3.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.158 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.96 -36.62 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.508 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 17' ' ' LEU . 14.3 mt -72.92 -70.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.84 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.957 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -52.56 -28.51 21.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.465 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.957 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -79.73 -23.67 42.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.814 0.34 . . . . 0.0 110.667 178.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -78.82 -39.08 36.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.903 0.383 . . . . 0.0 110.026 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.66 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.7 mm-40 -55.91 -43.73 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 60.68 0.16 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.32 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 61.7 m-85 -132.31 -171.51 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 111.061 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.39 82.9 56.33 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.926 ' HG3' HD21 ' A' ' 21' ' ' LEU . 21.3 Cg_exo -65.28 143.44 77.12 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.682 2.254 . . . . 0.0 112.634 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 30' ' ' THR . 6.2 t70 -116.78 -10.72 11.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.139 0.495 . . . . 0.0 111.983 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 29' ' ' ASP . 41.9 p 43.12 176.05 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.289 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.784 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -165.57 174.81 9.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.908 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 33' ' ' THR . 0.5 OUTLIER -112.82 -26.65 8.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.801 0.334 . . . . 0.0 111.236 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.12 -178.33 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.62 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.743 HD12 ' HA3' ' A' ' 58' ' ' GLY . 96.5 mt -61.01 -39.2 88.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -50.34 71.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.031 0.443 . . . . 0.0 109.831 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -33.16 75.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.172 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.524 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.07 -20.2 57.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 4.3 mt-10 -77.56 -38.31 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 109.85 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.41 -39.14 81.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.661 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mmtm -71.22 -36.19 71.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.769 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 37' ' ' ALA . 36.5 mt -86.19 -17.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.201 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -58.38 -19.09 32.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.441 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -134.8 -53.76 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.062 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -58.45 118.22 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.052 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -74.11 64.52 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.438 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.623 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 31.2 m-85 -56.65 113.69 6.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.297 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 60.3 Cg_endo -73.14 -27.38 13.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 112.032 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HB ' HG13 ' A' ' 4' ' ' VAL . 4.0 t -139.75 128.29 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.479 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.413 HG23 HD23 ' A' ' 5' ' ' LEU . 9.4 mm -112.59 146.85 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.68 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 5' ' ' LEU . 97.6 t -139.06 98.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.488 . . . . 0.0 110.576 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.426 ' HB3' HG13 ' A' ' 78' ' ' VAL . 24.7 tp -77.16 166.25 23.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.89 93.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.252 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.786 HG22 ' HB ' ' A' ' 80' ' ' THR . 6.8 m -76.71 57.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.55 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.446 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 55.7 t-105 -61.54 -90.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.652 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.666 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -90.64 -27.09 0.3 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 55' ' ' MET . 62.3 Cg_endo -85.93 -168.29 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.341 2.027 . . . . 0.0 113.021 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -147.59 -47.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.411 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.743 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . 46.79 -171.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.948 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.57 48.29 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.634 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -47.78 -34.38 10.7 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.452 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 90' ' ' LYS . 6.6 t -63.87 -49.91 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.942 0.401 . . . . 0.0 110.65 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.54 8.34 34.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.384 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.902 ' CE2' HD11 ' A' ' 67' ' ' ILE . 36.1 t80 -84.55 -41.83 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.772 0.32 . . . . 0.0 111.224 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.772 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.4 mp -46.01 -30.44 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.242 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -40.62 66.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.565 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 68.5 t80 -55.97 -43.36 77.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.902 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.0 mp -61.79 -44.37 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.462 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -78.95 -14.52 59.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.833 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.3 -43.07 58.31 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.968 0.413 . . . . 0.0 110.593 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -116.68 12.46 14.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.08 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.54 66.79 2.51 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.728 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.68 -19.04 32.23 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.616 2.211 . . . . 0.0 112.232 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -103.97 32.39 3.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.673 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 t -113.63 -158.45 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.689 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.514 HG22 ' CD1' ' A' ' 120' ' ' TYR . 39.2 t -147.49 136.2 15.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.812 HG12 HG23 ' A' ' 78' ' ' VAL . 18.3 t -114.25 110.99 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.608 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 79' ' ' ILE . 44.5 mm -99.23 -39.91 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.558 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.812 HG23 HG12 ' A' ' 76' ' ' VAL . 59.1 t 45.25 77.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.564 HG23 ' HB3' ' A' ' 100' ' ' LEU . 4.2 mt -93.45 148.51 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.579 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.786 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.4 p -149.82 -57.75 0.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.025 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 53.23 98.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.642 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -150.34 -47.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.316 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 173.13 137.87 2.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.37 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m 60.31 -175.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.814 0.34 . . . . 0.0 110.833 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.15 65.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -111.52 -24.21 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.192 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -32.08 22.67 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.798 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.96 -57.27 12.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.897 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.6 m -58.08 -26.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.016 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.576 ' O ' HG13 ' A' ' 61' ' ' VAL . 3.1 ttmm -81.76 -9.25 59.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.772 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -121.96 -26.45 4.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.877 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.5 pt -83.32 -42.16 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -23.73 41.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.679 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -25.06 65.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.94 -16.1 1.05 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.106 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -51.9 177.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.97 0.385 . . . . 0.0 111.464 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 72.3 t80 -95.29 28.55 2.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.501 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 1.2 tt0 70.09 139.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.208 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.608 ' H ' HG21 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -55.11 146.07 19.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.564 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -87.23 109.65 19.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -56.99 -170.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.059 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.5 mttm 62.69 83.58 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.91 146.26 82.42 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.623 2.215 . . . . 0.0 112.22 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.85 27.86 15.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.3 p -162.79 155.49 19.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.792 HG21 HD23 ' A' ' 17' ' ' LEU . 32.8 m -141.69 49.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.15 -60.67 2.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -30.55 53.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.824 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 80.8 t80 -61.91 -40.57 95.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.607 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.66 HD21 ' HG2' ' A' ' 24' ' ' GLU . 2.1 tt -52.41 -59.09 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.395 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.581 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.3 mp -66.23 -44.46 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.544 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.3 m -60.2 -37.8 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.125 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.824 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -49.02 -52.36 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.482 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -56.56 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.042 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.448 ' CE1' ' HG3' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -52.55 -36.49 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -58.9 -38.54 79.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 110.57 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 34.7 m-85 -82.73 -17.18 45.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.792 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -102.99 -65.45 1.0 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 115' ' ' HIS . 50.2 mm-40 -88.54 22.67 2.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.514 ' CD1' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -155.78 40.36 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.933 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.837 0.351 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.39 127.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.033 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -149.2 140.87 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.7 t -124.67 162.27 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.978 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.976 HD22 ' CD2' ' A' ' 46' ' ' PHE . 57.5 tp -119.8 121.82 39.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 110.588 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.859 HG21 ' CD1' ' A' ' 17' ' ' LEU . 40.0 t -102.77 122.88 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.19 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 41.3 t -111.41 105.26 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.866 0.365 . . . . 0.0 111.191 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -117.57 151.76 36.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.934 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 54' ' ' TRP . 32.3 t70 -81.27 49.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 111.667 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 61.96 116.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.361 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 175.63 39.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.318 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.3 t 58.01 58.49 3.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.262 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.097 HD12 HG21 ' A' ' 30' ' ' THR . 11.9 mm 55.6 169.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.499 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.606 ' N ' HG22 ' A' ' 13' ' ' ILE . 2.3 p -81.72 118.36 22.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 m -54.68 145.94 18.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.512 ' O ' HD12 ' A' ' 20' ' ' ILE . 42.1 t 66.03 10.86 7.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.839 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.079 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.22 -52.23 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.443 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 t -50.08 -55.26 15.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.06 73.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.968 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.72 HG23 ' CD1' ' A' ' 110' ' ' LEU . 54.3 mt -62.19 -66.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.079 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -49.38 -28.62 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.44 -27.68 61.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.79 -34.46 30.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.149 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.672 ' HG3' HD21 ' A' ' 110' ' ' LEU . 30.5 mm-40 -87.18 -30.58 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 60.53 1.48 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.45 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 44.8 m-85 -113.09 -173.67 2.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.25 83.83 54.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.882 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.882 ' HG3' HD13 ' A' ' 21' ' ' LEU . 92.2 Cg_endo -84.74 117.62 2.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.79 2.326 . . . . 0.0 111.636 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.26 -9.2 33.84 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.403 0.62 . . . . 0.0 112.046 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.097 HG21 HD12 ' A' ' 13' ' ' ILE . 71.5 p 49.66 173.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.216 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -158.55 -154.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.493 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 27.3 mttt -143.65 -42.96 0.28 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.0 170.07 20.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.591 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.678 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.3 mt -61.41 -26.77 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.51 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -76.2 -43.59 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.083 0.468 . . . . 0.0 109.819 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -25.98 59.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.607 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.506 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.52 -34.03 58.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.634 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 44.8 mt-10 -69.75 -41.46 75.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -61.83 -37.98 86.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.837 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -72.41 -47.03 52.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.615 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 37' ' ' ALA . 10.1 mt -68.71 -27.97 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.976 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -47.55 -29.12 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -116.82 -44.21 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.63 112.75 18.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -75.13 63.94 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.976 ' CD2' HD22 ' A' ' 5' ' ' LEU . 42.4 m-85 -56.03 125.58 63.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.526 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 72.2 Cg_endo -76.45 -34.04 2.9 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.307 2.004 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.865 HG13 ' HB ' ' A' ' 75' ' ' VAL . 23.5 t -130.16 111.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.007 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.468 HG23 HD23 ' A' ' 5' ' ' LEU . 2.3 mm -97.01 142.38 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.795 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.768 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.6 t -128.66 165.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 7' ' ' VAL . 16.2 tp -142.41 157.69 44.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.119 0.485 . . . . 0.0 111.539 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -141.93 79.95 1.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.011 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.694 HG22 ' HB ' ' A' ' 80' ' ' THR . 31.0 m -65.67 66.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.188 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.412 ' N ' ' O ' ' A' ' 52' ' ' ASP . 26.7 t-105 -67.16 -74.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.651 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 31.4 mtt -147.54 52.75 1.37 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.763 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.4 Cg_endo -89.72 -156.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -136.89 -43.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.246 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.44 148.37 34.11 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.647 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 127.53 43.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.71 -13.8 83.17 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.823 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 90' ' ' LYS . 21.7 t -53.57 -45.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.789 0.328 . . . . 0.0 111.339 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 -5.9 55.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.537 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.678 ' CD2' HD22 ' A' ' 34' ' ' LEU . 15.7 t80 -74.15 -37.74 63.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.347 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.521 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.5 mp -49.7 -27.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -39.45 69.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.632 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 18.8 t80 -60.3 -43.35 96.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.061 0.458 . . . . 0.0 109.914 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.626 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -57.33 -41.76 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -81.64 -24.16 36.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.0 110.638 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -66.39 -26.18 67.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.444 ' ND2' ' CE1' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -138.0 16.58 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.026 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.15 69.17 0.82 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.864 0.364 . . . . 0.0 110.748 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.44 -20.26 48.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.76 2.307 . . . . 0.0 112.11 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.78 39.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.853 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.8 t -119.61 177.59 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.865 ' HB ' HG13 ' A' ' 48' ' ' VAL . 2.7 t -107.9 178.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.754 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -157.52 79.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.898 0.38 . . . . 0.0 110.146 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.768 ' HB ' HG13 ' A' ' 50' ' ' VAL . 31.2 mm -62.21 -53.02 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.364 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.659 ' CG2' HG12 ' A' ' 76' ' ' VAL . 5.2 t 45.39 89.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.714 HG23 ' HB3' ' A' ' 100' ' ' LEU . 13.8 mt -104.21 167.2 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.614 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.694 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.6 m 84.21 147.49 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.425 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.43 49.26 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.168 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -55.18 -78.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.737 0.303 . . . . 0.0 111.203 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.95 46.48 2.69 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.542 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 87' ' ' THR . 0.4 OUTLIER -179.32 52.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.819 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.1 -31.94 52.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.96 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.595 ' O ' HG22 ' A' ' 89' ' ' VAL . 8.3 t0 -62.81 -32.91 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -52.39 -34.76 49.49 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.19 0.519 . . . . 0.0 109.954 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.885 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.41 -61.27 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.315 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 86' ' ' ASP . 33.4 m -61.92 -22.73 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.243 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.415 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 15.8 tttt -85.52 -25.13 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -98.91 -26.1 14.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.885 HG23 ' O ' ' A' ' 88' ' ' ALA . 4.2 pt -89.32 -17.0 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.436 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -71.71 -32.66 68.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 110.43 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -64.78 -61.99 1.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.84 33.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.986 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.11 -179.0 5.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.815 ' CE2' HG23 ' A' ' 112' ' ' THR . 26.4 t80 -98.52 28.54 4.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.452 . . . . 0.0 111.062 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.643 ' CD ' HD12 ' A' ' 92' ' ' ILE . 2.7 tp10 67.47 134.15 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.193 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.659 ' H ' HG21 ' A' ' 92' ' ' ILE . 2.3 m-85 -61.64 131.48 50.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.014 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.714 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -74.81 80.81 2.1 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -50.06 176.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.412 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.05 80.6 0.23 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.917 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.34 171.56 15.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.577 2.185 . . . . 0.0 112.249 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 56.83 23.47 8.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 p -147.99 60.74 1.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 110.657 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.646 HG13 HD11 ' A' ' 20' ' ' ILE . 7.6 p -53.91 -26.91 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.461 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -46.51 -33.92 4.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 110.838 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -36.25 69.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.933 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.891 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 3.4 t80 -59.64 -31.16 69.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.181 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.72 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -49.16 -49.21 43.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.29 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.6 mp -56.93 -57.56 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.75 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.815 HG23 ' CE2' ' A' ' 97' ' ' TYR . 93.0 m -44.68 -39.28 4.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.301 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.891 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 24.1 mm -59.13 -70.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.517 ' HE3' ' CD2' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -55.24 -23.07 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.563 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.517 ' CD2' ' HE3' ' A' ' 114' ' ' LYS . 31.9 m170 -84.75 -20.62 30.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.668 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.587 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -87.19 -45.22 10.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.45 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -60.44 -22.53 63.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -52.84 -25.46 11.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.271 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.72 30.62 2.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.009 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -115.99 28.31 8.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 -179.981 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt 60.74 91.89 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.95 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.477 ' HA ' ' H ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -111.71 135.07 52.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.862 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.66 HG13 ' HB ' ' A' ' 48' ' ' VAL . 24.0 t -126.5 154.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.411 -179.093 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.675 HD23 HD11 ' A' ' 41' ' ' ILE . 28.8 tp -105.73 127.98 53.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.709 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.673 HG21 ' CD1' ' A' ' 17' ' ' LEU . 45.2 t -107.52 90.1 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.716 HG13 ' HB2' ' A' ' 37' ' ' ALA . 5.1 t -85.08 105.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -138.36 143.04 39.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.037 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.873 ' HB2' HG23 ' A' ' 33' ' ' THR . 33.1 t70 -91.9 50.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.9 -172.69 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -127.93 40.54 3.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -100.38 -42.15 6.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.512 HG22 ' HB3' ' A' ' 17' ' ' LEU . 37.7 mm -98.88 -40.77 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 p -47.64 -29.54 3.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.427 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.51 -45.85 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 111.258 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 p -73.58 -68.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.085 HD23 HG21 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -44.78 -42.86 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.574 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.1 m -57.15 -44.18 83.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.43 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.69 78.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.431 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.917 HD13 HG22 ' A' ' 106' ' ' VAL . 1.5 mt -59.76 -57.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.587 179.539 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.622 HD11 HD11 ' A' ' 17' ' ' LEU . 1.4 mt -50.33 -33.49 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.664 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.02 -24.59 66.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.794 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.38 -36.61 45.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.752 ' HG2' HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -78.34 -19.12 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.157 179.693 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.17 52.95 2.11 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.186 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.1 m-85 -112.07 -172.21 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 0.0 111.163 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.477 ' H ' ' HA ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -131.41 69.41 81.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.805 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -62.61 143.26 92.35 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.628 2.218 . . . . 0.0 111.931 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.8 t70 -126.56 -9.11 6.24 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.625 ' O ' ' O ' ' A' ' 29' ' ' ASP . 29.9 p 41.9 163.68 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -170.61 142.87 2.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.778 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 41.5 mttt -74.01 -166.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.873 HG23 ' HB2' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -47.73 156.24 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 111.705 -178.101 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.85 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.2 mt -27.36 -43.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.833 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -50.56 -59.59 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.083 0.468 . . . . 0.0 110.333 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 1.4 tp10 -66.07 -39.1 89.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.716 ' HB2' HG13 ' A' ' 7' ' ' VAL . . . -60.15 -60.5 3.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.595 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 19.7 mt-10 -45.67 -42.18 11.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -60.8 -52.75 63.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -62.44 -34.59 77.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.328 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.675 HD11 HD23 ' A' ' 5' ' ' LEU . 48.6 mt -89.54 -6.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.52 -16.56 48.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.633 0.254 . . . . 0.0 111.262 179.901 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -132.95 -52.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.769 0.318 . . . . 0.0 111.093 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.95 133.25 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.073 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -96.52 63.89 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.706 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.647 ' CD2' HD22 ' A' ' 5' ' ' LEU . 45.2 m-85 -58.27 125.23 74.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.036 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.74 -24.78 17.83 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.317 2.011 . . . . 0.0 111.892 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.698 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.8 t -141.59 134.12 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.524 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 46' ' ' PHE . 21.8 mm -119.24 148.18 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.547 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.445 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 82.9 t -136.59 105.62 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.587 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.04 84.11 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.751 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 1.2 t70 -66.35 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG13 ' HB ' ' A' ' 80' ' ' THR . 2.5 p -53.24 88.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ASP . 34.0 t-105 -88.47 -80.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.49 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 mmt -147.22 47.27 0.55 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 55' ' ' MET . 97.8 Cg_endo -78.6 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.562 2.175 . . . . 0.0 112.323 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -152.2 30.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.57 -147.17 18.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.411 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' H ' HD12 ' A' ' 34' ' ' LEU . 50.0 m-20 -129.49 81.2 2.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.863 0.363 . . . . 0.0 110.9 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.9 92.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 90' ' ' LYS . 78.0 t -59.87 -38.64 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -23.41 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.108 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.85 ' CD2' HD22 ' A' ' 34' ' ' LEU . 13.4 t80 -75.35 -30.22 60.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.819 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 61' ' ' VAL . 7.9 mm -47.8 -37.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' GLU . 39.1 t70 -70.07 -42.93 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.554 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 23.4 t80 -50.99 -39.91 56.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.935 0.398 . . . . 0.0 110.651 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.846 HG21 HG22 ' A' ' 76' ' ' VAL . 2.7 mp -62.74 -52.08 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -74.63 -9.51 58.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.701 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 65' ' ' ASP . 18.0 tt0 -77.1 -48.04 18.86 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.554 ' ND2' ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -114.33 16.83 17.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.925 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.66 67.54 1.6 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.2 -18.59 34.86 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.672 2.248 . . . . 0.0 112.156 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.75 40.66 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.66 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.403 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 34.0 t -119.06 -157.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.698 ' HB ' HG13 ' A' ' 48' ' ' VAL . 41.1 t -147.01 139.0 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 112.102 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.846 HG22 HG21 ' A' ' 67' ' ' ILE . 2.1 t -120.74 94.16 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.175 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.521 HG21 ' HE1' ' A' ' 109' ' ' PHE . 39.6 mm -73.63 -57.11 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.917 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.832 HG23 HG12 ' A' ' 76' ' ' VAL . 21.7 t 52.59 94.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.699 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.7 mt -108.45 -148.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.326 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.723 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 54.85 174.54 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.829 0.347 . . . . 0.0 111.106 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.0 142.98 5.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.378 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -57.64 -61.8 2.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.994 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.41 -31.66 3.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.422 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m 58.02 51.36 8.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 m -127.1 -41.3 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.326 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.0 -24.77 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.288 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -33.56 26.62 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.867 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.1 -57.09 13.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.116 178.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 92' ' ' ILE . 13.4 m -59.94 -28.22 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.43 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 61' ' ' VAL . 10.3 ttmt -78.74 -2.26 38.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.606 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.05 -35.04 1.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.93 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 4.7 pt -73.69 -43.59 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 111.413 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -59.42 -31.44 69.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -64.71 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.736 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.34 29.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.845 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.25 -166.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.722 0.296 . . . . 0.0 111.135 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 20.9 t80 -113.51 26.71 10.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.5 OUTLIER 79.5 147.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.229 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.652 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -79.31 88.3 4.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.802 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 79' ' ' ILE . 13.8 tp -59.06 148.23 31.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -57.0 177.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.01 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -139.88 52.37 3.65 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.993 -179.991 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 41.8 Cg_endo -67.23 -166.07 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.509 2.14 . . . . 0.0 112.176 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -55.95 109.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.019 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.5 m 65.15 163.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.031 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.085 HG21 HD23 ' A' ' 17' ' ' LEU . 32.4 m -89.81 49.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.162 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -62.19 1.53 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.436 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -55.3 -29.32 57.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.163 0.506 . . . . 0.0 109.69 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.699 ' CE1' HD11 ' A' ' 79' ' ' ILE . 43.3 t80 -61.62 -44.18 97.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.985 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.752 HD22 ' HG2' ' A' ' 24' ' ' GLU . 1.8 mt -52.5 -31.17 33.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.465 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.656 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 4.1 mp -79.75 -36.05 37.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 m -69.16 -36.88 77.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.491 . . . . 0.0 109.811 179.509 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.651 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.7 mm -67.17 -51.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.068 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -47.26 -57.2 5.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.311 -179.018 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.435 ' CG ' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -57.33 -34.76 69.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.818 179.537 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -54.92 -32.42 61.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' A' ' 48' ' ' VAL . 29.8 m-85 -74.6 -46.11 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.076 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -88.9 6.95 36.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.658 -179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HG3' ' CG ' ' A' ' 115' ' ' HIS . 1.2 mm-40 -117.74 -8.45 10.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.684 0.278 . . . . 0.0 111.57 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -153.23 71.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.849 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.934 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.846 0.355 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 8.5 mmtt 65.42 -176.44 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.445 ' HD2' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 75.53 105.96 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.093 -179.781 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 48' ' ' VAL . 44.4 t -112.78 162.51 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 29' ' ' ASP . 59.5 tp -119.81 139.12 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.687 HG21 HD12 ' A' ' 17' ' ' LEU . 10.5 t -121.05 117.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.133 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 32' ' ' LYS . 61.9 t -105.75 111.6 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.361 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.01 157.21 38.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB2' ' CD ' ' A' ' 56' ' ' PRO . 8.4 t0 -83.5 -70.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.423 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.0 mm-40 -84.7 177.58 7.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 111.241 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -96.89 70.47 2.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.848 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.605 ' C ' HD12 ' A' ' 13' ' ' ILE . 7.6 m -106.63 -37.03 6.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 13' ' ' ILE . 1.6 mp -110.81 -33.24 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.748 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.523 ' HB ' HG21 ' A' ' 30' ' ' THR . 81.3 p -54.93 -44.63 74.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -82.1 58.56 4.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.065 0.459 . . . . 0.0 110.966 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 170.6 -56.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.415 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.687 HD12 HG21 ' A' ' 6' ' ' VAL . 1.4 tm? -59.81 -55.87 28.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 m -54.66 -41.8 70.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 179.425 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.474 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 17' ' ' LEU . 33.1 mt -57.64 -64.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.69 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.674 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -47.73 -36.46 11.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.51 179.518 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -29.39 70.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.97 -35.06 57.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HG3' HD21 ' A' ' 110' ' ' LEU . 18.5 mm-40 -77.48 -8.58 57.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.161 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.14 51.93 1.99 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.964 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 51.0 m-85 -124.04 -175.92 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 111.345 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -140.23 77.92 24.07 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.061 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HB3' HD13 ' A' ' 21' ' ' LEU . 71.8 Cg_endo -84.05 148.91 12.09 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.582 2.188 . . . . 0.0 113.617 -178.312 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.681 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -131.88 134.1 45.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.719 179.331 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.523 HG21 ' HB ' ' A' ' 14' ' ' THR . 44.4 p -99.36 147.4 25.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.909 0.385 . . . . 0.0 111.166 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -147.24 145.77 29.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.721 ' O ' HG13 ' A' ' 7' ' ' VAL . 13.7 mttt -62.83 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.0 p -48.65 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.255 0.55 . . . . 0.0 111.817 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.775 HD22 ' CD2' ' A' ' 63' ' ' PHE . 10.9 mt -45.51 -30.47 1.44 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.959 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -59.92 -61.67 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 4.3 tp10 -58.76 -38.46 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.86 178.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.02 75.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.06 -48.66 22.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.964 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -55.73 31.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.423 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -26.38 61.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.172 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 41' ' ' ILE . 10.0 mt -97.17 -6.87 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.75 25.21 5.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.359 . . . . 0.0 110.805 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.34 -58.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.489 HD22 ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -100.04 153.52 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.459 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 18.0 t80 -86.93 81.68 8.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.604 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 14.6 m-85 -67.88 117.17 45.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 56.8 Cg_endo -72.4 -38.88 3.17 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.493 2.128 . . . . 0.0 112.325 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.611 ' HB ' HG13 ' A' ' 4' ' ' VAL . 17.2 t -124.83 125.92 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.96 0.409 . . . . 0.0 111.79 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 7.9 mm -115.2 134.29 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.644 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 66.8 t -131.42 109.71 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 111.841 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' HB3' HG13 ' A' ' 78' ' ' VAL . 12.3 tp -78.44 170.58 16.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.423 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -134.63 -54.91 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.455 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.543 HG13 ' HA ' ' A' ' 57' ' ' ASP . 15.4 t 59.82 41.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.763 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 60.5 t-105 -62.73 -91.18 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.095 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.557 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -71.02 -48.76 13.55 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.438 -179.771 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 55' ' ' MET . 64.8 Cg_endo -72.52 -167.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.242 1.962 . . . . 0.0 112.283 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' HA ' HG13 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -163.07 55.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.833 179.856 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.02 115.89 8.54 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -92.84 31.19 1.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.806 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.09 64.37 0.95 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.365 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.861 ' O ' HD12 ' A' ' 64' ' ' ILE . 25.7 t -49.0 -43.02 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.939 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.54 -18.43 40.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.934 ' CE2' HD11 ' A' ' 67' ' ' ILE . 45.8 t80 -49.96 -43.32 50.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.569 0.223 . . . . 0.0 111.227 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.861 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mt -48.07 -30.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.056 0.455 . . . . 0.0 110.604 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -67.6 -53.25 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.184 179.373 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.411 ' CE1' ' HB ' ' A' ' 41' ' ' ILE . 6.7 t80 -46.26 -44.2 16.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.795 0.331 . . . . 0.0 110.863 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.934 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.6 mp -61.94 -47.8 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -14.32 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.886 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' ASP . 28.0 tt0 -73.23 -51.43 17.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.013 0.435 . . . . 0.0 110.546 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.33 14.14 22.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.086 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.417 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -159.49 65.14 2.6 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.648 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 71' ' ' SER . 14.8 Cg_exo -67.75 -20.88 45.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.647 2.231 . . . . 0.0 112.091 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -104.68 33.1 3.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.617 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.8 t -110.63 -178.22 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.561 HG21 ' HB1' ' A' ' 116' ' ' ALA . 40.5 t -129.11 139.64 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.826 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.913 HG12 HG23 ' A' ' 78' ' ' VAL . 2.9 t -125.68 104.74 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.444 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -91.35 -43.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.566 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.913 HG23 HG12 ' A' ' 76' ' ' VAL . 40.2 t 48.15 96.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.721 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 100' ' ' LEU . 6.1 mt -118.62 149.45 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.54 179.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 p -152.31 -57.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.62 0.247 . . . . 0.0 111.267 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 102' ' ' LYS . . . 164.23 -169.64 39.15 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.821 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -80.61 -23.21 39.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.627 0.251 . . . . 0.0 111.153 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.58 55.72 4.44 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.643 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.494 ' HB3' HG22 ' A' ' 87' ' ' THR . 0.1 OUTLIER 175.4 56.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.103 0.478 . . . . 0.0 110.622 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m -70.62 -25.09 25.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.514 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -88.84 -15.43 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.459 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 84' ' ' SER . 0.8 OUTLIER -82.98 -34.43 26.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.736 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -60.02 -61.28 2.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.93 178.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 92' ' ' ILE . 11.1 m -58.59 -29.11 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.849 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.54 -3.33 43.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.492 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -119.25 -39.88 2.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.373 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.947 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.9 pt -74.35 -46.26 44.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.435 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -60.49 -26.92 67.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.536 179.729 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.688 ' CB ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.59 -62.82 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 179.687 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.5 19.09 0.07 OUTLIER Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.537 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.947 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.41 -169.68 2.48 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.285 0.542 . . . . 0.0 110.961 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.511 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 62.0 t80 -103.91 -18.95 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.534 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 9.0 pt-20 151.28 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.34 0.656 . . . . 0.0 110.003 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -133.49 98.51 4.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.93 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 79' ' ' ILE . 9.8 tp -64.11 169.78 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.995 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.404 ' CB ' ' HB2' ' A' ' 104' ' ' PHE . 3.2 mt-10 -94.16 115.12 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.011 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.581 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.1 tmtt? -64.85 -48.01 73.33 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.6 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 48.6 Cg_endo -69.14 -5.55 16.09 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.17 1.914 . . . . 0.0 113.0 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.404 ' HB2' ' CB ' ' A' ' 101' ' ' GLU . 1.5 t80 -82.22 -172.98 4.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.732 0.301 . . . . 0.0 110.656 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.8 t -85.25 127.23 34.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.924 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.434 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.8 p -60.47 -18.82 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.248 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.65 -42.23 92.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.778 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -63.8 -34.73 78.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.244 179.465 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.644 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 9.7 t80 -60.66 -39.52 88.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.174 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.531 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -55.85 -36.46 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.187 179.871 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 108' ' ' ARG . 1.2 mt -60.44 -42.71 96.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.167 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.9 m -70.97 -46.67 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.549 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 5.1 mm -43.68 -58.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.508 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -47.41 -54.51 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.079 0.466 . . . . 0.0 110.123 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.07 66.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -66.41 -34.68 78.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.945 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE1' ' CA ' ' A' ' 2' ' ' LYS . 25.8 m-85 -74.45 -13.74 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.823 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -58.71 -20.82 52.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.282 . . . . 0.0 111.358 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.95 41.76 1.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.98 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -159.16 28.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.999 179.94 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.9 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.884 0.373 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HD3' ' CD2' ' A' ' 117' ' ' PHE . 9.8 mmtt -138.53 121.08 16.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -147.84 83.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.774 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.624 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.9 t -68.94 160.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 46' ' ' PHE . 55.3 tp -118.94 135.86 54.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 17' ' ' LEU . 14.2 t -118.17 139.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.052 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.775 ' HB ' HD12 ' A' ' 51' ' ' LEU . 24.3 t -125.85 119.27 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.496 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 52' ' ' ASP . 22.9 t0 -170.32 160.68 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -179.365 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 27.4 t70 -88.27 50.53 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.586 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.21 127.31 41.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.711 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -80.31 149.34 30.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.172 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.89 66.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.228 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.638 ' HA ' HG21 ' A' ' 30' ' ' THR . 23.0 mm 53.63 168.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.183 0.516 . . . . 0.0 111.454 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.609 ' N ' HG22 ' A' ' 13' ' ' ILE . 54.7 p -90.16 146.05 24.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.986 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 16' ' ' SER . 1.6 m -55.77 133.79 51.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.851 0.357 . . . . 0.0 111.771 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.692 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER 82.36 -43.55 0.14 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.328 179.159 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -52.21 -53.92 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.755 0.312 . . . . 0.0 111.367 -179.33 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.531 ' HB2' HG21 ' A' ' 13' ' ' ILE . 41.4 t -46.47 -71.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.54 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.3 -40.63 11.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 0.0 111.482 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.699 HD13 ' CG2' ' A' ' 106' ' ' VAL . 16.3 mt -64.18 -68.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.155 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.042 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.62 -29.92 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.89 -24.0 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.998 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.52 -37.46 27.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.234 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.09 -25.44 43.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.7 2.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.267 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CE2' HG21 ' A' ' 113' ' ' ILE . 11.2 m-30 -112.4 -178.01 3.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 111.366 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.12 78.75 72.37 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.539 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.715 ' HG3' HD13 ' A' ' 21' ' ' LEU . 84.3 Cg_endo -84.27 139.29 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.862 2.375 . . . . 0.0 113.889 -177.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.837 ' O ' HD12 ' A' ' 5' ' ' LEU . 11.1 t0 -121.97 118.27 28.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.342 178.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.819 HG22 ' HB ' ' A' ' 6' ' ' VAL . 72.8 p -102.34 127.05 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.93 0.395 . . . . 0.0 111.627 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.73 -165.18 1.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.526 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -127.43 -5.68 5.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.639 -179.834 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -170.58 -176.28 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.725 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.813 HD22 ' CD2' ' A' ' 63' ' ' PHE . 24.8 mt -77.36 -31.49 54.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.731 0.301 . . . . 0.0 110.339 179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -45.64 67.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -35.72 80.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.075 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' HB1' HD11 ' A' ' 41' ' ' ILE . . . -69.96 -48.18 59.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 82.4 mt-10 -46.42 -48.36 18.82 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.905 0.383 . . . . 0.0 110.503 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.84 -52.79 64.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.712 178.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.891 ' O ' HD22 ' A' ' 44' ' ' LEU . 9.8 mttt -63.71 -23.47 67.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.283 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.432 HD11 ' HB1' ' A' ' 37' ' ' ALA . 21.0 mt -93.33 -16.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -100.86 22.26 12.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 179.552 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.634 ' C ' HD13 ' A' ' 44' ' ' LEU . 26.7 mt-10 -143.22 -52.98 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.02 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -99.64 12.95 35.2 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.413 0.625 . . . . 0.0 109.818 179.691 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 44' ' ' LEU . 16.1 t80 23.72 86.19 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.748 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.939 ' CE2' HD13 ' A' ' 5' ' ' LEU . 49.3 m-85 -68.42 148.57 98.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.407 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' C ' ' HG ' ' A' ' 74' ' ' SER . 8.4 Cg_endo -83.67 -47.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.792 2.328 . . . . 0.0 111.88 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.624 ' HB ' HG13 ' A' ' 4' ' ' VAL . 24.7 t -116.94 126.79 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.628 HD12 HD23 ' A' ' 5' ' ' LEU . 21.5 mm -111.97 125.68 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.853 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.668 HG21 ' CE1' ' A' ' 109' ' ' PHE . 52.9 t -127.16 106.31 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.08 0.467 . . . . 0.0 112.031 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.775 HD12 ' HB ' ' A' ' 7' ' ' VAL . 42.9 tp -79.04 165.11 23.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.304 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 42.4 t0 -127.59 -56.79 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.668 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.411 HG23 ' HG ' ' A' ' 51' ' ' LEU . 18.1 t 67.96 66.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.935 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.422 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 26.8 t-105 -96.54 -82.93 0.39 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 111.442 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.607 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.2 mtt -83.68 -31.76 0.5 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 55' ' ' MET . 87.7 Cg_endo -83.05 -174.25 1.96 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.099 1.866 . . . . 0.0 112.922 -179.225 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -170.19 58.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.563 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.71 12.69 60.74 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.955 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.45 92.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.792 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.33 -9.05 60.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.852 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 90' ' ' LYS . 18.0 t -51.32 -49.72 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.403 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.58 -3.9 40.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.941 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.813 ' CD2' HD22 ' A' ' 34' ' ' LEU . 12.2 t80 -88.64 -42.09 12.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.538 0.209 . . . . 0.0 111.504 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.511 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.8 mp -43.84 -30.07 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.771 0.319 . . . . 0.0 111.272 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -67.24 -54.63 19.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -48.15 -40.6 24.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 110.52 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.634 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mp -60.45 -48.34 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.511 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -77.24 -18.97 57.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.971 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.89 -50.68 54.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.956 0.408 . . . . 0.0 110.716 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.07 17.26 16.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.6 OUTLIER -161.26 68.33 2.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.771 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.11 -16.63 25.28 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.764 2.309 . . . . 0.0 112.297 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.07 -2.45 34.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.377 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.463 ' HG ' ' C ' ' A' ' 47' ' ' PRO . 46.6 t -82.37 176.82 9.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.051 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.744 HG21 ' HB1' ' A' ' 116' ' ' ALA . 47.0 t -114.61 159.25 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.88 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.756 HG12 ' CG2' ' A' ' 78' ' ' VAL . 1.1 t -143.54 83.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.571 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.699 HD13 ' HB3' ' A' ' 97' ' ' TYR . 37.4 mm -71.53 -45.32 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.656 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.756 ' CG2' HG12 ' A' ' 76' ' ' VAL . 6.8 t 48.67 85.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.489 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 7.6 mt -107.19 152.5 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 p -155.58 -171.59 3.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.94 -43.28 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.54 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -77.34 62.83 2.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.68 -161.46 26.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.507 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -116.23 168.83 9.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.3 -14.81 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.496 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.3 -22.17 66.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.315 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.7 39.48 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.51 -58.58 7.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.004 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.12 -23.43 27.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.842 179.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' O ' HG22 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -91.09 39.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.376 179.566 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.511 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -170.16 -38.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.083 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.919 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -74.36 -30.03 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -29.84 67.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.7 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.69 65.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.144 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.77 -2.18 3.31 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.231 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.919 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -56.99 -168.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.046 0.423 . . . . 0.0 111.111 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.699 ' HB3' HD13 ' A' ' 77' ' ' ILE . 6.8 t80 -110.73 27.87 9.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 80.67 156.78 0.14 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.434 179.705 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.727 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -88.54 110.26 20.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 -179.993 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.42 HD23 HD13 ' A' ' 79' ' ' ILE . 8.3 tp -63.72 149.42 46.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.862 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -99.75 166.84 10.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.7 78.77 0.28 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.71 -3.94 14.59 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.628 2.219 . . . . 0.0 112.788 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -77.07 -59.22 2.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.712 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.6 t -112.86 131.82 55.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.941 HG21 HD23 ' A' ' 17' ' ' LEU . 32.8 m -95.99 37.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.024 0.44 . . . . 0.0 111.181 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.7 -55.64 18.7 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.14 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -60.94 -31.54 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.807 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.671 ' CE1' HD11 ' A' ' 113' ' ' ILE . 27.8 t80 -57.65 -39.28 76.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.893 179.065 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.644 HD11 HG23 ' A' ' 20' ' ' ILE . 1.5 mt -60.45 -51.03 71.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.174 179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -57.29 -46.13 83.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.549 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 m -69.27 -44.96 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 0.0 110.959 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.671 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.6 mm -40.63 -52.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.78 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.19 12.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.651 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -62.08 -36.21 80.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.744 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.92 -39.46 85.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.445 ' CE1' HG22 ' A' ' 4' ' ' VAL . 19.5 m-85 -65.36 -19.42 65.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.291 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -52.17 -25.32 8.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.333 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -74.68 -6.59 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -162.03 61.66 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.907 0.384 . . . . 0.0 110.813 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.942 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mmt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.865 0.364 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp 59.81 87.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -142.35 118.09 10.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.967 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.65 HG13 ' HB ' ' A' ' 48' ' ' VAL . 14.3 t -118.6 160.81 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.655 HD22 ' CD2' ' A' ' 46' ' ' PHE . 42.5 tp -114.74 133.44 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.871 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.728 ' HB ' HG22 ' A' ' 30' ' ' THR . 24.5 t -113.58 90.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.407 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 t -82.2 111.85 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.87 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -147.73 137.54 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 13.2 t0 -61.38 -80.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.68 163.0 18.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.995 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -84.6 78.87 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.671 ' C ' HD12 ' A' ' 13' ' ' ILE . 40.2 t -109.91 -35.25 6.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.671 HD12 ' C ' ' A' ' 12' ' ' SER . 1.6 mp -114.21 -35.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.817 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 p -47.85 -28.05 2.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.438 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -80.43 -54.54 5.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.024 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -69.62 -63.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -45.21 -46.17 12.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.315 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.813 ' HA ' HD12 ' A' ' 21' ' ' LEU . 5.7 t -44.73 -37.76 3.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.2 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.238 0.542 . . . . 0.0 110.391 179.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.65 ' CD1' HG11 ' A' ' 106' ' ' VAL . 3.0 mp -68.54 -68.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.144 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -48.51 -27.24 2.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.316 179.438 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.946 ' N ' HD13 ' A' ' 21' ' ' LEU . 15.5 mt-10 -73.71 -28.44 61.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.711 0.291 . . . . 0.0 111.011 179.129 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.31 -36.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.826 0.346 . . . . 0.0 110.511 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -64.46 -17.37 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 -179.98 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.99 65.51 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.22 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 24' ' ' GLU . 20.3 m-85 -137.69 -176.92 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.217 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.84 91.89 43.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.716 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.837 ' HG3' HD11 ' A' ' 21' ' ' LEU . 72.7 Cg_endo -84.3 133.3 5.45 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.625 2.216 . . . . 0.0 112.91 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.549 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -110.26 7.23 23.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.344 -179.731 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.728 HG22 ' HB ' ' A' ' 6' ' ' VAL . 15.4 p 6.5 122.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 -170.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.116 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 18.9 tttt -104.39 -43.33 5.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -161.15 -168.28 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.317 179.535 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.596 HD22 ' CD2' ' A' ' 63' ' ' PHE . 32.1 mt -67.19 -52.9 35.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -57.36 -45.78 84.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.58 -35.16 75.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.36 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.483 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -68.45 -34.73 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 77.5 mt-10 -64.51 -43.38 94.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -39.11 78.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -72.36 -49.93 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.687 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 37' ' ' ALA . 6.0 mt -64.19 -27.33 42.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -27.92 5.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -124.2 -42.34 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.08 115.01 19.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -80.34 101.34 8.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.709 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CD2' HD22 ' A' ' 5' ' ' LEU . 35.2 m-85 -97.25 119.15 63.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.0 Cg_endo -73.06 -17.69 24.63 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.477 2.118 . . . . 0.0 111.899 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.679 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -147.85 132.21 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.565 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.501 HD12 HD23 ' A' ' 5' ' ' LEU . 15.5 mm -115.77 160.1 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 178.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.677 ' CG1' HD11 ' A' ' 79' ' ' ILE . 60.0 t -152.67 99.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.206 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -71.39 164.56 25.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' TRP . 4.8 t70 -152.61 57.6 0.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -44.43 91.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.04 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.414 ' N ' ' O ' ' A' ' 52' ' ' ASP . 30.3 t-105 -88.16 -75.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.828 179.257 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.736 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 7.8 ttp -147.18 46.22 0.48 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.161 179.002 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.736 ' HD3' ' N ' ' A' ' 55' ' ' MET . 28.1 Cg_endo -95.48 -160.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.235 2.623 . . . . 0.0 112.204 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -149.54 60.03 1.01 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.03 131.24 4.49 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.508 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.44 ' O ' HD13 ' A' ' 34' ' ' LEU . 11.8 p-10 -74.23 144.94 44.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -103.79 -18.95 12.69 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.766 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.0 t -52.94 -40.61 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.16 -11.44 49.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.84 ' CE2' HD11 ' A' ' 67' ' ' ILE . 26.5 t80 -78.76 -39.64 35.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.371 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.709 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.7 mp -47.57 -32.79 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.359 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.64 -32.96 60.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.662 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 48.3 t80 -61.29 -44.96 96.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.84 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.1 mp -58.02 -42.64 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.271 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -80.25 -19.23 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.15 -30.92 67.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.947 0.403 . . . . 0.0 110.703 179.719 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.437 HD21 HG22 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -132.37 17.21 4.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 180.0 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.57 68.73 1.05 Allowed Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.59 -21.25 46.16 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.77 2.313 . . . . 0.0 112.183 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.67 31.09 3.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.9 t -112.65 -163.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' HB ' HG13 ' A' ' 48' ' ' VAL . 45.8 t -152.58 135.85 7.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-O 121.025 0.441 . . . . 0.0 111.421 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.944 HG12 HG23 ' A' ' 78' ' ' VAL . 2.5 t -107.89 109.85 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.723 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.85 HD12 ' CG2' ' A' ' 112' ' ' THR . 33.7 mm -87.75 -56.32 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 179.388 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.944 HG23 HG12 ' A' ' 76' ' ' VAL . 20.3 t 53.65 103.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.518 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -102.98 -173.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.227 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.716 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 59.28 162.25 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.85 179.923 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.84 -155.63 14.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.555 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.11 30.98 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.92 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.1 -97.35 0.47 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.617 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.409 ' O ' ' CG2' ' A' ' 85' ' ' VAL . 1.2 m -97.93 36.8 1.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.809 0.337 . . . . 0.0 110.94 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 84' ' ' SER . 35.4 m 43.34 30.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.825 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 89' ' ' VAL . 38.8 m-20 -78.85 -52.93 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.694 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.407 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.2 t -47.29 -32.5 4.73 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.205 0.526 . . . . 0.0 110.062 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.99 -60.04 4.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.16 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 86' ' ' ASP . 17.5 m -66.32 -24.66 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.118 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -83.63 -20.23 34.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.258 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.709 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -102.52 -39.14 7.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.662 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.91 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.8 pt -69.32 -27.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.408 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -32.08 64.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.697 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -64.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 29.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.916 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.91 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.18 -167.22 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 84.1 t80 -117.67 26.03 9.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.1 pt-20 85.74 146.43 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.415 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -78.8 105.39 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.772 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 79' ' ' ILE . 10.5 tp -57.59 167.01 1.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.05 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.65 132.35 53.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.458 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 10.9 mtmm -81.21 -48.34 1.06 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 102' ' ' LYS . 90.2 Cg_endo -83.73 52.89 3.92 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.501 2.134 . . . . 0.0 112.462 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 108' ' ' ARG . 0.6 OUTLIER -127.31 160.89 29.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 179.888 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -63.56 1.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.159 -179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.65 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.4 p -179.99 -34.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 -179.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -39.87 -38.31 0.66 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 0.6 OUTLIER -71.04 -39.77 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.413 179.564 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.714 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 21.0 t80 -57.14 -28.32 62.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.74 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -48.03 67.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.331 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.4 mp -66.73 -52.19 47.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.973 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.85 ' CG2' HD12 ' A' ' 77' ' ' ILE . 28.8 m -46.36 -32.61 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 0.0 110.728 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.714 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 22.1 mm -78.18 -67.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.488 ' HZ1' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -50.42 -19.66 0.91 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.941 -179.939 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.41 ' CG ' ' OH ' ' A' ' 97' ' ' TYR . 1.8 t-80 -89.58 -27.84 19.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 110.754 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.01 -35.49 57.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 48' ' ' VAL . 63.7 m-85 -79.73 -45.77 18.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -54.52 -50.27 68.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.1 -3.65 46.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.41 44.41 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.977 0.418 . . . . 0.0 110.962 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.84 179.978 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.795 0.331 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm 63.82 128.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.466 ' HB3' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -162.37 127.66 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.721 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' A' ' 48' ' ' VAL . 39.5 t -116.86 143.72 26.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.727 0.298 . . . . 0.0 110.685 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.599 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 19.1 tp -96.88 132.3 42.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.061 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.874 ' HB ' HG22 ' A' ' 30' ' ' THR . 21.9 t -116.35 89.0 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 32' ' ' LYS . 23.9 t -84.88 112.74 22.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.104 0.478 . . . . 0.0 111.167 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -146.12 136.51 23.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.565 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -51.27 -24.31 4.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -58.82 -163.47 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.688 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -147.15 150.16 34.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.915 0.388 . . . . 0.0 111.283 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 13' ' ' ILE . 2.9 m 58.73 77.27 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.211 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.781 ' HA ' HG21 ' A' ' 30' ' ' THR . 8.1 mm 50.55 159.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.742 0.782 . . . . 0.0 112.557 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.521 ' N ' HG22 ' A' ' 13' ' ' ILE . 72.0 p -91.55 145.81 24.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.983 178.737 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -68.2 137.11 54.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.601 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.529 ' CB ' HG11 ' A' ' 106' ' ' VAL . 0.8 OUTLIER 83.59 -16.94 0.52 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.28 179.316 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.005 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -86.39 -50.18 7.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 110.796 -179.899 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.15 -53.67 12.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.884 HD11 HG13 ' A' ' 106' ' ' VAL . 85.9 mt -67.85 -69.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.005 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.94 -30.23 1.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.98 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.87 -30.59 69.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.734 179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.47 -35.29 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.014 179.486 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.887 ' HG3' HD21 ' A' ' 110' ' ' LEU . 23.4 mm-40 -85.06 178.56 7.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.662 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.25 31.58 6.93 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.219 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.36 -175.55 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.199 0.523 . . . . 0.0 111.301 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.9 OUTLIER -151.05 95.79 3.35 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.811 179.61 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.547 ' HB3' HD13 ' A' ' 21' ' ' LEU . 57.6 Cg_endo -72.94 140.51 31.77 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.251 1.968 . . . . 0.0 112.481 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -115.42 -1.31 12.87 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.874 HG22 ' HB ' ' A' ' 6' ' ' VAL . 48.9 p 12.66 122.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -132.38 159.96 37.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.444 178.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.737 ' O ' HG13 ' A' ' 7' ' ' VAL . 31.5 mttt -73.48 -168.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 56' ' ' PRO . 16.8 p -48.04 161.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 111.909 -178.212 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.68 HD22 ' CD2' ' A' ' 63' ' ' PHE . 10.4 mt -27.24 -44.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.648 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.18 -62.36 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.318 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 2.1 tp10 -65.38 -34.73 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.507 ' C ' HD12 ' A' ' 41' ' ' ILE . . . -61.22 -63.14 1.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -44.67 -40.7 6.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.382 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -52.62 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.42 -34.28 76.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.835 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.507 HD12 ' C ' ' A' ' 37' ' ' ALA . 4.3 mt -85.27 -5.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.667 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -93.02 29.18 1.9 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.959 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -147.69 -53.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.953 HD11 ' CE1' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -99.31 -174.63 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -122.48 111.16 16.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.953 ' CE1' HD11 ' A' ' 44' ' ' LEU . 67.6 m-85 -98.58 125.59 42.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.41 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 4.3 Cg_endo -81.44 -23.97 4.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.711 2.274 . . . . 0.0 111.485 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.626 HG21 ' CE1' ' A' ' 117' ' ' PHE . 6.2 t -141.55 131.06 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.567 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 46' ' ' PHE . 8.8 mm -118.25 152.08 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.344 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.52 102.29 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.036 0.445 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.739 ' HB3' HG22 ' A' ' 78' ' ' VAL . 8.8 tp -94.3 129.62 40.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.063 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -113.33 113.15 24.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.417 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.816 HG22 ' CB ' ' A' ' 80' ' ' THR . 5.2 m -76.08 56.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.41 . . . . 0.0 111.542 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -64.76 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.489 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.677 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 35.1 mtm -149.01 51.78 1.03 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.949 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.5 Cg_exo -81.12 -153.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -163.19 30.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.23 134.51 7.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -58.64 105.79 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.89 -33.82 70.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.598 HG13 ' HG3' ' A' ' 94' ' ' LYS . 57.4 t -55.49 -39.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.014 0.435 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -23.64 59.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.183 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.839 ' CE2' HD11 ' A' ' 67' ' ' ILE . 39.7 t80 -75.35 -30.16 60.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 61' ' ' VAL . 5.4 mm -50.65 -33.74 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 69' ' ' GLU . 27.3 t70 -71.56 -39.57 70.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.53 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 14.7 t80 -55.19 -43.68 74.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.845 HG21 HG22 ' A' ' 76' ' ' VAL . 4.0 mp -59.57 -46.28 93.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.397 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -79.31 -13.27 59.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.748 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 65' ' ' ASP . 43.2 tt0 -74.38 -43.15 57.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.113 0.483 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.53 ' ND2' ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -118.55 13.61 13.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.037 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.89 66.43 2.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.925 0.393 . . . . 0.0 110.72 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.4 Cg_exo -69.13 -19.63 38.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.632 2.221 . . . . 0.0 112.243 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' HB3' ' CD2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -103.29 27.3 7.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.931 179.909 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -109.68 -157.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 116' ' ' ALA . 60.7 t -150.23 137.54 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.064 0.459 . . . . 0.0 111.726 179.212 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.845 HG22 HG21 ' A' ' 67' ' ' ILE . 1.6 t -116.35 91.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.445 HG22 ' CG1' ' A' ' 79' ' ' ILE . 27.6 mm -72.38 -59.26 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.114 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 51' ' ' LEU . 47.9 t 51.63 92.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.837 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.936 HG23 ' O ' ' A' ' 100' ' ' LEU . 3.0 mt -116.42 145.71 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.992 0.425 . . . . 0.0 111.558 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.816 ' CB ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER 168.27 104.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.686 179.504 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.77 119.64 6.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.496 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 31.6 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 162.68 -113.71 0.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.47 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.92 168.48 9.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 85' ' ' VAL . 29.3 m -83.06 59.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.021 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -103.92 -28.78 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -85.47 -31.81 22.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 109.953 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -61.55 -56.59 18.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.777 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.8 m -52.58 -30.71 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.888 179.445 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.583 ' CD ' HG21 ' A' ' 61' ' ' VAL . 8.2 ttmt -75.98 -22.34 55.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.48 -40.72 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.87 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.892 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 9.2 pt -70.91 -42.94 77.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.321 -179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -23.38 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.554 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.598 ' HG3' HG13 ' A' ' 61' ' ' VAL . 4.1 mmpt? -79.76 -57.83 3.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.61 28.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.495 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.18 -164.52 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.12 0.46 . . . . 0.0 110.68 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.519 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 54.8 t80 -101.87 -23.18 14.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.6 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 3.8 pt-20 150.07 -11.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.603 0.565 . . . . 0.0 111.932 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.625 ' CE1' HG12 ' A' ' 78' ' ' VAL . 1.5 t80 69.98 71.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.121 0.486 . . . . 0.0 110.085 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.936 ' O ' HG23 ' A' ' 79' ' ' ILE . 66.1 tp -49.77 165.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.189 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.456 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 7.7 mt-10 -124.12 97.43 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.635 ' HD3' HG23 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -142.25 51.72 2.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.058 -179.781 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 60.2 Cg_endo -71.73 -5.8 17.82 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.483 2.122 . . . . 0.0 112.812 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -137.44 -45.43 0.55 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.048 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 92.5 p -107.23 96.03 6.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.884 HG13 HD11 ' A' ' 20' ' ' ILE . 7.1 p -82.0 -1.97 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.389 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.93 -41.91 77.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -60.83 -34.85 75.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.455 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.613 ' HA ' HD21 ' A' ' 100' ' ' LEU . 6.2 t80 -61.35 -39.78 91.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.429 178.826 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.887 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.2 tt -48.72 -51.71 27.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.31 179.379 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -57.35 -46.57 83.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.4 m -60.8 -40.17 91.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.223 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.0 mm -47.97 -54.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.535 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.91 -59.15 3.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -51.73 -29.46 18.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.867 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -65.33 -33.94 77.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.965 0.412 . . . . 0.0 110.672 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.626 ' CE1' HG21 ' A' ' 48' ' ' VAL . 35.1 m-85 -78.45 -23.01 46.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.291 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.37 -25.58 10.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.808 0.337 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.7 -12.8 61.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.198 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -138.25 34.56 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.755 179.8 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.988 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.812 0.339 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmtp -128.42 116.93 20.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.33 133.57 24.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.842 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 48' ' ' VAL . 18.6 t -128.03 161.08 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.799 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.697 HD22 ' CD2' ' A' ' 46' ' ' PHE . 28.0 tp -112.51 134.64 53.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.718 ' HB ' HG22 ' A' ' 30' ' ' THR . 22.0 t -116.23 90.28 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.823 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.6 106.02 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.772 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 14' ' ' THR . 10.0 t70 -136.66 133.11 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.989 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 16.8 t70 -51.85 -45.1 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.277 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -176.64 135.87 0.24 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.661 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 12' ' ' SER . 3.8 pt-20 45.34 -161.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.779 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 47.3 t 74.39 -86.3 0.03 OUTLIER 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.39 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.554 HG23 ' HB2' ' A' ' 17' ' ' LEU . 32.4 mm -78.63 -49.84 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.761 0.315 . . . . 0.0 111.674 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.472 HG22 ' HB ' ' A' ' 30' ' ' THR . 12.1 p -49.9 -31.3 11.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.63 -179.422 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -90.11 -47.02 8.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.544 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -74.88 -69.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.661 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.891 HD13 ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -40.71 -48.02 2.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.68 -179.393 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.68 ' O ' HD22 ' A' ' 21' ' ' LEU . 6.6 t -51.17 -41.73 60.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 110.924 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.35 74.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.313 0.577 . . . . 0.0 109.892 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.846 ' CD1' HG11 ' A' ' 106' ' ' VAL . 2.0 mp -75.51 -63.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.965 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.891 ' CD1' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.11 -13.35 1.17 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.088 -179.241 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.68 ' N ' HD23 ' A' ' 21' ' ' LEU . 3.6 mt-10 -85.07 -26.03 27.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.79 0.329 . . . . 0.0 110.313 179.034 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -35.55 26.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.394 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.868 ' HG2' HD21 ' A' ' 110' ' ' LEU . 3.3 mp0 -73.98 -50.37 20.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.67 57.05 0.22 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.194 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 82.1 m-85 -120.24 -174.74 2.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.072 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.77 89.17 40.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.058 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 85.2 Cg_endo -81.32 124.95 4.97 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.522 2.148 . . . . 0.0 113.062 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.97 7.52 46.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.718 HG22 ' HB ' ' A' ' 6' ' ' VAL . 11.7 p 4.42 122.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.2 168.18 10.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.428 178.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' ASP . 37.1 mttm -88.93 -37.89 14.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -155.95 -179.5 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.734 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.542 HD22 ' CG ' ' A' ' 63' ' ' PHE . 11.2 mt -61.88 -33.89 75.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.549 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -48.19 71.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.191 179.293 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.51 -30.15 68.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.498 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.4 -33.9 69.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 33.7 mt-10 -67.84 -42.56 81.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -33.73 76.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.088 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -75.83 -42.81 48.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.509 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.498 HD12 ' O ' ' A' ' 37' ' ' ALA . 9.3 mt -72.49 -26.95 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.109 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -26.76 13.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -122.27 -42.5 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 139.83 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -103.72 101.93 11.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.77 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.697 ' CD2' HD22 ' A' ' 5' ' ' LEU . 25.8 m-85 -94.82 120.09 65.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.9 Cg_endo -73.64 -12.38 24.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.43 2.087 . . . . 0.0 111.759 179.096 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.649 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.4 t -151.94 135.11 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.43 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 12.3 mm -115.83 161.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.633 178.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' LEU . 60.7 t -149.72 94.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.542 . . . . 0.0 111.642 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.884 ' HB3' HG13 ' A' ' 78' ' ' VAL . 11.6 tp -77.59 171.1 15.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.289 179.624 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 6.4 t70 -139.65 -46.43 0.45 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.395 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 53' ' ' VAL . 21.5 t 66.24 40.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -57.79 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.525 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.676 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.7 mmm -148.05 51.36 1.03 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.059 179.241 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.676 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.8 Cg_endo -87.56 -155.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.036 2.49 . . . . 0.0 112.021 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -148.67 38.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.02 168.87 22.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.515 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.0 111.58 24.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.38 -19.4 66.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.752 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.574 ' O ' HD12 ' A' ' 64' ' ' ILE . 18.8 t -53.12 -48.85 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.859 0.362 . . . . 0.0 111.357 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -14.08 58.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.299 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 67' ' ' ILE . 44.6 t80 -71.87 -37.7 70.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.683 0.277 . . . . 0.0 111.225 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mt -47.89 -28.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.285 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -34.24 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 72.6 t80 -60.12 -38.68 83.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.139 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -60.32 -45.97 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 179.369 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -77.91 -24.24 48.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -64.57 -33.61 76.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.0 17.52 5.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.182 -179.836 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.82 70.02 1.04 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.823 0.344 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.2 -18.79 34.73 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.842 2.361 . . . . 0.0 112.254 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -98.89 30.42 3.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.824 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 41.6 t -114.71 -162.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.641 ' HB ' HG13 ' A' ' 48' ' ' VAL . 30.8 t -154.31 136.5 6.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.68 0.276 . . . . 0.0 111.284 179.201 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.953 HG12 HG23 ' A' ' 78' ' ' VAL . 4.9 t -110.38 110.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.837 -179.036 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 77' ' ' ILE . 28.1 mm -111.11 43.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.662 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.953 HG23 HG12 ' A' ' 76' ' ' VAL . 47.7 t -43.36 121.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.587 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.521 HG23 ' HB3' ' A' ' 100' ' ' LEU . 3.8 mt -121.34 150.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.805 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.478 HG22 ' CG2' ' A' ' 53' ' ' VAL . 30.5 p -157.66 166.32 33.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.9 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.76 65.83 0.58 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.505 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -93.79 -30.53 14.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.778 0.323 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.77 20.14 69.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.6 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.4 m -119.06 -7.51 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m 43.11 31.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.727 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -111.25 -10.36 14.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.401 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.5 t -89.38 -36.5 15.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.013 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -57.62 -58.21 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.843 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.406 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.1 m -55.14 -27.11 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.578 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HE3' HG22 ' A' ' 61' ' ' VAL . 31.0 ttpt -82.21 -20.35 37.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.134 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.59 -40.3 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.498 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.939 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 12.5 pt -68.71 -31.52 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -26.4 67.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.697 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -73.74 -59.59 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 31.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.332 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.939 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.09 -164.67 1.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.025 0.412 . . . . 0.0 110.438 179.3 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.555 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.6 t80 -105.22 -22.02 13.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.53 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 144.52 14.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.733 0.645 . . . . 0.0 111.773 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER 62.15 163.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 110.643 -179.881 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -107.48 97.04 6.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.649 179.856 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.1 164.76 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.529 ' N ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER 64.3 58.71 1.63 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.244 -179.914 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 102' ' ' LYS . 15.5 Cg_exo -67.47 63.99 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.571 2.181 . . . . 0.0 112.108 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.29 -61.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.03 -179.849 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.5 p -97.97 136.42 38.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 20' ' ' ILE . 12.4 p -80.23 -35.84 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.007 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -45.94 -41.82 12.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.936 0.398 . . . . 0.0 110.909 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.467 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -64.04 -34.79 78.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.166 179.362 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.631 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 6.3 t80 -68.03 -28.93 67.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.522 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.868 HD21 ' HG2' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -50.67 -42.69 56.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.068 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 108' ' ' ARG . 3.3 mp -56.37 -56.2 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.836 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.418 ' CG2' HD12 ' A' ' 77' ' ' ILE . 90.9 m -46.62 -44.06 17.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.055 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.631 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 24.2 mm -54.53 -69.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.037 0.446 . . . . 0.0 110.43 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.418 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -54.9 -17.9 4.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.876 179.111 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -89.8 -21.23 22.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.34 -37.34 18.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.971 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 48' ' ' VAL . 35.0 m-85 -73.09 -39.29 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.9 -28.2 61.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.294 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.65 -5.72 44.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.596 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.48 31.23 2.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.899 0.38 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 25.4 mmtt 62.26 117.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.405 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -147.99 124.75 11.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 48' ' ' VAL . 25.2 t -119.6 159.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.707 HD23 HG23 ' A' ' 49' ' ' ILE . 41.7 tp -114.04 136.29 53.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.579 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.777 HG21 HD12 ' A' ' 17' ' ' LEU . 3.6 t -120.79 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 37' ' ' ALA . 30.2 t -78.14 119.47 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.567 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 12.3 t0 -163.75 154.74 16.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.747 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -85.23 48.99 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.73 139.44 50.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.653 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.87 -67.66 0.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.109 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.5 p -85.28 -165.79 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.008 -179.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.606 HG21 ' CA ' ' A' ' 18' ' ' SER . 7.6 mm -49.28 164.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.813 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.517 ' N ' HG22 ' A' ' 13' ' ' ILE . 64.2 p -90.23 -99.42 0.1 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.103 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.721 ' HB3' HG13 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -91.46 -155.13 0.39 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.745 0.307 . . . . 0.0 111.523 -179.591 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' LEU . 52.6 m -47.53 -22.23 0.45 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.869 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.977 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -32.14 -49.55 0.2 Allowed 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 110.482 179.238 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.606 ' CA ' HG21 ' A' ' 13' ' ' ILE . 7.7 t -47.78 -67.14 0.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.111 179.289 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.53 75.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.693 ' CD1' HG23 ' A' ' 106' ' ' VAL . 13.7 mt -61.59 -63.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.346 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.977 HD11 HD13 ' A' ' 17' ' ' LEU . 1.5 mt -45.07 -36.18 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.329 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -27.85 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.136 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' ILE . 12.3 tt0 -87.1 -41.98 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.507 ' OE2' HD21 ' A' ' 110' ' ' LEU . 5.3 mm-40 -75.31 -43.33 51.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.75 32.71 5.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.558 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.698 ' HB2' HD23 ' A' ' 21' ' ' LEU . 48.9 m-85 -81.42 -174.63 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.894 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.98 86.05 53.1 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.031 179.332 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.546 ' HG3' HD13 ' A' ' 21' ' ' LEU . 94.0 Cg_endo -81.46 136.82 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 112.505 -179.363 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 30' ' ' THR . 7.2 t70 -113.53 3.02 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.03 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.731 HG22 ' HB ' ' A' ' 6' ' ' VAL . 26.4 p 9.84 121.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.12 -178.54 3.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.699 179.041 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 30.7 tttp -95.39 -38.62 10.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.667 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 6.2 t -165.76 -162.47 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.899 HD11 ' O ' ' A' ' 59' ' ' ASP . 14.9 mt -68.4 -47.36 67.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.657 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -60.78 -45.63 93.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 109.989 179.167 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -34.13 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 7' ' ' VAL . . . -70.29 -35.06 73.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.705 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG2' ' CD1' ' A' ' 66' ' ' PHE . 90.3 mt-10 -65.92 -41.31 91.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -38.07 85.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.601 178.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -74.06 -49.94 21.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.873 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.57 HG22 HD21 ' A' ' 70' ' ' ASN . 11.6 mt -66.9 -27.75 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.145 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -62.85 -23.99 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.095 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.06 -42.89 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.247 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 129.16 38.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -82.18 62.39 5.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.461 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.564 ' HB2' HD11 ' A' ' 49' ' ' ILE . 60.0 m-85 -55.34 121.31 36.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.475 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.446 ' O ' ' HA ' ' A' ' 74' ' ' SER . 61.0 Cg_endo -72.9 -22.92 19.35 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.435 2.09 . . . . 0.0 111.805 179.318 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 117' ' ' PHE . 4.5 t -142.68 125.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.316 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.707 HG23 HD23 ' A' ' 5' ' ' LEU . 8.3 mm -111.91 152.52 13.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.029 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 51' ' ' LEU . 4.9 t -134.87 177.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.432 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.875 ' HB3' HG13 ' A' ' 78' ' ' VAL . 29.4 tp -161.74 78.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.072 0.463 . . . . 0.0 111.101 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 8.6 t70 -70.72 67.84 0.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.517 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' A' ' 51' ' ' LEU . 50.4 t -47.12 92.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.474 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -79.19 -80.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.502 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.681 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -152.5 50.6 0.64 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.13 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.681 ' HD3' ' N ' ' A' ' 55' ' ' MET . 10.1 Cg_endo -90.57 -158.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.043 2.495 . . . . 0.0 112.015 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -157.74 58.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.096 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.48 10.79 4.06 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.788 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.899 ' O ' HD11 ' A' ' 34' ' ' LEU . 3.3 m-20 52.98 -162.02 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.717 0.258 . . . . 0.0 110.679 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.23 28.96 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.674 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.632 HG21 ' HD3' ' A' ' 90' ' ' LYS . 17.6 t -89.44 -44.91 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.13 9.56 27.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.569 -179.693 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.774 ' CE2' HD11 ' A' ' 67' ' ' ILE . 17.6 t80 -90.03 -36.88 14.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.704 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.6 mp -46.79 -28.97 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.403 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -35.89 65.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.539 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 12.3 t80 -62.74 -44.2 96.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.422 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.774 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.0 mp -59.27 -37.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.321 179.411 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -85.7 -20.19 29.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.719 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -69.59 -29.26 66.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.57 HD21 HG22 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -131.93 9.05 4.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.251 -179.873 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.03 67.79 3.21 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.854 0.359 . . . . 0.0 110.745 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.65 -15.37 21.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.799 2.333 . . . . 0.0 112.285 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.35 27.35 9.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.067 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 39.8 t -107.18 -163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.489 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.869 HG21 ' HB1' ' A' ' 116' ' ' ALA . 21.2 t -146.36 131.64 12.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 121.239 0.542 . . . . 0.0 112.457 179.338 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.006 HG12 HG23 ' A' ' 78' ' ' VAL . 1.3 t -105.25 110.72 31.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.094 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.704 HD12 ' CG2' ' A' ' 112' ' ' THR . 29.2 mm -109.25 38.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.137 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.006 HG23 HG12 ' A' ' 76' ' ' VAL . 60.0 t -42.63 115.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.295 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.896 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -105.64 179.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.87 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.692 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 59.5 122.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 111.289 179.787 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.54 172.85 22.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.431 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -68.1 -68.35 0.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 110.939 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.53 144.56 5.92 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.5 p 57.81 30.79 19.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.708 0.29 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m 42.18 59.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.776 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -104.12 -18.92 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -90.84 -36.16 14.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.393 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.78 -57.27 13.17 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.84 178.794 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -51.76 -26.86 7.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.632 ' HD3' HG21 ' A' ' 61' ' ' VAL . 8.9 tttt -89.09 36.74 0.83 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.22 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.704 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -170.31 -42.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.614 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -75.47 157.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.808 179.997 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.16 -3.2 2.52 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.102 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -112.6 -25.33 9.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.31 -34.92 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.25 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -68.91 177.63 2.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.773 0.321 . . . . 0.0 111.151 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.46 ' HB3' HD13 ' A' ' 77' ' ' ILE . 45.4 t80 -108.77 29.94 6.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.486 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.1 OUTLIER 80.15 142.71 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.932 179.773 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.61 ' CG ' ' HB2' ' A' ' 88' ' ' ALA . 1.6 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.38 -179.605 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.896 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -89.94 89.46 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.593 179.655 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -54.93 179.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.26 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp 61.59 64.44 2.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.99 178.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.538 2.159 . . . . 0.0 112.295 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 63.35 127.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.7 m 60.57 110.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.755 HG21 HD23 ' A' ' 17' ' ' LEU . 33.3 m -86.65 10.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.761 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -45.93 -47.85 16.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.664 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -70.45 -30.34 67.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.987 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.508 ' CE2' HG21 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -65.71 -25.15 67.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.447 179.522 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.507 HD21 ' OE2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -47.44 -50.15 23.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.883 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.608 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.5 mp -55.63 -47.56 76.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.476 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.704 ' CG2' HD12 ' A' ' 77' ' ' ILE . 97.7 m -49.29 -38.36 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.632 179.58 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.472 HG23 ' CE1' ' A' ' 117' ' ' PHE . 8.3 mm -66.48 -62.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.16 179.237 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.478 ' CG ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -55.56 -14.94 2.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.456 179.402 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.416 ' N ' ' HD3' ' A' ' 114' ' ' LYS . 2.0 m80 -90.41 -19.69 23.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.072 0.463 . . . . 0.0 110.266 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.869 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -89.98 -49.1 6.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.963 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 48' ' ' VAL . 36.9 m-85 -56.8 -30.8 64.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -55.4 -24.45 30.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.2 32.13 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -134.89 30.47 3.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.951 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.9 mtm . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.786 0.327 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 19.9 mmtt 61.05 97.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -143.64 128.04 17.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.651 179.948 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.2 t -121.5 151.45 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 -179.806 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.58 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 33.5 tp -101.24 136.53 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.752 0.31 . . . . 0.0 110.516 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.819 HG21 HD12 ' A' ' 17' ' ' LEU . 8.4 t -117.14 95.57 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 32' ' ' LYS . 87.6 t -89.34 116.22 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 0.0 111.243 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -145.37 112.68 6.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.879 179.841 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.537 ' HB2' HG23 ' A' ' 33' ' ' THR . 4.8 t70 -50.42 -79.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -178.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.7 OUTLIER -89.77 174.1 7.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.915 0.388 . . . . 0.0 111.244 -179.411 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.83 112.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.2 t -53.57 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.044 HD12 HG21 ' A' ' 30' ' ' THR . 24.0 mm 66.45 165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 121.163 0.506 . . . . 0.0 110.442 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.588 ' N ' HG22 ' A' ' 13' ' ' ILE . 2.7 p -90.34 101.59 14.32 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.788 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -42.57 140.92 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.285 -178.733 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.57 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.6 m 85.56 -17.57 0.41 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.62 179.054 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.991 HD23 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.66 -54.45 11.87 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.052 -179.672 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.0 -67.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.676 -179.562 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.65 -40.36 27.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.496 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.882 HG23 HD11 ' A' ' 110' ' ' LEU . 60.3 mt -64.72 -66.27 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.918 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.65 -29.44 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.13 -25.09 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.09 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -81.89 -41.11 21.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.869 0.366 . . . . 0.0 110.246 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.612 ' HG2' HD22 ' A' ' 110' ' ' LEU . 1.6 mp0 -75.85 -32.09 59.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.059 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.74 31.17 6.46 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 51.1 m-85 -88.27 -174.69 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -139.01 91.61 11.38 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.635 179.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 66.9 Cg_endo -76.88 145.49 25.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.18 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.9 t70 -120.09 -4.61 10.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.703 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.044 HG21 HD12 ' A' ' 13' ' ' ILE . 10.2 p 23.54 123.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.64 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -131.74 145.69 51.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.297 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.646 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -58.61 -173.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.521 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -48.36 167.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 111.654 -178.591 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 63' ' ' PHE . 11.8 mt -31.44 -39.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.481 -178.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -62.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.149 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.463 ' CB ' ' CB ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -64.81 -27.25 68.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.865 179.568 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.45 -57.39 4.47 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.391 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.472 ' HG3' ' CE1' ' A' ' 63' ' ' PHE . 64.5 mt-10 -46.31 -41.34 13.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -61.0 -53.28 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.541 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HD2' ' HB2' ' A' ' 31' ' ' ALA . 20.1 mttm -59.66 -35.03 73.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.129 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.731 HD12 ' HZ ' ' A' ' 63' ' ' PHE . 47.3 mt -92.3 -5.23 10.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLU . 2.8 tmtm? -56.75 -19.61 17.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.299 -179.813 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -139.43 -46.23 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 121.07 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -87.14 75.22 9.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 27.2 m-85 -66.09 132.33 94.56 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 74.1 Cg_endo -75.23 -30.38 6.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.411 2.074 . . . . 0.0 111.878 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.778 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.4 t -140.32 132.98 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.537 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 46' ' ' PHE . 20.9 mm -115.47 145.23 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.453 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 44.1 t -130.3 105.74 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 111.446 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 ' HA3' ' A' ' 60' ' ' GLY . 45.7 tp -100.33 147.88 25.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.3 179.398 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.704 ' C ' HG22 ' A' ' 80' ' ' THR . 7.4 t0 -119.11 -31.76 4.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.563 -179.38 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 53' ' ' VAL . 88.5 t 60.64 63.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.73 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.455 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 37.1 t-105 -58.83 -81.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.834 0.349 . . . . 0.0 110.383 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.71 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 ttt -151.97 48.82 0.5 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.085 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.8 Cg_exo -76.87 -150.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.789 2.326 . . . . 0.0 112.032 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -135.18 21.48 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.212 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.67 -3.71 4.98 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.029 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 61' ' ' VAL . 16.4 m-20 52.64 25.1 3.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.018 0.437 . . . . 0.0 111.167 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.668 ' HA3' HD21 ' A' ' 51' ' ' LEU . . . 49.6 18.63 1.73 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.623 179.637 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 90' ' ' LYS . 23.2 t -87.25 -45.1 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 117.149 0.474 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -65.78 -16.16 63.53 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 34' ' ' LEU . 3.7 t80 -85.65 -29.05 24.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.564 ' CD1' ' HB1' ' A' ' 91' ' ' ALA . 20.2 mm -46.59 -43.47 6.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.327 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -44.91 70.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 21.1 t80 -49.4 -41.06 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.975 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.792 HG21 HG22 ' A' ' 76' ' ' VAL . 2.1 mp -62.61 -49.97 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -12.09 60.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.466 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.92 -49.37 20.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.059 0.457 . . . . 0.0 110.394 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -114.18 17.04 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.05 67.2 2.05 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.736 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.22 -15.77 22.66 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.776 2.317 . . . . 0.0 112.265 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -112.61 32.91 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.83 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -111.89 -159.83 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.878 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.833 HG11 ' HB1' ' A' ' 116' ' ' ALA . 41.2 t -138.08 138.98 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.309 0.576 . . . . 0.0 112.293 179.728 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.874 HG12 HG23 ' A' ' 78' ' ' VAL . 6.2 t -114.41 99.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.317 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.641 HG21 ' CD1' ' A' ' 109' ' ' PHE . 35.0 mm -103.41 43.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.874 HG23 HG12 ' A' ' 76' ' ' VAL . 98.9 t -54.72 87.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.652 HG23 ' HB3' ' A' ' 100' ' ' LEU . 19.2 mt -66.25 -101.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.704 HG22 ' C ' ' A' ' 52' ' ' ASP . 1.0 OUTLIER 72.05 -61.96 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.237 . . . . 0.0 111.041 179.55 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' N ' ' OG1' ' A' ' 80' ' ' THR . . . 57.51 -88.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.565 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.68 29.0 18.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.951 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.17 -61.8 3.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.547 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.71 135.5 55.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.3 m -107.25 -7.74 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.609 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.72 -27.06 68.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.685 0.279 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.52 -34.24 54.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.8 -57.81 11.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.018 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 m -56.84 -22.83 16.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.956 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.523 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -80.41 2.81 23.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.248 179.753 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . -138.71 -40.53 0.5 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 1.6 pt -70.84 -24.59 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -71.74 -35.58 70.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -59.77 -59.21 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.65 31.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.995 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.24 -178.74 5.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.471 ' HB3' HD13 ' A' ' 77' ' ' ILE . 18.9 t80 -101.25 27.91 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.426 -179.758 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 77.64 151.96 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.971 179.927 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -74.19 139.26 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.652 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -83.64 92.11 7.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.556 179.869 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.53 154.16 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.066 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.42 72.59 0.72 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.995 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.23 57.0 6.27 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.575 2.183 . . . . 0.0 112.401 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -101.56 105.77 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.1 t 56.61 24.25 8.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.994 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.991 HG21 HD23 ' A' ' 17' ' ' LEU . 2.6 m 39.88 35.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.041 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.1 -50.86 29.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HA ' HD13 ' A' ' 111' ' ' LEU . 13.8 tpt180 -61.94 -29.63 70.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.417 178.514 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CD1' HG21 ' A' ' 77' ' ' ILE . 24.0 t80 -62.12 -40.71 96.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.712 178.804 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.882 HD11 HG23 ' A' ' 20' ' ' ILE . 2.0 mt -54.65 -48.83 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.263 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.482 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.4 mp -59.54 -50.45 73.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.028 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.0 m -61.5 -37.55 84.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.707 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.502 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 1.6 mm -55.76 -53.13 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.375 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -60.0 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 109.853 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -58.4 -26.13 62.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.998 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.833 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -66.14 -38.35 87.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.926 0.393 . . . . 0.0 110.977 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.597 ' CE2' HG21 ' A' ' 48' ' ' VAL . 20.7 m-85 -68.84 -20.04 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.632 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -56.99 -21.82 33.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -94.79 28.78 2.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.173 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -115.3 28.08 8.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.919 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ptp . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.862 0.363 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' HG3' ' CD2' ' A' ' 117' ' ' PHE . 2.0 mptt -111.94 119.59 39.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -111.39 124.73 52.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.458 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.671 HG13 ' HB ' ' A' ' 48' ' ' VAL . 26.9 t -124.33 144.33 34.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.329 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.654 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 46.8 tp -95.02 128.76 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.321 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.555 HG21 ' CD1' ' A' ' 17' ' ' LEU . 18.9 t -112.91 92.56 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.482 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 32' ' ' LYS . 60.1 t -89.99 118.72 35.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.029 0.442 . . . . 0.0 111.082 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -153.63 125.12 7.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.681 ' HB2' HG22 ' A' ' 33' ' ' THR . 21.2 t0 -85.73 47.59 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.329 -179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' CG ' ' CD1' ' A' ' 54' ' ' TRP . 4.0 tm-20 -120.68 -40.63 2.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.676 179.727 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -178.37 -165.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.407 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 p -56.81 -93.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.456 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.022 HD13 HG21 ' A' ' 30' ' ' THR . 7.8 mm -87.84 161.37 2.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.951 0.405 . . . . 0.0 111.052 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.477 ' N ' HG22 ' A' ' 13' ' ' ILE . 65.6 p -90.34 131.37 36.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.242 179.249 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -52.19 139.46 23.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 0.0 112.185 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.752 ' O ' HD12 ' A' ' 20' ' ' ILE . 8.7 t 73.54 0.72 3.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.449 179.109 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.36 -59.45 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.157 -179.918 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.63 ' O ' HD22 ' A' ' 21' ' ' LEU . 7.8 t -46.5 -45.94 18.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.591 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.14 73.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.376 0.607 . . . . 0.0 110.17 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 110' ' ' LEU . 41.7 mt -76.14 -64.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.774 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.771 ' CD1' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -56.74 -10.46 1.04 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.978 -179.186 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.571 ' N ' HD23 ' A' ' 21' ' ' LEU . 17.4 mt-10 -89.23 -28.6 19.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.033 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -36.1 32.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.013 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.769 ' CG ' HD21 ' A' ' 110' ' ' LEU . 30.5 mm-40 -77.77 -31.33 51.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.019 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 42.89 3.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.512 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 7.2 m-85 -95.83 -170.31 2.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 -179.066 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.08 93.47 5.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.455 ' HD3' ' HG ' ' A' ' 21' ' ' LEU . 73.3 Cg_endo -79.67 146.78 19.17 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.384 2.056 . . . . 0.0 112.011 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.658 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -115.76 -7.26 12.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.022 HG21 HD13 ' A' ' 13' ' ' ILE . 11.7 p 25.51 124.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -141.89 141.88 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.901 178.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.844 ' O ' HG13 ' A' ' 7' ' ' VAL . 39.4 mtmt -58.79 -165.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.56 0.219 . . . . 0.0 110.564 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.681 HG22 ' HB2' ' A' ' 9' ' ' ASP . 14.9 p -47.89 168.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 112.149 -177.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.815 HD11 ' O ' ' A' ' 59' ' ' ASP . 22.5 mt -40.81 -31.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.97 -179.075 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -64.3 0.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.14 0.495 . . . . 0.0 109.84 179.181 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.5 -33.72 76.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.461 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 34' ' ' LEU . . . -64.88 -61.66 2.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.729 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 7.5 mt-10 -44.05 -42.12 5.93 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -61.44 -51.74 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -63.35 -33.95 76.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.336 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 41' ' ' ILE . 8.3 mt -88.95 -9.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -57.67 -19.42 26.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.501 -179.735 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -134.64 -47.25 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 124.72 20.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -84.96 72.0 10.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.654 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 25.0 m-85 -65.79 126.77 92.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.79 -27.62 3.84 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.508 2.139 . . . . 0.0 112.074 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.717 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.8 t -140.51 132.62 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.346 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.448 HD11 ' CB ' ' A' ' 46' ' ' PHE . 18.5 mm -118.73 148.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.138 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 49.0 t -136.86 104.57 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.488 179.532 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp -98.99 97.68 8.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -83.42 92.79 7.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.953 178.936 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.761 HG22 ' HB ' ' A' ' 80' ' ' THR . 28.0 m -63.87 74.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.789 -179.211 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.442 ' CD1' ' CG ' ' A' ' 10' ' ' GLU . 30.3 t-105 -81.75 -80.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.514 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.498 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 21.9 mmt -145.67 61.4 7.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.809 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 55' ' ' MET . 11.1 Cg_endo -89.2 -159.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.128 2.552 . . . . 0.0 112.32 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -153.77 25.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.141 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.96 10.66 5.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.629 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.815 ' O ' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 55.92 -157.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.788 0.294 . . . . 0.0 110.212 -179.703 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.7 22.04 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.898 ' O ' HD12 ' A' ' 64' ' ' ILE . 20.4 t -86.83 -45.15 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 110.879 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -1.16 50.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CD2' HD11 ' A' ' 67' ' ' ILE . 6.5 t80 -76.32 -41.14 49.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.4 mt -43.81 -38.42 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.329 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.32 -51.37 57.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.427 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 34.0 t80 -53.68 -28.5 33.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.097 179.289 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.984 HG21 HG22 ' A' ' 76' ' ' VAL . 2.9 mm -68.25 -54.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -71.3 -22.06 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.557 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.93 -52.89 61.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.701 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -112.62 18.0 18.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.161 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.4 68.15 1.71 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 110.801 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.35 -19.33 33.45 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.804 2.336 . . . . 0.0 112.361 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -113.17 35.96 3.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -112.64 -156.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.809 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.717 ' HB ' HG13 ' A' ' 48' ' ' VAL . 50.0 t -146.49 138.72 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.436 0.636 . . . . 0.0 112.16 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 67' ' ' ILE . 2.8 t -118.35 80.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.149 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -65.56 -54.93 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.78 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.809 HG23 HG12 ' A' ' 76' ' ' VAL . 34.4 t 49.44 89.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.32 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.749 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -99.33 -173.96 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.761 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.7 m 80.22 103.62 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.352 . . . . 0.0 110.963 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.76 59.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.43 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.0 -54.81 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 110.97 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.45 -91.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.546 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 t -63.82 110.29 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.6 t -92.09 14.38 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.407 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.49 -15.87 28.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.099 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.13 -32.86 38.92 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.51 -57.95 10.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.099 178.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 92' ' ' ILE . 17.5 m -61.84 -27.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.207 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.528 ' O ' HG13 ' A' ' 61' ' ' VAL . 4.8 ttmt -80.56 -12.91 59.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.647 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.663 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -114.1 -24.34 9.05 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.834 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 4.9 pt -90.1 -15.05 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.272 . . . . 0.0 111.635 -179.564 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.69 -42.74 67.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.737 0.303 . . . . 0.0 111.123 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.611 ' HB3' HD13 ' A' ' 64' ' ' ILE . 9.4 ttmt -54.82 -35.1 63.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.77 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.157 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.1 -167.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.33 . . . . 0.0 110.899 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 9.3 t80 -108.44 27.28 9.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.219 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.9 OUTLIER 80.66 159.7 0.16 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.154 179.759 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.734 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -92.13 104.39 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.827 -179.962 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HB3' HG23 ' A' ' 79' ' ' ILE . 9.9 tp -57.78 147.33 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -102.01 167.64 9.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.992 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.1 mttm 62.75 55.91 2.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.32 81.53 2.01 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.523 2.149 . . . . 0.0 112.239 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -148.17 -66.07 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.2 t -100.83 9.32 42.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.625 -179.731 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.722 HG21 HD23 ' A' ' 17' ' ' LEU . 3.5 m 33.9 36.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -70.72 -51.89 24.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -58.64 -32.22 68.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.583 ' CE1' HD11 ' A' ' 113' ' ' ILE . 28.4 t80 -61.54 -36.92 81.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.267 178.557 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.833 ' CD1' HG23 ' A' ' 20' ' ' ILE . 3.2 tt -55.61 -60.09 3.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.1 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' H ' HD12 ' A' ' 111' ' ' LEU . 3.5 mp -60.29 -46.98 87.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.628 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.6 m -61.19 -40.07 92.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.583 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.7 mm -50.28 -52.38 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.657 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -55.52 7.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.115 0.483 . . . . 0.0 110.323 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -56.03 -27.37 52.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.949 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.696 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -65.94 -36.19 82.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.98 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.675 ' CE1' HG21 ' A' ' 48' ' ' VAL . 50.9 m-85 -80.82 -35.23 33.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.69 -54.18 5.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.229 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -72.89 -7.43 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.542 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.47 41.02 1.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.347 . . . . 0.0 110.92 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.942 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -134.37 125.33 27.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.786 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.01 134.21 21.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.667 HG13 ' HB ' ' A' ' 48' ' ' VAL . 5.6 t -124.16 152.6 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.905 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 52.4 tp -105.03 127.93 53.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.166 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.908 HG21 ' CD1' ' A' ' 17' ' ' LEU . 21.5 t -113.42 92.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.372 . . . . 0.0 111.604 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.653 ' HB ' HD12 ' A' ' 51' ' ' LEU . 43.8 t -78.97 115.24 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 34.5 t70 -157.31 155.53 30.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.806 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -88.27 49.33 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.969 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -126.75 167.16 16.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.24 -149.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -44.09 106.41 0.07 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.895 0.378 . . . . 0.0 111.178 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.612 HD13 ' CG2' ' A' ' 30' ' ' THR . 19.8 mm 56.05 168.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.644 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.596 ' N ' HG22 ' A' ' 13' ' ' ILE . 37.5 p -83.58 168.17 16.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.19 127.11 31.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 t 80.41 -39.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.52 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.908 ' CD1' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -46.04 -61.13 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.145 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.823 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -39.79 -61.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.7 -178.703 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.98 12.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.277 0.561 . . . . 0.0 110.88 179.427 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.619 HD13 HG22 ' A' ' 106' ' ' VAL . 10.4 mt -76.04 -71.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.019 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -50.49 -30.25 12.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.416 -179.558 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.946 ' N ' HD13 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -74.22 -25.95 59.97 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.764 0.316 . . . . 0.0 110.705 178.945 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.75 -37.13 30.99 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.171 179.43 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.635 ' CD ' HD21 ' A' ' 110' ' ' LEU . 16.5 mm-40 -66.84 -28.82 68.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.46 42.91 3.31 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.377 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 72.5 m-85 -113.82 -177.61 3.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 111.156 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.95 106.7 28.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.776 179.124 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.671 ' HD3' HD21 ' A' ' 21' ' ' LEU . 98.3 Cg_endo -92.9 128.32 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.809 2.34 . . . . 0.0 113.218 -178.806 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.1 t70 -107.32 6.55 28.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.794 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.638 HG22 ' HB ' ' A' ' 6' ' ' VAL . 1.7 p -2.74 125.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.31 -162.2 0.88 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.713 179.16 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -109.4 -40.86 4.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.016 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.11 -175.58 5.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.7 HD22 ' CD2' ' A' ' 63' ' ' PHE . 60.8 mt -61.77 -45.99 91.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -61.26 -46.77 88.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.993 0.425 . . . . 0.0 110.1 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.23 -30.49 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.413 179.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.46 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.23 -31.62 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.677 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 60.9 mt-10 -70.14 -40.16 74.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.9 77.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.317 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -75.04 -37.54 61.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.811 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 37' ' ' ALA . 12.9 mt -75.48 -26.04 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -7.33 47.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -112.82 -30.73 6.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.76 0.314 . . . . 0.0 111.233 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.622 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -128.21 156.1 43.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.786 -179.862 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 48.2 t80 -93.96 98.14 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 39.4 m-85 -80.44 123.54 82.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.33 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.476 ' O ' ' HA ' ' A' ' 74' ' ' SER . 87.9 Cg_endo -82.75 -21.59 4.88 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.578 2.186 . . . . 0.0 111.905 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.667 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.8 t -148.76 133.57 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.095 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.536 HD12 HD23 ' A' ' 5' ' ' LEU . 15.3 mm -119.66 160.81 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.794 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 79' ' ' ILE . 95.1 t -153.27 99.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.653 HD12 ' HB ' ' A' ' 7' ' ' VAL . 12.6 tp -69.1 166.17 18.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.565 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -161.88 76.09 0.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.422 -179.742 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -63.42 75.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.583 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -66.94 -80.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.749 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -152.65 44.28 0.26 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.28 178.767 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.749 ' HD3' ' N ' ' A' ' 55' ' ' MET . 41.1 Cg_endo -97.96 -77.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.178 2.585 . . . . 0.0 112.368 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -170.15 -51.39 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.509 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.45 -131.64 42.74 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.946 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.59 44.08 7.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.54 67.93 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.839 ' O ' HD12 ' A' ' 64' ' ' ILE . 80.1 t -59.35 -33.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.035 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.11 5.96 24.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.7 ' CD2' HD22 ' A' ' 34' ' ' LEU . 19.4 t80 -72.17 -35.26 68.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.756 0.312 . . . . 0.0 111.164 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.2 mp -51.38 -32.96 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.222 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.86 -33.36 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.553 179.673 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 33.7 t80 -60.19 -42.87 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.3 mp -61.32 -44.85 99.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.21 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -74.85 -22.66 58.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.54 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -67.09 -38.06 85.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.36 18.23 8.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.442 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -167.73 69.58 0.89 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.629 -179.941 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.85 -20.04 39.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.788 2.325 . . . . 0.0 112.312 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -107.26 30.9 5.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.895 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 32.3 t -108.27 -162.48 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HB ' HG13 ' A' ' 48' ' ' VAL . 63.7 t -149.9 135.02 10.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 111.834 179.249 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.644 HG12 HG23 ' A' ' 78' ' ' VAL . 22.6 t -107.42 116.8 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.063 -178.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.69 HD12 ' CG2' ' A' ' 112' ' ' THR . 17.2 mm -120.85 48.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.118 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.65 HG13 HD23 ' A' ' 51' ' ' LEU . 89.3 t -45.64 134.31 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.228 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.561 HD11 HG13 ' A' ' 50' ' ' VAL . 3.3 mt -132.66 167.74 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER 66.52 156.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 179.565 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.47 173.31 32.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.391 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -59.41 -51.29 70.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -166.78 -45.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.84 167.98 9.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.837 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.7 t -87.48 66.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.096 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 89' ' ' VAL . 33.5 t70 -115.01 -58.62 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -47.34 -34.2 6.61 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.12 0.485 . . . . 0.0 110.498 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.831 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.94 -59.49 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.192 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 86' ' ' ASP . 25.0 m -62.03 -24.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.005 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.591 ' HD3' HG21 ' A' ' 61' ' ' VAL . 7.5 ttmm -84.77 -18.95 33.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.356 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.05 -32.54 8.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.7 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.908 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 8.1 pt -78.19 -17.73 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.774 -179.382 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -85.68 -17.18 36.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.68 0.276 . . . . 0.0 111.209 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.623 ' HB3' HD13 ' A' ' 64' ' ' ILE . 8.7 tttp -80.1 -24.52 40.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.302 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.27 -17.73 0.37 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.297 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.908 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.39 176.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.0 0.428 . . . . 0.0 111.426 -179.759 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.636 ' HB3' HD13 ' A' ' 77' ' ' ILE . 75.8 t80 -104.32 28.28 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.269 -179.458 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 81.63 140.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -59.48 143.96 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.105 -179.755 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.867 HD21 ' HA ' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -85.51 104.98 15.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.734 179.938 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -65.36 157.4 29.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.117 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.47 66.89 1.08 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.988 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.0 56.6 6.13 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.65 2.234 . . . . 0.0 112.31 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.477 ' HD2' ' HG ' ' A' ' 105' ' ' SER . 54.7 t80 -104.42 -67.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.661 ' O ' HG22 ' A' ' 106' ' ' VAL . 49.1 m -130.86 35.49 3.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.064 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.776 HG21 HD23 ' A' ' 17' ' ' LEU . 2.9 m 50.94 19.25 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.008 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.1 -52.97 30.5 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.543 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.69 -27.76 66.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.05 0.453 . . . . 0.0 110.138 179.115 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.867 ' HA ' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -61.22 -26.27 67.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.563 179.607 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.635 HD21 ' CD ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -52.13 -47.56 65.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 179.963 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.615 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 3.5 mp -70.8 -53.02 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.69 ' CG2' HD12 ' A' ' 77' ' ' ILE . 54.3 m -44.49 -35.78 2.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.12 0.485 . . . . 0.0 110.151 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 4' ' ' VAL . 14.3 mm -67.17 -66.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.173 178.824 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -55.88 -19.52 12.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 179.581 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -90.43 -35.51 15.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.649 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -69.66 -53.81 16.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.173 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.49 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 29.7 m-85 -56.04 -24.55 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -61.56 -18.18 58.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.391 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -88.88 14.02 11.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.503 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.415 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 37.6 t80 -105.92 31.55 4.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 110.778 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.977 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 mtp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.447 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 9.6 mmtm -106.55 124.35 49.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.44 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.66 100.65 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.639 HG13 ' HB ' ' A' ' 48' ' ' VAL . 36.3 t -90.57 161.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.686 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.591 HD13 ' CE2' ' A' ' 46' ' ' PHE . 25.8 tp -108.78 136.17 48.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG21 HD12 ' A' ' 17' ' ' LEU . 6.5 t -123.94 90.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 37' ' ' ALA . 25.4 t -89.33 104.3 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.071 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.7 142.71 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.479 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.26 48.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 0.0 111.025 -179.759 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.8 tp10 -160.94 111.96 1.8 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.99 179.848 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 55.91 -179.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.138 179.703 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -67.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.757 ' CD1' HG21 ' A' ' 30' ' ' THR . 8.9 mm -98.08 162.8 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.515 HG23 ' CG1' ' A' ' 6' ' ' VAL . 63.2 p -90.21 145.56 24.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.737 179.012 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.0 t -57.44 133.52 55.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.028 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.457 ' O ' HD12 ' A' ' 20' ' ' ILE . 7.0 t 84.95 -31.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.752 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.926 HD23 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -66.77 -59.79 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.49 -179.122 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.634 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -47.32 -49.73 23.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.623 -179.211 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.435 0.636 . . . . 0.0 110.122 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.638 HD13 HG23 ' A' ' 106' ' ' VAL . 45.4 mt -75.88 -65.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.723 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.907 HD12 HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.82 -11.47 1.01 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.172 -179.181 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.619 ' N ' HD23 ' A' ' 21' ' ' LEU . 6.0 mt-10 -88.07 -27.29 22.07 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.891 0.377 . . . . 0.0 110.155 178.954 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.86 -36.06 23.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.918 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.6 mp0 -76.53 -29.87 56.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.247 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.36 47.9 2.49 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.179 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.61 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.0 m-85 -103.66 -172.08 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.056 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -143.56 89.9 7.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.357 179.568 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.7 Cg_endo -80.46 137.26 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.484 2.123 . . . . 0.0 112.612 -179.377 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -99.6 -1.41 38.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.574 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.757 HG21 ' CD1' ' A' ' 13' ' ' ILE . 12.9 p 8.51 123.43 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.14 -162.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.209 178.434 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -117.96 -28.55 5.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.754 0.311 . . . . 0.0 111.361 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.57 -168.91 1.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.804 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.63 HD22 ' CD2' ' A' ' 63' ' ' PHE . 29.5 mt -65.06 -43.85 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.79 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -57.67 -50.79 72.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.447 179.566 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -69.42 -29.47 67.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.717 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CB ' HG21 ' A' ' 7' ' ' VAL . . . -75.51 -29.59 59.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 71.4 mt-10 -73.03 -37.37 66.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.979 0.418 . . . . 0.0 109.887 179.088 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -68.46 -35.65 77.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.167 179.223 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.16 -32.55 61.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.697 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 37' ' ' ALA . 23.9 mt -86.95 -24.67 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.183 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -25.61 8.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.228 179.997 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.92 -61.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 122.82 15.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.9 76.38 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.877 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CE2' HD13 ' A' ' 5' ' ' LEU . 55.6 m-85 -64.91 141.28 98.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.704 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 2.7 Cg_endo -84.48 -20.45 3.95 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.938 2.425 . . . . 0.0 111.81 179.382 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.67 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.6 t -146.57 133.03 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 46' ' ' PHE . 23.7 mm -116.52 157.09 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.419 HG13 HG13 ' A' ' 79' ' ' ILE . 84.3 t -149.76 97.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.156 0.503 . . . . 0.0 111.139 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HB3' HG22 ' A' ' 78' ' ' VAL . 5.4 tp -92.37 129.59 38.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.747 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -110.49 115.67 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.668 179.693 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 53' ' ' VAL . 4.7 m -78.52 56.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.839 -179.346 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.472 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 35.4 t-105 -63.07 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.778 179.83 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.517 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.4 ttt -147.4 44.05 0.36 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.252 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.3 Cg_endo -76.97 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.441 2.094 . . . . 0.0 112.144 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -125.27 -42.86 1.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.989 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.57 148.05 51.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -76.38 116.24 16.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.16 -30.28 63.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.604 ' O ' HD12 ' A' ' 64' ' ' ILE . 22.8 t -54.18 -44.67 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 111.514 -179.9 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.89 0.84 37.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.742 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.796 ' CE2' HD11 ' A' ' 67' ' ' ILE . 23.5 t80 -89.81 -34.0 16.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.891 0.377 . . . . 0.0 111.043 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.644 HG23 HG11 ' A' ' 76' ' ' VAL . 2.7 mp -47.74 -28.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.428 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 16.1 t0 -79.64 -32.87 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.711 179.797 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 17.2 t80 -61.87 -39.31 91.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.796 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.5 mp -63.86 -50.54 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.174 179.14 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -69.29 -26.7 64.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.404 179.205 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 17.8 tt0 -60.3 -42.51 95.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.657 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.9 18.5 13.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.9 75.12 0.48 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.337 . . . . 0.0 110.844 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -85.96 -6.71 8.46 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.202 2.601 . . . . 0.0 113.099 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -98.74 -15.62 19.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.986 0.422 . . . . 0.0 111.303 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -72.18 -153.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -179.914 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' HG13 ' A' ' 48' ' ' VAL . 47.1 t -144.48 133.59 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-O 121.335 0.588 . . . . 0.0 111.921 178.692 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.644 HG11 HG23 ' A' ' 64' ' ' ILE . 97.3 t -104.83 99.16 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.147 -179.368 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.514 HG22 HG12 ' A' ' 79' ' ' ILE . 45.8 mm -90.36 -56.41 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.755 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 44.7 t 49.4 85.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.495 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.894 HD11 ' CD1' ' A' ' 109' ' ' PHE . 2.1 mt -96.31 143.0 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.044 0.45 . . . . 0.0 111.757 -179.259 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.634 HG21 ' N ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 162.6 -175.7 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.46 179.567 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.45 -52.71 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.532 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 61.9 t60 60.28 29.49 19.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.22 -54.23 0.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 t -137.03 -172.84 3.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.37 . . . . 0.0 110.976 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 88' ' ' ALA . 20.9 t -111.07 41.66 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.199 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.494 ' O ' HG22 ' A' ' 89' ' ' VAL . 23.6 p30 -82.25 -26.85 32.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.949 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CE2' ' A' ' 99' ' ' PHE . 4.5 t -71.56 -34.78 70.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 179.392 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -56.45 -58.86 6.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.066 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 86' ' ' ASP . 35.9 m -55.08 -24.89 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.913 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 61' ' ' VAL . 12.4 ttmt -85.85 7.42 24.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.265 179.805 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.72 -41.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.618 -179.82 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.903 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.9 pt -65.01 -18.44 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.322 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -94.67 21.79 7.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.743 179.382 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -138.33 -51.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.48 15.08 0.07 OUTLIER Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.802 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.903 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -89.26 175.08 7.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.602 0.701 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.549 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 67.4 t80 -94.77 -14.86 24.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.62 -179.356 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 5.5 pt-20 142.87 -13.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.523 0.729 . . . . 0.0 111.163 179.275 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.755 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 73.71 131.66 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.912 0.387 . . . . 0.0 110.539 -179.67 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -91.67 155.59 18.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -179.866 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -92.04 173.65 7.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.522 179.668 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 65.2 84.37 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.678 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.85 -6.8 17.83 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.748 2.299 . . . . 0.0 113.101 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -98.24 -54.82 2.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.049 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.4 p -102.82 163.96 11.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.098 -179.856 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.926 HG21 HD23 ' A' ' 17' ' ' LEU . 24.5 m -130.09 4.63 2.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.577 -179.895 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -38.34 -44.77 0.93 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.741 0.305 . . . . 0.0 111.627 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -74.01 -36.22 64.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.133 179.385 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.894 ' CD1' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -54.99 -24.16 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.696 179.278 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -65.72 -44.45 86.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.508 -179.831 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' H ' HD12 ' A' ' 111' ' ' LEU . 7.0 mp -54.98 -55.85 26.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.044 -179.647 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 98.1 m -60.82 -39.03 87.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.2 -179.872 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -45.91 -53.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.754 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.48 -61.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -56.66 -27.31 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.924 179.606 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -64.5 -42.11 96.03 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.903 0.383 . . . . 0.0 110.926 179.833 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.67 ' CE1' HG21 ' A' ' 48' ' ' VAL . 19.0 m-85 -69.5 -22.4 63.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.274 -179.964 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.68 -24.02 19.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.202 -179.878 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.76 -10.88 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.432 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -143.08 29.99 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.828 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.989 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.0 mtp . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.823 0.344 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.424 ' HD2' ' CD1' ' A' ' 117' ' ' PHE . 6.5 mmtt -110.64 137.18 48.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.404 ' CG ' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -144.63 126.29 15.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.913 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 48' ' ' VAL . 24.8 t -117.72 144.37 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 110.592 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 61.7 tp -100.89 127.54 47.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.23 -179.488 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.698 HG21 ' CD1' ' A' ' 17' ' ' LEU . 29.3 t -112.71 94.99 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 179.875 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.915 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 84.4 t -85.6 117.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.505 179.596 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -159.26 149.97 19.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.947 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 25.5 t70 -70.22 -74.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.064 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -76.87 167.84 21.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -98.74 44.99 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.99 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 p -82.22 -43.51 17.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.532 HG22 ' CB ' ' A' ' 17' ' ' LEU . 44.7 mm -90.08 -41.32 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.044 179.907 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 p -56.97 -21.15 28.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.257 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -30.28 57.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.16 -61.61 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.961 -179.846 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.698 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.8 tm? -43.54 -50.8 7.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.038 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -54.27 -39.35 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.424 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.02 84.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.903 ' CD1' HG11 ' A' ' 106' ' ' VAL . 1.6 mp -56.61 -64.0 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.705 179.661 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -50.36 -35.43 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.122 0.487 . . . . 0.0 110.472 179.374 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -24.15 65.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.948 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.78 -37.62 26.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.41 179.877 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -69.61 -48.38 60.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 179.912 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.19 44.84 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 98.9 m-85 -113.74 -170.46 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 0.0 111.159 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 3' ' ' ARG . 0.7 OUTLIER -139.5 72.08 37.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.388 179.578 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 35.8 Cg_exo -57.76 136.62 76.63 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.804 2.336 . . . . 0.0 112.359 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.1 t70 -113.54 -12.95 12.82 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.694 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 29' ' ' ASP . 69.5 p 44.39 177.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.677 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.915 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -160.84 -165.51 1.4 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.374 179.771 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' HG23 ' A' ' 33' ' ' THR . 7.7 mttm -124.84 -35.27 2.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.849 0.357 . . . . 0.0 111.064 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -166.36 177.06 7.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.216 179.904 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.09 HD21 HD22 ' A' ' 51' ' ' LEU . 26.5 mt -61.06 -37.04 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.645 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -47.88 69.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.918 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.51 -31.58 72.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB2' ' CG2' ' A' ' 7' ' ' VAL . . . -69.37 -65.06 0.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.487 179.588 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -41.58 -41.23 2.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -64.43 -48.85 73.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.825 178.937 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -69.2 -25.65 64.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.543 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 37' ' ' ALA . 7.2 mt -92.43 -20.82 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.699 0.285 . . . . 0.0 111.439 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -47.53 -26.96 1.58 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.656 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.02 -51.08 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.134 -179.779 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.11 128.75 38.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.137 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -85.57 68.83 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.653 179.64 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 26.1 m-85 -65.54 122.82 82.37 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.309 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' VAL . 77.3 Cg_endo -77.21 -28.49 5.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.629 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 4' ' ' VAL . 6.3 t -140.39 125.66 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.496 -179.632 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.13 149.2 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.497 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 79' ' ' ILE . 86.8 t -141.57 96.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 179.927 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.09 HD22 HD21 ' A' ' 34' ' ' LEU . 24.2 tp -84.63 78.35 9.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.5 t0 -73.32 83.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 53' ' ' VAL . 3.4 m -63.1 109.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -108.12 -84.39 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.585 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -72.85 -43.43 8.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.327 179.428 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 55' ' ' MET . 78.7 Cg_endo -76.09 -167.9 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.338 2.025 . . . . 0.0 112.345 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -102.92 -33.01 9.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.93 50.36 68.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.398 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -96.78 32.48 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -73.71 63.59 1.9 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.341 179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -51.48 -44.63 33.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -70.98 -24.57 62.43 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.418 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.003 ' CE2' HD11 ' A' ' 67' ' ' ILE . 59.2 t80 -56.34 -46.56 79.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.288 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.708 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.3 mp -47.02 -29.04 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.108 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -37.4 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 4.4 t80 -56.43 -47.26 79.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 1.003 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -55.55 -42.78 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.585 179.605 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -78.61 -23.16 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.663 179.361 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.71 -41.63 83.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.987 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.86 12.78 13.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.246 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.88 66.87 2.07 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.66 179.792 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.59 -19.74 41.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.594 2.196 . . . . 0.0 112.029 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.2 18.18 18.13 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.3 t -99.39 -161.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.408 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 47' ' ' PRO . 21.4 t -151.22 135.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.314 0.578 . . . . 0.0 112.536 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 78' ' ' VAL . 6.1 t -102.95 90.94 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.579 -179.564 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.665 HG21 ' HE1' ' A' ' 109' ' ' PHE . 24.1 mm -101.01 36.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.219 179.283 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 76' ' ' VAL . 63.2 t -43.95 107.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.785 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 100' ' ' LEU . 4.4 mt -101.4 147.99 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.587 ' HB ' HG22 ' A' ' 53' ' ' VAL . 30.9 p -156.16 153.86 29.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.25 136.39 4.63 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.428 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 62.18 75.53 0.4 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.902 0.382 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.39 59.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.582 -179.998 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m 63.6 131.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -109.77 30.78 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 89' ' ' VAL . 46.1 t0 -94.5 -41.95 9.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.991 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -53.68 -30.91 45.72 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 121.157 0.504 . . . . 0.0 109.876 179.146 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.841 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.69 -60.14 4.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.33 179.096 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 86' ' ' ASP . 32.9 m -63.06 -25.3 38.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.579 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.82 -29.84 25.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -88.66 -39.05 14.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.906 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.8 pt -72.06 -11.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.473 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.86 -35.03 22.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.926 0.393 . . . . 0.0 110.495 179.573 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -60.03 -61.61 2.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.32 28.63 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.111 179.897 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.21 176.36 6.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.928 0.364 . . . . 0.0 110.962 179.717 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.448 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.6 t80 -101.08 29.38 4.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.779 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 78.22 138.46 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.995 179.904 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.3 m-85 -66.1 126.28 28.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.715 -179.916 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -69.9 67.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.884 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -120.23 111.13 17.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.057 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.472 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -169.07 -63.01 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.679 179.715 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 102' ' ' LYS . 93.1 Cg_endo -82.27 -167.37 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.504 2.136 . . . . 0.0 112.229 179.733 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.54 31.28 4.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.409 . . . . 0.0 110.744 179.695 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.8 t -152.51 -167.77 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.814 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.903 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.6 p -107.13 -31.76 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.147 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -40.2 -43.26 1.63 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.587 -179.751 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.68 -41.19 88.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 0.0 110.462 179.65 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.665 ' HE1' HG21 ' A' ' 77' ' ' ILE . 6.4 t80 -59.02 -29.08 66.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.651 179.497 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.448 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -65.92 -38.37 88.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.48 -55.57 33.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.969 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.3 m -59.94 -42.65 94.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.625 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 3.9 mm -44.25 -56.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.781 -179.588 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -59.88 3.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.808 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -53.65 -27.0 24.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.936 179.508 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -68.17 -40.75 82.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.912 0.386 . . . . 0.0 110.774 179.721 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 19.6 m-85 -69.69 -24.65 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.503 -179.87 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -52.22 -25.39 9.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.286 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.34 -6.08 49.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.374 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 31.4 t80 -128.45 30.6 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.964 0.412 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.3 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.988 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ttt . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.829 0.347 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 6.2 mmtp -129.28 93.97 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.969 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -145.93 110.21 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.502 HG13 ' HB ' ' A' ' 48' ' ' VAL . 12.2 t -95.31 149.09 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 29' ' ' ASP . 61.5 tp -111.33 137.06 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 0.0 111.288 -179.438 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.866 HG21 ' CD1' ' A' ' 17' ' ' LEU . 21.8 t -118.31 138.37 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.56 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' HD12 ' A' ' 51' ' ' LEU . 8.1 t -129.58 115.99 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.306 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.17 135.06 12.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -92.0 50.03 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.9 -45.57 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.877 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.26 -79.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.717 179.924 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 p -128.8 -82.18 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.464 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.539 HG23 HG21 ' A' ' 30' ' ' THR . 8.5 mm -101.28 161.01 3.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.918 0.39 . . . . 0.0 110.969 179.742 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.503 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 7.2 p -90.46 136.27 33.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.919 178.795 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.4 m -51.07 131.45 27.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.995 -179.04 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.54 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER 85.85 -31.46 0.05 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.94 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.979 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -57.06 -61.82 2.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.701 0.286 . . . . 0.0 111.126 -179.498 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.51 -64.98 0.55 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.474 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.86 -39.93 40.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.233 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.608 HG23 ' CD1' ' A' ' 110' ' ' LEU . 46.3 mt -67.68 -70.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 -179.917 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.979 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -48.06 -30.14 4.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.056 0.455 . . . . 0.0 110.368 179.507 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.84 -30.03 71.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -78.19 -39.45 40.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.076 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.815 ' HG3' HD21 ' A' ' 110' ' ' LEU . 70.5 mm-40 -79.23 -174.25 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.355 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.28 42.84 1.83 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.119 179.852 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.572 ' CE2' HG21 ' A' ' 113' ' ' ILE . 22.0 m-85 -100.8 178.95 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.491 0.662 . . . . 0.0 111.731 -179.428 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.3 85.82 60.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.762 178.458 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.684 ' HB3' HD22 ' A' ' 21' ' ' LEU . 80.6 Cg_endo -79.97 127.54 6.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.7 2.266 . . . . 0.0 114.041 -177.939 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.854 ' O ' HD12 ' A' ' 5' ' ' LEU . 5.1 t70 -119.14 117.32 28.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.474 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.539 HG21 HG23 ' A' ' 13' ' ' ILE . 27.7 p -104.08 143.3 33.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 112.061 -178.558 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.2 -167.04 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.054 179.13 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -130.82 -6.55 4.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -170.72 175.13 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.765 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 63' ' ' PHE . 87.6 mt -66.12 -32.98 74.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -70.11 -40.19 75.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.997 179.203 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.1 -36.17 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.344 179.375 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.51 -50.22 22.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.608 179.521 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 4.9 tt0 -47.22 -45.87 23.75 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.409 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -53.73 54.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.584 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 7.6 mmtp -58.0 -24.57 58.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.823 179.498 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 41' ' ' ILE . 16.4 mt -98.53 -11.77 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.589 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -73.17 -10.42 59.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.691 0.281 . . . . 0.0 111.316 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -135.78 -46.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.763 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -75.1 116.5 15.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.715 179.869 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.2 64.32 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.36 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 19.9 m-85 -58.12 119.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.092 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 46.4 Cg_endo -69.13 -45.1 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.696 2.264 . . . . 0.0 111.946 179.772 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.502 ' HB ' HG13 ' A' ' 4' ' ' VAL . 21.3 t -118.54 125.02 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.553 -179.437 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -109.26 128.29 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG21 ' CE1' ' A' ' 109' ' ' PHE . 62.0 t -123.02 104.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.061 0.457 . . . . 0.0 111.206 -179.872 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.472 HD12 ' HB ' ' A' ' 7' ' ' VAL . 36.5 tp -92.96 83.9 4.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.958 179.954 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.4 OUTLIER -72.62 75.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 -179.85 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.711 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.2 p -55.36 84.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.474 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 25.3 t-105 -86.34 -82.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.735 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.474 ' HG2' ' CD1' ' A' ' 54' ' ' TRP . 3.4 ptm -142.04 48.46 1.14 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 111.131 179.456 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 55' ' ' MET . 72.7 Cg_endo -76.31 -168.19 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.493 2.129 . . . . 0.0 112.253 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -137.59 31.27 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.76 175.35 18.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.16 93.64 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.16 65.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.652 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 64' ' ' ILE . 26.3 t -53.85 -43.6 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 111.419 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 2.75 32.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.536 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.806 ' CE2' HD11 ' A' ' 67' ' ' ILE . 20.0 t80 -89.99 -43.26 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.054 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 91' ' ' ALA . 2.3 mp -45.37 -28.84 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.652 -179.808 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -70.38 -56.06 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.579 ' HD1' HD12 ' A' ' 67' ' ' ILE . 1.5 t80 -48.57 -37.63 18.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.832 0.348 . . . . 0.0 110.557 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.806 HD11 ' CE2' ' A' ' 63' ' ' PHE . 1.5 mp -60.77 -46.44 96.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.085 179.435 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -77.31 -21.44 53.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.549 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.85 -50.6 63.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.67 12.58 21.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.379 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -158.48 66.65 3.29 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.803 0.335 . . . . 0.0 110.784 179.766 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 6.5 Cg_exo -72.72 -16.95 26.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.727 2.285 . . . . 0.0 112.205 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.71 28.41 6.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -112.07 -178.05 3.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 76' ' ' VAL . 16.4 t -119.35 162.99 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.786 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.889 HG12 HG23 ' A' ' 78' ' ' VAL . 1.7 t -137.92 83.77 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 77' ' ' ILE . 16.5 mm -91.84 48.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.889 HG23 HG12 ' A' ' 76' ' ' VAL . 34.9 t -57.42 136.31 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.95 HG21 ' HG2' ' A' ' 102' ' ' LYS . 1.7 mt -134.82 -149.0 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.365 -179.506 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.711 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 57.76 -172.51 0.09 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 111.006 179.791 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.41 94.04 1.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -77.57 173.96 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.24 -159.63 39.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.58 169.79 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.61 63.38 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -109.54 -26.48 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.436 HG23 ' CE2' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -74.32 -32.29 62.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.909 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.724 ' HB1' ' HB2' ' A' ' 99' ' ' PHE . . . -59.79 -59.22 5.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.16 178.927 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -59.23 -23.47 24.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.013 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -90.74 40.58 1.02 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -170.06 -38.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -76.16 -28.68 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.947 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -31.4 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.597 179.713 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -63.76 -30.26 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.67 28.31 0.12 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.265 179.792 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.14 178.87 6.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.901 0.35 . . . . 0.0 110.808 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 47.9 t80 -97.49 28.27 3.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER 85.11 162.75 0.1 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.556 179.583 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.724 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.56 97.01 10.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.728 179.982 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 16.1 tp -55.84 160.68 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.191 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.444 ' C ' ' HG3' ' A' ' 102' ' ' LYS . 12.7 mp0 -100.9 -37.67 8.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 179.796 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.95 ' HG2' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 32.4 57.23 1.28 Allowed Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.354 179.909 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 87.9 Cg_endo -81.97 50.38 3.45 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.668 2.246 . . . . 0.0 112.461 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 103' ' ' PRO . 2.0 m-85 -175.31 40.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.34 . . . . 0.0 111.301 -179.907 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 16' ' ' SER . 0.9 OUTLIER 69.45 67.85 0.25 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 179.672 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.941 HG21 HD23 ' A' ' 17' ' ' LEU . 3.0 m 40.49 25.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.4 tt0 -65.17 -51.87 58.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.338 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -60.43 -33.92 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.623 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.526 ' CE1' HD11 ' A' ' 113' ' ' ILE . 13.7 t80 -59.44 -33.4 71.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.415 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.815 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -64.03 -44.65 91.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.772 179.116 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 107' ' ' GLU . 3.9 mp -65.92 -46.47 78.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.213 -179.802 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.0 m -67.84 -41.43 82.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.423 . . . . 0.0 110.366 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.572 HG21 ' CE2' ' A' ' 26' ' ' TYR . 1.6 mm -46.96 -52.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.194 179.758 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.3 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 179.798 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -56.87 -39.93 75.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.561 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -54.52 -30.89 55.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.504 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.489 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 52.7 m-85 -91.13 -55.44 3.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.462 -179.799 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.89 -50.26 69.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.606 -179.53 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -73.31 -6.56 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.759 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.23 45.16 2.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.907 0.384 . . . . 0.0 110.916 179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.945 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.911 0.386 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -155.4 128.7 8.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.002 -179.916 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 136.07 25.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.993 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 48' ' ' VAL . 34.4 t -128.53 150.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.984 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.019 HD23 HG23 ' A' ' 49' ' ' ILE . 24.4 tp -113.75 142.52 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.038 0.447 . . . . 0.0 111.575 -179.195 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.762 HG21 HD12 ' A' ' 17' ' ' LEU . 21.9 t -117.06 143.81 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.298 179.866 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.609 ' HB ' HD12 ' A' ' 51' ' ' LEU . 17.6 t -133.26 119.76 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.339 179.251 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 2.8 t70 -154.59 163.5 40.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.487 -179.324 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.58 49.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.0 111.104 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -126.55 -174.19 3.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.715 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.54 -79.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' ILE . 0.5 OUTLIER -93.83 177.07 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.687 179.953 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.675 ' HA ' HG21 ' A' ' 30' ' ' THR . 5.5 mm -30.79 157.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.017 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.466 ' N ' HG22 ' A' ' 13' ' ' ILE . 7.7 p -90.26 125.84 35.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.229 179.117 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -45.95 142.42 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.302 -179.611 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 87.85 -36.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.768 179.799 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.081 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -71.99 -48.17 46.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 -179.968 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 p -50.74 -65.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.81 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.457 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.69 HG23 ' CD1' ' A' ' 110' ' ' LEU . 71.2 mt -63.64 -69.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.966 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.081 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -48.57 -31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 179.819 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.63 66.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.829 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.3 -34.49 31.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.763 ' HG3' HD21 ' A' ' 110' ' ' LEU . 68.4 mm-40 -77.57 -38.1 49.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.141 -179.913 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.51 43.83 3.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.052 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 9.6 m-85 -102.29 -174.93 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.218 0.533 . . . . 0.0 111.328 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.5 80.01 16.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.904 178.381 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.694 ' CB ' HD13 ' A' ' 21' ' ' LEU . 91.6 Cg_endo -84.45 131.78 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.756 2.304 . . . . 0.0 113.972 -178.088 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.477 ' O ' HD12 ' A' ' 5' ' ' LEU . 11.4 t70 -129.24 132.35 47.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.447 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.682 HG22 ' HB ' ' A' ' 6' ' ' VAL . 17.8 p -119.97 139.24 52.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.0 112.069 -178.837 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 36' ' ' GLU . . . -110.82 -165.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 179.313 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 31.3 mttt -117.65 -25.73 6.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.844 0.354 . . . . 0.0 111.228 -179.975 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -164.11 174.18 11.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.398 179.891 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.853 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.9 mt -58.63 -28.85 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.606 179.835 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -47.83 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.649 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -64.45 -35.0 79.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.374 179.263 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.39 -53.46 48.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.478 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 28.6 mt-10 -50.83 -38.98 52.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.452 179.55 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -59.89 -43.29 94.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.721 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -73.88 -47.01 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.641 179.41 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.62 -18.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -19.82 61.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.729 0.299 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.14 -50.73 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 117.38 13.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -83.42 66.26 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.751 179.825 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 5' ' ' LEU . 44.8 m-85 -58.62 135.84 86.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.963 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 7.4 Cg_endo -81.16 -35.19 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.512 2.141 . . . . 0.0 112.009 179.451 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.607 ' O ' HD13 ' A' ' 49' ' ' ILE . 18.3 t -126.69 136.3 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 179.691 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.019 HG23 HD23 ' A' ' 5' ' ' LEU . 1.6 mm -135.67 105.37 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.834 HG22 ' CG1' ' A' ' 77' ' ' ILE . 21.8 t -103.42 131.8 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.759 0.314 . . . . 0.0 110.632 179.519 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 7' ' ' VAL . 11.5 tp -99.78 146.87 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.138 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.83 106.85 9.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.415 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.454 ' C ' HG21 ' A' ' 80' ' ' THR . 23.7 t -80.95 70.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.521 -179.482 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.41 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 4.4 t-105 -72.06 -78.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.081 179.399 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.6 ptt? -149.15 48.95 0.63 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.213 179.132 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 55' ' ' MET . 14.7 Cg_endo -92.86 -159.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.164 2.576 . . . . 0.0 112.165 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -161.22 52.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.932 179.786 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.86 149.79 19.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.553 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.21 108.74 10.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.17 -18.73 48.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.903 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.727 ' O ' HD12 ' A' ' 64' ' ' ILE . 21.4 t -58.52 -58.96 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.27 -21.9 63.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.915 ' CE2' HD11 ' A' ' 67' ' ' ILE . 33.8 t80 -60.32 -40.46 90.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.5 mt -47.19 -28.33 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -74.76 -35.67 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.679 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CE1' ' HG2' ' A' ' 38' ' ' GLU . 19.1 t80 -61.57 -45.14 95.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.323 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.915 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -58.0 -41.68 80.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 179.341 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -81.44 -23.3 37.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 179.521 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -64.36 -31.6 72.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.361 179.476 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.67 16.04 4.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.923 179.944 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -169.53 73.41 0.69 Allowed Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.725 179.948 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.09 -7.35 11.12 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.093 2.529 . . . . 0.0 112.604 -179.79 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.5 -6.25 27.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.63 -179.866 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.44 -172.65 4.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 -179.768 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.437 HG11 ' HB1' ' A' ' 116' ' ' ALA . 67.2 t -127.24 144.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 -179.781 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG12 HG23 ' A' ' 78' ' ' VAL . 2.1 t -123.12 98.08 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.06 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.834 ' CG1' HG22 ' A' ' 50' ' ' VAL . 44.2 mm -73.91 -67.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.731 -179.068 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.549 HG13 HD23 ' A' ' 51' ' ' LEU . 12.2 t 63.17 98.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -98.14 -144.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.623 -179.109 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.466 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 56.5 87.44 0.06 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.827 0.346 . . . . 0.0 110.897 -179.796 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.96 42.41 0.24 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -73.99 -44.86 53.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 110.866 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.77 -51.41 1.66 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.439 -179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -97.66 68.56 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.46 -19.09 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.286 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.6 ' O ' HG22 ' A' ' 89' ' ' VAL . 1.6 m-20 -53.28 -34.4 57.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.126 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.452 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 2.2 t -59.15 -33.95 71.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.969 0.414 . . . . 0.0 110.376 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.21 -59.11 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.248 179.355 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 86' ' ' ASP . 33.5 m -58.94 -27.52 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.056 179.499 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -80.54 -13.25 59.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.94 -35.02 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 111.736 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.891 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -77.16 -26.32 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.65 -179.484 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -66.19 -28.33 68.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.587 179.652 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -58.12 3.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.8 37.2 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -89.99 -163.77 1.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.903 179.797 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 40.1 t80 -107.99 23.37 14.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.544 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.425 ' HA ' HG21 ' A' ' 92' ' ' ILE . 0.4 OUTLIER 80.56 19.89 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.755 179.449 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 61.78 162.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 111.038 179.465 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 101' ' ' GLU . 1.1 tm? -101.02 133.28 45.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.82 ' N ' HD13 ' A' ' 100' ' ' LEU . 1.6 mm-40 -65.05 -65.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.505 ' HB2' HD12 ' A' ' 100' ' ' LEU . 1.3 ttpm? 62.27 62.12 2.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.49 0.48 9.9 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.686 2.258 . . . . 0.0 112.854 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.27 -75.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.0 110.948 -179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -155.42 -168.9 2.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.867 HG21 HD23 ' A' ' 17' ' ' LEU . 13.2 p -59.83 -33.84 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.051 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -45.69 -38.17 6.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 179.877 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.53 80.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.02 179.282 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 4.7 t80 -58.52 -26.47 63.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.168 179.293 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.763 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -58.75 -49.67 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.102 179.708 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.3 -54.78 35.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.083 -179.797 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 113' ' ' ILE . 66.5 m -49.48 -57.32 7.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.878 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 11.3 mm -29.9 -63.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.64 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 114' ' ' LYS . 4.9 tmmm? -48.91 -58.66 4.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.792 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -53.69 -27.72 29.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.579 178.979 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -70.89 -42.55 69.85 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.762 179.692 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.53 ' CE1' HG21 ' A' ' 48' ' ' VAL . 24.7 m-85 -59.63 -21.48 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.0 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.4 -21.09 22.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.18 27.72 2.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.166 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 47' ' ' PRO . 11.0 t80 -110.73 28.8 8.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.835 179.794 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.969 -179.996 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.83 0.348 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER -121.03 127.93 52.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.912 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -153.69 133.85 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 179.88 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 48' ' ' VAL . 45.6 t -116.54 162.0 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.781 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 29' ' ' ASP . 66.8 tp -118.21 147.24 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 111.446 -179.526 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.643 HG11 HG23 ' A' ' 14' ' ' THR . 4.0 t -126.42 142.56 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.058 179.775 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 7.0 t -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.301 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 3.3 t70 -150.6 153.98 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.333 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.6 48.71 1.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.841 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.25 148.09 24.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.685 179.881 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.48 163.16 24.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.047 -179.784 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m 64.29 -171.3 0.18 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.151 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.779 HD13 HG21 ' A' ' 30' ' ' THR . 20.4 mm -79.41 166.38 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.643 HG23 HG11 ' A' ' 6' ' ' VAL . 29.3 p -80.4 128.37 33.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.255 179.505 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 16' ' ' SER . 13.9 p -35.07 128.02 0.52 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 15' ' ' SER . 3.2 p 82.99 -43.84 0.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.222 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.893 HD13 HD11 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -53.23 -50.84 63.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 111.216 -179.566 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.69 -65.47 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.47 -40.65 18.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.757 HG23 ' CD1' ' A' ' 110' ' ' LEU . 37.4 mt -59.44 -67.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.893 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -48.74 -31.72 7.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.805 179.525 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.16 -31.63 71.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.748 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.91 -34.89 22.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.472 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.667 ' CD ' HD21 ' A' ' 110' ' ' LEU . 52.9 mm-40 -81.29 -38.39 26.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.206 -179.795 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 76.8 1.32 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.168 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 39.8 m-85 -130.65 -174.43 3.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.349 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -119.84 80.8 25.47 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.17 178.798 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 97.6 Cg_endo -84.22 135.03 6.14 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.771 2.314 . . . . 0.0 113.928 -178.335 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.804 ' O ' HD12 ' A' ' 5' ' ' LEU . 16.3 t70 -123.42 128.63 50.12 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.384 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.779 HG21 HD13 ' A' ' 13' ' ' ILE . 82.7 p -98.66 146.74 25.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -126.87 128.9 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.433 178.93 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 33' ' ' THR . 7.7 mttm -82.48 -10.32 59.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.65 167.11 7.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.304 179.791 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.722 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.8 mt -59.18 -22.35 60.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 110.329 179.436 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -46.2 33.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.794 178.834 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.92 -30.96 71.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.135 179.176 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.69 -56.05 5.21 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.619 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HG3' ' CE1' ' A' ' 63' ' ' PHE . 54.3 mt-10 -44.81 -43.27 8.54 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.618 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.95 -53.0 61.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.74 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 4.5 mmtt -60.6 -30.01 69.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.978 179.581 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 41' ' ' ILE . 50.9 mt -92.23 -9.29 10.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 38' ' ' GLU . 13.7 tttt -74.3 -8.64 56.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 111.027 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.36 -47.13 0.51 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -73.91 118.54 16.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.708 179.764 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -76.46 62.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.757 179.856 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.702 ' CD2' HD22 ' A' ' 5' ' ' LEU . 25.4 m-85 -55.3 116.75 12.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.77 -31.51 10.32 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.333 2.022 . . . . 0.0 112.203 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.63 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.8 t -132.16 129.87 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.587 -179.791 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.711 HD12 HD23 ' A' ' 5' ' ' LEU . 14.3 mm -118.71 144.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.185 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.481 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 60.6 t -137.23 109.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.388 -179.98 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 42.1 tp -98.28 93.13 6.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . 6.6 t0 -77.88 91.93 4.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.398 179.275 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 53' ' ' VAL . 27.9 m -62.65 79.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.793 -179.383 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -78.9 -91.05 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.249 179.599 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.544 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 ttm -143.36 58.72 6.79 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.639 0.257 . . . . 0.0 110.855 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.7 Cg_endo -89.51 -157.64 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.176 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -155.59 28.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.37 149.43 18.64 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 81.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.75 0.309 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.26 90.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 90' ' ' LYS . 50.8 t -62.03 -40.25 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.965 0.412 . . . . 0.0 110.909 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -15.45 62.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.39 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.903 ' CE2' HD11 ' A' ' 67' ' ' ILE . 30.4 t80 -84.33 -30.0 25.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 61' ' ' VAL . 6.4 mm -48.63 -30.57 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.092 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.3 t0 -74.14 -47.95 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.734 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.575 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 10.2 t80 -48.25 -43.52 32.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.851 0.357 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.903 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.9 mp -59.96 -47.85 90.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.421 179.438 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.85 -16.19 59.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.964 179.576 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 65' ' ' ASP . 12.2 tt0 -73.12 -46.69 49.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.765 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.575 ' ND2' ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -114.41 13.72 17.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.948 -179.78 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.422 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.44 65.53 2.35 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.776 179.836 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.6 Cg_exo -76.07 -13.97 19.06 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.646 2.231 . . . . 0.0 112.192 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.06 27.63 8.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -112.28 -166.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 48' ' ' VAL . 21.4 t -129.02 139.96 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.342 0.592 . . . . 0.0 111.831 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.829 HG12 HG23 ' A' ' 78' ' ' VAL . 3.0 t -128.18 89.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.08 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.8 mm -79.63 -43.03 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.857 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.829 HG23 HG12 ' A' ' 76' ' ' VAL . 59.7 t 45.17 89.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.813 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.8 mt -99.66 179.05 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.035 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.655 ' H ' HG22 ' A' ' 79' ' ' ILE . 6.6 m 76.49 151.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.054 179.925 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.24 -108.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.364 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -164.07 -68.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.842 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.06 -80.94 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.418 -179.97 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -66.23 173.68 3.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.765 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 89' ' ' VAL . 11.4 m -100.52 33.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -75.93 -37.19 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.945 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -33.18 63.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.054 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 99' ' ' PHE . . . -60.91 -59.07 5.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.109 179.032 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 92' ' ' ILE . 14.2 m -58.9 -26.08 31.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.118 179.812 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 61' ' ' VAL . 7.5 ttmt -78.03 -4.59 47.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.244 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.71 -38.67 2.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.379 -179.911 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.924 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 6.1 pt -76.95 -41.65 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.133 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -57.95 -28.79 64.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -62.57 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 179.63 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.092 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.924 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.35 -174.7 4.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.983 0.392 . . . . 0.0 110.943 179.725 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 69.0 t80 -94.46 -23.1 17.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 11.3 pt-20 147.87 -167.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.54 0.736 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.05 107.07 10.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.708 0.29 . . . . 0.0 110.622 179.606 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.532 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -56.4 92.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.07 -179.908 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -59.56 88.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 179.951 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.48 72.3 0.15 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 -179.959 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.78 -13.3 25.8 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.669 2.246 . . . . 0.0 112.703 179.975 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -109.38 109.12 19.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.748 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.8 t 63.91 146.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.036 -179.872 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.84 HG21 HD23 ' A' ' 17' ' ' LEU . 18.0 m -106.15 40.47 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.09 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.58 -52.7 28.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -31.4 70.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.431 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.813 ' CD1' HD11 ' A' ' 79' ' ' ILE . 15.8 t80 -57.52 -40.95 79.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.757 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -48.43 -48.39 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.236 179.349 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mp -54.98 -45.57 75.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.399 -179.561 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -67.12 -39.8 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 2.7 mm -47.43 -55.88 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -55.62 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 110.16 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.71 69.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.81 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.582 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.86 -37.08 83.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.798 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 48' ' ' VAL . 49.0 m-85 -80.27 -28.6 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.058 179.862 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -56.47 -22.84 35.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.994 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -97.61 29.86 3.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -102.77 28.77 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.81 179.953 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.7 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.975 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HB2' ' HD3' ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 . . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 7.5 mmtp 56.2 97.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 111.34 179.761 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -121.23 139.99 52.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.284 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 48' ' ' VAL . 21.3 t -128.61 158.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 110.932 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.65 HD22 ' CD2' ' A' ' 46' ' ' PHE . 16.4 tp -117.03 131.83 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.651 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.751 HG21 HD12 ' A' ' 17' ' ' LEU . 25.4 t -115.81 89.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.201 179.866 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.92 103.16 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.757 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.81 137.63 45.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.782 -179.769 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.07 48.65 1.67 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.042 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -178.97 179.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 179.953 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -119.83 88.67 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.93 -44.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.41 HG22 ' HB3' ' A' ' 17' ' ' LEU . 27.3 mm -79.78 -43.65 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.998 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.542 ' HB ' HG21 ' A' ' 30' ' ' THR . 10.2 p -60.34 -16.93 39.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.433 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -80.13 -43.33 21.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.283 . . . . 0.0 111.146 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -60.23 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.209 -179.673 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.751 HD12 HG21 ' A' ' 6' ' ' VAL . 2.3 tm? -46.9 -50.95 17.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.088 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -56.67 -48.91 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.572 179.75 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.24 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.684 ' CD1' HG11 ' A' ' 106' ' ' VAL . 57.0 mt -57.41 -66.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.822 179.755 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.02 -35.43 11.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.139 0.495 . . . . 0.0 110.468 179.615 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.51 -28.22 69.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.84 -35.18 38.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.079 179.469 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -4.63 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.487 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.39 56.38 1.57 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.383 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-85 -128.41 -176.16 3.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 3' ' ' ARG . 4.1 t60 -138.9 70.8 42.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.76 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 34.9 Cg_exo -60.15 142.3 98.02 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.821 2.347 . . . . 0.0 112.581 -179.678 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -121.64 2.97 10.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.398 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.712 HG22 ' HB ' ' A' ' 6' ' ' VAL . 13.7 p 9.86 122.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.996 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.22 -164.22 1.02 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.436 178.631 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 33' ' ' THR . 9.6 ttmt -118.47 -30.2 5.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.122 -179.754 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -170.25 -172.71 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.668 179.96 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.775 HD22 ' CD2' ' A' ' 63' ' ' PHE . 29.8 mt -65.86 -49.5 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.516 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.84 -48.83 80.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.447 . . . . 0.0 109.852 179.195 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.1 -30.8 71.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.17 179.144 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HB1' HD11 ' A' ' 41' ' ' ILE . . . -71.41 -62.92 1.23 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.253 179.337 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 22.7 mt-10 -41.88 -39.93 1.97 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -49.24 73.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 178.91 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -68.19 -32.39 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.148 179.8 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.402 HD11 ' HB1' ' A' ' 37' ' ' ALA . 11.5 mt -86.34 -15.79 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -24.29 6.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.548 -179.741 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -122.41 -55.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 129.03 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.21 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -92.03 86.41 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.528 179.621 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.65 ' CD2' HD22 ' A' ' 5' ' ' LEU . 49.8 m-85 -79.32 119.31 76.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.508 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 59.7 Cg_endo -73.54 -19.45 21.66 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.474 2.116 . . . . 0.0 111.974 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.636 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.2 t -143.44 130.15 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.724 -179.911 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 46' ' ' PHE . 10.7 mm -118.59 156.19 20.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 179.54 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.7 t -146.31 102.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.494 . . . . 0.0 110.679 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.443 ' CD2' ' HA3' ' A' ' 60' ' ' GLY . 57.0 tp -90.09 91.1 8.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.42 92.3 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.857 178.728 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.704 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.4 m -64.5 72.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.14 -179.006 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 25.5 t-105 -73.39 -77.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.361 . . . . 0.0 110.324 179.35 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.483 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.2 ttm -162.23 61.99 1.29 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.4 Cg_endo -84.61 -155.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.068 2.512 . . . . 0.0 112.216 -179.825 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.82 -42.2 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.93 177.55 53.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.07 127.77 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' CD2' ' A' ' 51' ' ' LEU . . . -79.16 -1.55 85.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.989 -179.969 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.9 ' O ' HD12 ' A' ' 64' ' ' ILE . 45.8 t -61.49 -59.75 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.989 -179.922 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.4 -21.5 62.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.512 -179.856 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.775 ' CD2' HD22 ' A' ' 34' ' ' LEU . 14.0 t80 -61.33 -36.7 80.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.468 -179.565 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.6 mt -47.64 -27.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.285 -179.853 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.56 -40.91 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 38' ' ' GLU . 17.6 t80 -57.25 -43.02 82.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.469 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.674 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.9 mp -61.41 -42.78 95.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 179.417 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -18.85 56.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.326 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.48 -42.33 68.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.551 179.701 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.93 14.15 15.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.068 -179.843 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.74 67.65 1.59 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.847 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.84 -20.24 39.67 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.673 2.249 . . . . 0.0 112.232 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -104.12 35.67 2.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.747 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -111.79 -157.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.798 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 120' ' ' TYR . 41.3 t -154.53 137.94 7.95 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 111.659 179.498 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.883 HG12 HG23 ' A' ' 78' ' ' VAL . 2.5 t -117.43 100.26 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.335 -179.478 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 97' ' ' TYR . 36.1 mm -82.68 -51.12 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.737 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.883 HG23 HG12 ' A' ' 76' ' ' VAL . 78.0 t 52.37 96.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.644 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -106.12 -155.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.085 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.704 ' HB ' HG22 ' A' ' 53' ' ' VAL . 8.3 m 71.0 115.14 0.05 OUTLIER 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 179.918 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.99 144.81 11.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.33 179.932 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -93.39 -78.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.986 -179.803 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -159.78 45.97 0.42 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -154.03 138.45 16.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.794 0.331 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.1 t -106.99 39.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.05 -24.65 12.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -82.49 -38.69 23.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.019 0.437 . . . . 0.0 109.944 179.292 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.863 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.31 -57.38 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.142 178.991 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HA ' HG12 ' A' ' 92' ' ' ILE . 13.1 m -58.01 -28.95 35.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.289 179.702 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HD3' HG21 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -78.9 -15.86 57.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.626 -179.694 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.87 -33.86 6.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 -179.546 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.904 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.2 pt -79.3 -34.99 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.263 -179.554 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -31.26 71.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.781 179.889 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.2 32.91 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.859 -179.956 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.16 -165.3 1.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 110.998 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.632 ' HB3' HD13 ' A' ' 77' ' ' ILE . 26.0 t80 -114.16 27.14 9.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 -179.787 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 76.01 141.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.09 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -66.0 118.33 9.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 -179.707 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -59.05 129.14 40.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.883 179.703 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -61.68 -67.35 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.01 57.37 4.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.31 2.0 8.82 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.619 2.213 . . . . 0.0 112.788 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -131.61 -61.98 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.72 0.295 . . . . 0.0 110.937 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.0 p -171.03 179.15 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.038 -179.985 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.684 HG11 ' CD1' ' A' ' 20' ' ' ILE . 9.5 p -53.0 -38.36 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.227 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -38.02 -38.46 0.32 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.823 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -70.82 -41.65 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.482 . . . . 0.0 110.494 179.642 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.542 ' CZ ' HD11 ' A' ' 79' ' ' ILE . 6.2 t80 -57.38 -30.43 64.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.802 179.528 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.626 HD11 ' CG2' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -59.18 -43.77 92.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.505 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mp -53.66 -52.29 60.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.829 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.566 HG23 ' HE2' ' A' ' 97' ' ' TYR . 99.3 m -59.61 -40.98 89.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.777 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.617 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 4.6 mm -49.78 -57.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.634 -179.634 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.58 -63.4 1.1 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.455 ' CD2' ' CG ' ' A' ' 119' ' ' GLU . 5.5 t-160 -50.81 -27.35 7.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.821 179.31 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -66.88 -39.96 87.64 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.927 0.394 . . . . 0.0 110.479 179.432 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.636 ' CE1' HG21 ' A' ' 48' ' ' VAL . 23.1 m-85 -71.88 -30.03 64.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.233 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -88.47 -37.54 15.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.368 -179.686 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.455 ' CG ' ' CD2' ' A' ' 115' ' ' HIS . 1.6 mm-40 -75.55 -5.25 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.668 -179.816 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.415 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -144.06 45.0 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 110.915 179.952 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.801 0.334 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -94.05 154.87 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.685 ' NH1' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -164.33 125.42 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 -179.906 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.634 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.5 t -114.64 143.56 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.862 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.682 HD23 HD12 ' A' ' 49' ' ' ILE . 59.6 tp -93.95 129.63 40.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.808 -179.875 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.822 HG21 ' CD1' ' A' ' 17' ' ' LEU . 17.5 t -115.44 104.71 17.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.797 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 42.4 t -91.6 124.07 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.744 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -168.9 157.75 8.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 -179.839 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -89.56 49.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.168 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -108.72 -171.99 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.721 179.807 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -69.41 -66.79 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -131.82 -79.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 179.921 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.811 HD13 HG21 ' A' ' 30' ' ' THR . 8.6 mm -97.68 163.0 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.091 179.834 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.5 ' N ' HG22 ' A' ' 13' ' ' ILE . 71.5 p -90.27 142.58 27.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.212 179.442 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -52.94 136.68 34.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.695 -179.213 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 84.77 -36.55 0.05 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.08 179.442 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.927 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -59.74 -52.64 64.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 -179.582 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -45.63 -67.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.588 -179.488 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.33 -40.58 35.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.495 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.656 ' CD1' HG23 ' A' ' 106' ' ' VAL . 60.0 mt -65.88 -67.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.37 -179.717 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.927 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.926 0.394 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.55 -31.32 66.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 tt0 -85.0 -36.04 21.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.513 179.716 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.649 ' CD ' HD21 ' A' ' 110' ' ' LEU . 78.5 mm-40 -78.16 -39.13 41.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.918 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.43 30.28 5.98 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.632 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.411 ' HB2' HD23 ' A' ' 21' ' ' LEU . 40.1 m-85 -89.6 -175.56 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.2 OUTLIER -140.06 94.84 8.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 179.81 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.702 ' HG3' HD13 ' A' ' 21' ' ' LEU . 72.1 Cg_endo -77.45 134.2 13.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.501 2.134 . . . . 0.0 112.818 -179.514 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.9 t0 -103.66 -12.01 17.3 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.414 0.626 . . . . 0.0 111.618 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.811 HG21 HD13 ' A' ' 13' ' ' ILE . 71.5 p 44.07 175.3 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.832 179.353 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.797 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -158.75 -166.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.438 179.833 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 33' ' ' THR . 22.9 mtpt -129.48 -37.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 32' ' ' LYS . 4.2 p -163.07 178.24 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.304 179.828 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.743 HD22 ' CD2' ' A' ' 63' ' ' PHE . 85.6 mt -62.36 -41.45 98.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 110.536 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.96 48.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 178.962 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.79 -29.63 70.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.205 179.036 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -75.33 -22.04 57.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.946 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 13.9 mt-10 -75.46 -41.52 55.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.897 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.3 -37.38 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.061 178.995 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -72.52 -30.07 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.646 HG22 HD21 ' A' ' 70' ' ' ASN . 36.9 mt -89.44 -23.13 6.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.906 179.671 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -81.07 -0.29 39.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 179.941 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -117.36 -41.33 2.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.681 179.789 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.685 HD11 ' NH1' ' A' ' 3' ' ' ARG . 0.3 OUTLIER -116.26 156.03 27.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.174 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.421 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 8.1 t80 -96.55 94.95 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.726 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.626 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 26.3 m-85 -78.18 124.8 85.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 73.8 Cg_endo -74.72 -29.33 8.86 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.402 2.068 . . . . 0.0 111.928 179.616 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.634 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.7 t -142.86 129.01 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.446 -179.819 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.682 HD12 HD23 ' A' ' 5' ' ' LEU . 26.8 mm -111.71 151.31 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.91 179.124 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.46 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 46.6 t -144.19 100.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.0 111.752 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HB3' HG13 ' A' ' 78' ' ' VAL . 7.2 tp -75.28 175.02 8.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.038 179.339 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.631 ' C ' HG22 ' A' ' 80' ' ' THR . 2.6 t70 -146.41 -52.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.568 -179.543 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 53' ' ' VAL . 61.5 t 61.82 50.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.052 0.454 . . . . 0.0 110.47 -179.562 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -71.16 -82.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.799 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.514 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -76.06 -48.64 3.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 55' ' ' MET . 96.7 Cg_endo -77.73 -173.18 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.436 2.091 . . . . 0.0 112.619 -179.518 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HA ' HG13 ' A' ' 53' ' ' VAL . 67.4 m-20 -158.28 47.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.671 179.844 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.03 166.77 3.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.656 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -82.97 74.05 9.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.26 -22.39 36.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.692 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 90' ' ' LYS . 32.7 t -54.26 -41.7 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 111.496 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.35 4.96 44.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.743 ' CD2' HD22 ' A' ' 34' ' ' LEU . 8.0 t80 -90.03 -37.07 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.58 0.229 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -45.15 -44.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.908 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.84 -47.45 83.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.556 ' CE1' ' ND2' ' A' ' 70' ' ' ASN . 42.5 t80 -55.22 -31.46 61.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.005 179.244 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.834 HG21 HG22 ' A' ' 76' ' ' VAL . 3.8 mm -66.25 -53.42 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.184 179.145 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -71.93 -19.98 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.369 179.206 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -67.08 -50.0 63.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.538 179.588 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.646 HD21 HG22 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -113.98 19.67 16.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.135 -179.812 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.35 67.92 1.05 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.42 -16.03 22.0 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.781 2.321 . . . . 0.0 112.302 -179.898 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.61 31.12 6.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -112.99 -159.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.523 ' HB ' HG13 ' A' ' 48' ' ' VAL . 52.6 t -148.07 135.68 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.371 0.605 . . . . 0.0 112.251 179.453 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.834 HG22 HG21 ' A' ' 67' ' ' ILE . 24.7 t -105.44 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.514 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 97' ' ' TYR . 16.6 mm -120.23 44.25 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.997 179.677 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.636 HG23 HG12 ' A' ' 76' ' ' VAL . 57.4 t -46.52 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.665 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.638 HG23 ' HB3' ' A' ' 100' ' ' LEU . 20.8 mt -74.2 -107.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.35 -179.639 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.631 HG22 ' C ' ' A' ' 52' ' ' ASP . 1.0 OUTLIER 71.24 110.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.65 -179.865 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.84 -105.8 0.39 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.603 -179.756 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 166.91 1.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.816 0.341 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.69 -66.0 0.57 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.1 t -177.63 109.55 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 179.96 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m -62.13 -21.95 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.233 179.841 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.87 -8.55 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.473 179.997 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.42 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -81.62 -33.64 31.34 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.067 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.819 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.74 -57.65 11.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.125 178.998 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.62 -22.64 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.538 ' O ' HG13 ' A' ' 61' ' ' VAL . 5.1 ttmt -91.29 25.89 2.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.874 0.369 . . . . 0.0 110.772 179.606 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.2 -40.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.818 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.931 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.3 pt -71.86 -43.91 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.172 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 2.2 ttmt -63.13 -22.77 67.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -71.65 -28.37 63.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.076 179.901 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.01 -19.7 0.35 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.32 179.971 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.73 176.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.001 0.401 . . . . 0.0 111.318 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.704 ' HE2' HG23 ' A' ' 112' ' ' THR . 32.5 t80 -98.98 28.5 4.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.477 -179.582 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.518 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 79.82 147.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.135 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.1 m-85 -73.85 139.89 45.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.082 -179.72 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.638 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -90.32 130.23 36.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.545 179.708 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' N ' HD13 ' A' ' 100' ' ' LEU . 9.6 mt-10 -49.93 -72.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 179.946 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.48 70.98 1.45 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.801 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' A' ' 104' ' ' PHE . 61.3 Cg_endo -73.01 -6.84 19.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.452 2.101 . . . . 0.0 112.675 -179.837 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.417 ' CD1' ' HG2' ' A' ' 103' ' ' PRO . 47.3 p90 -179.65 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.984 179.798 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 81.0 p -128.22 156.31 43.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.014 -179.874 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.814 HG21 HD23 ' A' ' 17' ' ' LEU . 33.5 m -83.88 6.05 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.68 179.95 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -40.87 -47.36 2.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.819 0.342 . . . . 0.0 111.281 -179.856 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -68.93 -36.11 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.0 110.011 179.188 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.61 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 1.9 t80 -56.53 -23.54 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 179.229 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.649 HD21 ' CD ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -63.64 -43.76 95.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.353 179.937 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.8 mp -54.27 -57.06 12.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 -179.739 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.704 HG23 ' HE2' ' A' ' 97' ' ' TYR . 97.3 m -57.71 -43.25 85.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.61 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -44.35 -53.38 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.786 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.08 -61.6 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -53.64 -28.24 31.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -65.17 -41.47 94.63 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 45.3 m-85 -79.66 -29.78 41.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -55.79 -25.1 39.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 179.974 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -97.51 30.06 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 47' ' ' PRO . 6.1 t80 -102.48 28.32 6.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.988 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.848 0.356 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 3.8 mmtm 60.07 65.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.984 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.459 ' HA ' ' H ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -117.62 141.5 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 179.989 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 48' ' ' VAL . 41.3 t -126.66 159.87 35.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.942 HD22 ' CD2' ' A' ' 46' ' ' PHE . 35.4 tp -113.12 129.26 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.079 -179.901 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.696 ' HB ' HG22 ' A' ' 30' ' ' THR . 23.5 t -115.62 89.95 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.517 179.916 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 t -83.56 103.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.9 140.2 42.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.435 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 33.6 t70 -88.45 27.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.508 -179.865 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HG3' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -156.14 -175.57 5.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.809 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -121.59 46.6 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 t -103.22 -51.78 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.043 179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.572 HG22 ' CB ' ' A' ' 17' ' ' LEU . 30.2 mm -75.7 -46.01 37.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.077 179.96 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.4 p -57.11 -21.73 34.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.18 -43.41 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.4 -57.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.676 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.8 tm? -46.21 -56.87 5.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -52.86 -45.11 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.769 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.13 96.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.67 179.58 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.771 ' CD1' HG11 ' A' ' 106' ' ' VAL . 5.9 mt -57.59 -65.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.65 -32.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.731 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.26 -29.61 69.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -79.27 -34.4 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 109.887 179.441 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.788 ' HG3' HD21 ' A' ' 110' ' ' LEU . 53.4 mm-40 -77.52 -12.11 59.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.114 179.722 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.06 62.71 1.16 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.892 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.46 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 46.3 m-85 -127.22 -172.69 2.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 111.38 -179.319 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.459 ' H ' ' HA ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -135.9 68.43 64.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.498 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 27.1 Cg_exo -60.74 131.09 35.86 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.641 2.227 . . . . 0.0 111.952 179.952 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -109.6 3.31 20.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.266 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.696 HG22 ' HB ' ' A' ' 6' ' ' VAL . 8.7 p 1.87 123.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.74 -162.46 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.487 178.836 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -114.93 -31.63 6.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.16 -168.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.686 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.604 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -63.95 -45.38 89.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -50.68 72.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.259 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.76 -29.64 67.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.49 179.422 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.63 -26.31 54.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.95 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 30.8 mt-10 -74.74 -38.47 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.073 0.463 . . . . 0.0 109.931 179.124 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.65 77.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.903 179.036 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -74.67 -35.64 62.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.676 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.519 HD12 ' O ' ' A' ' 37' ' ' ALA . 28.5 mt -84.11 -21.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -18.65 59.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.279 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -129.02 -44.82 1.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.13 120.6 25.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 71' ' ' SER . 52.1 t80 -83.27 88.66 6.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.718 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.942 ' CD2' HD22 ' A' ' 5' ' ' LEU . 20.1 m-85 -79.23 133.37 60.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 9.3 Cg_endo -84.55 -20.4 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.815 2.344 . . . . 0.0 111.947 179.204 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.646 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -145.25 131.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.59 HG23 HD23 ' A' ' 5' ' ' LEU . 5.1 mm -119.04 156.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.483 179.609 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -146.86 101.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 110.764 179.787 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.729 ' HB3' HG13 ' A' ' 78' ' ' VAL . 59.8 tp -88.94 108.14 19.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.825 -179.255 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.06 91.32 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.141 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.699 HG22 ' HB ' ' A' ' 80' ' ' THR . 33.4 m -67.47 68.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.727 -179.154 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.45 ' CG ' ' N ' ' A' ' 55' ' ' MET . 29.0 t90 -67.16 -96.97 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.208 179.426 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.541 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -129.36 41.62 0.76 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.471 0.177 . . . . 0.0 111.27 179.361 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 55' ' ' MET . 91.6 Cg_endo -80.38 -165.98 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.52 2.147 . . . . 0.0 112.286 179.949 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -150.02 46.91 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.85 -179.35 16.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -104.83 95.42 5.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.97 -30.56 63.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 90' ' ' LYS . 21.8 t -56.19 -44.74 80.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.352 -179.93 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 1.89 35.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.507 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 67' ' ' ILE . 11.9 t80 -88.5 -36.37 16.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.801 0.334 . . . . 0.0 111.098 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -47.5 -29.33 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.147 -179.936 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -78.38 -35.62 47.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.637 179.708 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.423 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 9.0 t80 -58.64 -41.53 86.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.709 HG21 HG22 ' A' ' 76' ' ' VAL . 3.0 mp -61.58 -45.74 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.376 179.5 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -76.63 -20.16 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.75 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.59 -42.25 78.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.828 179.749 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.39 15.4 12.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.193 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.419 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -163.48 67.75 1.66 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.809 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.39 -20.39 36.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.737 2.291 . . . . 0.0 112.232 -179.93 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -103.13 28.02 6.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.79 179.774 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 t -107.56 -156.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.363 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -153.91 137.66 8.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.996 0.426 . . . . 0.0 111.406 179.114 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.784 HG12 HG23 ' A' ' 78' ' ' VAL . 13.1 t -119.85 108.46 23.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.373 -179.257 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mm -93.16 -53.7 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.784 HG23 HG12 ' A' ' 76' ' ' VAL . 24.6 t 54.31 94.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 179.702 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.678 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -94.8 -157.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 179.679 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.699 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.4 m 64.71 82.69 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.8 -173.97 20.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.531 -179.899 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -127.43 -175.08 3.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.4 -28.15 64.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.546 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.4 -35.75 60.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.84 0.352 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 85' ' ' VAL . 15.7 t 63.95 33.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.155 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -95.6 -15.51 22.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 179.864 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.15 -34.89 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.112 0.482 . . . . 0.0 109.734 179.104 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.16 -58.54 8.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.117 178.895 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.483 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.7 m -57.53 -28.99 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.575 ' O ' HG13 ' A' ' 61' ' ' VAL . 1.5 ttmp? -75.44 -6.61 50.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.442 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.77 -44.33 1.95 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 111.387 -179.772 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.789 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.4 pt -67.89 155.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.924 -179.723 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.454 ' CG ' HG13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER 81.46 -47.27 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 -179.148 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -65.13 -16.83 63.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.495 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.23 -29.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.791 -179.955 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -74.5 176.31 6.95 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 111.31 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 13.4 t80 -102.16 -8.95 20.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.048 -179.983 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 8.5 pt-20 137.03 172.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.778 0.831 . . . . 0.0 110.181 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.552 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -103.67 96.77 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.616 179.687 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 79' ' ' ILE . 13.1 tp -54.98 90.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.282 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -113.81 -18.52 11.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.296 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.416 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 9.2 tttt -55.13 -52.82 68.0 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.122 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.473 ' CG ' HD11 ' A' ' 100' ' ' LEU . 50.1 Cg_exo -56.8 -161.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.524 2.149 . . . . 0.0 112.465 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -154.32 -45.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.805 -180.0 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.98 -73.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.771 HG11 ' CD1' ' A' ' 20' ' ' ILE . 7.6 p 178.78 -37.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -36.07 -44.76 0.39 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.126 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.414 ' HB3' ' HB3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -67.04 -42.36 84.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 0.0 110.734 179.798 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' VAL . 8.4 t80 -53.59 -30.88 44.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.889 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.788 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -56.55 -44.2 80.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.3 -179.972 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mp -56.7 -55.16 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.33 -179.701 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.9 m -56.37 -41.85 76.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.409 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.1 mm -44.62 -54.48 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 -179.506 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -48.35 -61.31 2.07 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -48.18 -31.87 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.749 179.287 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -63.56 -36.47 83.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.978 0.418 . . . . 0.0 110.504 179.417 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.646 ' CE1' HG21 ' A' ' 48' ' ' VAL . 48.6 m-85 -83.77 -28.29 28.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 179.853 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -54.32 -24.1 17.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.428 -179.809 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.6 -5.94 47.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.479 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -100.29 35.31 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 12.5 mmtm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.83 0.348 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.62 127.74 14.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 48' ' ' VAL . 61.3 t -126.15 163.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 29' ' ' ASP . 55.4 tp -121.28 134.95 55.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.015 0.436 . . . . 0.0 111.671 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.811 HG21 ' CD1' ' A' ' 17' ' ' LEU . 12.8 t -119.41 128.23 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.127 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.434 ' HB ' HD12 ' A' ' 51' ' ' LEU . 11.9 t -119.56 125.82 74.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.993 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.0 t0 -162.1 145.86 12.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.653 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.32 51.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.871 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 12.4 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.072 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 53.3 p . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.899 0.381 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.87 133.18 22.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 m 78.77 -14.31 0.88 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.653 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.969 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -76.77 -54.79 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.942 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.41 -64.27 0.76 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.519 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.98 -40.76 31.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.197 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.835 HG23 ' CD1' ' A' ' 110' ' ' LEU . 56.0 mt -63.14 -67.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.218 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.969 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -49.44 -31.14 9.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 110.851 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.61 -27.47 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.879 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.47 -34.91 27.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.317 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.814 ' CG ' HD21 ' A' ' 110' ' ' LEU . 21.8 mm-40 -80.38 -36.28 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.051 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.4 49.76 2.52 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.066 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 3.8 m-85 -103.8 -174.61 2.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.326 0.584 . . . . 0.0 111.429 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.13 77.13 76.95 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.938 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.647 ' HG3' HD13 ' A' ' 21' ' ' LEU . 97.3 Cg_endo -85.79 142.78 8.03 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.836 2.358 . . . . 0.0 113.851 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.884 ' O ' HD12 ' A' ' 5' ' ' LEU . 8.6 t0 -123.67 120.33 32.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.145 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.587 HG22 ' HB ' ' A' ' 6' ' ' VAL . 47.5 p -100.81 139.86 35.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.11 0.481 . . . . 0.0 112.011 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.48 -164.37 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.228 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 2.4 mttt -134.65 -7.67 2.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.36 -172.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 0.0 110.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.785 HD11 ' O ' ' A' ' 59' ' ' ASP . 96.3 mt -78.64 -28.73 45.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.473 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.49 -41.64 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -34.0 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.233 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.68 ' C ' HD12 ' A' ' 41' ' ' ILE . . . -73.51 -52.39 13.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 42' ' ' LYS . 41.3 mt-10 -46.38 -45.08 17.58 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.525 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -53.35 58.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -61.86 -23.9 66.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.075 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 ' C ' ' A' ' 37' ' ' ALA . 5.5 mt -95.82 -14.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.688 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 1.2 tmtt? -78.83 -5.32 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.645 0.26 . . . . 0.0 111.48 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -136.96 -49.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.382 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.32 116.29 16.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.783 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -74.75 64.12 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.518 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 22.9 m-85 -58.35 122.08 56.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.087 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 10.8 Cg_exo -66.1 -50.05 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.468 2.112 . . . . 0.0 112.277 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 4' ' ' VAL . 35.8 t -116.85 127.11 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.671 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 14.6 mm -113.81 127.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.273 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.861 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 84.7 t -124.3 105.93 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 78' ' ' VAL . 4.9 tp -93.52 145.36 24.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.711 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' HA ' ' HG1' ' A' ' 80' ' ' THR . 2.7 t70 -110.33 178.66 4.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.115 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.603 HG22 ' CB ' ' A' ' 80' ' ' THR . 4.8 m -149.52 42.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.155 0.502 . . . . 0.0 111.527 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 57.6 t-105 -49.9 -90.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 25.6 ttp -149.6 50.84 0.83 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.312 . . . . 0.0 111.072 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 55' ' ' MET . 73.0 Cg_endo -75.95 -168.29 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.487 2.125 . . . . 0.0 112.281 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -145.4 39.77 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -139.26 20.86 2.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.647 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.785 ' O ' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER 62.07 -159.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.612 0.244 . . . . 0.0 110.488 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.11 -39.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.641 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.753 HG21 ' HD3' ' A' ' 90' ' ' LYS . 40.3 t -56.85 -42.1 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.059 0.457 . . . . 0.0 110.756 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -20.24 64.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.674 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.964 ' CE2' HD11 ' A' ' 67' ' ' ILE . 36.0 t80 -80.53 -33.32 36.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 61' ' ' VAL . 4.6 mm -47.03 -29.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.81 0.338 . . . . 0.0 111.154 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -75.17 -47.54 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 12.2 t80 -50.02 -42.47 49.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.964 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.2 mp -60.6 -44.04 95.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.351 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -80.31 -17.45 52.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.807 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.441 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 31.6 tt0 -71.4 -46.7 59.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.495 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -112.49 7.51 19.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.186 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.426 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -154.63 65.38 4.79 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 110.656 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 71' ' ' SER . 2.7 Cg_exo -74.65 -15.59 21.58 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.683 2.255 . . . . 0.0 112.103 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -97.48 -9.47 27.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.216 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t -80.36 -173.95 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.584 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.683 HG21 ' HB1' ' A' ' 116' ' ' ALA . 31.1 t -120.5 157.23 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.094 0.473 . . . . 0.0 111.217 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.597 HG12 HG23 ' A' ' 78' ' ' VAL . 1.1 t -143.19 89.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.093 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.838 HD13 ' HB3' ' A' ' 97' ' ' TYR . 21.5 mm -80.5 -45.35 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.597 HG23 HG12 ' A' ' 76' ' ' VAL . 58.5 t 54.99 101.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.791 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 77' ' ' ILE . 7.7 mt -133.1 145.69 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.763 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.603 ' CB ' HG22 ' A' ' 53' ' ' VAL . 14.5 m . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.832 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.812 0.339 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.5 -12.93 62.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.5 -35.46 27.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.09 0.471 . . . . 0.0 109.798 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.09 -57.56 12.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.753 ' HD3' HG21 ' A' ' 61' ' ' VAL . 12.7 ttmt -89.75 39.92 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.019 0.438 . . . . 0.0 110.554 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.24 -42.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.9 pt -71.25 -28.08 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.263 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.53 19.83 6.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -0.63 8.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.483 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.91 11.5 1.84 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.956 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.13 -168.67 2.18 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.252 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.838 ' HB3' HD13 ' A' ' 77' ' ' ILE . 17.8 t80 -116.22 27.39 9.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.344 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.476 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 79.29 141.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.579 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -67.45 129.3 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.124 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.688 HD11 ' HB3' ' A' ' 108' ' ' ARG . 0.2 OUTLIER -71.42 106.42 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.72 HG21 HD23 ' A' ' 17' ' ' LEU . 3.1 m . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.3 -47.52 79.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.688 ' HB3' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -63.69 -34.14 77.2 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.861 ' CZ ' HG21 ' A' ' 50' ' ' VAL . 8.3 t80 -56.75 -35.26 68.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.366 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.835 ' CD1' HG23 ' A' ' 20' ' ' ILE . 1.4 tt -56.85 -53.3 59.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.031 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.98 -42.61 94.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.534 HG23 ' HE2' ' A' ' 97' ' ' TYR . 87.7 m -64.83 -40.42 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.883 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.655 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.6 mm -44.11 -52.68 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.785 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.55 -56.8 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.321 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -60.48 -32.47 71.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.683 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.57 -39.04 82.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.548 ' CE1' HG21 ' A' ' 48' ' ' VAL . 39.2 m-85 -77.78 -13.2 59.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.43 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 120.798 0.332 . . . . 0.0 111.248 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 32.3 mmtp . . . . . 0 C--O 1.225 -0.237 0 CA-C-O 120.756 0.312 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 3.5 mpt_? 64.64 108.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.8 t -123.22 159.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.911 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.709 HD23 HG23 ' A' ' 49' ' ' ILE . 42.9 tp -115.43 135.17 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.847 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.701 ' HB ' HG22 ' A' ' 30' ' ' THR . 17.2 t -117.53 89.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.696 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.47 107.55 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -143.17 140.73 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 111.301 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 34.9 t0 -64.04 -70.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.974 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.716 0.293 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.34 -43.01 67.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.2 p -101.81 -53.2 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.328 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.75 ' CD1' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -47.84 -51.84 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.081 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.726 ' HA ' HD12 ' A' ' 21' ' ' LEU . 46.0 m -50.68 -46.61 58.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.773 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.07 91.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.777 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.717 ' CD1' HG13 ' A' ' 106' ' ' VAL . 17.1 mt -55.99 -59.92 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.532 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.019 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -46.9 -40.23 13.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.854 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.22 -27.96 69.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.987 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -80.09 -34.73 37.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.982 0.42 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.759 ' HG3' HD21 ' A' ' 110' ' ' LEU . 66.2 mm-40 -76.71 -24.73 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 28.38 6.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.416 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 59.9 m-85 -98.93 -175.86 3.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -134.56 90.0 24.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 1.019 ' HB3' HD13 ' A' ' 21' ' ' LEU . 74.4 Cg_endo -78.8 132.64 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.432 2.088 . . . . 0.0 112.873 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -108.78 6.0 25.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.235 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.701 HG22 ' HB ' ' A' ' 6' ' ' VAL . 14.3 p 4.33 122.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.83 -164.17 1.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.925 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 33' ' ' THR . 13.2 tttt -115.1 -40.08 3.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 32' ' ' LYS . 12.7 p -159.23 -173.95 4.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.466 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.746 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -65.64 -45.34 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.617 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -61.67 -48.65 79.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.074 0.464 . . . . 0.0 109.749 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.06 -32.22 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.01 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -70.55 -29.77 66.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.699 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 17.6 mt-10 -68.58 -44.27 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -36.28 78.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.106 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -74.12 -43.03 59.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.491 HD12 ' O ' ' A' ' 37' ' ' ALA . 10.9 mt -73.61 -24.17 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -51.58 -25.89 7.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.277 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -124.37 -58.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.096 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.75 123.64 18.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.04 79.93 8.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.628 ' CE2' HD13 ' A' ' 5' ' ' LEU . 33.0 m-85 -73.94 116.34 51.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.025 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.549 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 74.0 Cg_endo -73.2 -16.16 25.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.524 2.149 . . . . 0.0 111.816 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.5 t -147.23 132.29 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.709 HG23 HD23 ' A' ' 5' ' ' LEU . 10.2 mm -118.18 159.96 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.11 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.403 HG13 HG13 ' A' ' 79' ' ' ILE . 62.1 t -147.97 97.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.252 0.548 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 78' ' ' VAL . 58.7 tp -80.39 130.03 34.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.468 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.62 89.71 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.033 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.715 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.8 m -67.31 66.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.875 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 69.3 t-105 -69.86 -96.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.195 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.604 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -134.66 32.16 0.21 Allowed Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.8 Cg_endo -81.97 -165.18 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.106 1.871 . . . . 0.0 112.236 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -116.29 28.54 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.866 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' CA ' HD12 ' A' ' 34' ' ' LEU . . . -85.07 -99.49 0.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.499 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 56.91 46.39 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.773 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.93 103.81 2.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.907 ' O ' HD12 ' A' ' 64' ' ' ILE . 48.1 t -61.07 -40.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 0.0 110.828 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -13.01 61.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.362 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 67' ' ' ILE . 35.6 t80 -54.3 -39.23 66.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 111.265 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.5 mt -50.01 -29.8 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' GLU . 1.5 t0 -75.81 -34.19 60.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 51.4 t80 -59.56 -47.48 85.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.015 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.873 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -58.34 -43.7 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.398 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -77.03 -22.85 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.699 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 65' ' ' ASP . 42.3 tt0 -65.0 -34.23 77.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -129.55 18.65 5.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.853 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.91 75.6 0.66 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.2 -8.08 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.162 2.575 . . . . 0.0 112.733 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -107.31 12.96 27.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.459 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.23 -160.15 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.98 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HB ' HG13 ' A' ' 48' ' ' VAL . 26.3 t -148.94 134.42 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 111.47 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.915 HG12 HG23 ' A' ' 78' ' ' VAL . 23.9 t -115.01 109.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.575 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.727 HD13 ' HB3' ' A' ' 97' ' ' TYR . 31.7 mm -90.36 -51.06 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.956 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.915 HG23 HG12 ' A' ' 76' ' ' VAL . 30.1 t 54.21 97.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.74 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -102.68 -170.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.315 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.74 ' H ' HG22 ' A' ' 79' ' ' ILE . 2.8 m . . . . . 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.342 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.609 0.242 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.3 -1.88 28.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.326 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.59 -37.06 14.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.825 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.55 -57.44 12.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.159 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.9 m -58.27 -29.27 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.314 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.666 ' HD3' HG21 ' A' ' 61' ' ' VAL . 3.9 ttmp? -76.86 -14.96 59.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.378 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.91 -44.8 3.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 111.528 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.87 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.2 pt -67.6 169.84 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.038 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.8 mttp 74.31 -44.01 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -16.44 63.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.077 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.95 -29.43 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.26 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.87 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -59.56 -178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.421 . . . . 0.0 111.11 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.727 ' HB3' HD13 ' A' ' 77' ' ' ILE . 85.0 t80 -115.67 27.49 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.904 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 86.65 157.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.376 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.474 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -86.16 100.27 12.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.024 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.886 HD21 ' HA ' ' A' ' 109' ' ' PHE . 39.2 tp -70.47 131.47 44.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.008 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.352 179.617 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.717 HG13 ' CD1' ' A' ' 20' ' ' ILE . 8.6 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.513 0.196 . . . . 0.0 111.498 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -45.8 -34.6 3.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -38.96 62.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.153 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.886 ' HA ' HD21 ' A' ' 100' ' ' LEU . 4.2 t80 -55.61 -28.64 56.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.41 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -47.87 -39.57 19.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.4 mp -57.97 -58.06 10.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.874 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.823 ' OG1' HD22 ' A' ' 100' ' ' LEU . 52.3 m -45.95 -43.65 14.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.626 HD12 HG21 ' A' ' 4' ' ' VAL . 18.6 mm -53.66 -66.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 110.382 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -16.21 5.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.979 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -90.19 -26.53 20.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 110.518 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.59 -40.83 40.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.018 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 38.0 m-85 -76.35 -19.03 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.699 -179.864 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 1.4 mptp? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.795 0.331 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -145.49 133.57 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 48' ' ' VAL . 20.8 t -126.2 160.66 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.695 HD23 HG23 ' A' ' 49' ' ' ILE . 40.9 tp -118.8 136.34 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.808 0.337 . . . . 0.0 110.996 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.659 ' HB ' HG22 ' A' ' 30' ' ' THR . 13.7 t -117.35 90.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.89 104.86 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.842 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -140.32 137.99 34.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -88.76 48.83 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.841 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.628 0.252 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -90.04 -26.42 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.731 0.3 . . . . 0.0 111.231 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.24 -63.03 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.199 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.003 HD13 HD11 ' A' ' 21' ' ' LEU . 2.1 tm? -52.24 -50.18 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.02 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.796 ' HA ' HD12 ' A' ' 21' ' ' LEU . 7.0 t -53.09 -59.42 4.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.217 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.0 -39.51 59.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.05 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.728 HG23 HD11 ' A' ' 110' ' ' LEU . 8.9 mt -57.41 -58.3 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.9 -39.61 19.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.408 . . . . 0.0 110.78 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.59 -28.34 68.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.6 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.37 -34.47 31.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.233 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.748 ' HG3' HD21 ' A' ' 110' ' ' LEU . 15.8 mm-40 -76.49 -70.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 149.23 57.45 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 81.0 m-85 -129.84 -169.31 2.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.53 88.04 20.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.967 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.907 ' HB3' HD13 ' A' ' 21' ' ' LEU . 66.6 Cg_endo -78.81 132.6 10.85 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.419 2.079 . . . . 0.0 113.148 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 30' ' ' THR . 17.5 t70 -111.56 8.43 20.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.221 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.659 HG22 ' HB ' ' A' ' 6' ' ' VAL . 5.9 p 0.83 123.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 -165.69 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.702 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -116.61 -33.52 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.776 HG23 ' HB3' ' A' ' 56' ' ' PRO . 0.7 OUTLIER -162.03 175.23 12.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.612 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.71 HD22 ' CD2' ' A' ' 63' ' ' PHE . 54.3 mt -55.56 -33.41 63.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.757 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -48.13 76.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.506 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.838 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.32 -36.02 63.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 83.6 mt-10 -68.48 -40.81 80.81 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.06 -35.09 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.9 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -76.65 -44.72 32.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.721 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.96 -26.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.18 -25.79 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.427 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -125.67 -45.58 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.012 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -74.66 135.06 41.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -92.25 95.47 9.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 75.8 m-85 -91.98 113.4 58.85 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.8 Cg_endo -73.43 -16.5 24.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.387 2.058 . . . . 0.0 111.886 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.8 t -148.43 131.61 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.47 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.695 HG23 HD23 ' A' ' 5' ' ' LEU . 7.3 mm -119.16 162.65 17.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.5 t -149.85 98.42 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.178 0.514 . . . . 0.0 111.454 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB3' HG22 ' A' ' 78' ' ' VAL . 37.7 tp -81.73 148.87 28.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.588 ' O ' HG21 ' A' ' 80' ' ' THR . 8.0 t70 -107.84 -19.92 13.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.484 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.681 HG22 ' HB ' ' A' ' 80' ' ' THR . 2.4 m 45.93 32.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -56.6 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.676 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.567 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 13.3 mtp -152.54 57.52 2.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.964 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.776 ' HB3' HG23 ' A' ' 33' ' ' THR . 4.9 Cg_endo -86.3 -156.38 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.061 2.507 . . . . 0.0 112.199 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -157.39 37.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.94 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.584 ' C ' HD12 ' A' ' 34' ' ' LEU . . . -127.98 -0.69 6.48 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.065 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.424 ' C ' HD11 ' A' ' 34' ' ' LEU . 19.7 m-20 58.4 105.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.18 -0.8 87.04 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.142 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.918 ' O ' HD12 ' A' ' 64' ' ' ILE . 46.4 t -67.25 -66.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 120.898 0.38 . . . . 0.0 111.161 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -67.09 -14.33 62.8 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CD2' HD22 ' A' ' 34' ' ' LEU . 21.4 t80 -63.4 -38.92 93.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.1 mt -48.35 -33.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.5 t70 -70.03 -32.8 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.29 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 6.9 t80 -62.33 -43.96 97.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.686 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mp -59.57 -44.64 93.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.41 -21.31 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.563 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' ASP . 37.4 tt0 -67.0 -31.77 72.55 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -134.05 18.63 3.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.044 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.86 70.06 0.88 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.24 -19.37 38.71 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.721 2.281 . . . . 0.0 112.241 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.22 29.14 3.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.978 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 48.0 t -110.87 -163.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.42 ' N ' ' OG ' ' A' ' 74' ' ' SER . 31.9 t -154.55 136.2 5.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 120.836 0.351 . . . . 0.0 111.399 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.845 HG12 HG23 ' A' ' 78' ' ' VAL . 2.0 t -115.43 109.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.412 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.564 HG21 ' CE1' ' A' ' 109' ' ' PHE . 38.3 mm -83.27 -59.68 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.913 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.845 HG23 HG12 ' A' ' 76' ' ' VAL . 55.7 t 55.48 89.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.667 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -96.21 -152.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.681 ' HB ' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.809 0.338 . . . . 0.0 110.976 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 85' ' ' VAL . 11.7 p . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.562 0.22 . . . . 0.0 111.584 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.52 -8.97 57.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -89.79 -39.29 13.21 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.571 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -56.42 -57.99 9.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.3 m -55.19 -31.1 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.772 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.555 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -76.97 -5.38 48.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.91 -38.12 3.0 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.909 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 9.1 pt -73.93 -34.52 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.435 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -65.34 -18.12 65.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.935 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -85.89 -56.27 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.045 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.29 32.03 0.05 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.043 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.909 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.27 -162.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.329 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.558 ' CE2' HG23 ' A' ' 112' ' ' THR . 81.3 t80 -111.98 23.32 13.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.439 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 0.7 OUTLIER 83.89 20.33 0.17 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.95 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER 58.43 163.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 0.0 111.453 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HB3' HG23 ' A' ' 79' ' ' ILE . 1.8 tm? -116.02 81.23 1.57 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.222 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.494 ' CG2' HD23 ' A' ' 17' ' ' LEU . 11.4 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.657 0.265 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -40.62 -40.57 1.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.913 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -39.3 74.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.765 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.564 ' CE1' HG21 ' A' ' 77' ' ' ILE . 5.5 t80 -57.23 -30.04 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.748 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -50.76 -34.92 29.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.1 mp -61.8 -51.65 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.313 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.558 HG23 ' CE2' ' A' ' 97' ' ' TYR . 87.9 m -51.51 -39.2 57.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.997 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.431 ' HA ' HD13 ' A' ' 113' ' ' ILE . 12.6 mm -53.58 -65.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.981 0.419 . . . . 0.0 110.132 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -13.45 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.716 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -90.49 -25.49 20.26 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 110.065 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.94 -47.37 13.78 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 48' ' ' VAL . 34.2 m-85 -57.93 -21.8 45.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.195 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.185 -179.93 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 23.8 mmtt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.804 0.335 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.67 135.41 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.4 t -127.12 143.92 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.824 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.723 HD23 HD11 ' A' ' 41' ' ' ILE . 15.1 tp -99.99 125.33 46.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.791 HG21 HD12 ' A' ' 17' ' ' LEU . 21.9 t -112.11 88.78 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.07 103.47 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -137.08 138.8 40.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.43 38.5 1.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 17.0 tp10 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.64 0.257 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.1 t -90.14 23.16 2.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.524 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.9 t -163.27 -53.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.583 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.791 HD12 HG21 ' A' ' 6' ' ' VAL . 1.6 tm? -57.88 -50.97 71.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.572 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 30' ' ' THR . 0.7 OUTLIER -56.99 -51.52 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.336 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.54 70.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.538 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.667 ' CD1' HG11 ' A' ' 106' ' ' VAL . 40.7 mt -58.16 -66.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.678 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.2 mt -49.7 -31.42 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.469 . . . . 0.0 110.369 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.42 -30.63 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.57 -34.89 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.037 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.805 ' HG3' HD21 ' A' ' 110' ' ' LEU . 41.9 mm-40 -75.08 -12.09 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.207 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 53.36 1.08 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.197 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.465 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 64.5 m-85 -126.38 -176.33 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 111.108 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.48 71.95 51.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 33.9 Cg_exo -60.34 138.66 82.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.776 2.318 . . . . 0.0 112.645 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.9 t70 -121.04 4.59 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.748 HG22 ' HB ' ' A' ' 6' ' ' VAL . 12.8 p 3.38 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 -163.21 0.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.391 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -118.85 -28.26 5.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.278 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -163.48 -170.12 2.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.806 0.336 . . . . 0.0 110.806 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 63' ' ' PHE . 47.0 mt -68.41 -45.87 71.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -48.56 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.67 -30.19 69.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.491 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.505 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.29 -25.32 54.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.443 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 45.7 mt-10 -75.56 -36.27 60.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -37.33 77.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.58 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -71.82 -37.48 70.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.542 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.723 HD11 HD23 ' A' ' 5' ' ' LEU . 23.7 mt -85.76 -16.86 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.387 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -52.59 -22.19 4.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.619 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -133.3 -51.66 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.824 0.345 . . . . 0.0 111.154 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 118.71 5.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -73.96 72.26 1.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 38.8 m-85 -66.41 111.24 6.23 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.476 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.408 ' HG2' ' CE2' ' A' ' 117' ' ' PHE . 72.3 Cg_endo -74.42 -20.67 18.09 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.628 2.219 . . . . 0.0 112.207 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.631 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.4 t -144.0 130.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.295 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 9.9 mm -117.7 156.99 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.407 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.15 102.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 tp -86.12 84.72 7.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.976 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.49 77.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.66 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.718 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.2 p -59.33 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.599 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 44.5 t-105 -74.46 -82.78 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.097 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.545 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.39 45.45 0.35 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.313 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 55' ' ' MET . 82.3 Cg_endo -85.12 -165.54 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.442 2.095 . . . . 0.0 112.261 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -154.55 48.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.949 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.0 -16.67 6.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.85 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 62.58 104.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.791 0.329 . . . . 0.0 110.733 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.06 18.57 57.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.895 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.68 ' O ' HD12 ' A' ' 64' ' ' ILE . 13.1 t -58.98 -58.36 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.879 0.371 . . . . 0.0 111.098 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.05 -4.79 43.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.745 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 67' ' ' ILE . 26.7 t80 -69.15 -39.99 78.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.618 0.247 . . . . 0.0 111.496 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mp -46.89 -33.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.766 0.317 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.483 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -70.04 -34.75 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 75.0 t80 -63.06 -39.92 96.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mp -62.77 -47.12 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.909 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.483 ' HG3' ' HA ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -75.41 -18.95 59.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 36.6 tt0 -69.45 -42.75 74.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.718 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -120.75 18.36 11.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.054 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.85 67.11 1.09 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.81 -20.29 34.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.653 2.235 . . . . 0.0 112.218 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.41 32.72 2.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 t -113.2 -157.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.2 t -155.37 137.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 111.505 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.84 HG12 HG23 ' A' ' 78' ' ' VAL . 2.8 t -117.83 100.4 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.376 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 97' ' ' TYR . 38.2 mm -81.5 -55.12 8.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.739 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 76' ' ' VAL . 40.3 t 57.69 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -114.31 -159.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.334 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.718 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 85' ' ' VAL . 14.0 p . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.893 0.378 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.57 -22.26 28.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -79.78 -36.38 37.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.144 0.497 . . . . 0.0 109.726 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.1 -57.74 10.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.203 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 -26.17 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.948 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 61' ' ' VAL . 5.3 tttt -87.93 40.54 0.95 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.625 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.36 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.945 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.4 pt -75.08 -29.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.501 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -80.08 -19.27 47.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -23.15 58.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.76 22.88 0.14 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.595 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.945 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.36 -165.15 1.28 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 117.22 0.51 . . . . 0.0 111.147 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.452 ' HB3' HD13 ' A' ' 77' ' ' ILE . 70.3 t80 -114.11 25.14 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 79.95 139.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.562 ' H ' HG21 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -57.19 130.11 44.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.676 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -78.26 120.3 22.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.684 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.419 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.1 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.014 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.667 HG11 ' CD1' ' A' ' 20' ' ' ILE . 11.7 p . . . . . 0 CA--C 1.526 0.029 0 CA-C-O 120.614 0.245 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -38.96 -44.16 1.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.635 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -64.45 -42.33 96.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 0.0 110.345 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 8.8 t80 -59.51 -27.24 65.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.692 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.805 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -60.27 -48.15 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.404 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.9 mp -51.39 -51.52 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.227 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.91 -41.34 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 3.4 mm -50.35 -56.15 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.608 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -63.22 1.13 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -49.97 -32.56 15.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.776 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -60.92 -41.35 95.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.458 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.628 ' CE1' HG21 ' A' ' 48' ' ' VAL . 32.6 m-85 -76.13 -34.81 59.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.597 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HB3' ' CG ' ' A' ' 26' ' ' TYR . 13.3 mmtt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.905 0.383 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.4 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -148.22 121.95 9.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.633 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.577 HG13 ' HB ' ' A' ' 48' ' ' VAL . 38.0 t -127.36 158.15 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.892 HD12 ' O ' ' A' ' 29' ' ' ASP . 52.3 tp -117.96 141.55 48.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 111.43 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.69 HG21 HD12 ' A' ' 17' ' ' LEU . 16.9 t -121.24 141.65 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.158 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 14.2 t -132.84 121.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.1 t70 -159.25 159.75 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 110.621 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.53 50.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.936 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 179.765 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.633 HG21 HG11 ' A' ' 6' ' ' VAL . 30.1 p . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 16' ' ' SER . 29.6 t -54.21 132.46 43.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.955 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.684 ' HB3' HG11 ' A' ' 106' ' ' VAL . 5.7 t 83.08 -15.02 0.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.719 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.905 ' CD1' HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -77.4 -48.49 17.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.855 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -50.7 -57.0 9.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.31 80.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.655 HD11 HG13 ' A' ' 106' ' ' VAL . 81.9 mt -59.91 -70.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.905 HD11 ' CD1' ' A' ' 17' ' ' LEU . 1.2 mt -47.84 -31.17 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -73.79 -30.54 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.884 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.16 -35.53 25.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.89 -33.74 62.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.5 42.17 3.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' CG ' ' HB3' ' A' ' 2' ' ' LYS . 3.1 m-85 -104.12 -175.67 2.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.4 ' HB2' ' HG3' ' A' ' 3' ' ' ARG . 2.5 t-80 -127.59 82.27 68.62 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.05 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.664 ' HB3' HD22 ' A' ' 21' ' ' LEU . 88.0 Cg_endo -83.44 130.94 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 113.884 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.892 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -119.74 116.82 26.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.856 178.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.541 HG22 ' HB ' ' A' ' 6' ' ' VAL . 18.5 p -105.76 137.14 44.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 112.039 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 36' ' ' GLU . . . -106.93 -164.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.076 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -131.59 -5.84 3.68 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.7 167.66 7.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.674 HD22 ' CD2' ' A' ' 63' ' ' PHE . 33.8 mt -60.78 -29.6 69.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.848 0.356 . . . . 0.0 110.225 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -70.63 -45.98 64.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.722 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.515 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 2.5 mm-40 -62.66 -33.07 74.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.069 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.97 34.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.718 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' LYS . 49.8 mt-10 -46.17 -46.55 17.41 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -58.95 -54.45 47.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.51 -24.63 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.014 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 41' ' ' ILE . 18.2 mt -97.07 -13.49 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.22 -9.28 58.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.587 0.232 . . . . 0.0 111.288 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.03 -62.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 113.12 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.21 68.26 0.49 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.481 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 35.2 m-85 -63.28 130.18 94.04 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 5.1 Cg_endo -80.39 -45.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.393 2.062 . . . . 0.0 111.924 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 4' ' ' VAL . 23.9 t -117.37 123.41 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.91 128.35 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.785 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.64 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 60.2 t -120.35 106.27 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.068 0.461 . . . . 0.0 111.552 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.735 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.8 tp -89.07 153.84 20.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -145.68 109.03 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.742 ' H ' HG22 ' A' ' 80' ' ' THR . 79.9 t -86.75 70.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.973 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -71.96 -80.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.485 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.612 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.97 55.0 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.96 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 55' ' ' MET . 6.9 Cg_endo -88.34 -156.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.136 2.557 . . . . 0.0 112.161 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -146.34 36.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.97 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.21 129.25 3.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.447 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.49 141.99 53.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.72 -23.06 11.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.658 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.691 ' O ' HD12 ' A' ' 64' ' ' ILE . 21.7 t -53.51 -46.73 60.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.572 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -75.65 -5.39 45.29 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.1 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.901 ' CE2' HD11 ' A' ' 67' ' ' ILE . 16.4 t80 -84.43 -35.72 22.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.571 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.9 mp -45.07 -29.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.466 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.615 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 9.9 t0 -72.34 -51.45 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.12 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 8.8 t80 -50.58 -41.63 54.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.942 0.401 . . . . 0.0 110.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.901 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.1 mp -63.6 -50.19 79.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.42 -15.79 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 110.688 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -73.42 -52.09 14.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.673 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.14 19.75 17.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.436 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -163.67 64.29 1.3 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.684 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 71' ' ' SER . 5.0 Cg_exo -76.02 -13.5 19.33 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.602 2.201 . . . . 0.0 111.99 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 25.54 11.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.083 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.5 t -108.76 -173.3 2.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.976 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.2 t -123.9 162.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.009 0.433 . . . . 0.0 111.293 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.943 HG12 HG23 ' A' ' 78' ' ' VAL . 1.5 t -140.34 105.54 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.378 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 77' ' ' ILE . 34.4 mm -107.25 41.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.943 HG23 HG12 ' A' ' 76' ' ' VAL . 58.8 t -46.23 97.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.572 HG23 ' HB3' ' A' ' 100' ' ' LEU . 31.7 mt -71.61 -101.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.455 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.696 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.09 -14.0 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -81.33 -35.43 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 109.799 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.87 -57.59 12.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.172 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.2 m -59.38 -29.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -75.79 -12.9 60.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.57 -36.34 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.3 pt -80.31 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.917 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.4 mptp? 73.64 -46.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.613 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -21.92 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.786 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.15 -30.07 0.11 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.62 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.766 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -62.48 176.52 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.95 0.405 . . . . 0.0 111.331 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -104.82 27.43 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 79.64 142.67 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.855 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.5 m-30 -63.82 149.39 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.572 ' HB3' HG23 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -81.57 101.72 10.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.205 -179.788 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.881 HG21 HD23 ' A' ' 17' ' ' LEU . 8.0 p . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.673 0.273 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -37.58 87.81 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.81 -36.32 83.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.675 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.64 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 9.6 t80 -59.46 -37.04 77.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.643 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.599 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.53 -42.95 79.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.136 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.34 -47.07 76.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.408 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.7 m -66.15 -41.69 90.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.518 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.9 mm -45.27 -54.33 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.52 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.29 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.033 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -60.92 -30.36 70.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.989 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.612 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -60.38 -39.37 87.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.914 0.387 . . . . 0.0 110.857 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 48' ' ' VAL . 28.2 m-85 -69.6 -15.04 63.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.345 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.77 0.319 . . . . 0.0 111.428 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.835 0.35 . . . . 0.0 111.013 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.418 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -144.98 151.04 37.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.787 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' A' ' 48' ' ' VAL . 30.3 t -133.37 143.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.711 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 29' ' ' ASP . 46.3 tp -106.45 129.75 54.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.959 HG21 ' CD1' ' A' ' 17' ' ' LEU . 17.7 t -117.94 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.594 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 42.9 t -81.84 119.14 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 26.3 t0 -155.15 149.99 26.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 32.3 t70 -90.31 51.43 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.732 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.788 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.78 HG21 ' CG1' ' A' ' 6' ' ' VAL . 61.1 p . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.886 0.374 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 t -58.84 138.03 57.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.981 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.409 ' CB ' HG11 ' A' ' 106' ' ' VAL . 3.1 m 75.84 -0.89 3.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.417 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.046 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -89.96 -52.67 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.347 . . . . 0.0 110.804 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.85 -58.59 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.024 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.22 48.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.011 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.889 HD11 HG13 ' A' ' 106' ' ' VAL . 62.1 mt -68.18 -71.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.331 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.046 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -49.59 -29.72 7.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -74.32 -27.02 60.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.654 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.28 -35.07 28.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.877 ' HG3' HD21 ' A' ' 110' ' ' LEU . 20.7 mm-40 -81.17 -34.62 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.045 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.19 53.27 1.91 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.227 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.475 ' CE2' HG21 ' A' ' 113' ' ' ILE . 7.8 m-85 -112.03 -175.69 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.357 0.599 . . . . 0.0 111.259 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 82.03 31.23 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.816 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.805 ' CB ' HD13 ' A' ' 21' ' ' LEU . 78.2 Cg_endo -82.06 128.02 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.752 2.301 . . . . 0.0 113.926 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.932 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -121.67 114.23 20.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 20.3 p -95.46 128.83 42.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.009 0.433 . . . . 0.0 111.648 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -98.96 163.35 12.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.39 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 5.8 mttt -111.93 -9.15 14.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.249 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.61 152.71 3.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.576 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.2 mt -52.16 -26.64 11.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.55 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -43.45 59.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.986 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 7' ' ' VAL . . . -73.24 -48.83 31.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.479 ' HG3' ' CE2' ' A' ' 66' ' ' PHE . 4.8 tt0 -47.11 -47.39 23.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.33 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -55.39 35.64 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -58.23 -26.33 62.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 41' ' ' ILE . 14.5 mt -90.16 -13.27 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.32 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -97.53 20.71 11.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -140.89 -52.65 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -98.83 155.51 17.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.379 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.417 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 52.5 t80 -88.67 78.23 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.047 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.639 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 16.1 m-85 -66.49 120.39 70.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.7 Cg_endo -80.63 -47.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.311 2.007 . . . . 0.0 111.889 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.813 HG23 ' CE1' ' A' ' 117' ' ' PHE . 36.6 t -115.06 124.9 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.577 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 46' ' ' PHE . 29.2 mm -112.82 124.48 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.51 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.674 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 46.4 t -128.12 108.58 18.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 112.051 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD23 HG13 ' A' ' 78' ' ' VAL . 49.7 tp -82.76 157.76 23.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.408 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -140.17 89.93 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.71 66.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.154 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -77.94 -80.51 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.561 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.8 ttm -146.0 50.46 1.05 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.029 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 55' ' ' MET . 58.0 Cg_endo -92.66 -165.92 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.96 2.44 . . . . 0.0 112.377 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.01 30.6 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.82 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.67 -73.54 0.89 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.562 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 31.2 20.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.17 91.33 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.813 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.892 ' O ' HD12 ' A' ' 64' ' ' ILE . 57.8 t -58.69 -39.78 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.836 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -15.51 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.348 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.94 ' CE2' HD11 ' A' ' 67' ' ' ILE . 45.9 t80 -53.26 -47.12 69.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.892 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.8 mt -46.62 -29.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -65.72 -49.67 67.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.418 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 38' ' ' GLU . 2.0 t80 -53.92 -41.4 67.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.95 0.405 . . . . 0.0 110.138 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.94 HD11 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -62.47 -43.89 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -79.9 -17.35 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.041 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 65' ' ' ASP . 4.0 tt0 -72.07 -45.5 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.45 8.06 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.198 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.445 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -155.54 63.95 3.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.877 0.37 . . . . 0.0 110.57 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 71' ' ' SER . 15.0 Cg_exo -67.86 -20.87 45.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.548 2.165 . . . . 0.0 112.082 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.48 23.03 7.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.869 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.407 ' HG ' ' C ' ' A' ' 47' ' ' PRO . 34.7 t -104.81 -176.98 3.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.643 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.682 HG21 ' HB1' ' A' ' 116' ' ' ALA . 31.0 t -123.36 157.23 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.068 0.461 . . . . 0.0 111.257 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -146.2 104.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.134 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 112' ' ' THR . 43.3 mm -90.11 -42.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 HG12 ' A' ' 76' ' ' VAL . 47.2 t 45.97 88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.351 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.713 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -104.28 -177.74 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.503 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.713 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 85' ' ' VAL . 21.3 t . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.594 0.235 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.24 -17.07 62.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.344 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -74.25 -35.23 63.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 0.0 109.944 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.75 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.87 -58.78 6.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.044 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 92' ' ' ILE . 21.3 m -60.25 -25.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.101 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.551 ' HD3' HG21 ' A' ' 61' ' ' VAL . 18.4 ttmm -76.22 -17.27 59.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.78 -39.67 4.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.852 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.8 pt -72.76 -22.73 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.689 0.28 . . . . 0.0 111.53 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -68.72 -30.65 69.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.385 . . . . 0.0 110.41 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -64.76 -57.07 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 34.75 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.29 -167.77 1.93 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.158 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 75.2 t80 -107.64 -17.97 13.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.45 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 4.6 pt-20 145.17 -173.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.504 0.721 . . . . 0.0 110.066 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.512 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -121.45 94.24 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.7 tp -54.15 140.74 31.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.294 -179.816 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.889 HG13 HD11 ' A' ' 20' ' ' ILE . 8.1 p . . . . . 0 C--O 1.232 0.143 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -46.74 -35.87 6.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -39.53 80.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.941 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.742 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 18.0 t80 -55.97 -31.46 63.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.926 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.877 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.4 tt -60.55 -52.55 64.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.147 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -47.05 -40.87 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.499 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.538 HG21 HD12 ' A' ' 77' ' ' ILE . 96.7 m -64.69 -50.19 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.742 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.4 mp -45.5 -52.95 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.922 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -59.12 4.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.0 0.429 . . . . 0.0 109.962 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -31.7 70.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.838 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.682 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.63 -28.36 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.813 ' CE1' HG23 ' A' ' 48' ' ' VAL . 10.7 m-85 -86.93 -56.4 3.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.529 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.457 ' HB2' ' CG ' ' A' ' 26' ' ' TYR . 13.8 mmtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.837 0.351 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.405 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.62 122.65 12.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 48.2 t -129.89 144.81 36.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.934 HD23 HG23 ' A' ' 49' ' ' ILE . 46.5 tp -106.67 140.1 40.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.496 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.83 HG21 ' CD1' ' A' ' 17' ' ' LEU . 19.2 t -118.39 127.07 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.182 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.803 ' HB ' HD12 ' A' ' 51' ' ' LEU . 37.4 t -117.01 115.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -140.49 162.59 34.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.618 -179.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' CG ' ' A' ' 56' ' ' PRO . 17.4 t70 -63.54 -85.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.618 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.44 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 68.4 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.704 0.288 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -50.6 138.7 17.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.796 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.519 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.2 m 78.04 -1.98 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.283 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.897 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.12 -53.95 4.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.8 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.31 -60.59 2.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.36 -39.86 47.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.078 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.748 HG23 ' CD1' ' A' ' 110' ' ' LEU . 46.3 mt -64.26 -66.61 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.159 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.897 HD11 HD13 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -50.66 -28.78 9.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -72.61 -27.98 62.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.649 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -82.6 -35.01 27.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.281 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.735 ' HG3' HD21 ' A' ' 110' ' ' LEU . 8.9 mm-40 -80.99 -39.85 25.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.037 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.31 51.0 2.29 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.166 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' A' ' 2' ' ' LYS . 3.4 m-30 -104.1 -174.85 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.376 0.608 . . . . 0.0 111.315 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 77.47 59.45 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.722 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.774 ' HB3' HD22 ' A' ' 21' ' ' LEU . 92.1 Cg_endo -86.45 154.29 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.685 2.257 . . . . 0.0 114.585 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.485 ' O ' HD12 ' A' ' 5' ' ' LEU . 20.5 t70 -140.3 137.36 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.558 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.1 p -114.89 143.38 45.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.208 0.528 . . . . 0.0 112.135 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.89 -173.69 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.056 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 33' ' ' THR . 0.3 OUTLIER -117.65 -22.24 8.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.773 0.321 . . . . 0.0 111.288 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -166.08 167.38 16.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.379 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.785 HD22 ' CD2' ' A' ' 63' ' ' PHE . 12.1 mt -54.53 -32.51 58.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.708 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.002 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -35.42 80.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.01 -56.21 16.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 27.3 mt-10 -45.86 -42.61 12.71 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -45.89 86.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.874 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -71.73 -42.02 67.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.9 mt -71.54 -21.28 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -61.8 -20.73 63.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.125 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -126.68 -55.98 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -64.92 115.62 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -74.26 65.77 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.483 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 37.8 m-85 -63.75 128.78 93.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 11.1 Cg_endo -82.57 -27.6 2.11 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.491 2.127 . . . . 0.0 112.125 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.861 ' O ' HD13 ' A' ' 49' ' ' ILE . 10.6 t -130.48 139.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.934 HG23 HD23 ' A' ' 5' ' ' LEU . 2.0 mm -139.03 108.84 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.727 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.797 HG22 ' CG1' ' A' ' 77' ' ' ILE . 41.8 t -111.05 142.18 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 110.662 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.803 HD12 ' HB ' ' A' ' 7' ' ' VAL . 20.2 tp -101.39 159.88 14.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 6.9 t70 -141.99 79.82 1.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 53' ' ' VAL . 45.3 t -65.89 68.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.666 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 31.0 t-105 -68.57 -79.62 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.923 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.763 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.2 ptt? -144.07 40.61 0.3 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.667 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.763 ' HD3' ' N ' ' A' ' 55' ' ' MET . 57.1 Cg_endo -99.45 -162.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.201 2.601 . . . . 0.0 112.198 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -91.52 -47.27 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.451 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.06 -121.65 14.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.014 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.96 31.32 18.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.408 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -95.04 59.65 1.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.524 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 90' ' ' LYS . 57.6 t -56.39 -38.11 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.153 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.09 15.96 9.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.44 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.958 ' CE2' HD11 ' A' ' 67' ' ' ILE . 47.8 t80 -79.7 -38.42 33.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.81 0.338 . . . . 0.0 110.742 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -48.58 -28.52 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.29 -37.78 60.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 19.4 t80 -57.68 -44.87 86.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.281 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.958 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.0 mp -59.29 -41.88 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.361 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.66 -24.85 49.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.551 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.14 -41.5 94.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.71 12.86 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 68.15 1.18 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.842 0.354 . . . . 0.0 110.668 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -67.98 -20.32 44.84 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.771 2.314 . . . . 0.0 112.138 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.6 28.73 6.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 47.5 t -112.1 -176.25 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.973 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.638 HG11 ' HB1' ' A' ' 116' ' ' ALA . 47.6 t -126.03 143.59 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.125 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.738 HG22 HG21 ' A' ' 67' ' ' ILE . 3.3 t -127.06 95.84 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.726 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.797 ' CG1' HG22 ' A' ' 50' ' ' VAL . 47.9 mm -74.22 -65.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.483 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 76' ' ' VAL . 11.3 t 67.8 88.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -106.45 175.7 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.563 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.594 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.916 0.389 . . . . 0.0 110.892 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 85' ' ' VAL . 15.2 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.878 0.371 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.5 -31.56 32.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.455 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 2.6 t -63.16 -34.48 77.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.874 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.849 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.13 -59.84 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.227 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 92' ' ' ILE . 10.3 m -64.53 -23.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.019 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.519 ' O ' HG13 ' A' ' 61' ' ' VAL . 22.0 ttpt -81.25 -7.6 59.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.427 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -123.29 -40.13 2.41 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.868 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.5 pt -69.8 -40.75 79.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.288 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -56.42 -25.46 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -19.75 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.347 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.85 -3.68 3.49 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.063 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -56.52 -167.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.901 0.381 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.524 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.8 t80 -108.53 26.05 10.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.44 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 79.66 152.65 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.203 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -74.83 103.08 4.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.948 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.4 tp -80.61 53.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.654 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 111.323 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.632 HG21 HD23 ' A' ' 17' ' ' LEU . 5.4 m . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -40.95 -50.51 3.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.203 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -35.41 80.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.23 0.538 . . . . 0.0 109.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.6 ' HE2' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -58.3 -24.09 58.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.213 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.748 ' CD1' HG23 ' A' ' 20' ' ' ILE . 1.2 tt -60.27 -49.08 79.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.221 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.596 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.4 mp -56.31 -56.15 24.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.33 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.436 HG23 ' HE2' ' A' ' 97' ' ' TYR . 60.8 m -53.72 -57.95 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 7.4 mm -31.58 -62.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.5 -59.2 3.97 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -52.67 -28.33 21.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.693 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.638 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -70.27 -32.66 70.57 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS . 26.6 m-85 -68.75 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.141 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.377 -179.575 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.2 mptt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.912 0.387 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.8 132.5 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.709 HG11 ' CD1' ' A' ' 113' ' ' ILE . 7.4 t -123.75 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.63 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.6 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 43.5 tp -103.66 132.74 49.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.733 HG21 ' CD1' ' A' ' 17' ' ' LEU . 34.1 t -113.26 90.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.254 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.14 104.63 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -135.32 134.39 39.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.95 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 t0 -73.29 -40.79 64.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.41 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.7 p . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 t -76.99 -65.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.44 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m -73.16 -53.43 11.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.396 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.7 tm? -46.81 -53.94 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.246 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.533 ' OG ' HG21 ' A' ' 30' ' ' THR . 71.3 m -52.8 -43.58 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.94 96.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.424 ' CG2' ' CD1' ' A' ' 110' ' ' LEU . 55.5 mt -56.22 -67.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.59 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.527 HD21 HG13 ' A' ' 113' ' ' ILE . 1.4 mt -47.47 -33.32 6.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 110.497 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.23 -29.96 71.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.589 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -78.51 -37.07 44.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.408 ' CD ' HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -70.61 -22.27 62.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.085 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.54 58.47 0.81 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.378 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.464 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 55.7 m-85 -130.14 -177.27 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.431 . . . . 0.0 111.116 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.1 76.18 77.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.448 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 11.7 Cg_exo -67.7 137.7 42.94 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.795 2.33 . . . . 0.0 112.631 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.2 t70 -120.63 7.85 10.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 6' ' ' VAL . 13.7 p 6.04 122.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.24 -162.41 0.93 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.86 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 ttpt -117.22 -38.46 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 32' ' ' LYS . 13.9 p -161.3 -173.06 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.538 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 63' ' ' PHE . 16.5 mt -66.79 -45.75 77.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.456 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -62.85 -45.88 90.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.157 0.504 . . . . 0.0 109.937 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -32.35 71.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -72.93 -28.68 62.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.704 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mt-10 -69.76 -43.49 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -60.04 -39.9 87.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.66 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -70.37 -46.82 63.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.721 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 37' ' ' ALA . 11.7 mt -73.0 -20.43 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.567 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -57.98 -21.17 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.371 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -126.46 -43.73 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -77.76 122.93 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.044 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -81.05 85.25 6.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.6 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 61.1 m-85 -80.79 113.97 44.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.367 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 74' ' ' SER . 71.6 Cg_endo -74.17 -20.39 19.01 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.655 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.3 t -144.72 129.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.299 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 7.6 mm -117.22 157.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.251 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 109' ' ' PHE . 74.9 t -149.34 102.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 110.767 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.479 HD23 HG13 ' A' ' 78' ' ' VAL . 60.1 tp -78.42 148.17 33.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.312 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.5 OUTLIER -130.24 84.06 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.242 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.649 ' N ' HG21 ' A' ' 80' ' ' THR . 87.3 t -62.88 72.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.978 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 55' ' ' MET . 27.9 t90 -64.92 -97.15 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.623 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -135.99 38.58 0.39 Allowed Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 55' ' ' MET . 69.5 Cg_endo -85.33 -164.72 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.425 2.083 . . . . 0.0 112.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -143.96 41.45 1.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.5 179.9 36.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.388 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.97 77.46 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.83 -25.87 62.09 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.554 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.451 ' O ' HD12 ' A' ' 64' ' ' ILE . 24.4 t -54.56 -44.53 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 120.756 0.312 . . . . 0.0 111.45 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.7 6.67 40.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.472 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 67' ' ' ILE . 34.9 t80 -90.07 -37.51 14.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.7 mp -47.95 -28.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.359 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -77.15 -36.22 55.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.703 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 61.2 t80 -59.15 -42.83 91.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.974 0.416 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.869 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.5 mp -59.85 -43.27 91.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.317 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.25 -16.04 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 3.1 tm-20 -74.0 -34.34 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.412 . . . . 0.0 110.737 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.442 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -126.41 13.31 7.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.029 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.29 66.89 1.94 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.584 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.25 -20.9 42.48 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.655 2.237 . . . . 0.0 112.187 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -100.04 30.42 3.76 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 44.5 t -113.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.478 HG11 ' HB1' ' A' ' 116' ' ' ALA . 58.0 t -152.92 136.83 8.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 111.646 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.635 HG12 HG23 ' A' ' 78' ' ' VAL . 3.4 t -108.77 113.94 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.866 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 79' ' ' ILE . 47.3 mm -91.22 -65.33 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.635 HG23 HG12 ' A' ' 76' ' ' VAL . 58.0 t 52.8 97.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.134 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.695 HD13 HD23 ' A' ' 100' ' ' LEU . 17.0 mt -126.22 142.54 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.649 HG21 ' N ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.736 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.758 0.313 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -83.76 3.44 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.216 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -37.57 13.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.28 -57.66 11.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.154 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.7 m -60.96 -25.89 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.478 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 61' ' ' VAL . 6.0 tttp -81.22 -18.21 46.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.531 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.7 -30.12 8.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 88' ' ' ALA . 4.7 pt -82.17 -23.45 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.197 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -68.95 -35.37 76.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpm? -59.25 -27.51 65.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.888 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.82 35.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.934 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.83 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.06 -165.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.481 ' HE2' HG23 ' A' ' 112' ' ' THR . 59.2 t80 -110.98 25.09 12.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.303 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.8 OUTLIER 85.37 161.9 0.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.653 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.739 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -95.36 95.07 8.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.306 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.695 HD23 HD13 ' A' ' 79' ' ' ILE . 20.2 tp -49.88 98.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.541 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 106' ' ' VAL . 7.2 p . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.76 -43.66 18.07 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -62.24 -34.83 77.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.307 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.615 ' HD2' HG23 ' A' ' 106' ' ' VAL . 1.6 t80 -63.32 -46.44 86.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.167 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.424 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -48.91 -37.26 19.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.456 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.21 -45.79 72.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.328 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.661 ' CG2' HD12 ' A' ' 77' ' ' ILE . 86.8 m -46.46 -40.79 12.92 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.399 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.709 ' CD1' HG11 ' A' ' 4' ' ' VAL . 12.9 mm -62.32 -65.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.716 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -14.9 3.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.743 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.25 -30.92 18.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.112 0.482 . . . . 0.0 109.718 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -79.44 -33.94 42.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.385 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 14.8 m-85 -70.26 -29.59 66.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.815 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.52 120.26 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.609 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.653 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.9 t -116.28 159.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.772 HD11 ' HD3' ' A' ' 40' ' ' LYS . 49.8 tp -109.58 129.66 55.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.896 HG21 ' CD1' ' A' ' 17' ' ' LEU . 24.6 t -115.38 89.45 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.673 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.13 115.21 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.137 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -149.35 143.15 25.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.403 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -87.44 50.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.437 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.434 HG21 ' CG1' ' A' ' 6' ' ' VAL . 52.6 p . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.8 136.3 47.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.138 0.494 . . . . 0.0 112.028 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.653 ' CB ' HG11 ' A' ' 106' ' ' VAL . 1.4 m 74.26 0.57 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.364 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.984 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.05 -53.35 4.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.859 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 t -44.57 -55.56 5.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.29 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.935 HD11 HG13 ' A' ' 106' ' ' VAL . 64.6 mt -65.22 -69.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.984 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.97 -30.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.51 -30.32 67.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -34.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 110.273 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.845 ' HG3' HD21 ' A' ' 110' ' ' LEU . 10.1 mm-40 -83.41 -36.98 23.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.08 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.11 54.26 1.77 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.269 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -108.59 -173.3 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 111.241 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.42 88.8 33.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.219 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HG3' HD13 ' A' ' 21' ' ' LEU . 85.1 Cg_endo -80.93 130.98 7.75 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.653 2.235 . . . . 0.0 112.811 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.4 t70 -105.57 5.04 30.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.347 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.79 HG22 ' HB ' ' A' ' 6' ' ' VAL . 10.4 p 2.14 124.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.786 ' HB2' ' CD ' ' A' ' 40' ' ' LYS . . . -106.71 -163.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.625 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -118.14 -36.45 3.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -158.56 179.94 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD22 ' CD2' ' A' ' 63' ' ' PHE . 56.3 mt -60.03 -47.41 85.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.92 -45.26 86.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.542 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -70.87 -32.15 69.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -75.19 -28.97 60.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 55.4 mt-10 -72.1 -39.95 68.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -32.26 69.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.688 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.786 ' CD ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -78.31 -37.6 44.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.773 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 37' ' ' ALA . 21.7 mt -76.97 -27.16 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -5.48 30.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.776 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.03 -27.38 10.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -134.83 156.38 49.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 69.1 t80 -91.66 96.46 10.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.947 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 38.9 m-85 -79.76 122.49 83.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.341 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.71 -20.5 7.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.511 2.141 . . . . 0.0 111.934 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.9 t -148.31 133.82 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.17 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.699 HG23 HD23 ' A' ' 5' ' ' LEU . 6.2 mm -121.01 163.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 60.1 t -154.06 99.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.843 ' HB3' HG13 ' A' ' 78' ' ' VAL . 42.5 tp -79.6 163.3 24.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 8.7 t70 -151.17 88.84 1.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.224 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.9 m -67.63 66.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.652 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -58.32 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.43 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.692 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.8 OUTLIER -152.5 49.5 0.53 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.104 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.692 ' HD3' ' N ' ' A' ' 55' ' ' MET . 36.6 Cg_endo -94.53 -162.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.09 2.527 . . . . 0.0 112.293 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -152.08 43.64 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.92 -21.26 5.02 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.815 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.434 ' OD1' HG23 ' A' ' 61' ' ' VAL . 0.4 OUTLIER 63.97 123.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.758 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -94.65 11.98 69.28 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.971 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 90' ' ' LYS . 46.5 t -68.78 -41.9 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.851 0.358 . . . . 0.0 111.045 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.28 4.79 49.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.85 ' CE2' HD11 ' A' ' 67' ' ' ILE . 24.8 t80 -90.09 -36.63 14.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.285 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.518 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.2 mp -47.05 -29.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.366 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -35.35 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 29.8 t80 -59.88 -41.36 91.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.85 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.2 mp -61.57 -43.46 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.212 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -25.89 58.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.396 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -63.84 -39.98 95.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 16.38 11.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.428 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -166.56 70.13 1.09 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.817 0.341 . . . . 0.0 110.822 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.46 -18.4 29.58 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.795 2.33 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.75 27.19 9.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.989 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.7 t -104.4 -159.82 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.395 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 48' ' ' VAL . 52.4 t -150.11 135.15 10.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 111.695 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.763 HG12 HG23 ' A' ' 78' ' ' VAL . 8.2 t -110.53 116.05 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.643 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.793 HG21 HG21 ' A' ' 112' ' ' THR . 16.1 mm -118.49 50.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 51' ' ' LEU . 44.7 t -49.64 115.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.677 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -110.26 179.16 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.749 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.723 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.832 0.348 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -94.84 -19.88 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -34.31 23.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.49 -59.38 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.846 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.8 m -55.39 -28.02 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.096 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 61' ' ' VAL . 14.4 tttt -80.13 -9.16 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.414 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -120.08 -31.41 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.953 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.3 pt -79.21 -44.72 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.738 0.304 . . . . 0.0 111.417 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.42 ' N ' HG13 ' A' ' 92' ' ' ILE . 27.8 mttp -63.21 -17.93 62.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.782 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -25.87 52.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.2 -16.13 0.29 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.629 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -59.17 -179.65 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.41 0.605 . . . . 0.0 111.043 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 85.1 t80 -99.81 -7.8 24.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.785 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.561 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 17.9 pt-20 140.99 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.276 0.63 . . . . 0.0 110.663 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.563 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.41 91.11 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.751 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.662 ' HB3' HG23 ' A' ' 79' ' ' ILE . 14.6 tp -55.64 167.34 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.935 HG13 HD11 ' A' ' 20' ' ' ILE . 7.3 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.666 0.269 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -44.96 -31.94 1.46 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.939 0.4 . . . . 0.0 110.481 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.426 ' HA ' HD13 ' A' ' 111' ' ' LEU . 4.6 mmt180 -70.17 -41.44 73.79 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.679 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 3.7 t80 -55.02 -29.26 57.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.954 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -56.36 -39.74 73.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.764 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 108' ' ' ARG . 8.2 mp -59.21 -60.03 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.793 HG21 HG21 ' A' ' 77' ' ' ILE . 80.0 m -44.12 -48.38 9.07 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.148 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.679 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 40.7 mm -54.76 -73.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.603 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -17.75 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -90.13 -20.81 22.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.4 -47.24 12.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 48' ' ' VAL . 57.7 m-85 -56.8 -29.86 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.103 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 179.88 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 17.1 mmtm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.919 0.39 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.9 134.65 23.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.597 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.627 HG13 ' HB ' ' A' ' 48' ' ' VAL . 10.9 t -125.34 160.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.572 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 61.5 tp -112.93 128.59 56.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.845 HG21 HD12 ' A' ' 17' ' ' LEU . 44.4 t -108.47 90.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.865 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 19.1 t -86.89 119.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.159 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -158.93 139.67 12.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.495 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.417 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 43.4 t0 -90.24 50.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.897 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 p . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 p -63.37 140.59 58.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.9 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.734 ' HB2' HG11 ' A' ' 106' ' ' VAL . 2.5 m 79.37 -5.36 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.563 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.019 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.18 -49.06 6.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 110.922 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.2 p -47.68 -49.24 28.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.79 68.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.745 HG23 HD11 ' A' ' 110' ' ' LEU . 91.4 mt -54.2 -69.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.162 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.019 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -45.08 -33.65 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.18 -28.82 65.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -83.07 -35.65 25.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.848 ' HG3' HD21 ' A' ' 110' ' ' LEU . 69.4 mm-40 -78.21 -38.72 42.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.943 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.58 26.58 7.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.354 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 49.2 m-85 -84.25 -174.94 5.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.989 0.423 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -133.13 86.57 41.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' A' ' 21' ' ' LEU . 95.2 Cg_endo -81.38 129.54 6.69 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.663 2.242 . . . . 0.0 112.442 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.0 t70 -106.92 -4.65 18.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 112.049 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 29' ' ' ASP . 69.2 p 43.72 174.54 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.703 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.865 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -164.01 170.43 16.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.419 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -104.76 -40.75 5.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -161.86 -174.49 4.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.571 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.687 HD22 ' CD2' ' A' ' 63' ' ' PHE . 45.8 mt -65.26 -41.34 94.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.708 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -61.53 -49.29 77.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 109.989 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.86 -34.85 77.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.57 -26.85 63.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 27.4 mt-10 -69.97 -46.62 64.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.873 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -62.28 -32.96 73.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.223 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -77.95 -40.36 39.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.229 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.661 HD12 ' HZ ' ' A' ' 63' ' ' PHE . 96.6 mt -76.87 -29.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 111.308 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.27 -25.84 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.358 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.79 -60.43 1.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.082 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -59.4 129.34 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.14 80.9 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 56.8 m-85 -78.77 119.2 76.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 95.8 Cg_endo -78.97 -22.11 8.96 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.512 2.141 . . . . 0.0 111.958 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.627 ' HB ' HG13 ' A' ' 4' ' ' VAL . 4.6 t -145.43 127.6 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.623 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.546 HG23 HD23 ' A' ' 5' ' ' LEU . 11.8 mm -113.98 152.09 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.827 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.79 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 84.5 t -139.56 94.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.508 . . . . 0.0 110.682 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 78' ' ' VAL . 37.6 tp -76.75 160.27 29.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.592 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 5.1 t0 -153.55 79.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.984 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.784 HG22 ' HB ' ' A' ' 80' ' ' THR . 28.6 m -59.24 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.283 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.432 ' CG ' ' N ' ' A' ' 55' ' ' MET . 14.8 t90 -63.41 -90.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.649 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.5 tpt -148.5 51.68 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.87 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.649 ' HD3' ' N ' ' A' ' 55' ' ' MET . 44.5 Cg_endo -92.54 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.898 2.399 . . . . 0.0 112.676 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -170.22 -68.5 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.785 0.326 . . . . 0.0 111.296 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.36 159.35 3.99 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.97 23.72 14.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 10.24 8.81 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.779 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 64' ' ' ILE . 27.3 t -84.34 -44.39 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.512 0.656 . . . . 0.0 110.964 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -68.39 -13.52 62.35 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.856 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.687 ' CD2' HD22 ' A' ' 34' ' ' LEU . 4.7 t80 -86.88 -27.45 23.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.315 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 61' ' ' VAL . 15.2 mm -47.59 -46.05 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.0 111.204 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -42.42 93.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.523 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 26.6 t80 -58.71 -29.97 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.113 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 1.065 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mm -64.71 -48.44 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.491 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -82.04 -14.28 56.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.24 -39.37 68.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.917 0.389 . . . . 0.0 110.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.48 11.48 9.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -157.43 66.62 3.77 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 110.673 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.0 Cg_exo -70.17 -19.49 34.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.745 2.297 . . . . 0.0 112.207 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.39 29.74 6.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.675 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 35.1 t -111.83 -162.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.757 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' PRO . 25.8 t -151.51 134.41 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.035 0.445 . . . . 0.0 111.81 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.065 HG22 HG21 ' A' ' 67' ' ' ILE . 2.0 t -111.44 111.79 37.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.756 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.626 HD13 ' HB3' ' A' ' 97' ' ' TYR . 37.5 mm -92.83 -42.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.309 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.014 HG23 HG12 ' A' ' 76' ' ' VAL . 40.7 t 46.0 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.271 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 100' ' ' LEU . 31.8 mt -56.3 -101.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.212 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.784 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.1 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 110.752 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.764 0.316 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -89.67 -60.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.729 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.645 HG23 ' CE2' ' A' ' 99' ' ' PHE . 5.3 t -46.09 -32.77 3.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.139 0.495 . . . . 0.0 110.305 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.902 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.24 -60.27 3.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.086 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 86' ' ' ASP . 28.0 m -61.88 -24.43 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.223 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.456 ' CD ' HG21 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -81.23 -32.48 33.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.14 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.17 -34.92 14.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.48 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.902 HG23 ' O ' ' A' ' 88' ' ' ALA . 2.7 pt -80.3 157.19 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.781 0.324 . . . . 0.0 110.754 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 mttm 72.42 6.1 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.162 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.49 26.66 5.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 110.565 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.62 -18.82 5.97 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.402 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -84.96 -169.8 2.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 111.248 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 77' ' ' ILE . 82.9 t80 -125.72 29.77 5.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 80.95 138.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.921 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.655 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.6 m-85 -66.08 128.97 38.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.061 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -71.93 118.11 14.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.952 HG21 HD23 ' A' ' 17' ' ' LEU . 7.4 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.666 0.27 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -45.23 -34.1 2.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.6 -39.99 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.9 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.79 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 1.5 t80 -56.39 -30.45 62.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.961 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.848 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -51.81 -42.84 62.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.229 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.427 ' H ' HD12 ' A' ' 111' ' ' LEU . 7.3 mp -57.61 -58.76 6.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.055 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.54 HG21 HD22 ' A' ' 100' ' ' LEU . 94.0 m -46.94 -41.28 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.76 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 23.0 mm -54.13 -68.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.313 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -15.51 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.839 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -90.27 -22.3 21.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -84.31 -37.75 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.06 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.419 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -66.84 -34.42 77.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.311 -179.832 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.944 0.402 . . . . 0.0 110.931 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.5 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -143.98 139.98 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.966 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.547 HG13 ' HB ' ' A' ' 48' ' ' VAL . 78.2 t -128.56 155.18 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.959 0.409 . . . . 0.0 111.065 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.077 HD23 HG23 ' A' ' 49' ' ' ILE . 40.6 tp -115.19 134.55 55.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.75 HG21 HD12 ' A' ' 17' ' ' LEU . 14.4 t -120.35 102.61 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.986 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.463 ' HB ' HD12 ' A' ' 51' ' ' LEU . 31.9 t -93.21 117.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.576 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 23.1 t0 -159.5 157.47 30.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 26.6 t70 -89.6 51.12 2.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.181 0.515 . . . . 0.0 110.569 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.515 179.795 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.8 0.333 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 52.8 p -50.06 141.74 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.619 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.588 ' CB ' HG11 ' A' ' 106' ' ' VAL . 1.3 m 85.95 -20.93 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.196 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.094 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -86.99 -47.12 9.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -50.33 -47.42 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.32 74.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.694 HG23 ' CD1' ' A' ' 110' ' ' LEU . 97.8 mt -58.12 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.094 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -45.12 -32.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.388 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.06 -29.79 63.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -83.52 -35.76 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.563 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.874 ' HG3' HD21 ' A' ' 110' ' ' LEU . 65.1 mm-40 -75.33 -35.49 61.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.21 44.4 2.79 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.529 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 53.6 m-85 -102.97 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 81.46 67.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.429 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.631 ' HB3' HD22 ' A' ' 21' ' ' LEU . 91.8 Cg_endo -83.12 142.11 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.78 2.32 . . . . 0.0 113.468 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.639 ' O ' HD12 ' A' ' 5' ' ' LEU . 24.2 t0 -136.23 65.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.373 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 6' ' ' VAL . 10.5 p -56.14 133.29 52.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.832 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.07 -160.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.336 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 33' ' ' THR . 3.7 mttt -120.66 -30.17 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.622 0.248 . . . . 0.0 111.336 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 32' ' ' LYS . 3.1 p -163.18 179.2 7.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.724 HD22 ' CD2' ' A' ' 63' ' ' PHE . 9.0 mt -61.45 -40.2 93.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.52 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 110.093 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -61.6 -33.53 74.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.196 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.68 -57.41 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 38.3 mt-10 -46.77 -41.13 14.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.766 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -43.41 95.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -44.44 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.854 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mt -71.17 -19.83 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.41 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -22.96 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -129.92 -59.38 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.88 114.45 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -79.83 67.05 5.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 46.0 m-85 -57.63 132.53 82.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 1.1 Cg_endo -77.74 -36.0 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.544 2.163 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.568 ' O ' HD13 ' A' ' 49' ' ' ILE . 20.0 t -125.82 133.93 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.077 HG23 HD23 ' A' ' 5' ' ' LEU . 1.8 mm -132.67 102.13 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.666 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 77' ' ' ILE . 31.0 t -100.47 125.61 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.279 . . . . 0.0 110.976 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.641 ' HB3' HG13 ' A' ' 78' ' ' VAL . 37.7 tp -90.53 161.49 15.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.45 . . . . 0.0 110.842 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -152.8 93.14 1.72 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 53' ' ' VAL . 57.2 t -73.9 63.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.404 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -63.39 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.319 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 35.6 mmm -139.71 37.19 0.27 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.648 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 55' ' ' MET . 92.8 Cg_endo -79.24 -165.42 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.294 1.996 . . . . 0.0 112.278 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -134.37 27.36 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.53 -86.64 1.9 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 59.16 54.37 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.69 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.35 110.49 3.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.831 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.863 ' O ' HD12 ' A' ' 64' ' ' ILE . 99.0 t -63.22 -36.13 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -6.53 48.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.61 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.0 ' CE2' HD11 ' A' ' 67' ' ' ILE . 48.3 t80 -62.07 -38.07 87.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.698 0.285 . . . . 0.0 111.165 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.863 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mt -48.57 -30.2 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.154 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.39 -34.01 63.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.651 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 26.8 t80 -61.2 -44.27 97.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 1.0 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -60.85 -41.2 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.393 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -21.0 46.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -68.03 -37.29 81.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.33 9.04 10.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.309 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.64 67.26 2.54 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.51 -18.93 33.15 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.702 2.268 . . . . 0.0 112.233 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -102.18 30.35 4.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.714 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.4 t -117.93 -179.79 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.797 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.6 143.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.574 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 67' ' ' ILE . 2.6 t -123.01 100.31 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.888 0.375 . . . . 0.0 110.976 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.824 ' O ' HG13 ' A' ' 50' ' ' VAL . 12.2 mm -104.18 74.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.641 HG13 ' HB3' ' A' ' 51' ' ' LEU . 19.6 t -67.79 118.75 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 100' ' ' LEU . 17.1 mt -125.83 157.97 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.479 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.455 HG22 HG23 ' A' ' 53' ' ' VAL . 25.1 p . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.117 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.787 0.327 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.32 -23.64 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.092 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -35.38 76.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -55.32 -59.16 5.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' HG12 ' A' ' 92' ' ' ILE . 26.3 m -62.38 -34.74 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.996 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.618 ' HD3' HG21 ' A' ' 61' ' ' VAL . 5.7 tttm -72.67 -10.67 60.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.603 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.543 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -106.9 -27.97 10.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.906 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.3 pt -88.17 -35.75 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -61.25 -31.33 71.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.844 ' HB2' HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -60.32 -65.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.744 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 25.69 0.08 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.044 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.38 -167.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.834 0.317 . . . . 0.0 110.897 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.661 ' HB3' HD13 ' A' ' 77' ' ' ILE . 62.0 t80 -108.98 -17.56 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.31 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 13.1 pt-20 152.01 -173.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.244 0.617 . . . . 0.0 110.375 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -122.66 90.45 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.718 ' O ' HG23 ' A' ' 79' ' ' ILE . 9.1 tp -50.46 107.82 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.34 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.958 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.887 HG21 HD23 ' A' ' 17' ' ' LEU . 10.5 p . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.844 0.354 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.06 -37.03 19.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 tpt85 -68.17 -40.07 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.768 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 50' ' ' VAL . 2.0 t80 -57.46 -27.09 62.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.992 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.874 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.2 tt -57.71 -48.4 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.137 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.4 mp -52.64 -53.19 50.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.307 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 m -51.89 -58.61 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.387 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 9.0 mm -32.93 -63.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.969 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -59.58 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -51.46 -27.54 10.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.688 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -71.56 -35.34 70.58 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.817 0.341 . . . . 0.0 111.033 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.7 -39.18 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.978 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.274 -179.607 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 3.6 mptt . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 124.21 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.71 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.638 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.5 t -122.64 143.75 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.992 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.516 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 20.3 tp -90.12 132.5 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.73 HG21 ' CD1' ' A' ' 17' ' ' LEU . 14.0 t -119.3 89.59 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.66 114.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 31.6 t0 -155.09 152.1 29.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.5 48.73 1.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.677 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.501 HG23 ' CG1' ' A' ' 6' ' ' VAL . 81.3 p . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 t -71.42 131.9 44.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.961 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.452 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.8 m 77.35 -5.84 2.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.511 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.39 -55.15 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.063 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 t -47.07 -56.99 5.53 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.373 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.41 -39.2 64.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.05 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.879 HD12 HG23 ' A' ' 106' ' ' VAL . 45.2 mt -64.56 -66.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.304 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.953 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.62 -29.73 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -69.92 -28.82 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.902 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.79 -36.06 23.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.487 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.842 ' HG3' HD21 ' A' ' 110' ' ' LEU . 6.8 mm-40 -81.73 -39.0 24.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.39 31.89 5.97 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.177 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 4.9 m-85 -81.66 -172.79 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 88.76 25.4 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HG3' HD13 ' A' ' 21' ' ' LEU . 74.3 Cg_endo -78.63 129.35 9.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.469 2.113 . . . . 0.0 112.592 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 30' ' ' THR . 18.2 t70 -99.96 2.17 43.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.754 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.703 HG22 ' HB ' ' A' ' 6' ' ' VAL . 3.2 p 1.76 124.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.93 -160.65 0.73 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.349 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 19.0 mttp -113.65 -31.94 6.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -163.12 -175.28 4.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.745 HD22 ' CD2' ' A' ' 63' ' ' PHE . 9.6 mt -63.23 -44.23 95.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.638 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.03 -54.02 51.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.195 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.119 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.488 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.44 -28.62 64.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.772 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 19.0 mt-10 -71.47 -43.18 67.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.23 75.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.009 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -75.59 -35.35 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 37' ' ' ALA . 20.3 mt -76.03 -26.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.787 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -77.77 -5.4 50.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.26 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -101.07 -51.74 3.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.764 0.316 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.918 HD11 ' CE1' ' A' ' 46' ' ' PHE . 3.0 pp -117.69 -179.61 3.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.077 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.6 ' N ' HD12 ' A' ' 44' ' ' LEU . 1.7 t80 -107.14 111.02 23.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.918 ' CE1' HD11 ' A' ' 44' ' ' LEU . 64.0 m-85 -98.08 113.01 63.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.406 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HG2' ' CE2' ' A' ' 117' ' ' PHE . 63.6 Cg_endo -73.15 -19.38 22.78 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.659 2.239 . . . . 0.0 111.929 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.5 t -148.63 134.23 11.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.422 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.408 HD12 HD23 ' A' ' 5' ' ' LEU . 23.4 mm -116.89 157.15 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.425 HG21 ' CE1' ' A' ' 109' ' ' PHE . 43.1 t -151.42 101.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.183 0.516 . . . . 0.0 112.073 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.455 ' HB3' HG13 ' A' ' 78' ' ' VAL . 14.1 tp -75.03 168.63 19.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.797 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -127.37 -47.27 1.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.674 0.273 . . . . 0.0 111.404 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 53' ' ' VAL . 23.2 t 68.54 37.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.965 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -63.92 -82.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.53 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.704 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.2 ttm -152.1 47.69 0.42 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.358 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.704 ' HD3' ' N ' ' A' ' 55' ' ' MET . 29.3 Cg_endo -95.05 -161.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.06 2.507 . . . . 0.0 112.162 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.32 29.68 7.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.65 -97.79 2.08 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.601 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 55.36 54.21 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.418 . . . . 0.0 110.535 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' H ' HD11 ' A' ' 34' ' ' LEU . . . -100.1 106.66 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.746 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.691 HG21 ' HD2' ' A' ' 90' ' ' LYS . 97.0 t -63.69 -32.47 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.825 0.345 . . . . 0.0 111.012 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -3.77 48.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.754 ' CE2' HD11 ' A' ' 67' ' ' ILE . 23.6 t80 -60.77 -31.38 70.73 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.578 0.228 . . . . 0.0 110.987 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -46.74 -38.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.59 -53.29 56.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 20.1 t80 -51.11 -30.75 17.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 110.217 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.838 HG21 HG22 ' A' ' 76' ' ' VAL . 3.8 mm -64.87 -53.34 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -74.21 -19.05 60.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.851 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.17 -44.62 83.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.867 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.56 10.19 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.436 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.69 66.62 2.79 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.777 0.322 . . . . 0.0 110.832 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.54 -19.62 32.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.84 2.36 . . . . 0.0 112.305 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -107.33 34.66 3.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 48.5 t -116.35 -158.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' A' ' 48' ' ' VAL . 39.2 t -150.57 135.58 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-O 120.917 0.389 . . . . 0.0 111.449 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.838 HG22 HG21 ' A' ' 67' ' ' ILE . 1.7 t -112.53 106.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.414 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' A' ' 97' ' ' TYR . 36.5 mm -89.0 -49.38 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.72 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.821 HG23 HG12 ' A' ' 76' ' ' VAL . 59.3 t 52.69 81.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.363 . . . . 0.0 111.104 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 77' ' ' ILE . 2.4 mt -105.39 155.11 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.353 . . . . 0.0 111.006 -179.855 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.748 0.309 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.86 -26.47 65.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.5 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.5 t -75.55 -33.26 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -59.94 -59.28 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.99 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 92' ' ' ILE . 18.0 m -58.78 -21.48 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.018 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.691 ' HD2' HG21 ' A' ' 61' ' ' VAL . 22.3 ttpt -83.85 -9.65 58.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.591 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.32 -33.93 4.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.873 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 12.2 pt -73.05 -38.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.673 0.273 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -25.29 64.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.636 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.6 -57.54 3.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.11 33.45 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.19 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.873 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.11 -164.29 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 110.727 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.582 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.1 t80 -108.53 25.32 11.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.245 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.443 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 82.49 17.98 0.33 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.013 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.586 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 57.56 166.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.25 179.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -119.56 122.17 41.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.786 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.879 HG23 HD12 ' A' ' 20' ' ' ILE . 34.3 m . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.596 0.236 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -41.46 -44.7 2.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.815 0.341 . . . . 0.0 111.225 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -36.07 74.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.138 0.494 . . . . 0.0 109.816 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.639 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 1.4 t80 -56.17 -23.97 38.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.842 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -62.23 -49.2 76.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.663 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.0 mp -57.09 -57.68 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.49 HG23 ' HE2' ' A' ' 97' ' ' TYR . 97.4 m -54.47 -43.68 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -41.8 -54.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.011 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 0.0 109.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -55.87 -24.89 39.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -67.55 -37.68 83.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.049 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.572 ' CE1' HG21 ' A' ' 48' ' ' VAL . 27.4 m-85 -75.57 -17.49 60.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.956 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.257 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.457 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 6.0 mptt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.878 0.371 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 126.25 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.726 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.652 HG13 ' HB ' ' A' ' 48' ' ' VAL . 23.8 t -122.47 152.53 26.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 110.867 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.641 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 47.0 tp -103.48 135.33 45.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.856 ' HB ' HG22 ' A' ' 30' ' ' THR . 15.1 t -120.74 89.01 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.69 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.509 ' HB ' HD12 ' A' ' 51' ' ' LEU . 21.2 t -78.88 115.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.716 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 22.5 t70 -155.27 163.24 40.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.313 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -83.8 48.75 1.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.987 0.422 . . . . 0.0 111.08 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.674 179.697 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.621 HG21 ' CG1' ' A' ' 6' ' ' VAL . 60.7 p . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.5 t -83.77 134.96 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 111.679 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m 81.35 -10.38 1.19 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.306 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.938 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.15 -50.67 5.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 110.613 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.06 -54.95 7.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.86 66.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.777 HD11 HG13 ' A' ' 106' ' ' VAL . 70.8 mt -69.22 -69.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.309 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -45.72 -32.7 2.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.486 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -27.83 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.013 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -82.94 -35.56 25.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.441 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.916 ' HG3' HD21 ' A' ' 110' ' ' LEU . 2.9 mm-40 -81.31 -31.87 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.988 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.2 29.83 6.58 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.189 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CE1' ' CG ' ' A' ' 2' ' ' LYS . 46.1 m-85 -86.31 -173.97 4.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.049 0.452 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -138.25 89.36 14.3 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.037 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HB3' HD13 ' A' ' 21' ' ' LEU . 73.3 Cg_endo -77.95 132.38 11.7 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.54 2.16 . . . . 0.0 112.594 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -104.5 -4.31 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.193 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.856 HG22 ' HB ' ' A' ' 6' ' ' VAL . 43.0 p 12.95 121.75 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.38 156.35 21.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.364 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.688 ' O ' HG23 ' A' ' 33' ' ' THR . 2.2 mtmp? -80.68 -28.36 36.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -167.93 178.76 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.615 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 63' ' ' PHE . 16.6 mt -57.5 -33.12 67.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -56.32 18.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.22 -29.43 70.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.33 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -72.9 -29.02 62.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 26.5 mt-10 -71.19 -41.23 70.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 109.903 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -33.9 76.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -77.83 -35.91 50.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.854 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 37' ' ' ALA . 19.9 mt -78.47 -25.17 13.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.812 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -90.26 28.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.257 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -146.17 -46.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.531 HD22 ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -113.55 155.52 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.451 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 9.1 t80 -85.5 90.42 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.332 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.641 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 9.5 m-85 -76.66 113.82 33.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.55 -23.8 9.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.472 2.115 . . . . 0.0 112.146 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.652 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.6 t -146.58 133.41 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.625 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.582 HG23 HD23 ' A' ' 5' ' ' LEU . 23.8 mm -115.96 150.01 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.098 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.633 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 77.9 t -142.78 100.06 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.398 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.589 HD23 HG13 ' A' ' 78' ' ' VAL . 8.9 tp -86.09 149.1 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 t0 -140.2 107.15 5.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 53' ' ' VAL . 20.3 m -75.31 61.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.673 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -69.58 -79.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.801 0.334 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.697 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 6.1 ttt -153.72 49.96 0.53 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.983 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.697 ' HD3' ' N ' ' A' ' 55' ' ' MET . 19.5 Cg_endo -93.47 -159.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.143 2.562 . . . . 0.0 112.119 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -142.61 38.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.22 -82.24 1.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.34 68.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.824 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.42 93.29 0.66 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.641 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.625 HG21 ' HD3' ' A' ' 90' ' ' LYS . 81.6 t -58.96 -33.84 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.927 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.19 -0.85 42.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.682 ' CD2' HD22 ' A' ' 34' ' ' LEU . 12.6 t80 -60.15 -38.13 82.2 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.8 mp -46.44 -42.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -43.03 95.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.134 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HD1' HD13 ' A' ' 67' ' ' ILE . 12.1 t80 -57.84 -33.66 68.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.762 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mm -65.12 -53.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.266 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -72.69 -16.71 61.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.727 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.27 -44.29 72.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.53 13.07 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.326 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.42 66.57 1.86 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.37 -18.75 29.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.754 2.302 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -106.57 31.35 5.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.666 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.9 t -111.41 -158.3 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.545 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 48' ' ' VAL . 46.7 t -149.64 136.24 12.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.777 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 67' ' ' ILE . 16.4 t -114.13 115.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.674 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mm -100.95 -47.47 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.75 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.73 HG23 HG12 ' A' ' 76' ' ' VAL . 59.9 t 49.74 86.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.314 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.639 HG23 ' HB3' ' A' ' 100' ' ' LEU . 8.9 mt -94.22 162.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.915 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.497 ' HB ' HG22 ' A' ' 53' ' ' VAL . 48.4 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.792 0.329 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.79 -12.62 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.429 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.8 t -78.78 -35.45 44.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.069 0.461 . . . . 0.0 109.864 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.8 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.54 -58.55 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.091 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.32 -25.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.769 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.625 ' HD3' HG21 ' A' ' 61' ' ' VAL . 1.5 ttmp? -90.06 39.01 0.95 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.556 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.26 -39.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.99 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.9 pt -74.88 -42.46 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -21.46 63.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.781 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -73.95 -27.65 61.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.17 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.29 -18.29 0.38 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.378 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.99 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.9 176.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.152 0.476 . . . . 0.0 111.464 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 74.4 t80 -97.6 26.14 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.456 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.479 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.6 OUTLIER 77.44 146.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.652 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.9 OUTLIER -65.83 138.87 58.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.908 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 101' ' ' GLU . 1.5 tm? -68.93 137.94 54.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.502 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.881 ' N ' HD13 ' A' ' 100' ' ' LEU . 1.8 mp0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.244 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.777 HG13 HD11 ' A' ' 20' ' ' ILE . 9.5 p . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.64 0.257 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.2 -36.18 3.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.95 0.405 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HA ' HD13 ' A' ' 111' ' ' LEU . 2.1 tpm_? -67.29 -41.03 86.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.776 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.633 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 24.4 t80 -57.54 -27.27 62.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.153 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.916 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -60.07 -47.81 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.243 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.5 mp -51.79 -52.6 47.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.187 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.8 m -57.41 -45.92 84.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.14 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.9 mm -45.47 -56.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.587 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.29 -62.57 1.42 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -49.56 -27.34 4.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.926 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -67.73 -29.55 68.81 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.914 0.388 . . . . 0.0 110.782 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 61.6 m-85 -89.67 -26.45 20.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.818 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.044 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HD2' ' CD2' ' A' ' 117' ' ' PHE . 5.1 mmtm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.832 0.349 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.566 ' HB3' ' CB ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -175.43 93.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 48' ' ' VAL . 18.3 t -77.41 160.49 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 29' ' ' ASP . 60.7 tp -117.07 135.09 53.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.31 90.66 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.732 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.596 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 16.6 t -88.91 121.44 39.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.342 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -157.37 141.16 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.859 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.51 48.8 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 7.8 tp10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.801 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.748 0.309 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -26.32 65.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 t -93.27 -68.31 0.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -46.17 -56.89 5.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.487 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.81 ' HA ' HD12 ' A' ' 21' ' ' LEU . 21.3 t -41.25 -51.52 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.271 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -38.54 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.095 0.474 . . . . 0.0 110.622 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.857 HD13 HG11 ' A' ' 106' ' ' VAL . 6.1 mt -69.06 -70.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.322 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.936 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.49 -23.72 2.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.508 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.867 ' N ' HD13 ' A' ' 21' ' ' LEU . 31.5 mt-10 -78.48 -29.92 47.04 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 -37.92 58.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 109.923 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.726 ' HG3' HD21 ' A' ' 110' ' ' LEU . 19.2 mm-40 -59.34 -18.89 42.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.207 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.4 73.45 1.14 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.767 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 29.5 m-85 -147.01 -178.86 6.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 111.649 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.566 ' CB ' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -121.42 81.95 39.05 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.837 ' CG ' HD11 ' A' ' 21' ' ' LEU . 37.4 Cg_endo -89.86 137.9 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.699 2.266 . . . . 0.0 114.041 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.899 ' O ' HD12 ' A' ' 5' ' ' LEU . 13.1 t70 -126.15 125.07 41.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.6 p -97.2 135.96 38.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 111.643 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -108.44 178.5 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 mttt -122.75 -8.79 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.92 -171.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.773 HD22 ' CD2' ' A' ' 63' ' ' PHE . 75.5 mt -79.36 -32.34 43.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 0.0 110.154 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -70.9 -44.38 66.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.795 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.12 -33.81 76.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.58 -49.23 33.78 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -46.93 -45.94 21.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.365 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -54.89 41.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -57.66 -27.87 63.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.692 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 41' ' ' ILE . 42.9 mt -92.82 -8.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.55 8.22 29.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.73 0.3 . . . . 0.0 111.147 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -148.9 -48.14 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.58 116.09 21.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -69.22 71.29 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.731 ' CE2' HD13 ' A' ' 5' ' ' LEU . 13.1 m-85 -69.68 116.16 40.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.1 Cg_exo -74.56 -35.7 3.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.183 1.922 . . . . 0.0 111.44 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.913 HG23 ' CE1' ' A' ' 117' ' ' PHE . 16.5 t -124.8 126.59 71.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.784 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.574 HG23 HD23 ' A' ' 5' ' ' LEU . 15.5 mm -113.61 130.1 68.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.605 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.746 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 61.0 t -123.81 107.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.103 0.477 . . . . 0.0 111.168 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.543 ' HB3' HG22 ' A' ' 78' ' ' VAL . 13.0 tp -93.87 147.08 23.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 1.1 t70 -126.02 97.37 5.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 80' ' ' THR . 23.4 t -67.05 72.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.354 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.452 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 59.4 t-105 -80.04 -91.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 ttp -140.73 46.0 0.86 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.102 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 55' ' ' MET . 86.2 Cg_endo -77.65 -167.02 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.547 2.164 . . . . 0.0 112.4 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.8 -44.09 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.72 163.76 51.67 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.582 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.39 120.47 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.17 -20.96 80.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.57 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.498 HG21 ' HD3' ' A' ' 90' ' ' LYS . 91.4 t -57.36 -38.13 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.32 -22.09 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.773 ' CD2' HD22 ' A' ' 34' ' ' LEU . 14.9 t80 -65.01 -40.66 95.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.811 0.339 . . . . 0.0 111.057 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.451 HG23 HG11 ' A' ' 76' ' ' VAL . 3.2 mt -46.32 -28.68 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -70.48 -51.7 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -48.82 -40.67 30.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.826 0.346 . . . . 0.0 110.559 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.831 HG21 HG22 ' A' ' 76' ' ' VAL . 3.5 mp -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.412 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -76.45 -19.58 57.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.789 0.328 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.8 -50.87 54.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.712 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.08 14.7 20.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.372 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.2 66.86 2.65 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.9 -19.1 35.89 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.21 . . . . 0.0 112.113 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.8 28.11 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.805 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.9 t -117.31 -175.77 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.775 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.527 HG21 ' HB1' ' A' ' 116' ' ' ALA . 45.6 t -127.17 139.95 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.371 0.605 . . . . 0.0 111.783 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.831 HG22 HG21 ' A' ' 67' ' ' ILE . 1.7 t -122.96 88.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 97' ' ' TYR . 44.8 mm -73.8 -69.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.369 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 51' ' ' LEU . 38.2 t 63.15 118.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.302 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.531 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.6 mt -121.0 -142.36 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.839 0.352 . . . . 0.0 110.815 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.621 HG13 ' OE2' ' A' ' 101' ' ' GLU . 16.3 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.861 0.363 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -90.08 -24.44 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.5 t -77.48 -35.28 53.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.188 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.505 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.69 -57.52 12.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.94 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.1 m -55.72 -30.37 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.844 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.498 ' HD3' HG21 ' A' ' 61' ' ' VAL . 30.4 tttt -76.84 -13.28 60.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.088 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.45 -41.77 5.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.658 0.266 . . . . 0.0 111.433 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.846 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.3 pt -70.47 -31.36 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 111.028 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -24.32 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.18 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -84.93 -54.89 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.661 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.87 28.98 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.641 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.25 177.62 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.24 0.52 . . . . 0.0 110.565 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.695 ' HE2' HG23 ' A' ' 112' ' ' THR . 39.8 t80 -88.24 -23.34 23.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.526 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.498 ' HA ' HG21 ' A' ' 92' ' ' ILE . 2.6 pt-20 152.56 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.292 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 78' ' ' VAL . 1.5 t80 80.61 111.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.644 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.662 HD21 ' HA ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -51.95 96.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.207 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.621 ' OE2' HG13 ' A' ' 85' ' ' VAL . 4.9 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.857 HG11 HD13 ' A' ' 20' ' ' ILE . 12.5 p . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 120.63 0.252 . . . . 0.0 111.617 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -52.11 -51.11 59.86 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 110.902 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -38.69 74.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.746 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 28.0 t80 -60.58 -29.77 69.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.379 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.726 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -70.12 -46.21 65.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.038 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mp -50.23 -42.78 52.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.695 HG23 ' HE2' ' A' ' 97' ' ' TYR . 75.1 m -69.37 -46.7 66.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.891 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.526 HD13 HG11 ' A' ' 48' ' ' VAL . 6.8 mm -45.52 -59.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.727 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -55.64 7.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.78 -29.2 69.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.74 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.96 -37.65 85.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 0.0 110.853 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.913 ' CE1' HG23 ' A' ' 48' ' ' VAL . 6.4 m-85 -73.02 -17.1 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.372 179.912 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.896 0.379 . . . . 0.0 110.984 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.426 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.45 85.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.857 HG21 HD12 ' A' ' 113' ' ' ILE . 21.9 t -81.79 146.43 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.842 HD13 ' CE2' ' A' ' 46' ' ' PHE . 37.3 tp -106.96 139.77 40.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 0.0 111.218 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.752 ' HB ' HG22 ' A' ' 30' ' ' THR . 21.7 t -117.3 145.9 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.44 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.449 ' HB ' HD12 ' A' ' 51' ' ' LEU . 15.5 t -132.94 120.96 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.284 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 9.9 t0 -156.68 148.69 22.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -83.79 49.32 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.449 . . . . 0.0 111.19 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.662 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 20.3 p . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.896 0.379 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.7 m -41.01 133.82 2.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.477 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.531 ' O ' HD12 ' A' ' 20' ' ' ILE . 6.5 t 79.72 -9.05 1.49 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.486 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.979 HD23 HG21 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -90.15 -53.88 4.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.33 . . . . 0.0 111.103 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -51.52 -52.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.92 79.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.011 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.724 HG23 ' CD1' ' A' ' 110' ' ' LEU . 38.4 mt -60.54 -66.52 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.034 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.4 mt -50.98 -34.1 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -68.72 -26.75 65.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.74 -35.1 30.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.068 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.865 ' HG3' HD21 ' A' ' 110' ' ' LEU . 31.4 mm-40 -81.23 -27.97 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.057 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.12 1.21 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.233 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.455 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 6.2 m-85 -120.9 -176.18 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.307 0.575 . . . . 0.0 111.357 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.62 79.54 67.51 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.554 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.797 ' HB3' HD13 ' A' ' 21' ' ' LEU . 84.7 Cg_endo -84.34 146.86 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.864 2.376 . . . . 0.0 114.348 -177.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' O ' HD12 ' A' ' 5' ' ' LEU . 20.8 t70 -139.24 135.27 33.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.545 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.752 HG22 ' HB ' ' A' ' 6' ' ' VAL . 17.7 p -122.53 133.75 54.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 111.883 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.33 -163.14 0.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 11.0 mttm -112.76 -31.21 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -162.76 -175.04 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.678 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.4 mt -64.31 -41.16 96.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -61.42 -46.04 91.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 109.94 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.57 -38.58 89.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.3 -56.06 19.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.435 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 41.0 mt-10 -47.27 -41.4 18.75 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.756 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -59.73 -43.06 94.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.922 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -73.25 -44.03 60.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.84 -18.56 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.472 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.2 -23.6 15.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -127.17 -52.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.99 121.61 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.28 58.34 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.842 ' CE2' HD13 ' A' ' 5' ' ' LEU . 16.0 m-85 -57.73 123.35 62.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' SER . 58.5 Cg_endo -71.97 -32.56 10.99 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.548 2.165 . . . . 0.0 112.21 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.639 ' HB ' HG13 ' A' ' 4' ' ' VAL . 8.0 t -128.32 139.55 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.257 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.822 HG23 HD23 ' A' ' 5' ' ' LEU . 1.2 mm -139.77 108.34 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.299 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG22 ' CG1' ' A' ' 77' ' ' ILE . 50.9 t -105.54 133.69 49.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.769 0.318 . . . . 0.0 110.305 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.568 HD23 HG13 ' A' ' 78' ' ' VAL . 30.7 tp -101.96 136.44 41.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.88 81.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.015 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.745 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.4 p -60.58 80.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.3 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 13.6 t-105 -84.82 -78.04 0.26 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.355 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.678 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.65 50.34 0.97 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.678 ' HD3' ' N ' ' A' ' 55' ' ' MET . 15.3 Cg_endo -92.78 -159.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.163 2.575 . . . . 0.0 112.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -153.6 62.84 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.93 0.395 . . . . 0.0 111.004 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.39 162.78 29.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.541 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.542 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -85.07 116.54 23.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 110.864 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.49 -26.58 24.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.629 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.636 HG21 ' HD3' ' A' ' 90' ' ' LYS . 50.4 t -63.35 -41.21 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 111.2 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.74 -26.88 57.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 67' ' ' ILE . 16.0 t80 -61.05 -36.01 78.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.08 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.423 ' CG2' ' HA3' ' A' ' 95' ' ' GLY . 2.1 mp -45.81 -29.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.373 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -78.77 -38.67 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 38' ' ' GLU . 16.3 t80 -56.84 -41.64 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.753 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.9 mp -58.99 -46.3 91.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.382 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -75.34 -25.01 57.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -63.74 -43.68 95.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.86 16.93 13.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.04 69.44 0.98 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.81 -19.27 41.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.726 2.284 . . . . 0.0 112.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -104.99 28.24 7.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.6 t -111.72 179.99 3.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.462 ' HB ' HG13 ' A' ' 48' ' ' VAL . 61.8 t -127.15 146.11 33.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 0.0 111.206 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.678 HG22 HG21 ' A' ' 67' ' ' ILE . 3.7 t -125.43 119.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.335 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.759 ' CG1' HG22 ' A' ' 50' ' ' VAL . 42.3 mm -97.33 -63.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.592 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 76' ' ' VAL . 6.0 t 63.13 115.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 53' ' ' VAL . 1.4 mt -129.31 -145.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.879 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.745 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 121.008 0.433 . . . . 0.0 111.368 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.501 HG12 ' HB3' ' A' ' 88' ' ' ALA . 22.2 t . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 89' ' ' VAL . 39.1 t70 -100.03 -47.86 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.0 t -55.6 -31.55 62.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.966 0.413 . . . . 0.0 110.353 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.73 -60.0 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.123 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 86' ' ' ASP . 32.8 m -58.11 -24.73 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.914 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.636 ' HD3' HG21 ' A' ' 61' ' ' VAL . 8.1 ttmt -83.03 -10.92 58.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.27 -37.52 5.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.683 0.278 . . . . 0.0 111.6 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.886 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 14.1 pt -71.99 159.66 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.167 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HG2' HG13 ' A' ' 92' ' ' ILE . 7.7 mmmt 80.52 -47.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.579 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.4 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' A' ' 64' ' ' ILE . . . -175.52 -33.19 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.464 -0.875 . . . . 0.0 113.237 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.886 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -62.8 176.22 0.72 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.194 0.497 . . . . 0.0 110.671 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.562 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -100.67 -8.35 22.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 140.23 -11.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.411 0.684 . . . . 0.0 111.438 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER 77.71 120.27 0.05 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.88 0.372 . . . . 0.0 110.924 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.499 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -72.93 157.95 36.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.551 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 -179.849 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.979 HG21 HD23 ' A' ' 17' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -44.19 -42.1 6.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.952 0.406 . . . . 0.0 110.706 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -68.2 -37.51 80.98 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.889 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 5.0 t80 -58.52 -22.86 56.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.261 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.865 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.1 tt -63.8 -51.15 66.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.319 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mp -53.78 -54.49 37.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.018 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.507 HG23 ' CZ ' ' A' ' 97' ' ' TYR . 86.3 m -51.39 -56.78 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.091 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.889 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 9.9 mm -30.06 -63.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.695 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.67 -59.29 3.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.64 -24.86 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.828 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -70.87 -45.38 64.52 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 0.0 111.379 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.585 ' CE1' HG21 ' A' ' 48' ' ' VAL . 55.1 m-85 -66.53 -13.26 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.32 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.441 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 4.3 mmmm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.848 0.356 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -143.59 127.11 16.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.777 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 48' ' ' VAL . 42.7 t -115.59 154.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.61 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 37.0 tp -115.01 132.78 56.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.706 HG21 HD12 ' A' ' 17' ' ' LEU . 25.0 t -116.62 89.55 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.338 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' A' ' 37' ' ' ALA . 14.0 t -84.7 96.92 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.3 132.14 53.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.56 -65.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.763 0.316 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 t -90.28 29.41 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.565 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.3 p -157.97 -61.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.683 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.706 HD12 HG21 ' A' ' 6' ' ' VAL . 1.5 tm? -56.58 -49.73 74.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.594 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 p -54.75 -46.2 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.383 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.62 85.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.576 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.698 HG23 HD11 ' A' ' 110' ' ' LEU . 24.1 mt -57.28 -64.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.843 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 17' ' ' LEU . 1.4 mt -49.27 -32.58 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -27.43 68.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -79.01 -37.39 39.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.985 0.421 . . . . 0.0 110.013 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' HG3' HD22 ' A' ' 110' ' ' LEU . 1.1 tm-20 -70.09 -51.06 34.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 58.91 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.522 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -135.88 -173.89 3.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -136.47 75.04 52.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.066 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 50.5 Cg_exo -54.8 151.4 32.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.684 2.256 . . . . 0.0 112.638 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -132.66 6.25 4.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.662 HG22 ' HB ' ' A' ' 6' ' ' VAL . 3.5 p 0.7 126.52 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 166.14 21.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.222 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.628 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 mtpt -79.41 -163.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.38 168.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.136 0.493 . . . . 0.0 111.82 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.661 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.3 mt -36.41 -35.53 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.261 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -54.34 -63.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.056 0.455 . . . . 0.0 110.146 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 2.0 mp0 -65.18 -33.8 76.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.704 ' HB2' HG13 ' A' ' 7' ' ' VAL . . . -63.22 -65.5 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -43.13 -42.25 4.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.525 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -61.06 -51.0 71.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.63 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -34.78 79.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.191 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 41' ' ' ILE . 31.4 mt -86.07 -6.15 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.844 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.64 31.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.79 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -150.26 -52.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -103.36 154.96 18.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.926 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.441 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 42.5 t80 -93.65 87.19 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.644 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.61 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 28.6 m-85 -70.15 125.2 91.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.37 -26.2 7.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.585 2.19 . . . . 0.0 112.062 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 113' ' ' ILE . 3.0 t -139.28 130.94 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 46' ' ' PHE . 8.4 mm -120.31 153.02 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.617 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' VAL . 49.1 t -143.23 107.09 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.451 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HB3' HG22 ' A' ' 78' ' ' VAL . 43.6 tp -96.9 85.89 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.257 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.487 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.6 OUTLIER -68.02 72.52 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.527 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.3 p -53.16 85.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.716 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.453 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 21.8 t-105 -71.94 -80.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.605 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.9 54.99 0.61 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 55' ' ' MET . 5.6 Cg_endo -87.55 -155.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.172 2.581 . . . . 0.0 112.141 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -159.81 49.69 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.14 11.68 9.87 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.86 78.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.06 -20.9 63.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.888 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 90' ' ' LYS . 23.8 t -50.95 -44.82 27.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.423 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.14 -25.03 59.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.745 ' CE2' HD11 ' A' ' 67' ' ' ILE . 14.0 t80 -60.97 -39.63 90.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 91' ' ' ALA . 2.6 mp -47.02 -28.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.7 t0 -75.63 -41.46 54.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.815 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.76 -42.07 83.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.745 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.7 mp -63.92 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -81.89 -12.02 58.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.7 -40.69 47.94 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.004 0.431 . . . . 0.0 110.593 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 9.76 12.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.983 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.409 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.07 66.23 3.38 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.866 0.365 . . . . 0.0 110.787 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.4 Cg_exo -76.03 -14.32 19.03 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 112.22 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -109.53 29.55 7.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.813 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -106.96 -155.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.62 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.669 HG21 ' HB1' ' A' ' 116' ' ' ALA . 36.8 t -147.2 137.96 17.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 121.039 0.447 . . . . 0.0 112.018 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.779 HG12 HG23 ' A' ' 78' ' ' VAL . 1.2 t -123.39 112.08 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.448 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.616 HG21 ' CE1' ' A' ' 109' ' ' PHE . 32.2 mm -113.63 44.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.506 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.779 HG23 HG12 ' A' ' 76' ' ' VAL . 49.0 t -45.43 116.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.261 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.643 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.6 mt -106.43 -148.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.194 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.7 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.55 -17.31 15.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -36.16 30.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.27 -59.36 5.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.968 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.608 ' HA ' HG12 ' A' ' 92' ' ' ILE . 12.4 m -58.99 -30.77 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.949 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.479 ' O ' HG13 ' A' ' 61' ' ' VAL . 13.6 ttmt -75.04 -8.5 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.347 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.485 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -118.27 -35.54 3.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.475 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 88' ' ' ALA . 8.7 pt -80.02 158.07 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.192 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' CG ' HG13 ' A' ' 92' ' ' ILE . 9.2 mmtt 80.77 -45.83 0.25 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -22.97 64.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.97 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.03 -29.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.187 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -79.77 175.82 10.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.082 0.441 . . . . 0.0 111.009 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.524 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 56.0 t80 -100.69 -12.06 19.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.323 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 147.54 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.158 0.583 . . . . 0.0 110.368 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.56 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -118.97 131.09 56.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.534 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -93.88 44.81 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.822 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.265 -179.805 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' CD1' ' A' ' 20' ' ' ILE . 10.4 p . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.596 0.236 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -47.52 76.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.861 0.362 . . . . 0.0 110.367 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.29 -33.61 69.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.071 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.616 ' CE1' HG21 ' A' ' 77' ' ' ILE . 10.1 t80 -64.44 -37.8 88.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.183 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.698 HD11 HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -55.33 -48.21 74.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -44.71 83.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.1 m -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.75 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.7 mm -57.22 -53.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -59.46 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -55.75 -30.79 61.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.738 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.61 -38.77 88.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.505 ' CE2' HG21 ' A' ' 48' ' ' VAL . 31.0 m-85 -75.23 -28.75 60.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.906 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmmp? . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.775 0.321 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -136.06 142.22 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.629 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.5 t -125.96 163.9 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.857 HD22 ' CD2' ' A' ' 46' ' ' PHE . 34.0 tp -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.2 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.959 HG21 ' CD1' ' A' ' 17' ' ' LEU . 27.6 t -115.28 97.33 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.95 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.748 HG22 ' HB3' ' A' ' 31' ' ' ALA . 40.7 t -83.23 119.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.797 0.332 . . . . 0.0 110.985 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -154.35 131.57 11.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.9 46.77 1.39 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.29 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 110.99 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.652 HG21 ' CG1' ' A' ' 6' ' ' VAL . 76.0 p . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -65.43 141.91 58.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.158 0.504 . . . . 0.0 112.259 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.426 ' O ' HD12 ' A' ' 20' ' ' ILE . 28.2 m 65.1 9.39 5.48 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.721 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.057 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -90.49 -53.07 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.483 179.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -45.88 -59.67 2.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.23 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.52 53.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.08 0.467 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.769 HG23 ' CD1' ' A' ' 110' ' ' LEU . 75.1 mt -68.29 -70.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.057 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.73 -30.36 3.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.044 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -73.42 -29.67 62.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.845 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -81.08 -34.84 32.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 110.12 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.783 ' CG ' HD21 ' A' ' 110' ' ' LEU . 5.7 mm-40 -81.48 -35.0 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.4 47.75 2.72 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.221 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 2' ' ' LYS . 44.3 m-85 -105.23 -173.26 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.127 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.56 85.68 47.16 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.814 ' HG3' HD13 ' A' ' 21' ' ' LEU . 91.4 Cg_endo -82.45 127.71 5.2 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.689 2.259 . . . . 0.0 111.953 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -105.65 -1.01 25.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.482 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.625 ' O ' ' O ' ' A' ' 29' ' ' ASP . 58.7 p 24.49 122.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB3' HG22 ' A' ' 7' ' ' VAL . . . -105.82 167.72 9.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.549 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -88.29 -46.06 9.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.821 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.436 HG23 ' HB3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -158.47 -167.03 2.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.606 HD22 ' CD2' ' A' ' 63' ' ' PHE . 58.1 mt -67.44 -46.53 72.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -63.1 -45.47 91.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.044 0.45 . . . . 0.0 109.873 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -32.2 70.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.38 -28.82 63.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.686 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 13.6 mt-10 -70.85 -42.03 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -63.77 -35.33 80.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.009 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -75.68 -42.41 51.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.898 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.77 -27.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.031 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -52.03 -25.98 9.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -120.72 -55.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.19 133.57 50.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -95.28 102.04 13.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.857 ' CD2' HD22 ' A' ' 5' ' ' LEU . 40.7 m-85 -102.74 122.04 47.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 74' ' ' SER . 65.4 Cg_endo -73.68 -19.16 21.63 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.331 2.021 . . . . 0.0 111.788 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.629 ' HB ' HG13 ' A' ' 4' ' ' VAL . 10.8 t -143.7 120.53 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.494 HD11 ' HB2' ' A' ' 46' ' ' PHE . 6.5 mm -107.18 153.75 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.83 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 51' ' ' LEU . 7.4 t -135.49 174.59 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.651 ' H ' HG12 ' A' ' 50' ' ' VAL . 29.2 tp -159.92 117.27 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.548 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.46 89.62 3.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.141 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 53' ' ' VAL . 35.2 m -58.68 82.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.834 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -81.52 -83.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.402 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.504 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 3.2 mtt -148.45 44.78 0.37 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 55' ' ' MET . 85.4 Cg_endo -80.19 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.461 2.107 . . . . 0.0 112.226 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -137.99 49.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 110.97 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.47 139.85 6.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.445 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.44 144.27 37.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.641 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -93.63 -15.94 47.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.892 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 90' ' ' LYS . 26.2 t -53.81 -52.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.014 0.435 . . . . 0.0 111.209 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.7 -6.29 47.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.765 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.829 ' CE2' HD11 ' A' ' 67' ' ' ILE . 22.3 t80 -85.67 -36.52 20.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.645 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.028 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.0 mp -49.52 -31.95 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.681 0.277 . . . . 0.0 111.084 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.3 t70 -79.41 -25.26 42.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.572 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 48.1 t80 -67.85 -42.32 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.829 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.8 mp -60.03 -43.23 92.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.035 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.88 -20.96 52.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 33.7 tt0 -68.72 -34.8 76.25 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.407 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -126.39 14.58 7.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.034 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.49 67.39 1.38 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.889 0.376 . . . . 0.0 110.579 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.02 -20.79 50.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.65 2.233 . . . . 0.0 112.064 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.29 25.5 6.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.055 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 33.5 t -113.37 -166.18 1.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -148.67 131.56 7.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 121.248 0.547 . . . . 0.0 112.428 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 38.9 t -100.89 113.65 37.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.63 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.731 HD12 ' CG2' ' A' ' 112' ' ' THR . 44.8 mm -94.01 -62.35 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.915 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 HD23 ' A' ' 51' ' ' LEU . 99.4 t 59.15 111.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.718 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.8 mt -122.48 178.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.641 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.8 m . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 85' ' ' VAL . 7.2 p . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.862 0.363 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.725 ' O ' HG22 ' A' ' 89' ' ' VAL . 23.9 t0 -139.2 -60.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.842 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 t -48.8 -30.74 6.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.261 0.553 . . . . 0.0 110.1 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.847 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.26 -59.72 5.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.156 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 86' ' ' ASP . 30.2 m -61.61 -21.96 26.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.325 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 61' ' ' VAL . 15.7 ttmt -87.32 -14.22 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.673 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 1.028 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -114.8 -31.82 6.01 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.942 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 8.7 pt -74.63 -21.88 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.692 0.282 . . . . 0.0 111.625 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.65 15.38 16.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.22 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -119.64 -21.2 7.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.555 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.39 -24.2 0.16 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.937 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.942 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -55.13 176.26 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.584 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.458 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 56.4 t80 -108.5 27.37 9.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.9 OUTLIER 85.61 138.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.187 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.619 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -71.38 94.77 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.608 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 109' ' ' PHE . 28.3 tp -54.94 146.69 17.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.653 ' H ' HD12 ' A' ' 100' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 20' ' ' ILE . 7.4 p . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.641 0.258 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -46.22 -35.45 5.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.496 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -71.65 -35.78 70.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.934 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.913 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 29.3 t80 -58.16 -30.82 66.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.783 HD21 ' CG ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -50.0 -43.33 50.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.318 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 108' ' ' ARG . 3.7 mp -59.3 -60.21 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.121 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.731 ' CG2' HD12 ' A' ' 77' ' ' ILE . 97.8 m -44.12 -39.14 4.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.343 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 29.2 mm -56.23 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -54.16 -21.09 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.739 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -85.66 -24.73 26.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.695 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -80.55 -30.86 37.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -78.29 -20.08 52.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.365 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.658 -179.58 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 7.8 mmmt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.494 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 131.18 20.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.718 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 48' ' ' VAL . 27.0 t -121.31 144.15 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.823 HD13 ' CE2' ' A' ' 46' ' ' PHE . 29.9 tp -107.2 137.7 44.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 0.0 111.214 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.873 HG21 HD12 ' A' ' 17' ' ' LEU . 3.8 t -116.3 123.88 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.528 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.558 ' HB ' HD12 ' A' ' 51' ' ' LEU . 44.4 t -114.29 110.38 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.24 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 40.8 t0 -158.76 160.63 36.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.057 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.4 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 25.5 t70 -89.16 49.45 1.77 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.05 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.771 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.63 HG21 HG11 ' A' ' 6' ' ' VAL . 72.3 p . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 16' ' ' SER . 73.5 m -43.0 136.44 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.775 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.4 m 88.16 -36.35 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.161 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.927 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.89 -50.82 63.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 110.93 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.5 -64.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.463 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.27 60.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 111.443 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.611 HG23 HD11 ' A' ' 110' ' ' LEU . 91.5 mt -65.72 -70.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.927 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -46.94 -31.03 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.938 0.399 . . . . 0.0 111.071 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.46 -31.67 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.707 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -83.0 -35.21 26.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.877 ' HG3' HD21 ' A' ' 110' ' ' LEU . 43.9 mm-40 -75.1 -29.98 60.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.046 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.88 1.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.227 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 43.2 m-85 -131.76 -176.3 4.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.243 0.544 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.41 80.74 46.04 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.837 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.662 ' HB3' HD13 ' A' ' 21' ' ' LEU . 88.0 Cg_endo -82.5 141.53 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.838 2.359 . . . . 0.0 113.759 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' O ' HD12 ' A' ' 5' ' ' LEU . 6.5 t0 -138.54 136.18 35.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.868 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.496 HG22 ' HB ' ' A' ' 6' ' ' VAL . 14.7 p -121.62 132.58 54.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.114 0.483 . . . . 0.0 111.745 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.69 -121.57 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.226 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 13.8 mttp -157.63 -41.75 0.07 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.937 0.399 . . . . 0.0 110.59 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 p -152.83 175.66 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.622 HD22 ' CD2' ' A' ' 63' ' ' PHE . 39.8 mt -58.14 -37.34 74.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -44.83 78.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -35.81 82.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.336 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.27 61.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 34.1 mt-10 -49.16 -44.21 42.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.533 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -56.43 -44.6 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.063 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -73.23 -44.39 59.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.979 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.3 mt -70.32 -17.75 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.556 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -21.25 41.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.218 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.99 -63.46 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.12 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -55.35 132.42 48.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 45' ' ' PHE . 60.4 t80 -97.2 59.56 1.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.77 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.823 ' CE2' HD13 ' A' ' 5' ' ' LEU . 44.2 m-85 -57.93 126.53 77.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.494 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 53.1 Cg_endo -70.93 -28.79 19.21 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.318 2.012 . . . . 0.0 111.66 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.611 HG21 ' CE1' ' A' ' 117' ' ' PHE . 15.2 t -128.66 136.59 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.567 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 46' ' ' PHE . 5.9 mm -135.78 103.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.63 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 77' ' ' ILE . 59.8 t -101.79 129.81 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.596 HD23 HG13 ' A' ' 78' ' ' VAL . 28.6 tp -92.13 162.84 14.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.334 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -153.81 69.96 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.806 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 80' ' ' THR . 2.4 p -59.79 81.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.683 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 52' ' ' ASP . 65.3 t-105 -86.41 -92.23 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.772 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.576 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mtt -64.25 -52.09 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.075 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 55' ' ' MET . 39.7 Cg_endo -65.97 -169.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.37 2.047 . . . . 0.0 112.37 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.92 -24.07 7.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.84 -89.13 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.428 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 48.69 30.76 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.2 72.28 2.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.562 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 64' ' ' ILE . 58.2 t -58.11 -39.65 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -75.0 -11.79 60.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.523 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.027 ' CE2' HD11 ' A' ' 67' ' ' ILE . 50.4 t80 -64.36 -43.77 93.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.734 0.302 . . . . 0.0 111.429 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mp -48.24 -28.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -77.58 -30.85 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 4.5 t80 -63.73 -44.76 92.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 1.027 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -61.21 -43.62 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.21 -22.52 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.667 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 21.6 tt0 -62.91 -39.81 95.67 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.073 0.463 . . . . 0.0 110.222 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.53 15.68 9.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.26 71.21 0.6 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.71 -7.71 11.43 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.039 2.493 . . . . 0.0 112.56 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.03 -3.06 30.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.558 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -170.31 2.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 0.0 111.302 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.737 HG11 ' HB1' ' A' ' 116' ' ' ALA . 50.1 t -127.34 147.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.025 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 67' ' ' ILE . 3.3 t -126.7 100.45 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.87 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.0 mm -101.62 71.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.145 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.622 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 32.1 t -67.09 133.31 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.176 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 80' ' ' THR . 2.1 mt -142.4 175.64 4.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.901 0.381 . . . . 0.0 111.163 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 85' ' ' VAL . 14.4 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.882 0.373 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 89' ' ' VAL . 13.4 p-10 -115.51 -34.29 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.82 -31.1 70.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.745 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.28 -59.62 5.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 86' ' ' ASP . 22.1 m -62.75 -23.33 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.931 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.546 ' HD3' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.73 27.68 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.6 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.53 -41.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.035 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.006 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.8 pt -69.17 -21.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.505 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.53 26.47 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -133.8 7.27 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.517 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.25 -23.26 3.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.912 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 1.006 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -60.48 -177.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.373 . . . . 0.0 111.266 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.758 ' HB3' HD13 ' A' ' 77' ' ' ILE . 48.9 t80 -117.21 29.14 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.269 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 87.89 158.13 0.07 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.227 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.622 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -91.97 103.91 16.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.078 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.578 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.4 tp -57.97 160.9 4.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.041 -179.628 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.926 HG21 HD23 ' A' ' 17' ' ' LEU . 1.2 m . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -45.78 44.77 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.919 0.39 . . . . 0.0 110.608 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.445 ' HA ' HD13 ' A' ' 111' ' ' LEU . 7.5 tpt85 -66.59 -36.67 83.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.819 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.842 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 7.2 t80 -59.82 -27.81 66.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.245 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.877 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -60.11 -44.25 95.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.364 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.525 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.5 mp -54.38 -56.64 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' ILE . 92.4 m -51.73 -59.53 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.342 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.842 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 13.6 mm -31.05 -64.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.891 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -58.1 5.76 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -27.32 15.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.737 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -73.41 -36.57 66.01 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.611 ' CE1' HG21 ' A' ' 48' ' ' VAL . 27.2 m-85 -66.85 -14.93 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.257 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--N 1.332 -0.181 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.468 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 21.1 mmtt . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.85 0.357 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.445 ' HD2' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 73.95 113.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.044 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.613 HG13 ' HB ' ' A' ' 48' ' ' VAL . 43.6 t -118.99 158.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.489 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.623 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 56.2 tp -112.65 127.98 56.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 111.394 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.26 91.97 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.317 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.784 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 33.2 t -85.02 117.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.483 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -156.51 147.03 21.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.914 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.43 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 36.3 t70 -72.62 -73.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.096 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 1.6 tm-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.115 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -66.06 -32.95 74.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 t -102.13 -59.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.792 HD23 HG21 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -47.04 -57.21 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.428 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.832 ' HA ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -41.41 -54.66 3.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.158 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.96 -36.62 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.508 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 17' ' ' LEU . 14.3 mt -72.92 -70.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.84 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.957 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -52.56 -28.51 21.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.465 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.957 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -79.73 -23.67 42.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.814 0.34 . . . . 0.0 110.667 178.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -78.82 -39.08 36.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.903 0.383 . . . . 0.0 110.026 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.66 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.7 mm-40 -55.91 -43.73 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 60.68 0.16 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.32 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 61.7 m-85 -132.31 -171.51 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 111.061 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.39 82.9 56.33 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.926 ' HG3' HD21 ' A' ' 21' ' ' LEU . 21.3 Cg_exo -65.28 143.44 77.12 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.682 2.254 . . . . 0.0 112.634 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 30' ' ' THR . 6.2 t70 -116.78 -10.72 11.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.139 0.495 . . . . 0.0 111.983 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 29' ' ' ASP . 41.9 p 43.12 176.05 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.289 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.784 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -165.57 174.81 9.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.908 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 33' ' ' THR . 0.5 OUTLIER -112.82 -26.65 8.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.801 0.334 . . . . 0.0 111.236 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.12 -178.33 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.62 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.743 HD12 ' HA3' ' A' ' 58' ' ' GLY . 96.5 mt -61.01 -39.2 88.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -50.34 71.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.031 0.443 . . . . 0.0 109.831 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -33.16 75.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.172 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.524 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.07 -20.2 57.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 4.3 mt-10 -77.56 -38.31 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 109.85 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.41 -39.14 81.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.661 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mmtm -71.22 -36.19 71.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.769 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 37' ' ' ALA . 36.5 mt -86.19 -17.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.201 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -58.38 -19.09 32.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.441 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -134.8 -53.76 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.062 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -58.45 118.22 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.052 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -74.11 64.52 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.438 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.623 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 31.2 m-85 -56.65 113.69 6.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.297 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 60.3 Cg_endo -73.14 -27.38 13.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 112.032 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HB ' HG13 ' A' ' 4' ' ' VAL . 4.0 t -139.75 128.29 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.479 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.413 HG23 HD23 ' A' ' 5' ' ' LEU . 9.4 mm -112.59 146.85 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.68 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 5' ' ' LEU . 97.6 t -139.06 98.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.488 . . . . 0.0 110.576 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.426 ' HB3' HG13 ' A' ' 78' ' ' VAL . 24.7 tp -77.16 166.25 23.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.89 93.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.252 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.786 HG22 ' HB ' ' A' ' 80' ' ' THR . 6.8 m -76.71 57.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.55 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.446 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 55.7 t-105 -61.54 -90.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.652 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.666 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -90.64 -27.09 0.3 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 55' ' ' MET . 62.3 Cg_endo -85.93 -168.29 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.341 2.027 . . . . 0.0 113.021 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -147.59 -47.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.411 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.743 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . 46.79 -171.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.948 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.57 48.29 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.634 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -47.78 -34.38 10.7 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.452 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 90' ' ' LYS . 6.6 t -63.87 -49.91 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.942 0.401 . . . . 0.0 110.65 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.54 8.34 34.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.384 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.902 ' CE2' HD11 ' A' ' 67' ' ' ILE . 36.1 t80 -84.55 -41.83 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.772 0.32 . . . . 0.0 111.224 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.772 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.4 mp -46.01 -30.44 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.242 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -40.62 66.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.565 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 68.5 t80 -55.97 -43.36 77.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.902 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.0 mp -61.79 -44.37 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.462 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -78.95 -14.52 59.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.833 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.3 -43.07 58.31 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.968 0.413 . . . . 0.0 110.593 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.68 12.46 14.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.08 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.54 66.79 2.51 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.728 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.68 -19.04 32.23 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.616 2.211 . . . . 0.0 112.232 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -103.97 32.39 3.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.673 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 t -113.63 -158.45 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.689 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.491 HG21 ' HB1' ' A' ' 116' ' ' ALA . 39.2 t -147.49 136.2 15.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.812 HG12 HG23 ' A' ' 78' ' ' VAL . 18.3 t -114.25 110.99 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.608 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 79' ' ' ILE . 44.5 mm -99.23 -39.91 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.558 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.812 HG23 HG12 ' A' ' 76' ' ' VAL . 59.1 t 45.25 77.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.564 HG23 ' HB3' ' A' ' 100' ' ' LEU . 4.2 mt -93.45 148.51 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.579 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.786 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.4 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.025 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.929 0.395 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -111.52 -24.21 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.192 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -32.08 22.67 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.798 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.96 -57.27 12.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.897 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.6 m -58.08 -26.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.016 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.576 ' O ' HG13 ' A' ' 61' ' ' VAL . 3.1 ttmm -81.76 -9.25 59.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.772 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -121.96 -26.45 4.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.877 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.5 pt -83.32 -42.16 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -23.73 41.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.679 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -25.06 65.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.94 -16.1 1.05 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.106 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -51.9 177.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.97 0.385 . . . . 0.0 111.464 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 72.3 t80 -95.29 28.55 2.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.501 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 1.2 tt0 70.09 139.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.208 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.608 ' H ' HG21 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -55.11 146.07 19.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.564 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -87.23 109.65 19.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.059 -179.87 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.792 HG21 HD23 ' A' ' 17' ' ' LEU . 32.8 m . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.971 0.415 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.15 -60.67 2.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -30.55 53.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.824 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 80.8 t80 -61.91 -40.57 95.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.607 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.66 HD21 ' HG2' ' A' ' 24' ' ' GLU . 2.1 tt -52.41 -59.09 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.395 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.581 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.3 mp -66.23 -44.46 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.544 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.3 m -60.2 -37.8 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.125 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.824 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -49.02 -52.36 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.482 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -56.56 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.042 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.55 -36.49 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -58.9 -38.54 79.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 110.57 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 34.7 m-85 -82.73 -17.18 45.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.792 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.911 0.386 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -149.2 140.87 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.7 t -124.67 162.27 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.978 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.976 HD22 ' CD2' ' A' ' 46' ' ' PHE . 57.5 tp -119.8 121.82 39.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 110.588 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.859 HG21 ' CD1' ' A' ' 17' ' ' LEU . 40.0 t -102.77 122.88 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.19 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 41.3 t -111.41 105.26 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.866 0.365 . . . . 0.0 111.191 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -117.57 151.76 36.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.934 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 54' ' ' TRP . 32.3 t70 -81.27 49.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 111.667 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.361 179.241 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.525 ' CG2' HG11 ' A' ' 6' ' ' VAL . 2.3 p . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 m -54.68 145.94 18.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.512 ' O ' HD12 ' A' ' 20' ' ' ILE . 42.1 t 66.03 10.86 7.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.839 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.079 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.22 -52.23 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.443 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 t -50.08 -55.26 15.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.06 73.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.968 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.72 HG23 ' CD1' ' A' ' 110' ' ' LEU . 54.3 mt -62.19 -66.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.079 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -49.38 -28.62 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.44 -27.68 61.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.79 -34.46 30.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.149 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.672 ' HG3' HD21 ' A' ' 110' ' ' LEU . 30.5 mm-40 -87.18 -30.58 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 60.53 1.48 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.45 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 44.8 m-85 -113.09 -173.67 2.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.25 83.83 54.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.882 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.882 ' HG3' HD13 ' A' ' 21' ' ' LEU . 92.2 Cg_endo -84.74 117.62 2.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.79 2.326 . . . . 0.0 111.636 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.26 -9.2 33.84 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.403 0.62 . . . . 0.0 112.046 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 71.5 p 49.66 173.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.216 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -158.55 -154.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.493 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 27.3 mttt -143.65 -42.96 0.28 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.0 170.07 20.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.591 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.678 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.3 mt -61.41 -26.77 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.51 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -76.2 -43.59 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.083 0.468 . . . . 0.0 109.819 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -25.98 59.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.607 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.506 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.52 -34.03 58.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.634 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 44.8 mt-10 -69.75 -41.46 75.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -61.83 -37.98 86.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.837 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -72.41 -47.03 52.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.615 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 37' ' ' ALA . 10.1 mt -68.71 -27.97 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.976 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -47.55 -29.12 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -116.82 -44.21 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.63 112.75 18.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -75.13 63.94 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.976 ' CD2' HD22 ' A' ' 5' ' ' LEU . 42.4 m-85 -56.03 125.58 63.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.526 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 72.2 Cg_endo -76.45 -34.04 2.9 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.307 2.004 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.865 HG13 ' HB ' ' A' ' 75' ' ' VAL . 23.5 t -130.16 111.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.007 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.468 HG23 HD23 ' A' ' 5' ' ' LEU . 2.3 mm -97.01 142.38 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.795 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.768 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.6 t -128.66 165.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 7' ' ' VAL . 16.2 tp -142.41 157.69 44.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.119 0.485 . . . . 0.0 111.539 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -141.93 79.95 1.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.011 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.694 HG22 ' HB ' ' A' ' 80' ' ' THR . 31.0 m -65.67 66.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.188 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.412 ' N ' ' O ' ' A' ' 52' ' ' ASP . 26.7 t-105 -67.16 -74.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.651 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 31.4 mtt -147.54 52.75 1.37 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.763 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.4 Cg_endo -89.72 -156.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -136.89 -43.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.246 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.44 148.37 34.11 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.647 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 127.53 43.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.71 -13.8 83.17 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.823 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 90' ' ' LYS . 21.7 t -53.57 -45.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.789 0.328 . . . . 0.0 111.339 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 -5.9 55.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.537 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.678 ' CD2' HD22 ' A' ' 34' ' ' LEU . 15.7 t80 -74.15 -37.74 63.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.347 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.521 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.5 mp -49.7 -27.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -39.45 69.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.632 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.429 ' CE1' ' HG2' ' A' ' 38' ' ' GLU . 18.8 t80 -60.3 -43.35 96.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.061 0.458 . . . . 0.0 109.914 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.626 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -57.33 -41.76 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -81.64 -24.16 36.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.0 110.638 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -66.39 -26.18 67.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -138.0 16.58 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.026 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.15 69.17 0.82 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.864 0.364 . . . . 0.0 110.748 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.44 -20.26 48.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.76 2.307 . . . . 0.0 112.11 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.78 39.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.853 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.8 t -119.61 177.59 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.865 ' HB ' HG13 ' A' ' 48' ' ' VAL . 2.7 t -107.9 178.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.754 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -157.52 79.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.898 0.38 . . . . 0.0 110.146 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.768 ' HB ' HG13 ' A' ' 50' ' ' VAL . 31.2 mm -62.21 -53.02 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.364 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.659 ' CG2' HG12 ' A' ' 76' ' ' VAL . 5.2 t 45.39 89.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.714 HG23 ' HB3' ' A' ' 100' ' ' LEU . 13.8 mt -104.21 167.2 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.614 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.694 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.6 m . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.425 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.793 0.33 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.595 ' O ' HG22 ' A' ' 89' ' ' VAL . 8.3 t0 -62.81 -32.91 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.39 -34.76 49.49 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.19 0.519 . . . . 0.0 109.954 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.885 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.41 -61.27 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.315 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 86' ' ' ASP . 33.4 m -61.92 -22.73 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.243 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.415 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 15.8 tttt -85.52 -25.13 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -98.91 -26.1 14.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.885 HG23 ' O ' ' A' ' 88' ' ' ALA . 4.2 pt -89.32 -17.0 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.436 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -71.71 -32.66 68.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 110.43 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -64.78 -61.99 1.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.84 33.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.986 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.11 -179.0 5.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.815 ' CE2' HG23 ' A' ' 112' ' ' THR . 26.4 t80 -98.52 28.54 4.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.452 . . . . 0.0 111.062 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.643 ' CD ' HD12 ' A' ' 92' ' ' ILE . 2.7 tp10 67.47 134.15 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.193 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.659 ' H ' HG21 ' A' ' 92' ' ' ILE . 2.3 m-85 -61.64 131.48 50.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.014 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.714 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -74.81 80.81 2.1 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.412 -179.681 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.646 HG13 HD11 ' A' ' 20' ' ' ILE . 7.6 p . . . . . 0 CA--C 1.526 0.039 0 CA-C-O 120.69 0.281 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -46.51 -33.92 4.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 110.838 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -36.25 69.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.933 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.891 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 3.4 t80 -59.64 -31.16 69.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.181 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.72 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -49.16 -49.21 43.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.29 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.6 mp -56.93 -57.56 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.75 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.815 HG23 ' CE2' ' A' ' 97' ' ' TYR . 93.0 m -44.68 -39.28 4.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.301 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.891 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 24.1 mm -59.13 -70.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -55.24 -23.07 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.563 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 111' ' ' LEU . 13.9 m-70 -84.75 -20.62 30.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.668 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.587 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -87.19 -45.22 10.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.45 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -60.44 -22.53 63.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.271 -179.965 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.746 0.308 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.477 ' HA ' ' H ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -111.71 135.07 52.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.862 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.66 HG13 ' HB ' ' A' ' 48' ' ' VAL . 24.0 t -126.5 154.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.411 -179.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.675 HD23 HD11 ' A' ' 41' ' ' ILE . 28.8 tp -105.73 127.98 53.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.709 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.673 HG21 ' CD1' ' A' ' 17' ' ' LEU . 45.2 t -107.52 90.1 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.716 HG13 ' HB2' ' A' ' 37' ' ' ALA . 5.1 t -85.08 105.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -138.36 143.04 39.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.037 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.873 ' HB2' HG23 ' A' ' 33' ' ' THR . 33.1 t70 -91.9 50.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.674 0.273 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.51 -45.85 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 111.258 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 p -73.58 -68.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.085 HD23 HG21 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -44.78 -42.86 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.574 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.1 m -57.15 -44.18 83.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.43 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.69 78.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.431 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.917 HD13 HG22 ' A' ' 106' ' ' VAL . 1.5 mt -59.76 -57.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.587 179.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.622 HD11 HD11 ' A' ' 17' ' ' LEU . 1.4 mt -50.33 -33.49 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.664 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.02 -24.59 66.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.794 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.38 -36.61 45.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.752 ' HG2' HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -78.34 -19.12 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.157 179.693 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.17 52.95 2.11 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.186 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.1 m-85 -112.07 -172.21 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 0.0 111.163 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.477 ' H ' ' HA ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -131.41 69.41 81.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.805 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -62.61 143.26 92.35 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.628 2.218 . . . . 0.0 111.931 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.8 t70 -126.56 -9.11 6.24 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.625 ' O ' ' O ' ' A' ' 29' ' ' ASP . 29.9 p 41.9 163.68 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -170.61 142.87 2.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.778 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 41.5 mttt -74.01 -166.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.873 HG23 ' HB2' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -47.73 156.24 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 111.705 -178.101 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.85 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.2 mt -27.36 -43.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.833 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -50.56 -59.59 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.083 0.468 . . . . 0.0 110.333 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 1.4 tp10 -66.07 -39.1 89.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.716 ' HB2' HG13 ' A' ' 7' ' ' VAL . . . -60.15 -60.5 3.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.595 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.44 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 19.7 mt-10 -45.67 -42.18 11.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -60.8 -52.75 63.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -62.44 -34.59 77.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.328 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.675 HD11 HD23 ' A' ' 5' ' ' LEU . 48.6 mt -89.54 -6.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.52 -16.56 48.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.633 0.254 . . . . 0.0 111.262 179.901 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -132.95 -52.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.769 0.318 . . . . 0.0 111.093 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.95 133.25 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.073 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -96.52 63.89 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.706 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.647 ' CD2' HD22 ' A' ' 5' ' ' LEU . 45.2 m-85 -58.27 125.23 74.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.036 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.74 -24.78 17.83 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.317 2.011 . . . . 0.0 111.892 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.698 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.8 t -141.59 134.12 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.524 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 46' ' ' PHE . 21.8 mm -119.24 148.18 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.547 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.445 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 82.9 t -136.59 105.62 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.587 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.04 84.11 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.751 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 1.2 t70 -66.35 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG13 ' HB ' ' A' ' 80' ' ' THR . 2.5 p -53.24 88.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ASP . 34.0 t-105 -88.47 -80.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.49 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 mmt -147.22 47.27 0.55 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 55' ' ' MET . 97.8 Cg_endo -78.6 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.562 2.175 . . . . 0.0 112.323 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -152.2 30.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.57 -147.17 18.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.411 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.471 ' H ' HD12 ' A' ' 34' ' ' LEU . 50.0 m-20 -129.49 81.2 2.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.863 0.363 . . . . 0.0 110.9 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.9 92.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 90' ' ' LYS . 78.0 t -59.87 -38.64 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -23.41 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.108 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.85 ' CD2' HD22 ' A' ' 34' ' ' LEU . 13.4 t80 -75.35 -30.22 60.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.819 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 61' ' ' VAL . 7.9 mm -47.8 -37.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' GLU . 39.1 t70 -70.07 -42.93 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.44 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 23.4 t80 -50.99 -39.91 56.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.935 0.398 . . . . 0.0 110.651 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.846 HG21 HG22 ' A' ' 76' ' ' VAL . 2.7 mp -62.74 -52.08 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -74.63 -9.51 58.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.701 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 18.0 tt0 -77.1 -48.04 18.86 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -114.33 16.83 17.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.925 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.66 67.54 1.6 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.2 -18.59 34.86 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.672 2.248 . . . . 0.0 112.156 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.75 40.66 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.66 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.0 t -119.06 -157.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.698 ' HB ' HG13 ' A' ' 48' ' ' VAL . 41.1 t -147.01 139.0 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 112.102 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.846 HG22 HG21 ' A' ' 67' ' ' ILE . 2.1 t -120.74 94.16 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.175 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.521 HG21 ' HE1' ' A' ' 109' ' ' PHE . 39.6 mm -73.63 -57.11 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.917 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.832 HG23 HG12 ' A' ' 76' ' ' VAL . 21.7 t 52.59 94.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.699 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.7 mt -108.45 -148.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.326 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.723 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.829 0.347 . . . . 0.0 111.106 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.687 0.28 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.0 -24.77 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.288 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -33.56 26.62 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.867 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.1 -57.09 13.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.116 178.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 92' ' ' ILE . 13.4 m -59.94 -28.22 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.43 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 61' ' ' VAL . 10.3 ttmt -78.74 -2.26 38.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.606 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.05 -35.04 1.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.93 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 4.7 pt -73.69 -43.59 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 111.413 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -59.42 -31.44 69.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -64.71 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.736 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.34 29.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.845 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.25 -166.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.722 0.296 . . . . 0.0 111.135 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 20.9 t80 -113.51 26.71 10.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.5 OUTLIER 79.5 147.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.229 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.652 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -79.31 88.3 4.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.802 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 79' ' ' ILE . 13.8 tp -59.06 148.23 31.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.01 -179.986 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.085 HG21 HD23 ' A' ' 17' ' ' LEU . 32.4 m . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -62.19 1.53 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.436 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -55.3 -29.32 57.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.163 0.506 . . . . 0.0 109.69 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.699 ' CE1' HD11 ' A' ' 79' ' ' ILE . 43.3 t80 -61.62 -44.18 97.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.985 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.752 HD22 ' HG2' ' A' ' 24' ' ' GLU . 1.8 mt -52.5 -31.17 33.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.465 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.656 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 4.1 mp -79.75 -36.05 37.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 m -69.16 -36.88 77.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.491 . . . . 0.0 109.811 179.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.651 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.7 mm -67.17 -51.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.068 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -47.26 -57.2 5.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.311 -179.018 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -34.76 69.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.818 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -54.92 -32.42 61.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' A' ' 48' ' ' VAL . 29.8 m-85 -74.6 -46.11 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.076 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.658 -179.762 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 8.5 mmtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.812 0.339 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.445 ' HD2' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 75.53 105.96 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.093 -179.781 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 48' ' ' VAL . 44.4 t -112.78 162.51 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 29' ' ' ASP . 59.5 tp -119.81 139.12 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.687 HG21 HD12 ' A' ' 17' ' ' LEU . 10.5 t -121.05 117.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.133 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 32' ' ' LYS . 61.9 t -105.75 111.6 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.361 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.01 157.21 38.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB2' ' CD ' ' A' ' 56' ' ' PRO . 8.4 t0 -83.5 -70.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.423 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.0 mm-40 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 111.241 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.523 ' HB ' HG21 ' A' ' 30' ' ' THR . 81.3 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.753 0.311 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -82.1 58.56 4.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.065 0.459 . . . . 0.0 110.966 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 170.6 -56.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.415 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.687 HD12 HG21 ' A' ' 6' ' ' VAL . 1.4 tm? -59.81 -55.87 28.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 m -54.66 -41.8 70.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 179.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.474 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 17' ' ' LEU . 33.1 mt -57.64 -64.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.69 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.674 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -47.73 -36.46 11.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.51 179.518 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -29.39 70.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.97 -35.06 57.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HG3' HD21 ' A' ' 110' ' ' LEU . 18.5 mm-40 -77.48 -8.58 57.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.161 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.14 51.93 1.99 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.964 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 51.0 m-85 -124.04 -175.92 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 111.345 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -140.23 77.92 24.07 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.061 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HB3' HD13 ' A' ' 21' ' ' LEU . 71.8 Cg_endo -84.05 148.91 12.09 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.582 2.188 . . . . 0.0 113.617 -178.312 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.681 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -131.88 134.1 45.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.719 179.331 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.523 HG21 ' HB ' ' A' ' 14' ' ' THR . 44.4 p -99.36 147.4 25.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.909 0.385 . . . . 0.0 111.166 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -147.24 145.77 29.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.721 ' O ' HG13 ' A' ' 7' ' ' VAL . 13.7 mttt -62.83 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.0 p -48.65 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.255 0.55 . . . . 0.0 111.817 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.775 HD22 ' CD2' ' A' ' 63' ' ' PHE . 10.9 mt -45.51 -30.47 1.44 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.959 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -59.92 -61.67 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 4.3 tp10 -58.76 -38.46 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.86 178.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.02 75.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.06 -48.66 22.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.964 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -55.73 31.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -26.38 61.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.172 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 41' ' ' ILE . 10.0 mt -97.17 -6.87 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.75 25.21 5.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.359 . . . . 0.0 110.805 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.34 -58.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.489 HD22 ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -100.04 153.52 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.459 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 18.0 t80 -86.93 81.68 8.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.604 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 14.6 m-85 -67.88 117.17 45.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 56.8 Cg_endo -72.4 -38.88 3.17 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.493 2.128 . . . . 0.0 112.325 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.611 ' HB ' HG13 ' A' ' 4' ' ' VAL . 17.2 t -124.83 125.92 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.96 0.409 . . . . 0.0 111.79 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 7.9 mm -115.2 134.29 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.644 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 66.8 t -131.42 109.71 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 111.841 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' HB3' HG13 ' A' ' 78' ' ' VAL . 12.3 tp -78.44 170.58 16.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.423 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -134.63 -54.91 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.455 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.543 HG13 ' HA ' ' A' ' 57' ' ' ASP . 15.4 t 59.82 41.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.763 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 60.5 t-105 -62.73 -91.18 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.095 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.557 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -71.02 -48.76 13.55 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.438 -179.771 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 55' ' ' MET . 64.8 Cg_endo -72.52 -167.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.242 1.962 . . . . 0.0 112.283 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' HA ' HG13 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -163.07 55.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.833 179.856 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.02 115.89 8.54 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -92.84 31.19 1.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.806 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.09 64.37 0.95 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.365 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.861 ' O ' HD12 ' A' ' 64' ' ' ILE . 25.7 t -49.0 -43.02 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.939 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.54 -18.43 40.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.934 ' CE2' HD11 ' A' ' 67' ' ' ILE . 45.8 t80 -49.96 -43.32 50.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.569 0.223 . . . . 0.0 111.227 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.861 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mt -48.07 -30.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.056 0.455 . . . . 0.0 110.604 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -67.6 -53.25 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.184 179.373 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.411 ' CE1' ' HB ' ' A' ' 41' ' ' ILE . 6.7 t80 -46.26 -44.2 16.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.795 0.331 . . . . 0.0 110.863 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.934 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.6 mp -61.94 -47.8 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -14.32 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.886 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' ASP . 28.0 tt0 -73.23 -51.43 17.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.013 0.435 . . . . 0.0 110.546 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.33 14.14 22.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.086 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.417 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -159.49 65.14 2.6 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.648 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 71' ' ' SER . 14.8 Cg_exo -67.75 -20.88 45.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.647 2.231 . . . . 0.0 112.091 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -104.68 33.1 3.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.617 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.8 t -110.63 -178.22 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.561 HG21 ' HB1' ' A' ' 116' ' ' ALA . 40.5 t -129.11 139.64 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.826 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.913 HG12 HG23 ' A' ' 78' ' ' VAL . 2.9 t -125.68 104.74 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.444 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -91.35 -43.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.566 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.913 HG23 HG12 ' A' ' 76' ' ' VAL . 40.2 t 48.15 96.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.721 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 100' ' ' LEU . 6.1 mt -118.62 149.45 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.54 179.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.62 0.247 . . . . 0.0 111.267 -179.92 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.683 0.278 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -88.84 -15.43 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.459 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.98 -34.43 26.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -60.02 -61.28 2.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.93 178.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 92' ' ' ILE . 11.1 m -58.59 -29.11 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.849 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.54 -3.33 43.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.492 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -119.25 -39.88 2.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.373 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.947 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.9 pt -74.35 -46.26 44.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.435 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -60.49 -26.92 67.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.536 179.729 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.688 ' CB ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.59 -62.82 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 179.687 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.5 19.09 0.07 OUTLIER Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.537 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.947 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.41 -169.68 2.48 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.285 0.542 . . . . 0.0 110.961 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.511 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 62.0 t80 -103.91 -18.95 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.534 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 9.0 pt-20 151.28 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.34 0.656 . . . . 0.0 110.003 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -133.49 98.51 4.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.93 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 79' ' ' ILE . 9.8 tp -64.11 169.78 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.995 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.011 179.948 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.434 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.8 p . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.718 0.294 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.65 -42.23 92.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.778 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -63.8 -34.73 78.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.244 179.465 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.644 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 9.7 t80 -60.66 -39.52 88.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.174 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.531 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -55.85 -36.46 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.187 179.871 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 108' ' ' ARG . 1.2 mt -60.44 -42.71 96.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.167 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.9 m -70.97 -46.67 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.549 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 5.1 mm -43.68 -58.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.508 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -47.41 -54.51 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.079 0.466 . . . . 0.0 110.123 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.07 66.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -66.41 -34.68 78.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.945 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE1' ' CA ' ' A' ' 2' ' ' LYS . 25.8 m-85 -74.45 -13.74 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.823 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 . . . . . 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.282 . . . . 0.0 111.358 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HD3' ' CD2' ' A' ' 117' ' ' PHE . 9.8 mmtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.836 0.35 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -147.84 83.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.774 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.624 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.9 t -68.94 160.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 46' ' ' PHE . 55.3 tp -118.94 135.86 54.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 17' ' ' LEU . 14.2 t -118.17 139.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.052 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.775 ' HB ' HD12 ' A' ' 51' ' ' LEU . 24.3 t -125.85 119.27 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.496 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 52' ' ' ASP . 22.9 t0 -170.32 160.68 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -179.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 27.4 t70 -88.27 50.53 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.586 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.711 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 54.7 p . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 16' ' ' SER . 1.6 m -55.77 133.79 51.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.851 0.357 . . . . 0.0 111.771 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.692 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER 82.36 -43.55 0.14 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.328 179.159 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -52.21 -53.92 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.755 0.312 . . . . 0.0 111.367 -179.33 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.4 t -46.47 -71.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.54 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.3 -40.63 11.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 0.0 111.482 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.699 HD13 ' CG2' ' A' ' 106' ' ' VAL . 16.3 mt -64.18 -68.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.155 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.042 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.62 -29.92 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.89 -24.0 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.998 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.52 -37.46 27.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.234 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.09 -25.44 43.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.7 2.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.267 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CE2' HG21 ' A' ' 113' ' ' ILE . 11.2 m-30 -112.4 -178.01 3.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 111.366 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.12 78.75 72.37 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.539 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.715 ' HG3' HD13 ' A' ' 21' ' ' LEU . 84.3 Cg_endo -84.27 139.29 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.862 2.375 . . . . 0.0 113.889 -177.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.837 ' O ' HD12 ' A' ' 5' ' ' LEU . 11.1 t0 -121.97 118.27 28.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.342 178.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.819 HG22 ' HB ' ' A' ' 6' ' ' VAL . 72.8 p -102.34 127.05 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.93 0.395 . . . . 0.0 111.627 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.73 -165.18 1.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.526 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -127.43 -5.68 5.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.639 -179.834 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -170.58 -176.28 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.725 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.813 HD22 ' CD2' ' A' ' 63' ' ' PHE . 24.8 mt -77.36 -31.49 54.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.731 0.301 . . . . 0.0 110.339 179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -45.64 67.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -35.72 80.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.075 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.432 ' HB1' HD11 ' A' ' 41' ' ' ILE . . . -69.96 -48.18 59.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 82.4 mt-10 -46.42 -48.36 18.82 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.905 0.383 . . . . 0.0 110.503 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.84 -52.79 64.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.712 178.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.891 ' O ' HD22 ' A' ' 44' ' ' LEU . 9.8 mttt -63.71 -23.47 67.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.283 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.432 HD11 ' HB1' ' A' ' 37' ' ' ALA . 21.0 mt -93.33 -16.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -100.86 22.26 12.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 179.552 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.634 ' C ' HD13 ' A' ' 44' ' ' LEU . 26.7 mt-10 -143.22 -52.98 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.02 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -99.64 12.95 35.2 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.413 0.625 . . . . 0.0 109.818 179.691 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 44' ' ' LEU . 16.1 t80 23.72 86.19 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.748 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.939 ' CE2' HD13 ' A' ' 5' ' ' LEU . 49.3 m-85 -68.42 148.57 98.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.407 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' C ' ' HG ' ' A' ' 74' ' ' SER . 8.4 Cg_endo -83.67 -47.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.792 2.328 . . . . 0.0 111.88 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.624 ' HB ' HG13 ' A' ' 4' ' ' VAL . 24.7 t -116.94 126.79 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.628 HD12 HD23 ' A' ' 5' ' ' LEU . 21.5 mm -111.97 125.68 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.853 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.668 HG21 ' CE1' ' A' ' 109' ' ' PHE . 52.9 t -127.16 106.31 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.08 0.467 . . . . 0.0 112.031 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.775 HD12 ' HB ' ' A' ' 7' ' ' VAL . 42.9 tp -79.04 165.11 23.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.304 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 42.4 t0 -127.59 -56.79 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.668 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.411 HG23 ' HG ' ' A' ' 51' ' ' LEU . 18.1 t 67.96 66.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.935 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.422 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 26.8 t-105 -96.54 -82.93 0.39 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 111.442 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.607 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.2 mtt -83.68 -31.76 0.5 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 55' ' ' MET . 87.7 Cg_endo -83.05 -174.25 1.96 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.099 1.866 . . . . 0.0 112.922 -179.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -170.19 58.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.563 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.71 12.69 60.74 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.955 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.45 92.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.792 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.33 -9.05 60.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.852 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 90' ' ' LYS . 18.0 t -51.32 -49.72 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.403 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.58 -3.9 40.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.941 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.813 ' CD2' HD22 ' A' ' 34' ' ' LEU . 12.2 t80 -88.64 -42.09 12.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.538 0.209 . . . . 0.0 111.504 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.511 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.8 mp -43.84 -30.07 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.771 0.319 . . . . 0.0 111.272 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -67.24 -54.63 19.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -48.15 -40.6 24.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 110.52 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.634 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mp -60.45 -48.34 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.511 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -77.24 -18.97 57.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.971 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.89 -50.68 54.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.956 0.408 . . . . 0.0 110.716 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.07 17.26 16.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.6 OUTLIER -161.26 68.33 2.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.771 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.11 -16.63 25.28 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.764 2.309 . . . . 0.0 112.297 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.07 -2.45 34.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.377 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.463 ' HG ' ' C ' ' A' ' 47' ' ' PRO . 46.6 t -82.37 176.82 9.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.051 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.744 HG21 ' HB1' ' A' ' 116' ' ' ALA . 47.0 t -114.61 159.25 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.88 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.756 HG12 ' CG2' ' A' ' 78' ' ' VAL . 1.1 t -143.54 83.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.571 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.699 HD13 ' HB3' ' A' ' 97' ' ' TYR . 37.4 mm -71.53 -45.32 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.656 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.756 ' CG2' HG12 ' A' ' 76' ' ' VAL . 6.8 t 48.67 85.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.489 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 7.6 mt -107.19 152.5 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 -179.977 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.66 0.267 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.3 -22.17 66.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.315 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.7 39.48 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.51 -58.58 7.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.004 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.12 -23.43 27.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.842 179.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.507 ' O ' HG22 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -91.09 39.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.376 179.566 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.511 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -170.16 -38.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.083 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.919 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -74.36 -30.03 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -29.84 67.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.7 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.69 65.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.144 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.77 -2.18 3.31 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.231 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.919 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -56.99 -168.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.046 0.423 . . . . 0.0 111.111 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.699 ' HB3' HD13 ' A' ' 77' ' ' ILE . 6.8 t80 -110.73 27.87 9.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 80.67 156.78 0.14 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.434 179.705 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.727 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -88.54 110.26 20.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 -179.993 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.42 HD23 HD13 ' A' ' 79' ' ' ILE . 8.3 tp -63.72 149.42 46.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.862 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.875 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.941 HG21 HD23 ' A' ' 17' ' ' LEU . 32.8 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.024 0.44 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.7 -55.64 18.7 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.14 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -60.94 -31.54 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.807 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.671 ' CE1' HD11 ' A' ' 113' ' ' ILE . 27.8 t80 -57.65 -39.28 76.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.893 179.065 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.644 HD11 HG23 ' A' ' 20' ' ' ILE . 1.5 mt -60.45 -51.03 71.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.174 179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -57.29 -46.13 83.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.549 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 m -69.27 -44.96 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 0.0 110.959 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.671 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.6 mm -40.63 -52.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.78 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.19 12.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.651 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -62.08 -36.21 80.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.744 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.92 -39.46 85.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.445 ' CE1' HG22 ' A' ' 4' ' ' VAL . 19.5 m-85 -65.36 -19.42 65.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.291 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.333 -179.878 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -142.35 118.09 10.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.967 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.65 HG13 ' HB ' ' A' ' 48' ' ' VAL . 14.3 t -118.6 160.81 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.655 HD22 ' CD2' ' A' ' 46' ' ' PHE . 42.5 tp -114.74 133.44 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.871 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.728 ' HB ' HG22 ' A' ' 30' ' ' THR . 24.5 t -113.58 90.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.407 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 t -82.2 111.85 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.87 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -147.73 137.54 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 13.2 t0 -61.38 -80.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.995 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 p . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.722 0.296 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -80.43 -54.54 5.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.024 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -69.62 -63.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -45.21 -46.17 12.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.315 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.813 ' HA ' HD12 ' A' ' 21' ' ' LEU . 5.7 t -44.73 -37.76 3.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.2 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.238 0.542 . . . . 0.0 110.391 179.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.65 ' CD1' HG11 ' A' ' 106' ' ' VAL . 3.0 mp -68.54 -68.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.144 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -48.51 -27.24 2.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.316 179.438 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.946 ' N ' HD13 ' A' ' 21' ' ' LEU . 15.5 mt-10 -73.71 -28.44 61.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.711 0.291 . . . . 0.0 111.011 179.129 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.31 -36.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.826 0.346 . . . . 0.0 110.511 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -64.46 -17.37 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 -179.98 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.99 65.51 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.22 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 24' ' ' GLU . 20.3 m-85 -137.69 -176.92 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.217 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.84 91.89 43.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.716 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.837 ' HG3' HD11 ' A' ' 21' ' ' LEU . 72.7 Cg_endo -84.3 133.3 5.45 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.625 2.216 . . . . 0.0 112.91 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.549 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -110.26 7.23 23.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.344 -179.731 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.728 HG22 ' HB ' ' A' ' 6' ' ' VAL . 15.4 p 6.5 122.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 -170.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.116 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 18.9 tttt -104.39 -43.33 5.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -161.15 -168.28 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.317 179.535 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.596 HD22 ' CD2' ' A' ' 63' ' ' PHE . 32.1 mt -67.19 -52.9 35.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -57.36 -45.78 84.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.58 -35.16 75.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.36 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.483 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -68.45 -34.73 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 77.5 mt-10 -64.51 -43.38 94.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -39.11 78.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -72.36 -49.93 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.687 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 37' ' ' ALA . 6.0 mt -64.19 -27.33 42.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -27.92 5.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -124.2 -42.34 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.08 115.01 19.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -80.34 101.34 8.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.709 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CD2' HD22 ' A' ' 5' ' ' LEU . 35.2 m-85 -97.25 119.15 63.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.0 Cg_endo -73.06 -17.69 24.63 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.477 2.118 . . . . 0.0 111.899 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.679 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -147.85 132.21 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.565 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.501 HD12 HD23 ' A' ' 5' ' ' LEU . 15.5 mm -115.77 160.1 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 178.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.677 ' CG1' HD11 ' A' ' 79' ' ' ILE . 60.0 t -152.67 99.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.206 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -71.39 164.56 25.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' TRP . 4.8 t70 -152.61 57.6 0.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -44.43 91.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.04 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.414 ' N ' ' O ' ' A' ' 52' ' ' ASP . 30.3 t-105 -88.16 -75.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.828 179.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.736 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 7.8 ttp -147.18 46.22 0.48 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.161 179.002 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.736 ' HD3' ' N ' ' A' ' 55' ' ' MET . 28.1 Cg_endo -95.48 -160.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.235 2.623 . . . . 0.0 112.204 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -149.54 60.03 1.01 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.03 131.24 4.49 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.508 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.44 ' O ' HD13 ' A' ' 34' ' ' LEU . 11.8 p-10 -74.23 144.94 44.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -103.79 -18.95 12.69 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.766 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.0 t -52.94 -40.61 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.16 -11.44 49.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.84 ' CE2' HD11 ' A' ' 67' ' ' ILE . 26.5 t80 -78.76 -39.64 35.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.371 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.709 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.7 mp -47.57 -32.79 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.359 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.64 -32.96 60.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.662 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 48.3 t80 -61.29 -44.96 96.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.84 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.1 mp -58.02 -42.64 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.271 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -80.25 -19.23 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 18.4 tt0 -71.15 -30.92 67.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.947 0.403 . . . . 0.0 110.703 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.438 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -132.37 17.21 4.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 180.0 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.57 68.73 1.05 Allowed Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.59 -21.25 46.16 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.77 2.313 . . . . 0.0 112.183 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.67 31.09 3.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.9 t -112.65 -163.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' HB ' HG13 ' A' ' 48' ' ' VAL . 45.8 t -152.58 135.85 7.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-O 121.025 0.441 . . . . 0.0 111.421 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.944 HG12 HG23 ' A' ' 78' ' ' VAL . 2.5 t -107.89 109.85 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.723 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.85 HD12 ' CG2' ' A' ' 112' ' ' THR . 33.7 mm -87.75 -56.32 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 179.388 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.944 HG23 HG12 ' A' ' 76' ' ' VAL . 20.3 t 53.65 103.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.518 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -102.98 -173.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.227 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.716 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.85 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.763 0.316 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 89' ' ' VAL . 38.8 m-20 -78.85 -52.93 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.694 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.407 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.2 t -47.29 -32.5 4.73 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.205 0.526 . . . . 0.0 110.062 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.99 -60.04 4.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.16 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 86' ' ' ASP . 17.5 m -66.32 -24.66 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.118 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -83.63 -20.23 34.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.258 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.709 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -102.52 -39.14 7.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.662 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.91 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.8 pt -69.32 -27.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.408 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -32.08 64.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.697 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -64.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 29.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.916 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.91 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.18 -167.22 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 84.1 t80 -117.67 26.03 9.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.1 pt-20 85.74 146.43 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.415 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -78.8 105.39 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.772 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 79' ' ' ILE . 10.5 tp -57.59 167.01 1.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.05 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 179.942 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.65 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.4 p . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.764 0.316 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -39.87 -38.31 0.66 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.04 -39.77 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.413 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.714 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 21.0 t80 -57.14 -28.32 62.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.74 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -48.03 67.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.331 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.4 mp -66.73 -52.19 47.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.973 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.85 ' CG2' HD12 ' A' ' 77' ' ' ILE . 28.8 m -46.36 -32.61 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 0.0 110.728 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.714 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 22.1 mm -78.18 -67.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.488 ' HZ1' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -50.42 -19.66 0.91 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.941 -179.939 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.41 ' CG ' ' OH ' ' A' ' 97' ' ' TYR . 1.8 t-80 -89.58 -27.84 19.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 110.754 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.01 -35.49 57.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 48' ' ' VAL . 63.7 m-85 -79.73 -45.77 18.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.783 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.912 0.386 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.466 ' HB3' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -162.37 127.66 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.721 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' A' ' 48' ' ' VAL . 39.5 t -116.86 143.72 26.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.727 0.298 . . . . 0.0 110.685 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.599 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 19.1 tp -96.88 132.3 42.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.061 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.874 ' HB ' HG22 ' A' ' 30' ' ' THR . 21.9 t -116.35 89.0 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 32' ' ' LYS . 23.9 t -84.88 112.74 22.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.104 0.478 . . . . 0.0 111.167 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -146.12 136.51 23.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.565 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -51.27 -24.31 4.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.688 179.621 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.494 HG21 ' CG1' ' A' ' 6' ' ' VAL . 72.0 p . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -68.2 137.11 54.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.601 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.529 ' CB ' HG11 ' A' ' 106' ' ' VAL . 0.8 OUTLIER 83.59 -16.94 0.52 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.28 179.316 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.005 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -86.39 -50.18 7.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 110.796 -179.899 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.15 -53.67 12.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.884 HD11 HG13 ' A' ' 106' ' ' VAL . 85.9 mt -67.85 -69.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.005 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.94 -30.23 1.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.98 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.87 -30.59 69.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.734 179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.47 -35.29 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.014 179.486 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.887 ' HG3' HD21 ' A' ' 110' ' ' LEU . 23.4 mm-40 -85.06 178.56 7.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.662 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.25 31.58 6.93 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.219 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.36 -175.55 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.199 0.523 . . . . 0.0 111.301 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.9 OUTLIER -151.05 95.79 3.35 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.811 179.61 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.547 ' HB3' HD13 ' A' ' 21' ' ' LEU . 57.6 Cg_endo -72.94 140.51 31.77 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.251 1.968 . . . . 0.0 112.481 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -115.42 -1.31 12.87 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.874 HG22 ' HB ' ' A' ' 6' ' ' VAL . 48.9 p 12.66 122.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -132.38 159.96 37.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.444 178.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.737 ' O ' HG13 ' A' ' 7' ' ' VAL . 31.5 mttt -73.48 -168.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 56' ' ' PRO . 16.8 p -48.04 161.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 111.909 -178.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.68 HD22 ' CD2' ' A' ' 63' ' ' PHE . 10.4 mt -27.24 -44.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.648 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.18 -62.36 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.318 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 2.1 tp10 -65.38 -34.73 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.507 ' C ' HD12 ' A' ' 41' ' ' ILE . . . -61.22 -63.14 1.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -44.67 -40.7 6.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.382 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -52.62 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.42 -34.28 76.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.835 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.507 HD12 ' C ' ' A' ' 37' ' ' ALA . 4.3 mt -85.27 -5.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.667 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -93.02 29.18 1.9 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.959 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -147.69 -53.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.953 HD11 ' CE1' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -99.31 -174.63 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -122.48 111.16 16.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.953 ' CE1' HD11 ' A' ' 44' ' ' LEU . 67.6 m-85 -98.58 125.59 42.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.41 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 4.3 Cg_endo -81.44 -23.97 4.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.711 2.274 . . . . 0.0 111.485 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.626 HG21 ' CE1' ' A' ' 117' ' ' PHE . 6.2 t -141.55 131.06 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.567 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 46' ' ' PHE . 8.8 mm -118.25 152.08 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.344 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.52 102.29 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.036 0.445 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.739 ' HB3' HG22 ' A' ' 78' ' ' VAL . 8.8 tp -94.3 129.62 40.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.063 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -113.33 113.15 24.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.417 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.816 HG22 ' CB ' ' A' ' 80' ' ' THR . 5.2 m -76.08 56.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.41 . . . . 0.0 111.542 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -64.76 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.489 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.677 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 35.1 mtm -149.01 51.78 1.03 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.949 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.5 Cg_exo -81.12 -153.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -163.19 30.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.23 134.51 7.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -58.64 105.79 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.89 -33.82 70.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.598 HG13 ' HG3' ' A' ' 94' ' ' LYS . 57.4 t -55.49 -39.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.014 0.435 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -23.64 59.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.183 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.839 ' CE2' HD11 ' A' ' 67' ' ' ILE . 39.7 t80 -75.35 -30.16 60.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 61' ' ' VAL . 5.4 mm -50.65 -33.74 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 69' ' ' GLU . 27.3 t70 -71.56 -39.57 70.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.401 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 14.7 t80 -55.19 -43.68 74.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.845 HG21 HG22 ' A' ' 76' ' ' VAL . 4.0 mp -59.57 -46.28 93.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.397 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -79.31 -13.27 59.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.748 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 43.2 tt0 -74.38 -43.15 57.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.113 0.483 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.476 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -118.55 13.61 13.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.037 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.89 66.43 2.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.925 0.393 . . . . 0.0 110.72 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.4 Cg_exo -69.13 -19.63 38.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.632 2.221 . . . . 0.0 112.243 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.29 27.3 7.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -109.68 -157.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 116' ' ' ALA . 60.7 t -150.23 137.54 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.064 0.459 . . . . 0.0 111.726 179.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.845 HG22 HG21 ' A' ' 67' ' ' ILE . 1.6 t -116.35 91.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.445 HG22 ' CG1' ' A' ' 79' ' ' ILE . 27.6 mm -72.38 -59.26 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.114 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 51' ' ' LEU . 47.9 t 51.63 92.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.837 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.936 HG23 ' O ' ' A' ' 100' ' ' LEU . 3.0 mt -116.42 145.71 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.992 0.425 . . . . 0.0 111.558 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.816 ' CB ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.686 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 85' ' ' VAL . 29.3 m . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.948 0.404 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -103.92 -28.78 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -85.47 -31.81 22.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 109.953 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.536 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -61.55 -56.59 18.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.777 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.8 m -52.58 -30.71 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.888 179.445 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.583 ' CD ' HG21 ' A' ' 61' ' ' VAL . 8.2 ttmt -75.98 -22.34 55.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.48 -40.72 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.87 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.892 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 9.2 pt -70.91 -42.94 77.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.321 -179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -23.38 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.554 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.598 ' HG3' HG13 ' A' ' 61' ' ' VAL . 4.1 mmpt? -79.76 -57.83 3.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.61 28.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.495 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.18 -164.52 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.12 0.46 . . . . 0.0 110.68 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.519 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 54.8 t80 -101.87 -23.18 14.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.6 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 3.8 pt-20 150.07 -11.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.603 0.565 . . . . 0.0 111.932 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.625 ' CE1' HG12 ' A' ' 78' ' ' VAL . 1.5 t80 69.98 71.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.121 0.486 . . . . 0.0 110.085 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.936 ' O ' HG23 ' A' ' 79' ' ' ILE . 66.1 tp -49.77 165.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.189 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.456 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 7.7 mt-10 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.884 HG13 HD11 ' A' ' 20' ' ' ILE . 7.1 p . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.632 0.254 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.93 -41.91 77.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -60.83 -34.85 75.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.455 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.613 ' HA ' HD21 ' A' ' 100' ' ' LEU . 6.2 t80 -61.35 -39.78 91.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.429 178.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.887 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.2 tt -48.72 -51.71 27.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.31 179.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -57.35 -46.57 83.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.4 m -60.8 -40.17 91.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.223 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.0 mm -47.97 -54.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.535 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.91 -59.15 3.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -51.73 -29.46 18.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.867 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -65.33 -33.94 77.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.965 0.412 . . . . 0.0 110.672 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.626 ' CE1' HG21 ' A' ' 48' ' ' VAL . 35.1 m-85 -78.45 -23.01 46.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.291 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.808 0.337 . . . . 0.0 111.186 179.969 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmtp . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.866 0.365 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.33 133.57 24.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.842 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 48' ' ' VAL . 18.6 t -128.03 161.08 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.799 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.697 HD22 ' CD2' ' A' ' 46' ' ' PHE . 28.0 tp -112.51 134.64 53.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.718 ' HB ' HG22 ' A' ' 30' ' ' THR . 22.0 t -116.23 90.28 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.823 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.6 106.02 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.772 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 14' ' ' THR . 10.0 t70 -136.66 133.11 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.989 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 16.8 t70 -51.85 -45.1 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.277 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.661 -179.99 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.472 HG22 ' HB ' ' A' ' 30' ' ' THR . 12.1 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.639 0.257 . . . . 0.0 111.63 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -90.11 -47.02 8.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.544 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -74.88 -69.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.661 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.891 HD13 ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -40.71 -48.02 2.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.68 -179.393 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.68 ' O ' HD22 ' A' ' 21' ' ' LEU . 6.6 t -51.17 -41.73 60.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 110.924 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.35 74.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.313 0.577 . . . . 0.0 109.892 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.846 ' CD1' HG11 ' A' ' 106' ' ' VAL . 2.0 mp -75.51 -63.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.965 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.891 ' CD1' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.11 -13.35 1.17 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.088 -179.241 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.68 ' N ' HD23 ' A' ' 21' ' ' LEU . 3.6 mt-10 -85.07 -26.03 27.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.79 0.329 . . . . 0.0 110.313 179.034 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -35.55 26.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.394 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.868 ' HG2' HD21 ' A' ' 110' ' ' LEU . 3.3 mp0 -73.98 -50.37 20.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.67 57.05 0.22 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.194 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 82.1 m-85 -120.24 -174.74 2.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.072 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.77 89.17 40.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.058 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 85.2 Cg_endo -81.32 124.95 4.97 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.522 2.148 . . . . 0.0 113.062 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.97 7.52 46.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.718 HG22 ' HB ' ' A' ' 6' ' ' VAL . 11.7 p 4.42 122.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.2 168.18 10.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.428 178.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' ASP . 37.1 mttm -88.93 -37.89 14.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -155.95 -179.5 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.734 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.542 HD22 ' CG ' ' A' ' 63' ' ' PHE . 11.2 mt -61.88 -33.89 75.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.549 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -48.19 71.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.191 179.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.51 -30.15 68.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.498 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.4 -33.9 69.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 33.7 mt-10 -67.84 -42.56 81.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -33.73 76.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.088 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -75.83 -42.81 48.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.509 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.498 HD12 ' O ' ' A' ' 37' ' ' ALA . 9.3 mt -72.49 -26.95 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.109 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -26.76 13.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -122.27 -42.5 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 139.83 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -103.72 101.93 11.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.77 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.697 ' CD2' HD22 ' A' ' 5' ' ' LEU . 25.8 m-85 -94.82 120.09 65.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.9 Cg_endo -73.64 -12.38 24.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.43 2.087 . . . . 0.0 111.759 179.096 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.649 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.4 t -151.94 135.11 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.43 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 12.3 mm -115.83 161.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.633 178.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' LEU . 60.7 t -149.72 94.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.542 . . . . 0.0 111.642 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.884 ' HB3' HG13 ' A' ' 78' ' ' VAL . 11.6 tp -77.59 171.1 15.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.289 179.624 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 6.4 t70 -139.65 -46.43 0.45 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.395 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 53' ' ' VAL . 21.5 t 66.24 40.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -57.79 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.525 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.676 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.7 mmm -148.05 51.36 1.03 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.059 179.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.676 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.8 Cg_endo -87.56 -155.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.036 2.49 . . . . 0.0 112.021 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -148.67 38.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.02 168.87 22.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.515 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.0 111.58 24.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.38 -19.4 66.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.752 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.574 ' O ' HD12 ' A' ' 64' ' ' ILE . 18.8 t -53.12 -48.85 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.859 0.362 . . . . 0.0 111.357 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -14.08 58.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.299 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 67' ' ' ILE . 44.6 t80 -71.87 -37.7 70.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.683 0.277 . . . . 0.0 111.225 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mt -47.89 -28.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.285 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -34.24 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 72.6 t80 -60.12 -38.68 83.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.139 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -60.32 -45.97 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 179.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -77.91 -24.24 48.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 25.9 tt0 -64.57 -33.61 76.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.42 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -131.0 17.52 5.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.182 -179.836 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.82 70.02 1.04 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.823 0.344 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.2 -18.79 34.73 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.842 2.361 . . . . 0.0 112.254 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -98.89 30.42 3.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.824 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 41.6 t -114.71 -162.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.641 ' HB ' HG13 ' A' ' 48' ' ' VAL . 30.8 t -154.31 136.5 6.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.68 0.276 . . . . 0.0 111.284 179.201 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.953 HG12 HG23 ' A' ' 78' ' ' VAL . 4.9 t -110.38 110.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.837 -179.036 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 77' ' ' ILE . 28.1 mm -111.11 43.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.662 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.953 HG23 HG12 ' A' ' 76' ' ' VAL . 47.7 t -43.36 121.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.587 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.521 HG23 ' HB3' ' A' ' 100' ' ' LEU . 3.8 mt -121.34 150.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.805 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.478 HG22 ' CG2' ' A' ' 53' ' ' VAL . 30.5 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -111.25 -10.36 14.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.401 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.5 t -89.38 -36.5 15.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.013 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -57.62 -58.21 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.843 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.406 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.1 m -55.14 -27.11 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.578 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HE3' HG22 ' A' ' 61' ' ' VAL . 31.0 ttpt -82.21 -20.35 37.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.134 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.59 -40.3 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.498 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.939 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 12.5 pt -68.71 -31.52 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -26.4 67.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.697 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -73.74 -59.59 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 31.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.332 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.939 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.09 -164.67 1.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.025 0.412 . . . . 0.0 110.438 179.3 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.555 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.6 t80 -105.22 -22.02 13.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.53 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 144.52 14.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.733 0.645 . . . . 0.0 111.773 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER 62.15 163.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 110.643 -179.881 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -107.48 97.04 6.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.649 179.856 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.032 -179.889 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 20' ' ' ILE . 12.4 p . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.746 0.308 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -45.94 -41.82 12.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.936 0.398 . . . . 0.0 110.909 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.467 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -64.04 -34.79 78.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.166 179.362 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.631 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 6.3 t80 -68.03 -28.93 67.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.522 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.868 HD21 ' HG2' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -50.67 -42.69 56.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.068 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 108' ' ' ARG . 3.3 mp -56.37 -56.2 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.836 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.418 ' CG2' HD12 ' A' ' 77' ' ' ILE . 90.9 m -46.62 -44.06 17.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.055 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.631 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 24.2 mm -54.53 -69.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.037 0.446 . . . . 0.0 110.43 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.418 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -54.9 -17.9 4.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.876 179.111 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -89.8 -21.23 22.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.34 -37.34 18.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.971 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 48' ' ' VAL . 35.0 m-85 -73.09 -39.29 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.294 -179.741 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 25.4 mmtt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.861 0.362 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.405 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -147.99 124.75 11.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 48' ' ' VAL . 25.2 t -119.6 159.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.707 HD23 HG23 ' A' ' 49' ' ' ILE . 41.7 tp -114.04 136.29 53.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.579 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.777 HG21 HD12 ' A' ' 17' ' ' LEU . 3.6 t -120.79 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 37' ' ' ALA . 30.2 t -78.14 119.47 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.567 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 12.3 t0 -163.75 154.74 16.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.747 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -85.23 48.99 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.653 179.707 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.429 HG22 ' OD2' ' A' ' 8' ' ' ASP . 64.2 p . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.721 ' HB3' HG13 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -91.46 -155.13 0.39 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.745 0.307 . . . . 0.0 111.523 -179.591 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' LEU . 52.6 m -47.53 -22.23 0.45 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.869 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.977 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -32.14 -49.55 0.2 Allowed 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 110.482 179.238 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 t -47.78 -67.14 0.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.111 179.289 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.53 75.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.693 ' CD1' HG23 ' A' ' 106' ' ' VAL . 13.7 mt -61.59 -63.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.346 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.977 HD11 HD13 ' A' ' 17' ' ' LEU . 1.5 mt -45.07 -36.18 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.329 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -27.85 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.136 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' ILE . 12.3 tt0 -87.1 -41.98 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.507 ' OE2' HD21 ' A' ' 110' ' ' LEU . 5.3 mm-40 -75.31 -43.33 51.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.75 32.71 5.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.558 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.698 ' HB2' HD23 ' A' ' 21' ' ' LEU . 48.9 m-85 -81.42 -174.63 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.894 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.98 86.05 53.1 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.031 179.332 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.546 ' HG3' HD13 ' A' ' 21' ' ' LEU . 94.0 Cg_endo -81.46 136.82 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 112.505 -179.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 30' ' ' THR . 7.2 t70 -113.53 3.02 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.03 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.731 HG22 ' HB ' ' A' ' 6' ' ' VAL . 26.4 p 9.84 121.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.12 -178.54 3.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.699 179.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 30.7 tttp -95.39 -38.62 10.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.667 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 6.2 t -165.76 -162.47 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.899 HD11 ' O ' ' A' ' 59' ' ' ASP . 14.9 mt -68.4 -47.36 67.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.657 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -60.78 -45.63 93.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 109.989 179.167 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -34.13 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 7' ' ' VAL . . . -70.29 -35.06 73.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.705 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG2' ' CD1' ' A' ' 66' ' ' PHE . 90.3 mt-10 -65.92 -41.31 91.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -38.07 85.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.601 178.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -74.06 -49.94 21.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.873 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 mt -66.9 -27.75 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.145 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -62.85 -23.99 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.095 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.06 -42.89 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.247 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 129.16 38.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -82.18 62.39 5.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.461 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.564 ' HB2' HD11 ' A' ' 49' ' ' ILE . 60.0 m-85 -55.34 121.31 36.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.475 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.446 ' O ' ' HA ' ' A' ' 74' ' ' SER . 61.0 Cg_endo -72.9 -22.92 19.35 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.435 2.09 . . . . 0.0 111.805 179.318 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 117' ' ' PHE . 4.5 t -142.68 125.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.316 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.707 HG23 HD23 ' A' ' 5' ' ' LEU . 8.3 mm -111.91 152.52 13.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.029 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 51' ' ' LEU . 4.9 t -134.87 177.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.875 ' HB3' HG13 ' A' ' 78' ' ' VAL . 29.4 tp -161.74 78.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.072 0.463 . . . . 0.0 111.101 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 8.6 t70 -70.72 67.84 0.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.517 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' A' ' 51' ' ' LEU . 50.4 t -47.12 92.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.474 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -79.19 -80.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.502 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.681 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -152.5 50.6 0.64 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.13 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.681 ' HD3' ' N ' ' A' ' 55' ' ' MET . 10.1 Cg_endo -90.57 -158.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.043 2.495 . . . . 0.0 112.015 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -157.74 58.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.096 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.48 10.79 4.06 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.788 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.899 ' O ' HD11 ' A' ' 34' ' ' LEU . 3.3 m-20 52.98 -162.02 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.717 0.258 . . . . 0.0 110.679 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.23 28.96 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.674 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.632 HG21 ' HD3' ' A' ' 90' ' ' LYS . 17.6 t -89.44 -44.91 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.13 9.56 27.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.569 -179.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.774 ' CE2' HD11 ' A' ' 67' ' ' ILE . 17.6 t80 -90.03 -36.88 14.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.704 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.6 mp -46.79 -28.97 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.403 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -35.89 65.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD1' ' HG2' ' A' ' 38' ' ' GLU . 12.3 t80 -62.74 -44.2 96.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.422 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.774 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.0 mp -59.27 -37.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.321 179.411 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -85.7 -20.19 29.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.719 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -69.59 -29.26 66.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -131.93 9.05 4.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.251 -179.873 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.03 67.79 3.21 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.854 0.359 . . . . 0.0 110.745 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.65 -15.37 21.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.799 2.333 . . . . 0.0 112.285 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.35 27.35 9.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.067 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 39.8 t -107.18 -163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.489 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.869 HG21 ' HB1' ' A' ' 116' ' ' ALA . 21.2 t -146.36 131.64 12.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 121.239 0.542 . . . . 0.0 112.457 179.338 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.006 HG12 HG23 ' A' ' 78' ' ' VAL . 1.3 t -105.25 110.72 31.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.094 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.704 HD12 ' CG2' ' A' ' 112' ' ' THR . 29.2 mm -109.25 38.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.006 HG23 HG12 ' A' ' 76' ' ' VAL . 60.0 t -42.63 115.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.295 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.896 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -105.64 179.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.87 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.692 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 111.289 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.935 0.398 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -104.12 -18.92 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -90.84 -36.16 14.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.78 -57.27 13.17 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.84 178.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -51.76 -26.86 7.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.632 ' HD3' HG21 ' A' ' 61' ' ' VAL . 8.9 tttt -89.09 36.74 0.83 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.22 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.704 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -170.31 -42.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.614 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -75.47 157.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.808 179.997 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.16 -3.2 2.52 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.102 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -112.6 -25.33 9.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.31 -34.92 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.25 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -68.91 177.63 2.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.773 0.321 . . . . 0.0 111.151 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.46 ' HB3' HD13 ' A' ' 77' ' ' ILE . 45.4 t80 -108.77 29.94 6.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.486 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.1 OUTLIER 80.15 142.71 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.932 179.773 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.61 ' CG ' ' HB2' ' A' ' 88' ' ' ALA . 1.6 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.38 -179.605 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.896 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -89.94 89.46 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.593 179.655 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.26 -179.882 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.755 HG21 HD23 ' A' ' 17' ' ' LEU . 33.3 m . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -45.93 -47.85 16.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.664 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -70.45 -30.34 67.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.987 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.508 ' CE2' HG21 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -65.71 -25.15 67.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.447 179.522 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.507 HD21 ' OE2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -47.44 -50.15 23.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.883 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.608 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.5 mp -55.63 -47.56 76.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.476 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.704 ' CG2' HD12 ' A' ' 77' ' ' ILE . 97.7 m -49.29 -38.36 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.632 179.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.472 HG23 ' CE1' ' A' ' 117' ' ' PHE . 8.3 mm -66.48 -62.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.16 179.237 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.478 ' CG ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -55.56 -14.94 2.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.456 179.402 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.416 ' N ' ' HD3' ' A' ' 114' ' ' LYS . 2.0 m80 -90.41 -19.69 23.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.072 0.463 . . . . 0.0 110.266 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.869 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -89.98 -49.1 6.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.963 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 48' ' ' VAL . 36.9 m-85 -56.8 -30.8 64.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.985 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 19.9 mmtt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.836 0.351 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -143.64 128.04 17.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.651 179.948 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.2 t -121.5 151.45 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 -179.806 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.58 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 33.5 tp -101.24 136.53 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.752 0.31 . . . . 0.0 110.516 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.819 HG21 HD12 ' A' ' 17' ' ' LEU . 8.4 t -117.14 95.57 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 32' ' ' LYS . 87.6 t -89.34 116.22 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 0.0 111.243 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -145.37 112.68 6.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.879 179.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.537 ' HB2' HG23 ' A' ' 33' ' ' THR . 4.8 t70 -50.42 -79.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -178.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.915 0.388 . . . . 0.0 111.244 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.52 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 2.7 p . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -42.57 140.92 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.285 -178.733 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.57 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.6 m 85.56 -17.57 0.41 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.62 179.054 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.991 HD23 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.66 -54.45 11.87 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.052 -179.672 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.0 -67.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.676 -179.562 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.65 -40.36 27.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.496 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.882 HG23 HD11 ' A' ' 110' ' ' LEU . 60.3 mt -64.72 -66.27 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.918 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.65 -29.44 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.13 -25.09 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.09 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -81.89 -41.11 21.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.869 0.366 . . . . 0.0 110.246 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.612 ' HG2' HD22 ' A' ' 110' ' ' LEU . 1.6 mp0 -75.85 -32.09 59.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.059 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.74 31.17 6.46 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 51.1 m-85 -88.27 -174.69 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -139.01 91.61 11.38 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.635 179.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 66.9 Cg_endo -76.88 145.49 25.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.18 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.9 t70 -120.09 -4.61 10.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.703 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.613 ' O ' ' O ' ' A' ' 29' ' ' ASP . 10.2 p 23.54 123.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.64 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -131.74 145.69 51.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.297 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.646 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -58.61 -173.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.521 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -48.36 167.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 111.654 -178.591 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 63' ' ' PHE . 11.8 mt -31.44 -39.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.481 -178.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -62.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.149 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.463 ' CB ' ' CB ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -64.81 -27.25 68.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.865 179.568 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.45 -57.39 4.47 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.391 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.472 ' HG3' ' CE1' ' A' ' 63' ' ' PHE . 64.5 mt-10 -46.31 -41.34 13.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -61.0 -53.28 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HD2' ' HB2' ' A' ' 31' ' ' ALA . 20.1 mttm -59.66 -35.03 73.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.129 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.731 HD12 ' HZ ' ' A' ' 63' ' ' PHE . 47.3 mt -92.3 -5.23 10.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLU . 2.8 tmtm? -56.75 -19.61 17.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.299 -179.813 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -139.43 -46.23 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 121.07 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -87.14 75.22 9.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 27.2 m-85 -66.09 132.33 94.56 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 74.1 Cg_endo -75.23 -30.38 6.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.411 2.074 . . . . 0.0 111.878 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.778 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.4 t -140.32 132.98 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.537 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 46' ' ' PHE . 20.9 mm -115.47 145.23 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.453 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 44.1 t -130.3 105.74 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 111.446 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 ' HA3' ' A' ' 60' ' ' GLY . 45.7 tp -100.33 147.88 25.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.3 179.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.704 ' C ' HG22 ' A' ' 80' ' ' THR . 7.4 t0 -119.11 -31.76 4.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.563 -179.38 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 53' ' ' VAL . 88.5 t 60.64 63.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.73 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.455 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 37.1 t-105 -58.83 -81.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.834 0.349 . . . . 0.0 110.383 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.71 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 ttt -151.97 48.82 0.5 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.085 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.8 Cg_exo -76.87 -150.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.789 2.326 . . . . 0.0 112.032 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -135.18 21.48 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.212 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.67 -3.71 4.98 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.029 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 61' ' ' VAL . 16.4 m-20 52.64 25.1 3.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.018 0.437 . . . . 0.0 111.167 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.668 ' HA3' HD21 ' A' ' 51' ' ' LEU . . . 49.6 18.63 1.73 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.623 179.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 90' ' ' LYS . 23.2 t -87.25 -45.1 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 117.149 0.474 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -65.78 -16.16 63.53 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 34' ' ' LEU . 3.7 t80 -85.65 -29.05 24.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.564 ' CD1' ' HB1' ' A' ' 91' ' ' ALA . 20.2 mm -46.59 -43.47 6.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.327 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -44.91 70.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 21.1 t80 -49.4 -41.06 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.975 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.792 HG21 HG22 ' A' ' 76' ' ' VAL . 2.1 mp -62.61 -49.97 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -12.09 60.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.466 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.92 -49.37 20.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.059 0.457 . . . . 0.0 110.394 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.18 17.04 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.976 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.05 67.2 2.05 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.736 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.22 -15.77 22.66 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.776 2.317 . . . . 0.0 112.265 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -112.61 32.91 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.83 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -111.89 -159.83 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.878 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.833 HG11 ' HB1' ' A' ' 116' ' ' ALA . 41.2 t -138.08 138.98 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.309 0.576 . . . . 0.0 112.293 179.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.874 HG12 HG23 ' A' ' 78' ' ' VAL . 6.2 t -114.41 99.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.317 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.641 HG21 ' CD1' ' A' ' 109' ' ' PHE . 35.0 mm -103.41 43.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.874 HG23 HG12 ' A' ' 76' ' ' VAL . 98.9 t -54.72 87.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.652 HG23 ' HB3' ' A' ' 100' ' ' LEU . 19.2 mt -66.25 -101.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.704 HG22 ' C ' ' A' ' 52' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.237 . . . . 0.0 111.041 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 C--O 1.231 0.094 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.72 -27.06 68.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.685 0.279 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.52 -34.24 54.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.8 -57.81 11.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.018 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 m -56.84 -22.83 16.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.956 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.523 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -80.41 2.81 23.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.248 179.753 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . -138.71 -40.53 0.5 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 1.6 pt -70.84 -24.59 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -71.74 -35.58 70.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -59.77 -59.21 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.65 31.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.995 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.24 -178.74 5.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.471 ' HB3' HD13 ' A' ' 77' ' ' ILE . 18.9 t80 -101.25 27.91 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.426 -179.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 77.64 151.96 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.971 179.927 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -74.19 139.26 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.652 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -83.64 92.11 7.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.556 179.869 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.066 -179.823 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.991 HG21 HD23 ' A' ' 17' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.465 0.304 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.1 -50.86 29.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HA ' HD13 ' A' ' 111' ' ' LEU . 13.8 tpt180 -61.94 -29.63 70.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.417 178.514 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CD1' HG21 ' A' ' 77' ' ' ILE . 24.0 t80 -62.12 -40.71 96.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.712 178.804 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.882 HD11 HG23 ' A' ' 20' ' ' ILE . 2.0 mt -54.65 -48.83 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.263 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.482 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.4 mp -59.54 -50.45 73.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.028 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.0 m -61.5 -37.55 84.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.707 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.502 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 1.6 mm -55.76 -53.13 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.375 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -60.0 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 109.853 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -58.4 -26.13 62.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.998 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.833 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -66.14 -38.35 87.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.926 0.393 . . . . 0.0 110.977 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.597 ' CE2' HG21 ' A' ' 48' ' ' VAL . 20.7 m-85 -68.84 -20.04 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.632 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.961 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.486 ' HG3' ' CD2' ' A' ' 117' ' ' PHE . 2.0 mptt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.909 0.385 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -111.39 124.73 52.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.458 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.671 HG13 ' HB ' ' A' ' 48' ' ' VAL . 26.9 t -124.33 144.33 34.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.329 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.654 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 46.8 tp -95.02 128.76 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.321 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.555 HG21 ' CD1' ' A' ' 17' ' ' LEU . 18.9 t -112.91 92.56 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.482 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 32' ' ' LYS . 60.1 t -89.99 118.72 35.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.029 0.442 . . . . 0.0 111.082 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -153.63 125.12 7.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.681 ' HB2' HG22 ' A' ' 33' ' ' THR . 21.2 t0 -85.73 47.59 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.329 -179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' CG ' ' CD1' ' A' ' 54' ' ' TRP . 4.0 tm-20 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.676 179.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.438 HG23 ' CG1' ' A' ' 6' ' ' VAL . 65.6 p . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.799 0.333 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -52.19 139.46 23.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 0.0 112.185 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.752 ' O ' HD12 ' A' ' 20' ' ' ILE . 8.7 t 73.54 0.72 3.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.449 179.109 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.36 -59.45 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.157 -179.918 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.63 ' O ' HD22 ' A' ' 21' ' ' LEU . 7.8 t -46.5 -45.94 18.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.591 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.14 73.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.376 0.607 . . . . 0.0 110.17 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 110' ' ' LEU . 41.7 mt -76.14 -64.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.774 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.771 ' CD1' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -56.74 -10.46 1.04 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.978 -179.186 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.571 ' N ' HD23 ' A' ' 21' ' ' LEU . 17.4 mt-10 -89.23 -28.6 19.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.033 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -36.1 32.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.013 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.769 ' CG ' HD21 ' A' ' 110' ' ' LEU . 30.5 mm-40 -77.77 -31.33 51.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.019 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 42.89 3.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.512 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 7.2 m-85 -95.83 -170.31 2.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 -179.066 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.08 93.47 5.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.455 ' HD3' ' HG ' ' A' ' 21' ' ' LEU . 73.3 Cg_endo -79.67 146.78 19.17 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.384 2.056 . . . . 0.0 112.011 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.658 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -115.76 -7.26 12.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 29' ' ' ASP . 11.7 p 25.51 124.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -141.89 141.88 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.901 178.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.844 ' O ' HG13 ' A' ' 7' ' ' VAL . 39.4 mtmt -58.79 -165.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.56 0.219 . . . . 0.0 110.564 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.681 HG22 ' HB2' ' A' ' 9' ' ' ASP . 14.9 p -47.89 168.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 112.149 -177.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.815 HD11 ' O ' ' A' ' 59' ' ' ASP . 22.5 mt -40.81 -31.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.97 -179.075 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -64.3 0.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.14 0.495 . . . . 0.0 109.84 179.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.5 -33.72 76.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.461 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 34' ' ' LEU . . . -64.88 -61.66 2.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.729 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 7.5 mt-10 -44.05 -42.12 5.93 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -61.44 -51.74 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -63.35 -33.95 76.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.336 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 41' ' ' ILE . 8.3 mt -88.95 -9.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -57.67 -19.42 26.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.501 -179.735 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -134.64 -47.25 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 124.72 20.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -84.96 72.0 10.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.654 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 25.0 m-85 -65.79 126.77 92.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.79 -27.62 3.84 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.508 2.139 . . . . 0.0 112.074 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.717 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.8 t -140.51 132.62 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.346 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.448 HD11 ' CB ' ' A' ' 46' ' ' PHE . 18.5 mm -118.73 148.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.138 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 49.0 t -136.86 104.57 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.488 179.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp -98.99 97.68 8.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -83.42 92.79 7.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.953 178.936 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.761 HG22 ' HB ' ' A' ' 80' ' ' THR . 28.0 m -63.87 74.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.789 -179.211 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.442 ' CD1' ' CG ' ' A' ' 10' ' ' GLU . 30.3 t-105 -81.75 -80.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.514 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.498 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 21.9 mmt -145.67 61.4 7.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.809 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 55' ' ' MET . 11.1 Cg_endo -89.2 -159.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.128 2.552 . . . . 0.0 112.32 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -153.77 25.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.141 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.96 10.66 5.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.629 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.815 ' O ' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 55.92 -157.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.788 0.294 . . . . 0.0 110.212 -179.703 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.7 22.04 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.898 ' O ' HD12 ' A' ' 64' ' ' ILE . 20.4 t -86.83 -45.15 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 110.879 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -1.16 50.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CD2' HD11 ' A' ' 67' ' ' ILE . 6.5 t80 -76.32 -41.14 49.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.4 mt -43.81 -38.42 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.329 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.32 -51.37 57.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.427 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 34.0 t80 -53.68 -28.5 33.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.097 179.289 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.984 HG21 HG22 ' A' ' 76' ' ' VAL . 2.9 mm -68.25 -54.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -71.3 -22.06 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.557 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.93 -52.89 61.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.701 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.62 18.0 18.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.161 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.4 68.15 1.71 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 110.801 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.35 -19.33 33.45 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.804 2.336 . . . . 0.0 112.361 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -113.17 35.96 3.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -112.64 -156.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.809 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.717 ' HB ' HG13 ' A' ' 48' ' ' VAL . 50.0 t -146.49 138.72 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.436 0.636 . . . . 0.0 112.16 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 67' ' ' ILE . 2.8 t -118.35 80.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.149 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -65.56 -54.93 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.78 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.809 HG23 HG12 ' A' ' 76' ' ' VAL . 34.4 t 49.44 89.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.32 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.749 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -99.33 -173.96 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.761 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.7 m . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.352 . . . . 0.0 110.963 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.6 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.618 0.247 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.49 -15.87 28.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.099 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.13 -32.86 38.92 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.51 -57.95 10.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.099 178.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 92' ' ' ILE . 17.5 m -61.84 -27.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.207 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.528 ' O ' HG13 ' A' ' 61' ' ' VAL . 4.8 ttmt -80.56 -12.91 59.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.647 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.663 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -114.1 -24.34 9.05 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.834 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 4.9 pt -90.1 -15.05 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.272 . . . . 0.0 111.635 -179.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.69 -42.74 67.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.737 0.303 . . . . 0.0 111.123 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.611 ' HB3' HD13 ' A' ' 64' ' ' ILE . 9.4 ttmt -54.82 -35.1 63.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.77 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.157 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.1 -167.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.33 . . . . 0.0 110.899 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 9.3 t80 -108.44 27.28 9.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.219 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.9 OUTLIER 80.66 159.7 0.16 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.154 179.759 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.734 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -92.13 104.39 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.827 -179.962 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HB3' HG23 ' A' ' 79' ' ' ILE . 9.9 tp -57.78 147.33 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.992 -179.974 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.722 HG21 HD23 ' A' ' 17' ' ' LEU . 3.5 m . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -70.72 -51.89 24.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -58.64 -32.22 68.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.583 ' CE1' HD11 ' A' ' 113' ' ' ILE . 28.4 t80 -61.54 -36.92 81.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.267 178.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.833 ' CD1' HG23 ' A' ' 20' ' ' ILE . 3.2 tt -55.61 -60.09 3.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.1 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.421 ' H ' HD12 ' A' ' 111' ' ' LEU . 3.5 mp -60.29 -46.98 87.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.628 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.6 m -61.19 -40.07 92.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.583 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.7 mm -50.28 -52.38 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.657 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -55.52 7.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.115 0.483 . . . . 0.0 110.323 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -56.03 -27.37 52.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.949 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.696 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -65.94 -36.19 82.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.98 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.675 ' CE1' HG21 ' A' ' 48' ' ' VAL . 50.9 m-85 -80.82 -35.23 33.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.229 -179.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.849 0.356 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.01 134.21 21.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.667 HG13 ' HB ' ' A' ' 48' ' ' VAL . 5.6 t -124.16 152.6 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.905 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 52.4 tp -105.03 127.93 53.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.166 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.908 HG21 ' CD1' ' A' ' 17' ' ' LEU . 21.5 t -113.42 92.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.372 . . . . 0.0 111.604 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.653 ' HB ' HD12 ' A' ' 51' ' ' LEU . 43.8 t -78.97 115.24 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 34.5 t70 -157.31 155.53 30.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.806 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -88.27 49.33 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.969 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.983 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 37.5 p . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.19 127.11 31.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 t 80.41 -39.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.52 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.908 ' CD1' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -46.04 -61.13 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.145 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.823 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -39.79 -61.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.7 -178.703 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.98 12.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.277 0.561 . . . . 0.0 110.88 179.427 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.619 HD13 HG22 ' A' ' 106' ' ' VAL . 10.4 mt -76.04 -71.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.019 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -50.49 -30.25 12.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.416 -179.558 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.946 ' N ' HD13 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -74.22 -25.95 59.97 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.764 0.316 . . . . 0.0 110.705 178.945 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.75 -37.13 30.99 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.171 179.43 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.635 ' CD ' HD21 ' A' ' 110' ' ' LEU . 16.5 mm-40 -66.84 -28.82 68.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.46 42.91 3.31 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.377 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 72.5 m-85 -113.82 -177.61 3.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 111.156 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.95 106.7 28.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.776 179.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.671 ' HD3' HD21 ' A' ' 21' ' ' LEU . 98.3 Cg_endo -92.9 128.32 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.809 2.34 . . . . 0.0 113.218 -178.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.1 t70 -107.32 6.55 28.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.794 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.638 HG22 ' HB ' ' A' ' 6' ' ' VAL . 1.7 p -2.74 125.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.31 -162.2 0.88 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.713 179.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -109.4 -40.86 4.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.016 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.11 -175.58 5.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.7 HD22 ' CD2' ' A' ' 63' ' ' PHE . 60.8 mt -61.77 -45.99 91.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -61.26 -46.77 88.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.993 0.425 . . . . 0.0 110.1 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.23 -30.49 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.413 179.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.46 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.23 -31.62 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.677 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 60.9 mt-10 -70.14 -40.16 74.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.9 77.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.317 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -75.04 -37.54 61.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.811 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 37' ' ' ALA . 12.9 mt -75.48 -26.04 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -7.33 47.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -112.82 -30.73 6.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.76 0.314 . . . . 0.0 111.233 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.622 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -128.21 156.1 43.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.786 -179.862 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 48.2 t80 -93.96 98.14 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 39.4 m-85 -80.44 123.54 82.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.33 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.476 ' O ' ' HA ' ' A' ' 74' ' ' SER . 87.9 Cg_endo -82.75 -21.59 4.88 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.578 2.186 . . . . 0.0 111.905 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.667 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.8 t -148.76 133.57 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.095 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.536 HD12 HD23 ' A' ' 5' ' ' LEU . 15.3 mm -119.66 160.81 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.794 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 79' ' ' ILE . 95.1 t -153.27 99.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.653 HD12 ' HB ' ' A' ' 7' ' ' VAL . 12.6 tp -69.1 166.17 18.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.565 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -161.88 76.09 0.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.422 -179.742 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -63.42 75.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.583 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -66.94 -80.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.749 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -152.65 44.28 0.26 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.28 178.767 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.749 ' HD3' ' N ' ' A' ' 55' ' ' MET . 41.1 Cg_endo -97.96 -77.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.178 2.585 . . . . 0.0 112.368 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -170.15 -51.39 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.509 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.45 -131.64 42.74 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.946 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.59 44.08 7.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.54 67.93 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.839 ' O ' HD12 ' A' ' 64' ' ' ILE . 80.1 t -59.35 -33.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.035 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.11 5.96 24.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.7 ' CD2' HD22 ' A' ' 34' ' ' LEU . 19.4 t80 -72.17 -35.26 68.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.756 0.312 . . . . 0.0 111.164 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.2 mp -51.38 -32.96 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.222 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.86 -33.36 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.553 179.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 33.7 t80 -60.19 -42.87 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.3 mp -61.32 -44.85 99.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.21 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -74.85 -22.66 58.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.54 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -67.09 -38.06 85.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.36 18.23 8.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.442 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -167.73 69.58 0.89 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.629 -179.941 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.85 -20.04 39.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.788 2.325 . . . . 0.0 112.312 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -107.26 30.9 5.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.895 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 32.3 t -108.27 -162.48 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HB ' HG13 ' A' ' 48' ' ' VAL . 63.7 t -149.9 135.02 10.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 111.834 179.249 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.644 HG12 HG23 ' A' ' 78' ' ' VAL . 22.6 t -107.42 116.8 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.063 -178.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.69 HD12 ' CG2' ' A' ' 112' ' ' THR . 17.2 mm -120.85 48.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.118 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.65 HG13 HD23 ' A' ' 51' ' ' LEU . 89.3 t -45.64 134.31 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.228 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.561 HD11 HG13 ' A' ' 50' ' ' VAL . 3.3 mt -132.66 167.74 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 179.565 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.7 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 89' ' ' VAL . 33.5 t70 -115.01 -58.62 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -47.34 -34.2 6.61 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.12 0.485 . . . . 0.0 110.498 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.831 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.94 -59.49 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.192 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 86' ' ' ASP . 25.0 m -62.03 -24.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.005 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.591 ' HD3' HG21 ' A' ' 61' ' ' VAL . 7.5 ttmm -84.77 -18.95 33.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.356 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.05 -32.54 8.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.7 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.908 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 8.1 pt -78.19 -17.73 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.774 -179.382 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -85.68 -17.18 36.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.68 0.276 . . . . 0.0 111.209 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.623 ' HB3' HD13 ' A' ' 64' ' ' ILE . 8.7 tttp -80.1 -24.52 40.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.302 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.27 -17.73 0.37 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.297 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.908 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.39 176.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.0 0.428 . . . . 0.0 111.426 -179.759 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.636 ' HB3' HD13 ' A' ' 77' ' ' ILE . 75.8 t80 -104.32 28.28 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.269 -179.458 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 81.63 140.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -59.48 143.96 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.105 -179.755 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.867 HD21 ' HA ' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -85.51 104.98 15.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.734 179.938 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.117 -179.8 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.776 HG21 HD23 ' A' ' 17' ' ' LEU . 2.9 m . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.1 -52.97 30.5 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.543 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.69 -27.76 66.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.05 0.453 . . . . 0.0 110.138 179.115 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.867 ' HA ' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -61.22 -26.27 67.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.563 179.607 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.635 HD21 ' CD ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -52.13 -47.56 65.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 179.963 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.615 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 3.5 mp -70.8 -53.02 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.69 ' CG2' HD12 ' A' ' 77' ' ' ILE . 54.3 m -44.49 -35.78 2.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.12 0.485 . . . . 0.0 110.151 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 4' ' ' VAL . 14.3 mm -67.17 -66.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.173 178.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -55.88 -19.52 12.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 179.581 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -90.43 -35.51 15.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.649 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -69.66 -53.81 16.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.173 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.49 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 29.7 m-85 -56.04 -24.55 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.391 179.896 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.447 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 9.6 mmtm . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.802 0.334 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.44 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.66 100.65 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.639 HG13 ' HB ' ' A' ' 48' ' ' VAL . 36.3 t -90.57 161.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.686 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.591 HD13 ' CE2' ' A' ' 46' ' ' PHE . 25.8 tp -108.78 136.17 48.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG21 HD12 ' A' ' 17' ' ' LEU . 6.5 t -123.94 90.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 37' ' ' ALA . 25.4 t -89.33 104.3 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.071 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.7 142.71 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.479 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.26 48.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 0.0 111.025 -179.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.8 tp10 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.99 179.848 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.515 HG23 ' CG1' ' A' ' 6' ' ' VAL . 63.2 p . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.0 t -57.44 133.52 55.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.028 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.457 ' O ' HD12 ' A' ' 20' ' ' ILE . 7.0 t 84.95 -31.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.752 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.926 HD23 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -66.77 -59.79 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.49 -179.122 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.634 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -47.32 -49.73 23.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.623 -179.211 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.435 0.636 . . . . 0.0 110.122 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.638 HD13 HG23 ' A' ' 106' ' ' VAL . 45.4 mt -75.88 -65.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.723 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.907 HD12 HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.82 -11.47 1.01 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.172 -179.181 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.619 ' N ' HD23 ' A' ' 21' ' ' LEU . 6.0 mt-10 -88.07 -27.29 22.07 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.891 0.377 . . . . 0.0 110.155 178.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.86 -36.06 23.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.918 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.6 mp0 -76.53 -29.87 56.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.247 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.36 47.9 2.49 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.179 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.61 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.0 m-85 -103.66 -172.08 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.056 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -143.56 89.9 7.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.357 179.568 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.7 Cg_endo -80.46 137.26 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.484 2.123 . . . . 0.0 112.612 -179.377 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -99.6 -1.41 38.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.574 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.664 HG22 ' HB ' ' A' ' 6' ' ' VAL . 12.9 p 8.51 123.43 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.14 -162.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.209 178.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -117.96 -28.55 5.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.754 0.311 . . . . 0.0 111.361 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.57 -168.91 1.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.804 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.63 HD22 ' CD2' ' A' ' 63' ' ' PHE . 29.5 mt -65.06 -43.85 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.79 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -57.67 -50.79 72.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.447 179.566 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -69.42 -29.47 67.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.717 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CB ' HG21 ' A' ' 7' ' ' VAL . . . -75.51 -29.59 59.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 71.4 mt-10 -73.03 -37.37 66.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.979 0.418 . . . . 0.0 109.887 179.088 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -68.46 -35.65 77.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.167 179.223 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.16 -32.55 61.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.697 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 37' ' ' ALA . 23.9 mt -86.95 -24.67 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.183 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -25.61 8.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.228 179.997 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.92 -61.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 122.82 15.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.9 76.38 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.877 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CE2' HD13 ' A' ' 5' ' ' LEU . 55.6 m-85 -64.91 141.28 98.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.704 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 2.7 Cg_endo -84.48 -20.45 3.95 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.938 2.425 . . . . 0.0 111.81 179.382 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.67 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.6 t -146.57 133.03 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 46' ' ' PHE . 23.7 mm -116.52 157.09 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.419 HG13 HG13 ' A' ' 79' ' ' ILE . 84.3 t -149.76 97.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.156 0.503 . . . . 0.0 111.139 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HB3' HG22 ' A' ' 78' ' ' VAL . 5.4 tp -92.37 129.59 38.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.747 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -110.49 115.67 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.668 179.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 53' ' ' VAL . 4.7 m -78.52 56.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.839 -179.346 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.472 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 35.4 t-105 -63.07 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.778 179.83 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.517 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.4 ttt -147.4 44.05 0.36 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.252 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.3 Cg_endo -76.97 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.441 2.094 . . . . 0.0 112.144 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -125.27 -42.86 1.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.989 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.57 148.05 51.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -76.38 116.24 16.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.16 -30.28 63.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.604 ' O ' HD12 ' A' ' 64' ' ' ILE . 22.8 t -54.18 -44.67 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 111.514 -179.9 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.89 0.84 37.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.742 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.796 ' CE2' HD11 ' A' ' 67' ' ' ILE . 23.5 t80 -89.81 -34.0 16.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.891 0.377 . . . . 0.0 111.043 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.644 HG23 HG11 ' A' ' 76' ' ' VAL . 2.7 mp -47.74 -28.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.428 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 16.1 t0 -79.64 -32.87 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.711 179.797 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 17.2 t80 -61.87 -39.31 91.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.796 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.5 mp -63.86 -50.54 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.174 179.14 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -69.29 -26.7 64.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.404 179.205 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 17.8 tt0 -60.3 -42.51 95.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.657 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.9 18.5 13.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.9 75.12 0.48 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.337 . . . . 0.0 110.844 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -85.96 -6.71 8.46 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.202 2.601 . . . . 0.0 113.099 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -98.74 -15.62 19.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.986 0.422 . . . . 0.0 111.303 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -72.18 -153.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -179.914 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' HG13 ' A' ' 48' ' ' VAL . 47.1 t -144.48 133.59 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-O 121.335 0.588 . . . . 0.0 111.921 178.692 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.644 HG11 HG23 ' A' ' 64' ' ' ILE . 97.3 t -104.83 99.16 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.147 -179.368 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.514 HG22 HG12 ' A' ' 79' ' ' ILE . 45.8 mm -90.36 -56.41 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.755 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 44.7 t 49.4 85.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.495 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.894 HD11 ' CD1' ' A' ' 109' ' ' PHE . 2.1 mt -96.31 143.0 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.044 0.45 . . . . 0.0 111.757 -179.259 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.634 HG21 ' N ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.46 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 88' ' ' ALA . 20.9 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.888 0.375 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.494 ' O ' HG22 ' A' ' 89' ' ' VAL . 23.6 p30 -82.25 -26.85 32.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.949 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CE2' ' A' ' 99' ' ' PHE . 4.5 t -71.56 -34.78 70.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 179.392 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -56.45 -58.86 6.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.066 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 86' ' ' ASP . 35.9 m -55.08 -24.89 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.913 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 61' ' ' VAL . 12.4 ttmt -85.85 7.42 24.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.265 179.805 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.72 -41.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.618 -179.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.903 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.9 pt -65.01 -18.44 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.322 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -94.67 21.79 7.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.743 179.382 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -138.33 -51.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.48 15.08 0.07 OUTLIER Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.802 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.903 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -89.26 175.08 7.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.602 0.701 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.549 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 67.4 t80 -94.77 -14.86 24.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.62 -179.356 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 5.5 pt-20 142.87 -13.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.523 0.729 . . . . 0.0 111.163 179.275 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.755 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 73.71 131.66 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.912 0.387 . . . . 0.0 110.539 -179.67 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -91.67 155.59 18.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -179.866 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.522 179.668 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.926 HG21 HD23 ' A' ' 17' ' ' LEU . 24.5 m . . . . . 0 CA--C 1.53 0.177 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -38.34 -44.77 0.93 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.741 0.305 . . . . 0.0 111.627 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -74.01 -36.22 64.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.133 179.385 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.894 ' CD1' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -54.99 -24.16 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.696 179.278 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -65.72 -44.45 86.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.508 -179.831 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.47 ' H ' HD12 ' A' ' 111' ' ' LEU . 7.0 mp -54.98 -55.85 26.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.044 -179.647 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 98.1 m -60.82 -39.03 87.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.2 -179.872 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -45.91 -53.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.754 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.48 -61.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -56.66 -27.31 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.924 179.606 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -64.5 -42.11 96.03 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.903 0.383 . . . . 0.0 110.926 179.833 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.67 ' CE1' HG21 ' A' ' 48' ' ' VAL . 19.0 m-85 -69.5 -22.4 63.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.274 -179.964 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.202 -179.878 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.424 ' HD2' ' CD1' ' A' ' 117' ' ' PHE . 6.5 mmtt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.836 0.351 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.404 ' CG ' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -144.63 126.29 15.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.913 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 48' ' ' VAL . 24.8 t -117.72 144.37 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 110.592 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 61.7 tp -100.89 127.54 47.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.23 -179.488 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.698 HG21 ' CD1' ' A' ' 17' ' ' LEU . 29.3 t -112.71 94.99 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 179.875 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.915 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 84.4 t -85.6 117.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.505 179.596 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -159.26 149.97 19.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.947 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 25.5 t70 -70.22 -74.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.064 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.91 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.616 0.246 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -30.28 57.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.16 -61.61 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.961 -179.846 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.698 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.8 tm? -43.54 -50.8 7.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.038 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -54.27 -39.35 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.424 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.02 84.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.903 ' CD1' HG11 ' A' ' 106' ' ' VAL . 1.6 mp -56.61 -64.0 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.705 179.661 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -50.36 -35.43 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.122 0.487 . . . . 0.0 110.472 179.374 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -24.15 65.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.948 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.78 -37.62 26.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.41 179.877 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -69.61 -48.38 60.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 179.912 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.19 44.84 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 98.9 m-85 -113.74 -170.46 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 0.0 111.159 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 3' ' ' ARG . 0.7 OUTLIER -139.5 72.08 37.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.388 179.578 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 35.8 Cg_exo -57.76 136.62 76.63 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.804 2.336 . . . . 0.0 112.359 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.1 t70 -113.54 -12.95 12.82 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.694 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 29' ' ' ASP . 69.5 p 44.39 177.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.677 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.915 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -160.84 -165.51 1.4 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.374 179.771 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' HG23 ' A' ' 33' ' ' THR . 7.7 mttm -124.84 -35.27 2.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.849 0.357 . . . . 0.0 111.064 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -166.36 177.06 7.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.216 179.904 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.09 HD21 HD22 ' A' ' 51' ' ' LEU . 26.5 mt -61.06 -37.04 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.645 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -47.88 69.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.51 -31.58 72.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB2' ' CG2' ' A' ' 7' ' ' VAL . . . -69.37 -65.06 0.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.487 179.588 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -41.58 -41.23 2.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -64.43 -48.85 73.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.825 178.937 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -69.2 -25.65 64.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.543 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 37' ' ' ALA . 7.2 mt -92.43 -20.82 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.699 0.285 . . . . 0.0 111.439 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -47.53 -26.96 1.58 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.656 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.02 -51.08 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.134 -179.779 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.11 128.75 38.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.137 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -85.57 68.83 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.653 179.64 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 26.1 m-85 -65.54 122.82 82.37 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.309 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' VAL . 77.3 Cg_endo -77.21 -28.49 5.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.629 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 4' ' ' VAL . 6.3 t -140.39 125.66 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.496 -179.632 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.13 149.2 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.497 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 79' ' ' ILE . 86.8 t -141.57 96.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 179.927 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.09 HD22 HD21 ' A' ' 34' ' ' LEU . 24.2 tp -84.63 78.35 9.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.5 t0 -73.32 83.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 53' ' ' VAL . 3.4 m -63.1 109.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -108.12 -84.39 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.585 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -72.85 -43.43 8.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.327 179.428 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 55' ' ' MET . 78.7 Cg_endo -76.09 -167.9 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.338 2.025 . . . . 0.0 112.345 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -102.92 -33.01 9.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.93 50.36 68.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.398 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -96.78 32.48 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -73.71 63.59 1.9 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.341 179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -51.48 -44.63 33.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -70.98 -24.57 62.43 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.418 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.003 ' CE2' HD11 ' A' ' 67' ' ' ILE . 59.2 t80 -56.34 -46.56 79.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.288 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.708 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.3 mp -47.02 -29.04 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.108 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -37.4 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 4.4 t80 -56.43 -47.26 79.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 1.003 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -55.55 -42.78 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.585 179.605 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -78.61 -23.16 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.663 179.361 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.71 -41.63 83.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.987 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.86 12.78 13.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.246 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.88 66.87 2.07 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.66 179.792 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.59 -19.74 41.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.594 2.196 . . . . 0.0 112.029 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.2 18.18 18.13 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.3 t -99.39 -161.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.408 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 47' ' ' PRO . 21.4 t -151.22 135.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.314 0.578 . . . . 0.0 112.536 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 78' ' ' VAL . 6.1 t -102.95 90.94 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.579 -179.564 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.665 HG21 ' HE1' ' A' ' 109' ' ' PHE . 24.1 mm -101.01 36.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.219 179.283 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 76' ' ' VAL . 63.2 t -43.95 107.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.785 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 100' ' ' LEU . 4.4 mt -101.4 147.99 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.587 ' HB ' HG22 ' A' ' 53' ' ' VAL . 30.9 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.87 0.367 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 89' ' ' VAL . 46.1 t0 -94.5 -41.95 9.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.991 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -53.68 -30.91 45.72 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 121.157 0.504 . . . . 0.0 109.876 179.146 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.841 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.69 -60.14 4.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.33 179.096 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 86' ' ' ASP . 32.9 m -63.06 -25.3 38.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.579 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.82 -29.84 25.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -88.66 -39.05 14.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.906 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.8 pt -72.06 -11.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.473 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.86 -35.03 22.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.926 0.393 . . . . 0.0 110.495 179.573 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -60.03 -61.61 2.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.32 28.63 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.111 179.897 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.21 176.36 6.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.928 0.364 . . . . 0.0 110.962 179.717 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.448 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.6 t80 -101.08 29.38 4.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.779 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 78.22 138.46 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.995 179.904 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.3 m-85 -66.1 126.28 28.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.715 -179.916 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -69.9 67.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.884 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.057 -179.816 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.903 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.6 p . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.612 0.244 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -40.2 -43.26 1.63 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.587 -179.751 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.68 -41.19 88.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 0.0 110.462 179.65 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.665 ' HE1' HG21 ' A' ' 77' ' ' ILE . 6.4 t80 -59.02 -29.08 66.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.651 179.497 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.448 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -65.92 -38.37 88.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.48 -55.57 33.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.3 m -59.94 -42.65 94.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.625 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 3.9 mm -44.25 -56.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.781 -179.588 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -59.88 3.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.808 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -53.65 -27.0 24.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.936 179.508 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -68.17 -40.75 82.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.912 0.386 . . . . 0.0 110.774 179.721 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 19.6 m-85 -69.69 -24.65 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.503 -179.87 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.286 -179.895 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.442 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 6.2 mmtp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.884 0.374 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -145.93 110.21 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.502 HG13 ' HB ' ' A' ' 48' ' ' VAL . 12.2 t -95.31 149.09 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 29' ' ' ASP . 61.5 tp -111.33 137.06 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 0.0 111.288 -179.438 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.866 HG21 ' CD1' ' A' ' 17' ' ' LEU . 21.8 t -118.31 138.37 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.56 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' HD12 ' A' ' 51' ' ' LEU . 8.1 t -129.58 115.99 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.306 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.17 135.06 12.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -92.0 50.03 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.877 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.503 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 7.2 p . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.4 m -51.07 131.45 27.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.995 -179.04 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.54 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER 85.85 -31.46 0.05 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.94 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.979 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -57.06 -61.82 2.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.701 0.286 . . . . 0.0 111.126 -179.498 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.51 -64.98 0.55 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.474 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.86 -39.93 40.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.233 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.608 HG23 ' CD1' ' A' ' 110' ' ' LEU . 46.3 mt -67.68 -70.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 -179.917 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.979 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -48.06 -30.14 4.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.056 0.455 . . . . 0.0 110.368 179.507 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.84 -30.03 71.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -78.19 -39.45 40.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.076 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.815 ' HG3' HD21 ' A' ' 110' ' ' LEU . 70.5 mm-40 -79.23 -174.25 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.355 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.28 42.84 1.83 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.119 179.852 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.572 ' CE2' HG21 ' A' ' 113' ' ' ILE . 22.0 m-85 -100.8 178.95 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.491 0.662 . . . . 0.0 111.731 -179.428 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.3 85.82 60.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.762 178.458 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.684 ' HB3' HD22 ' A' ' 21' ' ' LEU . 80.6 Cg_endo -79.97 127.54 6.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.7 2.266 . . . . 0.0 114.041 -177.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.854 ' O ' HD12 ' A' ' 5' ' ' LEU . 5.1 t70 -119.14 117.32 28.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.474 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.533 HG22 ' HB ' ' A' ' 6' ' ' VAL . 27.7 p -104.08 143.3 33.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 112.061 -178.558 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.2 -167.04 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.054 179.13 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -130.82 -6.55 4.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -170.72 175.13 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.765 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 63' ' ' PHE . 87.6 mt -66.12 -32.98 74.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -70.11 -40.19 75.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.997 179.203 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.1 -36.17 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.344 179.375 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.51 -50.22 22.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.608 179.521 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 4.9 tt0 -47.22 -45.87 23.75 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.409 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -53.73 54.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.584 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 7.6 mmtp -58.0 -24.57 58.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.823 179.498 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 41' ' ' ILE . 16.4 mt -98.53 -11.77 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.589 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -73.17 -10.42 59.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.691 0.281 . . . . 0.0 111.316 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -135.78 -46.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.763 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -75.1 116.5 15.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.715 179.869 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.2 64.32 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.36 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 19.9 m-85 -58.12 119.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.092 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 46.4 Cg_endo -69.13 -45.1 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.696 2.264 . . . . 0.0 111.946 179.772 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.502 ' HB ' HG13 ' A' ' 4' ' ' VAL . 21.3 t -118.54 125.02 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.553 -179.437 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -109.26 128.29 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG21 ' CE1' ' A' ' 109' ' ' PHE . 62.0 t -123.02 104.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.061 0.457 . . . . 0.0 111.206 -179.872 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.472 HD12 ' HB ' ' A' ' 7' ' ' VAL . 36.5 tp -92.96 83.9 4.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.958 179.954 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.468 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.4 OUTLIER -72.62 75.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 -179.85 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.711 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.2 p -55.36 84.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.474 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 25.3 t-105 -86.34 -82.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.735 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.474 ' HG2' ' CD1' ' A' ' 54' ' ' TRP . 3.4 ptm -142.04 48.46 1.14 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 111.131 179.456 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 55' ' ' MET . 72.7 Cg_endo -76.31 -168.19 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.493 2.129 . . . . 0.0 112.253 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -137.59 31.27 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.76 175.35 18.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.16 93.64 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.16 65.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.652 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 64' ' ' ILE . 26.3 t -53.85 -43.6 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 111.419 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 2.75 32.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.536 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.806 ' CE2' HD11 ' A' ' 67' ' ' ILE . 20.0 t80 -89.99 -43.26 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.054 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 91' ' ' ALA . 2.3 mp -45.37 -28.84 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.652 -179.808 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -70.38 -56.06 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.579 ' HD1' HD12 ' A' ' 67' ' ' ILE . 1.5 t80 -48.57 -37.63 18.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.832 0.348 . . . . 0.0 110.557 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.806 HD11 ' CE2' ' A' ' 63' ' ' PHE . 1.5 mp -60.77 -46.44 96.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.085 179.435 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -77.31 -21.44 53.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.549 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.85 -50.6 63.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.67 12.58 21.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.379 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -158.48 66.65 3.29 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.803 0.335 . . . . 0.0 110.784 179.766 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 6.5 Cg_exo -72.72 -16.95 26.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.727 2.285 . . . . 0.0 112.205 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.71 28.41 6.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -112.07 -178.05 3.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 76' ' ' VAL . 16.4 t -119.35 162.99 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.786 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.889 HG12 HG23 ' A' ' 78' ' ' VAL . 1.7 t -137.92 83.77 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 77' ' ' ILE . 16.5 mm -91.84 48.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.889 HG23 HG12 ' A' ' 76' ' ' VAL . 34.9 t -57.42 136.31 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -134.82 -149.0 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.365 -179.506 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.711 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 111.006 179.791 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.924 0.392 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -109.54 -26.48 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.436 HG23 ' CE2' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -74.32 -32.29 62.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.909 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.724 ' HB1' ' HB2' ' A' ' 99' ' ' PHE . . . -59.79 -59.22 5.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.16 178.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -59.23 -23.47 24.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.013 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -90.74 40.58 1.02 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -170.06 -38.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -76.16 -28.68 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.947 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -31.4 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.597 179.713 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -63.76 -30.26 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.67 28.31 0.12 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.265 179.792 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.14 178.87 6.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.901 0.35 . . . . 0.0 110.808 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 47.9 t80 -97.49 28.27 3.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER 85.11 162.75 0.1 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.556 179.583 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.724 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.56 97.01 10.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.728 179.982 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 16.1 tp -55.84 160.68 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.191 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 179.796 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.941 HG21 HD23 ' A' ' 17' ' ' LEU . 3.0 m . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.4 tt0 -65.17 -51.87 58.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.338 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -60.43 -33.92 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.623 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.526 ' CE1' HD11 ' A' ' 113' ' ' ILE . 13.7 t80 -59.44 -33.4 71.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.415 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.815 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -64.03 -44.65 91.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.772 179.116 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 107' ' ' GLU . 3.9 mp -65.92 -46.47 78.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.213 -179.802 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.0 m -67.84 -41.43 82.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.423 . . . . 0.0 110.366 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.572 HG21 ' CE2' ' A' ' 26' ' ' TYR . 1.6 mm -46.96 -52.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.194 179.758 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.3 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 179.798 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -56.87 -39.93 75.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.561 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -54.52 -30.89 55.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.504 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.489 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 52.7 m-85 -91.13 -55.44 3.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.462 -179.799 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.606 -179.53 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.846 0.355 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 136.07 25.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.993 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 48' ' ' VAL . 34.4 t -128.53 150.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.984 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.019 HD23 HG23 ' A' ' 49' ' ' ILE . 24.4 tp -113.75 142.52 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.038 0.447 . . . . 0.0 111.575 -179.195 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.762 HG21 HD12 ' A' ' 17' ' ' LEU . 21.9 t -117.06 143.81 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.298 179.866 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.609 ' HB ' HD12 ' A' ' 51' ' ' LEU . 17.6 t -133.26 119.76 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.339 179.251 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 2.8 t70 -154.59 163.5 40.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.487 -179.324 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.58 49.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.0 111.104 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.715 179.706 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -45.95 142.42 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.302 -179.611 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 87.85 -36.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.768 179.799 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.081 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -71.99 -48.17 46.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 -179.968 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 p -50.74 -65.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.81 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.457 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.69 HG23 ' CD1' ' A' ' 110' ' ' LEU . 71.2 mt -63.64 -69.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.966 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.081 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -48.57 -31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 179.819 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.63 66.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.829 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.3 -34.49 31.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.763 ' HG3' HD21 ' A' ' 110' ' ' LEU . 68.4 mm-40 -77.57 -38.1 49.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.141 -179.913 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.51 43.83 3.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.052 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 9.6 m-85 -102.29 -174.93 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.218 0.533 . . . . 0.0 111.328 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.5 80.01 16.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.904 178.381 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.694 ' CB ' HD13 ' A' ' 21' ' ' LEU . 91.6 Cg_endo -84.45 131.78 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.756 2.304 . . . . 0.0 113.972 -178.088 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.477 ' O ' HD12 ' A' ' 5' ' ' LEU . 11.4 t70 -129.24 132.35 47.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.447 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.682 HG22 ' HB ' ' A' ' 6' ' ' VAL . 17.8 p -119.97 139.24 52.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.0 112.069 -178.837 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 36' ' ' GLU . . . -110.82 -165.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 179.313 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 31.3 mttt -117.65 -25.73 6.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.844 0.354 . . . . 0.0 111.228 -179.975 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -164.11 174.18 11.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.398 179.891 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.853 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.9 mt -58.63 -28.85 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.606 179.835 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -47.83 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.649 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -64.45 -35.0 79.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.374 179.263 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.39 -53.46 48.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.478 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 28.6 mt-10 -50.83 -38.98 52.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.452 179.55 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -59.89 -43.29 94.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.721 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -73.88 -47.01 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.641 179.41 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.62 -18.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -19.82 61.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.729 0.299 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.14 -50.73 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 117.38 13.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -83.42 66.26 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.751 179.825 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 5' ' ' LEU . 44.8 m-85 -58.62 135.84 86.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.963 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 7.4 Cg_endo -81.16 -35.19 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.512 2.141 . . . . 0.0 112.009 179.451 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.607 ' O ' HD13 ' A' ' 49' ' ' ILE . 18.3 t -126.69 136.3 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 179.691 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.019 HG23 HD23 ' A' ' 5' ' ' LEU . 1.6 mm -135.67 105.37 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.834 HG22 ' CG1' ' A' ' 77' ' ' ILE . 21.8 t -103.42 131.8 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.759 0.314 . . . . 0.0 110.632 179.519 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 7' ' ' VAL . 11.5 tp -99.78 146.87 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.138 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.83 106.85 9.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.415 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.454 ' C ' HG21 ' A' ' 80' ' ' THR . 23.7 t -80.95 70.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.521 -179.482 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.41 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 4.4 t-105 -72.06 -78.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.081 179.399 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.6 ptt? -149.15 48.95 0.63 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.213 179.132 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 55' ' ' MET . 14.7 Cg_endo -92.86 -159.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.164 2.576 . . . . 0.0 112.165 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -161.22 52.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.932 179.786 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.86 149.79 19.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.553 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.21 108.74 10.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.17 -18.73 48.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.903 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.727 ' O ' HD12 ' A' ' 64' ' ' ILE . 21.4 t -58.52 -58.96 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.27 -21.9 63.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.915 ' CE2' HD11 ' A' ' 67' ' ' ILE . 33.8 t80 -60.32 -40.46 90.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.5 mt -47.19 -28.33 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -74.76 -35.67 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.679 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.439 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 19.1 t80 -61.57 -45.14 95.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.323 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.915 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -58.0 -41.68 80.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 179.341 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -81.44 -23.3 37.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 179.521 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 61.7 tt0 -64.36 -31.6 72.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.361 179.476 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -132.67 16.04 4.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.923 179.944 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -169.53 73.41 0.69 Allowed Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.725 179.948 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.09 -7.35 11.12 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.093 2.529 . . . . 0.0 112.604 -179.79 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.5 -6.25 27.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.63 -179.866 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.44 -172.65 4.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 -179.768 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.437 HG11 ' HB1' ' A' ' 116' ' ' ALA . 67.2 t -127.24 144.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 -179.781 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG12 HG23 ' A' ' 78' ' ' VAL . 2.1 t -123.12 98.08 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.06 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.834 ' CG1' HG22 ' A' ' 50' ' ' VAL . 44.2 mm -73.91 -67.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.731 -179.068 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.549 HG13 HD23 ' A' ' 51' ' ' LEU . 12.2 t 63.17 98.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -98.14 -144.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.623 -179.109 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.466 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.827 0.346 . . . . 0.0 110.897 -179.796 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.64 0.257 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.6 ' O ' HG22 ' A' ' 89' ' ' VAL . 1.6 m-20 -53.28 -34.4 57.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.126 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.452 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 2.2 t -59.15 -33.95 71.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.969 0.414 . . . . 0.0 110.376 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.21 -59.11 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.248 179.355 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 86' ' ' ASP . 33.5 m -58.94 -27.52 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.056 179.499 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -80.54 -13.25 59.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.94 -35.02 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 111.736 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.891 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -77.16 -26.32 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.65 -179.484 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -66.19 -28.33 68.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.587 179.652 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -58.12 3.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.8 37.2 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -89.99 -163.77 1.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.903 179.797 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 40.1 t80 -107.99 23.37 14.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.544 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.425 ' HA ' HG21 ' A' ' 92' ' ' ILE . 0.4 OUTLIER 80.56 19.89 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.755 179.449 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 61.78 162.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 111.038 179.465 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 101' ' ' GLU . 1.1 tm? -101.02 133.28 45.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.82 ' N ' HD13 ' A' ' 100' ' ' LEU . 1.6 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.867 HG21 HD23 ' A' ' 17' ' ' LEU . 13.2 p . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.721 0.296 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -45.69 -38.17 6.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 179.877 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.53 80.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.02 179.282 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 4.7 t80 -58.52 -26.47 63.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.168 179.293 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.763 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -58.75 -49.67 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.102 179.708 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.3 -54.78 35.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.083 -179.797 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 113' ' ' ILE . 66.5 m -49.48 -57.32 7.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.878 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 11.3 mm -29.9 -63.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.64 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.436 ' HE3' ' CE1' ' A' ' 115' ' ' HIS . 4.9 tmmm? -48.91 -58.66 4.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.792 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.436 ' CE1' ' HE3' ' A' ' 114' ' ' LYS . 98.4 m-70 -53.69 -27.72 29.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.579 178.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -70.89 -42.55 69.85 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.762 179.692 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.53 ' CE1' HG21 ' A' ' 48' ' ' VAL . 24.7 m-85 -59.63 -21.48 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.0 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.943 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.907 0.384 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -153.69 133.85 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 179.88 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 48' ' ' VAL . 45.6 t -116.54 162.0 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.781 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 29' ' ' ASP . 66.8 tp -118.21 147.24 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 111.446 -179.526 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.643 HG11 HG23 ' A' ' 14' ' ' THR . 4.0 t -126.42 142.56 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.058 179.775 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 7.0 t -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.301 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 3.3 t70 -150.6 153.98 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.333 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.6 48.71 1.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.841 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.685 179.881 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.643 HG23 HG11 ' A' ' 6' ' ' VAL . 29.3 p . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.797 0.332 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 16' ' ' SER . 13.9 p -35.07 128.02 0.52 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 15' ' ' SER . 3.2 p 82.99 -43.84 0.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.222 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.893 HD13 HD11 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -53.23 -50.84 63.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 111.216 -179.566 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.69 -65.47 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.47 -40.65 18.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.757 HG23 ' CD1' ' A' ' 110' ' ' LEU . 37.4 mt -59.44 -67.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.893 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -48.74 -31.72 7.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.805 179.525 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.16 -31.63 71.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.748 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.91 -34.89 22.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.472 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.667 ' CD ' HD21 ' A' ' 110' ' ' LEU . 52.9 mm-40 -81.29 -38.39 26.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.206 -179.795 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 76.8 1.32 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.168 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 39.8 m-85 -130.65 -174.43 3.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.349 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -119.84 80.8 25.47 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.17 178.798 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 97.6 Cg_endo -84.22 135.03 6.14 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.771 2.314 . . . . 0.0 113.928 -178.335 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.804 ' O ' HD12 ' A' ' 5' ' ' LEU . 16.3 t70 -123.42 128.63 50.12 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.384 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.7 p -98.66 146.74 25.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -126.87 128.9 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.433 178.93 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 33' ' ' THR . 7.7 mttm -82.48 -10.32 59.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.65 167.11 7.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.304 179.791 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.722 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.8 mt -59.18 -22.35 60.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 110.329 179.436 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -46.2 33.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.794 178.834 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.92 -30.96 71.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.135 179.176 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.69 -56.05 5.21 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.619 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HG3' ' CE1' ' A' ' 63' ' ' PHE . 54.3 mt-10 -44.81 -43.27 8.54 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.618 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.95 -53.0 61.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.74 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 4.5 mmtt -60.6 -30.01 69.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.978 179.581 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 41' ' ' ILE . 50.9 mt -92.23 -9.29 10.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 38' ' ' GLU . 13.7 tttt -74.3 -8.64 56.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 111.027 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.36 -47.13 0.51 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -73.91 118.54 16.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.708 179.764 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -76.46 62.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.757 179.856 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.702 ' CD2' HD22 ' A' ' 5' ' ' LEU . 25.4 m-85 -55.3 116.75 12.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.77 -31.51 10.32 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.333 2.022 . . . . 0.0 112.203 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.63 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.8 t -132.16 129.87 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.587 -179.791 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.711 HD12 HD23 ' A' ' 5' ' ' LEU . 14.3 mm -118.71 144.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.185 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.481 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 60.6 t -137.23 109.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.388 -179.98 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 42.1 tp -98.28 93.13 6.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . 6.6 t0 -77.88 91.93 4.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.398 179.275 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 53' ' ' VAL . 27.9 m -62.65 79.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.793 -179.383 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -78.9 -91.05 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.249 179.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.544 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 ttm -143.36 58.72 6.79 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.639 0.257 . . . . 0.0 110.855 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.7 Cg_endo -89.51 -157.64 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.176 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -155.59 28.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.37 149.43 18.64 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 81.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.75 0.309 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.26 90.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 90' ' ' LYS . 50.8 t -62.03 -40.25 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.965 0.412 . . . . 0.0 110.909 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -15.45 62.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.39 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.903 ' CE2' HD11 ' A' ' 67' ' ' ILE . 30.4 t80 -84.33 -30.0 25.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 61' ' ' VAL . 6.4 mm -48.63 -30.57 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.092 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.3 t0 -74.14 -47.95 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.734 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.425 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 10.2 t80 -48.25 -43.52 32.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.851 0.357 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.903 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.9 mp -59.96 -47.85 90.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.421 179.438 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.85 -16.19 59.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.964 179.576 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 12.2 tt0 -73.12 -46.69 49.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.765 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.489 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -114.41 13.72 17.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.948 -179.78 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.422 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.44 65.53 2.35 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.776 179.836 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.6 Cg_exo -76.07 -13.97 19.06 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.646 2.231 . . . . 0.0 112.192 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.06 27.63 8.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -112.28 -166.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 48' ' ' VAL . 21.4 t -129.02 139.96 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.342 0.592 . . . . 0.0 111.831 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.829 HG12 HG23 ' A' ' 78' ' ' VAL . 3.0 t -128.18 89.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.08 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.8 mm -79.63 -43.03 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.857 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.829 HG23 HG12 ' A' ' 76' ' ' VAL . 59.7 t 45.17 89.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.813 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.8 mt -99.66 179.05 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.035 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.655 ' H ' HG22 ' A' ' 79' ' ' ILE . 6.6 m . . . . . 0 C--N 1.332 -0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.054 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 89' ' ' VAL . 11.4 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.798 0.332 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -75.93 -37.19 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -33.18 63.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.054 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 99' ' ' PHE . . . -60.91 -59.07 5.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.109 179.032 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 92' ' ' ILE . 14.2 m -58.9 -26.08 31.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.118 179.812 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 61' ' ' VAL . 7.5 ttmt -78.03 -4.59 47.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.244 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.71 -38.67 2.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.379 -179.911 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.924 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 6.1 pt -76.95 -41.65 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.133 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -57.95 -28.79 64.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -62.57 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 179.63 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.092 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.924 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.35 -174.7 4.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.983 0.392 . . . . 0.0 110.943 179.725 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.531 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 69.0 t80 -94.46 -23.1 17.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 11.3 pt-20 147.87 -167.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.54 0.736 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.05 107.07 10.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.708 0.29 . . . . 0.0 110.622 179.606 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.532 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -56.4 92.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.07 -179.908 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 179.951 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.84 HG21 HD23 ' A' ' 17' ' ' LEU . 18.0 m . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.05 0.452 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.58 -52.7 28.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -31.4 70.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.431 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.813 ' CD1' HD11 ' A' ' 79' ' ' ILE . 15.8 t80 -57.52 -40.95 79.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.757 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -48.43 -48.39 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.236 179.349 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mp -54.98 -45.57 75.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.399 -179.561 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -67.12 -39.8 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 2.7 mm -47.43 -55.88 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -55.62 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 110.16 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.71 69.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.81 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.582 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.86 -37.08 83.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.798 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 48' ' ' VAL . 49.0 m-85 -80.27 -28.6 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.058 179.862 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.994 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 7.5 mmtp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.867 0.365 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -121.23 139.99 52.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.284 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 48' ' ' VAL . 21.3 t -128.61 158.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 110.932 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.65 HD22 ' CD2' ' A' ' 46' ' ' PHE . 16.4 tp -117.03 131.83 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.651 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.751 HG21 HD12 ' A' ' 17' ' ' LEU . 25.4 t -115.81 89.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.201 179.866 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.92 103.16 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.757 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.81 137.63 45.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.782 -179.769 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.07 48.65 1.67 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.042 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.542 ' HB ' HG21 ' A' ' 30' ' ' THR . 10.2 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.54 0.209 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -80.13 -43.33 21.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.283 . . . . 0.0 111.146 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -60.23 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.209 -179.673 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.751 HD12 HG21 ' A' ' 6' ' ' VAL . 2.3 tm? -46.9 -50.95 17.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.088 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -56.67 -48.91 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.572 179.75 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.24 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.684 ' CD1' HG11 ' A' ' 106' ' ' VAL . 57.0 mt -57.41 -66.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.822 179.755 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.02 -35.43 11.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.139 0.495 . . . . 0.0 110.468 179.615 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.51 -28.22 69.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.84 -35.18 38.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.079 179.469 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -4.63 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.487 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.39 56.38 1.57 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.383 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-85 -128.41 -176.16 3.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 3' ' ' ARG . 4.1 t60 -138.9 70.8 42.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.76 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 34.9 Cg_exo -60.15 142.3 98.02 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.821 2.347 . . . . 0.0 112.581 -179.678 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -121.64 2.97 10.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.398 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.712 HG22 ' HB ' ' A' ' 6' ' ' VAL . 13.7 p 9.86 122.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.996 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.22 -164.22 1.02 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.436 178.631 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 33' ' ' THR . 9.6 ttmt -118.47 -30.2 5.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.122 -179.754 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -170.25 -172.71 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.668 179.96 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.775 HD22 ' CD2' ' A' ' 63' ' ' PHE . 29.8 mt -65.86 -49.5 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.516 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.84 -48.83 80.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.447 . . . . 0.0 109.852 179.195 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.1 -30.8 71.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.17 179.144 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HB1' HD11 ' A' ' 41' ' ' ILE . . . -71.41 -62.92 1.23 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.253 179.337 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 22.7 mt-10 -41.88 -39.93 1.97 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -49.24 73.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 178.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -68.19 -32.39 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.148 179.8 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.402 HD11 ' HB1' ' A' ' 37' ' ' ALA . 11.5 mt -86.34 -15.79 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -24.29 6.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.548 -179.741 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -122.41 -55.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 129.03 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.21 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -92.03 86.41 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.528 179.621 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.65 ' CD2' HD22 ' A' ' 5' ' ' LEU . 49.8 m-85 -79.32 119.31 76.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.508 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 59.7 Cg_endo -73.54 -19.45 21.66 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.474 2.116 . . . . 0.0 111.974 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.636 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.2 t -143.44 130.15 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.724 -179.911 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 46' ' ' PHE . 10.7 mm -118.59 156.19 20.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 179.54 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.7 t -146.31 102.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.494 . . . . 0.0 110.679 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.443 ' CD2' ' HA3' ' A' ' 60' ' ' GLY . 57.0 tp -90.09 91.1 8.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.42 92.3 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.857 178.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.704 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.4 m -64.5 72.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.14 -179.006 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 25.5 t-105 -73.39 -77.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.361 . . . . 0.0 110.324 179.35 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.483 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.2 ttm -162.23 61.99 1.29 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.4 Cg_endo -84.61 -155.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.068 2.512 . . . . 0.0 112.216 -179.825 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.82 -42.2 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.93 177.55 53.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.07 127.77 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' CD2' ' A' ' 51' ' ' LEU . . . -79.16 -1.55 85.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.989 -179.969 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.9 ' O ' HD12 ' A' ' 64' ' ' ILE . 45.8 t -61.49 -59.75 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.989 -179.922 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.4 -21.5 62.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.512 -179.856 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.775 ' CD2' HD22 ' A' ' 34' ' ' LEU . 14.0 t80 -61.33 -36.7 80.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.468 -179.565 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.6 mt -47.64 -27.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.285 -179.853 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.56 -40.91 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 38' ' ' GLU . 17.6 t80 -57.25 -43.02 82.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.469 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.674 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.9 mp -61.41 -42.78 95.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 179.417 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -18.85 56.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.326 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.48 -42.33 68.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.551 179.701 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.93 14.15 15.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.068 -179.843 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.74 67.65 1.59 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.847 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.84 -20.24 39.67 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.673 2.249 . . . . 0.0 112.232 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -104.12 35.67 2.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.747 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -111.79 -157.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.798 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -154.53 137.94 7.95 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 111.659 179.498 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.883 HG12 HG23 ' A' ' 78' ' ' VAL . 2.5 t -117.43 100.26 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.335 -179.478 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 97' ' ' TYR . 36.1 mm -82.68 -51.12 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.737 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.883 HG23 HG12 ' A' ' 76' ' ' VAL . 78.0 t 52.37 96.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.644 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -106.12 -155.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.085 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.704 ' HB ' HG22 ' A' ' 53' ' ' VAL . 8.3 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 179.918 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.1 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.872 0.368 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.05 -24.65 12.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -82.49 -38.69 23.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.019 0.437 . . . . 0.0 109.944 179.292 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.863 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.31 -57.38 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.142 178.991 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HA ' HG12 ' A' ' 92' ' ' ILE . 13.1 m -58.01 -28.95 35.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.289 179.702 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HD3' HG21 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -78.9 -15.86 57.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.626 -179.694 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.87 -33.86 6.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 -179.546 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.904 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.2 pt -79.3 -34.99 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.263 -179.554 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -31.26 71.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.781 179.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.2 32.91 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.859 -179.956 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.16 -165.3 1.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 110.998 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.632 ' HB3' HD13 ' A' ' 77' ' ' ILE . 26.0 t80 -114.16 27.14 9.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 -179.787 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 76.01 141.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.09 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -66.0 118.33 9.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 -179.707 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -59.05 129.14 40.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.883 179.703 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 -179.993 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.684 HG11 ' CD1' ' A' ' 20' ' ' ILE . 9.5 p . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.558 0.218 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -38.02 -38.46 0.32 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.823 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -70.82 -41.65 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.482 . . . . 0.0 110.494 179.642 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.542 ' CZ ' HD11 ' A' ' 79' ' ' ILE . 6.2 t80 -57.38 -30.43 64.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.802 179.528 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.626 HD11 ' CG2' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -59.18 -43.77 92.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.505 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mp -53.66 -52.29 60.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.829 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.566 HG23 ' HE2' ' A' ' 97' ' ' TYR . 99.3 m -59.61 -40.98 89.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.777 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.617 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 4.6 mm -49.78 -57.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.634 -179.634 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.58 -63.4 1.1 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -50.81 -27.35 7.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.821 179.31 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -66.88 -39.96 87.64 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.927 0.394 . . . . 0.0 110.479 179.432 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.636 ' CE1' HG21 ' A' ' 48' ' ' VAL . 23.1 m-85 -71.88 -30.03 64.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.233 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.368 -179.686 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.685 ' NH1' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -164.33 125.42 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 -179.906 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.634 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.5 t -114.64 143.56 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.862 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.682 HD23 HD12 ' A' ' 49' ' ' ILE . 59.6 tp -93.95 129.63 40.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.808 -179.875 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.822 HG21 ' CD1' ' A' ' 17' ' ' LEU . 17.5 t -115.44 104.71 17.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.797 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 42.4 t -91.6 124.07 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -168.9 157.75 8.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 -179.839 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -89.56 49.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.168 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.721 179.807 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.484 ' CG2' HG11 ' A' ' 6' ' ' VAL . 71.5 p . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -52.94 136.68 34.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.695 -179.213 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 84.77 -36.55 0.05 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.08 179.442 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.927 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -59.74 -52.64 64.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 -179.582 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -45.63 -67.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.588 -179.488 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.33 -40.58 35.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.495 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.656 ' CD1' HG23 ' A' ' 106' ' ' VAL . 60.0 mt -65.88 -67.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.37 -179.717 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.927 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.926 0.394 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.55 -31.32 66.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 tt0 -85.0 -36.04 21.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.513 179.716 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.649 ' CD ' HD21 ' A' ' 110' ' ' LEU . 78.5 mm-40 -78.16 -39.13 41.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.918 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.43 30.28 5.98 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.632 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.411 ' HB2' HD23 ' A' ' 21' ' ' LEU . 40.1 m-85 -89.6 -175.56 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.2 OUTLIER -140.06 94.84 8.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 179.81 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.702 ' HG3' HD13 ' A' ' 21' ' ' LEU . 72.1 Cg_endo -77.45 134.2 13.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.501 2.134 . . . . 0.0 112.818 -179.514 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.9 t0 -103.66 -12.01 17.3 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.414 0.626 . . . . 0.0 111.618 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' ASP . 71.5 p 44.07 175.3 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.832 179.353 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.797 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -158.75 -166.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.438 179.833 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 33' ' ' THR . 22.9 mtpt -129.48 -37.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 32' ' ' LYS . 4.2 p -163.07 178.24 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.304 179.828 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.743 HD22 ' CD2' ' A' ' 63' ' ' PHE . 85.6 mt -62.36 -41.45 98.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 110.536 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.96 48.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 178.962 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.79 -29.63 70.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.205 179.036 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -75.33 -22.04 57.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.946 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 13.9 mt-10 -75.46 -41.52 55.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.897 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.3 -37.38 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.061 178.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -72.52 -30.07 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 37' ' ' ALA . 36.9 mt -89.44 -23.13 6.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.906 179.671 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -81.07 -0.29 39.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 179.941 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -117.36 -41.33 2.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.681 179.789 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.685 HD11 ' NH1' ' A' ' 3' ' ' ARG . 0.3 OUTLIER -116.26 156.03 27.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.174 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.421 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 8.1 t80 -96.55 94.95 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.726 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.626 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 26.3 m-85 -78.18 124.8 85.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.72 -29.33 8.86 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.402 2.068 . . . . 0.0 111.928 179.616 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.634 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.7 t -142.86 129.01 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.446 -179.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.682 HD12 HD23 ' A' ' 5' ' ' LEU . 26.8 mm -111.71 151.31 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.91 179.124 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.46 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 46.6 t -144.19 100.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.0 111.752 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HB3' HG13 ' A' ' 78' ' ' VAL . 7.2 tp -75.28 175.02 8.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.038 179.339 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.631 ' C ' HG22 ' A' ' 80' ' ' THR . 2.6 t70 -146.41 -52.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.568 -179.543 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 53' ' ' VAL . 61.5 t 61.82 50.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.052 0.454 . . . . 0.0 110.47 -179.562 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -71.16 -82.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.799 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.514 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -76.06 -48.64 3.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 55' ' ' MET . 96.7 Cg_endo -77.73 -173.18 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.436 2.091 . . . . 0.0 112.619 -179.518 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HA ' HG13 ' A' ' 53' ' ' VAL . 67.4 m-20 -158.28 47.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.671 179.844 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.03 166.77 3.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.656 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -82.97 74.05 9.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.26 -22.39 36.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.692 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 90' ' ' LYS . 32.7 t -54.26 -41.7 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 111.496 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.35 4.96 44.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.743 ' CD2' HD22 ' A' ' 34' ' ' LEU . 8.0 t80 -90.03 -37.07 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.58 0.229 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -45.15 -44.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.908 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.84 -47.45 83.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 42.5 t80 -55.22 -31.46 61.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.005 179.244 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.834 HG21 HG22 ' A' ' 76' ' ' VAL . 3.8 mm -66.25 -53.42 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.184 179.145 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -71.93 -19.98 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.369 179.206 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.432 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 20.0 tt0 -67.08 -50.0 63.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.538 179.588 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.475 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -113.98 19.67 16.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.135 -179.812 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.35 67.92 1.05 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.42 -16.03 22.0 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.781 2.321 . . . . 0.0 112.302 -179.898 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.61 31.12 6.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -112.99 -159.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.523 ' HB ' HG13 ' A' ' 48' ' ' VAL . 52.6 t -148.07 135.68 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.371 0.605 . . . . 0.0 112.251 179.453 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.834 HG22 HG21 ' A' ' 67' ' ' ILE . 24.7 t -105.44 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.514 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 97' ' ' TYR . 16.6 mm -120.23 44.25 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.997 179.677 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.636 HG23 HG12 ' A' ' 76' ' ' VAL . 57.4 t -46.52 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.665 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.638 HG23 ' HB3' ' A' ' 100' ' ' LEU . 20.8 mt -74.2 -107.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.35 -179.639 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.631 HG22 ' C ' ' A' ' 52' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.65 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.715 0.293 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.87 -8.55 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.473 179.997 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.42 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -81.62 -33.64 31.34 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.067 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.819 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.74 -57.65 11.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.125 178.998 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.62 -22.64 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.538 ' O ' HG13 ' A' ' 61' ' ' VAL . 5.1 ttmt -91.29 25.89 2.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.874 0.369 . . . . 0.0 110.772 179.606 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.2 -40.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.818 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.931 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.3 pt -71.86 -43.91 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.172 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 2.2 ttmt -63.13 -22.77 67.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -71.65 -28.37 63.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.076 179.901 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.01 -19.7 0.35 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.32 179.971 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.73 176.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.001 0.401 . . . . 0.0 111.318 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.704 ' HE2' HG23 ' A' ' 112' ' ' THR . 32.5 t80 -98.98 28.5 4.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.477 -179.582 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.518 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 79.82 147.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.135 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.1 m-85 -73.85 139.89 45.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.082 -179.72 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.638 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -90.32 130.23 36.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.545 179.708 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.532 ' N ' HD13 ' A' ' 100' ' ' LEU . 9.6 mt-10 . . . . . 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.814 HG21 HD23 ' A' ' 17' ' ' LEU . 33.5 m . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -40.87 -47.36 2.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.819 0.342 . . . . 0.0 111.281 -179.856 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -68.93 -36.11 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.0 110.011 179.188 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.61 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 1.9 t80 -56.53 -23.54 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 179.229 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.649 HD21 ' CD ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -63.64 -43.76 95.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.353 179.937 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.8 mp -54.27 -57.06 12.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 -179.739 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.704 HG23 ' HE2' ' A' ' 97' ' ' TYR . 97.3 m -57.71 -43.25 85.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.61 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -44.35 -53.38 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.786 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.08 -61.6 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -53.64 -28.24 31.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -65.17 -41.47 94.63 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 45.3 m-85 -79.66 -29.78 41.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 179.974 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 3.8 mmtm . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.459 ' HA ' ' H ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -117.62 141.5 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 179.989 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 48' ' ' VAL . 41.3 t -126.66 159.87 35.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.942 HD22 ' CD2' ' A' ' 46' ' ' PHE . 35.4 tp -113.12 129.26 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.079 -179.901 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.696 ' HB ' HG22 ' A' ' 30' ' ' THR . 23.5 t -115.62 89.95 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.517 179.916 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 t -83.56 103.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.9 140.2 42.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.435 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 33.6 t70 -88.45 27.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.508 -179.865 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HG3' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.809 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.704 0.288 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.18 -43.41 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.4 -57.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.676 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.8 tm? -46.21 -56.87 5.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -52.86 -45.11 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.769 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.13 96.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.67 179.58 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.771 ' CD1' HG11 ' A' ' 106' ' ' VAL . 5.9 mt -57.59 -65.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.65 -32.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.731 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.26 -29.61 69.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -79.27 -34.4 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 109.887 179.441 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.788 ' HG3' HD21 ' A' ' 110' ' ' LEU . 53.4 mm-40 -77.52 -12.11 59.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.114 179.722 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.06 62.71 1.16 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.892 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.46 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 46.3 m-85 -127.22 -172.69 2.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 111.38 -179.319 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.459 ' H ' ' HA ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -135.9 68.43 64.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.498 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 27.1 Cg_exo -60.74 131.09 35.86 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.641 2.227 . . . . 0.0 111.952 179.952 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -109.6 3.31 20.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.266 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.696 HG22 ' HB ' ' A' ' 6' ' ' VAL . 8.7 p 1.87 123.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.74 -162.46 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.487 178.836 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -114.93 -31.63 6.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.16 -168.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.686 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.604 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -63.95 -45.38 89.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -50.68 72.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.259 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.76 -29.64 67.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.49 179.422 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.63 -26.31 54.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.95 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 30.8 mt-10 -74.74 -38.47 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.073 0.463 . . . . 0.0 109.931 179.124 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.65 77.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.903 179.036 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -74.67 -35.64 62.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.676 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.519 HD12 ' O ' ' A' ' 37' ' ' ALA . 28.5 mt -84.11 -21.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -18.65 59.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.279 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -129.02 -44.82 1.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.13 120.6 25.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 71' ' ' SER . 52.1 t80 -83.27 88.66 6.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.718 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.942 ' CD2' HD22 ' A' ' 5' ' ' LEU . 20.1 m-85 -79.23 133.37 60.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 9.3 Cg_endo -84.55 -20.4 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.815 2.344 . . . . 0.0 111.947 179.204 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.646 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -145.25 131.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.59 HG23 HD23 ' A' ' 5' ' ' LEU . 5.1 mm -119.04 156.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.483 179.609 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -146.86 101.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 110.764 179.787 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.729 ' HB3' HG13 ' A' ' 78' ' ' VAL . 59.8 tp -88.94 108.14 19.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.825 -179.255 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.06 91.32 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.141 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.699 HG22 ' HB ' ' A' ' 80' ' ' THR . 33.4 m -67.47 68.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.727 -179.154 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.45 ' CG ' ' N ' ' A' ' 55' ' ' MET . 29.0 t90 -67.16 -96.97 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.208 179.426 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.541 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -129.36 41.62 0.76 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.471 0.177 . . . . 0.0 111.27 179.361 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 55' ' ' MET . 91.6 Cg_endo -80.38 -165.98 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.52 2.147 . . . . 0.0 112.286 179.949 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -150.02 46.91 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.85 -179.35 16.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -104.83 95.42 5.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.97 -30.56 63.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 90' ' ' LYS . 21.8 t -56.19 -44.74 80.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.352 -179.93 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 1.89 35.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.507 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 67' ' ' ILE . 11.9 t80 -88.5 -36.37 16.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.801 0.334 . . . . 0.0 111.098 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -47.5 -29.33 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.147 -179.936 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -78.38 -35.62 47.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.637 179.708 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.423 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 9.0 t80 -58.64 -41.53 86.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.709 HG21 HG22 ' A' ' 76' ' ' VAL . 3.0 mp -61.58 -45.74 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.376 179.5 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -76.63 -20.16 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.75 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.59 -42.25 78.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.828 179.749 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.39 15.4 12.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.193 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.419 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -163.48 67.75 1.66 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.809 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.39 -20.39 36.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.737 2.291 . . . . 0.0 112.232 -179.93 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -103.13 28.02 6.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.79 179.774 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 t -107.56 -156.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.363 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -153.91 137.66 8.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.996 0.426 . . . . 0.0 111.406 179.114 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.784 HG12 HG23 ' A' ' 78' ' ' VAL . 13.1 t -119.85 108.46 23.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.373 -179.257 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mm -93.16 -53.7 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.784 HG23 HG12 ' A' ' 76' ' ' VAL . 24.6 t 54.31 94.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 179.702 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.678 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -94.8 -157.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 179.679 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.699 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.4 m . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.877 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 85' ' ' VAL . 15.7 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.778 0.323 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -95.6 -15.51 22.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 179.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.15 -34.89 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.112 0.482 . . . . 0.0 109.734 179.104 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.16 -58.54 8.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.117 178.895 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.483 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.7 m -57.53 -28.99 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.575 ' O ' HG13 ' A' ' 61' ' ' VAL . 1.5 ttmp? -75.44 -6.61 50.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.442 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.77 -44.33 1.95 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 111.387 -179.772 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.789 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.4 pt -67.89 155.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.924 -179.723 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.454 ' CG ' HG13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER 81.46 -47.27 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 -179.148 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -65.13 -16.83 63.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.495 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.23 -29.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.791 -179.955 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -74.5 176.31 6.95 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 111.31 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 13.4 t80 -102.16 -8.95 20.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.048 -179.983 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 8.5 pt-20 137.03 172.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.778 0.831 . . . . 0.0 110.181 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.552 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -103.67 96.77 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.616 179.687 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 79' ' ' ILE . 13.1 tp -54.98 90.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.282 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.296 -179.84 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.771 HG11 ' CD1' ' A' ' 20' ' ' ILE . 7.6 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.702 0.287 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -36.07 -44.76 0.39 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.126 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -42.36 84.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 0.0 110.734 179.798 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' VAL . 8.4 t80 -53.59 -30.88 44.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.889 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.788 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -56.55 -44.2 80.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.3 -179.972 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mp -56.7 -55.16 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.33 -179.701 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.9 m -56.37 -41.85 76.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.409 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.1 mm -44.62 -54.48 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 -179.506 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -48.35 -61.31 2.07 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -48.18 -31.87 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.749 179.287 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -63.56 -36.47 83.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.978 0.418 . . . . 0.0 110.504 179.417 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.646 ' CE1' HG21 ' A' ' 48' ' ' VAL . 48.6 m-85 -83.77 -28.29 28.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 179.853 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.428 -179.809 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.871 0.367 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 12.5 mmtm -120.98 124.15 44.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.982 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.62 127.74 14.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 48' ' ' VAL . 61.3 t -126.15 163.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 29' ' ' ASP . 55.4 tp -121.28 134.95 55.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.015 0.436 . . . . 0.0 111.671 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.811 HG21 ' CD1' ' A' ' 17' ' ' LEU . 12.8 t -119.41 128.23 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.127 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.434 ' HB ' HD12 ' A' ' 51' ' ' LEU . 11.9 t -119.56 125.82 74.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.993 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.0 t0 -162.1 145.86 12.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.653 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.32 51.69 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.871 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 12.4 pt-20 -173.58 127.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.072 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 58.82 160.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.049 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -69.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.553 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.645 ' HA ' HG21 ' A' ' 30' ' ' THR . 9.7 mm -96.96 164.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 13' ' ' ILE . 53.3 p -89.25 130.86 35.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.354 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.87 133.18 22.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.199 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.403 ' CB ' ' HA ' ' A' ' 105' ' ' SER . 11.7 m 78.77 -14.31 0.88 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.653 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.969 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -76.77 -54.79 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.942 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.41 -64.27 0.76 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.519 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.98 -40.76 31.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.197 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.835 HG23 ' CD1' ' A' ' 110' ' ' LEU . 56.0 mt -63.14 -67.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.218 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.969 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -49.44 -31.14 9.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 110.851 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.61 -27.47 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.879 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.47 -34.91 27.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.317 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.814 ' CG ' HD21 ' A' ' 110' ' ' LEU . 21.8 mm-40 -80.38 -36.28 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.051 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.4 49.76 2.52 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.066 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 3.8 m-85 -103.8 -174.61 2.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.326 0.584 . . . . 0.0 111.429 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.13 77.13 76.95 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.938 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.647 ' HG3' HD13 ' A' ' 21' ' ' LEU . 97.3 Cg_endo -85.79 142.78 8.03 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.836 2.358 . . . . 0.0 113.851 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.884 ' O ' HD12 ' A' ' 5' ' ' LEU . 8.6 t0 -123.67 120.33 32.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.145 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.645 HG21 ' HA ' ' A' ' 13' ' ' ILE . 47.5 p -100.81 139.86 35.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.11 0.481 . . . . 0.0 112.011 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.48 -164.37 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.228 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 2.4 mttt -134.65 -7.67 2.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.36 -172.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 0.0 110.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.785 HD11 ' O ' ' A' ' 59' ' ' ASP . 96.3 mt -78.64 -28.73 45.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.473 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.49 -41.64 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -34.0 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.233 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.68 ' C ' HD12 ' A' ' 41' ' ' ILE . . . -73.51 -52.39 13.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.751 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 42' ' ' LYS . 41.3 mt-10 -46.38 -45.08 17.58 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.525 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -53.35 58.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -61.86 -23.9 66.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.075 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 ' C ' ' A' ' 37' ' ' ALA . 5.5 mt -95.82 -14.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.688 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 1.2 tmtt? -78.83 -5.32 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.645 0.26 . . . . 0.0 111.48 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -136.96 -49.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.901 0.382 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.32 116.29 16.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.783 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -74.75 64.12 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.518 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 22.9 m-85 -58.35 122.08 56.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.087 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 10.8 Cg_exo -66.1 -50.05 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.468 2.112 . . . . 0.0 112.277 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 4' ' ' VAL . 35.8 t -116.85 127.11 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.671 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 14.6 mm -113.81 127.69 71.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.273 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.861 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 84.7 t -124.3 105.93 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.81 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 78' ' ' VAL . 4.9 tp -93.52 145.36 24.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.711 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' HA ' ' HG1' ' A' ' 80' ' ' THR . 2.7 t70 -110.33 178.66 4.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.115 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.603 HG22 ' CB ' ' A' ' 80' ' ' THR . 4.8 m -149.52 42.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.155 0.502 . . . . 0.0 111.527 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 10' ' ' GLU . 57.6 t-105 -49.9 -90.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 25.6 ttp -149.6 50.84 0.83 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.312 . . . . 0.0 111.072 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 55' ' ' MET . 73.0 Cg_endo -75.95 -168.29 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.487 2.125 . . . . 0.0 112.281 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -145.4 39.77 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -139.26 20.86 2.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.647 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.785 ' O ' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER 62.07 -159.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.612 0.244 . . . . 0.0 110.488 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.11 -39.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.641 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.753 HG21 ' HD3' ' A' ' 90' ' ' LYS . 40.3 t -56.85 -42.1 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.059 0.457 . . . . 0.0 110.756 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -20.24 64.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.674 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.964 ' CE2' HD11 ' A' ' 67' ' ' ILE . 36.0 t80 -80.53 -33.32 36.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 61' ' ' VAL . 4.6 mm -47.03 -29.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.81 0.338 . . . . 0.0 111.154 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -75.17 -47.54 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 12.2 t80 -50.02 -42.47 49.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.319 . . . . 0.0 110.849 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.964 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.2 mp -60.6 -44.04 95.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.351 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -80.31 -17.45 52.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.807 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.441 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 31.6 tt0 -71.4 -46.7 59.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.495 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -112.49 7.51 19.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.186 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.426 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -154.63 65.38 4.79 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 110.656 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 71' ' ' SER . 2.7 Cg_exo -74.65 -15.59 21.58 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.683 2.255 . . . . 0.0 112.103 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -97.48 -9.47 27.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.216 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t -80.36 -173.95 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.584 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.683 HG21 ' HB1' ' A' ' 116' ' ' ALA . 31.1 t -120.5 157.23 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.094 0.473 . . . . 0.0 111.217 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.597 HG12 HG23 ' A' ' 78' ' ' VAL . 1.1 t -143.19 89.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.093 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.838 HD13 ' HB3' ' A' ' 97' ' ' TYR . 21.5 mm -80.5 -45.35 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.597 HG23 HG12 ' A' ' 76' ' ' VAL . 58.5 t 54.99 101.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.791 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 77' ' ' ILE . 7.7 mt -133.1 145.69 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.763 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.603 ' CB ' HG22 ' A' ' 53' ' ' VAL . 14.5 m -166.53 163.63 17.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.832 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.442 ' N ' HG22 ' A' ' 80' ' ' THR . . . -120.72 34.59 4.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.47 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -156.4 101.34 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 110.84 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 166.57 -110.31 0.4 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 87' ' ' THR . 31.1 t -174.39 154.14 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.91 -26.27 27.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.253 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.5 -12.93 62.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -82.5 -35.46 27.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.09 0.471 . . . . 0.0 109.798 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.09 -57.56 12.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.137 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.987 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.753 ' HD3' HG21 ' A' ' 61' ' ' VAL . 12.7 ttmt -89.75 39.92 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.019 0.438 . . . . 0.0 110.554 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.24 -42.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.9 pt -71.25 -28.08 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.263 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.53 19.83 6.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -0.63 8.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.483 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 132.91 11.5 1.84 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.575 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.956 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.13 -168.67 2.18 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.252 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.838 ' HB3' HD13 ' A' ' 77' ' ' ILE . 17.8 t80 -116.22 27.39 9.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.344 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.476 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 79.29 141.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.579 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -67.45 129.3 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.124 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.688 HD11 ' HB3' ' A' ' 108' ' ' ARG . 0.2 OUTLIER -71.42 106.42 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.05 69.25 4.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.444 ' HB3' ' HZ3' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -179.49 58.7 0.1 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.813 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.64 176.03 9.91 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.563 2.176 . . . . 0.0 112.407 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.433 ' CE2' ' HA3' ' A' ' 81' ' ' GLY . 60.4 m-85 58.92 38.11 24.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 0.9 OUTLIER 171.7 -28.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.394 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.72 HG21 HD23 ' A' ' 17' ' ' LEU . 3.1 m 41.12 28.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.3 -47.52 79.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.688 ' HB3' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -63.69 -34.14 77.2 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.861 ' CZ ' HG21 ' A' ' 50' ' ' VAL . 8.3 t80 -56.75 -35.26 68.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.366 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.835 ' CD1' HG23 ' A' ' 20' ' ' ILE . 1.4 tt -56.85 -53.3 59.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.031 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.98 -42.61 94.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.534 HG23 ' HE2' ' A' ' 97' ' ' TYR . 87.7 m -64.83 -40.42 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.883 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.655 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.6 mm -44.11 -52.68 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.785 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.55 -56.8 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.321 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -60.48 -32.47 71.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.683 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.57 -39.04 82.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.548 ' CE1' HG21 ' A' ' 48' ' ' VAL . 39.2 m-85 -77.78 -13.2 59.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.43 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -55.91 -30.75 62.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.798 0.332 . . . . 0.0 111.248 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 82.6 mm-40 -75.24 -6.48 49.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.447 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -140.83 24.72 2.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.97 179.918 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.765 0.316 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 32.3 mmtp 59.66 -170.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.949 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 3.5 mpt_? 64.64 108.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.8 t -123.22 159.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.911 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.709 HD23 HG23 ' A' ' 49' ' ' ILE . 42.9 tp -115.43 135.17 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.847 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.701 ' HB ' HG22 ' A' ' 30' ' ' THR . 17.2 t -117.53 89.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.696 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.47 107.55 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.381 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -143.17 140.73 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 111.301 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 34.9 t0 -64.04 -70.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -81.47 -174.38 4.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.974 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -114.18 69.38 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -108.63 -49.48 3.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.583 HG22 ' CB ' ' A' ' 17' ' ' LEU . 38.9 mm -82.36 -41.44 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p -56.26 -22.06 27.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.317 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.34 -43.01 67.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.2 p -101.81 -53.2 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.328 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.75 ' CD1' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -47.84 -51.84 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.081 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.726 ' HA ' HD12 ' A' ' 21' ' ' LEU . 46.0 m -50.68 -46.61 58.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.773 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.07 91.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.777 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.717 ' CD1' HG13 ' A' ' 106' ' ' VAL . 17.1 mt -55.99 -59.92 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.532 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.019 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -46.9 -40.23 13.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.854 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.22 -27.96 69.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.987 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -80.09 -34.73 37.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.982 0.42 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.759 ' HG3' HD21 ' A' ' 110' ' ' LEU . 66.2 mm-40 -76.71 -24.73 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.56 28.38 6.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.416 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 59.9 m-85 -98.93 -175.86 3.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -134.56 90.0 24.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 1.019 ' HB3' HD13 ' A' ' 21' ' ' LEU . 74.4 Cg_endo -78.8 132.64 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.432 2.088 . . . . 0.0 112.873 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -108.78 6.0 25.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.235 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.701 HG22 ' HB ' ' A' ' 6' ' ' VAL . 14.3 p 4.33 122.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.83 -164.17 1.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.925 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 33' ' ' THR . 13.2 tttt -115.1 -40.08 3.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 32' ' ' LYS . 12.7 p -159.23 -173.95 4.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.466 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.746 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -65.64 -45.34 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.617 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -61.67 -48.65 79.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.074 0.464 . . . . 0.0 109.749 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.06 -32.22 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.01 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -70.55 -29.77 66.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.699 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 17.6 mt-10 -68.58 -44.27 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -36.28 78.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.106 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -74.12 -43.03 59.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.491 HD12 ' O ' ' A' ' 37' ' ' ALA . 10.9 mt -73.61 -24.17 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -51.58 -25.89 7.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.277 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -124.37 -58.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.096 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.75 123.64 18.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.04 79.93 8.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.628 ' CE2' HD13 ' A' ' 5' ' ' LEU . 33.0 m-85 -73.94 116.34 51.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.025 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.549 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 74.0 Cg_endo -73.2 -16.16 25.23 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.524 2.149 . . . . 0.0 111.816 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.5 t -147.23 132.29 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.709 HG23 HD23 ' A' ' 5' ' ' LEU . 10.2 mm -118.18 159.96 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.11 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.403 HG13 HG13 ' A' ' 79' ' ' ILE . 62.1 t -147.97 97.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.252 0.548 . . . . 0.0 110.93 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 78' ' ' VAL . 58.7 tp -80.39 130.03 34.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.468 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.62 89.71 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.033 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.715 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.8 m -67.31 66.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.875 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 69.3 t-105 -69.86 -96.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.195 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.604 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -134.66 32.16 0.21 Allowed Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.8 Cg_endo -81.97 -165.18 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.106 1.871 . . . . 0.0 112.236 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -116.29 28.54 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.866 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' CA ' HD12 ' A' ' 34' ' ' LEU . . . -85.07 -99.49 0.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.499 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 56.91 46.39 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.984 0.421 . . . . 0.0 110.773 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.93 103.81 2.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.907 ' O ' HD12 ' A' ' 64' ' ' ILE . 48.1 t -61.07 -40.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 0.0 110.828 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -13.01 61.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.362 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 67' ' ' ILE . 35.6 t80 -54.3 -39.23 66.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.686 0.279 . . . . 0.0 111.265 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.5 mt -50.01 -29.8 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' GLU . 1.5 t0 -75.81 -34.19 60.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 51.4 t80 -59.56 -47.48 85.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.015 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.873 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -58.34 -43.7 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.398 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -77.03 -22.85 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.699 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 65' ' ' ASP . 42.3 tt0 -65.0 -34.23 77.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -129.55 18.65 5.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.853 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.91 75.6 0.66 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.2 -8.08 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.162 2.575 . . . . 0.0 112.733 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' OD2' ' CE2' ' A' ' 120' ' ' TYR . 5.8 t0 -107.31 12.96 27.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.459 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.23 -160.15 0.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.98 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HB ' HG13 ' A' ' 48' ' ' VAL . 26.3 t -148.94 134.42 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 120.848 0.356 . . . . 0.0 111.47 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.915 HG12 HG23 ' A' ' 78' ' ' VAL . 23.9 t -115.01 109.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.575 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.727 HD13 ' HB3' ' A' ' 97' ' ' TYR . 31.7 mm -90.36 -51.06 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.956 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.915 HG23 HG12 ' A' ' 76' ' ' VAL . 30.1 t 54.21 97.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.74 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -102.68 -170.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.315 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.74 ' H ' HG22 ' A' ' 79' ' ' ILE . 2.8 m 74.98 114.25 0.06 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.342 . . . . 0.0 110.878 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.12 75.51 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.431 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.13 -54.29 3.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.795 0.331 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.37 46.15 2.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 p -178.13 86.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.888 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.46 9.15 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.498 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.3 -1.88 28.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.326 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.59 -37.06 14.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.825 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.55 -57.44 12.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.159 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.9 m -58.27 -29.27 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.314 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.666 ' HD3' HG21 ' A' ' 61' ' ' VAL . 3.9 ttmp? -76.86 -14.96 59.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.378 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.91 -44.8 3.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 111.528 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.87 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.2 pt -67.6 169.84 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.038 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.8 mttp 74.31 -44.01 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -16.44 63.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.077 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.95 -29.43 0.18 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.26 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.87 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -59.56 -178.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.421 . . . . 0.0 111.11 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.727 ' HB3' HD13 ' A' ' 77' ' ' ILE . 85.0 t80 -115.67 27.49 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.904 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 86.65 157.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.376 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.474 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -86.16 100.27 12.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.024 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.886 HD21 ' HA ' ' A' ' 109' ' ' PHE . 39.2 tp -70.47 131.47 44.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.008 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.426 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 2.2 mm-40 -65.17 -169.84 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.352 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.728 ' HE2' HG21 ' A' ' 79' ' ' ILE . 1.2 mmpm? -135.63 45.3 1.31 Allowed Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 92.8 Cg_endo -78.38 138.85 16.05 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.5 2.133 . . . . 0.0 112.151 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 58.18 36.93 26.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.048 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.75 -169.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.184 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.717 HG13 ' CD1' ' A' ' 20' ' ' ILE . 8.6 p -62.92 -19.69 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.498 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -45.8 -34.6 3.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.406 ' NH2' ' HG3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -74.62 -38.96 62.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.153 179.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.886 ' HA ' HD21 ' A' ' 100' ' ' LEU . 4.2 t80 -55.61 -28.64 56.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.41 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -47.87 -39.57 19.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.928 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.4 mp -57.97 -58.06 10.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.874 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.823 ' OG1' HD22 ' A' ' 100' ' ' LEU . 52.3 m -45.95 -43.65 14.19 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.626 HD12 HG21 ' A' ' 4' ' ' VAL . 18.6 mm -53.66 -66.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 110.382 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -16.21 5.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.979 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -90.19 -26.53 20.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 110.518 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.59 -40.83 40.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.018 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 38.0 m-85 -76.35 -19.03 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -72.2 -6.85 45.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.699 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.59 42.38 1.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.402 ' CE2' ' OD2' ' A' ' 73' ' ' ASP . 5.2 t80 -168.26 31.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.989 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ptp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.957 0.408 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 1.4 mptp? -160.53 122.48 3.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.976 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -145.49 133.57 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 48' ' ' VAL . 20.8 t -126.2 160.66 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.78 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.695 HD23 HG23 ' A' ' 49' ' ' ILE . 40.9 tp -118.8 136.34 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.808 0.337 . . . . 0.0 110.996 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.659 ' HB ' HG22 ' A' ' 30' ' ' THR . 13.7 t -117.35 90.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.89 104.86 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.842 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -140.32 137.99 34.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -88.76 48.83 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.841 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 179.89 167.4 1.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.35 54.12 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 m -111.31 -56.02 2.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.971 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 13' ' ' ILE . 1.6 mp -79.69 -33.14 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.756 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p -59.85 -19.73 52.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -90.04 -26.42 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.731 0.3 . . . . 0.0 111.231 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.24 -63.03 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.199 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.003 HD13 HD11 ' A' ' 21' ' ' LEU . 2.1 tm? -52.24 -50.18 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.02 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.796 ' HA ' HD12 ' A' ' 21' ' ' LEU . 7.0 t -53.09 -59.42 4.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.217 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.0 -39.51 59.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.05 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.728 HG23 HD11 ' A' ' 110' ' ' LEU . 8.9 mt -57.41 -58.3 6.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.9 -39.61 19.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.408 . . . . 0.0 110.78 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.59 -28.34 68.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.6 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.37 -34.47 31.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.233 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.748 ' HG3' HD21 ' A' ' 110' ' ' LEU . 15.8 mm-40 -76.49 -70.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 149.23 57.45 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.527 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 81.0 m-85 -129.84 -169.31 2.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.53 88.04 20.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.967 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.907 ' HB3' HD13 ' A' ' 21' ' ' LEU . 66.6 Cg_endo -78.81 132.6 10.85 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.419 2.079 . . . . 0.0 113.148 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 30' ' ' THR . 17.5 t70 -111.56 8.43 20.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.221 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.659 HG22 ' HB ' ' A' ' 6' ' ' VAL . 5.9 p 0.83 123.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 -165.69 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.702 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -116.61 -33.52 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.08 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.776 HG23 ' HB3' ' A' ' 56' ' ' PRO . 0.7 OUTLIER -162.03 175.23 12.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.612 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.71 HD22 ' CD2' ' A' ' 63' ' ' PHE . 54.3 mt -55.56 -33.41 63.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.757 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -48.13 76.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.506 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.838 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.32 -36.02 63.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 83.6 mt-10 -68.48 -40.81 80.81 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.06 -35.09 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.9 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -76.65 -44.72 32.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.721 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.96 -26.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.18 -25.79 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.427 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -125.67 -45.58 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.012 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -74.66 135.06 41.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -92.25 95.47 9.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 75.8 m-85 -91.98 113.4 58.85 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.8 Cg_endo -73.43 -16.5 24.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.387 2.058 . . . . 0.0 111.886 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.8 t -148.43 131.61 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.47 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.695 HG23 HD23 ' A' ' 5' ' ' LEU . 7.3 mm -119.16 162.65 17.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.735 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.5 t -149.85 98.42 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.178 0.514 . . . . 0.0 111.454 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB3' HG22 ' A' ' 78' ' ' VAL . 37.7 tp -81.73 148.87 28.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.588 ' O ' HG21 ' A' ' 80' ' ' THR . 8.0 t70 -107.84 -19.92 13.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.484 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.681 HG22 ' HB ' ' A' ' 80' ' ' THR . 2.4 m 45.93 32.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -56.6 -81.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.676 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.567 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 13.3 mtp -152.54 57.52 2.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.964 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.776 ' HB3' HG23 ' A' ' 33' ' ' THR . 4.9 Cg_endo -86.3 -156.38 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.061 2.507 . . . . 0.0 112.199 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -157.39 37.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.94 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.584 ' C ' HD12 ' A' ' 34' ' ' LEU . . . -127.98 -0.69 6.48 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.065 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.424 ' C ' HD11 ' A' ' 34' ' ' LEU . 19.7 m-20 58.4 105.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.18 -0.8 87.04 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.142 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.918 ' O ' HD12 ' A' ' 64' ' ' ILE . 46.4 t -67.25 -66.07 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 120.898 0.38 . . . . 0.0 111.161 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -67.09 -14.33 62.8 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.785 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CD2' HD22 ' A' ' 34' ' ' LEU . 21.4 t80 -63.4 -38.92 93.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.1 mt -48.35 -33.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.5 t70 -70.03 -32.8 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.29 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 6.9 t80 -62.33 -43.96 97.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.686 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mp -59.57 -44.64 93.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.41 -21.31 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.563 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' ASP . 37.4 tt0 -67.0 -31.77 72.55 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -134.05 18.63 3.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.044 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.86 70.06 0.88 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.24 -19.37 38.71 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.721 2.281 . . . . 0.0 112.241 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -98.22 29.14 3.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.978 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 48.0 t -110.87 -163.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.42 ' N ' ' OG ' ' A' ' 74' ' ' SER . 31.9 t -154.55 136.2 5.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 120.836 0.351 . . . . 0.0 111.399 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.845 HG12 HG23 ' A' ' 78' ' ' VAL . 2.0 t -115.43 109.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.412 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.564 HG21 ' CE1' ' A' ' 109' ' ' PHE . 38.3 mm -83.27 -59.68 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.913 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.845 HG23 HG12 ' A' ' 76' ' ' VAL . 55.7 t 55.48 89.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.667 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -96.21 -152.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.681 ' HB ' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER 69.16 139.86 0.04 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.809 0.338 . . . . 0.0 110.976 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.04 37.92 0.67 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.435 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -69.89 71.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.825 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.9 -33.96 0.14 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.431 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 m -129.43 106.18 8.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 110.865 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 85' ' ' VAL . 11.7 p -81.21 -0.1 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.584 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.52 -8.97 57.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -89.79 -39.29 13.21 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.571 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -56.42 -57.99 9.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.968 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.3 m -55.19 -31.1 25.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.772 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.555 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -76.97 -5.38 48.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.91 -38.12 3.0 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.909 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 9.1 pt -73.93 -34.52 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.435 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -65.34 -18.12 65.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.935 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -85.89 -56.27 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.045 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 178.29 32.03 0.05 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.043 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.909 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.27 -162.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.329 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.558 ' CE2' HG23 ' A' ' 112' ' ' THR . 81.3 t80 -111.98 23.32 13.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.439 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 0.7 OUTLIER 83.89 20.33 0.17 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.95 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER 58.43 163.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 0.0 111.453 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HB3' HG23 ' A' ' 79' ' ' ILE . 1.8 tm? -116.02 81.23 1.57 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -115.12 112.42 22.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.222 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.637 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 0.3 OUTLIER 177.21 -54.42 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.944 179.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 102' ' ' LYS . 89.9 Cg_endo -81.04 -168.03 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.383 2.055 . . . . 0.0 112.601 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -145.84 25.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.8 t -149.38 -84.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.966 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' CG2' HD23 ' A' ' 17' ' ' LEU . 11.4 p 178.7 -39.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.657 0.265 . . . . 0.0 111.313 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -40.62 -40.57 1.3 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.913 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.442 ' CB ' ' HB3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -70.43 -39.3 74.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.765 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.564 ' CE1' HG21 ' A' ' 77' ' ' ILE . 5.5 t80 -57.23 -30.04 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.748 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -50.76 -34.92 29.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.1 mp -61.8 -51.65 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.313 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.558 HG23 ' CE2' ' A' ' 97' ' ' TYR . 87.9 m -51.51 -39.2 57.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.997 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.431 ' HA ' HD13 ' A' ' 113' ' ' ILE . 12.6 mm -53.58 -65.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.981 0.419 . . . . 0.0 110.132 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -13.45 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.716 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -90.49 -25.49 20.26 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 110.065 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.94 -47.37 13.78 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 48' ' ' VAL . 34.2 m-85 -57.93 -21.8 45.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.195 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -49.53 -28.01 5.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.185 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -98.32 31.08 2.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -149.41 31.26 0.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.737 0.303 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 23.8 mmtt -146.77 96.07 2.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.979 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.67 135.41 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.4 t -127.12 143.92 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.824 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.723 HD23 HD11 ' A' ' 41' ' ' ILE . 15.1 tp -99.99 125.33 46.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.791 HG21 HD12 ' A' ' 17' ' ' LEU . 21.9 t -112.11 88.78 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.07 103.47 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -137.08 138.8 40.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.43 38.5 1.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 17.0 tp10 -150.21 164.84 34.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.4 -36.13 58.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.009 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 14' ' ' THR . 38.4 t -59.08 -173.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 14' ' ' THR . 11.8 mm 62.52 -72.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.194 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.455 ' N ' HG22 ' A' ' 13' ' ' ILE . 31.4 p -53.8 -22.75 10.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.353 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.1 t -90.14 23.16 2.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.524 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.9 t -163.27 -53.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.583 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.791 HD12 HG21 ' A' ' 6' ' ' VAL . 1.6 tm? -57.88 -50.97 71.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.572 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 30' ' ' THR . 0.7 OUTLIER -56.99 -51.52 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.023 0.44 . . . . 0.0 110.336 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.54 70.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.538 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.667 ' CD1' HG11 ' A' ' 106' ' ' VAL . 40.7 mt -58.16 -66.75 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.678 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.2 mt -49.7 -31.42 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.469 . . . . 0.0 110.369 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.42 -30.63 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.57 -34.89 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.037 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.805 ' HG3' HD21 ' A' ' 110' ' ' LEU . 41.9 mm-40 -75.08 -12.09 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.207 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 53.36 1.08 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.197 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.465 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 64.5 m-85 -126.38 -176.33 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 111.108 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.48 71.95 51.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 33.9 Cg_exo -60.34 138.66 82.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.776 2.318 . . . . 0.0 112.645 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.9 t70 -121.04 4.59 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.748 HG22 ' HB ' ' A' ' 6' ' ' VAL . 12.8 p 3.38 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 -163.21 0.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.391 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -118.85 -28.26 5.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.278 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -163.48 -170.12 2.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.806 0.336 . . . . 0.0 110.806 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 63' ' ' PHE . 47.0 mt -68.41 -45.87 71.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -48.56 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.67 -30.19 69.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.491 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.505 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.29 -25.32 54.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.997 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.443 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 45.7 mt-10 -75.56 -36.27 60.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -37.33 77.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.58 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -71.82 -37.48 70.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.542 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.723 HD11 HD23 ' A' ' 5' ' ' LEU . 23.7 mt -85.76 -16.86 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.387 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -52.59 -22.19 4.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.619 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -133.3 -51.66 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.824 0.345 . . . . 0.0 111.154 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 118.71 5.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -73.96 72.26 1.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 38.8 m-85 -66.41 111.24 6.23 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.476 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.408 ' HG2' ' CE2' ' A' ' 117' ' ' PHE . 72.3 Cg_endo -74.42 -20.67 18.09 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.628 2.219 . . . . 0.0 112.207 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.631 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.4 t -144.0 130.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.295 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 9.9 mm -117.7 156.99 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.407 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.15 102.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 tp -86.12 84.72 7.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.976 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.49 77.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.66 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.718 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.2 p -59.33 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.599 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 44.5 t-105 -74.46 -82.78 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.097 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.545 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.39 45.45 0.35 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.313 179.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 55' ' ' MET . 82.3 Cg_endo -85.12 -165.54 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.442 2.095 . . . . 0.0 112.261 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -154.55 48.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.949 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.0 -16.67 6.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.85 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 62.58 104.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.791 0.329 . . . . 0.0 110.733 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.06 18.57 57.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.895 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.68 ' O ' HD12 ' A' ' 64' ' ' ILE . 13.1 t -58.98 -58.36 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.879 0.371 . . . . 0.0 111.098 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.05 -4.79 43.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.745 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 67' ' ' ILE . 26.7 t80 -69.15 -39.99 78.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.618 0.247 . . . . 0.0 111.496 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mp -46.89 -33.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.766 0.317 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.483 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -70.04 -34.75 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 75.0 t80 -63.06 -39.92 96.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.7 mp -62.77 -47.12 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.909 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.483 ' HG3' ' HA ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -75.41 -18.95 59.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 36.6 tt0 -69.45 -42.75 74.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.718 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -120.75 18.36 11.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.054 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.85 67.11 1.09 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.81 -20.29 34.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.653 2.235 . . . . 0.0 112.218 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.41 32.72 2.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 t -113.2 -157.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.439 HG22 ' CD2' ' A' ' 120' ' ' TYR . 39.2 t -155.37 137.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 111.505 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.84 HG12 HG23 ' A' ' 78' ' ' VAL . 2.8 t -117.83 100.4 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.376 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 97' ' ' TYR . 38.2 mm -81.5 -55.12 8.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.739 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 76' ' ' VAL . 40.3 t 57.69 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -114.31 -159.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.334 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.718 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 57.36 165.04 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.21 43.16 0.41 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.413 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -59.17 139.57 56.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.49 99.05 1.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m 63.06 146.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 85' ' ' VAL . 14.0 p -105.96 37.79 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.047 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.57 -22.26 28.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -79.78 -36.38 37.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.144 0.497 . . . . 0.0 109.726 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.1 -57.74 10.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.203 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 -26.17 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.948 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.503 ' O ' HG13 ' A' ' 61' ' ' VAL . 5.3 tttt -87.93 40.54 0.95 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.625 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.36 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.945 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.4 pt -75.08 -29.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.501 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -80.08 -19.27 47.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -23.15 58.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.283 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.76 22.88 0.14 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.595 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.945 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.36 -165.15 1.28 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 117.22 0.51 . . . . 0.0 111.147 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.452 ' HB3' HD13 ' A' ' 77' ' ' ILE . 70.3 t80 -114.11 25.14 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 79.95 139.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.562 ' H ' HG21 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -57.19 130.11 44.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.676 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -78.26 120.3 22.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.684 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.419 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.1 mt-10 -58.49 -168.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.014 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -150.52 53.62 1.27 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.857 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.17 -2.32 12.16 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.592 2.194 . . . . 0.0 112.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.96 -75.72 0.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.737 0.303 . . . . 0.0 110.845 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.7 t 178.15 -51.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.667 HG11 ' CD1' ' A' ' 20' ' ' ILE . 11.7 p -155.79 -44.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -38.96 -44.16 1.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.635 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -64.45 -42.33 96.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 0.0 110.345 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 8.8 t80 -59.51 -27.24 65.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.692 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.805 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -60.27 -48.15 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.404 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.9 mp -51.39 -51.52 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.227 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.91 -41.34 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 3.4 mm -50.35 -56.15 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.608 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -63.22 1.13 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -49.97 -32.56 15.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.776 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -60.92 -41.35 95.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.458 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.628 ' CE1' HG21 ' A' ' 48' ' ' VAL . 32.6 m-85 -76.13 -34.81 59.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 -77.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.597 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 -21.44 12.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.788 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.439 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -127.3 54.95 1.62 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.88 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttm . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.9 0.381 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HB3' ' CG ' ' A' ' 26' ' ' TYR . 13.3 mmtt 65.39 100.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.4 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -148.22 121.95 9.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.633 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.577 HG13 ' HB ' ' A' ' 48' ' ' VAL . 38.0 t -127.36 158.15 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.892 HD12 ' O ' ' A' ' 29' ' ' ASP . 52.3 tp -117.96 141.55 48.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 111.43 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.69 HG21 HD12 ' A' ' 17' ' ' LEU . 16.9 t -121.24 141.65 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.158 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 51' ' ' LEU . 14.2 t -132.84 121.49 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.529 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 6.1 t70 -159.25 159.75 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.728 0.299 . . . . 0.0 110.621 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.53 50.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.936 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -138.55 123.9 19.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -88.12 53.8 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -164.56 36.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.798 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.74 HD13 ' OG1' ' A' ' 30' ' ' THR . 23.2 mm 55.71 168.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 121.116 0.484 . . . . 0.0 110.923 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.633 HG21 HG11 ' A' ' 6' ' ' VAL . 30.1 p -86.1 122.15 29.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.129 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 16' ' ' SER . 29.6 t -54.21 132.46 43.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.955 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.684 ' HB3' HG11 ' A' ' 106' ' ' VAL . 5.7 t 83.08 -15.02 0.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.719 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.905 ' CD1' HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -77.4 -48.49 17.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.855 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -50.7 -57.0 9.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.31 80.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.655 HD11 HG13 ' A' ' 106' ' ' VAL . 81.9 mt -59.91 -70.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.905 HD11 ' CD1' ' A' ' 17' ' ' LEU . 1.2 mt -47.84 -31.17 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -73.79 -30.54 62.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.884 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.16 -35.53 25.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.89 -33.74 62.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.5 42.17 3.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' CG ' ' HB3' ' A' ' 2' ' ' LYS . 3.1 m-85 -104.12 -175.67 2.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.4 ' HB2' ' HG3' ' A' ' 3' ' ' ARG . 2.5 t-80 -127.59 82.27 68.62 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.05 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.664 ' HB3' HD22 ' A' ' 21' ' ' LEU . 88.0 Cg_endo -83.44 130.94 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 113.884 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.892 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -119.74 116.82 26.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.856 178.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.74 ' OG1' HD13 ' A' ' 13' ' ' ILE . 18.5 p -105.76 137.14 44.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 112.039 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 36' ' ' GLU . . . -106.93 -164.77 1.01 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.076 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -131.59 -5.84 3.68 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.7 167.66 7.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.674 HD22 ' CD2' ' A' ' 63' ' ' PHE . 33.8 mt -60.78 -29.6 69.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.848 0.356 . . . . 0.0 110.225 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -70.63 -45.98 64.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.722 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.515 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 2.5 mm-40 -62.66 -33.07 74.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.069 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.97 34.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.718 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' LYS . 49.8 mt-10 -46.17 -46.55 17.41 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.387 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -58.95 -54.45 47.01 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -59.51 -24.63 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.014 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 41' ' ' ILE . 18.2 mt -97.07 -13.49 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.22 -9.28 58.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.587 0.232 . . . . 0.0 111.288 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.03 -62.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 113.12 2.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.21 68.26 0.49 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.481 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 35.2 m-85 -63.28 130.18 94.04 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 5.1 Cg_endo -80.39 -45.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.393 2.062 . . . . 0.0 111.924 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 4' ' ' VAL . 23.9 t -117.37 123.41 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.91 128.35 64.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.785 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.64 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 60.2 t -120.35 106.27 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.068 0.461 . . . . 0.0 111.552 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.735 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.8 tp -89.07 153.84 20.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -145.68 109.03 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.742 ' H ' HG22 ' A' ' 80' ' ' THR . 79.9 t -86.75 70.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.973 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -71.96 -80.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.485 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.612 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -150.97 55.0 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.96 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 55' ' ' MET . 6.9 Cg_endo -88.34 -156.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.136 2.557 . . . . 0.0 112.161 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -146.34 36.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.97 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.21 129.25 3.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.447 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.49 141.99 53.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.72 -23.06 11.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.658 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.691 ' O ' HD12 ' A' ' 64' ' ' ILE . 21.7 t -53.51 -46.73 60.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.572 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -75.65 -5.39 45.29 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.1 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.901 ' CE2' HD11 ' A' ' 67' ' ' ILE . 16.4 t80 -84.43 -35.72 22.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.571 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.9 mp -45.07 -29.09 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.466 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.615 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 9.9 t0 -72.34 -51.45 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.12 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 8.8 t80 -50.58 -41.63 54.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.942 0.401 . . . . 0.0 110.546 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.901 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.1 mp -63.6 -50.19 79.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.42 -15.79 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 110.688 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -73.42 -52.09 14.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.673 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.14 19.75 17.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.436 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -163.67 64.29 1.3 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.684 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 71' ' ' SER . 5.0 Cg_exo -76.02 -13.5 19.33 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.602 2.201 . . . . 0.0 111.99 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 25.54 11.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.083 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.5 t -108.76 -173.3 2.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.976 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.2 t -123.9 162.11 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.009 0.433 . . . . 0.0 111.293 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.943 HG12 HG23 ' A' ' 78' ' ' VAL . 1.5 t -140.34 105.54 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.378 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 77' ' ' ILE . 34.4 mm -107.25 41.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.943 HG23 HG12 ' A' ' 76' ' ' VAL . 58.8 t -46.23 97.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.572 HG23 ' HB3' ' A' ' 100' ' ' LEU . 31.7 mt -71.61 -101.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.455 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER 69.8 130.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.696 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.79 -111.2 1.79 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.58 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 62.92 -79.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 111.061 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.77 51.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.565 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.633 ' O ' HG22 ' A' ' 87' ' ' THR . 0.5 OUTLIER -129.41 80.59 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.74 0.305 . . . . 0.0 110.916 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.59 -30.73 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.09 -14.0 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -81.33 -35.43 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 109.799 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.87 -57.59 12.39 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.172 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.2 m -59.38 -29.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -75.79 -12.9 60.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.57 -36.34 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.3 pt -80.31 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.917 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 1.4 mptp? 73.64 -46.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.613 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -21.92 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.786 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.15 -30.07 0.11 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.62 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.766 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -62.48 176.52 0.63 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.95 0.405 . . . . 0.0 111.331 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -104.82 27.43 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 79.64 142.67 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.855 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.5 m-30 -63.82 149.39 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.572 ' HB3' HG23 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -81.57 101.72 10.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -53.27 154.61 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.205 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.39 72.48 0.67 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.63 61.59 3.63 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.576 2.184 . . . . 0.0 112.303 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -147.56 -47.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 p -96.88 136.37 37.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.881 HG21 HD23 ' A' ' 17' ' ' LEU . 8.0 p -100.26 -15.73 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.235 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -37.58 87.81 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.81 -36.32 83.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.675 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.64 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 9.6 t80 -59.46 -37.04 77.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.643 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.599 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.53 -42.95 79.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.136 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.34 -47.07 76.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.408 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.7 m -66.15 -41.69 90.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.518 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.9 mm -45.27 -54.33 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.52 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.29 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.033 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -60.92 -30.36 70.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.989 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.612 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -60.38 -39.37 87.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.914 0.387 . . . . 0.0 110.857 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 48' ' ' VAL . 28.2 m-85 -69.6 -15.04 63.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.345 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.25 -25.4 9.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.77 0.319 . . . . 0.0 111.428 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.76 40.84 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -166.19 32.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.837 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.881 0.372 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -109.16 135.09 50.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.013 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.418 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.7 OUTLIER -144.98 151.04 37.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.787 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' A' ' 48' ' ' VAL . 30.3 t -133.37 143.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.711 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 29' ' ' ASP . 46.3 tp -106.45 129.75 54.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.959 HG21 ' CD1' ' A' ' 17' ' ' LEU . 17.7 t -117.94 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.594 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 42.9 t -81.84 119.14 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 26.3 t0 -155.15 149.99 26.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 32.3 t70 -90.31 51.43 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.732 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.43 -165.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.788 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.99 -67.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.984 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 m -129.3 105.25 8.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 14' ' ' THR . 15.1 mm 55.54 168.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.78 HG21 ' CG1' ' A' ' 6' ' ' VAL . 61.1 p -90.36 128.58 36.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.203 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 t -58.84 138.03 57.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.981 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.409 ' CB ' HG11 ' A' ' 106' ' ' VAL . 3.1 m 75.84 -0.89 3.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.417 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.046 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -89.96 -52.67 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.347 . . . . 0.0 110.804 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.85 -58.59 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.024 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.22 48.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.011 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.889 HD11 HG13 ' A' ' 106' ' ' VAL . 62.1 mt -68.18 -71.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.331 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.046 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -49.59 -29.72 7.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -74.32 -27.02 60.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.654 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.28 -35.07 28.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.227 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.877 ' HG3' HD21 ' A' ' 110' ' ' LEU . 20.7 mm-40 -81.17 -34.62 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.045 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.19 53.27 1.91 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.227 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.475 ' CE2' HG21 ' A' ' 113' ' ' ILE . 7.8 m-85 -112.03 -175.69 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.357 0.599 . . . . 0.0 111.259 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.37 82.03 31.23 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.816 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.805 ' CB ' HD13 ' A' ' 21' ' ' LEU . 78.2 Cg_endo -82.06 128.02 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.752 2.301 . . . . 0.0 113.926 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.932 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -121.67 114.23 20.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 13' ' ' ILE . 20.3 p -95.46 128.83 42.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.009 0.433 . . . . 0.0 111.648 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -98.96 163.35 12.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.39 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 5.8 mttt -111.93 -9.15 14.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.249 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.61 152.71 3.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.576 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.2 mt -52.16 -26.64 11.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.55 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -43.45 59.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.986 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 7' ' ' VAL . . . -73.24 -48.83 31.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.479 ' HG3' ' CE2' ' A' ' 66' ' ' PHE . 4.8 tt0 -47.11 -47.39 23.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.33 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -55.39 35.64 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -58.23 -26.33 62.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 41' ' ' ILE . 14.5 mt -90.16 -13.27 9.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.32 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -97.53 20.71 11.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -140.89 -52.65 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -98.83 155.51 17.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.379 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.417 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 52.5 t80 -88.67 78.23 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.047 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.639 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 16.1 m-85 -66.49 120.39 70.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.7 Cg_endo -80.63 -47.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.311 2.007 . . . . 0.0 111.889 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.813 HG23 ' CE1' ' A' ' 117' ' ' PHE . 36.6 t -115.06 124.9 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.577 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 46' ' ' PHE . 29.2 mm -112.82 124.48 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.51 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.674 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 46.4 t -128.12 108.58 18.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.079 0.466 . . . . 0.0 112.051 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD23 HG13 ' A' ' 78' ' ' VAL . 49.7 tp -82.76 157.76 23.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.408 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -140.17 89.93 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.71 66.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.154 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -77.94 -80.51 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.561 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.8 ttm -146.0 50.46 1.05 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.029 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 55' ' ' MET . 58.0 Cg_endo -92.66 -165.92 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.96 2.44 . . . . 0.0 112.377 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.01 30.6 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.82 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.67 -73.54 0.89 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.562 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.89 31.2 20.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.17 91.33 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.813 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.892 ' O ' HD12 ' A' ' 64' ' ' ILE . 57.8 t -58.69 -39.78 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.836 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -15.51 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.348 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.94 ' CE2' HD11 ' A' ' 67' ' ' ILE . 45.9 t80 -53.26 -47.12 69.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.852 0.358 . . . . 0.0 111.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.892 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.8 mt -46.62 -29.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -65.72 -49.67 67.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.418 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 38' ' ' GLU . 2.0 t80 -53.92 -41.4 67.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.95 0.405 . . . . 0.0 110.138 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.94 HD11 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mp -62.47 -43.89 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.425 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -79.9 -17.35 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.041 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 65' ' ' ASP . 4.0 tt0 -72.07 -45.5 60.48 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.45 8.06 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.198 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.445 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -155.54 63.95 3.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.877 0.37 . . . . 0.0 110.57 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 71' ' ' SER . 15.0 Cg_exo -67.86 -20.87 45.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.548 2.165 . . . . 0.0 112.082 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.48 23.03 7.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.869 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.407 ' HG ' ' C ' ' A' ' 47' ' ' PRO . 34.7 t -104.81 -176.98 3.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.643 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.682 HG21 ' HB1' ' A' ' 116' ' ' ALA . 31.0 t -123.36 157.23 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.068 0.461 . . . . 0.0 111.257 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -146.2 104.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.134 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 112' ' ' THR . 43.3 mm -90.11 -42.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 HG12 ' A' ' 76' ' ' VAL . 47.2 t 45.97 88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.351 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.713 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -104.28 -177.74 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.503 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.713 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 78.37 143.52 0.08 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 111.099 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.29 -116.6 0.41 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.365 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 179.25 -50.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.68 -41.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.482 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 t -81.41 124.52 29.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 110.99 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 85' ' ' VAL . 21.3 t -83.56 -5.59 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.455 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -63.24 -17.07 62.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.344 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -74.25 -35.23 63.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 0.0 109.944 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.75 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.87 -58.78 6.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.044 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 92' ' ' ILE . 21.3 m -60.25 -25.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.101 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.551 ' HD3' HG21 ' A' ' 61' ' ' VAL . 18.4 ttmm -76.22 -17.27 59.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.78 -39.67 4.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.852 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.8 pt -72.76 -22.73 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.689 0.28 . . . . 0.0 111.53 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -68.72 -30.65 69.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.385 . . . . 0.0 110.41 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -64.76 -57.07 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 34.75 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.29 -167.77 1.93 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.158 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 75.2 t80 -107.64 -17.97 13.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.45 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 4.6 pt-20 145.17 -173.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.504 0.721 . . . . 0.0 110.066 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.512 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -121.45 94.24 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.7 tp -54.15 140.74 31.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.75 16.49 12.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.294 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.568 ' N ' ' HD3' ' A' ' 103' ' ' PRO . 9.1 tttt 50.81 54.38 15.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.277 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 102' ' ' LYS . 39.3 Cg_exo -59.99 138.96 85.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.309 2.006 . . . . 0.0 112.114 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 63.98 -76.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.8 p -166.23 -39.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.2 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.889 HG13 HD11 ' A' ' 20' ' ' ILE . 8.1 p -176.66 -27.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.814 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -46.74 -35.87 6.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.402 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.61 -39.53 80.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.941 179.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.742 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 18.0 t80 -55.97 -31.46 63.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.926 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.877 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.4 tt -60.55 -52.55 64.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.147 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -47.05 -40.87 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.499 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.538 HG21 HD12 ' A' ' 77' ' ' ILE . 96.7 m -64.69 -50.19 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.742 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.4 mp -45.5 -52.95 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.922 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -59.12 4.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.0 0.429 . . . . 0.0 109.962 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -31.7 70.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.838 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.682 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.63 -28.36 67.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.813 ' CE1' HG23 ' A' ' 48' ' ' VAL . 10.7 m-85 -86.93 -56.4 3.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -48.82 79.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.529 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.17 -5.21 43.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.774 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.589 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -140.05 39.36 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 111.035 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.93 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.844 0.354 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.457 ' HB2' ' CG ' ' A' ' 26' ' ' TYR . 13.8 mmtm -132.3 161.66 32.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.405 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.62 122.65 12.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 48.2 t -129.89 144.81 36.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.934 HD23 HG23 ' A' ' 49' ' ' ILE . 46.5 tp -106.67 140.1 40.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 111.496 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.83 HG21 ' CD1' ' A' ' 17' ' ' LEU . 19.2 t -118.39 127.07 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.182 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.803 ' HB ' HD12 ' A' ' 51' ' ' LEU . 37.4 t -117.01 115.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -140.49 162.59 34.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.618 -179.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' CG ' ' A' ' 56' ' ' PRO . 17.4 t70 -63.54 -85.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.618 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.13 -164.94 1.25 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.44 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 74.86 126.03 0.04 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t -54.61 109.98 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.006 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 14' ' ' THR . 26.2 mm 58.13 166.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.593 ' N ' HG22 ' A' ' 13' ' ' ILE . 68.4 p -90.27 117.64 29.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.233 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -50.6 138.7 17.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.796 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.519 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.2 m 78.04 -1.98 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.283 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.897 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.12 -53.95 4.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.871 0.367 . . . . 0.0 110.8 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.31 -60.59 2.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.36 -39.86 47.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.078 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.748 HG23 ' CD1' ' A' ' 110' ' ' LEU . 46.3 mt -64.26 -66.61 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.159 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.897 HD11 HD13 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -50.66 -28.78 9.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -72.61 -27.98 62.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.649 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -82.6 -35.01 27.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.281 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.735 ' HG3' HD21 ' A' ' 110' ' ' LEU . 8.9 mm-40 -80.99 -39.85 25.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.037 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.31 51.0 2.29 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.166 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' A' ' 2' ' ' LYS . 3.4 m-30 -104.1 -174.85 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.376 0.608 . . . . 0.0 111.315 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 77.47 59.45 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.722 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.774 ' HB3' HD22 ' A' ' 21' ' ' LEU . 92.1 Cg_endo -86.45 154.29 9.19 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.685 2.257 . . . . 0.0 114.585 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.485 ' O ' HD12 ' A' ' 5' ' ' LEU . 20.5 t70 -140.3 137.36 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.558 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.405 HG21 ' CD1' ' A' ' 13' ' ' ILE . 16.1 p -114.89 143.38 45.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.208 0.528 . . . . 0.0 112.135 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.89 -173.69 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.056 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 33' ' ' THR . 0.3 OUTLIER -117.65 -22.24 8.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.773 0.321 . . . . 0.0 111.288 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -166.08 167.38 16.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.379 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.785 HD22 ' CD2' ' A' ' 63' ' ' PHE . 12.1 mt -54.53 -32.51 58.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.708 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -46.92 74.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.002 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -35.42 80.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.01 -56.21 16.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 27.3 mt-10 -45.86 -42.61 12.71 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -45.89 86.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.874 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -71.73 -42.02 67.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.9 mt -71.54 -21.28 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -61.8 -20.73 63.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.125 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -126.68 -55.98 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -64.92 115.62 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -74.26 65.77 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.483 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 37.8 m-85 -63.75 128.78 93.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 11.1 Cg_endo -82.57 -27.6 2.11 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.491 2.127 . . . . 0.0 112.125 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.861 ' O ' HD13 ' A' ' 49' ' ' ILE . 10.6 t -130.48 139.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.934 HG23 HD23 ' A' ' 5' ' ' LEU . 2.0 mm -139.03 108.84 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.727 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.797 HG22 ' CG1' ' A' ' 77' ' ' ILE . 41.8 t -111.05 142.18 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 110.662 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.803 HD12 ' HB ' ' A' ' 7' ' ' VAL . 20.2 tp -101.39 159.88 14.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 6.9 t70 -141.99 79.82 1.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 53' ' ' VAL . 45.3 t -65.89 68.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.666 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 31.0 t-105 -68.57 -79.62 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.923 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.763 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.2 ptt? -144.07 40.61 0.3 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.667 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.763 ' HD3' ' N ' ' A' ' 55' ' ' MET . 57.1 Cg_endo -99.45 -162.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.201 2.601 . . . . 0.0 112.198 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -91.52 -47.27 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.451 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.06 -121.65 14.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.014 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.96 31.32 18.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -95.04 59.65 1.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.524 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 90' ' ' LYS . 57.6 t -56.39 -38.11 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.153 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.09 15.96 9.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.44 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.958 ' CE2' HD11 ' A' ' 67' ' ' ILE . 47.8 t80 -79.7 -38.42 33.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.81 0.338 . . . . 0.0 110.742 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -48.58 -28.52 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.29 -37.78 60.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 19.4 t80 -57.68 -44.87 86.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.281 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.958 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.0 mp -59.29 -41.88 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.361 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.66 -24.85 49.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.551 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.14 -41.5 94.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.71 12.86 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 68.15 1.18 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.842 0.354 . . . . 0.0 110.668 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -67.98 -20.32 44.84 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.771 2.314 . . . . 0.0 112.138 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.6 28.73 6.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 47.5 t -112.1 -176.25 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.973 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.638 HG11 ' HB1' ' A' ' 116' ' ' ALA . 47.6 t -126.03 143.59 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.125 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.738 HG22 HG21 ' A' ' 67' ' ' ILE . 3.3 t -127.06 95.84 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.726 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.797 ' CG1' HG22 ' A' ' 50' ' ' VAL . 47.9 mm -74.22 -65.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.483 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 76' ' ' VAL . 11.3 t 67.8 88.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -106.45 175.7 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.563 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.594 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 72.24 121.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.916 0.389 . . . . 0.0 110.892 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.09 150.08 11.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.475 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -128.81 -178.15 4.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.357 . . . . 0.0 110.956 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.39 -139.73 16.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.7 m -98.42 29.52 3.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 85' ' ' VAL . 15.2 t 58.28 30.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.073 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.5 -31.56 32.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.019 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.455 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 2.6 t -63.16 -34.48 77.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.874 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.849 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.13 -59.84 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.227 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 92' ' ' ILE . 10.3 m -64.53 -23.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.019 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.519 ' O ' HG13 ' A' ' 61' ' ' VAL . 22.0 ttpt -81.25 -7.6 59.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.427 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -123.29 -40.13 2.41 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.868 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.5 pt -69.8 -40.75 79.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.288 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -56.42 -25.46 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -19.75 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.347 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.85 -3.68 3.49 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.063 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -56.52 -167.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.901 0.381 . . . . 0.0 111.312 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.524 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.8 t80 -108.53 26.05 10.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.44 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 79.66 152.65 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.203 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -74.83 103.08 4.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.948 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.4 tp -80.61 53.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.654 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.34 133.24 55.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 111.323 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.3 OUTLIER 175.41 -58.0 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 102' ' ' LYS . 97.2 Cg_endo -84.19 6.21 5.89 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.761 2.307 . . . . 0.0 112.743 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 61.88 171.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.704 0.288 . . . . 0.0 110.754 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m 59.06 -166.17 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.684 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.632 HG21 HD23 ' A' ' 17' ' ' LEU . 5.4 m -116.4 -11.82 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.648 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -40.95 -50.51 3.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.203 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -35.41 80.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.23 0.538 . . . . 0.0 109.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.6 ' HE2' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -58.3 -24.09 58.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.213 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.748 ' CD1' HG23 ' A' ' 20' ' ' ILE . 1.2 tt -60.27 -49.08 79.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.221 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.596 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.4 mp -56.31 -56.15 24.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.33 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.436 HG23 ' HE2' ' A' ' 97' ' ' TYR . 60.8 m -53.72 -57.95 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 7.4 mm -31.58 -62.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.5 -59.2 3.97 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -52.67 -28.33 21.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.693 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.638 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -70.27 -32.66 70.57 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS . 26.6 m-85 -68.75 -61.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.141 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -60.32 -41.23 93.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.377 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -72.28 -8.35 54.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.583 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.62 39.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.2 mptt 63.53 95.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.257 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.8 132.5 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.709 HG11 ' CD1' ' A' ' 113' ' ' ILE . 7.4 t -123.75 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.63 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.6 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 43.5 tp -103.66 132.74 49.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.733 HG21 ' CD1' ' A' ' 17' ' ' LEU . 34.1 t -113.26 90.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.254 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.14 104.63 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -135.32 134.39 39.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.938 0.399 . . . . 0.0 110.95 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.5 t0 -73.29 -40.79 64.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.41 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -178.72 120.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.403 ' HB3' HD13 ' A' ' 13' ' ' ILE . 3.2 tt0 179.73 -179.04 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.26 19.34 10.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.116 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 2.0 mp -80.69 -59.38 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.366 . . . . 0.0 110.716 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.7 p -46.0 -26.7 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.799 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 t -76.99 -65.36 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.316 . . . . 0.0 111.44 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m -73.16 -53.43 11.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.396 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.7 tm? -46.81 -53.94 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.246 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.533 ' OG ' HG21 ' A' ' 30' ' ' THR . 71.3 m -52.8 -43.58 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.94 96.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.424 ' CG2' ' CD1' ' A' ' 110' ' ' LEU . 55.5 mt -56.22 -67.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.59 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.527 HD21 HG13 ' A' ' 113' ' ' ILE . 1.4 mt -47.47 -33.32 6.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 110.497 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.23 -29.96 71.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.589 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -78.51 -37.07 44.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' CD ' HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -70.61 -22.27 62.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.085 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.54 58.47 0.81 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.378 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.464 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 55.7 m-85 -130.14 -177.27 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.431 . . . . 0.0 111.116 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.1 76.18 77.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.448 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 11.7 Cg_exo -67.7 137.7 42.94 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.795 2.33 . . . . 0.0 112.631 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.2 t70 -120.63 7.85 10.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 6' ' ' VAL . 13.7 p 6.04 122.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.24 -162.41 0.93 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.86 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 ttpt -117.22 -38.46 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 32' ' ' LYS . 13.9 p -161.3 -173.06 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.538 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 63' ' ' PHE . 16.5 mt -66.79 -45.75 77.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.456 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -62.85 -45.88 90.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.157 0.504 . . . . 0.0 109.937 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -32.35 71.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.285 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -72.93 -28.68 62.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.704 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mt-10 -69.76 -43.49 72.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -60.04 -39.9 87.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.66 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -70.37 -46.82 63.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.721 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 37' ' ' ALA . 11.7 mt -73.0 -20.43 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.567 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -57.98 -21.17 43.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.371 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -126.46 -43.73 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -77.76 122.93 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.044 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -81.05 85.25 6.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.6 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 61.1 m-85 -80.79 113.97 44.45 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.367 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 74' ' ' SER . 71.6 Cg_endo -74.17 -20.39 19.01 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.655 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.3 t -144.72 129.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.299 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 7.6 mm -117.22 157.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.251 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 109' ' ' PHE . 74.9 t -149.34 102.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 110.767 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.479 HD23 HG13 ' A' ' 78' ' ' VAL . 60.1 tp -78.42 148.17 33.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.312 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.5 OUTLIER -130.24 84.06 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.242 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.649 ' N ' HG21 ' A' ' 80' ' ' THR . 87.3 t -62.88 72.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.978 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 55' ' ' MET . 27.9 t90 -64.92 -97.15 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.623 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -135.99 38.58 0.39 Allowed Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 55' ' ' MET . 69.5 Cg_endo -85.33 -164.72 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.425 2.083 . . . . 0.0 112.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -143.96 41.45 1.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.5 179.9 36.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.388 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.97 77.46 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.83 -25.87 62.09 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.554 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.451 ' O ' HD12 ' A' ' 64' ' ' ILE . 24.4 t -54.56 -44.53 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 120.756 0.312 . . . . 0.0 111.45 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.7 6.67 40.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.472 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 67' ' ' ILE . 34.9 t80 -90.07 -37.51 14.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.7 mp -47.95 -28.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.359 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -77.15 -36.22 55.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.703 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 61.2 t80 -59.15 -42.83 91.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.974 0.416 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.869 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.5 mp -59.85 -43.27 91.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.317 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.25 -16.04 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 3.1 tm-20 -74.0 -34.34 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.966 0.412 . . . . 0.0 110.737 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.442 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -126.41 13.31 7.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.029 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.29 66.89 1.94 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.584 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.25 -20.9 42.48 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.655 2.237 . . . . 0.0 112.187 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -100.04 30.42 3.76 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.788 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 44.5 t -113.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG22 ' CG ' ' A' ' 120' ' ' TYR . 58.0 t -152.92 136.83 8.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 111.646 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.635 HG12 HG23 ' A' ' 78' ' ' VAL . 3.4 t -108.77 113.94 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.866 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 79' ' ' ILE . 47.3 mm -91.22 -65.33 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.635 HG23 HG12 ' A' ' 76' ' ' VAL . 58.0 t 52.8 97.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.134 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.695 HD13 HD23 ' A' ' 100' ' ' LEU . 17.0 mt -126.22 142.54 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.649 HG21 ' N ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 173.42 111.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.736 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.16 86.21 0.41 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.579 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -122.21 31.43 6.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.1 40.27 3.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.9 p -142.91 103.53 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 m -99.24 -27.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -83.76 3.44 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.216 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -37.57 13.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.28 -57.66 11.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.154 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.7 m -60.96 -25.89 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.478 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 61' ' ' VAL . 6.0 tttp -81.22 -18.21 46.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.531 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.7 -30.12 8.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 88' ' ' ALA . 4.7 pt -82.17 -23.45 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.197 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -68.95 -35.37 76.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 mmpm? -59.25 -27.51 65.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.888 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.82 35.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.934 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.83 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.06 -165.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.481 ' HE2' HG23 ' A' ' 112' ' ' THR . 59.2 t80 -110.98 25.09 12.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.303 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.8 OUTLIER 85.37 161.9 0.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.653 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.739 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -95.36 95.07 8.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.306 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.695 HD23 HD13 ' A' ' 79' ' ' ILE . 20.2 tp -49.88 98.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.541 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.62 75.82 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -151.58 59.26 3.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.76 90.42 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.604 2.203 . . . . 0.0 112.411 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.32 -71.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.47 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 15.3 p -159.85 42.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.61 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 106' ' ' VAL . 7.2 p 48.01 15.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.473 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.76 -43.66 18.07 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -62.24 -34.83 77.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.307 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.615 ' HD2' HG23 ' A' ' 106' ' ' VAL . 1.6 t80 -63.32 -46.44 86.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.167 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.424 ' CD1' ' CG2' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -48.91 -37.26 19.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.456 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.21 -45.79 72.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.328 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.661 ' CG2' HD12 ' A' ' 77' ' ' ILE . 86.8 m -46.46 -40.79 12.92 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.399 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.709 ' CD1' HG11 ' A' ' 4' ' ' VAL . 12.9 mm -62.32 -65.68 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.716 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -14.9 3.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.743 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.442 ' CD2' ' HG3' ' A' ' 119' ' ' GLU . 1.9 t-160 -89.25 -30.92 18.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.112 0.482 . . . . 0.0 109.718 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -79.44 -33.94 42.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.385 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 14.8 m-85 -70.26 -29.59 66.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.59 -35.67 9.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.815 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.442 ' HG3' ' CD2' ' A' ' 115' ' ' HIS . 2.0 mm-40 -91.61 18.78 6.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.653 0.263 . . . . 0.0 111.593 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.498 ' CG ' HG22 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -154.65 38.11 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 110.83 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.816 0.341 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 61.88 108.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.52 120.26 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.609 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.653 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.9 t -116.28 159.0 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.772 HD11 ' HD3' ' A' ' 40' ' ' LYS . 49.8 tp -109.58 129.66 55.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.896 HG21 ' CD1' ' A' ' 17' ' ' LEU . 24.6 t -115.38 89.45 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.673 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.13 115.21 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.137 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -149.35 143.15 25.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.403 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -87.44 50.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.99 5.43 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.437 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.6 148.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.809 0.338 . . . . 0.0 110.976 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m 54.03 178.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.936 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.582 HG23 HG21 ' A' ' 30' ' ' THR . 10.6 mm -52.93 163.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.867 0.365 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.508 ' N ' HG22 ' A' ' 13' ' ' ILE . 52.6 p -86.09 158.23 19.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.015 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.8 136.3 47.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.138 0.494 . . . . 0.0 112.028 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.653 ' CB ' HG11 ' A' ' 106' ' ' VAL . 1.4 m 74.26 0.57 3.63 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.364 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.984 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.05 -53.35 4.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.859 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 t -44.57 -55.56 5.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.29 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.935 HD11 HG13 ' A' ' 106' ' ' VAL . 64.6 mt -65.22 -69.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.984 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.97 -30.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.51 -30.32 67.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.965 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -34.71 30.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 110.273 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.845 ' HG3' HD21 ' A' ' 110' ' ' LEU . 10.1 mm-40 -83.41 -36.98 23.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.08 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.11 54.26 1.77 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.269 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -108.59 -173.3 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.06 0.457 . . . . 0.0 111.241 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.42 88.8 33.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.219 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HG3' HD13 ' A' ' 21' ' ' LEU . 85.1 Cg_endo -80.93 130.98 7.75 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.653 2.235 . . . . 0.0 112.811 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.4 t70 -105.57 5.04 30.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.347 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.79 HG22 ' HB ' ' A' ' 6' ' ' VAL . 10.4 p 2.14 124.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.786 ' HB2' ' CD ' ' A' ' 40' ' ' LYS . . . -106.71 -163.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.625 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -118.14 -36.45 3.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -158.56 179.94 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD22 ' CD2' ' A' ' 63' ' ' PHE . 56.3 mt -60.03 -47.41 85.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.92 -45.26 86.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.542 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -70.87 -32.15 69.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -75.19 -28.97 60.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 55.4 mt-10 -72.1 -39.95 68.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -32.26 69.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.688 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.786 ' CD ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -78.31 -37.6 44.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.773 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 37' ' ' ALA . 21.7 mt -76.97 -27.16 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -5.48 30.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.776 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.03 -27.38 10.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.6 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -134.83 156.38 49.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 69.1 t80 -91.66 96.46 10.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.947 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 38.9 m-85 -79.76 122.49 83.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.341 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.71 -20.5 7.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.511 2.141 . . . . 0.0 111.934 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.653 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.9 t -148.31 133.82 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.17 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.699 HG23 HD23 ' A' ' 5' ' ' LEU . 6.2 mm -121.01 163.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 60.1 t -154.06 99.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.843 ' HB3' HG13 ' A' ' 78' ' ' VAL . 42.5 tp -79.6 163.3 24.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 8.7 t70 -151.17 88.84 1.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.224 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.9 m -67.63 66.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.652 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -58.32 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.43 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.692 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.8 OUTLIER -152.5 49.5 0.53 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.104 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.692 ' HD3' ' N ' ' A' ' 55' ' ' MET . 36.6 Cg_endo -94.53 -162.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.09 2.527 . . . . 0.0 112.293 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -152.08 43.64 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.92 -21.26 5.02 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.815 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.434 ' OD1' HG23 ' A' ' 61' ' ' VAL . 0.4 OUTLIER 63.97 123.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.758 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -94.65 11.98 69.28 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.971 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 90' ' ' LYS . 46.5 t -68.78 -41.9 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.851 0.358 . . . . 0.0 111.045 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.28 4.79 49.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.85 ' CE2' HD11 ' A' ' 67' ' ' ILE . 24.8 t80 -90.09 -36.63 14.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.285 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.518 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.2 mp -47.05 -29.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.366 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -35.35 47.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 29.8 t80 -59.88 -41.36 91.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.85 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.2 mp -61.57 -43.46 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.212 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -25.89 58.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.396 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -63.84 -39.98 95.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 16.38 11.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.428 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -166.56 70.13 1.09 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.817 0.341 . . . . 0.0 110.822 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.46 -18.4 29.58 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.795 2.33 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.75 27.19 9.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.989 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.7 t -104.4 -159.82 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.395 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 48' ' ' VAL . 52.4 t -150.11 135.15 10.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 111.695 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.763 HG12 HG23 ' A' ' 78' ' ' VAL . 8.2 t -110.53 116.05 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.643 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.793 HG21 HG21 ' A' ' 112' ' ' THR . 16.1 mm -118.49 50.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 51' ' ' LEU . 44.7 t -49.64 115.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.677 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -110.26 179.16 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.749 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.723 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.4 m 81.73 110.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.832 0.348 . . . . 0.0 110.995 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.62 109.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.49 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -95.74 162.54 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.35 -153.87 31.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.523 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -59.76 129.93 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 m -71.74 64.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -94.84 -19.88 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -34.31 23.61 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.49 -59.38 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.846 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.8 m -55.39 -28.02 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.096 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 61' ' ' VAL . 14.4 tttt -80.13 -9.16 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.414 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -120.08 -31.41 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.953 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.3 pt -79.21 -44.72 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.738 0.304 . . . . 0.0 111.417 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.42 ' N ' HG13 ' A' ' 92' ' ' ILE . 27.8 mttp -63.21 -17.93 62.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.782 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -25.87 52.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.2 -16.13 0.29 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.629 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -59.17 -179.65 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.41 0.605 . . . . 0.0 111.043 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 85.1 t80 -99.81 -7.8 24.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.785 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.561 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 17.9 pt-20 140.99 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.276 0.63 . . . . 0.0 110.663 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.563 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.41 91.11 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.751 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.662 ' HB3' HG23 ' A' ' 79' ' ' ILE . 14.6 tp -55.64 167.34 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -93.0 116.21 28.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -57.58 -58.09 20.71 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.089 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 28.6 Cg_endo -62.7 -164.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.385 2.057 . . . . 0.0 112.141 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 74.95 -72.99 0.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.0 t 174.46 164.2 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.985 0.422 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.935 HG13 HD11 ' A' ' 20' ' ' ILE . 7.3 p -88.66 -28.82 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.8 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -44.96 -31.94 1.46 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.939 0.4 . . . . 0.0 110.481 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.426 ' HA ' HD13 ' A' ' 111' ' ' LEU . 4.6 mmt180 -70.17 -41.44 73.79 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.679 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 3.7 t80 -55.02 -29.26 57.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.954 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -56.36 -39.74 73.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.764 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 108' ' ' ARG . 8.2 mp -59.21 -60.03 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.793 HG21 HG21 ' A' ' 77' ' ' ILE . 80.0 m -44.12 -48.38 9.07 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.148 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.679 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 40.7 mm -54.76 -73.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.603 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -17.75 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -90.13 -20.81 22.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.4 -47.24 12.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.282 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 48' ' ' VAL . 57.7 m-85 -56.8 -29.86 63.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.103 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -57.48 -22.3 42.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -97.03 29.97 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 20.9 t80 -119.75 29.43 7.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.756 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.797 0.332 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 17.1 mmtm 61.59 99.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.072 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.9 134.65 23.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.597 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.627 HG13 ' HB ' ' A' ' 48' ' ' VAL . 10.9 t -125.34 160.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.572 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 61.5 tp -112.93 128.59 56.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.845 HG21 HD12 ' A' ' 17' ' ' LEU . 44.4 t -108.47 90.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.31 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.865 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 19.1 t -86.89 119.4 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.159 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -158.93 139.67 12.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.495 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.417 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 43.4 t0 -90.24 50.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.897 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -152.23 104.48 2.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 61.15 167.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.059 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.3 p -58.16 -56.65 19.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.851 ' CD1' HG21 ' A' ' 30' ' ' THR . 7.6 mm -112.4 161.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.047 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.485 ' N ' HG22 ' A' ' 13' ' ' ILE . 57.4 p -90.51 138.44 31.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.577 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 p -63.37 140.59 58.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.9 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.734 ' HB2' HG11 ' A' ' 106' ' ' VAL . 2.5 m 79.37 -5.36 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.563 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.019 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.18 -49.06 6.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.322 . . . . 0.0 110.922 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.2 p -47.68 -49.24 28.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -50.79 68.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.745 HG23 HD11 ' A' ' 110' ' ' LEU . 91.4 mt -54.2 -69.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.162 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.019 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -45.08 -33.65 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.18 -28.82 65.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -83.07 -35.65 25.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.848 ' HG3' HD21 ' A' ' 110' ' ' LEU . 69.4 mm-40 -78.21 -38.72 42.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.943 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.58 26.58 7.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.354 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 49.2 m-85 -84.25 -174.94 5.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.989 0.423 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -133.13 86.57 41.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' A' ' 21' ' ' LEU . 95.2 Cg_endo -81.38 129.54 6.69 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.663 2.242 . . . . 0.0 112.442 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 30' ' ' THR . 10.0 t70 -106.92 -4.65 18.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 112.049 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.851 HG21 ' CD1' ' A' ' 13' ' ' ILE . 69.2 p 43.72 174.54 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.703 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.865 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -164.01 170.43 16.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.419 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -104.76 -40.75 5.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -161.86 -174.49 4.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.571 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.687 HD22 ' CD2' ' A' ' 63' ' ' PHE . 45.8 mt -65.26 -41.34 94.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.708 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -61.53 -49.29 77.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 109.989 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.86 -34.85 77.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.57 -26.85 63.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 27.4 mt-10 -69.97 -46.62 64.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.873 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -62.28 -32.96 73.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.223 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -77.95 -40.36 39.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.229 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.661 HD12 ' HZ ' ' A' ' 63' ' ' PHE . 96.6 mt -76.87 -29.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 111.308 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.27 -25.84 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.358 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.79 -60.43 1.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.082 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -59.4 129.34 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.14 80.9 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 56.8 m-85 -78.77 119.2 76.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 95.8 Cg_endo -78.97 -22.11 8.96 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.512 2.141 . . . . 0.0 111.958 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.627 ' HB ' HG13 ' A' ' 4' ' ' VAL . 4.6 t -145.43 127.6 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.623 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.546 HG23 HD23 ' A' ' 5' ' ' LEU . 11.8 mm -113.98 152.09 15.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.827 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.79 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 84.5 t -139.56 94.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.168 0.508 . . . . 0.0 110.682 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 78' ' ' VAL . 37.6 tp -76.75 160.27 29.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.592 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 5.1 t0 -153.55 79.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.984 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.784 HG22 ' HB ' ' A' ' 80' ' ' THR . 28.6 m -59.24 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.283 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.432 ' CG ' ' N ' ' A' ' 55' ' ' MET . 14.8 t90 -63.41 -90.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.649 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.5 tpt -148.5 51.68 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.87 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.649 ' HD3' ' N ' ' A' ' 55' ' ' MET . 44.5 Cg_endo -92.54 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.898 2.399 . . . . 0.0 112.676 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -170.22 -68.5 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.785 0.326 . . . . 0.0 111.296 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.36 159.35 3.99 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.97 23.72 14.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.05 10.24 8.81 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.779 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 64' ' ' ILE . 27.3 t -84.34 -44.39 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.512 0.656 . . . . 0.0 110.964 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -68.39 -13.52 62.35 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.856 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.687 ' CD2' HD22 ' A' ' 34' ' ' LEU . 4.7 t80 -86.88 -27.45 23.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.315 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 61' ' ' VAL . 15.2 mm -47.59 -46.05 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.0 111.204 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -42.42 93.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.523 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 26.6 t80 -58.71 -29.97 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.113 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 1.065 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mm -64.71 -48.44 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.491 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -82.04 -14.28 56.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.24 -39.37 68.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.917 0.389 . . . . 0.0 110.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.48 11.48 9.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -157.43 66.62 3.77 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 110.673 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.0 Cg_exo -70.17 -19.49 34.12 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.745 2.297 . . . . 0.0 112.207 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.39 29.74 6.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.675 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 35.1 t -111.83 -162.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.757 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.44 HG22 ' CD2' ' A' ' 120' ' ' TYR . 25.8 t -151.51 134.41 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.035 0.445 . . . . 0.0 111.81 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.065 HG22 HG21 ' A' ' 67' ' ' ILE . 2.0 t -111.44 111.79 37.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.756 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.626 HD13 ' HB3' ' A' ' 97' ' ' TYR . 37.5 mm -92.83 -42.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.309 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.014 HG23 HG12 ' A' ' 76' ' ' VAL . 40.7 t 46.0 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.271 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 100' ' ' LEU . 31.8 mt -56.3 -101.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.212 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.784 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.1 p 68.87 -168.93 0.18 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 110.752 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.54 -151.02 18.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.557 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.0 43.2 9.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.389 . . . . 0.0 110.903 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 175.28 -62.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 m -130.85 -173.59 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.761 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.9 m -152.01 28.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.258 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -89.67 -60.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.729 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.645 HG23 ' CE2' ' A' ' 99' ' ' PHE . 5.3 t -46.09 -32.77 3.06 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.139 0.495 . . . . 0.0 110.305 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.902 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.24 -60.27 3.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.086 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 86' ' ' ASP . 28.0 m -61.88 -24.43 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.223 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.456 ' CD ' HG21 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -81.23 -32.48 33.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.14 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.17 -34.92 14.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.48 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.902 HG23 ' O ' ' A' ' 88' ' ' ALA . 2.7 pt -80.3 157.19 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.781 0.324 . . . . 0.0 110.754 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 mttm 72.42 6.1 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.162 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.49 26.66 5.35 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 110.565 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.62 -18.82 5.97 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.402 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -84.96 -169.8 2.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 111.248 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.626 ' HB3' HD13 ' A' ' 77' ' ' ILE . 82.9 t80 -125.72 29.77 5.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.923 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 80.95 138.72 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.921 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.655 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.6 m-85 -66.08 128.97 38.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.061 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -71.93 118.11 14.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.92 171.86 14.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.503 ' N ' ' HD3' ' A' ' 103' ' ' PRO . 25.9 mmtt 63.44 60.29 1.9 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.034 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 102' ' ' LYS . 17.7 Cg_exo -65.24 -10.67 26.75 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.597 2.198 . . . . 0.0 112.721 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -73.64 -56.65 4.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -95.62 119.11 33.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.952 HG21 HD23 ' A' ' 17' ' ' LEU . 7.4 p -78.32 -30.26 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -45.23 -34.1 2.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.6 -39.99 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.9 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.79 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 1.5 t80 -56.39 -30.45 62.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.961 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.848 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -51.81 -42.84 62.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.229 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.427 ' H ' HD12 ' A' ' 111' ' ' LEU . 7.3 mp -57.61 -58.76 6.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.055 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.54 HG21 HD22 ' A' ' 100' ' ' LEU . 94.0 m -46.94 -41.28 15.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.76 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 23.0 mm -54.13 -68.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.313 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -15.51 7.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.839 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -90.27 -22.3 21.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -84.31 -37.75 21.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.06 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.419 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -66.84 -34.42 77.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.037 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -81.43 -22.49 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.311 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -88.99 11.38 18.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.598 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.44 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -154.27 38.99 0.45 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 0.0 110.886 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.78 0.324 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -157.3 121.61 4.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.931 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.5 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -143.98 139.98 29.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.966 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.547 HG13 ' HB ' ' A' ' 48' ' ' VAL . 78.2 t -128.56 155.18 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.959 0.409 . . . . 0.0 111.065 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.077 HD23 HG23 ' A' ' 49' ' ' ILE . 40.6 tp -115.19 134.55 55.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.75 HG21 HD12 ' A' ' 17' ' ' LEU . 14.4 t -120.35 102.61 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.986 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.463 ' HB ' HD12 ' A' ' 51' ' ' LEU . 31.9 t -93.21 117.73 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.576 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 23.1 t0 -159.5 157.47 30.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . 26.6 t70 -89.6 51.12 2.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.181 0.515 . . . . 0.0 110.569 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.71 137.54 50.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.515 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.94 154.19 20.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.93 53.17 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.204 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.641 HG23 HG21 ' A' ' 30' ' ' THR . 21.3 mm 57.1 168.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.588 ' N ' HG22 ' A' ' 13' ' ' ILE . 20.6 p -90.26 118.61 29.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.225 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 52.8 p -50.06 141.74 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.619 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.588 ' CB ' HG11 ' A' ' 106' ' ' VAL . 1.3 m 85.95 -20.93 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.196 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.094 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -86.99 -47.12 9.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -50.33 -47.42 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.32 74.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.694 HG23 ' CD1' ' A' ' 110' ' ' LEU . 97.8 mt -58.12 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.094 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -45.12 -32.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.388 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.06 -29.79 63.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -83.52 -35.76 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.563 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.874 ' HG3' HD21 ' A' ' 110' ' ' LEU . 65.1 mm-40 -75.33 -35.49 61.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.21 44.4 2.79 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.529 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 53.6 m-85 -102.97 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 81.46 67.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.429 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.631 ' HB3' HD22 ' A' ' 21' ' ' LEU . 91.8 Cg_endo -83.12 142.11 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.78 2.32 . . . . 0.0 113.468 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.639 ' O ' HD12 ' A' ' 5' ' ' LEU . 24.2 t0 -136.23 65.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.373 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 6' ' ' VAL . 10.5 p -56.14 133.29 52.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.832 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.07 -160.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.336 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 33' ' ' THR . 3.7 mttt -120.66 -30.17 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.622 0.248 . . . . 0.0 111.336 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 32' ' ' LYS . 3.1 p -163.18 179.2 7.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.707 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.724 HD22 ' CD2' ' A' ' 63' ' ' PHE . 9.0 mt -61.45 -40.2 93.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.52 69.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 110.093 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -61.6 -33.53 74.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.196 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.68 -57.41 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 38.3 mt-10 -46.77 -41.13 14.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.766 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -43.41 95.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -44.44 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.854 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mt -71.17 -19.83 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.41 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -22.96 31.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -129.92 -59.38 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.88 114.45 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -79.83 67.05 5.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 46.0 m-85 -57.63 132.53 82.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 1.1 Cg_endo -77.74 -36.0 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.544 2.163 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.568 ' O ' HD13 ' A' ' 49' ' ' ILE . 20.0 t -125.82 133.93 67.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.077 HG23 HD23 ' A' ' 5' ' ' LEU . 1.8 mm -132.67 102.13 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.666 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 77' ' ' ILE . 31.0 t -100.47 125.61 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.279 . . . . 0.0 110.976 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.641 ' HB3' HG13 ' A' ' 78' ' ' VAL . 37.7 tp -90.53 161.49 15.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.45 . . . . 0.0 110.842 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -152.8 93.14 1.72 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.623 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 53' ' ' VAL . 57.2 t -73.9 63.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.404 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -63.39 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.319 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 35.6 mmm -139.71 37.19 0.27 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.648 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 55' ' ' MET . 92.8 Cg_endo -79.24 -165.42 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.294 1.996 . . . . 0.0 112.278 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -134.37 27.36 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.53 -86.64 1.9 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 59.16 54.37 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.69 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.35 110.49 3.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.831 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.863 ' O ' HD12 ' A' ' 64' ' ' ILE . 99.0 t -63.22 -36.13 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -6.53 48.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.61 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.0 ' CE2' HD11 ' A' ' 67' ' ' ILE . 48.3 t80 -62.07 -38.07 87.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.698 0.285 . . . . 0.0 111.165 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.863 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mt -48.57 -30.2 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.154 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.39 -34.01 63.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.651 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 26.8 t80 -61.2 -44.27 97.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 1.0 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -60.85 -41.2 87.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.393 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -21.0 46.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -68.03 -37.29 81.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.33 9.04 10.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.309 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.64 67.26 2.54 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.51 -18.93 33.15 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.702 2.268 . . . . 0.0 112.233 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -102.18 30.35 4.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.714 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.4 t -117.93 -179.79 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.797 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.6 143.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.574 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 67' ' ' ILE . 2.6 t -123.01 100.31 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.888 0.375 . . . . 0.0 110.976 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.824 ' O ' HG13 ' A' ' 50' ' ' VAL . 12.2 mm -104.18 74.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.641 HG13 ' HB3' ' A' ' 51' ' ' LEU . 19.6 t -67.79 118.75 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 100' ' ' LEU . 17.1 mt -125.83 157.97 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.479 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.455 HG22 HG23 ' A' ' 53' ' ' VAL . 25.1 p -156.55 28.22 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.117 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.45 ' H ' HG22 ' A' ' 79' ' ' ILE . . . 54.58 -125.02 33.44 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.652 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.3 136.5 42.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.827 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.74 147.85 8.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m 59.89 85.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.15 -31.29 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.32 -23.64 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.092 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -35.38 76.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -55.32 -59.16 5.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' HG12 ' A' ' 92' ' ' ILE . 26.3 m -62.38 -34.74 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.996 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.618 ' HD3' HG21 ' A' ' 61' ' ' VAL . 5.7 tttm -72.67 -10.67 60.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.603 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.543 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -106.9 -27.97 10.37 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.906 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.3 pt -88.17 -35.75 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -61.25 -31.33 71.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.678 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.844 ' HB2' HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -60.32 -65.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.744 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 25.69 0.08 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.044 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.38 -167.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.834 0.317 . . . . 0.0 110.897 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.661 ' HB3' HD13 ' A' ' 77' ' ' ILE . 62.0 t80 -108.98 -17.56 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.31 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 13.1 pt-20 152.01 -173.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.244 0.617 . . . . 0.0 110.375 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -122.66 90.45 3.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.565 179.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.718 ' O ' HG23 ' A' ' 79' ' ' ILE . 9.1 tp -50.46 107.82 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.34 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -95.09 -170.37 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.1 mttt 60.71 80.13 0.27 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.26 -177.1 1.87 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.506 2.138 . . . . 0.0 112.221 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 59.99 31.41 20.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.3 m -160.69 76.38 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.887 HG21 HD23 ' A' ' 17' ' ' LEU . 10.5 p -76.62 -28.61 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.06 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.06 -37.03 19.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 tpt85 -68.17 -40.07 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.768 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 50' ' ' VAL . 2.0 t80 -57.46 -27.09 62.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.992 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.874 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.2 tt -57.71 -48.4 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.137 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.4 mp -52.64 -53.19 50.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.307 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 m -51.89 -58.61 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.387 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 9.0 mm -32.93 -63.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.969 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -59.58 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -51.46 -27.54 10.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.688 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -71.56 -35.34 70.58 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.817 0.341 . . . . 0.0 111.033 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.7 -39.18 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.978 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.37 -36.63 33.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.274 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -74.11 -6.46 47.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.634 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.37 42.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 110.869 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.853 0.358 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 3.6 mptt -121.56 125.17 46.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 124.21 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.71 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.638 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.5 t -122.64 143.75 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.992 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.516 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 20.3 tp -90.12 132.5 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.746 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.73 HG21 ' CD1' ' A' ' 17' ' ' LEU . 14.0 t -119.3 89.59 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.66 114.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 31.6 t0 -155.09 152.1 29.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.5 48.73 1.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.85 -167.16 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.677 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -74.03 -46.67 41.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.829 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.33 -78.45 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.069 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.622 HD13 HG21 ' A' ' 30' ' ' THR . 9.4 mm -95.34 163.24 2.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.306 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.501 HG23 ' CG1' ' A' ' 6' ' ' VAL . 81.3 p -90.14 164.9 14.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.218 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 t -71.42 131.9 44.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.961 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.452 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.8 m 77.35 -5.84 2.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.511 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.39 -55.15 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.063 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.458 ' CB ' HG21 ' A' ' 13' ' ' ILE . 1.5 t -47.07 -56.99 5.53 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.373 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.41 -39.2 64.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.05 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.879 HD12 HG23 ' A' ' 106' ' ' VAL . 45.2 mt -64.56 -66.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.304 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.953 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.62 -29.73 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -69.92 -28.82 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.902 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.79 -36.06 23.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.487 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.842 ' HG3' HD21 ' A' ' 110' ' ' LEU . 6.8 mm-40 -81.73 -39.0 24.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.39 31.89 5.97 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.177 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 4.9 m-85 -81.66 -172.79 4.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 88.76 25.4 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HG3' HD13 ' A' ' 21' ' ' LEU . 74.3 Cg_endo -78.63 129.35 9.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.469 2.113 . . . . 0.0 112.592 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 30' ' ' THR . 18.2 t70 -99.96 2.17 43.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.754 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.703 HG22 ' HB ' ' A' ' 6' ' ' VAL . 3.2 p 1.76 124.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.93 -160.65 0.73 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.349 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 19.0 mttp -113.65 -31.94 6.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -163.12 -175.28 4.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.745 HD22 ' CD2' ' A' ' 63' ' ' PHE . 9.6 mt -63.23 -44.23 95.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.638 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.03 -54.02 51.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.195 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.119 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.488 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.44 -28.62 64.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.772 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 19.0 mt-10 -71.47 -43.18 67.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -33.23 75.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.009 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -75.59 -35.35 60.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 37' ' ' ALA . 20.3 mt -76.03 -26.39 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.787 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -77.77 -5.4 50.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.26 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -101.07 -51.74 3.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.764 0.316 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.918 HD11 ' CE1' ' A' ' 46' ' ' PHE . 3.0 pp -117.69 -179.61 3.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.077 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.6 ' N ' HD12 ' A' ' 44' ' ' LEU . 1.7 t80 -107.14 111.02 23.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.918 ' CE1' HD11 ' A' ' 44' ' ' LEU . 64.0 m-85 -98.08 113.01 63.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.406 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HG2' ' CE2' ' A' ' 117' ' ' PHE . 63.6 Cg_endo -73.15 -19.38 22.78 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.659 2.239 . . . . 0.0 111.929 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.5 t -148.63 134.23 11.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.422 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.408 HD12 HD23 ' A' ' 5' ' ' LEU . 23.4 mm -116.89 157.15 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.425 HG21 ' CE1' ' A' ' 109' ' ' PHE . 43.1 t -151.42 101.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.183 0.516 . . . . 0.0 112.073 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.455 ' HB3' HG13 ' A' ' 78' ' ' VAL . 14.1 tp -75.03 168.63 19.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.797 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -127.37 -47.27 1.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.674 0.273 . . . . 0.0 111.404 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 53' ' ' VAL . 23.2 t 68.54 37.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.965 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -63.92 -82.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.53 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.704 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.2 ttm -152.1 47.69 0.42 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.358 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.704 ' HD3' ' N ' ' A' ' 55' ' ' MET . 29.3 Cg_endo -95.05 -161.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.06 2.507 . . . . 0.0 112.162 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.32 29.68 7.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.65 -97.79 2.08 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.601 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 55.36 54.21 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.418 . . . . 0.0 110.535 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' H ' HD11 ' A' ' 34' ' ' LEU . . . -100.1 106.66 3.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.746 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.691 HG21 ' HD2' ' A' ' 90' ' ' LYS . 97.0 t -63.69 -32.47 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.825 0.345 . . . . 0.0 111.012 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -3.77 48.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.754 ' CE2' HD11 ' A' ' 67' ' ' ILE . 23.6 t80 -60.77 -31.38 70.73 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.578 0.228 . . . . 0.0 110.987 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -46.74 -38.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.59 -53.29 56.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 20.1 t80 -51.11 -30.75 17.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.059 0.457 . . . . 0.0 110.217 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.838 HG21 HG22 ' A' ' 76' ' ' VAL . 3.8 mm -64.87 -53.34 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -74.21 -19.05 60.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.851 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.17 -44.62 83.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.867 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.56 10.19 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.436 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.69 66.62 2.79 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.777 0.322 . . . . 0.0 110.832 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.54 -19.62 32.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.84 2.36 . . . . 0.0 112.305 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -107.33 34.66 3.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 48.5 t -116.35 -158.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' A' ' 48' ' ' VAL . 39.2 t -150.57 135.58 10.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-O 120.917 0.389 . . . . 0.0 111.449 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.838 HG22 HG21 ' A' ' 67' ' ' ILE . 1.7 t -112.53 106.85 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.414 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' A' ' 97' ' ' TYR . 36.5 mm -89.0 -49.38 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.72 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.821 HG23 HG12 ' A' ' 76' ' ' VAL . 59.3 t 52.69 81.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.363 . . . . 0.0 111.104 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 77' ' ' ILE . 2.4 mt -105.39 155.11 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.1 p -149.95 122.88 8.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.84 0.353 . . . . 0.0 111.006 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.6 95.17 2.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.604 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -165.78 -44.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.26 55.25 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.536 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 p -131.47 124.91 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 0.0 110.921 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.09 -30.44 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.221 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.86 -26.47 65.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.5 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.5 t -75.55 -33.26 60.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -59.94 -59.28 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.99 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 92' ' ' ILE . 18.0 m -58.78 -21.48 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.018 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.691 ' HD2' HG21 ' A' ' 61' ' ' VAL . 22.3 ttpt -83.85 -9.65 58.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.591 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.32 -33.93 4.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.873 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 12.2 pt -73.05 -38.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.673 0.273 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -25.29 64.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.636 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.6 -57.54 3.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.11 33.45 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.19 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.873 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.11 -164.29 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 110.727 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.582 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.1 t80 -108.53 25.32 11.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.245 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.443 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 82.49 17.98 0.33 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.013 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.586 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 57.56 166.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 111.25 179.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -119.56 122.17 41.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -170.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.786 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.0 80.41 0.24 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.784 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.36 -2.95 12.49 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.723 2.282 . . . . 0.0 113.004 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.75 -57.11 4.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.097 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -143.5 168.26 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.053 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.879 HG23 HD12 ' A' ' 20' ' ' ILE . 34.3 m -91.31 3.63 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.562 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -41.46 -44.7 2.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.815 0.341 . . . . 0.0 111.225 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -36.07 74.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.138 0.494 . . . . 0.0 109.816 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.639 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 1.4 t80 -56.17 -23.97 38.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.842 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -62.23 -49.2 76.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.663 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.0 mp -57.09 -57.68 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.49 HG23 ' HE2' ' A' ' 97' ' ' TYR . 97.4 m -54.47 -43.68 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -41.8 -54.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.011 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 0.0 109.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -55.87 -24.89 39.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -67.55 -37.68 83.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 111.049 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.572 ' CE1' HG21 ' A' ' 48' ' ' VAL . 27.4 m-85 -75.57 -17.49 60.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.956 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -109.86 -27.78 9.1 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -75.73 -4.68 41.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.706 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.447 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -131.9 38.24 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.021 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.771 0.319 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.457 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 6.0 mptt 61.08 99.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 126.25 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.726 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.652 HG13 ' HB ' ' A' ' 48' ' ' VAL . 23.8 t -122.47 152.53 26.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 110.867 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.641 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 47.0 tp -103.48 135.33 45.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.856 ' HB ' HG22 ' A' ' 30' ' ' THR . 15.1 t -120.74 89.01 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.69 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.509 ' HB ' HD12 ' A' ' 51' ' ' LEU . 21.2 t -78.88 115.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.716 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 22.5 t70 -155.27 163.24 40.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.313 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -83.8 48.75 1.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.987 0.422 . . . . 0.0 111.08 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -117.16 167.71 10.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.674 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.48 -81.52 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.054 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 13' ' ' ILE . 10.4 m -107.11 113.76 27.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.723 ' HA ' HG21 ' A' ' 30' ' ' THR . 14.0 mm 49.62 163.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.508 0.671 . . . . 0.0 112.312 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.621 HG21 ' CG1' ' A' ' 6' ' ' VAL . 60.7 p -90.91 165.53 13.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.302 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.5 t -83.77 134.96 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 111.679 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m 81.35 -10.38 1.19 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.306 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.938 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.15 -50.67 5.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 110.613 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.06 -54.95 7.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.86 66.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.777 HD11 HG13 ' A' ' 106' ' ' VAL . 70.8 mt -69.22 -69.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.309 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -45.72 -32.7 2.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.486 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -27.83 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.013 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -82.94 -35.56 25.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.441 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.916 ' HG3' HD21 ' A' ' 110' ' ' LEU . 2.9 mm-40 -81.31 -31.87 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.988 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.2 29.83 6.58 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.189 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CE1' ' CG ' ' A' ' 2' ' ' LYS . 46.1 m-85 -86.31 -173.97 4.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.049 0.452 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -138.25 89.36 14.3 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.037 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HB3' HD13 ' A' ' 21' ' ' LEU . 73.3 Cg_endo -77.95 132.38 11.7 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.54 2.16 . . . . 0.0 112.594 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -104.5 -4.31 22.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.193 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.856 HG22 ' HB ' ' A' ' 6' ' ' VAL . 43.0 p 12.95 121.75 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.38 156.35 21.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.364 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.688 ' O ' HG23 ' A' ' 33' ' ' THR . 2.2 mtmp? -80.68 -28.36 36.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 111.054 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -167.93 178.76 5.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.615 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 63' ' ' PHE . 16.6 mt -57.5 -33.12 67.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -56.32 18.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.22 -29.43 70.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.33 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -72.9 -29.02 62.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 26.5 mt-10 -71.19 -41.23 70.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 109.903 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -33.9 76.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -77.83 -35.91 50.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.854 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 37' ' ' ALA . 19.9 mt -78.47 -25.17 13.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.812 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -90.26 28.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.257 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -146.17 -46.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.531 HD22 ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -113.55 155.52 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.451 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 9.1 t80 -85.5 90.42 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.332 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.641 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 9.5 m-85 -76.66 113.82 33.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.55 -23.8 9.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.472 2.115 . . . . 0.0 112.146 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.652 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.6 t -146.58 133.41 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.625 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.582 HG23 HD23 ' A' ' 5' ' ' LEU . 23.8 mm -115.96 150.01 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.098 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.633 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 77.9 t -142.78 100.06 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.398 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.589 HD23 HG13 ' A' ' 78' ' ' VAL . 8.9 tp -86.09 149.1 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 t0 -140.2 107.15 5.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 53' ' ' VAL . 20.3 m -75.31 61.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.673 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -69.58 -79.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.801 0.334 . . . . 0.0 110.391 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.697 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 6.1 ttt -153.72 49.96 0.53 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.983 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.697 ' HD3' ' N ' ' A' ' 55' ' ' MET . 19.5 Cg_endo -93.47 -159.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.143 2.562 . . . . 0.0 112.119 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -142.61 38.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.22 -82.24 1.65 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.34 68.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.824 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.42 93.29 0.66 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.641 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.625 HG21 ' HD3' ' A' ' 90' ' ' LYS . 81.6 t -58.96 -33.84 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.927 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.19 -0.85 42.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.682 ' CD2' HD22 ' A' ' 34' ' ' LEU . 12.6 t80 -60.15 -38.13 82.2 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.8 mp -46.44 -42.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -43.03 95.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.134 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HD1' HD13 ' A' ' 67' ' ' ILE . 12.1 t80 -57.84 -33.66 68.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.762 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mm -65.12 -53.65 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.266 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -72.69 -16.71 61.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.727 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.27 -44.29 72.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.53 13.07 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.326 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.42 66.57 1.86 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.37 -18.75 29.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.754 2.302 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -106.57 31.35 5.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.666 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.9 t -111.41 -158.3 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.545 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 48' ' ' VAL . 46.7 t -149.64 136.24 12.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.099 0.476 . . . . 0.0 111.777 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 67' ' ' ILE . 16.4 t -114.13 115.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.674 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mm -100.95 -47.47 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.75 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG23 HG12 ' A' ' 76' ' ' VAL . 59.9 t 49.74 86.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.314 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.639 HG23 ' HB3' ' A' ' 100' ' ' LEU . 8.9 mt -94.22 162.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.915 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.497 ' HB ' HG22 ' A' ' 53' ' ' VAL . 48.4 p -156.52 156.49 33.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.09 -169.3 11.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.474 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.04 -77.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.777 0.322 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -159.15 108.09 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.519 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -170.43 119.17 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 0.0 110.929 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.44 -52.09 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.074 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.79 -12.62 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.429 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.8 t -78.78 -35.45 44.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.069 0.461 . . . . 0.0 109.864 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.8 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -58.54 -58.55 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.091 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.32 -25.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.769 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.625 ' HD3' HG21 ' A' ' 61' ' ' VAL . 1.5 ttmp? -90.06 39.01 0.95 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.556 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -170.26 -39.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.99 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.9 pt -74.88 -42.46 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -21.46 63.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.781 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -73.95 -27.65 61.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.17 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.29 -18.29 0.38 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.378 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.99 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.9 176.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.152 0.476 . . . . 0.0 111.464 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 74.4 t80 -97.6 26.14 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.456 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.479 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.6 OUTLIER 77.44 146.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.117 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.652 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.9 OUTLIER -65.83 138.87 58.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.908 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 101' ' ' GLU . 1.5 tm? -68.93 137.94 54.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.502 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.881 ' N ' HD13 ' A' ' 100' ' ' LEU . 1.8 mp0 -49.89 123.71 8.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.244 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.3 mptp? -57.02 -55.04 48.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.337 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 19.8 Cg_endo -58.71 -178.07 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.359 2.039 . . . . 0.0 112.111 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 62.22 147.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.724 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 t -73.5 171.29 13.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.777 HG13 HD11 ' A' ' 20' ' ' ILE . 9.5 p -55.42 -32.08 28.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.081 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.2 -36.18 3.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.95 0.405 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HA ' HD13 ' A' ' 111' ' ' LEU . 2.1 tpm_? -67.29 -41.03 86.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.776 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.633 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 24.4 t80 -57.54 -27.27 62.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.153 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.916 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -60.07 -47.81 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.243 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.5 mp -51.79 -52.6 47.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.187 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.8 m -57.41 -45.92 84.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.14 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.9 mm -45.47 -56.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.587 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.29 -62.57 1.42 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -49.56 -27.34 4.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.926 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -67.73 -29.55 68.81 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.914 0.388 . . . . 0.0 110.782 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 61.6 m-85 -89.67 -26.45 20.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.818 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.36 -41.35 7.87 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -91.41 27.16 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.685 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.633 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -161.85 38.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 0.0 110.872 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.831 0.348 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HD2' ' CD2' ' A' ' 117' ' ' PHE . 5.1 mmtm -138.22 140.0 39.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.566 ' HB3' ' CB ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -175.43 93.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 48' ' ' VAL . 18.3 t -77.41 160.49 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 29' ' ' ASP . 60.7 tp -117.07 135.09 53.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.31 90.66 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.732 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.596 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 16.6 t -88.91 121.44 39.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.342 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -157.37 141.16 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.859 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.51 48.8 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 7.8 tp10 -176.72 163.89 2.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.801 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.48 43.51 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.94 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.65 -86.21 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.425 HG22 ' HB3' ' A' ' 17' ' ' LEU . 48.8 mm -54.53 -40.45 49.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.749 0.309 . . . . 0.0 111.357 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.0 p -44.58 -46.58 10.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.456 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -26.32 65.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 t -93.27 -68.31 0.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -46.17 -56.89 5.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.487 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.81 ' HA ' HD12 ' A' ' 21' ' ' LEU . 21.3 t -41.25 -51.52 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.271 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -38.54 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.095 0.474 . . . . 0.0 110.622 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.857 HD13 HG11 ' A' ' 106' ' ' VAL . 6.1 mt -69.06 -70.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.322 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.936 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.49 -23.72 2.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.508 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.867 ' N ' HD13 ' A' ' 21' ' ' LEU . 31.5 mt-10 -78.48 -29.92 47.04 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 -37.92 58.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 109.923 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.726 ' HG3' HD21 ' A' ' 110' ' ' LEU . 19.2 mm-40 -59.34 -18.89 42.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.207 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.4 73.45 1.14 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.767 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 29.5 m-85 -147.01 -178.86 6.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 111.649 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.566 ' CB ' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -121.42 81.95 39.05 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.837 ' CG ' HD11 ' A' ' 21' ' ' LEU . 37.4 Cg_endo -89.86 137.9 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.699 2.266 . . . . 0.0 114.041 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.899 ' O ' HD12 ' A' ' 5' ' ' LEU . 13.1 t70 -126.15 125.07 41.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.6 p -97.2 135.96 38.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 111.643 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -108.44 178.5 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 mttt -122.75 -8.79 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.92 -171.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.773 HD22 ' CD2' ' A' ' 63' ' ' PHE . 75.5 mt -79.36 -32.34 43.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 0.0 110.154 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -70.9 -44.38 66.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.795 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.12 -33.81 76.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.58 -49.23 33.78 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -46.93 -45.94 21.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.365 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -54.89 41.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -57.66 -27.87 63.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.692 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 41' ' ' ILE . 42.9 mt -92.82 -8.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.55 8.22 29.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.73 0.3 . . . . 0.0 111.147 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -148.9 -48.14 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.58 116.09 21.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -69.22 71.29 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.731 ' CE2' HD13 ' A' ' 5' ' ' LEU . 13.1 m-85 -69.68 116.16 40.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 4.1 Cg_exo -74.56 -35.7 3.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.183 1.922 . . . . 0.0 111.44 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.913 HG23 ' CE1' ' A' ' 117' ' ' PHE . 16.5 t -124.8 126.59 71.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.784 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.574 HG23 HD23 ' A' ' 5' ' ' LEU . 15.5 mm -113.61 130.1 68.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.605 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.746 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 61.0 t -123.81 107.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.103 0.477 . . . . 0.0 111.168 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.543 ' HB3' HG22 ' A' ' 78' ' ' VAL . 13.0 tp -93.87 147.08 23.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 1.1 t70 -126.02 97.37 5.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 80' ' ' THR . 23.4 t -67.05 72.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.354 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.452 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 59.4 t-105 -80.04 -91.5 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 ttp -140.73 46.0 0.86 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.102 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 55' ' ' MET . 86.2 Cg_endo -77.65 -167.02 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.547 2.164 . . . . 0.0 112.4 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.8 -44.09 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.72 163.76 51.67 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.582 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.39 120.47 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.17 -20.96 80.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.57 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.498 HG21 ' HD3' ' A' ' 90' ' ' LYS . 91.4 t -57.36 -38.13 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.32 -22.09 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.773 ' CD2' HD22 ' A' ' 34' ' ' LEU . 14.9 t80 -65.01 -40.66 95.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.811 0.339 . . . . 0.0 111.057 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.451 HG23 HG11 ' A' ' 76' ' ' VAL . 3.2 mt -46.32 -28.68 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -70.48 -51.7 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -48.82 -40.67 30.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.826 0.346 . . . . 0.0 110.559 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.831 HG21 HG22 ' A' ' 76' ' ' VAL . 3.5 mp -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.412 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -76.45 -19.58 57.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.789 0.328 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.8 -50.87 54.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.712 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.08 14.7 20.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.372 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.2 66.86 2.65 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.9 -19.1 35.89 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.614 2.21 . . . . 0.0 112.113 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.8 28.11 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.805 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.9 t -117.31 -175.77 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.775 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.527 HG21 ' HB1' ' A' ' 116' ' ' ALA . 45.6 t -127.17 139.95 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.371 0.605 . . . . 0.0 111.783 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.831 HG22 HG21 ' A' ' 67' ' ' ILE . 1.7 t -122.96 88.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 97' ' ' TYR . 44.8 mm -73.8 -69.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.369 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 51' ' ' LEU . 38.2 t 63.15 118.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.302 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.531 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.6 mt -121.0 -142.36 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.467 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER 64.31 101.44 0.04 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.839 0.352 . . . . 0.0 110.815 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.52 39.14 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.389 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.57 88.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.72 -29.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -161.06 139.08 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.759 0.314 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.621 HG13 ' OE2' ' A' ' 101' ' ' GLU . 16.3 t -97.7 33.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.048 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -90.08 -24.44 21.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.5 t -77.48 -35.28 53.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.188 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.505 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -59.69 -57.52 12.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.94 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.1 m -55.72 -30.37 27.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.844 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.498 ' HD3' HG21 ' A' ' 61' ' ' VAL . 30.4 tttt -76.84 -13.28 60.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.088 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.45 -41.77 5.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.658 0.266 . . . . 0.0 111.433 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.846 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.3 pt -70.47 -31.36 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 111.028 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -24.32 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.18 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -84.93 -54.89 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.661 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.87 28.98 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.641 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.25 177.62 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.24 0.52 . . . . 0.0 110.565 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.695 ' HE2' HG23 ' A' ' 112' ' ' THR . 39.8 t80 -88.24 -23.34 23.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.526 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.498 ' HA ' HG21 ' A' ' 92' ' ' ILE . 2.6 pt-20 152.56 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.292 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 78' ' ' VAL . 1.5 t80 80.61 111.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.644 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.662 HD21 ' HA ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -51.95 96.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.207 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.621 ' OE2' HG13 ' A' ' 85' ' ' VAL . 4.9 mm-40 -95.09 161.73 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.402 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 8.3 ttmt 60.07 53.19 3.63 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 68.8 Cg_endo -74.15 105.48 2.04 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.633 2.222 . . . . 0.0 112.322 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -85.17 -31.33 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.6 t -176.96 -57.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.991 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.857 HG11 HD13 ' A' ' 20' ' ' ILE . 12.5 p 179.11 -26.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.617 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -52.11 -51.11 59.86 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 110.902 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -38.69 74.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.746 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 28.0 t80 -60.58 -29.77 69.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.379 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.726 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -70.12 -46.21 65.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.038 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mp -50.23 -42.78 52.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.695 HG23 ' HE2' ' A' ' 97' ' ' TYR . 75.1 m -69.37 -46.7 66.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.891 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.526 HD13 HG11 ' A' ' 48' ' ' VAL . 6.8 mm -45.52 -59.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.727 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 -55.64 7.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.78 -29.2 69.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.74 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.96 -37.65 85.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 0.0 110.853 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.913 ' CE1' HG23 ' A' ' 48' ' ' VAL . 6.4 m-85 -73.02 -17.1 61.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -57.3 -21.47 35.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.372 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -95.47 35.18 1.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.839 0.352 . . . . 0.0 111.078 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 13.6 t80 -135.85 26.98 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.797 0.332 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER 61.13 99.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.426 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.45 85.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.857 HG21 HD12 ' A' ' 113' ' ' ILE . 21.9 t -81.79 146.43 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.842 HD13 ' CE2' ' A' ' 46' ' ' PHE . 37.3 tp -106.96 139.77 40.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 0.0 111.218 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.752 ' HB ' HG22 ' A' ' 30' ' ' THR . 21.7 t -117.3 145.9 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.44 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.449 ' HB ' HD12 ' A' ' 51' ' ' LEU . 15.5 t -132.94 120.96 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.284 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 9.9 t0 -156.68 148.69 22.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -83.79 49.32 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.449 . . . . 0.0 111.19 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.78 -167.39 1.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.662 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -112.7 132.31 55.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' ILE . 16.8 p 58.01 164.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.718 ' HA ' HG21 ' A' ' 30' ' ' THR . 6.4 mm -31.32 158.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.483 ' N ' HG22 ' A' ' 13' ' ' ILE . 20.3 p -86.31 124.31 32.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.295 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.7 m -41.01 133.82 2.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.477 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.531 ' O ' HD12 ' A' ' 20' ' ' ILE . 6.5 t 79.72 -9.05 1.49 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.486 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.979 HD23 HG21 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -90.15 -53.88 4.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.33 . . . . 0.0 111.103 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.493 ' HB2' HG21 ' A' ' 13' ' ' ILE . 1.4 t -51.52 -52.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.92 79.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.011 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.724 HG23 ' CD1' ' A' ' 110' ' ' LEU . 38.4 mt -60.54 -66.52 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.034 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.4 mt -50.98 -34.1 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -68.72 -26.75 65.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.74 -35.1 30.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.068 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.865 ' HG3' HD21 ' A' ' 110' ' ' LEU . 31.4 mm-40 -81.23 -27.97 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.057 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.12 1.21 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.233 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.455 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 6.2 m-85 -120.9 -176.18 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.307 0.575 . . . . 0.0 111.357 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.62 79.54 67.51 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.554 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.797 ' HB3' HD13 ' A' ' 21' ' ' LEU . 84.7 Cg_endo -84.34 146.86 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.864 2.376 . . . . 0.0 114.348 -177.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' O ' HD12 ' A' ' 5' ' ' LEU . 20.8 t70 -139.24 135.27 33.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.545 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.752 HG22 ' HB ' ' A' ' 6' ' ' VAL . 17.7 p -122.53 133.75 54.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.018 0.437 . . . . 0.0 111.883 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.33 -163.14 0.96 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.455 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 11.0 mttm -112.76 -31.21 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -162.76 -175.04 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.678 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.4 mt -64.31 -41.16 96.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -61.42 -46.04 91.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 109.94 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.57 -38.58 89.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.336 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.3 -56.06 19.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.435 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 41.0 mt-10 -47.27 -41.4 18.75 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.756 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -59.73 -43.06 94.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.922 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -73.25 -44.03 60.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.84 -18.56 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.472 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.2 -23.6 15.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.239 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -127.17 -52.48 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.99 121.61 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.28 58.34 4.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.842 ' CE2' HD13 ' A' ' 5' ' ' LEU . 16.0 m-85 -57.73 123.35 62.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' SER . 58.5 Cg_endo -71.97 -32.56 10.99 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.548 2.165 . . . . 0.0 112.21 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.639 ' HB ' HG13 ' A' ' 4' ' ' VAL . 8.0 t -128.32 139.55 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.257 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.822 HG23 HD23 ' A' ' 5' ' ' LEU . 1.2 mm -139.77 108.34 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.299 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG22 ' CG1' ' A' ' 77' ' ' ILE . 50.9 t -105.54 133.69 49.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.769 0.318 . . . . 0.0 110.305 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.568 HD23 HG13 ' A' ' 78' ' ' VAL . 30.7 tp -101.96 136.44 41.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.88 81.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.015 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.745 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.4 p -60.58 80.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.3 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 13.6 t-105 -84.82 -78.04 0.26 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.355 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.678 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.65 50.34 0.97 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.678 ' HD3' ' N ' ' A' ' 55' ' ' MET . 15.3 Cg_endo -92.78 -159.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.163 2.575 . . . . 0.0 112.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -153.6 62.84 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.93 0.395 . . . . 0.0 111.004 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.39 162.78 29.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.541 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.542 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -85.07 116.54 23.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 110.864 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.49 -26.58 24.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.629 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.636 HG21 ' HD3' ' A' ' 90' ' ' LYS . 50.4 t -63.35 -41.21 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 111.2 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.74 -26.88 57.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 67' ' ' ILE . 16.0 t80 -61.05 -36.01 78.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.08 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.423 ' CG2' ' HA3' ' A' ' 95' ' ' GLY . 2.1 mp -45.81 -29.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.373 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -78.77 -38.67 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 38' ' ' GLU . 16.3 t80 -56.84 -41.64 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.753 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.9 mp -58.99 -46.3 91.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.382 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -75.34 -25.01 57.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -63.74 -43.68 95.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.86 16.93 13.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.04 69.44 0.98 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.81 -19.27 41.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.726 2.284 . . . . 0.0 112.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -104.99 28.24 7.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.6 t -111.72 179.99 3.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.462 ' HB ' HG13 ' A' ' 48' ' ' VAL . 61.8 t -127.15 146.11 33.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 0.0 111.206 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.678 HG22 HG21 ' A' ' 67' ' ' ILE . 3.7 t -125.43 119.96 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.335 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.759 ' CG1' HG22 ' A' ' 50' ' ' VAL . 42.3 mm -97.33 -63.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.592 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 76' ' ' VAL . 6.0 t 63.13 115.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 53' ' ' VAL . 1.4 mt -129.31 -145.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.879 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.745 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 51.32 179.87 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.008 0.433 . . . . 0.0 111.368 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.32 176.38 28.36 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.264 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.93 43.91 3.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.361 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.34 156.33 32.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.532 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.3 t 59.93 99.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.833 0.349 . . . . 0.0 111.007 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG12 ' HB3' ' A' ' 88' ' ' ALA . 22.2 t -70.39 65.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 89' ' ' VAL . 39.1 t70 -100.03 -47.86 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.0 t -55.6 -31.55 62.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.966 0.413 . . . . 0.0 110.353 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -60.73 -60.0 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.123 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 86' ' ' ASP . 32.8 m -58.11 -24.73 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.914 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.636 ' HD3' HG21 ' A' ' 61' ' ' VAL . 8.1 ttmt -83.03 -10.92 58.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.27 -37.52 5.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.683 0.278 . . . . 0.0 111.6 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.886 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 14.1 pt -71.99 159.66 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.167 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HG2' HG13 ' A' ' 92' ' ' ILE . 7.7 mmmt 80.52 -47.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.579 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -26.4 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' A' ' 64' ' ' ILE . . . -175.52 -33.19 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.464 -0.875 . . . . 0.0 113.237 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.886 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -62.8 176.22 0.72 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.194 0.497 . . . . 0.0 110.671 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.562 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -100.67 -8.35 22.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 140.23 -11.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.411 0.684 . . . . 0.0 111.438 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER 77.71 120.27 0.05 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.88 0.372 . . . . 0.0 110.924 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.499 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -72.93 157.95 36.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.551 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -117.28 153.86 32.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt 65.1 80.49 0.23 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 61.1 Cg_endo -72.62 60.08 3.43 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.634 2.223 . . . . 0.0 112.428 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -150.28 121.63 7.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.517 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.87 ' O ' HG22 ' A' ' 106' ' ' VAL . 1.7 p 81.4 -47.44 0.23 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.979 HG21 HD23 ' A' ' 17' ' ' LEU . 1.0 OUTLIER 76.71 1.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.877 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -44.19 -42.1 6.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.952 0.406 . . . . 0.0 110.706 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -68.2 -37.51 80.98 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.889 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 5.0 t80 -58.52 -22.86 56.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.261 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.865 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.1 tt -63.8 -51.15 66.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.319 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mp -53.78 -54.49 37.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.018 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.507 HG23 ' CZ ' ' A' ' 97' ' ' TYR . 86.3 m -51.39 -56.78 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.091 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.889 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 9.9 mm -30.06 -63.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.695 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.67 -59.29 3.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.64 -24.86 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.828 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -70.87 -45.38 64.52 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 0.0 111.379 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.585 ' CE1' HG21 ' A' ' 48' ' ' VAL . 55.1 m-85 -66.53 -13.26 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.32 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.24 -17.38 27.73 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.441 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -92.08 36.43 0.98 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.787 0.327 . . . . 0.0 111.269 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.94 22.93 4.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.954 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.883 179.986 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.783 0.325 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 4.3 mmmm -99.06 95.25 7.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.141 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -143.59 127.11 16.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.777 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 48' ' ' VAL . 42.7 t -115.59 154.64 17.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.61 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 37.0 tp -115.01 132.78 56.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.706 HG21 HD12 ' A' ' 17' ' ' LEU . 25.0 t -116.62 89.55 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.338 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' A' ' 37' ' ' ALA . 14.0 t -84.7 96.92 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -124.3 132.14 53.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.56 -65.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.45 115.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.474 ' CD ' HD13 ' A' ' 13' ' ' ILE . 1.3 pt-20 -162.35 -89.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -178.8 23.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 13' ' ' ILE . 1.4 mp -84.38 -36.5 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.783 0.325 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p -59.84 -33.24 71.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.976 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 t -90.28 29.41 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.565 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.3 p -157.97 -61.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 0.0 110.683 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.706 HD12 HG21 ' A' ' 6' ' ' VAL . 1.5 tm? -56.58 -49.73 74.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.594 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 p -54.75 -46.2 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.383 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.62 85.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.576 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.698 HG23 HD11 ' A' ' 110' ' ' LEU . 24.1 mt -57.28 -64.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.843 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 17' ' ' LEU . 1.4 mt -49.27 -32.58 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -27.43 68.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -79.01 -37.39 39.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.985 0.421 . . . . 0.0 110.013 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' HG3' HD22 ' A' ' 110' ' ' LEU . 1.1 tm-20 -70.09 -51.06 34.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 58.91 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.522 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -135.88 -173.89 3.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -136.47 75.04 52.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.066 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 50.5 Cg_exo -54.8 151.4 32.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.684 2.256 . . . . 0.0 112.638 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -132.66 6.25 4.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.662 HG22 ' HB ' ' A' ' 6' ' ' VAL . 3.5 p 0.7 126.52 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.52 166.14 21.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.222 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.628 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 mtpt -79.41 -163.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.38 168.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.136 0.493 . . . . 0.0 111.82 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.661 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.3 mt -36.41 -35.53 0.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.261 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -54.34 -63.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.056 0.455 . . . . 0.0 110.146 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 2.0 mp0 -65.18 -33.8 76.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.704 ' HB2' HG13 ' A' ' 7' ' ' VAL . . . -63.22 -65.5 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -43.13 -42.25 4.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.525 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -61.06 -51.0 71.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.63 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -34.78 79.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.191 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 41' ' ' ILE . 31.4 mt -86.07 -6.15 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.844 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.64 31.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.79 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -150.26 -52.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.292 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -103.36 154.96 18.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.926 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.441 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 42.5 t80 -93.65 87.19 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.644 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.61 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 28.6 m-85 -70.15 125.2 91.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 83.2 Cg_endo -77.37 -26.2 7.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.585 2.19 . . . . 0.0 112.062 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 113' ' ' ILE . 3.0 t -139.28 130.94 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.361 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 46' ' ' PHE . 8.4 mm -120.31 153.02 23.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.617 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' VAL . 49.1 t -143.23 107.09 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.451 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HB3' HG22 ' A' ' 78' ' ' VAL . 43.6 tp -96.9 85.89 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.257 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.487 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.6 OUTLIER -68.02 72.52 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.527 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.3 p -53.16 85.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.716 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.453 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 21.8 t-105 -71.94 -80.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.605 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -160.9 54.99 0.61 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 55' ' ' MET . 5.6 Cg_endo -87.55 -155.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.172 2.581 . . . . 0.0 112.141 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -159.81 49.69 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.14 11.68 9.87 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.86 78.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.06 -20.9 63.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.888 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 90' ' ' LYS . 23.8 t -50.95 -44.82 27.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.423 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.14 -25.03 59.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.745 ' CE2' HD11 ' A' ' 67' ' ' ILE . 14.0 t80 -60.97 -39.63 90.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 91' ' ' ALA . 2.6 mp -47.02 -28.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.7 t0 -75.63 -41.46 54.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.815 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.76 -42.07 83.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.745 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.7 mp -63.92 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -81.89 -12.02 58.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.7 -40.69 47.94 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.004 0.431 . . . . 0.0 110.593 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 9.76 12.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.983 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.409 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.07 66.23 3.38 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.866 0.365 . . . . 0.0 110.787 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.4 Cg_exo -76.03 -14.32 19.03 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 112.22 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -109.53 29.55 7.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.813 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -106.96 -155.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.62 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.669 HG21 ' HB1' ' A' ' 116' ' ' ALA . 36.8 t -147.2 137.96 17.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 121.039 0.447 . . . . 0.0 112.018 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.779 HG12 HG23 ' A' ' 78' ' ' VAL . 1.2 t -123.39 112.08 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.448 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.616 HG21 ' CE1' ' A' ' 109' ' ' PHE . 32.2 mm -113.63 44.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.506 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.779 HG23 HG12 ' A' ' 76' ' ' VAL . 49.0 t -45.43 116.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.261 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.643 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.6 mt -106.43 -148.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.194 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.7 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER 56.46 173.67 0.04 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.835 0.35 . . . . 0.0 111.131 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.74 76.81 1.07 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.476 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -98.27 28.8 3.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.74 -38.81 2.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.421 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 80.2 p -178.72 173.56 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.839 0.352 . . . . 0.0 110.797 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m -97.82 31.65 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.0 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.55 -17.31 15.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -36.16 30.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.27 -59.36 5.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.968 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.608 ' HA ' HG12 ' A' ' 92' ' ' ILE . 12.4 m -58.99 -30.77 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.949 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.479 ' O ' HG13 ' A' ' 61' ' ' VAL . 13.6 ttmt -75.04 -8.5 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.347 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.485 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -118.27 -35.54 3.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.475 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 88' ' ' ALA . 8.7 pt -80.02 158.07 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.192 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' CG ' HG13 ' A' ' 92' ' ' ILE . 9.2 mmtt 80.77 -45.83 0.25 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -22.97 64.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.97 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.03 -29.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.187 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -79.77 175.82 10.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.082 0.441 . . . . 0.0 111.009 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.524 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 56.0 t80 -100.69 -12.06 19.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.323 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 147.54 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.158 0.583 . . . . 0.0 110.368 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.56 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -118.97 131.09 56.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.534 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -93.88 44.81 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.822 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.33 -17.58 17.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.265 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.06 -58.8 8.43 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.69 -168.52 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.525 2.15 . . . . 0.0 112.299 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -137.2 31.2 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.825 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.7 m -144.33 -171.91 3.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' CD1' ' A' ' 20' ' ' ILE . 10.4 p -118.0 -8.65 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.524 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -47.52 76.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.861 0.362 . . . . 0.0 110.367 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.29 -33.61 69.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.071 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.616 ' CE1' HG21 ' A' ' 77' ' ' ILE . 10.1 t80 -64.44 -37.8 88.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.183 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.698 HD11 HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -55.33 -48.21 74.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -44.71 83.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.1 m -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.75 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.7 mm -57.22 -53.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -59.46 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -55.75 -30.79 61.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.738 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.61 -38.77 88.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.505 ' CE2' HG21 ' A' ' 48' ' ' VAL . 31.0 m-85 -75.23 -28.75 60.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.906 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.13 -28.77 62.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -97.41 30.08 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 47' ' ' PRO . 64.2 t80 -107.63 27.95 8.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.77 0.319 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmmp? -112.01 92.87 4.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -136.06 142.22 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.629 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.5 t -125.96 163.9 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.326 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.857 HD22 ' CD2' ' A' ' 46' ' ' PHE . 34.0 tp -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.2 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.959 HG21 ' CD1' ' A' ' 17' ' ' LEU . 27.6 t -115.28 97.33 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.95 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.748 HG22 ' HB3' ' A' ' 31' ' ' ALA . 40.7 t -83.23 119.76 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.797 0.332 . . . . 0.0 110.985 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -154.35 131.57 11.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.9 46.77 1.39 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.29 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -50.72 2.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 110.99 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.36 -168.21 1.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 t -57.34 -58.43 8.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.817 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.675 HG23 HG21 ' A' ' 30' ' ' THR . 8.4 mm -116.96 163.0 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.652 HG21 ' CG1' ' A' ' 6' ' ' VAL . 76.0 p -90.1 145.55 24.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.79 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -65.43 141.91 58.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.158 0.504 . . . . 0.0 112.259 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.426 ' O ' HD12 ' A' ' 20' ' ' ILE . 28.2 m 65.1 9.39 5.48 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.721 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.057 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -90.49 -53.07 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.483 179.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.7 t -45.88 -59.67 2.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.23 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -39.52 53.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.08 0.467 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.769 HG23 ' CD1' ' A' ' 110' ' ' LEU . 75.1 mt -68.29 -70.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.057 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -47.73 -30.36 3.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.044 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -73.42 -29.67 62.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.845 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -81.08 -34.84 32.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 110.12 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.783 ' CG ' HD21 ' A' ' 110' ' ' LEU . 5.7 mm-40 -81.48 -35.0 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.967 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.4 47.75 2.72 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.221 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 2' ' ' LYS . 44.3 m-85 -105.23 -173.26 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.127 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.56 85.68 47.16 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.814 ' HG3' HD13 ' A' ' 21' ' ' LEU . 91.4 Cg_endo -82.45 127.71 5.2 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.689 2.259 . . . . 0.0 111.953 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -105.65 -1.01 25.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.482 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.675 HG21 HG23 ' A' ' 13' ' ' ILE . 58.7 p 24.49 122.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB3' HG22 ' A' ' 7' ' ' VAL . . . -105.82 167.72 9.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.549 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -88.29 -46.06 9.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.821 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.436 HG23 ' HB3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -158.47 -167.03 2.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.606 HD22 ' CD2' ' A' ' 63' ' ' PHE . 58.1 mt -67.44 -46.53 72.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -63.1 -45.47 91.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.044 0.45 . . . . 0.0 109.873 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -32.2 70.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.38 -28.82 63.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.686 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 13.6 mt-10 -70.85 -42.03 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -63.77 -35.33 80.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.009 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -75.68 -42.41 51.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.898 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.77 -27.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.031 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -52.03 -25.98 9.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.255 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -120.72 -55.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.19 133.57 50.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -95.28 102.04 13.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.857 ' CD2' HD22 ' A' ' 5' ' ' LEU . 40.7 m-85 -102.74 122.04 47.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 74' ' ' SER . 65.4 Cg_endo -73.68 -19.16 21.63 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.331 2.021 . . . . 0.0 111.788 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.629 ' HB ' HG13 ' A' ' 4' ' ' VAL . 10.8 t -143.7 120.53 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.494 HD11 ' HB2' ' A' ' 46' ' ' PHE . 6.5 mm -107.18 153.75 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.83 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 51' ' ' LEU . 7.4 t -135.49 174.59 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.651 ' H ' HG12 ' A' ' 50' ' ' VAL . 29.2 tp -159.92 117.27 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.548 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.46 89.62 3.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.141 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 53' ' ' VAL . 35.2 m -58.68 82.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.834 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -81.52 -83.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.402 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.504 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 3.2 mtt -148.45 44.78 0.37 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 55' ' ' MET . 85.4 Cg_endo -80.19 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.461 2.107 . . . . 0.0 112.226 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -137.99 49.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.893 0.378 . . . . 0.0 110.97 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.47 139.85 6.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.445 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.44 144.27 37.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 110.942 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.641 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -93.63 -15.94 47.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.892 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 90' ' ' LYS . 26.2 t -53.81 -52.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.014 0.435 . . . . 0.0 111.209 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.7 -6.29 47.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.765 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.829 ' CE2' HD11 ' A' ' 67' ' ' ILE . 22.3 t80 -85.67 -36.52 20.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.645 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.028 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.0 mp -49.52 -31.95 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.681 0.277 . . . . 0.0 111.084 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.3 t70 -79.41 -25.26 42.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.572 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 48.1 t80 -67.85 -42.32 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.829 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.8 mp -60.03 -43.23 92.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.035 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.88 -20.96 52.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 33.7 tt0 -68.72 -34.8 76.25 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.407 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -126.39 14.58 7.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.034 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.49 67.39 1.38 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.889 0.376 . . . . 0.0 110.579 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.02 -20.79 50.29 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.65 2.233 . . . . 0.0 112.064 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.29 25.5 6.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.055 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 33.5 t -113.37 -166.18 1.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -148.67 131.56 7.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 121.248 0.547 . . . . 0.0 112.428 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 96' ' ' ALA . 38.9 t -100.89 113.65 37.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.63 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.731 HD12 ' CG2' ' A' ' 112' ' ' THR . 44.8 mm -94.01 -62.35 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.915 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 HD23 ' A' ' 51' ' ' LEU . 99.4 t 59.15 111.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.718 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.8 mt -122.48 178.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.641 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.8 m 73.59 155.25 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.479 ' HA2' HG21 ' A' ' 53' ' ' VAL . . . -163.65 141.83 7.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.396 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -124.75 37.52 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.929 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.21 46.26 0.39 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.422 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.91 -78.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.726 0.298 . . . . 0.0 110.922 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 85' ' ' VAL . 7.2 p -178.95 85.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.131 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.725 ' O ' HG22 ' A' ' 89' ' ' VAL . 23.9 t0 -139.2 -60.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.842 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 t -48.8 -30.74 6.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.261 0.553 . . . . 0.0 110.1 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.847 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.26 -59.72 5.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.156 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 86' ' ' ASP . 30.2 m -61.61 -21.96 26.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.325 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 61' ' ' VAL . 15.7 ttmt -87.32 -14.22 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.673 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.028 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -114.8 -31.82 6.01 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.942 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 8.7 pt -74.63 -21.88 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.692 0.282 . . . . 0.0 111.625 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.65 15.38 16.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.22 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -119.64 -21.2 7.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.555 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.39 -24.2 0.16 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.937 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.942 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -55.13 176.26 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.584 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.458 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 56.4 t80 -108.5 27.37 9.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.9 OUTLIER 85.61 138.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.187 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.619 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -71.38 94.77 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.608 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 109' ' ' PHE . 28.3 tp -54.94 146.69 17.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.653 ' H ' HD12 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -85.06 163.8 18.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -165.15 54.25 0.35 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.773 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.88 1.52 9.06 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.517 2.145 . . . . 0.0 112.897 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.26 -68.08 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.737 0.303 . . . . 0.0 111.084 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.1 t -159.82 -178.24 6.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.411 . . . . 0.0 111.334 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 20' ' ' ILE . 7.4 p -73.93 -16.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.417 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -46.22 -35.45 5.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.496 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -71.65 -35.78 70.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.934 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.913 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 29.3 t80 -58.16 -30.82 66.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.783 HD21 ' CG ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -50.0 -43.33 50.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.318 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 108' ' ' ARG . 3.7 mp -59.3 -60.21 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.121 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.731 ' CG2' HD12 ' A' ' 77' ' ' ILE . 97.8 m -44.12 -39.14 4.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.343 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 29.2 mm -56.23 -71.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -54.16 -21.09 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.739 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -85.66 -24.73 26.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.695 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -80.55 -30.86 37.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -78.29 -20.08 52.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.365 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -105.22 -20.4 13.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.658 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -95.46 34.38 1.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.736 0.303 . . . . 0.0 111.296 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.407 ' CE2' ' O ' ' A' ' 74' ' ' SER . 1.5 t80 -162.17 36.73 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.928 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 -179.998 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 tpp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.82 0.343 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 7.8 mmmt -117.45 112.81 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.494 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 131.18 20.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.718 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 48' ' ' VAL . 27.0 t -121.31 144.15 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.823 HD13 ' CE2' ' A' ' 46' ' ' PHE . 29.9 tp -107.2 137.7 44.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 0.0 111.214 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.873 HG21 HD12 ' A' ' 17' ' ' LEU . 3.8 t -116.3 123.88 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.528 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.558 ' HB ' HD12 ' A' ' 51' ' ' LEU . 44.4 t -114.29 110.38 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.24 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 40.8 t0 -158.76 160.63 36.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.057 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 25.5 t70 -89.16 49.45 1.77 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.05 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -109.01 -176.24 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.771 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -127.97 134.82 49.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.056 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t 58.12 71.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.627 ' HA ' HG21 ' A' ' 30' ' ' THR . 23.5 mm 57.91 166.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.63 HG21 HG11 ' A' ' 6' ' ' VAL . 72.3 p -90.37 114.4 26.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.045 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 16' ' ' SER . 73.5 m -43.0 136.44 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.775 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.4 m 88.16 -36.35 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.161 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.927 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.89 -50.82 63.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 110.93 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.5 -64.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.463 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.27 60.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 111.443 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.611 HG23 HD11 ' A' ' 110' ' ' LEU . 91.5 mt -65.72 -70.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.927 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -46.94 -31.03 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.938 0.399 . . . . 0.0 111.071 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -71.46 -31.67 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.707 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -83.0 -35.21 26.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.877 ' HG3' HD21 ' A' ' 110' ' ' LEU . 43.9 mm-40 -75.1 -29.98 60.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.046 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.88 1.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.227 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 43.2 m-85 -131.76 -176.3 4.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.243 0.544 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.41 80.74 46.04 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.837 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.662 ' HB3' HD13 ' A' ' 21' ' ' LEU . 88.0 Cg_endo -82.5 141.53 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.838 2.359 . . . . 0.0 113.759 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' O ' HD12 ' A' ' 5' ' ' LEU . 6.5 t0 -138.54 136.18 35.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.868 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.627 HG21 ' HA ' ' A' ' 13' ' ' ILE . 14.7 p -121.62 132.58 54.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.114 0.483 . . . . 0.0 111.745 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.69 -121.57 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.226 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 13.8 mttp -157.63 -41.75 0.07 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.937 0.399 . . . . 0.0 110.59 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 p -152.83 175.66 12.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.622 HD22 ' CD2' ' A' ' 63' ' ' PHE . 39.8 mt -58.14 -37.34 74.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -44.83 78.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -35.81 82.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.336 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.27 61.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 34.1 mt-10 -49.16 -44.21 42.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.533 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -56.43 -44.6 80.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.063 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -73.23 -44.39 59.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.979 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.3 mt -70.32 -17.75 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.556 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -21.25 41.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.218 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.99 -63.46 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.12 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -55.35 132.42 48.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 45' ' ' PHE . 60.4 t80 -97.2 59.56 1.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.77 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.823 ' CE2' HD13 ' A' ' 5' ' ' LEU . 44.2 m-85 -57.93 126.53 77.17 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.494 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 53.1 Cg_endo -70.93 -28.79 19.21 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.318 2.012 . . . . 0.0 111.66 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.611 HG21 ' CE1' ' A' ' 117' ' ' PHE . 15.2 t -128.66 136.59 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.567 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 46' ' ' PHE . 5.9 mm -135.78 103.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.63 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 77' ' ' ILE . 59.8 t -101.79 129.81 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.596 HD23 HG13 ' A' ' 78' ' ' VAL . 28.6 tp -92.13 162.84 14.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.334 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -153.81 69.96 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.806 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 80' ' ' THR . 2.4 p -59.79 81.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.683 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 52' ' ' ASP . 65.3 t-105 -86.41 -92.23 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.772 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.576 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mtt -64.25 -52.09 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.075 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 55' ' ' MET . 39.7 Cg_endo -65.97 -169.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.37 2.047 . . . . 0.0 112.37 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.92 -24.07 7.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.293 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.84 -89.13 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.428 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 48.69 30.76 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.2 72.28 2.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.562 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 64' ' ' ILE . 58.2 t -58.11 -39.65 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -75.0 -11.79 60.18 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.523 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.027 ' CE2' HD11 ' A' ' 67' ' ' ILE . 50.4 t80 -64.36 -43.77 93.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.734 0.302 . . . . 0.0 111.429 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.3 mp -48.24 -28.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -77.58 -30.85 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 4.5 t80 -63.73 -44.76 92.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 1.027 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -61.21 -43.62 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -78.21 -22.52 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.667 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 21.6 tt0 -62.91 -39.81 95.67 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.073 0.463 . . . . 0.0 110.222 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.53 15.68 9.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.26 71.21 0.6 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.71 -7.71 11.43 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.039 2.493 . . . . 0.0 112.56 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.03 -3.06 30.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.558 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -170.31 2.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 0.0 111.302 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.737 HG11 ' HB1' ' A' ' 116' ' ' ALA . 50.1 t -127.34 147.7 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.025 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 67' ' ' ILE . 3.3 t -126.7 100.45 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.894 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.87 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.0 mm -101.62 71.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.145 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.622 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 32.1 t -67.09 133.31 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.176 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 80' ' ' THR . 2.1 mt -142.4 175.64 4.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 79.55 148.92 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.901 0.381 . . . . 0.0 111.163 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.61 82.21 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.379 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -58.73 110.35 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.828 0.347 . . . . 0.0 111.177 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.13 59.8 9.41 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.666 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 m -167.49 101.67 0.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.83 0.348 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 85' ' ' VAL . 14.4 p -109.79 30.62 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.0 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 89' ' ' VAL . 13.4 p-10 -115.51 -34.29 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.82 -31.1 70.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.855 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.745 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.28 -59.62 5.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 86' ' ' ASP . 22.1 m -62.75 -23.33 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.931 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.546 ' HD3' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.73 27.68 2.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.6 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.53 -41.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.035 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.006 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.8 pt -69.17 -21.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.505 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.53 26.47 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -133.8 7.27 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.517 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.25 -23.26 3.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.912 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 1.006 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -60.48 -177.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.373 . . . . 0.0 111.266 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.758 ' HB3' HD13 ' A' ' 77' ' ' ILE . 48.9 t80 -117.21 29.14 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.269 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 87.89 158.13 0.07 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.227 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.622 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -91.97 103.91 16.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.078 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.578 HD21 ' HA ' ' A' ' 109' ' ' PHE . 11.4 tp -57.97 160.9 4.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -58.02 -108.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.041 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -178.94 52.61 0.06 OUTLIER Pre-proline 0 C--O 1.232 0.155 0 CA-C-O 120.77 0.319 . . . . 0.0 110.79 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 14.9 Cg_endo -56.93 159.95 13.48 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.749 2.299 . . . . 0.0 112.242 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.83 -53.27 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.797 ' O ' HG22 ' A' ' 106' ' ' VAL . 30.3 t -96.12 6.93 47.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.358 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.926 HG21 HD23 ' A' ' 17' ' ' LEU . 1.2 m 61.17 12.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -45.78 44.77 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.919 0.39 . . . . 0.0 110.608 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.445 ' HA ' HD13 ' A' ' 111' ' ' LEU . 7.5 tpt85 -66.59 -36.67 83.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.819 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.842 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 7.2 t80 -59.82 -27.81 66.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.245 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.877 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -60.11 -44.25 95.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.364 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.525 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.5 mp -54.38 -56.64 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' ILE . 92.4 m -51.73 -59.53 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.342 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.842 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 13.6 mm -31.05 -64.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.891 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -58.1 5.76 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -27.32 15.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.737 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -73.41 -36.57 66.01 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.611 ' CE1' HG21 ' A' ' 48' ' ' VAL . 27.2 m-85 -66.85 -14.93 63.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.257 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -57.57 -20.13 30.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.468 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -91.76 44.38 1.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.829 0.347 . . . . 0.0 111.011 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.407 ' CD2' ' O ' ' A' ' 120' ' ' TYR . 22.6 t80 -140.29 16.56 2.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.975 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.403 ' O ' ' HD2' ' A' ' 3' ' ' ARG . 3.4 mtt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.816 0.341 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 21.1 mmtt 63.72 -179.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.445 ' HD2' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 73.95 113.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.044 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.613 HG13 ' HB ' ' A' ' 48' ' ' VAL . 43.6 t -118.99 158.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.489 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.623 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 56.2 tp -112.65 127.98 56.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 111.394 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.26 91.97 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.317 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.784 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 33.2 t -85.02 117.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.483 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -156.51 147.03 21.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.914 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.43 ' CB ' ' HD3' ' A' ' 56' ' ' PRO . 36.3 t70 -72.62 -73.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.096 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 1.6 tm-20 -88.87 172.07 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.115 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -85.04 61.95 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.4 m -89.5 -65.73 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.625 HG22 ' CB ' ' A' ' 17' ' ' LEU . 32.7 mm -84.3 -43.72 17.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.289 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p -46.47 -35.3 5.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.524 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -66.06 -32.95 74.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.378 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 t -102.13 -59.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.792 HD23 HG21 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -47.04 -57.21 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.428 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.832 ' HA ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -41.41 -54.66 3.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.158 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.96 -36.62 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.508 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 17' ' ' LEU . 14.3 mt -72.92 -70.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.84 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.957 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -52.56 -28.51 21.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.465 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.957 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -79.73 -23.67 42.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.814 0.34 . . . . 0.0 110.667 178.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -78.82 -39.08 36.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.903 0.383 . . . . 0.0 110.026 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.66 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.7 mm-40 -55.91 -43.73 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.056 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.58 60.68 0.16 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.32 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 61.7 m-85 -132.31 -171.51 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 111.061 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.39 82.9 56.33 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.926 ' HG3' HD21 ' A' ' 21' ' ' LEU . 21.3 Cg_exo -65.28 143.44 77.12 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.682 2.254 . . . . 0.0 112.634 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 30' ' ' THR . 6.2 t70 -116.78 -10.72 11.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.139 0.495 . . . . 0.0 111.983 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 29' ' ' ASP . 41.9 p 43.12 176.05 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.289 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.784 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -165.57 174.81 9.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.908 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 33' ' ' THR . 0.5 OUTLIER -112.82 -26.65 8.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.801 0.334 . . . . 0.0 111.236 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.12 -178.33 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.62 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.743 HD12 ' HA3' ' A' ' 58' ' ' GLY . 96.5 mt -61.01 -39.2 88.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -50.34 71.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.031 0.443 . . . . 0.0 109.831 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -33.16 75.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.172 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.524 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.07 -20.2 57.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 4.3 mt-10 -77.56 -38.31 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 109.85 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.41 -39.14 81.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.661 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mmtm -71.22 -36.19 71.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.769 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 37' ' ' ALA . 36.5 mt -86.19 -17.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.201 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -58.38 -19.09 32.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.441 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -134.8 -53.76 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.062 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -58.45 118.22 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.052 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -74.11 64.52 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.438 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.623 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 31.2 m-85 -56.65 113.69 6.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.297 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 60.3 Cg_endo -73.14 -27.38 13.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 112.032 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HB ' HG13 ' A' ' 4' ' ' VAL . 4.0 t -139.75 128.29 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.479 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.413 HG23 HD23 ' A' ' 5' ' ' LEU . 9.4 mm -112.59 146.85 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.68 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 5' ' ' LEU . 97.6 t -139.06 98.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.488 . . . . 0.0 110.576 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.426 ' HB3' HG13 ' A' ' 78' ' ' VAL . 24.7 tp -77.16 166.25 23.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.89 93.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.252 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.786 HG22 ' HB ' ' A' ' 80' ' ' THR . 6.8 m -76.71 57.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.55 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.446 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 55.7 t-105 -61.54 -90.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.652 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.666 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -90.64 -27.09 0.3 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 55' ' ' MET . 62.3 Cg_endo -85.93 -168.29 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.341 2.027 . . . . 0.0 113.021 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -147.59 -47.48 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.411 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.743 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . 46.79 -171.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.948 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.57 48.29 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.634 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -47.78 -34.38 10.7 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.452 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 90' ' ' LYS . 6.6 t -63.87 -49.91 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.942 0.401 . . . . 0.0 110.65 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.54 8.34 34.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.384 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.902 ' CE2' HD11 ' A' ' 67' ' ' ILE . 36.1 t80 -84.55 -41.83 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.772 0.32 . . . . 0.0 111.224 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.772 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.4 mp -46.01 -30.44 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.242 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -40.62 66.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.565 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 68.5 t80 -55.97 -43.36 77.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.902 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.0 mp -61.79 -44.37 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.462 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -78.95 -14.52 59.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.833 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.3 -43.07 58.31 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.968 0.413 . . . . 0.0 110.593 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.68 12.46 14.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.08 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.54 66.79 2.51 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.728 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.68 -19.04 32.23 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.616 2.211 . . . . 0.0 112.232 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -103.97 32.39 3.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.673 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 t -113.63 -158.45 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.689 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.514 HG22 ' CD1' ' A' ' 120' ' ' TYR . 39.2 t -147.49 136.2 15.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.812 HG12 HG23 ' A' ' 78' ' ' VAL . 18.3 t -114.25 110.99 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.608 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 79' ' ' ILE . 44.5 mm -99.23 -39.91 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.558 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.812 HG23 HG12 ' A' ' 76' ' ' VAL . 59.1 t 45.25 77.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.564 HG23 ' HB3' ' A' ' 100' ' ' LEU . 4.2 mt -93.45 148.51 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.579 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.786 ' HB ' HG22 ' A' ' 53' ' ' VAL . 1.4 p -149.82 -57.75 0.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.025 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 53.23 98.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.642 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -150.34 -47.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.316 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 173.13 137.87 2.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.37 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m 60.31 -175.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.814 0.34 . . . . 0.0 110.833 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.15 65.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -111.52 -24.21 10.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.192 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -32.08 22.67 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.798 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.96 -57.27 12.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.897 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 92' ' ' ILE . 16.6 m -58.08 -26.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.016 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.576 ' O ' HG13 ' A' ' 61' ' ' VAL . 3.1 ttmm -81.76 -9.25 59.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.441 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.772 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -121.96 -26.45 4.78 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.877 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.5 pt -83.32 -42.16 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -23.73 41.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.679 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -25.06 65.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.94 -16.1 1.05 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.106 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -51.9 177.07 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.97 0.385 . . . . 0.0 111.464 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 72.3 t80 -95.29 28.55 2.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.501 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 1.2 tt0 70.09 139.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.208 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.608 ' H ' HG21 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -55.11 146.07 19.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.564 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -87.23 109.65 19.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -56.99 -170.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.059 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.5 mttm 62.69 83.58 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.91 146.26 82.42 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.623 2.215 . . . . 0.0 112.22 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.85 27.86 15.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.3 p -162.79 155.49 19.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.792 HG21 HD23 ' A' ' 17' ' ' LEU . 32.8 m -141.69 49.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.15 -60.67 2.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -30.55 53.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.824 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 80.8 t80 -61.91 -40.57 95.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.607 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.66 HD21 ' HG2' ' A' ' 24' ' ' GLU . 2.1 tt -52.41 -59.09 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.395 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.581 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.3 mp -66.23 -44.46 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.544 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.3 m -60.2 -37.8 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.125 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.824 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -49.02 -52.36 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.482 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -56.56 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.042 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.448 ' CE1' ' HG3' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -52.55 -36.49 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -58.9 -38.54 79.12 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 110.57 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 34.7 m-85 -82.73 -17.18 45.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.792 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -102.99 -65.45 1.0 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 115' ' ' HIS . 50.2 mm-40 -88.54 22.67 2.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.514 ' CD1' HG22 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -155.78 40.36 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.933 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.837 0.351 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.39 127.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.033 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -149.2 140.87 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 48' ' ' VAL . 17.7 t -124.67 162.27 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.978 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.976 HD22 ' CD2' ' A' ' 46' ' ' PHE . 57.5 tp -119.8 121.82 39.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 110.588 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.859 HG21 ' CD1' ' A' ' 17' ' ' LEU . 40.0 t -102.77 122.88 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.19 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 41.3 t -111.41 105.26 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.866 0.365 . . . . 0.0 111.191 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -117.57 151.76 36.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.934 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 54' ' ' TRP . 32.3 t70 -81.27 49.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 0.0 111.667 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 61.96 116.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.361 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 175.63 39.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.318 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.3 t 58.01 58.49 3.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.262 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.097 HD12 HG21 ' A' ' 30' ' ' THR . 11.9 mm 55.6 169.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.499 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.606 ' N ' HG22 ' A' ' 13' ' ' ILE . 2.3 p -81.72 118.36 22.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 m -54.68 145.94 18.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.512 ' O ' HD12 ' A' ' 20' ' ' ILE . 42.1 t 66.03 10.86 7.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.839 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.079 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.22 -52.23 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.443 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 t -50.08 -55.26 15.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.06 73.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.968 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.72 HG23 ' CD1' ' A' ' 110' ' ' LEU . 54.3 mt -62.19 -66.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.079 HD11 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -49.38 -28.62 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.44 -27.68 61.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.905 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.79 -34.46 30.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.018 0.437 . . . . 0.0 110.149 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.672 ' HG3' HD21 ' A' ' 110' ' ' LEU . 30.5 mm-40 -87.18 -30.58 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 60.53 1.48 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.45 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 44.8 m-85 -113.09 -173.67 2.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -132.25 83.83 54.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.882 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.882 ' HG3' HD13 ' A' ' 21' ' ' LEU . 92.2 Cg_endo -84.74 117.62 2.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.79 2.326 . . . . 0.0 111.636 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.26 -9.2 33.84 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.403 0.62 . . . . 0.0 112.046 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.097 HG21 HD12 ' A' ' 13' ' ' ILE . 71.5 p 49.66 173.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.216 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -158.55 -154.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.493 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 27.3 mttt -143.65 -42.96 0.28 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.0 170.07 20.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.591 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.678 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.3 mt -61.41 -26.77 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.51 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -76.2 -43.59 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.083 0.468 . . . . 0.0 109.819 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -25.98 59.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.607 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.506 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.52 -34.03 58.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.634 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 44.8 mt-10 -69.75 -41.46 75.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -61.83 -37.98 86.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.837 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -72.41 -47.03 52.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.615 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 37' ' ' ALA . 10.1 mt -68.71 -27.97 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.976 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -47.55 -29.12 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -116.82 -44.21 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.63 112.75 18.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -75.13 63.94 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.976 ' CD2' HD22 ' A' ' 5' ' ' LEU . 42.4 m-85 -56.03 125.58 63.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.526 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 72.2 Cg_endo -76.45 -34.04 2.9 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.307 2.004 . . . . 0.0 112.303 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.865 HG13 ' HB ' ' A' ' 75' ' ' VAL . 23.5 t -130.16 111.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.007 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.468 HG23 HD23 ' A' ' 5' ' ' LEU . 2.3 mm -97.01 142.38 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.795 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.768 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.6 t -128.66 165.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 7' ' ' VAL . 16.2 tp -142.41 157.69 44.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.119 0.485 . . . . 0.0 111.539 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -141.93 79.95 1.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.011 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.694 HG22 ' HB ' ' A' ' 80' ' ' THR . 31.0 m -65.67 66.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.188 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.412 ' N ' ' O ' ' A' ' 52' ' ' ASP . 26.7 t-105 -67.16 -74.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.651 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 31.4 mtt -147.54 52.75 1.37 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.763 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.4 Cg_endo -89.72 -156.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.215 2.61 . . . . 0.0 112.27 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -136.89 -43.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.246 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.44 148.37 34.11 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.647 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 127.53 43.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.71 -13.8 83.17 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.823 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 90' ' ' LYS . 21.7 t -53.57 -45.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.789 0.328 . . . . 0.0 111.339 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.23 -5.9 55.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.537 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.678 ' CD2' HD22 ' A' ' 34' ' ' LEU . 15.7 t80 -74.15 -37.74 63.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.674 0.273 . . . . 0.0 111.347 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.521 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.5 mp -49.7 -27.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -39.45 69.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.632 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' CE1' ' HG2' ' A' ' 38' ' ' GLU . 18.8 t80 -60.3 -43.35 96.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.061 0.458 . . . . 0.0 109.914 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.626 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -57.33 -41.76 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -81.64 -24.16 36.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.0 110.638 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -66.39 -26.18 67.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -138.0 16.58 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.026 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.15 69.17 0.82 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.864 0.364 . . . . 0.0 110.748 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.44 -20.26 48.26 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.76 2.307 . . . . 0.0 112.11 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.78 39.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.853 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.8 t -119.61 177.59 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.865 ' HB ' HG13 ' A' ' 48' ' ' VAL . 2.7 t -107.9 178.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.754 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -157.52 79.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.898 0.38 . . . . 0.0 110.146 179.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.768 ' HB ' HG13 ' A' ' 50' ' ' VAL . 31.2 mm -62.21 -53.02 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.364 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.659 ' CG2' HG12 ' A' ' 76' ' ' VAL . 5.2 t 45.39 89.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.714 HG23 ' HB3' ' A' ' 100' ' ' LEU . 13.8 mt -104.21 167.2 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.614 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.694 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.6 m 84.21 147.49 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.425 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.43 49.26 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.168 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -55.18 -78.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.737 0.303 . . . . 0.0 111.203 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.95 46.48 2.69 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.542 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 87' ' ' THR . 0.4 OUTLIER -179.32 52.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.819 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.1 -31.94 52.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.96 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.595 ' O ' HG22 ' A' ' 89' ' ' VAL . 8.3 t0 -62.81 -32.91 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -52.39 -34.76 49.49 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.19 0.519 . . . . 0.0 109.954 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.885 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.41 -61.27 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.315 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 86' ' ' ASP . 33.4 m -61.92 -22.73 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.243 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.415 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 15.8 tttt -85.52 -25.13 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -98.91 -26.1 14.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.628 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.885 HG23 ' O ' ' A' ' 88' ' ' ALA . 4.2 pt -89.32 -17.0 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.436 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -71.71 -32.66 68.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 110.43 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -64.78 -61.99 1.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.84 33.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.986 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.11 -179.0 5.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.815 ' CE2' HG23 ' A' ' 112' ' ' THR . 26.4 t80 -98.52 28.54 4.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.452 . . . . 0.0 111.062 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.643 ' CD ' HD12 ' A' ' 92' ' ' ILE . 2.7 tp10 67.47 134.15 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.193 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.659 ' H ' HG21 ' A' ' 92' ' ' ILE . 2.3 m-85 -61.64 131.48 50.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.014 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.714 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -74.81 80.81 2.1 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -50.06 176.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.412 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.05 80.6 0.23 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.917 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.34 171.56 15.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.577 2.185 . . . . 0.0 112.249 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 56.83 23.47 8.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 p -147.99 60.74 1.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 110.657 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.646 HG13 HD11 ' A' ' 20' ' ' ILE . 7.6 p -53.91 -26.91 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.461 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -46.51 -33.92 4.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 110.838 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -36.25 69.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.933 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.891 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 3.4 t80 -59.64 -31.16 69.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.181 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.72 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -49.16 -49.21 43.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.29 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.6 mp -56.93 -57.56 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.75 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.815 HG23 ' CE2' ' A' ' 97' ' ' TYR . 93.0 m -44.68 -39.28 4.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.301 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.891 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 24.1 mm -59.13 -70.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -55.24 -23.07 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.563 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 111' ' ' LEU . 13.9 m-70 -84.75 -20.62 30.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.668 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.587 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -87.19 -45.22 10.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.45 ' CE2' ' CE1' ' A' ' 26' ' ' TYR . 23.6 m-85 -60.44 -22.53 63.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.229 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -52.84 -25.46 11.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.271 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.72 30.62 2.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.009 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -115.99 28.31 8.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 -179.981 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt 60.74 91.89 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.95 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.477 ' HA ' ' H ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -111.71 135.07 52.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.862 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.66 HG13 ' HB ' ' A' ' 48' ' ' VAL . 24.0 t -126.5 154.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.411 -179.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.675 HD23 HD11 ' A' ' 41' ' ' ILE . 28.8 tp -105.73 127.98 53.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.709 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.673 HG21 ' CD1' ' A' ' 17' ' ' LEU . 45.2 t -107.52 90.1 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.716 HG13 ' HB2' ' A' ' 37' ' ' ALA . 5.1 t -85.08 105.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -138.36 143.04 39.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.037 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.873 ' HB2' HG23 ' A' ' 33' ' ' THR . 33.1 t70 -91.9 50.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.9 -172.69 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -127.93 40.54 3.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -100.38 -42.15 6.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.512 HG22 ' HB3' ' A' ' 17' ' ' LEU . 37.7 mm -98.88 -40.77 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 p -47.64 -29.54 3.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.427 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.51 -45.85 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 111.258 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 p -73.58 -68.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.085 HD23 HG21 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -44.78 -42.86 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.574 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.1 m -57.15 -44.18 83.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.43 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.69 78.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.431 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.917 HD13 HG22 ' A' ' 106' ' ' VAL . 1.5 mt -59.76 -57.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.587 179.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.622 HD11 HD11 ' A' ' 17' ' ' LEU . 1.4 mt -50.33 -33.49 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 110.664 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.02 -24.59 66.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.794 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.38 -36.61 45.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.752 ' HG2' HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -78.34 -19.12 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.157 179.693 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.17 52.95 2.11 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.186 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.1 m-85 -112.07 -172.21 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 0.0 111.163 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.477 ' H ' ' HA ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -131.41 69.41 81.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.805 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -62.61 143.26 92.35 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.628 2.218 . . . . 0.0 111.931 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.8 t70 -126.56 -9.11 6.24 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.625 ' O ' ' O ' ' A' ' 29' ' ' ASP . 29.9 p 41.9 163.68 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -170.61 142.87 2.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.778 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 41.5 mttt -74.01 -166.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.873 HG23 ' HB2' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -47.73 156.24 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 111.705 -178.101 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.85 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.2 mt -27.36 -43.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.833 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -50.56 -59.59 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.083 0.468 . . . . 0.0 110.333 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 1.4 tp10 -66.07 -39.1 89.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.716 ' HB2' HG13 ' A' ' 7' ' ' VAL . . . -60.15 -60.5 3.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.595 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' HG2' ' CD2' ' A' ' 66' ' ' PHE . 19.7 mt-10 -45.67 -42.18 11.25 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -60.8 -52.75 63.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -62.44 -34.59 77.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.328 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.675 HD11 HD23 ' A' ' 5' ' ' LEU . 48.6 mt -89.54 -6.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.52 -16.56 48.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.633 0.254 . . . . 0.0 111.262 179.901 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -132.95 -52.12 0.91 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.769 0.318 . . . . 0.0 111.093 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.95 133.25 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.073 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -96.52 63.89 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.706 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.647 ' CD2' HD22 ' A' ' 5' ' ' LEU . 45.2 m-85 -58.27 125.23 74.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.036 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.74 -24.78 17.83 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.317 2.011 . . . . 0.0 111.892 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.698 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.8 t -141.59 134.12 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.524 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 46' ' ' PHE . 21.8 mm -119.24 148.18 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.547 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.445 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 82.9 t -136.59 105.62 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.587 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.04 84.11 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.751 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 1.2 t70 -66.35 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG13 ' HB ' ' A' ' 80' ' ' THR . 2.5 p -53.24 88.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ASP . 34.0 t-105 -88.47 -80.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.49 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 mmt -147.22 47.27 0.55 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 55' ' ' MET . 97.8 Cg_endo -78.6 -166.6 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.562 2.175 . . . . 0.0 112.323 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -152.2 30.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.064 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.57 -147.17 18.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.411 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' H ' HD12 ' A' ' 34' ' ' LEU . 50.0 m-20 -129.49 81.2 2.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.863 0.363 . . . . 0.0 110.9 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.9 92.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 90' ' ' LYS . 78.0 t -59.87 -38.64 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.985 0.422 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -23.41 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.108 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.85 ' CD2' HD22 ' A' ' 34' ' ' LEU . 13.4 t80 -75.35 -30.22 60.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.819 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 61' ' ' VAL . 7.9 mm -47.8 -37.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' GLU . 39.1 t70 -70.07 -42.93 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.44 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 23.4 t80 -50.99 -39.91 56.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.935 0.398 . . . . 0.0 110.651 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.846 HG21 HG22 ' A' ' 76' ' ' VAL . 2.7 mp -62.74 -52.08 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -74.63 -9.51 58.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.701 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 18.0 tt0 -77.1 -48.04 18.86 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.137 0.494 . . . . 0.0 110.288 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -114.33 16.83 17.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.925 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.66 67.54 1.6 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.2 -18.59 34.86 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.672 2.248 . . . . 0.0 112.156 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.75 40.66 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.66 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.403 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 34.0 t -119.06 -157.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.698 ' HB ' HG13 ' A' ' 48' ' ' VAL . 41.1 t -147.01 139.0 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 112.102 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.846 HG22 HG21 ' A' ' 67' ' ' ILE . 2.1 t -120.74 94.16 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.175 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.521 HG21 ' HE1' ' A' ' 109' ' ' PHE . 39.6 mm -73.63 -57.11 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.917 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.832 HG23 HG12 ' A' ' 76' ' ' VAL . 21.7 t 52.59 94.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.699 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.7 mt -108.45 -148.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.326 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.723 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 54.85 174.54 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.829 0.347 . . . . 0.0 111.106 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.0 142.98 5.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.378 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -57.64 -61.8 2.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.994 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.41 -31.66 3.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.422 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m 58.02 51.36 8.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 m -127.1 -41.3 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.326 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.0 -24.77 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.288 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -33.56 26.62 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.867 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.1 -57.09 13.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.116 178.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 92' ' ' ILE . 13.4 m -59.94 -28.22 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.43 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' O ' HG13 ' A' ' 61' ' ' VAL . 10.3 ttmt -78.74 -2.26 38.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.606 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.05 -35.04 1.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.93 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 4.7 pt -73.69 -43.59 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 111.413 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -59.42 -31.44 69.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -64.71 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.736 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.34 29.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.845 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.25 -166.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.722 0.296 . . . . 0.0 111.135 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 20.9 t80 -113.51 26.71 10.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.5 OUTLIER 79.5 147.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.229 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.652 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -79.31 88.3 4.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.802 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 79' ' ' ILE . 13.8 tp -59.06 148.23 31.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -57.0 177.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.01 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -139.88 52.37 3.65 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.993 -179.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 41.8 Cg_endo -67.23 -166.07 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.509 2.14 . . . . 0.0 112.176 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -55.95 109.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.019 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.5 m 65.15 163.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.031 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.085 HG21 HD23 ' A' ' 17' ' ' LEU . 32.4 m -89.81 49.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.162 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -62.19 1.53 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.436 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -55.3 -29.32 57.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.163 0.506 . . . . 0.0 109.69 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.699 ' CE1' HD11 ' A' ' 79' ' ' ILE . 43.3 t80 -61.62 -44.18 97.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.985 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.752 HD22 ' HG2' ' A' ' 24' ' ' GLU . 1.8 mt -52.5 -31.17 33.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.465 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.656 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 4.1 mp -79.75 -36.05 37.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 m -69.16 -36.88 77.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.491 . . . . 0.0 109.811 179.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.651 ' CD1' HG11 ' A' ' 48' ' ' VAL . 1.7 mm -67.17 -51.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.068 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -47.26 -57.2 5.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.311 -179.018 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.435 ' CG ' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -57.33 -34.76 69.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.818 179.537 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -54.92 -32.42 61.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' A' ' 48' ' ' VAL . 29.8 m-85 -74.6 -46.11 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.076 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -88.9 6.95 36.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.658 -179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HG3' ' CG ' ' A' ' 115' ' ' HIS . 1.2 mm-40 -117.74 -8.45 10.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.684 0.278 . . . . 0.0 111.57 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -153.23 71.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.849 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.934 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.846 0.355 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' CA ' ' CE1' ' A' ' 117' ' ' PHE . 8.5 mmtt 65.42 -176.44 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.445 ' HD2' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 75.53 105.96 0.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.093 -179.781 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 48' ' ' VAL . 44.4 t -112.78 162.51 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 29' ' ' ASP . 59.5 tp -119.81 139.12 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.687 HG21 HD12 ' A' ' 17' ' ' LEU . 10.5 t -121.05 117.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.133 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 32' ' ' LYS . 61.9 t -105.75 111.6 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.361 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.01 157.21 38.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.407 ' HB2' ' CD ' ' A' ' 56' ' ' PRO . 8.4 t0 -83.5 -70.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.423 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.0 mm-40 -84.7 177.58 7.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 111.241 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -96.89 70.47 2.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.848 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.605 ' C ' HD12 ' A' ' 13' ' ' ILE . 7.6 m -106.63 -37.03 6.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 13' ' ' ILE . 1.6 mp -110.81 -33.24 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.748 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.523 ' HB ' HG21 ' A' ' 30' ' ' THR . 81.3 p -54.93 -44.63 74.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -82.1 58.56 4.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.065 0.459 . . . . 0.0 110.966 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 170.6 -56.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.415 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.687 HD12 HG21 ' A' ' 6' ' ' VAL . 1.4 tm? -59.81 -55.87 28.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 m -54.66 -41.8 70.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.974 0.416 . . . . 0.0 110.446 179.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.474 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 17' ' ' LEU . 33.1 mt -57.64 -64.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.69 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.674 HD13 ' HB3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -47.73 -36.46 11.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.51 179.518 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -29.39 70.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.97 -35.06 57.49 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HG3' HD21 ' A' ' 110' ' ' LEU . 18.5 mm-40 -77.48 -8.58 57.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.161 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.14 51.93 1.99 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.964 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 51.0 m-85 -124.04 -175.92 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 111.345 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -140.23 77.92 24.07 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.061 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HB3' HD13 ' A' ' 21' ' ' LEU . 71.8 Cg_endo -84.05 148.91 12.09 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.582 2.188 . . . . 0.0 113.617 -178.312 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.681 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -131.88 134.1 45.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.719 179.331 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.523 HG21 ' HB ' ' A' ' 14' ' ' THR . 44.4 p -99.36 147.4 25.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.909 0.385 . . . . 0.0 111.166 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -147.24 145.77 29.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.721 ' O ' HG13 ' A' ' 7' ' ' VAL . 13.7 mttt -62.83 -158.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.0 p -48.65 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.255 0.55 . . . . 0.0 111.817 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.775 HD22 ' CD2' ' A' ' 63' ' ' PHE . 10.9 mt -45.51 -30.47 1.44 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.959 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -59.92 -61.67 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 4.3 tp10 -58.76 -38.46 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.86 178.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.02 75.56 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.06 -48.66 22.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.964 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -55.73 31.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -26.38 61.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.172 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 41' ' ' ILE . 10.0 mt -97.17 -6.87 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.75 25.21 5.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.359 . . . . 0.0 110.805 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.34 -58.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.489 HD22 ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -100.04 153.52 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.459 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 18.0 t80 -86.93 81.68 8.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.604 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 14.6 m-85 -67.88 117.17 45.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.645 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 56.8 Cg_endo -72.4 -38.88 3.17 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.493 2.128 . . . . 0.0 112.325 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.611 ' HB ' HG13 ' A' ' 4' ' ' VAL . 17.2 t -124.83 125.92 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.96 0.409 . . . . 0.0 111.79 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 46' ' ' PHE . 7.9 mm -115.2 134.29 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.644 HG21 ' HZ ' ' A' ' 109' ' ' PHE . 66.8 t -131.42 109.71 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 111.841 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' HB3' HG13 ' A' ' 78' ' ' VAL . 12.3 tp -78.44 170.58 16.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.423 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -134.63 -54.91 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.455 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.543 HG13 ' HA ' ' A' ' 57' ' ' ASP . 15.4 t 59.82 41.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.763 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 60.5 t-105 -62.73 -91.18 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.095 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.557 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -71.02 -48.76 13.55 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.438 -179.771 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 55' ' ' MET . 64.8 Cg_endo -72.52 -167.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.242 1.962 . . . . 0.0 112.283 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' HA ' HG13 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -163.07 55.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.833 179.856 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.02 115.89 8.54 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.263 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -92.84 31.19 1.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.806 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.09 64.37 0.95 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.365 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.861 ' O ' HD12 ' A' ' 64' ' ' ILE . 25.7 t -49.0 -43.02 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.939 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.54 -18.43 40.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.934 ' CE2' HD11 ' A' ' 67' ' ' ILE . 45.8 t80 -49.96 -43.32 50.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.569 0.223 . . . . 0.0 111.227 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.861 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mt -48.07 -30.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.056 0.455 . . . . 0.0 110.604 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -67.6 -53.25 29.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.184 179.373 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.411 ' CE1' ' HB ' ' A' ' 41' ' ' ILE . 6.7 t80 -46.26 -44.2 16.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.795 0.331 . . . . 0.0 110.863 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.934 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.6 mp -61.94 -47.8 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -14.32 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.886 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' ASP . 28.0 tt0 -73.23 -51.43 17.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.013 0.435 . . . . 0.0 110.546 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.33 14.14 22.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.086 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.417 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -159.49 65.14 2.6 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.648 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 71' ' ' SER . 14.8 Cg_exo -67.75 -20.88 45.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.647 2.231 . . . . 0.0 112.091 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -104.68 33.1 3.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.617 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.8 t -110.63 -178.22 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.561 HG21 ' HB1' ' A' ' 116' ' ' ALA . 40.5 t -129.11 139.64 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.826 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.913 HG12 HG23 ' A' ' 78' ' ' VAL . 2.9 t -125.68 104.74 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.444 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -91.35 -43.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.566 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.913 HG23 HG12 ' A' ' 76' ' ' VAL . 40.2 t 48.15 96.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.721 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 100' ' ' LEU . 6.1 mt -118.62 149.45 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.54 179.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 p -152.31 -57.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.62 0.247 . . . . 0.0 111.267 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 102' ' ' LYS . . . 164.23 -169.64 39.15 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.821 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -80.61 -23.21 39.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.627 0.251 . . . . 0.0 111.153 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.58 55.72 4.44 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.643 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.494 ' HB3' HG22 ' A' ' 87' ' ' THR . 0.1 OUTLIER 175.4 56.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.103 0.478 . . . . 0.0 110.622 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m -70.62 -25.09 25.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.514 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -88.84 -15.43 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.459 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 84' ' ' SER . 0.8 OUTLIER -82.98 -34.43 26.38 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.736 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -60.02 -61.28 2.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.93 178.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 92' ' ' ILE . 11.1 m -58.59 -29.11 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.849 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.54 -3.33 43.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.492 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -119.25 -39.88 2.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.373 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.947 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.9 pt -74.35 -46.26 44.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.435 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -60.49 -26.92 67.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.536 179.729 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.688 ' CB ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.59 -62.82 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 179.687 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.5 19.09 0.07 OUTLIER Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.537 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.947 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.41 -169.68 2.48 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.285 0.542 . . . . 0.0 110.961 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.511 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 62.0 t80 -103.91 -18.95 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.534 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 9.0 pt-20 151.28 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.34 0.656 . . . . 0.0 110.003 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -133.49 98.51 4.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.93 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 79' ' ' ILE . 9.8 tp -64.11 169.78 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.995 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.404 ' CB ' ' HB2' ' A' ' 104' ' ' PHE . 3.2 mt-10 -94.16 115.12 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.011 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.581 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.1 tmtt? -64.85 -48.01 73.33 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.6 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 48.6 Cg_endo -69.14 -5.55 16.09 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.17 1.914 . . . . 0.0 113.0 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.404 ' HB2' ' CB ' ' A' ' 101' ' ' GLU . 1.5 t80 -82.22 -172.98 4.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.732 0.301 . . . . 0.0 110.656 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.8 t -85.25 127.23 34.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.924 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.434 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.8 p -60.47 -18.82 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.248 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.65 -42.23 92.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.441 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.778 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -63.8 -34.73 78.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.244 179.465 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.644 ' HZ ' HG21 ' A' ' 50' ' ' VAL . 9.7 t80 -60.66 -39.52 88.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.174 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.531 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -55.85 -36.46 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.187 179.871 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 108' ' ' ARG . 1.2 mt -60.44 -42.71 96.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.167 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.9 m -70.97 -46.67 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.549 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 5.1 mm -43.68 -58.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.508 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -47.41 -54.51 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.079 0.466 . . . . 0.0 110.123 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.07 66.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -66.41 -34.68 78.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.945 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.464 ' CE1' ' CA ' ' A' ' 2' ' ' LYS . 25.8 m-85 -74.45 -13.74 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.823 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -58.71 -20.82 52.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.282 . . . . 0.0 111.358 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.95 41.76 1.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.98 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -159.16 28.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.999 179.94 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.9 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.884 0.373 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HD3' ' CD2' ' A' ' 117' ' ' PHE . 9.8 mmtt -138.53 121.08 16.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -147.84 83.43 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.774 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.624 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.9 t -68.94 160.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 46' ' ' PHE . 55.3 tp -118.94 135.86 54.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.872 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 17' ' ' LEU . 14.2 t -118.17 139.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.052 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.775 ' HB ' HD12 ' A' ' 51' ' ' LEU . 24.3 t -125.85 119.27 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.496 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 52' ' ' ASP . 22.9 t0 -170.32 160.68 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -179.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 27.4 t70 -88.27 50.53 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.586 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.21 127.31 41.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.711 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -80.31 149.34 30.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.172 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.89 66.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.228 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.638 ' HA ' HG21 ' A' ' 30' ' ' THR . 23.0 mm 53.63 168.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.183 0.516 . . . . 0.0 111.454 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.609 ' N ' HG22 ' A' ' 13' ' ' ILE . 54.7 p -90.16 146.05 24.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.986 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 16' ' ' SER . 1.6 m -55.77 133.79 51.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.851 0.357 . . . . 0.0 111.771 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.692 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER 82.36 -43.55 0.14 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.328 179.159 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -52.21 -53.92 37.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.755 0.312 . . . . 0.0 111.367 -179.33 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.531 ' HB2' HG21 ' A' ' 13' ' ' ILE . 41.4 t -46.47 -71.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.54 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.3 -40.63 11.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 0.0 111.482 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.699 HD13 ' CG2' ' A' ' 106' ' ' VAL . 16.3 mt -64.18 -68.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.155 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.042 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.62 -29.92 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.89 -24.0 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.998 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.52 -37.46 27.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.899 0.38 . . . . 0.0 110.234 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.09 -25.44 43.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.7 2.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.267 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CE2' HG21 ' A' ' 113' ' ' ILE . 11.2 m-30 -112.4 -178.01 3.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 111.366 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.12 78.75 72.37 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.539 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.715 ' HG3' HD13 ' A' ' 21' ' ' LEU . 84.3 Cg_endo -84.27 139.29 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.862 2.375 . . . . 0.0 113.889 -177.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.837 ' O ' HD12 ' A' ' 5' ' ' LEU . 11.1 t0 -121.97 118.27 28.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.342 178.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.819 HG22 ' HB ' ' A' ' 6' ' ' VAL . 72.8 p -102.34 127.05 49.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.93 0.395 . . . . 0.0 111.627 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.73 -165.18 1.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.526 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -127.43 -5.68 5.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.639 -179.834 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -170.58 -176.28 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.725 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.813 HD22 ' CD2' ' A' ' 63' ' ' PHE . 24.8 mt -77.36 -31.49 54.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.731 0.301 . . . . 0.0 110.339 179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -45.64 67.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -35.72 80.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.075 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' HB1' HD11 ' A' ' 41' ' ' ILE . . . -69.96 -48.18 59.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 82.4 mt-10 -46.42 -48.36 18.82 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.905 0.383 . . . . 0.0 110.503 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.84 -52.79 64.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.712 178.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.891 ' O ' HD22 ' A' ' 44' ' ' LEU . 9.8 mttt -63.71 -23.47 67.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.283 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.432 HD11 ' HB1' ' A' ' 37' ' ' ALA . 21.0 mt -93.33 -16.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -100.86 22.26 12.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 179.552 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.634 ' C ' HD13 ' A' ' 44' ' ' LEU . 26.7 mt-10 -143.22 -52.98 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.02 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -99.64 12.95 35.2 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.413 0.625 . . . . 0.0 109.818 179.691 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 44' ' ' LEU . 16.1 t80 23.72 86.19 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.748 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.939 ' CE2' HD13 ' A' ' 5' ' ' LEU . 49.3 m-85 -68.42 148.57 98.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.407 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' C ' ' HG ' ' A' ' 74' ' ' SER . 8.4 Cg_endo -83.67 -47.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.792 2.328 . . . . 0.0 111.88 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.624 ' HB ' HG13 ' A' ' 4' ' ' VAL . 24.7 t -116.94 126.79 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.628 HD12 HD23 ' A' ' 5' ' ' LEU . 21.5 mm -111.97 125.68 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.853 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.668 HG21 ' CE1' ' A' ' 109' ' ' PHE . 52.9 t -127.16 106.31 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.08 0.467 . . . . 0.0 112.031 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.775 HD12 ' HB ' ' A' ' 7' ' ' VAL . 42.9 tp -79.04 165.11 23.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.304 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 42.4 t0 -127.59 -56.79 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.668 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.411 HG23 ' HG ' ' A' ' 51' ' ' LEU . 18.1 t 67.96 66.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.935 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.422 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 26.8 t-105 -96.54 -82.93 0.39 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 111.442 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.607 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.2 mtt -83.68 -31.76 0.5 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 55' ' ' MET . 87.7 Cg_endo -83.05 -174.25 1.96 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.099 1.866 . . . . 0.0 112.922 -179.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -170.19 58.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.563 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.71 12.69 60.74 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.955 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.45 92.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.792 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.33 -9.05 60.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.852 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 90' ' ' LYS . 18.0 t -51.32 -49.72 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.403 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -76.58 -3.9 40.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.941 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.813 ' CD2' HD22 ' A' ' 34' ' ' LEU . 12.2 t80 -88.64 -42.09 12.22 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.538 0.209 . . . . 0.0 111.504 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.511 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.8 mp -43.84 -30.07 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.771 0.319 . . . . 0.0 111.272 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -67.24 -54.63 19.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -48.15 -40.6 24.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 110.52 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.634 HG21 HG22 ' A' ' 76' ' ' VAL . 3.7 mp -60.45 -48.34 88.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.511 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -77.24 -18.97 57.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.971 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.89 -50.68 54.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.956 0.408 . . . . 0.0 110.716 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.07 17.26 16.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.6 OUTLIER -161.26 68.33 2.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.771 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.11 -16.63 25.28 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.764 2.309 . . . . 0.0 112.297 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.07 -2.45 34.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.377 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.463 ' HG ' ' C ' ' A' ' 47' ' ' PRO . 46.6 t -82.37 176.82 9.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.051 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.744 HG21 ' HB1' ' A' ' 116' ' ' ALA . 47.0 t -114.61 159.25 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.88 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.756 HG12 ' CG2' ' A' ' 78' ' ' VAL . 1.1 t -143.54 83.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.571 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.699 HD13 ' HB3' ' A' ' 97' ' ' TYR . 37.4 mm -71.53 -45.32 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.656 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.756 ' CG2' HG12 ' A' ' 76' ' ' VAL . 6.8 t 48.67 85.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.489 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 7.6 mt -107.19 152.5 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 p -155.58 -171.59 3.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.94 -43.28 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.54 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -77.34 62.83 2.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.68 -161.46 26.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.507 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -116.23 168.83 9.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.3 -14.81 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.496 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -64.3 -22.17 66.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.315 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -31.7 39.48 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -61.51 -58.58 7.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.004 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.12 -23.43 27.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.842 179.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' O ' HG22 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -91.09 39.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.376 179.566 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.511 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -170.16 -38.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.083 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.919 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -74.36 -30.03 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -29.84 67.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.7 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.69 65.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.144 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.77 -2.18 3.31 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.231 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.919 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -56.99 -168.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.046 0.423 . . . . 0.0 111.111 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.699 ' HB3' HD13 ' A' ' 77' ' ' ILE . 6.8 t80 -110.73 27.87 9.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER 80.67 156.78 0.14 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.434 179.705 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.727 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -88.54 110.26 20.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 -179.993 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.42 HD23 HD13 ' A' ' 79' ' ' ILE . 8.3 tp -63.72 149.42 46.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.862 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -99.75 166.84 10.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.7 78.77 0.28 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.71 -3.94 14.59 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.628 2.219 . . . . 0.0 112.788 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -77.07 -59.22 2.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.712 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.6 t -112.86 131.82 55.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.941 HG21 HD23 ' A' ' 17' ' ' LEU . 32.8 m -95.99 37.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.024 0.44 . . . . 0.0 111.181 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.7 -55.64 18.7 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.14 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -60.94 -31.54 71.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.807 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.671 ' CE1' HD11 ' A' ' 113' ' ' ILE . 27.8 t80 -57.65 -39.28 76.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.893 179.065 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.644 HD11 HG23 ' A' ' 20' ' ' ILE . 1.5 mt -60.45 -51.03 71.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.174 179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -57.29 -46.13 83.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.549 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 m -69.27 -44.96 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.367 . . . . 0.0 110.959 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.671 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.6 mm -40.63 -52.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.78 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.19 12.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.651 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -62.08 -36.21 80.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.744 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -59.92 -39.46 85.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.445 ' CE1' HG22 ' A' ' 4' ' ' VAL . 19.5 m-85 -65.36 -19.42 65.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.291 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -52.17 -25.32 8.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.333 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -74.68 -6.59 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -162.03 61.66 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.907 0.384 . . . . 0.0 110.813 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.942 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mmt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.865 0.364 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp 59.81 87.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -142.35 118.09 10.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.967 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.65 HG13 ' HB ' ' A' ' 48' ' ' VAL . 14.3 t -118.6 160.81 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.655 HD22 ' CD2' ' A' ' 46' ' ' PHE . 42.5 tp -114.74 133.44 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.871 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.728 ' HB ' HG22 ' A' ' 30' ' ' THR . 24.5 t -113.58 90.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.407 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 t -82.2 111.85 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.87 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -147.73 137.54 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 13.2 t0 -61.38 -80.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.68 163.0 18.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.995 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -84.6 78.87 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.671 ' C ' HD12 ' A' ' 13' ' ' ILE . 40.2 t -109.91 -35.25 6.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.671 HD12 ' C ' ' A' ' 12' ' ' SER . 1.6 mp -114.21 -35.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.817 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 p -47.85 -28.05 2.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.438 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -80.43 -54.54 5.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 111.024 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -69.62 -63.09 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -45.21 -46.17 12.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.315 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.813 ' HA ' HD12 ' A' ' 21' ' ' LEU . 5.7 t -44.73 -37.76 3.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.2 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.238 0.542 . . . . 0.0 110.391 179.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.65 ' CD1' HG11 ' A' ' 106' ' ' VAL . 3.0 mp -68.54 -68.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.144 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -48.51 -27.24 2.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.316 179.438 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.946 ' N ' HD13 ' A' ' 21' ' ' LEU . 15.5 mt-10 -73.71 -28.44 61.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.711 0.291 . . . . 0.0 111.011 179.129 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.31 -36.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.826 0.346 . . . . 0.0 110.511 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -64.46 -17.37 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 -179.98 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.99 65.51 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.22 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 24' ' ' GLU . 20.3 m-85 -137.69 -176.92 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.217 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.84 91.89 43.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.716 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.837 ' HG3' HD11 ' A' ' 21' ' ' LEU . 72.7 Cg_endo -84.3 133.3 5.45 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.625 2.216 . . . . 0.0 112.91 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.549 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -110.26 7.23 23.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.344 -179.731 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.728 HG22 ' HB ' ' A' ' 6' ' ' VAL . 15.4 p 6.5 122.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 -170.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.116 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 18.9 tttt -104.39 -43.33 5.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -161.15 -168.28 2.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.317 179.535 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.596 HD22 ' CD2' ' A' ' 63' ' ' PHE . 32.1 mt -67.19 -52.9 35.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -57.36 -45.78 84.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.58 -35.16 75.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.36 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.483 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -68.45 -34.73 76.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 77.5 mt-10 -64.51 -43.38 94.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -39.11 78.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.781 178.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -72.36 -49.93 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.687 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 37' ' ' ALA . 6.0 mt -64.19 -27.33 42.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -27.92 5.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -124.2 -42.34 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.08 115.01 19.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -80.34 101.34 8.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.709 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CD2' HD22 ' A' ' 5' ' ' LEU . 35.2 m-85 -97.25 119.15 63.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.0 Cg_endo -73.06 -17.69 24.63 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.477 2.118 . . . . 0.0 111.899 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.679 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -147.85 132.21 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.565 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.501 HD12 HD23 ' A' ' 5' ' ' LEU . 15.5 mm -115.77 160.1 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 178.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.677 ' CG1' HD11 ' A' ' 79' ' ' ILE . 60.0 t -152.67 99.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.206 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 14.5 tp -71.39 164.56 25.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 54' ' ' TRP . 4.8 t70 -152.61 57.6 0.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.508 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 82' ' ' HIS . 46.9 t -44.43 91.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.04 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.414 ' N ' ' O ' ' A' ' 52' ' ' ASP . 30.3 t-105 -88.16 -75.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.828 179.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.736 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 7.8 ttp -147.18 46.22 0.48 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.161 179.002 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.736 ' HD3' ' N ' ' A' ' 55' ' ' MET . 28.1 Cg_endo -95.48 -160.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.235 2.623 . . . . 0.0 112.204 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -149.54 60.03 1.01 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.03 131.24 4.49 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.508 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.44 ' O ' HD13 ' A' ' 34' ' ' LEU . 11.8 p-10 -74.23 144.94 44.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 64' ' ' ILE . . . -103.79 -18.95 12.69 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.766 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.0 t -52.94 -40.61 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.16 -11.44 49.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.84 ' CE2' HD11 ' A' ' 67' ' ' ILE . 26.5 t80 -78.76 -39.64 35.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.371 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.709 HD11 ' HB1' ' A' ' 91' ' ' ALA . 2.7 mp -47.57 -32.79 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.359 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.64 -32.96 60.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.662 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 48.3 t80 -61.29 -44.96 96.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.84 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.1 mp -58.02 -42.64 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.271 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -80.25 -19.23 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 18.4 tt0 -71.15 -30.92 67.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.947 0.403 . . . . 0.0 110.703 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.438 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -132.37 17.21 4.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 180.0 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.57 68.73 1.05 Allowed Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.59 -21.25 46.16 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.77 2.313 . . . . 0.0 112.183 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.67 31.09 3.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 46.9 t -112.65 -163.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' HB ' HG13 ' A' ' 48' ' ' VAL . 45.8 t -152.58 135.85 7.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-O 121.025 0.441 . . . . 0.0 111.421 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.944 HG12 HG23 ' A' ' 78' ' ' VAL . 2.5 t -107.89 109.85 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.723 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.85 HD12 ' CG2' ' A' ' 112' ' ' THR . 33.7 mm -87.75 -56.32 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 179.388 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.944 HG23 HG12 ' A' ' 76' ' ' VAL . 20.3 t 53.65 103.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.518 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -102.98 -173.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.227 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.716 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 59.28 162.25 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.85 179.923 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.84 -155.63 14.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.555 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.476 ' CD2' HG11 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -159.11 30.98 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.92 -179.951 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.1 -97.35 0.47 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.617 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.409 ' O ' ' CG2' ' A' ' 85' ' ' VAL . 1.2 m -97.93 36.8 1.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.809 0.337 . . . . 0.0 110.94 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 84' ' ' SER . 35.4 m 43.34 30.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.825 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 89' ' ' VAL . 38.8 m-20 -78.85 -52.93 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.694 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.407 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.2 t -47.29 -32.5 4.73 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.205 0.526 . . . . 0.0 110.062 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.99 -60.04 4.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.16 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 86' ' ' ASP . 17.5 m -66.32 -24.66 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.118 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -83.63 -20.23 34.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.258 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.709 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -102.52 -39.14 7.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.662 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.91 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.8 pt -69.32 -27.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.408 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -32.08 64.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.697 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -64.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.83 29.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.916 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.91 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.18 -167.22 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 84.1 t80 -117.67 26.03 9.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 1.1 pt-20 85.74 146.43 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.415 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -78.8 105.39 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.772 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 79' ' ' ILE . 10.5 tp -57.59 167.01 1.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.05 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.65 132.35 53.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.458 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 10.9 mtmm -81.21 -48.34 1.06 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 102' ' ' LYS . 90.2 Cg_endo -83.73 52.89 3.92 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.501 2.134 . . . . 0.0 112.462 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 108' ' ' ARG . 0.6 OUTLIER -127.31 160.89 29.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 179.888 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -63.56 1.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.159 -179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.65 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.4 p -179.99 -34.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 -179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -39.87 -38.31 0.66 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 0.6 OUTLIER -71.04 -39.77 72.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.058 0.456 . . . . 0.0 110.413 179.564 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.714 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 21.0 t80 -57.14 -28.32 62.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.74 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -48.03 67.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.331 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.4 mp -66.73 -52.19 47.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.973 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.85 ' CG2' HD12 ' A' ' 77' ' ' ILE . 28.8 m -46.36 -32.61 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 0.0 110.728 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.714 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 22.1 mm -78.18 -67.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.488 ' HZ1' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -50.42 -19.66 0.91 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.941 -179.939 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.41 ' CG ' ' OH ' ' A' ' 97' ' ' TYR . 1.8 t-80 -89.58 -27.84 19.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 110.754 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.01 -35.49 57.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 48' ' ' VAL . 63.7 m-85 -79.73 -45.77 18.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -54.52 -50.27 68.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.1 -3.65 46.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.41 44.41 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.977 0.418 . . . . 0.0 110.962 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.84 179.978 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.795 0.331 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm 63.82 128.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.466 ' HB3' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -162.37 127.66 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.721 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' A' ' 48' ' ' VAL . 39.5 t -116.86 143.72 26.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.727 0.298 . . . . 0.0 110.685 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.599 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 19.1 tp -96.88 132.3 42.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.061 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.874 ' HB ' HG22 ' A' ' 30' ' ' THR . 21.9 t -116.35 89.0 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 32' ' ' LYS . 23.9 t -84.88 112.74 22.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.104 0.478 . . . . 0.0 111.167 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -146.12 136.51 23.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.565 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -51.27 -24.31 4.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -58.82 -163.47 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.688 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -147.15 150.16 34.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.915 0.388 . . . . 0.0 111.283 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 13' ' ' ILE . 2.9 m 58.73 77.27 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.211 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.781 ' HA ' HG21 ' A' ' 30' ' ' THR . 8.1 mm 50.55 159.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.742 0.782 . . . . 0.0 112.557 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.521 ' N ' HG22 ' A' ' 13' ' ' ILE . 72.0 p -91.55 145.81 24.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.983 178.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -68.2 137.11 54.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.601 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.529 ' CB ' HG11 ' A' ' 106' ' ' VAL . 0.8 OUTLIER 83.59 -16.94 0.52 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.28 179.316 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.005 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -86.39 -50.18 7.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 110.796 -179.899 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.15 -53.67 12.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -39.97 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.03 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.884 HD11 HG13 ' A' ' 106' ' ' VAL . 85.9 mt -67.85 -69.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.005 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.94 -30.23 1.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.98 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.87 -30.59 69.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.734 179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.47 -35.29 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.014 179.486 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.887 ' HG3' HD21 ' A' ' 110' ' ' LEU . 23.4 mm-40 -85.06 178.56 7.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.662 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.25 31.58 6.93 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.219 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.36 -175.55 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.199 0.523 . . . . 0.0 111.301 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.9 OUTLIER -151.05 95.79 3.35 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.811 179.61 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.547 ' HB3' HD13 ' A' ' 21' ' ' LEU . 57.6 Cg_endo -72.94 140.51 31.77 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.251 1.968 . . . . 0.0 112.481 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -115.42 -1.31 12.87 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.874 HG22 ' HB ' ' A' ' 6' ' ' VAL . 48.9 p 12.66 122.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -132.38 159.96 37.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.444 178.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.737 ' O ' HG13 ' A' ' 7' ' ' VAL . 31.5 mttt -73.48 -168.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 56' ' ' PRO . 16.8 p -48.04 161.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 111.909 -178.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.68 HD22 ' CD2' ' A' ' 63' ' ' PHE . 10.4 mt -27.24 -44.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.648 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.18 -62.36 1.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.318 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 2.1 tp10 -65.38 -34.73 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.507 ' C ' HD12 ' A' ' 41' ' ' ILE . . . -61.22 -63.14 1.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -44.67 -40.7 6.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.382 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -52.62 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.42 -34.28 76.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.835 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.507 HD12 ' C ' ' A' ' 37' ' ' ALA . 4.3 mt -85.27 -5.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.667 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -93.02 29.18 1.9 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.959 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -147.69 -53.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.091 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.953 HD11 ' CE1' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -99.31 -174.63 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -122.48 111.16 16.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.953 ' CE1' HD11 ' A' ' 44' ' ' LEU . 67.6 m-85 -98.58 125.59 42.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.41 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 4.3 Cg_endo -81.44 -23.97 4.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.711 2.274 . . . . 0.0 111.485 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.626 HG21 ' CE1' ' A' ' 117' ' ' PHE . 6.2 t -141.55 131.06 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.567 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 46' ' ' PHE . 8.8 mm -118.25 152.08 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.344 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.52 102.29 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.036 0.445 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.739 ' HB3' HG22 ' A' ' 78' ' ' VAL . 8.8 tp -94.3 129.62 40.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.063 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -113.33 113.15 24.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.417 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.816 HG22 ' CB ' ' A' ' 80' ' ' THR . 5.2 m -76.08 56.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.41 . . . . 0.0 111.542 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -64.76 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.489 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.677 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 35.1 mtm -149.01 51.78 1.03 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.949 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.5 Cg_exo -81.12 -153.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -163.19 30.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.23 134.51 7.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -58.64 105.79 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.77 0.319 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.89 -33.82 70.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.598 HG13 ' HG3' ' A' ' 94' ' ' LYS . 57.4 t -55.49 -39.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.014 0.435 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -23.64 59.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.183 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.839 ' CE2' HD11 ' A' ' 67' ' ' ILE . 39.7 t80 -75.35 -30.16 60.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 61' ' ' VAL . 5.4 mm -50.65 -33.74 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 69' ' ' GLU . 27.3 t70 -71.56 -39.57 70.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.401 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 14.7 t80 -55.19 -43.68 74.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 179.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.845 HG21 HG22 ' A' ' 76' ' ' VAL . 4.0 mp -59.57 -46.28 93.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.397 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -79.31 -13.27 59.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.748 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 43.2 tt0 -74.38 -43.15 57.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.113 0.483 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.476 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -118.55 13.61 13.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.037 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.89 66.43 2.33 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.925 0.393 . . . . 0.0 110.72 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 12.4 Cg_exo -69.13 -19.63 38.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.632 2.221 . . . . 0.0 112.243 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' HB3' ' CD2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -103.29 27.3 7.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.931 179.909 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -109.68 -157.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 116' ' ' ALA . 60.7 t -150.23 137.54 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.064 0.459 . . . . 0.0 111.726 179.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.845 HG22 HG21 ' A' ' 67' ' ' ILE . 1.6 t -116.35 91.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.445 HG22 ' CG1' ' A' ' 79' ' ' ILE . 27.6 mm -72.38 -59.26 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.114 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 51' ' ' LEU . 47.9 t 51.63 92.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.837 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.936 HG23 ' O ' ' A' ' 100' ' ' LEU . 3.0 mt -116.42 145.71 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.992 0.425 . . . . 0.0 111.558 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.816 ' CB ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER 168.27 104.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.686 179.504 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.77 119.64 6.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.496 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 31.6 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 162.68 -113.71 0.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.47 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.92 168.48 9.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 85' ' ' VAL . 29.3 m -83.06 59.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.021 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -103.92 -28.78 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -85.47 -31.81 22.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 109.953 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . . . -61.55 -56.59 18.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.777 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 92' ' ' ILE . 33.8 m -52.58 -30.71 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.888 179.445 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.583 ' CD ' HG21 ' A' ' 61' ' ' VAL . 8.2 ttmt -75.98 -22.34 55.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.48 -40.72 8.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.87 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.892 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 9.2 pt -70.91 -42.94 77.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.321 -179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -23.38 65.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.554 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.598 ' HG3' HG13 ' A' ' 61' ' ' VAL . 4.1 mmpt? -79.76 -57.83 3.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.61 28.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.495 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.18 -164.52 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.12 0.46 . . . . 0.0 110.68 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.519 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 54.8 t80 -101.87 -23.18 14.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.6 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 3.8 pt-20 150.07 -11.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.603 0.565 . . . . 0.0 111.932 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.625 ' CE1' HG12 ' A' ' 78' ' ' VAL . 1.5 t80 69.98 71.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.121 0.486 . . . . 0.0 110.085 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.936 ' O ' HG23 ' A' ' 79' ' ' ILE . 66.1 tp -49.77 165.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.189 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.456 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 7.7 mt-10 -124.12 97.43 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.635 ' HD3' HG23 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -142.25 51.72 2.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.058 -179.781 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 102' ' ' LYS . 60.2 Cg_endo -71.73 -5.8 17.82 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.483 2.122 . . . . 0.0 112.812 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -137.44 -45.43 0.55 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.048 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 92.5 p -107.23 96.03 6.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.884 HG13 HD11 ' A' ' 20' ' ' ILE . 7.1 p -82.0 -1.97 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.389 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.93 -41.91 77.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -60.83 -34.85 75.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.455 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.613 ' HA ' HD21 ' A' ' 100' ' ' LEU . 6.2 t80 -61.35 -39.78 91.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.429 178.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.887 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.2 tt -48.72 -51.71 27.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.31 179.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -57.35 -46.57 83.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.4 m -60.8 -40.17 91.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.223 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.0 mm -47.97 -54.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.535 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.91 -59.15 3.27 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -51.73 -29.46 18.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.867 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -65.33 -33.94 77.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.965 0.412 . . . . 0.0 110.672 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.626 ' CE1' HG21 ' A' ' 48' ' ' VAL . 35.1 m-85 -78.45 -23.01 46.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.291 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.37 -25.58 10.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.808 0.337 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.7 -12.8 61.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.198 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -138.25 34.56 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.755 179.8 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.988 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.812 0.339 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 1.7 mmtp -128.42 116.93 20.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -143.33 133.57 24.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.842 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 48' ' ' VAL . 18.6 t -128.03 161.08 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.799 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.697 HD22 ' CD2' ' A' ' 46' ' ' PHE . 28.0 tp -112.51 134.64 53.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.718 ' HB ' HG22 ' A' ' 30' ' ' THR . 22.0 t -116.23 90.28 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.823 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.6 106.02 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.772 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 14' ' ' THR . 10.0 t70 -136.66 133.11 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.989 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 16.8 t70 -51.85 -45.1 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.277 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -176.64 135.87 0.24 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.661 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 12' ' ' SER . 3.8 pt-20 45.34 -161.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.779 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 47.3 t 74.39 -86.3 0.03 OUTLIER 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.39 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.554 HG23 ' HB2' ' A' ' 17' ' ' LEU . 32.4 mm -78.63 -49.84 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.761 0.315 . . . . 0.0 111.674 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.472 HG22 ' HB ' ' A' ' 30' ' ' THR . 12.1 p -49.9 -31.3 11.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.63 -179.422 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 p -90.11 -47.02 8.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.544 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -74.88 -69.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.661 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.891 HD13 ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -40.71 -48.02 2.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.68 -179.393 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.68 ' O ' HD22 ' A' ' 21' ' ' LEU . 6.6 t -51.17 -41.73 60.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 110.924 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.35 74.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.313 0.577 . . . . 0.0 109.892 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.846 ' CD1' HG11 ' A' ' 106' ' ' VAL . 2.0 mp -75.51 -63.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.965 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.891 ' CD1' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.11 -13.35 1.17 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.088 -179.241 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.68 ' N ' HD23 ' A' ' 21' ' ' LEU . 3.6 mt-10 -85.07 -26.03 27.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.79 0.329 . . . . 0.0 110.313 179.034 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -35.55 26.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.394 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.868 ' HG2' HD21 ' A' ' 110' ' ' LEU . 3.3 mp0 -73.98 -50.37 20.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.67 57.05 0.22 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.194 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 82.1 m-85 -120.24 -174.74 2.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.072 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.77 89.17 40.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.058 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 85.2 Cg_endo -81.32 124.95 4.97 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.522 2.148 . . . . 0.0 113.062 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.97 7.52 46.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.718 HG22 ' HB ' ' A' ' 6' ' ' VAL . 11.7 p 4.42 122.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.2 168.18 10.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.428 178.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' ASP . 37.1 mttm -88.93 -37.89 14.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -155.95 -179.5 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.734 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.542 HD22 ' CG ' ' A' ' 63' ' ' PHE . 11.2 mt -61.88 -33.89 75.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.549 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -48.19 71.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.191 179.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.51 -30.15 68.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.498 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.4 -33.9 69.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 33.7 mt-10 -67.84 -42.56 81.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -33.73 76.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.088 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -75.83 -42.81 48.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.509 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.498 HD12 ' O ' ' A' ' 37' ' ' ALA . 9.3 mt -72.49 -26.95 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.109 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -26.76 13.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -122.27 -42.5 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 139.83 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -103.72 101.93 11.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.77 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.697 ' CD2' HD22 ' A' ' 5' ' ' LEU . 25.8 m-85 -94.82 120.09 65.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 74' ' ' SER . 64.9 Cg_endo -73.64 -12.38 24.52 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.43 2.087 . . . . 0.0 111.759 179.096 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.649 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.4 t -151.94 135.11 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.43 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 12.3 mm -115.83 161.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.633 178.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' LEU . 60.7 t -149.72 94.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.542 . . . . 0.0 111.642 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.884 ' HB3' HG13 ' A' ' 78' ' ' VAL . 11.6 tp -77.59 171.1 15.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.289 179.624 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 6.4 t70 -139.65 -46.43 0.45 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.395 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 53' ' ' VAL . 21.5 t 66.24 40.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -57.79 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.525 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.676 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.7 mmm -148.05 51.36 1.03 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.059 179.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.676 ' HD3' ' N ' ' A' ' 55' ' ' MET . 4.8 Cg_endo -87.56 -155.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.036 2.49 . . . . 0.0 112.021 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -148.67 38.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.02 168.87 22.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.515 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.0 111.58 24.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.38 -19.4 66.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.752 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.574 ' O ' HD12 ' A' ' 64' ' ' ILE . 18.8 t -53.12 -48.85 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.859 0.362 . . . . 0.0 111.357 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -14.08 58.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.299 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 67' ' ' ILE . 44.6 t80 -71.87 -37.7 70.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.683 0.277 . . . . 0.0 111.225 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mt -47.89 -28.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.285 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -34.24 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 38' ' ' GLU . 72.6 t80 -60.12 -38.68 83.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.139 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.4 mp -60.32 -45.97 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 179.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -77.91 -24.24 48.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 25.9 tt0 -64.57 -33.61 76.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.42 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -131.0 17.52 5.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.182 -179.836 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.82 70.02 1.04 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.823 0.344 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.2 -18.79 34.73 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.842 2.361 . . . . 0.0 112.254 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -98.89 30.42 3.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.824 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 41.6 t -114.71 -162.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.641 ' HB ' HG13 ' A' ' 48' ' ' VAL . 30.8 t -154.31 136.5 6.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.68 0.276 . . . . 0.0 111.284 179.201 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.953 HG12 HG23 ' A' ' 78' ' ' VAL . 4.9 t -110.38 110.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.837 -179.036 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 77' ' ' ILE . 28.1 mm -111.11 43.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.662 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.953 HG23 HG12 ' A' ' 76' ' ' VAL . 47.7 t -43.36 121.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.587 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.521 HG23 ' HB3' ' A' ' 100' ' ' LEU . 3.8 mt -121.34 150.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.805 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.478 HG22 ' CG2' ' A' ' 53' ' ' VAL . 30.5 p -157.66 166.32 33.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.9 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.76 65.83 0.58 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.505 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -93.79 -30.53 14.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.778 0.323 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.77 20.14 69.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.6 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.4 m -119.06 -7.51 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m 43.11 31.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.727 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -111.25 -10.36 14.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.401 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 1.5 t -89.38 -36.5 15.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.013 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -57.62 -58.21 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.843 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.406 ' HA ' HG12 ' A' ' 92' ' ' ILE . 22.1 m -55.14 -27.11 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.578 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HE3' HG22 ' A' ' 61' ' ' VAL . 31.0 ttpt -82.21 -20.35 37.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.134 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.59 -40.3 7.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.498 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.939 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 12.5 pt -68.71 -31.52 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -26.4 67.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.697 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -73.74 -59.59 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 31.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.332 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.939 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.09 -164.67 1.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.025 0.412 . . . . 0.0 110.438 179.3 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.555 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.6 t80 -105.22 -22.02 13.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.53 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 144.52 14.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.733 0.645 . . . . 0.0 111.773 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER 62.15 163.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 110.643 -179.881 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -107.48 97.04 6.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.649 179.856 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.1 164.76 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.529 ' N ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER 64.3 58.71 1.63 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.244 -179.914 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 102' ' ' LYS . 15.5 Cg_exo -67.47 63.99 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.571 2.181 . . . . 0.0 112.108 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.29 -61.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.03 -179.849 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.5 p -97.97 136.42 38.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 20' ' ' ILE . 12.4 p -80.23 -35.84 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.007 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -45.94 -41.82 12.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.936 0.398 . . . . 0.0 110.909 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.467 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -64.04 -34.79 78.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.166 179.362 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.631 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 6.3 t80 -68.03 -28.93 67.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.522 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.868 HD21 ' HG2' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -50.67 -42.69 56.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.068 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 108' ' ' ARG . 3.3 mp -56.37 -56.2 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.836 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.418 ' CG2' HD12 ' A' ' 77' ' ' ILE . 90.9 m -46.62 -44.06 17.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.055 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.631 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 24.2 mm -54.53 -69.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.037 0.446 . . . . 0.0 110.43 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.418 ' O ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -54.9 -17.9 4.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.876 179.111 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -89.8 -21.23 22.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.34 -37.34 18.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.971 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 48' ' ' VAL . 35.0 m-85 -73.09 -39.29 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.9 -28.2 61.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.294 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.65 -5.72 44.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.596 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.48 31.23 2.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.899 0.38 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 25.4 mmtt 62.26 117.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.405 ' N ' ' CD ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -147.99 124.75 11.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' A' ' 48' ' ' VAL . 25.2 t -119.6 159.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.707 HD23 HG23 ' A' ' 49' ' ' ILE . 41.7 tp -114.04 136.29 53.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.579 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.777 HG21 HD12 ' A' ' 17' ' ' LEU . 3.6 t -120.79 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 37' ' ' ALA . 30.2 t -78.14 119.47 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.567 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 12.3 t0 -163.75 154.74 16.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.747 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -85.23 48.99 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.73 139.44 50.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.653 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.87 -67.66 0.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.109 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.5 p -85.28 -165.79 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.008 -179.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.606 HG21 ' CA ' ' A' ' 18' ' ' SER . 7.6 mm -49.28 164.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.813 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.517 ' N ' HG22 ' A' ' 13' ' ' ILE . 64.2 p -90.23 -99.42 0.1 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.103 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.721 ' HB3' HG13 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -91.46 -155.13 0.39 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.745 0.307 . . . . 0.0 111.523 -179.591 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' LEU . 52.6 m -47.53 -22.23 0.45 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.869 179.51 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.977 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -32.14 -49.55 0.2 Allowed 'General case' 0 C--N 1.339 0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 110.482 179.238 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.606 ' CA ' HG21 ' A' ' 13' ' ' ILE . 7.7 t -47.78 -67.14 0.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.111 179.289 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.53 75.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.693 ' CD1' HG23 ' A' ' 106' ' ' VAL . 13.7 mt -61.59 -63.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.346 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.977 HD11 HD13 ' A' ' 17' ' ' LEU . 1.5 mt -45.07 -36.18 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.329 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -27.85 67.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.136 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' ILE . 12.3 tt0 -87.1 -41.98 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.507 ' OE2' HD21 ' A' ' 110' ' ' LEU . 5.3 mm-40 -75.31 -43.33 51.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.75 32.71 5.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.558 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.698 ' HB2' HD23 ' A' ' 21' ' ' LEU . 48.9 m-85 -81.42 -174.63 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.894 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.98 86.05 53.1 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.031 179.332 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.546 ' HG3' HD13 ' A' ' 21' ' ' LEU . 94.0 Cg_endo -81.46 136.82 10.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.66 2.24 . . . . 0.0 112.505 -179.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 30' ' ' THR . 7.2 t70 -113.53 3.02 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.03 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.731 HG22 ' HB ' ' A' ' 6' ' ' VAL . 26.4 p 9.84 121.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.12 -178.54 3.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.699 179.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 30.7 tttp -95.39 -38.62 10.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.667 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 6.2 t -165.76 -162.47 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.899 HD11 ' O ' ' A' ' 59' ' ' ASP . 14.9 mt -68.4 -47.36 67.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.657 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -60.78 -45.63 93.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 109.989 179.167 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -34.13 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.439 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 7' ' ' VAL . . . -70.29 -35.06 73.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.705 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG2' ' CD1' ' A' ' 66' ' ' PHE . 90.3 mt-10 -65.92 -41.31 91.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -38.07 85.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.601 178.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -74.06 -49.94 21.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.873 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 mt -66.9 -27.75 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.145 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -62.85 -23.99 67.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.095 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.06 -42.89 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.247 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 129.16 38.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -82.18 62.39 5.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.461 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.564 ' HB2' HD11 ' A' ' 49' ' ' ILE . 60.0 m-85 -55.34 121.31 36.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.475 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.446 ' O ' ' HA ' ' A' ' 74' ' ' SER . 61.0 Cg_endo -72.9 -22.92 19.35 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.435 2.09 . . . . 0.0 111.805 179.318 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 117' ' ' PHE . 4.5 t -142.68 125.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.316 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.707 HG23 HD23 ' A' ' 5' ' ' LEU . 8.3 mm -111.91 152.52 13.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.029 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 51' ' ' LEU . 4.9 t -134.87 177.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.875 ' HB3' HG13 ' A' ' 78' ' ' VAL . 29.4 tp -161.74 78.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.072 0.463 . . . . 0.0 111.101 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 8.6 t70 -70.72 67.84 0.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.517 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' A' ' 51' ' ' LEU . 50.4 t -47.12 92.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.474 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -79.19 -80.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.502 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.681 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -152.5 50.6 0.64 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.13 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.681 ' HD3' ' N ' ' A' ' 55' ' ' MET . 10.1 Cg_endo -90.57 -158.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.043 2.495 . . . . 0.0 112.015 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -157.74 58.36 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.096 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.48 10.79 4.06 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.788 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.899 ' O ' HD11 ' A' ' 34' ' ' LEU . 3.3 m-20 52.98 -162.02 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.717 0.258 . . . . 0.0 110.679 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.23 28.96 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.674 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.632 HG21 ' HD3' ' A' ' 90' ' ' LYS . 17.6 t -89.44 -44.91 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.955 0.407 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.13 9.56 27.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.569 -179.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.774 ' CE2' HD11 ' A' ' 67' ' ' ILE . 17.6 t80 -90.03 -36.88 14.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.704 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.6 mp -46.79 -28.97 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.403 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -35.89 65.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD1' ' HG2' ' A' ' 38' ' ' GLU . 12.3 t80 -62.74 -44.2 96.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.422 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.774 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.0 mp -59.27 -37.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.321 179.411 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -85.7 -20.19 29.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.719 179.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -69.59 -29.26 66.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -131.93 9.05 4.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.251 -179.873 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.03 67.79 3.21 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.854 0.359 . . . . 0.0 110.745 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.65 -15.37 21.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.799 2.333 . . . . 0.0 112.285 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.35 27.35 9.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.067 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 39.8 t -107.18 -163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.489 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.869 HG21 ' HB1' ' A' ' 116' ' ' ALA . 21.2 t -146.36 131.64 12.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-O 121.239 0.542 . . . . 0.0 112.457 179.338 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.006 HG12 HG23 ' A' ' 78' ' ' VAL . 1.3 t -105.25 110.72 31.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.094 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.704 HD12 ' CG2' ' A' ' 112' ' ' THR . 29.2 mm -109.25 38.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.006 HG23 HG12 ' A' ' 76' ' ' VAL . 60.0 t -42.63 115.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.295 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.896 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -105.64 179.85 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.87 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.692 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 59.5 122.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 111.289 179.787 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.54 172.85 22.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.431 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -68.1 -68.35 0.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 110.939 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 179.53 144.56 5.92 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.5 p 57.81 30.79 19.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.708 0.29 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m 42.18 59.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.776 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -104.12 -18.92 14.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -90.84 -36.16 14.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -56.78 -57.27 13.17 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.84 178.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -51.76 -26.86 7.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.632 ' HD3' HG21 ' A' ' 61' ' ' VAL . 8.9 tttt -89.09 36.74 0.83 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.22 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.704 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -170.31 -42.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.614 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -75.47 157.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.808 179.997 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.16 -3.2 2.52 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.102 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -112.6 -25.33 9.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.31 -34.92 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.25 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -68.91 177.63 2.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.773 0.321 . . . . 0.0 111.151 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.46 ' HB3' HD13 ' A' ' 77' ' ' ILE . 45.4 t80 -108.77 29.94 6.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.486 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.1 OUTLIER 80.15 142.71 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.932 179.773 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.61 ' CG ' ' HB2' ' A' ' 88' ' ' ALA . 1.6 m-85 -67.79 142.06 56.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.38 -179.605 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.896 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -89.94 89.46 7.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.593 179.655 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -54.93 179.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.26 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp 61.59 64.44 2.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.99 178.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.538 2.159 . . . . 0.0 112.295 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 63.35 127.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.7 m 60.57 110.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.755 HG21 HD23 ' A' ' 17' ' ' LEU . 33.3 m -86.65 10.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.761 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -45.93 -47.85 16.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.664 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -70.45 -30.34 67.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.987 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.508 ' CE2' HG21 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -65.71 -25.15 67.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.447 179.522 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.507 HD21 ' OE2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -47.44 -50.15 23.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.883 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.608 ' H ' HD12 ' A' ' 111' ' ' LEU . 5.5 mp -55.63 -47.56 76.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.476 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.704 ' CG2' HD12 ' A' ' 77' ' ' ILE . 97.7 m -49.29 -38.36 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.632 179.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.472 HG23 ' CE1' ' A' ' 117' ' ' PHE . 8.3 mm -66.48 -62.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.16 179.237 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.478 ' CG ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -55.56 -14.94 2.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.456 179.402 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.416 ' N ' ' HD3' ' A' ' 114' ' ' LYS . 2.0 m80 -90.41 -19.69 23.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.072 0.463 . . . . 0.0 110.266 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.869 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -89.98 -49.1 6.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.963 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 48' ' ' VAL . 36.9 m-85 -56.8 -30.8 64.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -55.4 -24.45 30.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.291 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.2 32.13 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -134.89 30.47 3.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.951 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.9 mtm . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.786 0.327 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 19.9 mmtt 61.05 97.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -143.64 128.04 17.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.651 179.948 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.2 t -121.5 151.45 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 -179.806 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.58 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 33.5 tp -101.24 136.53 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.752 0.31 . . . . 0.0 110.516 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.819 HG21 HD12 ' A' ' 17' ' ' LEU . 8.4 t -117.14 95.57 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 32' ' ' LYS . 87.6 t -89.34 116.22 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.172 0.51 . . . . 0.0 111.243 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -145.37 112.68 6.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.879 179.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.537 ' HB2' HG23 ' A' ' 33' ' ' THR . 4.8 t70 -50.42 -79.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -178.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.7 OUTLIER -89.77 174.1 7.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.915 0.388 . . . . 0.0 111.244 -179.411 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.83 112.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.2 t -53.57 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.044 HD12 HG21 ' A' ' 30' ' ' THR . 24.0 mm 66.45 165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 121.163 0.506 . . . . 0.0 110.442 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.588 ' N ' HG22 ' A' ' 13' ' ' ILE . 2.7 p -90.34 101.59 14.32 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.788 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -42.57 140.92 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.285 -178.733 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.57 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.6 m 85.56 -17.57 0.41 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.62 179.054 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.991 HD23 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -70.66 -54.45 11.87 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.052 -179.672 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.0 -67.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.676 -179.562 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.65 -40.36 27.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.496 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.882 HG23 HD11 ' A' ' 110' ' ' LEU . 60.3 mt -64.72 -66.27 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.918 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -47.65 -29.44 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.13 -25.09 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.09 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -81.89 -41.11 21.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.869 0.366 . . . . 0.0 110.246 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.612 ' HG2' HD22 ' A' ' 110' ' ' LEU . 1.6 mp0 -75.85 -32.09 59.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.059 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.74 31.17 6.46 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 51.1 m-85 -88.27 -174.69 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -139.01 91.61 11.38 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.635 179.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 66.9 Cg_endo -76.88 145.49 25.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.49 2.127 . . . . 0.0 112.18 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.9 t70 -120.09 -4.61 10.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.703 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.044 HG21 HD12 ' A' ' 13' ' ' ILE . 10.2 p 23.54 123.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.64 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -131.74 145.69 51.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.297 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.646 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -58.61 -173.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.521 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -48.36 167.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 111.654 -178.591 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 63' ' ' PHE . 11.8 mt -31.44 -39.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.481 -178.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -62.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.149 179.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.463 ' CB ' ' CB ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -64.81 -27.25 68.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.865 179.568 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.45 -57.39 4.47 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.391 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.472 ' HG3' ' CE1' ' A' ' 63' ' ' PHE . 64.5 mt-10 -46.31 -41.34 13.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.452 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -61.0 -53.28 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HD2' ' HB2' ' A' ' 31' ' ' ALA . 20.1 mttm -59.66 -35.03 73.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.129 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.731 HD12 ' HZ ' ' A' ' 63' ' ' PHE . 47.3 mt -92.3 -5.23 10.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLU . 2.8 tmtm? -56.75 -19.61 17.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.299 -179.813 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -139.43 -46.23 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 121.07 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -87.14 75.22 9.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 27.2 m-85 -66.09 132.33 94.56 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 74.1 Cg_endo -75.23 -30.38 6.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.411 2.074 . . . . 0.0 111.878 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.778 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.4 t -140.32 132.98 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.537 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 46' ' ' PHE . 20.9 mm -115.47 145.23 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.453 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 44.1 t -130.3 105.74 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 111.446 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 ' HA3' ' A' ' 60' ' ' GLY . 45.7 tp -100.33 147.88 25.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.3 179.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.704 ' C ' HG22 ' A' ' 80' ' ' THR . 7.4 t0 -119.11 -31.76 4.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.563 -179.38 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 53' ' ' VAL . 88.5 t 60.64 63.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.73 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.455 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 37.1 t-105 -58.83 -81.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.834 0.349 . . . . 0.0 110.383 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.71 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 1.6 ttt -151.97 48.82 0.5 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.085 179.233 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.8 Cg_exo -76.87 -150.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.789 2.326 . . . . 0.0 112.032 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -135.18 21.48 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.212 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.67 -3.71 4.98 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.029 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 61' ' ' VAL . 16.4 m-20 52.64 25.1 3.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.018 0.437 . . . . 0.0 111.167 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.668 ' HA3' HD21 ' A' ' 51' ' ' LEU . . . 49.6 18.63 1.73 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.623 179.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 90' ' ' LYS . 23.2 t -87.25 -45.1 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 117.149 0.474 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -65.78 -16.16 63.53 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 34' ' ' LEU . 3.7 t80 -85.65 -29.05 24.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.564 ' CD1' ' HB1' ' A' ' 91' ' ' ALA . 20.2 mm -46.59 -43.47 6.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.327 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -44.91 70.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 21.1 t80 -49.4 -41.06 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.975 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.792 HG21 HG22 ' A' ' 76' ' ' VAL . 2.1 mp -62.61 -49.97 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -12.09 60.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.466 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.92 -49.37 20.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.059 0.457 . . . . 0.0 110.394 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.18 17.04 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.976 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.05 67.2 2.05 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.736 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.22 -15.77 22.66 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.776 2.317 . . . . 0.0 112.265 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -112.61 32.91 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.83 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -111.89 -159.83 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.878 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.833 HG11 ' HB1' ' A' ' 116' ' ' ALA . 41.2 t -138.08 138.98 43.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.309 0.576 . . . . 0.0 112.293 179.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.874 HG12 HG23 ' A' ' 78' ' ' VAL . 6.2 t -114.41 99.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.317 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.641 HG21 ' CD1' ' A' ' 109' ' ' PHE . 35.0 mm -103.41 43.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.874 HG23 HG12 ' A' ' 76' ' ' VAL . 98.9 t -54.72 87.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.652 HG23 ' HB3' ' A' ' 100' ' ' LEU . 19.2 mt -66.25 -101.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.704 HG22 ' C ' ' A' ' 52' ' ' ASP . 1.0 OUTLIER 72.05 -61.96 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.599 0.237 . . . . 0.0 111.041 179.55 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' N ' ' OG1' ' A' ' 80' ' ' THR . . . 57.51 -88.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.565 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.68 29.0 18.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.951 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.17 -61.8 3.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.547 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.71 135.5 55.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.3 m -107.25 -7.74 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.609 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.72 -27.06 68.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.685 0.279 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.52 -34.24 54.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.089 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.8 -57.81 11.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.018 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 m -56.84 -22.83 16.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.956 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.523 ' O ' HG13 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -80.41 2.81 23.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.248 179.753 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . -138.71 -40.53 0.5 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 1.6 pt -70.84 -24.59 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -71.74 -35.58 70.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -59.77 -59.21 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.65 31.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.995 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.24 -178.74 5.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.471 ' HB3' HD13 ' A' ' 77' ' ' ILE . 18.9 t80 -101.25 27.91 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.426 -179.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER 77.64 151.96 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.971 179.927 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -74.19 139.26 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.652 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -83.64 92.11 7.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.556 179.869 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.53 154.16 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.066 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.42 72.59 0.72 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.995 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.23 57.0 6.27 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.575 2.183 . . . . 0.0 112.401 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -101.56 105.77 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.1 t 56.61 24.25 8.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.994 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.991 HG21 HD23 ' A' ' 17' ' ' LEU . 2.6 m 39.88 35.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.041 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.1 -50.86 29.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HA ' HD13 ' A' ' 111' ' ' LEU . 13.8 tpt180 -61.94 -29.63 70.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.417 178.514 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CD1' HG21 ' A' ' 77' ' ' ILE . 24.0 t80 -62.12 -40.71 96.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.712 178.804 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.882 HD11 HG23 ' A' ' 20' ' ' ILE . 2.0 mt -54.65 -48.83 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.263 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.482 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.4 mp -59.54 -50.45 73.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.028 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.0 m -61.5 -37.55 84.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.707 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.502 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 1.6 mm -55.76 -53.13 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.375 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -60.0 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 109.853 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -58.4 -26.13 62.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.998 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.833 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -66.14 -38.35 87.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.926 0.393 . . . . 0.0 110.977 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.597 ' CE2' HG21 ' A' ' 48' ' ' VAL . 20.7 m-85 -68.84 -20.04 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.632 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -56.99 -21.82 33.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -94.79 28.78 2.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.173 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -115.3 28.08 8.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.919 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ptp . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.862 0.363 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' HG3' ' CD2' ' A' ' 117' ' ' PHE . 2.0 mptt -111.94 119.59 39.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -111.39 124.73 52.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.458 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.671 HG13 ' HB ' ' A' ' 48' ' ' VAL . 26.9 t -124.33 144.33 34.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.329 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.654 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 46.8 tp -95.02 128.76 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.321 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.555 HG21 ' CD1' ' A' ' 17' ' ' LEU . 18.9 t -112.91 92.56 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.482 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 32' ' ' LYS . 60.1 t -89.99 118.72 35.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.029 0.442 . . . . 0.0 111.082 179.623 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -153.63 125.12 7.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.681 ' HB2' HG22 ' A' ' 33' ' ' THR . 21.2 t0 -85.73 47.59 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.329 -179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' CG ' ' CD1' ' A' ' 54' ' ' TRP . 4.0 tm-20 -120.68 -40.63 2.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.676 179.727 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -178.37 -165.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.407 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 p -56.81 -93.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.456 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.022 HD13 HG21 ' A' ' 30' ' ' THR . 7.8 mm -87.84 161.37 2.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.951 0.405 . . . . 0.0 111.052 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.477 ' N ' HG22 ' A' ' 13' ' ' ILE . 65.6 p -90.34 131.37 36.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.242 179.249 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -52.19 139.46 23.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 0.0 112.185 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.752 ' O ' HD12 ' A' ' 20' ' ' ILE . 8.7 t 73.54 0.72 3.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.449 179.109 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -90.36 -59.45 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.157 -179.918 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.63 ' O ' HD22 ' A' ' 21' ' ' LEU . 7.8 t -46.5 -45.94 18.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.591 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.14 73.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.376 0.607 . . . . 0.0 110.17 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 110' ' ' LEU . 41.7 mt -76.14 -64.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.774 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.771 ' CD1' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -56.74 -10.46 1.04 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.978 -179.186 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.571 ' N ' HD23 ' A' ' 21' ' ' LEU . 17.4 mt-10 -89.23 -28.6 19.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.033 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -36.1 32.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.013 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.769 ' CG ' HD21 ' A' ' 110' ' ' LEU . 30.5 mm-40 -77.77 -31.33 51.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.019 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.98 42.89 3.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.512 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 7.2 m-85 -95.83 -170.31 2.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 -179.066 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.08 93.47 5.5 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.455 ' HD3' ' HG ' ' A' ' 21' ' ' LEU . 73.3 Cg_endo -79.67 146.78 19.17 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.384 2.056 . . . . 0.0 112.011 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.658 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -115.76 -7.26 12.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.022 HG21 HD13 ' A' ' 13' ' ' ILE . 11.7 p 25.51 124.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 7' ' ' VAL . . . -141.89 141.88 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.901 178.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.844 ' O ' HG13 ' A' ' 7' ' ' VAL . 39.4 mtmt -58.79 -165.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.56 0.219 . . . . 0.0 110.564 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.681 HG22 ' HB2' ' A' ' 9' ' ' ASP . 14.9 p -47.89 168.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 112.149 -177.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.815 HD11 ' O ' ' A' ' 59' ' ' ASP . 22.5 mt -40.81 -31.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.97 -179.075 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -64.3 0.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.14 0.495 . . . . 0.0 109.84 179.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.5 -33.72 76.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.461 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 34' ' ' LEU . . . -64.88 -61.66 2.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.729 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 7.5 mt-10 -44.05 -42.12 5.93 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -61.44 -51.74 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -63.35 -33.95 76.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.336 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 41' ' ' ILE . 8.3 mt -88.95 -9.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -57.67 -19.42 26.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.501 -179.735 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -134.64 -47.25 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 124.72 20.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -84.96 72.0 10.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.654 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 25.0 m-85 -65.79 126.77 92.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.79 -27.62 3.84 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.508 2.139 . . . . 0.0 112.074 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.717 HG13 ' HB ' ' A' ' 75' ' ' VAL . 2.8 t -140.51 132.62 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.346 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.448 HD11 ' CB ' ' A' ' 46' ' ' PHE . 18.5 mm -118.73 148.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.138 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 49.0 t -136.86 104.57 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.488 179.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp -98.99 97.68 8.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -83.42 92.79 7.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.953 178.936 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.761 HG22 ' HB ' ' A' ' 80' ' ' THR . 28.0 m -63.87 74.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.789 -179.211 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.442 ' CD1' ' CG ' ' A' ' 10' ' ' GLU . 30.3 t-105 -81.75 -80.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.514 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.498 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 21.9 mmt -145.67 61.4 7.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.809 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 55' ' ' MET . 11.1 Cg_endo -89.2 -159.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.128 2.552 . . . . 0.0 112.32 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -153.77 25.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.141 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.96 10.66 5.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.629 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.815 ' O ' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 55.92 -157.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.788 0.294 . . . . 0.0 110.212 -179.703 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.7 22.04 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.898 ' O ' HD12 ' A' ' 64' ' ' ILE . 20.4 t -86.83 -45.15 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 110.879 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -1.16 50.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CD2' HD11 ' A' ' 67' ' ' ILE . 6.5 t80 -76.32 -41.14 49.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.4 mt -43.81 -38.42 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.329 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.32 -51.37 57.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.427 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 63' ' ' PHE . 34.0 t80 -53.68 -28.5 33.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.097 179.289 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.984 HG21 HG22 ' A' ' 76' ' ' VAL . 2.9 mm -68.25 -54.61 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.302 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -71.3 -22.06 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.557 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.93 -52.89 61.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.701 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.62 18.0 18.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.161 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.4 68.15 1.71 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 110.801 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.35 -19.33 33.45 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.804 2.336 . . . . 0.0 112.361 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -113.17 35.96 3.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -112.64 -156.76 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.809 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.717 ' HB ' HG13 ' A' ' 48' ' ' VAL . 50.0 t -146.49 138.72 19.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.436 0.636 . . . . 0.0 112.16 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.984 HG22 HG21 ' A' ' 67' ' ' ILE . 2.8 t -118.35 80.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.149 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -65.56 -54.93 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.78 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.809 HG23 HG12 ' A' ' 76' ' ' VAL . 34.4 t 49.44 89.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.32 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.749 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -99.33 -173.96 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.761 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.7 m 80.22 103.62 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.352 . . . . 0.0 110.963 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.76 59.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.43 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.0 -54.81 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 110.97 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.45 -91.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.546 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 t -63.82 110.29 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.6 t -92.09 14.38 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.407 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.49 -15.87 28.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.099 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.13 -32.86 38.92 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.51 -57.95 10.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.099 178.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 92' ' ' ILE . 17.5 m -61.84 -27.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.207 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.528 ' O ' HG13 ' A' ' 61' ' ' VAL . 4.8 ttmt -80.56 -12.91 59.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.647 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.663 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -114.1 -24.34 9.05 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.834 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 4.9 pt -90.1 -15.05 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.272 . . . . 0.0 111.635 -179.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.69 -42.74 67.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.737 0.303 . . . . 0.0 111.123 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.611 ' HB3' HD13 ' A' ' 64' ' ' ILE . 9.4 ttmt -54.82 -35.1 63.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.77 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.157 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.1 -167.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.33 . . . . 0.0 110.899 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 9.3 t80 -108.44 27.28 9.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.219 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.9 OUTLIER 80.66 159.7 0.16 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.154 179.759 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.734 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -92.13 104.39 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.827 -179.962 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HB3' HG23 ' A' ' 79' ' ' ILE . 9.9 tp -57.78 147.33 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -102.01 167.64 9.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.992 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.1 mttm 62.75 55.91 2.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.32 81.53 2.01 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.523 2.149 . . . . 0.0 112.239 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -148.17 -66.07 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.2 t -100.83 9.32 42.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.625 -179.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.722 HG21 HD23 ' A' ' 17' ' ' LEU . 3.5 m 33.9 36.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -70.72 -51.89 24.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -58.64 -32.22 68.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.583 ' CE1' HD11 ' A' ' 113' ' ' ILE . 28.4 t80 -61.54 -36.92 81.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.267 178.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.833 ' CD1' HG23 ' A' ' 20' ' ' ILE . 3.2 tt -55.61 -60.09 3.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.1 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' H ' HD12 ' A' ' 111' ' ' LEU . 3.5 mp -60.29 -46.98 87.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.628 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.6 m -61.19 -40.07 92.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.583 HD11 ' CE1' ' A' ' 109' ' ' PHE . 1.7 mm -50.28 -52.38 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.657 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -55.52 7.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.115 0.483 . . . . 0.0 110.323 -179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -56.03 -27.37 52.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.949 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.696 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -65.94 -36.19 82.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.98 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.675 ' CE1' HG21 ' A' ' 48' ' ' VAL . 50.9 m-85 -80.82 -35.23 33.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.69 -54.18 5.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.229 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -72.89 -7.43 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.542 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.47 41.02 1.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.347 . . . . 0.0 110.92 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.942 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -134.37 125.33 27.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.786 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.01 134.21 21.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.667 HG13 ' HB ' ' A' ' 48' ' ' VAL . 5.6 t -124.16 152.6 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.905 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 52.4 tp -105.03 127.93 53.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.166 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.908 HG21 ' CD1' ' A' ' 17' ' ' LEU . 21.5 t -113.42 92.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.372 . . . . 0.0 111.604 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.653 ' HB ' HD12 ' A' ' 51' ' ' LEU . 43.8 t -78.97 115.24 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.674 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 34.5 t70 -157.31 155.53 30.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.806 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -88.27 49.33 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.969 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -126.75 167.16 16.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.24 -149.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -44.09 106.41 0.07 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.895 0.378 . . . . 0.0 111.178 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.612 HD13 ' CG2' ' A' ' 30' ' ' THR . 19.8 mm 56.05 168.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.644 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.596 ' N ' HG22 ' A' ' 13' ' ' ILE . 37.5 p -83.58 168.17 16.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.19 127.11 31.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 t 80.41 -39.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.52 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.908 ' CD1' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -46.04 -61.13 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.145 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.823 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -39.79 -61.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.7 -178.703 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.98 12.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.277 0.561 . . . . 0.0 110.88 179.427 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.619 HD13 HG22 ' A' ' 106' ' ' VAL . 10.4 mt -76.04 -71.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.019 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -50.49 -30.25 12.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.416 -179.558 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.946 ' N ' HD13 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -74.22 -25.95 59.97 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.764 0.316 . . . . 0.0 110.705 178.945 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -80.75 -37.13 30.99 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.171 179.43 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.635 ' CD ' HD21 ' A' ' 110' ' ' LEU . 16.5 mm-40 -66.84 -28.82 68.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.46 42.91 3.31 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.377 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CE1' ' CE2' ' A' ' 117' ' ' PHE . 72.5 m-85 -113.82 -177.61 3.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 111.156 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.95 106.7 28.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.776 179.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.671 ' HD3' HD21 ' A' ' 21' ' ' LEU . 98.3 Cg_endo -92.9 128.32 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.809 2.34 . . . . 0.0 113.218 -178.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.1 t70 -107.32 6.55 28.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.794 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.638 HG22 ' HB ' ' A' ' 6' ' ' VAL . 1.7 p -2.74 125.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.31 -162.2 0.88 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.713 179.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -109.4 -40.86 4.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.016 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.11 -175.58 5.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.7 HD22 ' CD2' ' A' ' 63' ' ' PHE . 60.8 mt -61.77 -45.99 91.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -61.26 -46.77 88.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.993 0.425 . . . . 0.0 110.1 179.234 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.23 -30.49 69.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.413 179.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.46 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -71.23 -31.62 67.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.677 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 60.9 mt-10 -70.14 -40.16 74.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.9 77.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.317 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -75.04 -37.54 61.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.811 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 37' ' ' ALA . 12.9 mt -75.48 -26.04 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -7.33 47.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -112.82 -30.73 6.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.76 0.314 . . . . 0.0 111.233 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.622 HD22 ' CE2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -128.21 156.1 43.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.786 -179.862 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 48.2 t80 -93.96 98.14 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 39.4 m-85 -80.44 123.54 82.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.33 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.476 ' O ' ' HA ' ' A' ' 74' ' ' SER . 87.9 Cg_endo -82.75 -21.59 4.88 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.578 2.186 . . . . 0.0 111.905 179.32 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.667 ' HB ' HG13 ' A' ' 4' ' ' VAL . 2.8 t -148.76 133.57 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.095 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.536 HD12 HD23 ' A' ' 5' ' ' LEU . 15.3 mm -119.66 160.81 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.794 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 79' ' ' ILE . 95.1 t -153.27 99.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.653 HD12 ' HB ' ' A' ' 7' ' ' VAL . 12.6 tp -69.1 166.17 18.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.745 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.565 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -161.88 76.09 0.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.422 -179.742 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -63.42 75.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.583 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -66.94 -80.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.749 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -152.65 44.28 0.26 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.28 178.767 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.749 ' HD3' ' N ' ' A' ' 55' ' ' MET . 41.1 Cg_endo -97.96 -77.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.178 2.585 . . . . 0.0 112.368 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -170.15 -51.39 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.509 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.45 -131.64 42.74 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.946 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.59 44.08 7.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.54 67.93 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.839 ' O ' HD12 ' A' ' 64' ' ' ILE . 80.1 t -59.35 -33.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.035 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.11 5.96 24.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.7 ' CD2' HD22 ' A' ' 34' ' ' LEU . 19.4 t80 -72.17 -35.26 68.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.756 0.312 . . . . 0.0 111.164 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 61' ' ' VAL . 2.2 mp -51.38 -32.96 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.222 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.86 -33.36 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.553 179.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 38' ' ' GLU . 33.7 t80 -60.19 -42.87 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.3 mp -61.32 -44.85 99.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.21 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -74.85 -22.66 58.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.54 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -67.09 -38.06 85.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.36 18.23 8.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.442 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -167.73 69.58 0.89 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.629 -179.941 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.85 -20.04 39.84 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.788 2.325 . . . . 0.0 112.312 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -107.26 30.9 5.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.895 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 47' ' ' PRO . 32.3 t -108.27 -162.48 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HB ' HG13 ' A' ' 48' ' ' VAL . 63.7 t -149.9 135.02 10.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 111.834 179.249 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.644 HG12 HG23 ' A' ' 78' ' ' VAL . 22.6 t -107.42 116.8 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.063 -178.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.69 HD12 ' CG2' ' A' ' 112' ' ' THR . 17.2 mm -120.85 48.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.118 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.65 HG13 HD23 ' A' ' 51' ' ' LEU . 89.3 t -45.64 134.31 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.228 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.561 HD11 HG13 ' A' ' 50' ' ' VAL . 3.3 mt -132.66 167.74 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 -179.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER 66.52 156.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 179.565 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.47 173.31 32.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.391 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -59.41 -51.29 70.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -166.78 -45.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.84 167.98 9.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.837 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.7 t -87.48 66.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.096 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 89' ' ' VAL . 33.5 t70 -115.01 -58.62 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -47.34 -34.2 6.61 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.12 0.485 . . . . 0.0 110.498 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.831 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.94 -59.49 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.192 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 86' ' ' ASP . 25.0 m -62.03 -24.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.005 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.591 ' HD3' HG21 ' A' ' 61' ' ' VAL . 7.5 ttmm -84.77 -18.95 33.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.356 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.05 -32.54 8.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.7 -179.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.908 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 8.1 pt -78.19 -17.73 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.774 -179.382 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -85.68 -17.18 36.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.68 0.276 . . . . 0.0 111.209 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.623 ' HB3' HD13 ' A' ' 64' ' ' ILE . 8.7 tttp -80.1 -24.52 40.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.302 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.27 -17.73 0.37 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.297 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.908 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.39 176.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.0 0.428 . . . . 0.0 111.426 -179.759 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.636 ' HB3' HD13 ' A' ' 77' ' ' ILE . 75.8 t80 -104.32 28.28 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.269 -179.458 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.8 OUTLIER 81.63 140.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -59.48 143.96 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.105 -179.755 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.867 HD21 ' HA ' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -85.51 104.98 15.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.734 179.938 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -65.36 157.4 29.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.117 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.47 66.89 1.08 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.988 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.0 56.6 6.13 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.65 2.234 . . . . 0.0 112.31 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.477 ' HD2' ' HG ' ' A' ' 105' ' ' SER . 54.7 t80 -104.42 -67.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.661 ' O ' HG22 ' A' ' 106' ' ' VAL . 49.1 m -130.86 35.49 3.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.064 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.776 HG21 HD23 ' A' ' 17' ' ' LEU . 2.9 m 50.94 19.25 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.008 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.1 -52.97 30.5 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.543 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -68.69 -27.76 66.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.05 0.453 . . . . 0.0 110.138 179.115 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.867 ' HA ' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -61.22 -26.27 67.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.563 179.607 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.635 HD21 ' CD ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -52.13 -47.56 65.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 179.963 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.615 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 3.5 mp -70.8 -53.02 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.69 ' CG2' HD12 ' A' ' 77' ' ' ILE . 54.3 m -44.49 -35.78 2.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.12 0.485 . . . . 0.0 110.151 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.627 HD12 HG21 ' A' ' 4' ' ' VAL . 14.3 mm -67.17 -66.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.173 178.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -55.88 -19.52 12.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 179.581 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -90.43 -35.51 15.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.649 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -69.66 -53.81 16.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.173 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.49 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 29.7 m-85 -56.04 -24.55 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -61.56 -18.18 58.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.391 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -88.88 14.02 11.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.503 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.415 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 37.6 t80 -105.92 31.55 4.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 110.778 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.977 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 mtp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.447 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 9.6 mmtm -106.55 124.35 49.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.44 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -146.66 100.65 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.639 HG13 ' HB ' ' A' ' 48' ' ' VAL . 36.3 t -90.57 161.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.686 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.591 HD13 ' CE2' ' A' ' 46' ' ' PHE . 25.8 tp -108.78 136.17 48.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG21 HD12 ' A' ' 17' ' ' LEU . 6.5 t -123.94 90.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 37' ' ' ALA . 25.4 t -89.33 104.3 14.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.071 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.7 142.71 41.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.479 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.26 48.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 0.0 111.025 -179.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 3.8 tp10 -160.94 111.96 1.8 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.99 179.848 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 55.91 -179.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.138 179.703 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -67.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.757 ' CD1' HG21 ' A' ' 30' ' ' THR . 8.9 mm -98.08 162.8 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.515 HG23 ' CG1' ' A' ' 6' ' ' VAL . 63.2 p -90.21 145.56 24.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.737 179.012 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.0 t -57.44 133.52 55.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.028 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.457 ' O ' HD12 ' A' ' 20' ' ' ILE . 7.0 t 84.95 -31.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.752 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.926 HD23 HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -66.77 -59.79 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.49 -179.122 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.634 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -47.32 -49.73 23.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.623 -179.211 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.435 0.636 . . . . 0.0 110.122 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.638 HD13 HG23 ' A' ' 106' ' ' VAL . 45.4 mt -75.88 -65.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.723 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.907 HD12 HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.82 -11.47 1.01 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.172 -179.181 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.619 ' N ' HD23 ' A' ' 21' ' ' LEU . 6.0 mt-10 -88.07 -27.29 22.07 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.891 0.377 . . . . 0.0 110.155 178.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.86 -36.06 23.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.918 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.6 mp0 -76.53 -29.87 56.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.247 -179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.36 47.9 2.49 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.179 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.61 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.0 m-85 -103.66 -172.08 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.056 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -143.56 89.9 7.32 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.357 179.568 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.7 Cg_endo -80.46 137.26 11.57 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.484 2.123 . . . . 0.0 112.612 -179.377 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -99.6 -1.41 38.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.574 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.757 HG21 ' CD1' ' A' ' 13' ' ' ILE . 12.9 p 8.51 123.43 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.14 -162.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.209 178.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -117.96 -28.55 5.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.754 0.311 . . . . 0.0 111.361 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.57 -168.91 1.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.804 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.63 HD22 ' CD2' ' A' ' 63' ' ' PHE . 29.5 mt -65.06 -43.85 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.79 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -57.67 -50.79 72.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.447 179.566 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -69.42 -29.47 67.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.717 179.643 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CB ' HG21 ' A' ' 7' ' ' VAL . . . -75.51 -29.59 59.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.091 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 71.4 mt-10 -73.03 -37.37 66.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.979 0.418 . . . . 0.0 109.887 179.088 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -68.46 -35.65 77.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.167 179.223 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.16 -32.55 61.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.697 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 37' ' ' ALA . 23.9 mt -86.95 -24.67 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.183 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -25.61 8.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.228 179.997 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.92 -61.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 122.82 15.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.9 76.38 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.877 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CE2' HD13 ' A' ' 5' ' ' LEU . 55.6 m-85 -64.91 141.28 98.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.704 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 2.7 Cg_endo -84.48 -20.45 3.95 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.938 2.425 . . . . 0.0 111.81 179.382 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.67 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.6 t -146.57 133.03 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 46' ' ' PHE . 23.7 mm -116.52 157.09 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.419 HG13 HG13 ' A' ' 79' ' ' ILE . 84.3 t -149.76 97.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.156 0.503 . . . . 0.0 111.139 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HB3' HG22 ' A' ' 78' ' ' VAL . 5.4 tp -92.37 129.59 38.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.747 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -110.49 115.67 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.668 179.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 53' ' ' VAL . 4.7 m -78.52 56.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.839 -179.346 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.472 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 35.4 t-105 -63.07 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.778 179.83 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.517 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 5.4 ttt -147.4 44.05 0.36 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.252 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 55' ' ' MET . 83.3 Cg_endo -76.97 -165.51 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.441 2.094 . . . . 0.0 112.144 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -125.27 -42.86 1.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.989 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.57 148.05 51.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -76.38 116.24 16.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.16 -30.28 63.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.561 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.604 ' O ' HD12 ' A' ' 64' ' ' ILE . 22.8 t -54.18 -44.67 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 111.514 -179.9 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.89 0.84 37.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.742 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.796 ' CE2' HD11 ' A' ' 67' ' ' ILE . 23.5 t80 -89.81 -34.0 16.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.891 0.377 . . . . 0.0 111.043 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.644 HG23 HG11 ' A' ' 76' ' ' VAL . 2.7 mp -47.74 -28.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.428 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 16.1 t0 -79.64 -32.87 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.711 179.797 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 17.2 t80 -61.87 -39.31 91.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 109.914 179.516 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.796 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.5 mp -63.86 -50.54 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.174 179.14 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -69.29 -26.7 64.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.404 179.205 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 17.8 tt0 -60.3 -42.51 95.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.657 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.9 18.5 13.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.9 75.12 0.48 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.337 . . . . 0.0 110.844 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -85.96 -6.71 8.46 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.202 2.601 . . . . 0.0 113.099 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -98.74 -15.62 19.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.986 0.422 . . . . 0.0 111.303 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -72.18 -153.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -179.914 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' HG13 ' A' ' 48' ' ' VAL . 47.1 t -144.48 133.59 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-O 121.335 0.588 . . . . 0.0 111.921 178.692 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.644 HG11 HG23 ' A' ' 64' ' ' ILE . 97.3 t -104.83 99.16 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.147 -179.368 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.514 HG22 HG12 ' A' ' 79' ' ' ILE . 45.8 mm -90.36 -56.41 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.755 HG12 ' CZ ' ' A' ' 99' ' ' PHE . 44.7 t 49.4 85.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.495 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.894 HD11 ' CD1' ' A' ' 109' ' ' PHE . 2.1 mt -96.31 143.0 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.044 0.45 . . . . 0.0 111.757 -179.259 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.634 HG21 ' N ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 162.6 -175.7 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.46 179.567 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.45 -52.71 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.532 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 61.9 t60 60.28 29.49 19.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.22 -54.23 0.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 t -137.03 -172.84 3.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.37 . . . . 0.0 110.976 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 88' ' ' ALA . 20.9 t -111.07 41.66 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.199 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.494 ' O ' HG22 ' A' ' 89' ' ' VAL . 23.6 p30 -82.25 -26.85 32.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.949 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' CE2' ' A' ' 99' ' ' PHE . 4.5 t -71.56 -34.78 70.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 179.392 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -56.45 -58.86 6.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.066 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 86' ' ' ASP . 35.9 m -55.08 -24.89 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.913 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 61' ' ' VAL . 12.4 ttmt -85.85 7.42 24.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.265 179.805 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.72 -41.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.618 -179.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.903 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 11.9 pt -65.01 -18.44 23.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.322 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -94.67 21.79 7.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.743 179.382 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -138.33 -51.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.48 15.08 0.07 OUTLIER Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.802 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.903 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -89.26 175.08 7.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.602 0.701 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.549 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 67.4 t80 -94.77 -14.86 24.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.62 -179.356 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 5.5 pt-20 142.87 -13.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.523 0.729 . . . . 0.0 111.163 179.275 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.755 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 73.71 131.66 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.912 0.387 . . . . 0.0 110.539 -179.67 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -91.67 155.59 18.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -179.866 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -92.04 173.65 7.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.522 179.668 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 65.2 84.37 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.678 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.85 -6.8 17.83 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.748 2.299 . . . . 0.0 113.101 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -98.24 -54.82 2.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.049 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.4 p -102.82 163.96 11.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.098 -179.856 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.926 HG21 HD23 ' A' ' 17' ' ' LEU . 24.5 m -130.09 4.63 2.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.577 -179.895 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -38.34 -44.77 0.93 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.741 0.305 . . . . 0.0 111.627 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -74.01 -36.22 64.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.133 179.385 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.894 ' CD1' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -54.99 -24.16 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.696 179.278 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -65.72 -44.45 86.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.508 -179.831 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' H ' HD12 ' A' ' 111' ' ' LEU . 7.0 mp -54.98 -55.85 26.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.044 -179.647 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 98.1 m -60.82 -39.03 87.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.2 -179.872 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.7 mm -45.91 -53.35 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.754 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.48 -61.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -56.66 -27.31 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.924 179.606 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -64.5 -42.11 96.03 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.903 0.383 . . . . 0.0 110.926 179.833 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.67 ' CE1' HG21 ' A' ' 48' ' ' VAL . 19.0 m-85 -69.5 -22.4 63.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.274 -179.964 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.68 -24.02 19.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.202 -179.878 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.76 -10.88 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.432 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -143.08 29.99 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.828 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.989 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.0 mtp . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.823 0.344 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.424 ' HD2' ' CD1' ' A' ' 117' ' ' PHE . 6.5 mmtt -110.64 137.18 48.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.404 ' CG ' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -144.63 126.29 15.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.913 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 48' ' ' VAL . 24.8 t -117.72 144.37 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 110.592 179.554 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 46' ' ' PHE . 61.7 tp -100.89 127.54 47.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.23 -179.488 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.698 HG21 ' CD1' ' A' ' 17' ' ' LEU . 29.3 t -112.71 94.99 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 179.875 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.915 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 84.4 t -85.6 117.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.505 179.596 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -159.26 149.97 19.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.947 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 25.5 t70 -70.22 -74.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.064 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -76.87 167.84 21.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -98.74 44.99 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.99 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 p -82.22 -43.51 17.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.532 HG22 ' CB ' ' A' ' 17' ' ' LEU . 44.7 mm -90.08 -41.32 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.044 179.907 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.1 p -56.97 -21.15 28.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.257 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -30.28 57.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.16 -61.61 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.961 -179.846 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.698 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.8 tm? -43.54 -50.8 7.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.038 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -54.27 -39.35 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.424 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.69 -41.02 84.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.903 ' CD1' HG11 ' A' ' 106' ' ' VAL . 1.6 mp -56.61 -64.0 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.705 179.661 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -50.36 -35.43 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.122 0.487 . . . . 0.0 110.472 179.374 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.82 -24.15 65.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.948 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.78 -37.62 26.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.41 179.877 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -69.61 -48.38 60.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 179.912 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.19 44.84 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 98.9 m-85 -113.74 -170.46 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 0.0 111.159 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 3' ' ' ARG . 0.7 OUTLIER -139.5 72.08 37.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.388 179.578 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 35.8 Cg_exo -57.76 136.62 76.63 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.804 2.336 . . . . 0.0 112.359 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 30' ' ' THR . 5.1 t70 -113.54 -12.95 12.82 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.694 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 29' ' ' ASP . 69.5 p 44.39 177.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.677 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.915 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -160.84 -165.51 1.4 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.374 179.771 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' HG23 ' A' ' 33' ' ' THR . 7.7 mttm -124.84 -35.27 2.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.849 0.357 . . . . 0.0 111.064 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -166.36 177.06 7.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.216 179.904 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.09 HD21 HD22 ' A' ' 51' ' ' LEU . 26.5 mt -61.06 -37.04 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.645 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -47.88 69.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.51 -31.58 72.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.305 179.168 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB2' ' CG2' ' A' ' 7' ' ' VAL . . . -69.37 -65.06 0.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.487 179.588 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -41.58 -41.23 2.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -64.43 -48.85 73.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.825 178.937 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -69.2 -25.65 64.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.543 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 37' ' ' ALA . 7.2 mt -92.43 -20.82 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.699 0.285 . . . . 0.0 111.439 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -47.53 -26.96 1.58 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.656 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -120.02 -51.08 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.134 -179.779 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.11 128.75 38.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.137 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -85.57 68.83 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.653 179.64 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 26.1 m-85 -65.54 122.82 82.37 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.309 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' VAL . 77.3 Cg_endo -77.21 -28.49 5.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.573 2.182 . . . . 0.0 112.102 179.629 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 4' ' ' VAL . 6.3 t -140.39 125.66 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.496 -179.632 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mm -110.13 149.2 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.497 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 79' ' ' ILE . 86.8 t -141.57 96.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 179.927 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.09 HD22 HD21 ' A' ' 34' ' ' LEU . 24.2 tp -84.63 78.35 9.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.5 t0 -73.32 83.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 53' ' ' VAL . 3.4 m -63.1 109.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -108.12 -84.39 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.585 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -72.85 -43.43 8.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.327 179.428 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 55' ' ' MET . 78.7 Cg_endo -76.09 -167.9 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.338 2.025 . . . . 0.0 112.345 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -102.92 -33.01 9.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.93 50.36 68.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.398 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -96.78 32.48 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -73.71 63.59 1.9 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.341 179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -51.48 -44.63 33.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.958 0.409 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -70.98 -24.57 62.43 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.418 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.003 ' CE2' HD11 ' A' ' 67' ' ' ILE . 59.2 t80 -56.34 -46.56 79.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.288 -179.623 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.708 HD11 ' HB1' ' A' ' 91' ' ' ALA . 3.3 mp -47.02 -29.04 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.108 -179.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -37.4 58.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 38' ' ' GLU . 4.4 t80 -56.43 -47.26 79.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 1.003 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.3 mp -55.55 -42.78 69.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.585 179.605 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -78.61 -23.16 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.663 179.361 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.71 -41.63 83.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.987 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.86 12.78 13.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.246 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.88 66.87 2.07 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.66 179.792 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.59 -19.74 41.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.594 2.196 . . . . 0.0 112.029 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.2 18.18 18.13 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.3 t -99.39 -161.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.408 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 47' ' ' PRO . 21.4 t -151.22 135.41 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.314 0.578 . . . . 0.0 112.536 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 78' ' ' VAL . 6.1 t -102.95 90.94 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.579 -179.564 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.665 HG21 ' HE1' ' A' ' 109' ' ' PHE . 24.1 mm -101.01 36.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.219 179.283 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 76' ' ' VAL . 63.2 t -43.95 107.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.785 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 100' ' ' LEU . 4.4 mt -101.4 147.99 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 179.319 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.587 ' HB ' HG22 ' A' ' 53' ' ' VAL . 30.9 p -156.16 153.86 29.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.25 136.39 4.63 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.428 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 62.18 75.53 0.4 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.902 0.382 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.39 59.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.582 -179.998 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m 63.6 131.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -109.77 30.78 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 89' ' ' VAL . 46.1 t0 -94.5 -41.95 9.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.991 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -53.68 -30.91 45.72 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 121.157 0.504 . . . . 0.0 109.876 179.146 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.841 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.69 -60.14 4.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.33 179.096 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 86' ' ' ASP . 32.9 m -63.06 -25.3 38.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.579 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.82 -29.84 25.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 64' ' ' ILE . . . -88.66 -39.05 14.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.906 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.8 pt -72.06 -11.56 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.473 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.86 -35.03 22.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.926 0.393 . . . . 0.0 110.495 179.573 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -60.03 -61.61 2.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.32 28.63 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.111 179.897 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.21 176.36 6.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.928 0.364 . . . . 0.0 110.962 179.717 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.448 ' HB3' HD13 ' A' ' 77' ' ' ILE . 36.6 t80 -101.08 29.38 4.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.779 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 78.22 138.46 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.995 179.904 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.3 m-85 -66.1 126.28 28.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.715 -179.916 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -69.9 67.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.884 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -120.23 111.13 17.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.057 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.472 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -169.07 -63.01 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.679 179.715 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 102' ' ' LYS . 93.1 Cg_endo -82.27 -167.37 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.504 2.136 . . . . 0.0 112.229 179.733 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.54 31.28 4.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.409 . . . . 0.0 110.744 179.695 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.8 t -152.51 -167.77 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.814 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.903 HG11 ' CD1' ' A' ' 20' ' ' ILE . 13.6 p -107.13 -31.76 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.147 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -40.2 -43.26 1.63 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.587 -179.751 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.68 -41.19 88.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 0.0 110.462 179.65 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.665 ' HE1' HG21 ' A' ' 77' ' ' ILE . 6.4 t80 -59.02 -29.08 66.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.651 179.497 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.448 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -65.92 -38.37 88.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.48 -55.57 33.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.3 m -59.94 -42.65 94.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.01 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.625 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 3.9 mm -44.25 -56.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.781 -179.588 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -59.88 3.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.808 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -53.65 -27.0 24.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.936 179.508 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -68.17 -40.75 82.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.912 0.386 . . . . 0.0 110.774 179.721 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 19.6 m-85 -69.69 -24.65 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.503 -179.87 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -52.22 -25.39 9.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.286 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.34 -6.08 49.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.374 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 31.4 t80 -128.45 30.6 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.964 0.412 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.3 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.988 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ttt . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.829 0.347 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 6.2 mmtp -129.28 93.97 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.969 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -145.93 110.21 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.713 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.502 HG13 ' HB ' ' A' ' 48' ' ' VAL . 12.2 t -95.31 149.09 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 110.803 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 29' ' ' ASP . 61.5 tp -111.33 137.06 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 0.0 111.288 -179.438 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.866 HG21 ' CD1' ' A' ' 17' ' ' LEU . 21.8 t -118.31 138.37 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.56 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' HD12 ' A' ' 51' ' ' LEU . 8.1 t -129.58 115.99 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.306 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.17 135.06 12.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -92.0 50.03 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.9 -45.57 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.877 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.26 -79.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.717 179.924 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 p -128.8 -82.18 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.464 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.539 HG23 HG21 ' A' ' 30' ' ' THR . 8.5 mm -101.28 161.01 3.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.918 0.39 . . . . 0.0 110.969 179.742 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.503 ' OG1' ' HB2' ' A' ' 17' ' ' LEU . 7.2 p -90.46 136.27 33.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.919 178.795 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' SER . 2.4 m -51.07 131.45 27.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.995 -179.04 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.54 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER 85.85 -31.46 0.05 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.94 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.979 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -57.06 -61.82 2.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.701 0.286 . . . . 0.0 111.126 -179.498 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.51 -64.98 0.55 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.474 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.86 -39.93 40.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.999 0.428 . . . . 0.0 111.233 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.608 HG23 ' CD1' ' A' ' 110' ' ' LEU . 46.3 mt -67.68 -70.05 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 -179.917 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.979 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -48.06 -30.14 4.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.056 0.455 . . . . 0.0 110.368 179.507 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.84 -30.03 71.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -78.19 -39.45 40.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.076 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.815 ' HG3' HD21 ' A' ' 110' ' ' LEU . 70.5 mm-40 -79.23 -174.25 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.355 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.28 42.84 1.83 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.119 179.852 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.572 ' CE2' HG21 ' A' ' 113' ' ' ILE . 22.0 m-85 -100.8 178.95 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.491 0.662 . . . . 0.0 111.731 -179.428 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.3 85.82 60.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.762 178.458 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.684 ' HB3' HD22 ' A' ' 21' ' ' LEU . 80.6 Cg_endo -79.97 127.54 6.99 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.7 2.266 . . . . 0.0 114.041 -177.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.854 ' O ' HD12 ' A' ' 5' ' ' LEU . 5.1 t70 -119.14 117.32 28.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.474 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.539 HG21 HG23 ' A' ' 13' ' ' ILE . 27.7 p -104.08 143.3 33.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 112.061 -178.558 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.2 -167.04 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.054 179.13 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -130.82 -6.55 4.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -170.72 175.13 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.765 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 63' ' ' PHE . 87.6 mt -66.12 -32.98 74.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -70.11 -40.19 75.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.997 179.203 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.1 -36.17 79.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.344 179.375 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.51 -50.22 22.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.608 179.521 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 4.9 tt0 -47.22 -45.87 23.75 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.409 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -53.73 54.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.584 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 7.6 mmtp -58.0 -24.57 58.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.823 179.498 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 41' ' ' ILE . 16.4 mt -98.53 -11.77 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.589 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -73.17 -10.42 59.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.691 0.281 . . . . 0.0 111.316 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -135.78 -46.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.763 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -75.1 116.5 15.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.715 179.869 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.2 64.32 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.36 179.797 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 19.9 m-85 -58.12 119.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.092 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 46.4 Cg_endo -69.13 -45.1 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.696 2.264 . . . . 0.0 111.946 179.772 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.502 ' HB ' HG13 ' A' ' 4' ' ' VAL . 21.3 t -118.54 125.02 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.553 -179.437 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -109.26 128.29 65.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG21 ' CE1' ' A' ' 109' ' ' PHE . 62.0 t -123.02 104.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.061 0.457 . . . . 0.0 111.206 -179.872 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.472 HD12 ' HB ' ' A' ' 7' ' ' VAL . 36.5 tp -92.96 83.9 4.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.958 179.954 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 0.4 OUTLIER -72.62 75.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 -179.85 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.711 HG13 ' HB ' ' A' ' 80' ' ' THR . 3.2 p -55.36 84.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.474 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 25.3 t-105 -86.34 -82.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.735 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.474 ' HG2' ' CD1' ' A' ' 54' ' ' TRP . 3.4 ptm -142.04 48.46 1.14 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 111.131 179.456 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 55' ' ' MET . 72.7 Cg_endo -76.31 -168.19 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.493 2.129 . . . . 0.0 112.253 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -137.59 31.27 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.76 175.35 18.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.516 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.16 93.64 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.16 65.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.652 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 64' ' ' ILE . 26.3 t -53.85 -43.6 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 111.419 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 2.75 32.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.536 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.806 ' CE2' HD11 ' A' ' 67' ' ' ILE . 20.0 t80 -89.99 -43.26 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.054 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 91' ' ' ALA . 2.3 mp -45.37 -28.84 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.652 -179.808 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -70.38 -56.06 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.579 ' HD1' HD12 ' A' ' 67' ' ' ILE . 1.5 t80 -48.57 -37.63 18.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.832 0.348 . . . . 0.0 110.557 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.806 HD11 ' CE2' ' A' ' 63' ' ' PHE . 1.5 mp -60.77 -46.44 96.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.085 179.435 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -77.31 -21.44 53.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.549 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.85 -50.6 63.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.67 12.58 21.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.379 -179.6 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -158.48 66.65 3.29 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.803 0.335 . . . . 0.0 110.784 179.766 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 71' ' ' SER . 6.5 Cg_exo -72.72 -16.95 26.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.727 2.285 . . . . 0.0 112.205 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.71 28.41 6.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -112.07 -178.05 3.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 76' ' ' VAL . 16.4 t -119.35 162.99 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.786 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.889 HG12 HG23 ' A' ' 78' ' ' VAL . 1.7 t -137.92 83.77 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 77' ' ' ILE . 16.5 mm -91.84 48.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.889 HG23 HG12 ' A' ' 76' ' ' VAL . 34.9 t -57.42 136.31 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.95 HG21 ' HG2' ' A' ' 102' ' ' LYS . 1.7 mt -134.82 -149.0 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.365 -179.506 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.711 ' HB ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 57.76 -172.51 0.09 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 111.006 179.791 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.41 94.04 1.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -77.57 173.96 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.24 -159.63 39.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.58 169.79 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.61 63.38 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -109.54 -26.48 9.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.436 HG23 ' CE2' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -74.32 -32.29 62.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.909 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.724 ' HB1' ' HB2' ' A' ' 99' ' ' PHE . . . -59.79 -59.22 5.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.16 178.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -59.23 -23.47 24.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.013 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -90.74 40.58 1.02 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -170.06 -38.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -76.16 -28.68 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.947 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -31.4 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.597 179.713 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -63.76 -30.26 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.67 28.31 0.12 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.265 179.792 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.14 178.87 6.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.901 0.35 . . . . 0.0 110.808 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.443 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 47.9 t80 -97.49 28.27 3.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER 85.11 162.75 0.1 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.556 179.583 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.724 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.56 97.01 10.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.728 179.982 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 109' ' ' PHE . 16.1 tp -55.84 160.68 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.191 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.444 ' C ' ' HG3' ' A' ' 102' ' ' LYS . 12.7 mp0 -100.9 -37.67 8.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 179.796 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.95 ' HG2' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 32.4 57.23 1.28 Allowed Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.354 179.909 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 87.9 Cg_endo -81.97 50.38 3.45 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.668 2.246 . . . . 0.0 112.461 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 103' ' ' PRO . 2.0 m-85 -175.31 40.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.34 . . . . 0.0 111.301 -179.907 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 16' ' ' SER . 0.9 OUTLIER 69.45 67.85 0.25 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 179.672 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.941 HG21 HD23 ' A' ' 17' ' ' LEU . 3.0 m 40.49 25.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.4 tt0 -65.17 -51.87 58.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.338 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -60.43 -33.92 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.623 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.526 ' CE1' HD11 ' A' ' 113' ' ' ILE . 13.7 t80 -59.44 -33.4 71.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.415 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.815 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -64.03 -44.65 91.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.772 179.116 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 107' ' ' GLU . 3.9 mp -65.92 -46.47 78.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.213 -179.802 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.0 m -67.84 -41.43 82.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.989 0.423 . . . . 0.0 110.366 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.572 HG21 ' CE2' ' A' ' 26' ' ' TYR . 1.6 mm -46.96 -52.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.194 179.758 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -53.3 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 179.798 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -56.87 -39.93 75.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.561 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -54.52 -30.89 55.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.504 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.489 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 52.7 m-85 -91.13 -55.44 3.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.462 -179.799 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.89 -50.26 69.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.606 -179.53 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -73.31 -6.56 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.759 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.23 45.16 2.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.907 0.384 . . . . 0.0 110.916 179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.945 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.911 0.386 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HB3' ' CD2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -155.4 128.7 8.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.002 -179.916 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -144.51 136.07 25.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.993 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 48' ' ' VAL . 34.4 t -128.53 150.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.984 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.019 HD23 HG23 ' A' ' 49' ' ' ILE . 24.4 tp -113.75 142.52 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.038 0.447 . . . . 0.0 111.575 -179.195 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.762 HG21 HD12 ' A' ' 17' ' ' LEU . 21.9 t -117.06 143.81 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.298 179.866 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.609 ' HB ' HD12 ' A' ' 51' ' ' LEU . 17.6 t -133.26 119.76 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.339 179.251 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 2.8 t70 -154.59 163.5 40.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.487 -179.324 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.58 49.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.0 111.104 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -126.55 -174.19 3.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.715 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.54 -79.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' ILE . 0.5 OUTLIER -93.83 177.07 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.687 179.953 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.675 ' HA ' HG21 ' A' ' 30' ' ' THR . 5.5 mm -30.79 157.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.017 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.466 ' N ' HG22 ' A' ' 13' ' ' ILE . 7.7 p -90.26 125.84 35.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.229 179.117 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -45.95 142.42 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.302 -179.611 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 87.85 -36.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.768 179.799 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.081 HD13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -71.99 -48.17 46.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 -179.968 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 p -50.74 -65.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.81 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.457 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.69 HG23 ' CD1' ' A' ' 110' ' ' LEU . 71.2 mt -63.64 -69.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.966 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.081 HD11 HD13 ' A' ' 17' ' ' LEU . 1.2 mt -48.57 -31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 179.819 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.63 66.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.829 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.3 -34.49 31.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.294 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.763 ' HG3' HD21 ' A' ' 110' ' ' LEU . 68.4 mm-40 -77.57 -38.1 49.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.141 -179.913 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.51 43.83 3.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.052 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 9.6 m-85 -102.29 -174.93 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.218 0.533 . . . . 0.0 111.328 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.5 80.01 16.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.904 178.381 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.694 ' CB ' HD13 ' A' ' 21' ' ' LEU . 91.6 Cg_endo -84.45 131.78 4.88 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.756 2.304 . . . . 0.0 113.972 -178.088 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.477 ' O ' HD12 ' A' ' 5' ' ' LEU . 11.4 t70 -129.24 132.35 47.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.447 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.682 HG22 ' HB ' ' A' ' 6' ' ' VAL . 17.8 p -119.97 139.24 52.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.167 0.508 . . . . 0.0 112.069 -178.837 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 36' ' ' GLU . . . -110.82 -165.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 179.313 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 31.3 mttt -117.65 -25.73 6.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.844 0.354 . . . . 0.0 111.228 -179.975 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -164.11 174.18 11.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.398 179.891 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.853 HD22 ' CD2' ' A' ' 63' ' ' PHE . 15.9 mt -58.63 -28.85 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.606 179.835 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -47.83 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.649 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -64.45 -35.0 79.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.374 179.263 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.39 -53.46 48.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.478 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 28.6 mt-10 -50.83 -38.98 52.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.452 179.55 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -59.89 -43.29 94.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.721 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -73.88 -47.01 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.641 179.41 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.62 -18.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -19.82 61.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.729 0.299 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.14 -50.73 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 117.38 13.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -83.42 66.26 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.751 179.825 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 5' ' ' LEU . 44.8 m-85 -58.62 135.84 86.19 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.963 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 7.4 Cg_endo -81.16 -35.19 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.512 2.141 . . . . 0.0 112.009 179.451 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.607 ' O ' HD13 ' A' ' 49' ' ' ILE . 18.3 t -126.69 136.3 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 179.691 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.019 HG23 HD23 ' A' ' 5' ' ' LEU . 1.6 mm -135.67 105.37 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.834 HG22 ' CG1' ' A' ' 77' ' ' ILE . 21.8 t -103.42 131.8 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.759 0.314 . . . . 0.0 110.632 179.519 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 7' ' ' VAL . 11.5 tp -99.78 146.87 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.138 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.83 106.85 9.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.415 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.454 ' C ' HG21 ' A' ' 80' ' ' THR . 23.7 t -80.95 70.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.521 -179.482 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.41 ' CD1' ' HG2' ' A' ' 55' ' ' MET . 4.4 t-105 -72.06 -78.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.081 179.399 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 11.6 ptt? -149.15 48.95 0.63 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.213 179.132 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 55' ' ' MET . 14.7 Cg_endo -92.86 -159.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.164 2.576 . . . . 0.0 112.165 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -161.22 52.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.932 179.786 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.86 149.79 19.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.553 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.21 108.74 10.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.17 -18.73 48.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.903 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.727 ' O ' HD12 ' A' ' 64' ' ' ILE . 21.4 t -58.52 -58.96 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.27 -21.9 63.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.915 ' CE2' HD11 ' A' ' 67' ' ' ILE . 33.8 t80 -60.32 -40.46 90.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.5 mt -47.19 -28.33 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -74.76 -35.67 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.679 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.439 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 19.1 t80 -61.57 -45.14 95.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.323 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.915 HD11 ' CE2' ' A' ' 63' ' ' PHE . 5.2 mp -58.0 -41.68 80.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 179.341 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -81.44 -23.3 37.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 179.521 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 61.7 tt0 -64.36 -31.6 72.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.361 179.476 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -132.67 16.04 4.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.923 179.944 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -169.53 73.41 0.69 Allowed Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.725 179.948 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.09 -7.35 11.12 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.093 2.529 . . . . 0.0 112.604 -179.79 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.5 -6.25 27.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.63 -179.866 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.44 -172.65 4.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 -179.768 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.437 HG11 ' HB1' ' A' ' 116' ' ' ALA . 67.2 t -127.24 144.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.114 -179.781 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG12 HG23 ' A' ' 78' ' ' VAL . 2.1 t -123.12 98.08 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.06 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.834 ' CG1' HG22 ' A' ' 50' ' ' VAL . 44.2 mm -73.91 -67.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.731 -179.068 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.549 HG13 HD23 ' A' ' 51' ' ' LEU . 12.2 t 63.17 98.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 110.089 -179.307 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 100' ' ' LEU . 1.8 mt -98.14 -144.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.623 -179.109 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.466 ' H ' HG22 ' A' ' 79' ' ' ILE . 0.0 OUTLIER 56.5 87.44 0.06 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.827 0.346 . . . . 0.0 110.897 -179.796 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.96 42.41 0.24 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -73.99 -44.86 53.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.349 . . . . 0.0 110.866 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.77 -51.41 1.66 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.439 -179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -97.66 68.56 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.46 -19.09 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.286 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.6 ' O ' HG22 ' A' ' 89' ' ' VAL . 1.6 m-20 -53.28 -34.4 57.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.126 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.452 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 2.2 t -59.15 -33.95 71.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.969 0.414 . . . . 0.0 110.376 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.21 -59.11 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.248 179.355 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 86' ' ' ASP . 33.5 m -58.94 -27.52 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.056 179.499 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -80.54 -13.25 59.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.94 -35.02 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 111.736 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.891 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 pt -77.16 -26.32 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.65 -179.484 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -66.19 -28.33 68.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.587 179.652 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -58.12 3.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.8 37.2 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -89.99 -163.77 1.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.903 179.797 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 97' ' ' TYR . 40.1 t80 -107.99 23.37 14.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.544 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.425 ' HA ' HG21 ' A' ' 92' ' ' ILE . 0.4 OUTLIER 80.56 19.89 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.755 179.449 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 61.78 162.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 111.038 179.465 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 101' ' ' GLU . 1.1 tm? -101.02 133.28 45.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.82 ' N ' HD13 ' A' ' 100' ' ' LEU . 1.6 mm-40 -65.05 -65.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.505 ' HB2' HD12 ' A' ' 100' ' ' LEU . 1.3 ttpm? 62.27 62.12 2.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.49 0.48 9.9 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.686 2.258 . . . . 0.0 112.854 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.27 -75.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.0 110.948 -179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -155.42 -168.9 2.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.867 HG21 HD23 ' A' ' 17' ' ' LEU . 13.2 p -59.83 -33.84 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.051 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -45.69 -38.17 6.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.917 0.389 . . . . 0.0 110.954 179.877 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.53 80.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.02 179.282 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 4.7 t80 -58.52 -26.47 63.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.168 179.293 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.763 HD21 ' HG3' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -58.75 -49.67 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.102 179.708 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.3 -54.78 35.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.083 -179.797 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 113' ' ' ILE . 66.5 m -49.48 -57.32 7.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.112 -179.898 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.878 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 11.3 mm -29.9 -63.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.64 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.436 ' HE3' ' CE1' ' A' ' 115' ' ' HIS . 4.9 tmmm? -48.91 -58.66 4.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.792 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.436 ' CE1' ' HE3' ' A' ' 114' ' ' LYS . 98.4 m-70 -53.69 -27.72 29.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.579 178.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -70.89 -42.55 69.85 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.762 179.692 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.53 ' CE1' HG21 ' A' ' 48' ' ' VAL . 24.7 m-85 -59.63 -21.48 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.0 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.4 -21.09 22.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.18 27.72 2.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.166 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 47' ' ' PRO . 11.0 t80 -110.73 28.8 8.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.835 179.794 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.969 -179.996 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.83 0.348 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER -121.03 127.93 52.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.912 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -153.69 133.85 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 179.88 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 48' ' ' VAL . 45.6 t -116.54 162.0 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.781 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 29' ' ' ASP . 66.8 tp -118.21 147.24 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 111.446 -179.526 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.643 HG11 HG23 ' A' ' 14' ' ' THR . 4.0 t -126.42 142.56 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.058 179.775 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 7.0 t -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.139 179.301 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 3.3 t70 -150.6 153.98 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.333 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.6 48.71 1.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.841 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.25 148.09 24.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.685 179.881 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.48 163.16 24.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.047 -179.784 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m 64.29 -171.3 0.18 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.151 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.779 HD13 HG21 ' A' ' 30' ' ' THR . 20.4 mm -79.41 166.38 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.643 HG23 HG11 ' A' ' 6' ' ' VAL . 29.3 p -80.4 128.37 33.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.255 179.505 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 16' ' ' SER . 13.9 p -35.07 128.02 0.52 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 15' ' ' SER . 3.2 p 82.99 -43.84 0.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.222 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.893 HD13 HD11 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -53.23 -50.84 63.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 111.216 -179.566 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.69 -65.47 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.47 -40.65 18.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.757 HG23 ' CD1' ' A' ' 110' ' ' LEU . 37.4 mt -59.44 -67.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.941 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.893 HD11 HD13 ' A' ' 17' ' ' LEU . 1.3 mt -48.74 -31.72 7.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.805 179.525 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.16 -31.63 71.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.748 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.91 -34.89 22.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.472 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.667 ' CD ' HD21 ' A' ' 110' ' ' LEU . 52.9 mm-40 -81.29 -38.39 26.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.206 -179.795 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 76.8 1.32 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.168 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 2' ' ' LYS . 39.8 m-85 -130.65 -174.43 3.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.349 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -119.84 80.8 25.47 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.17 178.798 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 97.6 Cg_endo -84.22 135.03 6.14 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.771 2.314 . . . . 0.0 113.928 -178.335 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.804 ' O ' HD12 ' A' ' 5' ' ' LEU . 16.3 t70 -123.42 128.63 50.12 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.384 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.779 HG21 HD13 ' A' ' 13' ' ' ILE . 82.7 p -98.66 146.74 25.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -126.87 128.9 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.433 178.93 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 33' ' ' THR . 7.7 mttm -82.48 -10.32 59.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -170.65 167.11 7.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.304 179.791 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.722 HD22 ' CD2' ' A' ' 63' ' ' PHE . 20.8 mt -59.18 -22.35 60.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 110.329 179.436 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -46.2 33.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.794 178.834 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.92 -30.96 71.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.135 179.176 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.69 -56.05 5.21 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.619 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HG3' ' CE1' ' A' ' 63' ' ' PHE . 54.3 mt-10 -44.81 -43.27 8.54 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.618 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.95 -53.0 61.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.74 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 4.5 mmtt -60.6 -30.01 69.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.978 179.581 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 41' ' ' ILE . 50.9 mt -92.23 -9.29 10.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 38' ' ' GLU . 13.7 tttt -74.3 -8.64 56.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.724 0.297 . . . . 0.0 111.027 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -138.36 -47.13 0.51 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -73.91 118.54 16.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.708 179.764 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -76.46 62.84 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.757 179.856 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.702 ' CD2' HD22 ' A' ' 5' ' ' LEU . 25.4 m-85 -55.3 116.75 12.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.77 -31.51 10.32 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.333 2.022 . . . . 0.0 112.203 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.63 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.8 t -132.16 129.87 60.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.587 -179.791 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.711 HD12 HD23 ' A' ' 5' ' ' LEU . 14.3 mm -118.71 144.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.185 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.481 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 60.6 t -137.23 109.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.388 -179.98 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 42.1 tp -98.28 93.13 6.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.315 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . 6.6 t0 -77.88 91.93 4.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.398 179.275 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 53' ' ' VAL . 27.9 m -62.65 79.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.793 -179.383 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -78.9 -91.05 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.249 179.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.544 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 2.1 ttm -143.36 58.72 6.79 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.639 0.257 . . . . 0.0 110.855 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 55' ' ' MET . 9.7 Cg_endo -89.51 -157.64 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.176 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -155.59 28.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.37 149.43 18.64 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 81.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.75 0.309 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.26 90.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.382 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 90' ' ' LYS . 50.8 t -62.03 -40.25 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.965 0.412 . . . . 0.0 110.909 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -15.45 62.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.39 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.903 ' CE2' HD11 ' A' ' 67' ' ' ILE . 30.4 t80 -84.33 -30.0 25.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 61' ' ' VAL . 6.4 mm -48.63 -30.57 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.092 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 8.3 t0 -74.14 -47.95 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.734 179.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.425 ' CE1' ' OD1' ' A' ' 70' ' ' ASN . 10.2 t80 -48.25 -43.52 32.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.851 0.357 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.903 HD11 ' CE2' ' A' ' 63' ' ' PHE . 3.9 mp -59.96 -47.85 90.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.421 179.438 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.85 -16.19 59.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.964 179.576 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 12.2 tt0 -73.12 -46.69 49.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.765 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.489 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -114.41 13.72 17.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.948 -179.78 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.422 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -160.44 65.53 2.35 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.776 179.836 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 71' ' ' SER . 4.6 Cg_exo -76.07 -13.97 19.06 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.646 2.231 . . . . 0.0 112.192 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.06 27.63 8.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -112.28 -166.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 48' ' ' VAL . 21.4 t -129.02 139.96 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.342 0.592 . . . . 0.0 111.831 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.829 HG12 HG23 ' A' ' 78' ' ' VAL . 3.0 t -128.18 89.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.08 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.8 mm -79.63 -43.03 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.857 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.829 HG23 HG12 ' A' ' 76' ' ' VAL . 59.7 t 45.17 89.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.813 HD11 ' CD1' ' A' ' 109' ' ' PHE . 1.8 mt -99.66 179.05 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.035 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.655 ' H ' HG22 ' A' ' 79' ' ' ILE . 6.6 m 76.49 151.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.054 179.925 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.24 -108.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.364 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -164.07 -68.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.842 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.06 -80.94 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.418 -179.97 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -66.23 173.68 3.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.765 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 89' ' ' VAL . 11.4 m -100.52 33.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -75.93 -37.19 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -33.18 63.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.054 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 99' ' ' PHE . . . -60.91 -59.07 5.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.109 179.032 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 92' ' ' ILE . 14.2 m -58.9 -26.08 31.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.118 179.812 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 61' ' ' VAL . 7.5 ttmt -78.03 -4.59 47.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.244 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.71 -38.67 2.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.379 -179.911 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.924 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 6.1 pt -76.95 -41.65 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.133 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -57.95 -28.79 64.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -62.57 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 179.63 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.36 25.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.092 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.924 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.35 -174.7 4.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.983 0.392 . . . . 0.0 110.943 179.725 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 69.0 t80 -94.46 -23.1 17.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 97' ' ' TYR . 11.3 pt-20 147.87 -167.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.54 0.736 . . . . 0.0 109.969 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -125.05 107.07 10.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.708 0.29 . . . . 0.0 110.622 179.606 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.532 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -56.4 92.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.07 -179.908 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -59.56 88.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.767 179.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.48 72.3 0.15 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 -179.959 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.78 -13.3 25.8 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.669 2.246 . . . . 0.0 112.703 179.975 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -109.38 109.12 19.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.748 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.8 t 63.91 146.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.036 -179.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.84 HG21 HD23 ' A' ' 17' ' ' LEU . 18.0 m -106.15 40.47 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.09 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.58 -52.7 28.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -31.4 70.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.431 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.813 ' CD1' HD11 ' A' ' 79' ' ' ILE . 15.8 t80 -57.52 -40.95 79.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.757 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -48.43 -48.39 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.236 179.349 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mp -54.98 -45.57 75.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.399 -179.561 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -67.12 -39.8 86.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.891 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 2.7 mm -47.43 -55.88 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -55.62 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 110.16 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -30.71 69.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.81 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.582 ' HB1' HG21 ' A' ' 75' ' ' VAL . . . -61.86 -37.08 83.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.798 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 48' ' ' VAL . 49.0 m-85 -80.27 -28.6 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.058 179.862 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -56.47 -22.84 35.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.994 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -97.61 29.86 3.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -102.77 28.77 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.81 179.953 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.7 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.975 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HB2' ' HD3' ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 . . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 7.5 mmtp 56.2 97.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 111.34 179.761 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -121.23 139.99 52.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.284 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 48' ' ' VAL . 21.3 t -128.61 158.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 110.932 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.65 HD22 ' CD2' ' A' ' 46' ' ' PHE . 16.4 tp -117.03 131.83 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.651 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.751 HG21 HD12 ' A' ' 17' ' ' LEU . 25.4 t -115.81 89.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.201 179.866 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.92 103.16 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.757 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.81 137.63 45.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.782 -179.769 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.07 48.65 1.67 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.042 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -178.97 179.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 179.953 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -119.83 88.67 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.93 -44.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.41 HG22 ' HB3' ' A' ' 17' ' ' LEU . 27.3 mm -79.78 -43.65 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.998 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.542 ' HB ' HG21 ' A' ' 30' ' ' THR . 10.2 p -60.34 -16.93 39.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.433 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 m -80.13 -43.33 21.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.283 . . . . 0.0 111.146 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -60.23 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.209 -179.673 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.751 HD12 HG21 ' A' ' 6' ' ' VAL . 2.3 tm? -46.9 -50.95 17.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.088 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 t -56.67 -48.91 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.572 179.75 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.24 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.684 ' CD1' HG11 ' A' ' 106' ' ' VAL . 57.0 mt -57.41 -66.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.822 179.755 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.02 -35.43 11.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.139 0.495 . . . . 0.0 110.468 179.615 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.51 -28.22 69.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.66 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.84 -35.18 38.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.079 179.469 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -4.63 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.487 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.39 56.38 1.57 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.383 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 57.1 m-85 -128.41 -176.16 3.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.894 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 3' ' ' ARG . 4.1 t60 -138.9 70.8 42.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.76 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 34.9 Cg_exo -60.15 142.3 98.02 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.821 2.347 . . . . 0.0 112.581 -179.678 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -121.64 2.97 10.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.398 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.712 HG22 ' HB ' ' A' ' 6' ' ' VAL . 13.7 p 9.86 122.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.996 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.22 -164.22 1.02 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.436 178.631 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 33' ' ' THR . 9.6 ttmt -118.47 -30.2 5.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.122 -179.754 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -170.25 -172.71 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.668 179.96 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.775 HD22 ' CD2' ' A' ' 63' ' ' PHE . 29.8 mt -65.86 -49.5 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.516 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -59.84 -48.83 80.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.447 . . . . 0.0 109.852 179.195 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.1 -30.8 71.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.17 179.144 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HB1' HD11 ' A' ' 41' ' ' ILE . . . -71.41 -62.92 1.23 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.253 179.337 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 22.7 mt-10 -41.88 -39.93 1.97 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -49.24 73.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 178.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -68.19 -32.39 72.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.148 179.8 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.402 HD11 ' HB1' ' A' ' 37' ' ' ALA . 11.5 mt -86.34 -15.79 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -24.29 6.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.548 -179.741 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -122.41 -55.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 129.03 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.21 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -92.03 86.41 5.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.528 179.621 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.65 ' CD2' HD22 ' A' ' 5' ' ' LEU . 49.8 m-85 -79.32 119.31 76.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.508 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 59.7 Cg_endo -73.54 -19.45 21.66 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.474 2.116 . . . . 0.0 111.974 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.636 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.2 t -143.44 130.15 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.724 -179.911 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 46' ' ' PHE . 10.7 mm -118.59 156.19 20.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.4 179.54 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.7 t -146.31 102.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.494 . . . . 0.0 110.679 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.443 ' CD2' ' HA3' ' A' ' 60' ' ' GLY . 57.0 tp -90.09 91.1 8.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.42 92.3 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.857 178.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.704 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.4 m -64.5 72.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.14 -179.006 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 10' ' ' GLU . 25.5 t-105 -73.39 -77.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.361 . . . . 0.0 110.324 179.35 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.483 ' N ' ' HD3' ' A' ' 56' ' ' PRO . 3.2 ttm -162.23 61.99 1.29 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 55' ' ' MET . 2.4 Cg_endo -84.61 -155.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.068 2.512 . . . . 0.0 112.216 -179.825 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -124.82 -42.2 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.93 177.55 53.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.07 127.77 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' CD2' ' A' ' 51' ' ' LEU . . . -79.16 -1.55 85.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.989 -179.969 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.9 ' O ' HD12 ' A' ' 64' ' ' ILE . 45.8 t -61.49 -59.75 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.989 -179.922 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.4 -21.5 62.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.512 -179.856 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.775 ' CD2' HD22 ' A' ' 34' ' ' LEU . 14.0 t80 -61.33 -36.7 80.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.468 -179.565 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.6 mt -47.64 -27.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.285 -179.853 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -73.56 -40.91 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 38' ' ' GLU . 17.6 t80 -57.25 -43.02 82.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.469 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.674 HD11 ' CE2' ' A' ' 63' ' ' PHE . 4.9 mp -61.41 -42.78 95.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 179.417 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -18.85 56.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.326 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.48 -42.33 68.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.551 179.701 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.93 14.15 15.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.068 -179.843 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.74 67.65 1.59 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.847 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.84 -20.24 39.67 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.673 2.249 . . . . 0.0 112.232 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -104.12 35.67 2.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.747 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 t -111.79 -157.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.798 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 120' ' ' TYR . 41.3 t -154.53 137.94 7.95 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 111.659 179.498 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.883 HG12 HG23 ' A' ' 78' ' ' VAL . 2.5 t -117.43 100.26 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.335 -179.478 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 97' ' ' TYR . 36.1 mm -82.68 -51.12 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.737 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.883 HG23 HG12 ' A' ' 76' ' ' VAL . 78.0 t 52.37 96.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.644 HG22 ' H ' ' A' ' 80' ' ' THR . 1.7 mt -106.12 -155.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.085 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.704 ' HB ' HG22 ' A' ' 53' ' ' VAL . 8.3 m 71.0 115.14 0.05 OUTLIER 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 179.918 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.99 144.81 11.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.33 179.932 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -93.39 -78.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.986 -179.803 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -159.78 45.97 0.42 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -154.03 138.45 16.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.794 0.331 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 85' ' ' VAL . 16.1 t -106.99 39.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.05 -24.65 12.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 t -82.49 -38.69 23.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.019 0.437 . . . . 0.0 109.944 179.292 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.863 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -57.31 -57.38 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.142 178.991 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HA ' HG12 ' A' ' 92' ' ' ILE . 13.1 m -58.01 -28.95 35.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.289 179.702 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HD3' HG21 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -78.9 -15.86 57.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.626 -179.694 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.87 -33.86 6.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 -179.546 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.904 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.2 pt -79.3 -34.99 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.263 -179.554 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -31.26 71.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.781 179.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.2 32.91 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.859 -179.956 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -90.16 -165.3 1.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 110.998 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.632 ' HB3' HD13 ' A' ' 77' ' ' ILE . 26.0 t80 -114.16 27.14 9.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 -179.787 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 76.01 141.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.09 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -66.0 118.33 9.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 -179.707 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -59.05 129.14 40.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.883 179.703 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -61.68 -67.35 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.01 57.37 4.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.31 2.0 8.82 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.619 2.213 . . . . 0.0 112.788 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -131.61 -61.98 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.72 0.295 . . . . 0.0 110.937 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.0 p -171.03 179.15 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.038 -179.985 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.684 HG11 ' CD1' ' A' ' 20' ' ' ILE . 9.5 p -53.0 -38.36 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.227 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -38.02 -38.46 0.32 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.823 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -70.82 -41.65 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.482 . . . . 0.0 110.494 179.642 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.542 ' CZ ' HD11 ' A' ' 79' ' ' ILE . 6.2 t80 -57.38 -30.43 64.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.802 179.528 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.626 HD11 ' CG2' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -59.18 -43.77 92.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.505 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mp -53.66 -52.29 60.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.829 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.566 HG23 ' HE2' ' A' ' 97' ' ' TYR . 99.3 m -59.61 -40.98 89.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.777 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.617 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 4.6 mm -49.78 -57.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.634 -179.634 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.58 -63.4 1.1 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.455 ' CD2' ' CG ' ' A' ' 119' ' ' GLU . 5.5 t-160 -50.81 -27.35 7.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.821 179.31 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -66.88 -39.96 87.64 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.927 0.394 . . . . 0.0 110.479 179.432 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.636 ' CE1' HG21 ' A' ' 48' ' ' VAL . 23.1 m-85 -71.88 -30.03 64.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.233 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -88.47 -37.54 15.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.368 -179.686 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.455 ' CG ' ' CD2' ' A' ' 115' ' ' HIS . 1.6 mm-40 -75.55 -5.25 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.668 -179.816 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.415 ' CD2' HG22 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -144.06 45.0 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 110.915 179.952 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.801 0.334 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -94.05 154.87 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.685 ' NH1' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -164.33 125.42 2.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 -179.906 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.634 HG13 ' HB ' ' A' ' 48' ' ' VAL . 22.5 t -114.64 143.56 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.862 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.682 HD23 HD12 ' A' ' 49' ' ' ILE . 59.6 tp -93.95 129.63 40.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.808 -179.875 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.822 HG21 ' CD1' ' A' ' 17' ' ' LEU . 17.5 t -115.44 104.71 17.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.797 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 42.4 t -91.6 124.07 43.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -168.9 157.75 8.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 -179.839 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -89.56 49.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.168 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -108.72 -171.99 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.721 179.807 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -69.41 -66.79 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -131.82 -79.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 179.921 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.811 HD13 HG21 ' A' ' 30' ' ' THR . 8.6 mm -97.68 163.0 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.091 179.834 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.5 ' N ' HG22 ' A' ' 13' ' ' ILE . 71.5 p -90.27 142.58 27.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.212 179.442 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -52.94 136.68 34.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.695 -179.213 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 15' ' ' SER . 1.0 OUTLIER 84.77 -36.55 0.05 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.08 179.442 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.927 HD13 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -59.74 -52.64 64.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 -179.582 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -45.63 -67.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.588 -179.488 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.33 -40.58 35.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.495 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.656 ' CD1' HG23 ' A' ' 106' ' ' VAL . 60.0 mt -65.88 -67.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.37 -179.717 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.927 HD11 HD13 ' A' ' 17' ' ' LEU . 1.1 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.926 0.394 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.55 -31.32 66.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 tt0 -85.0 -36.04 21.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.513 179.716 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.649 ' CD ' HD21 ' A' ' 110' ' ' LEU . 78.5 mm-40 -78.16 -39.13 41.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.918 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.43 30.28 5.98 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.632 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.411 ' HB2' HD23 ' A' ' 21' ' ' LEU . 40.1 m-85 -89.6 -175.56 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 3' ' ' ARG . 0.2 OUTLIER -140.06 94.84 8.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 179.81 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.702 ' HG3' HD13 ' A' ' 21' ' ' LEU . 72.1 Cg_endo -77.45 134.2 13.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.501 2.134 . . . . 0.0 112.818 -179.514 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 30' ' ' THR . 2.9 t0 -103.66 -12.01 17.3 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.414 0.626 . . . . 0.0 111.618 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.811 HG21 HD13 ' A' ' 13' ' ' ILE . 71.5 p 44.07 175.3 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.832 179.353 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.797 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . . . -158.75 -166.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.438 179.833 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 33' ' ' THR . 22.9 mtpt -129.48 -37.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 32' ' ' LYS . 4.2 p -163.07 178.24 8.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.304 179.828 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.743 HD22 ' CD2' ' A' ' 63' ' ' PHE . 85.6 mt -62.36 -41.45 98.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 110.536 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.96 48.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.142 0.496 . . . . 0.0 109.785 178.962 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.79 -29.63 70.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.205 179.036 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -75.33 -22.04 57.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.946 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . 13.9 mt-10 -75.46 -41.52 55.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.897 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.3 -37.38 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.061 178.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -72.52 -30.07 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.744 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 37' ' ' ALA . 36.9 mt -89.44 -23.13 6.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.906 179.671 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -81.07 -0.29 39.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.493 179.941 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -117.36 -41.33 2.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.942 0.401 . . . . 0.0 110.681 179.789 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.685 HD11 ' NH1' ' A' ' 3' ' ' ARG . 0.3 OUTLIER -116.26 156.03 27.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.174 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.421 ' N ' ' HG ' ' A' ' 44' ' ' LEU . 8.1 t80 -96.55 94.95 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.726 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.626 ' CZ ' HD13 ' A' ' 5' ' ' LEU . 26.3 m-85 -78.18 124.8 85.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 73.8 Cg_endo -74.72 -29.33 8.86 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.402 2.068 . . . . 0.0 111.928 179.616 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.634 ' HB ' HG13 ' A' ' 4' ' ' VAL . 3.7 t -142.86 129.01 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.446 -179.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.682 HD12 HD23 ' A' ' 5' ' ' LEU . 26.8 mm -111.71 151.31 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.91 179.124 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.46 HG21 ' CZ ' ' A' ' 109' ' ' PHE . 46.6 t -144.19 100.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.0 111.752 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HB3' HG13 ' A' ' 78' ' ' VAL . 7.2 tp -75.28 175.02 8.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.038 179.339 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.631 ' C ' HG22 ' A' ' 80' ' ' THR . 2.6 t70 -146.41 -52.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.568 -179.543 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 53' ' ' VAL . 61.5 t 61.82 50.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.052 0.454 . . . . 0.0 110.47 -179.562 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -71.16 -82.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.799 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.514 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -76.06 -48.64 3.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 55' ' ' MET . 96.7 Cg_endo -77.73 -173.18 1.7 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.436 2.091 . . . . 0.0 112.619 -179.518 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HA ' HG13 ' A' ' 53' ' ' VAL . 67.4 m-20 -158.28 47.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.671 179.844 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.03 166.77 3.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.656 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -82.97 74.05 9.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.26 -22.39 36.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.692 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 90' ' ' LYS . 32.7 t -54.26 -41.7 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.916 0.389 . . . . 0.0 111.496 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.35 4.96 44.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.538 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.743 ' CD2' HD22 ' A' ' 34' ' ' LEU . 8.0 t80 -90.03 -37.07 14.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.58 0.229 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -45.15 -44.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.908 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.84 -47.45 83.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 42.5 t80 -55.22 -31.46 61.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.005 179.244 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.834 HG21 HG22 ' A' ' 76' ' ' VAL . 3.8 mm -66.25 -53.42 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.184 179.145 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -71.93 -19.98 61.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.369 179.206 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.432 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 20.0 tt0 -67.08 -50.0 63.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.538 179.588 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.475 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -113.98 19.67 16.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.135 -179.812 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.35 67.92 1.05 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.42 -16.03 22.0 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.781 2.321 . . . . 0.0 112.302 -179.898 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.61 31.12 6.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -112.99 -159.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.523 ' HB ' HG13 ' A' ' 48' ' ' VAL . 52.6 t -148.07 135.68 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.371 0.605 . . . . 0.0 112.251 179.453 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.834 HG22 HG21 ' A' ' 67' ' ' ILE . 24.7 t -105.44 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.514 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 97' ' ' TYR . 16.6 mm -120.23 44.25 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.997 179.677 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.636 HG23 HG12 ' A' ' 76' ' ' VAL . 57.4 t -46.52 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.665 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.638 HG23 ' HB3' ' A' ' 100' ' ' LEU . 20.8 mt -74.2 -107.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.35 -179.639 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.631 HG22 ' C ' ' A' ' 52' ' ' ASP . 1.0 OUTLIER 71.24 110.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.65 -179.865 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.84 -105.8 0.39 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.603 -179.756 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 166.91 1.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.816 0.341 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.69 -66.0 0.57 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.1 t -177.63 109.55 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 179.96 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m -62.13 -21.95 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.233 179.841 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.87 -8.55 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.473 179.997 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.42 HG23 ' CZ ' ' A' ' 99' ' ' PHE . 0.8 OUTLIER -81.62 -33.64 31.34 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.067 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.819 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -60.74 -57.65 11.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.125 178.998 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.62 -22.64 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.538 ' O ' HG13 ' A' ' 61' ' ' VAL . 5.1 ttmt -91.29 25.89 2.4 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.874 0.369 . . . . 0.0 110.772 179.606 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.2 -40.33 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.085 -179.818 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.931 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 5.3 pt -71.86 -43.91 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.172 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 92' ' ' ILE . 2.2 ttmt -63.13 -22.77 67.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -71.65 -28.37 63.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.076 179.901 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.01 -19.7 0.35 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.32 179.971 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -50.73 176.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.001 0.401 . . . . 0.0 111.318 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.704 ' HE2' HG23 ' A' ' 112' ' ' THR . 32.5 t80 -98.98 28.5 4.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.477 -179.582 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.518 ' HA ' ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER 79.82 147.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.135 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 1.1 m-85 -73.85 139.89 45.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.082 -179.72 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.638 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -90.32 130.23 36.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.545 179.708 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' N ' HD13 ' A' ' 100' ' ' LEU . 9.6 mt-10 -49.93 -72.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 179.946 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.48 70.98 1.45 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.801 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' A' ' 104' ' ' PHE . 61.3 Cg_endo -73.01 -6.84 19.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.452 2.101 . . . . 0.0 112.675 -179.837 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.417 ' CD1' ' HG2' ' A' ' 103' ' ' PRO . 47.3 p90 -179.65 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.984 179.798 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 81.0 p -128.22 156.31 43.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.014 -179.874 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.814 HG21 HD23 ' A' ' 17' ' ' LEU . 33.5 m -83.88 6.05 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.68 179.95 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -40.87 -47.36 2.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.819 0.342 . . . . 0.0 111.281 -179.856 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -68.93 -36.11 77.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.0 110.011 179.188 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.61 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 1.9 t80 -56.53 -23.54 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 179.229 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.649 HD21 ' CD ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -63.64 -43.76 95.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.353 179.937 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 111' ' ' LEU . 6.8 mp -54.27 -57.06 12.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 -179.739 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.704 HG23 ' HE2' ' A' ' 97' ' ' TYR . 97.3 m -57.71 -43.25 85.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.61 HD11 ' CZ ' ' A' ' 109' ' ' PHE . 1.8 mm -44.35 -53.38 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.786 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -49.08 -61.6 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -53.64 -28.24 31.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -65.17 -41.47 94.63 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 45.3 m-85 -79.66 -29.78 41.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -55.79 -25.1 39.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 179.974 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -97.51 30.06 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 47' ' ' PRO . 6.1 t80 -102.48 28.32 6.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.988 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.848 0.356 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HA ' ' CE2' ' A' ' 117' ' ' PHE . 3.8 mmtm 60.07 65.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.984 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.459 ' HA ' ' H ' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -117.62 141.5 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 179.989 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 48' ' ' VAL . 41.3 t -126.66 159.87 35.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.942 HD22 ' CD2' ' A' ' 46' ' ' PHE . 35.4 tp -113.12 129.26 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.079 -179.901 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.696 ' HB ' HG22 ' A' ' 30' ' ' THR . 23.5 t -115.62 89.95 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.517 179.916 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 t -83.56 103.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.9 140.2 42.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.703 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.435 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 33.6 t70 -88.45 27.37 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.508 -179.865 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HG3' ' CZ2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -156.14 -175.57 5.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.809 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -121.59 46.6 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 t -103.22 -51.78 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.043 179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.572 HG22 ' CB ' ' A' ' 17' ' ' LEU . 30.2 mm -75.7 -46.01 37.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.077 179.96 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.4 p -57.11 -21.73 34.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.18 -43.41 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.162 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.4 -57.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.07 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.676 ' CD1' HG21 ' A' ' 6' ' ' VAL . 1.8 tm? -46.21 -56.87 5.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -52.86 -45.11 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.769 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.13 96.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.67 179.58 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.771 ' CD1' HG11 ' A' ' 106' ' ' VAL . 5.9 mt -57.59 -65.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 1.4 mt -48.65 -32.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.731 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.26 -29.61 69.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.684 179.489 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -79.27 -34.4 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 109.887 179.441 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.788 ' HG3' HD21 ' A' ' 110' ' ' LEU . 53.4 mm-40 -77.52 -12.11 59.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.114 179.722 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.06 62.71 1.16 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.892 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.46 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 46.3 m-85 -127.22 -172.69 2.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 111.38 -179.319 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.459 ' H ' ' HA ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -135.9 68.43 64.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.498 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 27.1 Cg_exo -60.74 131.09 35.86 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.641 2.227 . . . . 0.0 111.952 179.952 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -109.6 3.31 20.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.266 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.696 HG22 ' HB ' ' A' ' 6' ' ' VAL . 8.7 p 1.87 123.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.74 -162.46 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.487 178.836 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -114.93 -31.63 6.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.16 -168.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.686 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.604 HD22 ' CD2' ' A' ' 63' ' ' PHE . 38.4 mt -63.95 -45.38 89.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -50.68 72.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.259 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.76 -29.64 67.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.49 179.422 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -76.63 -26.31 54.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.95 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HG2' ' CE2' ' A' ' 66' ' ' PHE . 30.8 mt-10 -74.74 -38.47 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.073 0.463 . . . . 0.0 109.931 179.124 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.65 77.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.903 179.036 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -74.67 -35.64 62.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.676 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.519 HD12 ' O ' ' A' ' 37' ' ' ALA . 28.5 mt -84.11 -21.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -18.65 59.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.279 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -129.02 -44.82 1.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.13 120.6 25.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 71' ' ' SER . 52.1 t80 -83.27 88.66 6.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.718 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.942 ' CD2' HD22 ' A' ' 5' ' ' LEU . 20.1 m-85 -79.23 133.37 60.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 46' ' ' PHE . 9.3 Cg_endo -84.55 -20.4 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.815 2.344 . . . . 0.0 111.947 179.204 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.646 HG21 ' CE1' ' A' ' 117' ' ' PHE . 3.3 t -145.25 131.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.59 HG23 HD23 ' A' ' 5' ' ' LEU . 5.1 mm -119.04 156.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.483 179.609 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -146.86 101.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 110.764 179.787 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.729 ' HB3' HG13 ' A' ' 78' ' ' VAL . 59.8 tp -88.94 108.14 19.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.825 -179.255 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.06 91.32 7.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.141 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.699 HG22 ' HB ' ' A' ' 80' ' ' THR . 33.4 m -67.47 68.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.727 -179.154 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.45 ' CG ' ' N ' ' A' ' 55' ' ' MET . 29.0 t90 -67.16 -96.97 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.208 179.426 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.541 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -129.36 41.62 0.76 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.471 0.177 . . . . 0.0 111.27 179.361 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 55' ' ' MET . 91.6 Cg_endo -80.38 -165.98 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.52 2.147 . . . . 0.0 112.286 179.949 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -150.02 46.91 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.85 -179.35 16.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -104.83 95.42 5.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.97 -30.56 63.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 90' ' ' LYS . 21.8 t -56.19 -44.74 80.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.352 -179.93 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 1.89 35.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.507 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 67' ' ' ILE . 11.9 t80 -88.5 -36.37 16.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.801 0.334 . . . . 0.0 111.098 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 61' ' ' VAL . 3.2 mp -47.5 -29.33 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.147 -179.936 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -78.38 -35.62 47.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.637 179.708 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.423 ' CE2' ' HG2' ' A' ' 38' ' ' GLU . 9.0 t80 -58.64 -41.53 86.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.709 HG21 HG22 ' A' ' 76' ' ' VAL . 3.0 mp -61.58 -45.74 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.376 179.5 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -76.63 -20.16 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.75 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.59 -42.25 78.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.828 179.749 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.39 15.4 12.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.193 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.419 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -163.48 67.75 1.66 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.809 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.39 -20.39 36.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.737 2.291 . . . . 0.0 112.232 -179.93 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -103.13 28.02 6.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.79 179.774 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 t -107.56 -156.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.363 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -153.91 137.66 8.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 120.996 0.426 . . . . 0.0 111.406 179.114 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.784 HG12 HG23 ' A' ' 78' ' ' VAL . 13.1 t -119.85 108.46 23.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.373 -179.257 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mm -93.16 -53.7 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.784 HG23 HG12 ' A' ' 76' ' ' VAL . 24.6 t 54.31 94.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 179.702 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.678 HG22 ' H ' ' A' ' 80' ' ' THR . 1.8 mt -94.8 -157.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.847 179.679 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.699 ' HB ' HG22 ' A' ' 53' ' ' VAL . 2.4 m 64.71 82.69 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.8 -173.97 20.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.531 -179.899 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -127.43 -175.08 3.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.4 -28.15 64.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.546 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.4 -35.75 60.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.84 0.352 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 85' ' ' VAL . 15.7 t 63.95 33.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.155 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -95.6 -15.51 22.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 179.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.15 -34.89 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.112 0.482 . . . . 0.0 109.734 179.104 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 92' ' ' ILE . . . -59.16 -58.54 8.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.117 178.895 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.483 ' HA ' HG12 ' A' ' 92' ' ' ILE . 19.7 m -57.53 -28.99 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.215 179.661 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.575 ' O ' HG13 ' A' ' 61' ' ' VAL . 1.5 ttmp? -75.44 -6.61 50.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.442 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.77 -44.33 1.95 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 111.387 -179.772 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.789 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.4 pt -67.89 155.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.924 -179.723 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.454 ' CG ' HG13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER 81.46 -47.27 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 -179.148 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -65.13 -16.83 63.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.495 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.23 -29.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.791 -179.955 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . . . -74.5 176.31 6.95 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 111.31 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 13.4 t80 -102.16 -8.95 20.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.048 -179.983 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 8.5 pt-20 137.03 172.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.778 0.831 . . . . 0.0 110.181 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.552 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -103.67 96.77 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.616 179.687 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 79' ' ' ILE . 13.1 tp -54.98 90.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.282 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -113.81 -18.52 11.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.296 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.416 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 9.2 tttt -55.13 -52.82 68.0 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.122 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.473 ' CG ' HD11 ' A' ' 100' ' ' LEU . 50.1 Cg_exo -56.8 -161.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.524 2.149 . . . . 0.0 112.465 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -154.32 -45.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.805 -180.0 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.98 -73.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.771 HG11 ' CD1' ' A' ' 20' ' ' ILE . 7.6 p 178.78 -37.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -36.07 -44.76 0.39 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.126 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.414 ' HB3' ' HB3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -67.04 -42.36 84.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 0.0 110.734 179.798 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' VAL . 8.4 t80 -53.59 -30.88 44.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.889 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.788 HD21 ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -56.55 -44.2 80.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.3 -179.972 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mp -56.7 -55.16 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.33 -179.701 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.9 m -56.37 -41.85 76.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.409 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 2.1 mm -44.62 -54.48 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 -179.506 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -48.35 -61.31 2.07 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -48.18 -31.87 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.749 179.287 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 113' ' ' ILE . . . -63.56 -36.47 83.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.978 0.418 . . . . 0.0 110.504 179.417 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.646 ' CE1' HG21 ' A' ' 48' ' ' VAL . 48.6 m-85 -83.77 -28.29 28.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 179.853 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -54.32 -24.1 17.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.428 -179.809 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.6 -5.94 47.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.479 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -100.29 35.31 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 stop_ save_